data_2n6g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n6g _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.898 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 23.4 t80 . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 109.094 -0.706 . . . . 74.22 109.094 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -124.49 136.32 53.92 Favored 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 121.366 -0.833 . . . . 74.44 110.65 -169.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.8 t -143.6 131.31 18.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 CA-C-N 114.802 -1.09 . . . . 65.33 110.574 -169.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.649 HD22 ' HB3' ' A' ' 30' ' ' TRP . 43.8 tp -112.78 123.37 50.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.575 -0.739 . . . . 74.02 110.168 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -109.35 177.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.614 -0.514 . . . . 73.44 109.614 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.667 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 27.7 t-20 -144.37 149.87 36.83 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.482 -0.192 . . . . 74.14 110.482 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.46 -28.49 30.69 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.295 0.372 . . . . 75.14 111.741 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.75 20.27 1.83 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.179 -0.464 . . . . 73.32 111.322 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 71.16 10.61 6.82 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.499 0.719 . . . . 73.3 112.211 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.667 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 43.2 mt-30 -74.62 153.36 39.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.601 -0.518 . . . . 70.43 109.601 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -157.36 133.96 9.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 74.11 110.591 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.1 t -171.53 -163.96 0.3 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.534 -0.913 . . . . 70.43 108.534 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.62 166.27 11.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.775 -0.454 . . . . 74.34 109.775 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.649 ' HB3' HD22 ' A' ' 20' ' ' LEU . 32.5 p-90 -128.14 144.73 52.75 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.542 -0.299 . . . . 75.52 110.272 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.76 104.72 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.596 2.197 . . . . 54.3 111.605 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.22 -18.72 59.72 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.181 -0.463 . . . . 64.13 111.738 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -92.17 10.66 28.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.107 -0.497 . . . . 72.43 110.866 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.71 179.32 6.65 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.794 0.331 . . . . 42.14 110.76 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -95.5 139.96 31.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.959 -0.564 . . . . 74.13 109.874 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.54 124.03 89.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.575 -0.284 . . . . 74.22 110.404 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.427 ' HG2' ' CD1' ' A' ' 40' ' ' TRP . 29.2 Cg_endo -63.64 146.65 92.65 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.379 2.052 . . . . 74.14 111.789 178.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.04 145.97 28.86 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.126 -0.488 . . . . 34.34 111.075 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.86 -23.39 34.9 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.152 -0.476 . . . . 60.32 111.944 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.517 ' CE3' ' HB2' ' A' ' 22' ' ' ASN . 65.7 m95 -97.04 160.59 14.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.712 0.292 . . . . 74.51 110.221 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -132.64 125.58 30.69 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.911 -0.774 . . . . 64.44 108.911 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.05 114.09 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.481 -0.563 . . . . 73.31 109.481 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.8 m -86.92 -21.37 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.368 0.604 . . . . 73.33 110.417 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -153.78 129.4 10.0 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.342 -0.845 . . . . 73.35 109.347 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.08 -178.85 45.82 Favored Glycine 0 C--N 1.336 0.546 0 O-C-N 124.15 0.907 . . . . 61.03 112.122 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.68 145.09 50.54 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.855 0.359 . . . . 74.34 111.623 -174.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.25 -178.34 6.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.782 -0.644 . . . . 73.41 110.54 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -79.3 167.98 20.17 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 116.2 -0.455 . . . . 61.52 111.452 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.683 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 41.0 ttm180 -55.88 -33.76 64.88 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 115.989 -0.55 . . . . 74.33 110.941 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -56.32 -48.15 77.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.134 0.493 . . . . 72.03 109.949 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.66 -31.04 71.83 Favored 'General case' 0 C--O 1.26 1.61 0 CA-C-N 115.176 -0.92 . . . . 52.32 111.133 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.898 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 24.9 m -62.05 -50.29 72.57 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.666 -1.152 . . . . 74.52 109.643 173.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.7 mt -59.61 -40.95 89.2 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.614 -0.721 . . . . 74.32 110.463 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 17.6 mm-40 -58.64 -52.81 64.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.441 . . . . 75.13 110.26 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -56.22 -55.35 34.35 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.794 0.294 . . . . 73.43 111.794 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 52' ' ' CYS . 8.8 tt -61.92 -42.83 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 121.076 -0.25 . . . . 72.14 111.539 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.32 -43.89 93.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.263 0.554 . . . . 72.01 110.127 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -72.63 -14.51 61.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.755 -0.657 . . . . 74.42 110.864 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 . . . . . 0 N--CA 1.471 0.583 0 C-N-CA 123.758 0.823 . . . . 71.52 111.23 179.393 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.776 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 3.3 t80 . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 110.663 -0.125 . . . . 74.22 110.663 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.529 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 41.9 p90 -124.37 142.11 51.54 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.284 0.564 . . . . 74.44 110.813 -172.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.597 HG22 HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.37 142.49 5.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-N 115.012 -0.995 . . . . 65.33 110.858 -172.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 40' ' ' TRP . 43.1 tp -120.46 144.58 47.9 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.216 -0.902 . . . . 74.02 111.273 -171.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.35 141.82 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 115.997 -0.547 . . . . 73.44 109.94 173.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 25.3 t-20 -110.01 155.9 21.2 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.507 -0.553 . . . . 74.14 109.507 -176.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.0 -26.64 68.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.9 0.381 . . . . 75.14 111.152 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -86.43 22.88 1.73 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.279 0.562 . . . . 73.32 110.512 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 73.02 6.65 5.34 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.404 -0.816 . . . . 73.3 112.397 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.564 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 81.6 mm-40 -71.96 117.74 13.95 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.194 -0.669 . . . . 70.43 109.194 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -131.35 127.62 37.99 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.199 -0.313 . . . . 74.11 111.042 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.5 t -173.57 163.13 4.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 70.43 110.329 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.555 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.4 pt? -72.13 130.81 41.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.174 -1.047 . . . . 74.34 108.174 169.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.489 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 33.4 p-90 -95.87 141.84 23.73 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.529 -0.305 . . . . 75.52 110.917 -173.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 23.0 Cg_exo -64.98 105.32 0.66 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.616 2.21 . . . . 54.3 111.275 177.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.489 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -58.61 -26.89 64.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.965 -0.561 . . . . 64.13 111.66 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -98.63 23.75 8.29 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.096 -0.502 . . . . 72.43 110.968 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . . . -132.96 166.63 21.93 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.013 -0.54 . . . . 42.14 110.764 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -77.25 139.62 39.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 74.13 110.458 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.504 HG13 ' NE1' ' A' ' 40' ' ' TRP . 3.0 t -112.12 106.03 56.24 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.068 -0.515 . . . . 74.22 109.745 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 33.8 Cg_endo -64.85 116.28 3.73 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.124 2.549 . . . . 74.14 112.819 -174.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.84 152.25 0.38 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.12 0.785 . . . . 34.34 113.12 -174.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.13 18.62 6.69 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.827 -0.624 . . . . 60.32 111.817 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.504 ' NE1' HG13 ' A' ' 36' ' ' VAL . 12.3 p-90 -122.41 -173.28 2.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.141 0.496 . . . . 74.51 111.056 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -154.62 126.64 7.71 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.629 -0.878 . . . . 64.44 108.629 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.9 p -90.51 138.78 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.213 -0.449 . . . . 73.31 110.651 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.597 HG23 HG22 ' A' ' 19' ' ' VAL . 27.6 m -100.74 -22.85 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.909 0.385 . . . . 73.33 110.69 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.553 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 39.3 m80 -150.4 132.63 15.44 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.929 -0.578 . . . . 73.35 109.711 176.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.529 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -92.01 176.14 38.86 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 123.758 0.661 . . . . 61.03 112.784 -175.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.37 131.03 10.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.352 0.661 . . . . 74.34 111.232 -174.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.663 ' HB1' ' HA ' ' A' ' 17' ' ' PHE . . . -147.57 178.24 8.62 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.227 0.537 . . . . 73.41 111.566 -174.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -98.18 177.97 5.22 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.826 -0.625 . . . . 61.52 111.819 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.515 ' NH1' HD11 ' A' ' 53' ' ' LEU . 2.4 tmt_? -61.59 -44.71 96.5 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.697 -0.683 . . . . 74.33 110.493 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.45 -42.53 67.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.464 0.65 . . . . 72.03 110.028 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.98 -32.69 74.33 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.021 -0.991 . . . . 52.32 110.944 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.776 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 49.0 t -60.22 -51.06 71.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.045 -0.525 . . . . 74.52 109.918 173.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.515 HD11 ' NH1' ' A' ' 49' ' ' ARG . 82.0 mt -58.16 -40.16 80.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.522 -0.763 . . . . 74.32 110.8 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.94 -29.02 55.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.074 -0.512 . . . . 75.13 112.213 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.536 ' HB2' ' H ' ' A' ' 17' ' ' PHE . 54.9 t80 -65.43 -52.37 53.7 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.015 -0.428 . . . . 73.43 110.787 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 tt -59.34 -35.77 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 121.011 0.434 . . . . 72.14 110.574 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -70.99 -42.01 70.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.769 -0.65 . . . . 72.01 111.217 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -58.86 -30.22 67.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.713 0.292 . . . . 74.42 110.268 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 . . . . . 0 N--CA 1.466 0.362 0 CA-C-N 115.72 -0.673 . . . . 71.52 111.375 176.028 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.727 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 34.5 t80 . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 109.865 -0.42 . . . . 74.22 109.865 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.542 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 33.8 p90 -124.58 134.43 52.95 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 121.325 -0.86 . . . . 74.44 110.177 -173.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.57 HG23 HG21 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.7 128.85 2.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 115.146 -0.934 . . . . 65.33 111.247 -171.034 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.7 tp -108.54 137.55 46.3 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.608 -1.178 . . . . 74.02 109.946 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 58.4 t -124.95 126.45 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 73.44 110.016 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.749 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 27.2 t-20 -87.41 158.81 18.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.89 -0.411 . . . . 74.14 109.89 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -50.25 -33.28 19.13 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.203 -0.453 . . . . 75.14 112.004 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.58 30.46 0.72 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.207 0.527 . . . . 73.32 111.145 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 67.3 6.58 4.94 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.049 0.539 . . . . 73.3 112.141 174.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.749 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 81.6 mm-40 -63.17 117.81 7.06 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 109.554 -0.535 . . . . 70.43 109.554 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -121.56 111.25 17.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.855 0.36 . . . . 74.11 110.321 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -153.32 156.08 37.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.317 -0.402 . . . . 70.43 110.168 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.54 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.56 154.27 39.17 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.545 -0.539 . . . . 74.34 109.545 172.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 27.9 p-90 -126.16 148.95 65.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.687 -0.233 . . . . 75.52 110.556 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.06 102.57 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.238 1.959 . . . . 54.3 111.112 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . . . -57.06 -18.0 12.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.847 -0.615 . . . . 64.13 111.863 -175.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -102.15 24.47 10.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 72.43 111.215 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.4 172.53 12.58 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.378 -0.373 . . . . 42.14 111.059 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -95.68 139.81 31.4 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.966 -0.561 . . . . 74.13 109.869 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.8 t -88.99 118.73 69.52 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 110.601 -0.148 . . . . 74.22 110.601 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.04 160.0 48.66 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.755 2.304 . . . . 74.14 112.243 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.51 144.7 50.77 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.265 -0.425 . . . . 34.34 110.622 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.25 -18.63 48.25 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 111.55 -0.62 . . . . 60.32 111.55 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -107.61 118.88 37.9 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.93 -0.396 . . . . 74.51 109.93 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -103.41 126.04 50.34 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.695 -0.484 . . . . 64.44 109.695 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.6 p -91.29 134.08 30.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 110.054 -0.35 . . . . 73.31 110.054 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.57 HG21 HG23 ' A' ' 19' ' ' VAL . 29.5 m -99.7 -5.2 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.031 0.443 . . . . 73.33 110.837 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -175.99 130.78 0.24 Allowed 'General case' 0 C--O 1.246 0.872 0 CA-C-N 115.183 -0.917 . . . . 73.35 109.453 167.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -79.0 -171.47 40.52 Favored Glycine 0 C--N 1.338 0.665 0 O-C-N 123.935 0.772 . . . . 61.03 112.846 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -50.66 151.55 2.33 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.509 0.559 . . . . 74.34 112.509 -173.189 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 17' ' ' PHE . . . -161.42 179.19 8.46 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.097 -0.501 . . . . 73.41 112.252 -173.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -97.96 179.43 4.79 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.581 -0.736 . . . . 61.52 112.308 -171.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -56.91 -51.08 70.52 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.702 -0.681 . . . . 74.33 110.406 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.39 -34.19 56.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.412 -0.813 . . . . 72.03 110.186 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 47' ' ' ALA . . . -75.74 -31.59 59.65 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 115.284 -0.871 . . . . 52.32 111.098 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.727 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 56.2 m -58.94 -48.71 80.55 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.933 -0.766 . . . . 74.52 108.933 172.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.74 -36.37 82.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.989 -1.005 . . . . 74.32 110.539 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -62.27 -42.16 99.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.531 . . . . 75.13 110.566 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HB2' ' H ' ' A' ' 17' ' ' PHE . 59.9 t80 -64.51 -50.43 67.4 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.315 -0.402 . . . . 73.43 111.194 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 tt -64.24 -37.36 79.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 120.779 0.323 . . . . 72.14 110.371 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -73.25 -28.35 62.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 72.01 110.361 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.14 -41.52 96.88 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.933 -0.576 . . . . 74.42 109.51 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 . . . . . 0 N--CA 1.467 0.424 0 CA-C-N 115.42 -0.809 . . . . 71.52 111.609 170.582 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.832 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 3.8 t80 . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.203 0.049 . . . . 74.22 110.915 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.814 ' HB3' ' HA ' ' A' ' 46' ' ' GLU . 51.9 p90 -125.15 143.77 50.77 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.14 0.495 . . . . 74.44 111.357 -171.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 43' ' ' VAL . 48.2 t -146.49 133.04 13.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-N 115.077 -0.965 . . . . 65.33 110.331 -175.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.496 ' HB2' ' CE3' ' A' ' 30' ' ' TRP . 57.4 tp -109.2 133.88 52.46 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.694 -0.685 . . . . 74.02 109.847 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 m -120.6 126.27 75.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.705 0.765 . . . . 73.44 110.554 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.573 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 11.3 m120 -93.12 154.09 18.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.074 -0.966 . . . . 74.14 109.228 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -56.69 -24.3 48.09 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.032 0.444 . . . . 75.14 111.097 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -82.15 15.67 2.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.965 -0.562 . . . . 73.32 111.156 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 67.64 6.79 5.22 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.26 0.624 . . . . 73.3 111.477 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.573 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 15.4 mm100 -66.65 119.61 12.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.298 -0.63 . . . . 70.43 109.298 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -111.14 113.06 25.31 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.376 -0.602 . . . . 74.11 109.376 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -150.38 -162.26 1.51 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.16 -0.473 . . . . 70.43 109.985 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.586 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.3 pt? -127.93 172.21 11.1 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.633 -0.506 . . . . 74.34 109.633 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.526 ' CH2' ' HB2' ' A' ' 18' ' ' PHE . 13.1 p90 -135.67 157.8 75.49 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.411 -0.588 . . . . 75.52 109.411 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.653 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 37.4 Cg_exo -57.66 100.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.959 1.772 . . . . 54.3 110.211 171.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.18 -13.59 19.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.636 0.606 . . . . 64.13 112.636 -171.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -103.13 2.72 34.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.837 0.351 . . . . 72.43 110.602 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.653 ' HB1' ' HB2' ' A' ' 31' ' ' PRO . . . -121.61 -175.85 3.18 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.099 -0.5 . . . . 42.14 111.316 -173.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -81.91 137.92 35.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.594 -0.73 . . . . 74.13 110.434 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.5 t -82.34 132.79 51.8 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.934 -0.576 . . . . 74.22 110.022 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.06 132.68 48.84 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.345 2.03 . . . . 74.14 111.293 173.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.23 152.32 45.14 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.256 0.55 . . . . 34.34 112.056 -173.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.02 -35.55 4.6 Favored Glycine 0 N--CA 1.453 -0.193 0 CA-C-N 115.595 -0.73 . . . . 60.32 113.478 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -81.87 175.97 9.96 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.752 0.31 . . . . 74.51 110.694 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -121.92 126.64 49.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.006 0.431 . . . . 64.44 110.967 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.56 126.43 40.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.682 -0.859 . . . . 73.31 108.682 170.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 19' ' ' VAL . 14.7 p -95.83 -23.24 4.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 120.698 -0.401 . . . . 73.33 110.345 -175.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.451 ' ND1' ' O ' ' A' ' 17' ' ' PHE . 45.0 t-80 -158.26 133.42 8.62 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.301 -0.409 . . . . 73.35 110.469 174.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.24 176.86 46.71 Favored Glycine 0 C--N 1.337 0.629 0 O-C-N 124.14 0.9 . . . . 61.03 113.438 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.814 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -78.69 154.84 29.79 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.003 0.742 . . . . 74.34 113.003 -170.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.32 -178.11 5.74 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.802 -0.635 . . . . 73.41 111.065 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.16 170.17 16.81 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.78 0.659 . . . . 61.52 112.78 -173.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 31.9 ttm180 -45.7 -45.72 14.43 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.577 0.751 . . . . 74.33 111.631 176.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.576 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -53.66 -45.0 70.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.351 0.595 . . . . 72.03 109.964 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.99 -30.96 71.22 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 115.172 -0.922 . . . . 52.32 111.102 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.832 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 42.7 t -58.19 -47.47 83.33 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.682 -0.69 . . . . 74.52 109.731 171.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.57 -39.72 94.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.878 -0.601 . . . . 74.32 110.118 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 13.8 mm-40 -59.4 -39.32 83.03 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.121 -0.491 . . . . 75.13 110.742 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -58.68 -47.94 82.79 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.776 0.322 . . . . 73.43 110.668 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.45 -48.7 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.703 0.763 . . . . 72.14 109.623 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -68.85 -26.64 65.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.357 -1.292 . . . . 72.01 111.072 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -65.99 -39.55 90.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.448 . . . . 74.42 109.834 175.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 . . . . . 0 CA--C 1.537 0.45 0 CA-C-N 115.756 -0.656 . . . . 71.52 111.027 177.063 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.523 ' HD1' ' HB2' ' A' ' 55' ' ' TYR . 24.8 t80 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.057 -0.719 . . . . 74.22 109.057 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.432 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 47.6 p90 -141.6 131.02 23.74 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.71 -1.589 . . . . 74.44 106.71 168.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.664 HG22 HG13 ' A' ' 43' ' ' VAL . 2.8 m -156.36 135.49 3.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.539 0.685 . . . . 65.33 110.522 -167.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 8.5 tt -117.31 131.44 56.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.374 -0.83 . . . . 74.02 110.038 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.3 t -104.17 126.08 58.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.397 -0.594 . . . . 73.44 109.397 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.697 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 14.3 m120 -79.94 170.45 16.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.039 -0.528 . . . . 74.14 109.82 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -51.82 -42.17 62.32 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.11 0.481 . . . . 75.14 111.466 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -88.95 28.06 1.24 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.866 -0.606 . . . . 73.32 111.677 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 65.63 15.51 10.07 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.117 0.567 . . . . 73.3 111.734 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.697 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 56.0 tt0 -68.58 131.11 44.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 70.43 110.072 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -90.52 118.24 29.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.642 0.258 . . . . 74.11 110.658 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 m -144.46 -175.51 4.67 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.15 -0.477 . . . . 70.43 110.149 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.452 ' N ' HD23 ' A' ' 29' ' ' LEU . 1.7 pt? -142.33 135.43 28.68 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.439 -0.578 . . . . 74.34 109.439 173.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.432 ' CH2' ' HB2' ' A' ' 18' ' ' PHE . 4.8 p90 -85.31 152.02 57.41 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 75.52 110.114 -176.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.98 104.72 0.4 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.95 1.767 . . . . 54.3 110.169 171.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.69 -15.43 7.8 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.099 0.407 . . . . 64.13 112.099 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -92.07 6.79 45.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 72.43 111.024 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.94 179.49 6.31 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.897 0.38 . . . . 42.14 111.122 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -87.05 139.79 30.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.668 -0.696 . . . . 74.13 110.125 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.5 129.39 94.19 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.114 -0.494 . . . . 74.22 110.899 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.86 141.04 93.55 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.697 2.265 . . . . 74.14 111.841 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.98 147.41 52.47 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.023 -0.535 . . . . 34.34 111.56 -175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.43 -25.95 25.79 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.757 -0.656 . . . . 60.32 112.981 176.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -82.86 -177.42 6.74 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.816 0.341 . . . . 74.51 110.111 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 41' ' ' ARG . 50.7 ttt-85 -145.27 126.5 14.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.335 -0.393 . . . . 64.44 110.008 173.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 54.8 t -80.42 123.37 37.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.264 -0.643 . . . . 73.31 109.264 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.664 HG13 HG22 ' A' ' 19' ' ' VAL . 7.1 p -88.77 -19.11 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.198 0.523 . . . . 73.33 110.107 -175.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -157.53 121.89 4.3 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.029 -0.73 . . . . 73.35 109.029 171.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.66 -179.34 52.81 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.29 -0.481 . . . . 61.03 112.986 -174.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -53.72 138.73 34.52 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.824 -0.436 . . . . 74.34 109.824 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.8 -178.01 6.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.873 1.064 . . . . 73.41 113.873 -167.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.401 ' CG ' ' N ' ' A' ' 49' ' ' ARG . 14.0 t70 -91.14 175.09 7.07 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.513 -1.222 . . . . 61.52 111.528 -176.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.91 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 59.1 ttt180 -57.88 -27.86 63.66 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 122.327 -0.233 . . . . 74.33 111.052 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.87 -41.37 67.44 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.278 -0.638 . . . . 72.03 109.278 173.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 17' ' ' PHE . . . -75.81 -31.17 59.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.352 -0.84 . . . . 52.32 111.018 175.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.91 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 61.3 m -54.8 -55.05 34.39 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.565 0.697 . . . . 74.52 110.253 172.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.3 mt -64.68 -23.16 67.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.989 -1.005 . . . . 74.32 110.557 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 40.7 tt0 -71.73 -49.82 35.8 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.069 -0.514 . . . . 75.13 111.257 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.523 ' HB2' ' HD1' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -52.53 -40.93 63.03 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 111.98 0.363 . . . . 73.43 111.98 -175.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 tt -69.57 -39.0 77.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 120.879 0.371 . . . . 72.14 110.887 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -71.64 -34.0 69.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 72.01 110.899 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 59' ' ' HIS . 7.4 mm-40 -67.07 -13.91 62.39 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.853 -0.612 . . . . 74.42 111.639 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.481 ' HB3' ' O ' ' A' ' 58' ' ' GLU . 21.6 t-80 . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 121.6 0.714 . . . . 71.52 109.843 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.662 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 56.4 m-85 . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 113.063 0.764 . . . . 74.22 113.063 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -151.23 130.51 12.79 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.279 -1.378 . . . . 74.44 107.279 149.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.482 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 31.2 t -157.19 120.14 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.965 0 CA-C-O 121.081 0.467 . . . . 65.33 112.036 -173.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.436 HD13 HG23 ' A' ' 42' ' ' VAL . 64.6 tp -96.14 128.99 43.54 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.646 -0.706 . . . . 74.02 109.317 171.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 58.2 t -120.85 125.95 74.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.22 0.533 . . . . 73.44 110.302 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -85.66 153.2 22.52 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.168 -0.679 . . . . 74.14 109.168 175.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.34 -9.78 20.08 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.657 0.741 . . . . 75.14 109.535 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -79.79 7.58 8.39 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.943 -1.026 . . . . 73.32 110.174 173.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 72.23 7.02 5.66 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.47 0.708 . . . . 73.3 111.951 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 68.6 mt-30 -70.48 120.11 15.65 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 108.864 -0.791 . . . . 70.43 108.864 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -128.88 104.11 7.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.674 0.273 . . . . 74.11 110.688 -174.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.7 t -166.36 -169.43 1.41 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.722 0.296 . . . . 70.43 110.739 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 pp -71.12 172.88 8.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.12 -0.491 . . . . 74.34 111.511 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -153.21 156.13 32.35 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.552 -0.295 . . . . 75.52 110.739 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.22 93.46 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.432 2.088 . . . . 54.3 111.262 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.17 -1.71 3.52 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.23 0.455 . . . . 64.13 112.23 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -81.7 2.33 30.24 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.624 -0.262 . . . . 72.43 111.227 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.46 174.08 10.98 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.68 0.276 . . . . 42.14 110.782 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -87.99 139.98 29.96 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.058 -0.519 . . . . 74.13 109.981 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -59.39 119.93 43.8 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.964 -0.562 . . . . 74.22 111.412 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.85 138.82 82.96 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.611 2.207 . . . . 74.14 111.883 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.37 127.73 33.45 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.913 -0.585 . . . . 34.34 111.473 -177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.9 -23.43 13.05 Favored Glycine 0 C--N 1.33 0.223 0 CA-C-N 115.955 -0.566 . . . . 60.32 112.653 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -92.57 152.74 19.44 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.718 -0.283 . . . . 74.51 110.377 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.407 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 2.3 mmp_? -123.67 126.34 46.39 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.908 -0.405 . . . . 64.44 109.908 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.453 HG13 ' HA2' ' A' ' 45' ' ' GLY . 19.0 t -85.61 116.73 29.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.522 -0.918 . . . . 73.31 108.522 175.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.482 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 13.6 p -79.11 -29.98 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.411 0.624 . . . . 73.33 109.757 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -144.12 115.37 7.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.802 -1.184 . . . . 73.35 107.802 172.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.453 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . -61.77 163.67 23.49 Favored Glycine 0 CA--C 1.509 -0.314 0 O-C-N 123.7 0.625 . . . . 61.03 113.54 -172.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -61.67 137.73 58.26 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.683 -0.488 . . . . 74.34 109.683 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.32 -177.82 4.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.807 -0.633 . . . . 73.41 110.479 -173.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.6 151.33 6.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.073 -0.512 . . . . 61.52 110.343 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.746 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 18.6 ttm180 -48.51 -39.54 23.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.957 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 54' ' ' GLU . . . -63.96 -39.53 94.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.372 -0.376 . . . . 72.03 111.352 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.24 -33.34 59.19 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 120.925 0.393 . . . . 52.32 111.943 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.746 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 16.2 p -73.51 -42.83 61.28 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.796 -0.638 . . . . 74.52 110.501 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 57.2 mt -65.77 -28.68 69.2 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.09 0.472 . . . . 74.32 110.096 174.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 13.3 tp10 -75.27 -33.07 61.21 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.006 -0.543 . . . . 75.13 110.048 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.662 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 9.5 t80 -45.96 -60.19 2.4 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.415 0.524 . . . . 73.43 112.415 173.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.8 tt -56.28 -40.96 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 120.708 0.289 . . . . 72.14 111.319 -173.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.46 -30.68 63.34 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.028 0.442 . . . . 72.01 110.6 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.14 -34.48 77.71 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.873 -0.603 . . . . 74.42 109.85 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 . . . . . 0 N--CA 1.47 0.56 0 CA-C-N 115.445 -0.798 . . . . 71.52 112.259 175.092 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.667 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 2.4 t80 . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 110.151 -0.314 . . . . 74.22 110.151 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 27.5 p90 -123.94 136.73 54.51 Favored 'General case' 0 CA--C 1.509 -0.624 0 O-C-N 121.632 -0.668 . . . . 74.44 110.05 -170.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.557 HG22 ' HB ' ' A' ' 43' ' ' VAL . 23.4 m -144.56 129.18 13.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 114.88 -1.054 . . . . 65.33 111.551 -168.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.494 HD12 HG22 ' A' ' 36' ' ' VAL . 54.3 tp -106.78 132.5 52.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.005 -0.998 . . . . 74.02 109.163 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.02 126.38 75.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.925 0.393 . . . . 73.44 110.861 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -78.41 144.86 35.5 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.773 -0.825 . . . . 74.14 108.773 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -59.87 -18.27 43.11 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.891 0.377 . . . . 75.14 110.711 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.59 4.73 3.63 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.796 -0.638 . . . . 73.32 111.255 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 72.0 56.05 0.17 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.099 0.56 . . . . 73.3 111.357 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -143.16 131.57 22.22 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.654 -0.703 . . . . 70.43 109.608 175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -100.92 139.24 36.89 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.784 0.326 . . . . 74.11 110.735 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.8 m -154.92 -172.72 4.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.293 -0.632 . . . . 70.43 109.293 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.75 162.51 15.67 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.741 -0.466 . . . . 74.34 109.741 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.41 ' HH2' ' HA2' ' A' ' 45' ' ' GLY . 3.7 p90 -137.32 160.22 66.45 Favored Pre-proline 0 C--O 1.234 0.264 0 N-CA-C 109.613 -0.514 . . . . 75.52 109.613 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.6 97.86 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.04 1.827 . . . . 54.3 111.024 172.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . . . -53.23 -24.28 10.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.009 -0.541 . . . . 64.13 112.341 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -92.83 29.86 1.71 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.271 -0.422 . . . . 72.43 111.043 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.5 158.85 43.77 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.296 -0.411 . . . . 42.14 110.546 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.56 129.82 36.66 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.191 -0.459 . . . . 74.13 110.402 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.494 HG22 HD12 ' A' ' 20' ' ' LEU . 7.7 p -91.87 131.31 35.79 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 116.273 -0.421 . . . . 74.22 111.317 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.17 177.91 4.71 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.909 2.406 . . . . 74.14 113.047 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.12 152.07 43.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.538 -0.755 . . . . 34.34 110.763 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.13 -35.33 4.63 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.303 -0.719 . . . . 60.32 111.303 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -100.88 100.76 11.45 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.782 -0.821 . . . . 74.51 108.782 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -93.3 126.57 38.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.868 0.365 . . . . 64.44 110.589 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.0 p -83.69 128.52 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.039 -0.356 . . . . 73.31 110.039 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.557 ' HB ' HG22 ' A' ' 19' ' ' VAL . 93.4 t -89.7 -43.33 14.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.9 0.381 . . . . 73.33 110.221 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -139.22 132.8 30.42 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 109.18 -0.674 . . . . 73.35 109.18 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -79.69 -176.26 48.95 Favored Glycine 0 C--N 1.335 0.507 0 O-C-N 124.334 1.022 . . . . 61.03 112.964 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -46.35 144.33 2.13 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.703 0.631 . . . . 74.34 112.703 -174.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.56 ' HB1' ' HA ' ' A' ' 17' ' ' PHE . . . -151.36 -178.04 6.42 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.326 0.491 . . . . 73.41 112.326 -170.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.412 ' O ' ' HB1' ' A' ' 51' ' ' ALA . 3.7 m-20 -96.67 171.4 8.56 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.911 0.863 . . . . 61.52 112.924 -171.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.73 ' HD3' ' SG ' ' A' ' 52' ' ' CYS . 6.4 tpp180 -56.67 -45.82 81.49 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 114.867 -1.06 . . . . 74.33 110.294 173.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -57.21 -34.23 68.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.463 0.649 . . . . 72.03 110.098 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 48' ' ' ASP . . . -72.46 -33.06 66.77 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-N 115.277 -0.874 . . . . 52.32 111.622 -177.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.73 ' SG ' ' HD3' ' A' ' 49' ' ' ARG . 22.4 p -71.56 -38.83 70.95 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.308 -0.405 . . . . 74.52 110.387 172.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 92.0 mt -60.14 -35.85 76.21 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.981 -0.554 . . . . 74.32 110.449 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 42.1 mt-10 -77.07 -39.23 50.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.301 -0.409 . . . . 75.13 110.641 176.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -55.65 -48.19 75.39 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.69 0.256 . . . . 73.43 111.69 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.0 tt -62.92 -45.3 99.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 120.811 0.338 . . . . 72.14 111.145 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -60.98 -48.0 83.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.983 -0.553 . . . . 72.01 110.326 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -58.71 -34.66 71.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.822 -0.627 . . . . 74.42 110.25 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 N--CA 1.463 0.195 0 CA-C-N 115.596 -0.729 . . . . 71.52 110.226 -178.535 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.457 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 65.1 t80 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 121.311 0.577 . . . . 74.22 109.963 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.447 ' HB2' ' HE1' ' A' ' 30' ' ' TRP . 48.0 p90 -136.36 131.42 34.23 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.931 -1.507 . . . . 74.44 106.931 167.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.7 t -146.33 138.66 19.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 CA-C-O 121.263 0.554 . . . . 65.33 111.229 -167.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.75 ' HB2' ' HB3' ' A' ' 30' ' ' TRP . 33.8 tp -117.06 130.44 56.67 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.872 -1.058 . . . . 74.02 110.273 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.72 126.4 72.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.157 0.503 . . . . 73.44 110.216 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 52.8 t-20 -85.52 149.48 25.35 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.211 -0.663 . . . . 74.14 109.211 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 22' ' ' ASN . 27.4 t70 -56.44 -26.49 53.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.218 0.533 . . . . 75.14 110.174 176.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -80.69 15.9 1.57 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.596 -0.729 . . . . 73.32 111.589 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 73.68 18.75 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.582 0.753 . . . . 73.3 112.452 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 14.9 mm100 -77.24 129.78 36.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.512 -0.551 . . . . 70.43 109.512 173.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -123.88 108.53 12.55 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.564 0.221 . . . . 74.11 110.817 -175.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -154.91 -163.63 1.61 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.181 -0.303 . . . . 70.43 110.181 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.681 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.3 pt? -109.66 159.16 17.37 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.382 -0.599 . . . . 74.34 109.382 175.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.75 ' HB3' ' HB2' ' A' ' 20' ' ' LEU . 11.7 p-90 -112.05 148.26 38.65 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 120.557 0.218 . . . . 75.52 110.849 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.18 94.41 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.368 2.045 . . . . 54.3 110.847 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.88 -18.28 12.58 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.858 -0.61 . . . . 64.13 111.682 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -85.02 2.24 44.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 72.43 110.668 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.17 176.88 8.26 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.183 -0.462 . . . . 42.14 110.906 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.51 139.85 30.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.465 . . . . 74.13 110.067 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.7 124.41 90.87 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.308 -0.406 . . . . 74.22 110.052 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.42 -171.67 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.906 2.404 . . . . 74.14 112.797 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.48 145.63 30.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 34.34 110.974 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.23 -32.66 5.77 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.248 -0.433 . . . . 60.32 112.415 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.461 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 16.8 m95 -86.0 136.94 33.06 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.489 -0.56 . . . . 74.51 109.489 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.461 ' HD2' ' O ' ' A' ' 40' ' ' TRP . 16.0 mmm180 -121.51 126.48 49.33 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.257 -0.645 . . . . 64.44 109.257 176.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.0 p -85.9 132.78 31.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.343 -0.243 . . . . 73.31 110.343 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.95 -37.51 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.069 0.461 . . . . 73.33 110.069 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -148.19 132.14 17.15 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.652 -0.703 . . . . 73.35 109.682 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.0 -175.15 45.36 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.111 -0.796 . . . . 61.03 111.111 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -54.86 133.64 47.9 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.884 0.342 . . . . 74.34 110.281 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.63 -177.58 4.93 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.665 0.617 . . . . 73.41 112.665 -168.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.22 165.89 1.28 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.981 -1.009 . . . . 61.52 112.601 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 0.2 OUTLIER -60.75 -29.08 69.17 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.891 -0.595 . . . . 74.33 109.682 174.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.508 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -58.18 -46.89 84.97 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.348 -0.612 . . . . 72.03 109.348 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.83 -30.86 71.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.335 -0.848 . . . . 52.32 110.725 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 49' ' ' ARG . 54.1 t -58.4 -49.04 78.7 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.849 -0.426 . . . . 74.52 109.849 170.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.9 mt -67.75 -27.15 66.54 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.799 -0.637 . . . . 74.32 110.494 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 43.5 mt-10 -76.89 -36.69 56.52 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 116.236 -0.438 . . . . 75.13 111.649 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.457 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 1.9 t80 -61.86 -47.8 83.37 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.956 0.343 . . . . 73.43 110.798 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 tt -63.78 -41.84 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.73 -0.214 . . . . 72.14 110.932 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.31 -34.19 65.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.762 0.315 . . . . 72.01 111.183 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.23 -25.5 68.09 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.307 0.575 . . . . 74.42 109.47 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 . . . . . 0 C--O 1.233 0.187 0 CA-C-N 115.134 -0.939 . . . . 71.52 110.732 176.513 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.745 ' CD1' ' HB2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 112.444 0.535 . . . . 74.22 112.444 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.411 ' CB ' ' HA ' ' A' ' 46' ' ' GLU . 27.7 p90 -124.26 135.98 53.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.474 -0.784 . . . . 74.44 108.956 -173.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.426 HG22 ' CZ ' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -142.07 129.5 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.055 -0.52 . . . . 65.33 111.896 -167.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.599 HD23 ' HB3' ' A' ' 30' ' ' TRP . 49.5 tp -100.31 125.62 46.55 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.252 -0.886 . . . . 74.02 109.123 172.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 41' ' ' ARG . 12.2 p -109.26 126.34 66.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.24 0.543 . . . . 73.44 109.807 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -94.47 148.33 22.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.72 -0.673 . . . . 74.14 110.671 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.404 ' HB3' ' HZ3' ' A' ' 40' ' ' TRP . 15.3 t70 -56.06 -20.86 18.75 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.354 0.597 . . . . 75.14 110.199 174.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -73.55 3.72 5.83 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.262 -0.881 . . . . 73.32 111.531 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 63.31 56.83 1.63 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.37 0.605 . . . . 73.3 110.586 -175.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -137.93 132.55 32.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.251 -0.886 . . . . 70.43 109.171 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.8 109.12 16.7 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.13 0.491 . . . . 74.11 110.333 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.3 t -145.96 -167.77 2.81 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.564 -0.532 . . . . 70.43 109.564 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 pp -107.61 158.63 17.08 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.27 -0.27 . . . . 74.34 110.27 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.599 ' HB3' HD23 ' A' ' 20' ' ' LEU . 18.2 p-90 -111.79 153.24 44.48 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.453 -0.34 . . . . 75.52 110.431 -175.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.73 102.83 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.157 1.905 . . . . 54.3 110.979 175.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.09 -7.01 2.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.522 0.934 . . . . 64.13 113.522 -171.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -107.23 10.13 29.97 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.256 -0.278 . . . . 72.43 110.962 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.453 ' O ' ' HZ3' ' A' ' 30' ' ' TRP . . . -124.48 169.89 11.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.426 -0.352 . . . . 42.14 110.574 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.45 139.56 30.59 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.124 -0.324 . . . . 74.13 110.124 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.0 t -74.64 120.93 83.9 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.557 -0.292 . . . . 74.22 110.513 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.65 137.67 70.33 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.461 2.108 . . . . 74.14 111.436 175.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.73 134.94 57.5 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.46 -0.336 . . . . 34.34 110.571 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.31 -35.15 4.59 Favored Glycine 0 CA--C 1.511 -0.211 0 N-CA-C 111.062 -0.815 . . . . 60.32 111.062 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.404 ' HZ3' ' HB3' ' A' ' 23' ' ' ASP . 3.7 m95 -92.5 143.89 25.9 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.043 -1.095 . . . . 74.51 108.043 173.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.406 ' O ' HG12 ' A' ' 21' ' ' VAL . 44.6 ttm105 -141.22 133.7 28.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.96 0.41 . . . . 64.44 111.517 -174.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.2 t -85.49 121.09 36.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.959 -0.564 . . . . 73.31 110.31 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.42 -37.18 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.8 0.334 . . . . 73.33 110.873 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.409 ' HD2' ' O ' ' A' ' 45' ' ' GLY . 3.6 t-160 -134.67 129.89 35.49 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.226 -0.657 . . . . 73.35 109.226 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.409 ' O ' ' HD2' ' A' ' 44' ' ' HIS . . . -72.47 167.29 53.52 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 124.455 1.097 . . . . 61.03 113.543 -176.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 2.6 mp0 -50.91 128.69 21.83 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.715 0.806 . . . . 74.34 112.488 -171.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -133.18 -178.23 4.88 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.509 -0.768 . . . . 73.41 110.727 -176.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.37 164.57 23.94 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.772 0.796 . . . . 61.52 112.653 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -52.57 -38.37 59.77 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 114.753 -1.112 . . . . 74.33 109.787 173.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.42 -47.6 83.39 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 115.756 -0.656 . . . . 72.03 110.216 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 17' ' ' PHE . . . -59.86 -31.35 69.69 Favored 'General case' 0 C--O 1.258 1.515 0 CA-C-O 121.71 0.766 . . . . 52.32 111.015 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 47.8 t -71.25 -40.88 70.75 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.724 -1.125 . . . . 74.52 110.839 172.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.5 mt -67.66 -26.93 66.45 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.317 0.58 . . . . 74.32 109.796 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -77.11 -37.39 54.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.526 -0.761 . . . . 75.13 110.141 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.745 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -46.53 -58.04 4.16 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 111.861 0.319 . . . . 73.43 111.861 171.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 tt -60.81 -37.96 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.242 0.544 . . . . 72.14 110.552 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.45 -43.55 93.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.249 -0.887 . . . . 72.01 110.571 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -73.76 -27.95 61.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.868 -0.605 . . . . 74.42 110.106 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 . . . . . 0 CA--C 1.533 0.301 0 CA-C-N 115.185 -0.916 . . . . 71.52 110.121 -176.865 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.673 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.581 0 CA-C-O 120.897 0.379 . . . . 74.22 110.411 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.483 ' HB3' ' HA ' ' A' ' 46' ' ' GLU . 31.2 p90 -122.9 135.93 54.68 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.458 0.647 . . . . 74.44 109.66 -167.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.679 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 18.1 t -135.86 131.99 50.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.83 -1.077 . . . . 65.33 109.694 -167.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.488 ' HB2' ' CD1' ' A' ' 30' ' ' TRP . 29.6 tp -120.92 145.16 47.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.108 -0.497 . . . . 74.02 110.714 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 97.8 t -122.01 125.54 73.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.812 -0.811 . . . . 73.44 108.812 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -82.48 163.55 21.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.826 -0.435 . . . . 74.14 109.826 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -57.38 -31.17 65.53 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.929 0.395 . . . . 75.14 110.719 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -79.18 16.67 0.91 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.429 0.633 . . . . 73.32 110.338 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 65.44 24.62 11.95 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.473 -0.785 . . . . 73.3 111.538 173.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 93.7 mt-30 -78.73 121.19 24.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.789 -0.641 . . . . 70.43 110.104 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -99.15 116.8 32.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.265 -0.272 . . . . 74.11 110.265 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.4 t -166.33 -164.19 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.601 -0.518 . . . . 70.43 109.601 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.65 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.4 pt? -108.32 173.73 6.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.694 -0.484 . . . . 74.34 109.694 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.488 ' CD1' ' HB2' ' A' ' 20' ' ' LEU . 14.7 p-90 -134.6 149.34 70.63 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.693 -0.23 . . . . 75.52 111.163 -175.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.88 108.63 2.62 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.741 2.294 . . . . 54.3 111.703 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.28 -12.16 60.75 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.304 -0.407 . . . . 64.13 112.013 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -104.31 14.53 30.07 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.041 0.448 . . . . 72.43 110.749 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.68 179.96 6.27 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.022 -0.535 . . . . 42.14 110.51 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -79.16 118.9 21.54 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.509 -0.314 . . . . 74.13 110.443 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.613 HG21 ' NE1' ' A' ' 40' ' ' TRP . 7.7 p -96.19 110.38 51.95 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 109.02 -0.733 . . . . 74.22 109.02 173.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.463 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 36.5 Cg_endo -64.3 108.38 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.853 2.369 . . . . 74.14 114.043 -167.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.26 152.53 0.27 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.682 -0.69 . . . . 34.34 112.3 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.78 -8.1 21.83 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.735 -0.666 . . . . 60.32 111.702 -174.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.613 ' NE1' HG21 ' A' ' 36' ' ' VAL . 4.9 p-90 -87.72 -177.61 5.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 122.972 0.509 . . . . 74.51 110.746 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.0 mtt85 -128.95 125.38 37.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.288 -1.005 . . . . 64.44 108.288 171.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 p -91.47 116.63 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.962 0.41 . . . . 73.31 111.162 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.679 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 61.4 t -76.98 -35.36 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.095 0.474 . . . . 73.33 110.288 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -157.02 132.2 9.05 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.632 -0.713 . . . . 73.35 109.828 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -71.31 167.66 51.62 Favored Glycine 0 C--N 1.34 0.773 0 O-C-N 124.337 1.023 . . . . 61.03 112.461 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.483 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -55.45 147.1 18.24 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.389 0.885 . . . . 74.34 113.389 -170.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.614 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -148.99 -178.31 6.3 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.735 -1.12 . . . . 73.41 109.24 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -91.89 172.28 8.57 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.001 0.429 . . . . 61.52 111.357 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -57.8 -32.25 67.37 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.137 -0.483 . . . . 74.33 110.117 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.7 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -52.35 -52.66 52.14 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 109.343 -0.614 . . . . 72.03 109.343 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.48 ' C ' ' HB3' ' A' ' 17' ' ' PHE . . . -64.26 -31.56 72.8 Favored 'General case' 0 C--O 1.262 1.724 0 CA-C-N 115.439 -0.801 . . . . 52.32 111.274 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.673 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 53.0 t -66.14 -36.53 83.37 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 114.55 -1.204 . . . . 74.52 110.57 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.615 ' O ' HG21 ' A' ' 56' ' ' ILE . 76.0 mt -72.0 -44.39 63.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.52 -0.548 . . . . 74.32 109.52 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.7 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 4.3 mm-40 -62.34 -25.55 67.96 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.417 -0.356 . . . . 75.13 111.12 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.608 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -46.09 -27.17 0.89 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 111.715 0.265 . . . . 73.43 111.715 173.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.615 HG21 ' O ' ' A' ' 53' ' ' LEU . 19.7 tt -60.85 -47.83 91.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 121.477 0.656 . . . . 72.14 110.271 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -73.83 -35.47 64.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.098 -0.955 . . . . 72.01 110.364 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -74.89 -36.35 62.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.0 -1.0 . . . . 74.42 111.361 -172.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 . . . . . 0 N--CA 1.47 0.548 0 CA-C-N 115.845 -0.616 . . . . 71.52 111.63 -179.032 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 114.351 1.241 . . . . 74.22 114.351 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -151.51 130.71 12.73 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.306 -0.998 . . . . 74.44 108.306 150.456 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.43 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 64.0 t -158.1 136.71 3.13 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 CA-C-O 121.128 0.489 . . . . 65.33 112.152 -169.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.4 tp -102.21 122.96 45.21 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.445 -0.798 . . . . 74.02 109.514 174.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.55 125.82 50.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.241 -0.651 . . . . 73.44 109.241 174.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.447 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 14.3 m120 -96.92 139.26 33.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.781 -0.645 . . . . 74.14 110.254 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.72 -15.92 59.75 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.087 0.47 . . . . 75.14 110.843 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -85.24 26.56 0.88 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.031 -0.531 . . . . 73.32 111.078 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 69.8 6.25 5.64 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.314 0.646 . . . . 73.3 111.803 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.447 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 15.7 mm100 -90.86 153.78 19.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.929 0.395 . . . . 70.43 110.45 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -133.37 109.09 9.11 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.394 -0.965 . . . . 74.11 108.394 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.3 t -128.38 177.21 7.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.772 0.796 . . . . 70.43 111.889 -170.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.3 tt -111.71 106.59 15.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.594 -1.185 . . . . 74.34 108.065 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.447 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 25.3 p-90 -77.67 149.49 77.86 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.059 -0.519 . . . . 75.52 111.206 -174.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.89 104.07 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.038 1.825 . . . . 54.3 111.085 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -63.42 -2.15 1.43 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.23 -0.441 . . . . 64.13 111.621 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -89.78 -0.72 57.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 72.43 110.789 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.2 178.0 7.24 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.05 0.452 . . . . 42.14 111.688 -175.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -95.92 140.11 31.15 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.593 -0.731 . . . . 74.13 111.028 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.3 t -91.48 123.95 62.38 Favored Pre-proline 0 C--O 1.236 0.383 0 CA-C-N 116.243 -0.435 . . . . 74.22 111.037 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.54 153.75 73.04 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.616 2.211 . . . . 74.14 111.708 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.05 152.18 38.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.94 0.4 . . . . 34.34 110.714 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.4 -35.53 4.91 Favored Glycine 0 N--CA 1.455 -0.073 0 N-CA-C 111.036 -0.826 . . . . 60.32 111.036 -174.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -95.01 129.21 42.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.757 -1.201 . . . . 74.51 107.757 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -100.12 125.64 46.25 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.622 -0.51 . . . . 64.44 109.622 -171.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.69 117.88 34.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.99 -0.744 . . . . 73.31 108.99 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.43 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 14.4 p -84.16 -23.35 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.681 0.753 . . . . 73.33 109.548 -174.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -148.29 115.48 6.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.036 -0.984 . . . . 73.35 108.714 173.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -69.74 -171.51 8.73 Favored Glycine 0 N--CA 1.447 -0.583 0 O-C-N 123.864 0.728 . . . . 61.03 112.501 -175.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.44 133.88 34.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.146 0.498 . . . . 74.34 111.322 -178.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.87 175.89 9.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.541 -0.754 . . . . 73.41 110.017 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.74 159.58 21.96 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.984 -0.553 . . . . 61.52 111.273 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.557 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 15.7 ttm180 -58.38 -37.72 75.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.242 -0.651 . . . . 74.33 109.242 176.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.74 -36.82 84.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.028 -0.533 . . . . 72.03 110.468 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.02 -38.47 79.22 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-N 115.855 -0.611 . . . . 52.32 111.389 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.557 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 27.0 p -73.44 -47.26 43.06 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.411 -0.813 . . . . 74.52 110.995 174.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 72.8 mt -60.89 -34.5 74.74 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.503 -0.317 . . . . 74.32 110.594 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -76.82 -37.54 55.5 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.885 -0.326 . . . . 75.13 110.54 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -48.26 -58.12 5.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 120.438 -0.505 . . . . 73.43 111.588 170.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 52' ' ' CYS . 3.7 tt -61.65 -38.55 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 120.672 0.272 . . . . 72.14 111.032 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -60.54 -43.49 97.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 72.01 110.51 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -81.94 -14.89 55.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.895 -0.593 . . . . 74.42 111.428 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.4 t60 . . . . . 0 N--CA 1.467 0.378 0 CA-C-N 116.151 -0.477 . . . . 71.52 110.853 174.936 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.597 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 68.5 t80 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.363 0.601 . . . . 74.22 109.843 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -144.44 131.57 20.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.36 -1.348 . . . . 74.44 107.36 169.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -141.79 123.6 13.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.267 0.555 . . . . 65.33 111.003 -170.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.432 HD11 ' HB3' ' A' ' 40' ' ' TRP . 52.2 tp -93.48 127.99 39.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.202 -0.908 . . . . 74.02 109.64 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 61.8 t -121.44 129.16 75.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.232 0.539 . . . . 73.44 110.909 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 33.4 t30 -92.81 151.78 19.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.92 -0.77 . . . . 74.14 108.92 173.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -54.54 -19.94 6.86 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.159 0.504 . . . . 75.14 110.95 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -82.64 20.61 1.1 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.965 -0.561 . . . . 73.32 111.635 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 65.62 12.57 8.34 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.976 0.51 . . . . 73.3 111.849 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 34.6 tt0 -76.03 117.64 17.95 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.341 -0.615 . . . . 70.43 109.341 176.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -122.52 107.95 12.6 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.01 0.434 . . . . 74.11 111.298 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 m -132.38 -168.03 1.99 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.549 -0.75 . . . . 70.43 109.359 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.697 HD21 ' H ' ' A' ' 29' ' ' LEU . 1.9 pt? -106.38 161.63 14.4 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.238 -0.653 . . . . 74.34 109.238 174.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.463 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 20.0 p-90 -131.8 145.03 55.72 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.614 0.245 . . . . 75.52 111.31 -173.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 14.0 Cg_exo -69.86 103.67 1.21 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.727 2.285 . . . . 54.3 111.291 176.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.463 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -60.01 -22.52 62.7 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.14 -0.482 . . . . 64.13 112.03 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -84.88 4.26 34.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.615 -0.266 . . . . 72.43 111.436 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.99 162.44 22.33 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.806 0.336 . . . . 42.14 110.725 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -82.97 132.84 35.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 74.13 110.597 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.97 115.95 62.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 74.22 110.198 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.68 147.1 95.92 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.345 2.03 . . . . 74.14 112.169 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.37 137.76 57.0 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.203 -0.453 . . . . 34.34 110.685 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.42 -35.42 4.55 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.42 -0.672 . . . . 60.32 111.42 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.432 ' HB3' HD11 ' A' ' 20' ' ' LEU . 71.0 m95 -81.37 140.6 34.63 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.581 -0.526 . . . . 74.51 109.581 177.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -127.61 126.13 41.49 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.151 -0.314 . . . . 64.44 110.151 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.6 t -85.21 130.57 35.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.583 -0.525 . . . . 73.31 109.583 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -85.43 -31.33 6.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.228 0.537 . . . . 73.33 109.997 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -154.58 122.95 6.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.924 -0.769 . . . . 73.35 108.924 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.03 -172.41 42.18 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.28 -0.486 . . . . 61.03 112.522 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -61.73 154.52 25.3 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 110.244 -0.28 . . . . 74.34 110.244 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.44 ' HB1' ' CB ' ' A' ' 51' ' ' ALA . . . -160.71 -178.25 6.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.118 0.485 . . . . 73.41 111.762 -175.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -68.91 178.45 2.19 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.954 -1.021 . . . . 61.52 111.9 -175.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -61.15 -27.86 68.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.38 -0.827 . . . . 74.33 110.203 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -51.84 -44.97 63.81 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.162 0.505 . . . . 72.03 110.01 172.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.44 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -75.81 -31.74 59.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.428 -0.806 . . . . 52.32 110.846 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 52.8 t -54.12 -42.01 68.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.042 -0.527 . . . . 74.52 110.067 170.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.06 -29.85 68.91 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.055 -0.52 . . . . 74.32 110.665 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 94.8 mt-10 -70.05 -51.65 30.3 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.445 -0.343 . . . . 75.13 111.039 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.597 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 2.7 t80 -58.48 -41.9 86.34 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.603 -0.271 . . . . 73.43 111.693 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.7 tt -71.03 -45.62 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 121.085 -0.246 . . . . 72.14 111.146 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -64.57 -52.6 56.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.418 -0.356 . . . . 72.01 110.302 -177.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -70.68 -33.14 70.6 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.948 -0.569 . . . . 74.42 110.337 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 . . . . . 0 N--CA 1.472 0.644 0 C-N-CA 123.829 0.852 . . . . 71.52 111.826 -178.873 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.819 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 19.0 t80 . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 109.066 -0.716 . . . . 74.22 109.066 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.643 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 46.1 p90 -125.22 138.15 54.12 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.366 -0.834 . . . . 74.44 111.652 -172.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -142.15 133.81 26.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 114.955 -1.02 . . . . 65.33 110.11 -173.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.633 ' HB2' ' CE3' ' A' ' 30' ' ' TRP . 17.8 tp -120.88 142.67 49.46 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 122.978 0.511 . . . . 74.02 110.754 -174.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.8 147.8 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.619 -0.264 . . . . 73.44 110.356 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -122.72 161.4 23.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.531 -0.304 . . . . 74.14 110.628 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -58.5 -25.46 62.39 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.889 -0.596 . . . . 75.14 111.202 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -83.49 22.93 0.99 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.627 -0.715 . . . . 73.32 111.512 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 65.53 14.25 9.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.879 0.471 . . . . 73.3 111.321 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -86.57 123.08 31.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.497 -0.319 . . . . 70.43 110.534 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -120.56 126.51 50.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.544 -0.539 . . . . 74.11 109.544 176.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 p -164.42 -154.44 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 70.43 110.346 -173.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.508 HD21 ' H ' ' A' ' 29' ' ' LEU . 2.2 pt? -131.85 164.9 25.03 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.122 -0.695 . . . . 74.34 109.122 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.643 ' CH2' ' HB2' ' A' ' 18' ' ' PHE . 20.1 p90 -125.91 147.8 60.32 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-O 120.46 0.172 . . . . 75.52 111.033 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 13.8 Cg_exo -70.0 99.25 0.76 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.552 2.168 . . . . 54.3 111.133 173.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.99 -7.38 8.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.309 -0.405 . . . . 64.13 111.22 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -81.45 -2.46 49.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.985 -0.552 . . . . 72.43 110.706 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.0 177.62 7.84 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.413 -0.358 . . . . 42.14 110.642 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -80.79 138.55 36.27 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.814 -0.439 . . . . 74.13 109.814 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 t -90.45 126.29 56.93 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.138 -0.483 . . . . 74.22 110.45 -175.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' O ' ' HD1' ' A' ' 40' ' ' TRP . 38.6 Cg_endo -66.27 110.92 1.9 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.882 2.388 . . . . 74.14 112.501 -176.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -44.73 150.85 0.32 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.199 0.814 . . . . 34.34 113.199 -172.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.98 23.93 4.75 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.541 -0.754 . . . . 60.32 111.85 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.419 ' HD1' ' O ' ' A' ' 37' ' ' PRO . 25.3 p-90 -130.2 160.08 34.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.897 0.379 . . . . 74.51 111.18 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.41 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 4.6 mmp_? -122.7 127.01 48.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.708 -0.849 . . . . 64.44 108.708 171.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.437 HG22 ' CH2' ' A' ' 30' ' ' TRP . 7.5 p -89.4 119.6 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 120.825 0.345 . . . . 73.31 110.423 -177.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.85 -38.18 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.455 0.645 . . . . 73.33 110.555 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.632 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 26.0 m80 -132.56 136.39 46.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.349 -0.841 . . . . 73.35 108.849 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.43 160.44 22.01 Favored Glycine 0 C--N 1.332 0.334 0 O-C-N 123.525 0.516 . . . . 61.03 112.892 -176.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.67 132.98 54.12 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.843 0.354 . . . . 74.34 111.031 -178.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.5 -177.89 6.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.137 0.494 . . . . 73.41 111.734 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.76 172.71 2.06 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.241 -0.89 . . . . 61.52 112.716 -174.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.439 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 14.6 ttp180 -58.63 -42.91 89.34 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.575 -0.739 . . . . 74.33 111.172 178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.493 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -52.5 -46.5 66.67 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.299 -0.63 . . . . 72.03 109.299 177.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.21 -34.7 78.21 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.019 -0.991 . . . . 52.32 111.081 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.819 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 36.7 m -60.39 -46.14 91.06 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.367 -0.833 . . . . 74.52 109.928 171.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.18 -24.78 62.3 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.486 -0.779 . . . . 74.32 110.561 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 42.1 mt-10 -76.93 -36.95 56.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 75.13 110.844 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -54.82 -50.46 68.53 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.659 0.244 . . . . 73.43 111.659 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.8 -34.89 49.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.032 0.444 . . . . 72.14 110.007 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -73.67 -25.59 60.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.762 -0.654 . . . . 72.01 110.819 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -65.88 -54.62 24.17 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.108 0.48 . . . . 74.42 109.985 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 77.0 t60 . . . . . 0 CA--C 1.534 0.334 0 CA-C-N 115.21 -0.904 . . . . 71.52 109.16 -174.585 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.541 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 1.7 t80 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.968 0.413 . . . . 74.22 110.051 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -140.97 131.18 24.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.321 -1.363 . . . . 74.44 107.321 165.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 43' ' ' VAL . 98.7 t -147.91 129.86 6.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 121.002 0.429 . . . . 65.33 110.345 -170.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 40' ' ' TRP . 46.2 tp -105.42 139.29 40.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.566 -0.743 . . . . 74.02 110.124 -177.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.1 t -118.41 126.09 74.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 109.41 -0.589 . . . . 73.44 109.41 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -95.09 162.54 13.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.295 -0.411 . . . . 74.14 110.007 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.44 -11.9 37.98 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.236 0.541 . . . . 75.14 110.232 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -83.08 9.62 9.96 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.35 -0.841 . . . . 73.32 110.768 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 66.08 9.85 6.56 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.088 0.555 . . . . 73.3 110.65 -174.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.5 HE21 ' HB2' ' A' ' 28' ' ' SER . 48.4 tp60 -74.06 118.27 16.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.118 -0.492 . . . . 70.43 110.171 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -108.71 98.63 8.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.084 -0.507 . . . . 74.11 110.165 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.5 ' HB2' HE21 ' A' ' 26' ' ' GLN . 33.5 t -133.17 -173.17 3.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.354 -0.385 . . . . 70.43 110.06 -175.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.713 HD21 ' H ' ' A' ' 29' ' ' LEU . 2.1 pt? -107.57 147.84 30.06 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.423 -0.584 . . . . 74.34 109.423 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.446 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 43.2 p-90 -116.1 129.43 25.21 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.642 -0.254 . . . . 75.52 110.478 -177.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 33.3 Cg_exo -61.82 108.44 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.472 2.115 . . . . 54.3 111.67 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.446 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -60.59 -18.53 53.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.166 -0.47 . . . . 64.13 111.845 -178.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -93.05 9.41 35.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 72.43 111.285 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.57 175.8 7.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.224 -0.444 . . . . 42.14 110.754 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -95.94 128.49 42.88 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.248 -0.433 . . . . 74.13 110.799 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.499 HG12 ' NE1' ' A' ' 40' ' ' TRP . 3.2 t -91.87 110.78 46.09 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.263 -0.426 . . . . 74.22 110.138 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.43 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 38.5 Cg_endo -67.2 115.67 3.78 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 123.103 2.536 . . . . 74.14 112.582 -176.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -46.12 151.9 0.45 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.189 0.811 . . . . 34.34 113.189 -172.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.2 26.52 3.73 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.408 -0.814 . . . . 60.32 111.741 -175.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.499 ' NE1' HG12 ' A' ' 36' ' ' VAL . 17.2 p-90 -134.74 -178.82 5.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.151 0.5 . . . . 74.51 110.952 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -145.06 126.05 14.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.65 -0.871 . . . . 64.44 108.65 169.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.87 134.65 28.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.078 -0.341 . . . . 73.31 110.078 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 19' ' ' VAL . 9.8 p -89.79 -25.5 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.544 0.688 . . . . 73.33 109.965 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -155.05 121.51 5.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.213 -0.903 . . . . 73.35 109.095 175.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.45 -174.78 50.26 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.188 -0.529 . . . . 61.03 111.955 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.5 112.13 1.48 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.09 0.471 . . . . 74.34 109.857 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.21 -177.78 3.51 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.765 0.654 . . . . 73.41 112.765 -165.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -86.74 179.87 6.69 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.175 -0.92 . . . . 61.52 112.437 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.469 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 32.2 ttm180 -48.48 -41.44 29.75 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.629 -1.169 . . . . 74.33 111.393 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.518 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -52.82 -47.18 67.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.146 0.498 . . . . 72.03 110.094 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 17' ' ' PHE . . . -69.88 -31.17 68.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.564 -0.743 . . . . 52.32 110.838 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 49' ' ' ARG . 53.9 t -56.84 -42.5 79.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.961 0.41 . . . . 74.52 110.164 171.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.44 -26.16 62.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.929 -0.578 . . . . 74.32 111.105 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 52.9 mt-10 -74.94 -53.17 9.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.362 -0.381 . . . . 75.13 111.468 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.541 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 39.7 t80 -60.84 -35.5 76.7 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 111.755 0.28 . . . . 73.43 111.755 -175.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.7 tt -71.23 -41.16 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 120.996 -0.282 . . . . 72.14 111.064 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -73.72 -57.25 4.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.901 0.381 . . . . 72.01 110.913 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -61.22 -31.86 71.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.747 -0.66 . . . . 74.42 110.926 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.8 m80 . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 116.029 -0.532 . . . . 71.52 110.645 -177.849 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.738 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 112.643 0.608 . . . . 74.22 112.643 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.414 ' H ' ' HB2' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -152.45 130.59 11.91 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.989 0.813 . . . . 74.44 109.834 153.229 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -162.85 138.3 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.053 0 CA-C-O 121.242 0.544 . . . . 65.33 111.045 170.546 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.572 ' HB2' ' CD1' ' A' ' 30' ' ' TRP . 32.3 tp -104.19 153.7 20.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.418 -0.81 . . . . 74.02 108.972 175.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.515 HG11 ' O ' ' A' ' 41' ' ' ARG . 9.7 p -136.67 134.23 48.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.952 0.406 . . . . 73.44 110.373 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -73.05 154.76 40.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.875 -0.787 . . . . 74.14 108.875 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -57.13 -23.91 50.53 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.082 0.468 . . . . 75.14 110.512 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.42 13.04 1.69 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.837 -0.619 . . . . 73.32 111.004 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 56.88 56.81 5.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.8 0.81 . . . . 73.3 110.696 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -114.74 119.89 38.21 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.709 -1.132 . . . . 70.43 108.896 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -76.08 132.29 39.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.673 -0.24 . . . . 74.11 110.502 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.8 m -153.74 178.12 10.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.012 0.434 . . . . 70.43 110.741 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.59 ' H ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -124.57 159.83 29.77 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.949 -0.76 . . . . 74.34 108.949 177.131 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.572 ' CD1' ' HB2' ' A' ' 20' ' ' LEU . 6.0 p-90 -145.13 139.49 15.15 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 121.041 -0.264 . . . . 75.52 111.59 -173.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 5.2 Cg_exo -80.14 104.9 1.71 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.072 2.515 . . . . 54.3 110.833 173.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.29 -2.08 1.98 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.467 0.543 . . . . 64.13 112.467 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -91.05 -0.14 57.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.474 0.178 . . . . 72.43 111.36 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.65 170.31 12.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.597 0.237 . . . . 42.14 110.903 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -69.44 126.39 29.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.887 -0.597 . . . . 74.13 110.08 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 t -97.61 113.25 63.22 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.756 -0.461 . . . . 74.22 109.756 -176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 21.0 Cg_endo -60.64 107.23 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.982 2.454 . . . . 74.14 113.334 -172.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.89 151.82 0.42 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.447 0.699 . . . . 34.34 112.655 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.98 5.91 21.3 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.869 -0.605 . . . . 60.32 112.065 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.446 ' CD1' ' O ' ' A' ' 37' ' ' PRO . 18.4 p-90 -107.41 175.66 5.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 74.51 110.867 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.515 ' O ' HG11 ' A' ' 21' ' ' VAL . 15.0 tpp180 -141.61 142.98 33.44 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.26 -1.015 . . . . 64.44 108.26 170.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.2 p -90.68 131.2 38.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.013 -0.366 . . . . 73.31 110.013 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.1 m -99.47 -22.42 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.313 0.578 . . . . 73.33 110.313 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.522 ' HB3' ' HB2' ' A' ' 17' ' ' PHE . 92.1 m-70 -147.63 118.72 7.72 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.224 -1.028 . . . . 73.35 108.224 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.04 165.4 7.1 Favored Glycine 0 C--N 1.332 0.35 0 O-C-N 123.807 0.692 . . . . 61.03 113.481 -172.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.45 151.35 24.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.143 0.497 . . . . 74.34 110.594 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -162.95 -177.98 5.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.948 -0.569 . . . . 73.41 110.465 -175.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -54.18 161.37 1.32 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.234 0.54 . . . . 61.52 112.01 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.685 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 46.1 ttt180 -57.12 -29.81 63.85 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.574 -0.739 . . . . 74.33 110.47 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.42 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -62.25 -47.3 84.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.939 0.4 . . . . 72.03 110.154 174.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.27 -31.4 71.7 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 116.173 -0.467 . . . . 52.32 111.544 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.685 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 16.6 p -73.51 -50.59 20.68 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.711 -0.677 . . . . 74.52 111.244 173.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 78.6 mt -59.09 -34.66 72.25 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.414 0.626 . . . . 74.32 110.346 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 20.2 mm-40 -76.94 -35.19 57.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.72 -0.673 . . . . 75.13 110.485 176.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.738 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -46.33 -52.68 12.31 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 117.847 0.294 . . . . 73.43 111.599 171.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.6 tt -71.18 -36.58 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.661 0.267 . . . . 72.14 111.61 -173.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -73.31 -50.46 22.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.149 0.499 . . . . 72.01 110.498 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -61.47 -27.58 68.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.598 -0.728 . . . . 74.42 109.041 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 . . . . . 0 N--CA 1.463 0.196 0 CA-C-N 114.396 -1.275 . . . . 71.52 112.179 171.697 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.8 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.637 0.256 . . . . 74.22 111.543 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.481 ' HB3' ' HA ' ' A' ' 46' ' ' GLU . 28.3 p90 -125.12 137.45 54.18 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.92 0.39 . . . . 74.44 110.434 -173.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.407 HG12 ' CE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -155.14 142.86 12.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 121.567 0.699 . . . . 65.33 111.776 -178.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 30' ' ' TRP . 48.1 tp -105.25 147.99 27.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.194 -1.367 . . . . 74.02 108.8 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.6 144.42 28.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.13 0.49 . . . . 73.44 110.824 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -104.33 153.63 20.81 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.007 -0.738 . . . . 74.14 109.007 175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -57.59 -22.81 47.3 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.811 0.339 . . . . 75.14 111.087 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -77.9 15.4 0.88 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.15 -0.477 . . . . 73.32 111.577 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 67.11 15.81 10.15 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.135 0.574 . . . . 73.3 111.407 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -84.83 119.45 25.33 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.578 -0.527 . . . . 70.43 109.578 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -114.19 136.48 52.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.95 0.405 . . . . 74.11 111.191 -175.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -152.04 -172.12 4.13 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.213 -0.662 . . . . 70.43 109.213 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.664 HD21 ' H ' ' A' ' 29' ' ' LEU . 1.8 pt? -109.04 139.37 44.02 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.452 -0.573 . . . . 74.34 109.452 174.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 20' ' ' LEU . 21.4 p-90 -98.62 155.03 37.2 Favored Pre-proline 0 C--O 1.236 0.345 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.792 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.53 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . 31.1 Cg_exo -62.2 96.16 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.45 2.1 . . . . 54.3 111.012 174.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.39 -23.76 62.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.884 -0.598 . . . . 64.13 111.692 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -95.3 17.44 14.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.112 -0.495 . . . . 72.43 110.894 -178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.53 ' HB2' ' HB2' ' A' ' 31' ' ' PRO . . . -143.39 174.62 10.58 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.8 0.333 . . . . 42.14 110.762 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -92.21 139.88 30.18 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.057 -0.52 . . . . 74.13 110.244 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -76.06 130.91 76.85 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 74.22 110.603 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.4 ' HG2' ' CD1' ' A' ' 40' ' ' TRP . 45.3 Cg_endo -68.52 167.02 23.75 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.454 2.102 . . . . 74.14 112.141 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.94 151.57 47.37 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.969 -0.56 . . . . 34.34 111.548 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.97 -35.85 4.13 Favored Glycine 0 C--N 1.33 0.232 0 CA-C-N 115.65 -0.705 . . . . 60.32 112.342 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.4 ' CD1' ' HG2' ' A' ' 37' ' ' PRO . 41.9 m95 -88.23 145.37 25.91 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.256 -0.276 . . . . 74.51 110.256 -177.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -127.87 128.82 45.85 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.147 -0.316 . . . . 64.44 110.147 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.9 t -80.98 137.6 21.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.985 -0.376 . . . . 73.31 109.985 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.401 HG12 HG23 ' A' ' 19' ' ' VAL . 8.1 p -107.15 -28.98 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.992 0.425 . . . . 73.33 110.839 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.659 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 1.7 m-70 -139.79 138.58 35.97 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.799 -0.445 . . . . 73.35 109.799 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.48 174.81 36.9 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 123.674 0.609 . . . . 61.03 113.367 -173.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -58.99 138.31 57.56 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.127 0.571 . . . . 74.34 111.185 -172.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 17' ' ' PHE . . . -158.99 173.94 15.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.917 0.389 . . . . 73.41 111.493 -175.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -84.25 177.59 8.13 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.717 0.77 . . . . 61.52 112.894 -171.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.443 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 9.0 tpm_? -50.19 -44.29 52.9 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.331 -1.304 . . . . 74.33 111.143 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.31 -52.41 61.6 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 116.144 -0.48 . . . . 72.03 110.64 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.04 72.09 Favored 'General case' 0 C--O 1.263 1.801 0 CA-C-O 121.819 0.818 . . . . 52.32 111.608 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.8 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 73.2 m -72.58 -28.76 63.0 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 114.459 -1.246 . . . . 74.52 110.79 175.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.573 ' O ' HG21 ' A' ' 56' ' ' ILE . 92.6 mt -71.72 -51.96 20.2 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 108.81 -0.811 . . . . 74.32 108.81 169.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.17 -24.17 25.42 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.371 -0.831 . . . . 75.13 111.811 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.582 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -44.39 -31.25 1.0 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 121.118 -0.233 . . . . 73.43 111.276 171.27 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.573 HG21 ' O ' ' A' ' 53' ' ' LEU . 19.8 tt -60.16 -46.47 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.379 0.609 . . . . 72.14 110.455 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -74.37 -43.04 58.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.492 -0.776 . . . . 72.01 110.81 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -50.79 -58.89 4.84 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.302 -0.863 . . . . 74.42 111.956 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.2 m80 . . . . . 0 CA--C 1.533 0.292 0 CA-C-N 115.671 -0.695 . . . . 71.52 111.285 -175.879 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.601 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 114.596 1.332 . . . . 74.22 114.596 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -126.48 136.2 52.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 113.924 -1.489 . . . . 74.44 109.766 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.51 ' O ' HG11 ' A' ' 43' ' ' VAL . 54.3 t -147.75 131.44 8.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-O 121.053 0.454 . . . . 65.33 110.1 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.452 HD12 ' HB2' ' A' ' 40' ' ' TRP . 64.9 tp -102.97 137.66 40.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.753 -0.658 . . . . 74.02 110.851 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.1 t -113.04 152.78 14.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.127 -1.064 . . . . 73.44 108.127 171.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.674 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 34.6 t30 -123.57 144.72 49.4 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.572 -0.899 . . . . 74.14 108.572 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -68.5 -7.85 35.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.014 0.435 . . . . 75.14 110.504 -177.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 29.2 tt0 -75.39 4.09 7.93 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.329 -0.85 . . . . 73.32 109.893 168.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 47.6 mt-10 74.16 15.72 3.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.854 0.862 . . . . 73.3 111.693 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.674 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 6.2 tp-100 -76.6 148.75 36.77 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.212 -0.662 . . . . 70.43 109.212 172.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -150.77 114.36 4.93 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.661 0.267 . . . . 74.11 110.626 -177.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.5 t -171.75 175.72 3.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.143 -0.481 . . . . 70.43 109.752 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.637 HD21 ' H ' ' A' ' 29' ' ' LEU . 2.5 pt? -80.79 160.14 24.94 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.456 -0.572 . . . . 74.34 109.456 175.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 23.7 p-90 -126.46 132.84 24.47 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.65 0.262 . . . . 75.52 110.996 -174.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 12.6 Cg_exo -70.46 107.27 1.96 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.435 2.09 . . . . 54.3 111.549 177.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.04 -8.92 8.44 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.24 -0.436 . . . . 64.13 111.78 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -81.66 -10.86 59.3 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.307 -0.406 . . . . 72.43 110.606 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.36 166.33 11.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.231 -0.441 . . . . 42.14 110.577 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.64 134.29 35.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.055 -0.521 . . . . 74.13 109.705 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.458 HG12 ' NE1' ' A' ' 40' ' ' TRP . 2.5 t -95.47 104.09 14.63 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 110.078 -0.341 . . . . 74.22 110.078 -176.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 42.9 Cg_endo -67.2 114.42 3.21 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.982 2.455 . . . . 74.14 113.116 -174.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -44.48 152.49 0.2 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.727 0.811 . . . . 34.34 113.156 -173.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.1 12.65 10.81 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.747 -0.661 . . . . 60.32 111.468 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.458 ' NE1' HG12 ' A' ' 36' ' ' VAL . 10.4 p-90 -115.78 -172.53 2.18 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.912 0.485 . . . . 74.51 110.85 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -161.77 125.91 3.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.334 -0.848 . . . . 64.44 109.243 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.414 HG23 HD13 ' A' ' 20' ' ' LEU . 6.1 t -90.63 148.04 4.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.603 -0.271 . . . . 73.31 111.05 -171.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.51 HG11 ' O ' ' A' ' 19' ' ' VAL . 8.9 p -93.69 -34.26 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 109.508 -0.553 . . . . 73.33 109.508 173.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.441 ' ND1' ' O ' ' A' ' 17' ' ' PHE . 64.2 t-80 -158.31 132.14 7.8 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.434 -0.58 . . . . 73.35 109.434 173.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.66 -168.67 28.68 Favored Glycine 0 C--N 1.334 0.417 0 O-C-N 123.712 0.632 . . . . 61.03 114.021 -175.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -45.19 154.86 0.14 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.451 1.1 . . . . 74.34 113.449 -170.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . . . -157.79 162.49 38.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.597 -0.729 . . . . 73.41 111.707 -176.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.96 166.14 21.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.533 -0.758 . . . . 61.52 110.296 175.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.443 HH11 HD12 ' A' ' 53' ' ' LEU . 7.0 tmm_? -53.83 -45.3 70.83 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.311 -0.404 . . . . 74.33 110.499 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.92 -42.81 80.64 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 116.207 -0.451 . . . . 72.03 110.703 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . . . -66.67 -34.46 77.91 Favored 'General case' 0 C--O 1.273 2.324 0 CA-C-O 122.295 1.045 . . . . 52.32 111.616 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.601 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 36.1 t -66.17 -36.77 83.97 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 113.528 -1.669 . . . . 74.52 109.773 175.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.574 ' O ' HG21 ' A' ' 56' ' ' ILE . 79.8 mt -71.76 -39.8 69.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 74.32 110.183 171.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -60.92 -25.2 66.58 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 122.905 0.482 . . . . 75.13 111.224 -176.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.581 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -45.63 -24.91 0.39 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.319 0.387 . . . . 73.43 111.344 170.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.574 HG21 ' O ' ' A' ' 53' ' ' LEU . 17.0 tt -64.62 -49.38 80.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.082 0.467 . . . . 72.14 110.277 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.454 ' N ' HG23 ' A' ' 56' ' ' ILE . 9.5 tp10 -74.01 -42.51 60.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.315 -0.857 . . . . 72.01 111.049 -175.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.479 ' HG2' ' HA ' ' A' ' 55' ' ' TYR . 16.3 pt-20 -78.46 -37.98 42.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 74.42 111.269 -176.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.1 p80 . . . . . 0 N--CA 1.475 0.802 0 C-N-CA 123.772 0.829 . . . . 71.52 112.261 179.152 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.775 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 24.8 t80 . . . . . 0 N--CA 1.451 -0.41 0 CA-C-O 121.872 0.844 . . . . 74.22 109.502 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 29' ' ' LEU . 54.2 p90 -150.39 131.51 14.42 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.004 -1.48 . . . . 74.44 107.004 169.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.557 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 48.9 t -143.06 131.77 20.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.84 -0.344 . . . . 65.33 110.256 -169.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -120.91 123.57 42.82 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.263 -0.643 . . . . 74.02 109.263 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.3 m -112.19 125.97 69.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.444 0.64 . . . . 73.44 109.778 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.664 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 14.4 m120 -84.06 146.65 27.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.598 -0.728 . . . . 74.14 109.485 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -56.33 -23.35 36.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.029 0.443 . . . . 75.14 111.203 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -87.36 23.2 1.93 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.045 -0.525 . . . . 73.32 110.906 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 67.84 21.01 9.21 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.74 0.816 . . . . 73.3 112.391 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.664 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 15.6 mm-40 -83.43 117.96 23.41 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.011 -0.366 . . . . 70.43 110.011 175.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -92.92 116.82 29.39 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.364 -0.606 . . . . 74.11 109.364 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -152.9 -172.84 4.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.231 0.539 . . . . 70.43 110.758 -174.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.434 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 2.4 pp -125.72 -174.78 3.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.69 -0.686 . . . . 74.34 109.196 174.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.4 p-90 -145.3 128.78 8.49 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 110.122 -0.325 . . . . 75.52 110.122 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.52 130.62 41.04 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.457 2.104 . . . . 54.3 111.369 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.67 12.48 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.9 0.704 . . . . 64.13 112.9 -173.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -81.72 -27.37 33.94 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.712 0.292 . . . . 72.43 111.052 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.04 155.12 37.59 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.996 0.427 . . . . 42.14 111.17 -176.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -94.91 139.71 30.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.057 -0.52 . . . . 74.13 109.823 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.2 t -79.9 111.37 21.12 Favored Pre-proline 0 C--O 1.235 0.305 0 N-CA-C 110.006 -0.368 . . . . 74.22 110.006 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.11 133.44 57.71 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.666 2.244 . . . . 74.14 112.03 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.9 135.7 57.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.999 -0.546 . . . . 34.34 110.763 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.02 -24.83 11.31 Favored Glycine 0 C--O 1.235 0.201 0 C-N-CA 121.315 -0.469 . . . . 60.32 112.171 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -91.27 154.67 19.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.839 -0.8 . . . . 74.51 108.839 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -110.02 125.97 53.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.919 0.39 . . . . 64.44 110.141 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.1 p -91.87 122.99 43.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.98 0.419 . . . . 73.31 110.68 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.557 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 58.4 t -72.94 -41.05 60.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.261 0.553 . . . . 73.33 109.561 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -160.96 141.89 11.57 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.492 -0.777 . . . . 73.35 109.24 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.08 -170.68 47.25 Favored Glycine 0 N--CA 1.452 -0.297 0 O-C-N 123.598 0.561 . . . . 61.03 112.617 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.17 140.31 21.38 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.063 0.545 . . . . 74.34 110.583 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.57 -178.32 5.83 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.429 0.529 . . . . 73.41 112.429 -170.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -91.66 179.72 5.57 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.324 -0.853 . . . . 61.52 112.213 -173.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.516 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 4.4 tmt_? -60.93 -40.82 94.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.428 -0.805 . . . . 74.33 111.734 -177.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.65 -36.05 81.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.144 0.497 . . . . 72.03 109.729 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' PHE . . . -68.31 -30.71 69.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.576 -0.738 . . . . 52.32 110.532 175.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.564 ' O ' HG21 ' A' ' 56' ' ' ILE . 53.9 t -59.43 -47.59 84.88 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.356 -0.609 . . . . 74.52 109.356 170.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.489 HD13 ' NH1' ' A' ' 49' ' ' ARG . 85.5 mt -57.88 -32.76 68.02 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.6 -0.727 . . . . 74.32 110.689 177.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.54 -53.53 22.44 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.341 -0.39 . . . . 75.13 110.728 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.775 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 40.4 t80 -64.59 -43.83 92.59 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.991 0.367 . . . . 73.43 111.991 -173.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.564 HG21 ' O ' ' A' ' 52' ' ' CYS . 12.4 tt -64.11 -39.83 86.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.121 0.486 . . . . 72.14 110.978 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -73.52 -35.31 65.56 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.078 -0.51 . . . . 72.01 110.537 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -65.24 -38.72 91.24 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.285 -0.635 . . . . 74.42 109.285 171.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 . . . . . 0 C--O 1.236 0.38 0 CA-C-N 114.711 -1.131 . . . . 71.52 110.584 179.166 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.663 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 3.4 p90 . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 114.278 1.214 . . . . 74.22 114.278 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -151.15 130.5 12.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.333 -1.729 . . . . 74.44 106.333 148.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.59 HG22 ' CE1' ' A' ' 55' ' ' TYR . 17.3 t -151.87 122.25 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 112.373 0.509 . . . . 65.33 112.373 -168.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 54.5 tp -96.42 144.83 26.19 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.621 -0.718 . . . . 74.02 109.785 174.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.68 126.1 64.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.278 0.561 . . . . 73.44 110.008 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.402 ' ND2' ' HZ3' ' A' ' 40' ' ' TRP . 1.1 m-20 -77.47 144.77 37.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.439 -0.8 . . . . 74.14 109.633 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -58.4 -17.85 23.59 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.802 0.811 . . . . 75.14 109.683 172.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.56 0.96 9.06 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.76 -1.109 . . . . 73.32 111.04 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 72.69 14.36 5.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.411 0.684 . . . . 73.3 111.035 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -90.05 161.31 15.89 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.546 -0.909 . . . . 70.43 108.546 172.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -152.33 140.85 20.71 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.186 0.448 . . . . 74.11 111.253 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -168.22 -166.27 0.69 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.552 -0.536 . . . . 70.43 109.552 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.703 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.1 pt? -94.44 161.65 14.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.691 0.281 . . . . 74.34 110.461 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -138.25 147.3 55.19 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.43 -0.35 . . . . 75.52 110.65 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.15 116.9 4.72 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.488 2.125 . . . . 54.3 111.543 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.0 -21.29 64.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.279 -0.418 . . . . 64.13 111.655 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -81.43 -20.16 40.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.855 0.359 . . . . 72.43 110.524 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.97 150.62 23.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.367 -0.379 . . . . 42.14 110.439 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -95.37 111.64 23.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.659 -0.497 . . . . 74.13 109.659 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.469 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.1 p -81.49 120.4 78.0 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.361 -0.381 . . . . 74.22 110.936 -176.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 5.9 Cg_exo -75.57 173.1 15.07 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.401 2.734 . . . . 74.14 113.107 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.42 152.35 44.12 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.957 -0.565 . . . . 34.34 110.911 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.54 -28.55 11.85 Favored Glycine 0 C--N 1.329 0.186 0 N-CA-C 110.935 -0.866 . . . . 60.32 110.935 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.402 ' HZ3' ' ND2' ' A' ' 22' ' ' ASN . 11.7 m95 -105.09 98.67 8.35 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.075 -1.083 . . . . 74.51 108.075 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -99.59 126.34 45.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.855 0.36 . . . . 64.44 111.3 -172.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 8.5 p -82.94 119.76 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.117 -0.492 . . . . 73.31 109.907 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.08 -26.87 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.527 0.679 . . . . 73.33 110.059 -175.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -131.96 107.18 8.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.218 -0.901 . . . . 73.35 108.652 174.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.55 173.26 5.72 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.19 -0.914 . . . . 61.03 114.453 -169.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.92 137.27 58.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.772 -0.714 . . . . 74.34 110.061 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.85 -177.97 6.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.678 0.275 . . . . 73.41 111.138 -174.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.08 160.45 4.88 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.685 -0.689 . . . . 61.52 112.178 -175.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.573 ' O ' ' SG ' ' A' ' 52' ' ' CYS . 6.6 ttm180 -53.87 -44.18 70.2 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.477 -0.783 . . . . 74.33 110.004 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.69 -33.79 74.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.099 0.476 . . . . 72.03 110.539 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.52 -42.22 87.6 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-N 115.751 -0.659 . . . . 52.32 111.059 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 49' ' ' ARG . 30.0 p -73.54 -35.79 65.57 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.66 -1.154 . . . . 74.52 111.233 174.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 60.0 mt -65.12 -34.75 79.15 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.363 -0.381 . . . . 74.32 110.222 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.19 -37.24 54.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.239 -0.437 . . . . 75.13 110.504 173.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.663 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 23.2 t80 -46.35 -45.24 17.53 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.324 0.49 . . . . 73.43 112.324 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.444 HG21 ' O ' ' A' ' 53' ' ' LEU . 11.5 tt -63.48 -39.35 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 120.491 -0.484 . . . . 72.14 111.326 -176.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -73.78 -43.21 59.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.625 0.25 . . . . 72.01 110.973 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 69.5 mm-40 -77.7 -41.12 39.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.151 -0.477 . . . . 74.42 111.758 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 95.2 m-70 . . . . . 0 N--CA 1.477 0.897 0 C-N-CA 124.428 1.091 . . . . 71.52 113.076 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.762 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 38.4 m-85 . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 117.049 -1.453 . . . . 74.22 107.93 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.602 ' CE2' ' HB1' ' A' ' 51' ' ' ALA . 98.1 m-85 -151.83 130.54 12.35 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 121.843 2.11 . . . . 74.44 109.871 172.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -164.22 143.29 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 112.559 0.577 . . . . 65.33 112.559 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.8 tp -102.3 123.6 46.4 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.575 -0.898 . . . . 74.02 108.575 165.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.58 125.83 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 73.44 110.15 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 3.8 m-20 -97.53 158.34 15.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.419 -0.355 . . . . 74.14 110.435 -178.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.25 -20.54 59.37 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.705 0.764 . . . . 75.14 109.816 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -76.49 9.56 2.63 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.8 -1.091 . . . . 73.32 111.143 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 67.86 15.37 9.58 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.304 0.642 . . . . 73.3 111.09 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.427 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 80.6 mm-40 -78.06 146.42 35.28 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.789 -0.819 . . . . 70.43 108.789 173.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -153.48 102.54 2.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.022 -0.362 . . . . 74.11 110.022 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.3 t -170.86 -170.1 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.823 -0.626 . . . . 70.43 110.096 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.431 HD11 ' N ' ' A' ' 29' ' ' LEU . 6.4 mp -80.65 166.26 21.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.771 -0.65 . . . . 74.34 110.67 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.503 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 17.3 p-90 -143.36 155.29 61.13 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.521 -0.309 . . . . 75.52 111.11 -175.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.6 95.72 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.5 2.133 . . . . 54.3 111.585 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.503 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -67.42 -18.31 65.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.657 -0.701 . . . . 64.13 112.004 -175.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -81.58 -20.84 39.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 72.43 110.709 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.13 176.38 6.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 42.14 110.837 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.46 138.57 37.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.944 -0.571 . . . . 74.13 109.873 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.624 HG21 ' NE1' ' A' ' 40' ' ' TRP . 7.4 p -104.46 129.77 24.45 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 109.968 -0.382 . . . . 74.22 109.968 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.511 ' O ' ' NE1' ' A' ' 40' ' ' TRP . 77.7 Cg_endo -76.4 -169.43 0.7 Allowed 'Trans proline' 0 N--CA 1.481 0.778 0 C-N-CA 123.125 2.55 . . . . 74.14 114.299 -171.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.95 152.43 24.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.92 -0.582 . . . . 34.34 111.14 171.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.0 27.18 7.51 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.741 -0.743 . . . . 60.32 114.42 168.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.624 ' NE1' HG21 ' A' ' 36' ' ' VAL . 48.2 p-90 -130.36 174.63 9.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.337 0.589 . . . . 74.51 111.213 176.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -154.66 125.92 7.32 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.964 -1.124 . . . . 64.44 107.964 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.87 131.93 36.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.735 -0.469 . . . . 73.31 109.735 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.3 t -91.29 -23.99 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.655 0.74 . . . . 73.33 109.56 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.439 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -171.06 131.24 0.79 Allowed 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.605 -1.18 . . . . 73.35 107.928 174.244 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 18' ' ' PHE . . . -73.41 139.91 27.44 Favored Glycine 0 C--N 1.338 0.642 0 O-C-N 124.333 1.021 . . . . 61.03 114.089 -167.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -25.89 124.63 0.06 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.015 1.326 . . . . 74.34 114.539 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . . . -131.65 -176.98 4.22 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.015 -0.993 . . . . 73.41 109.419 175.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -52.57 153.01 3.29 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.267 0.556 . . . . 61.52 110.98 176.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.44 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 14.0 ttp180 -54.26 -31.28 53.18 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 115.293 -0.867 . . . . 74.33 110.248 -176.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.89 -45.05 83.42 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.09 0.471 . . . . 72.03 111.012 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.602 ' HB1' ' CE2' ' A' ' 18' ' ' PHE . . . -63.21 -40.18 96.73 Favored 'General case' 0 C--O 1.274 2.359 0 CA-C-O 121.683 0.754 . . . . 52.32 111.483 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.593 ' O ' ' HB3' ' A' ' 55' ' ' TYR . 64.9 m -73.46 -37.99 65.61 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 113.57 -1.65 . . . . 74.52 112.309 175.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 25.9 mt -70.11 -44.3 69.28 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.823 -0.436 . . . . 74.32 109.823 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.5 ' HA ' ' HB3' ' A' ' 57' ' ' GLU . 0.8 OUTLIER -68.72 -25.98 65.03 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 118.911 -0.566 . . . . 75.13 110.353 175.353 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.762 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -45.39 -61.5 1.65 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 118.141 -1.424 . . . . 73.43 111.352 162.584 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 tt -68.59 -35.76 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.754 0.311 . . . . 72.14 111.302 -176.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.5 ' HB3' ' HA ' ' A' ' 54' ' ' GLU . 8.3 tp10 -62.53 -43.26 99.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.181 0.515 . . . . 72.01 110.244 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -66.97 -40.24 87.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.144 -0.935 . . . . 74.42 110.57 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.7 t60 . . . . . 0 N--CA 1.469 0.515 0 CA-C-N 115.621 -0.718 . . . . 71.52 111.2 175.653 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.805 0 N-CA-C 111.697 -0.561 . . . . 64.54 111.697 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.82 140.52 11.58 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.579 2.186 . . . . 72.44 112.702 -175.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.89 -111.92 3.4 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.849 -0.614 . . . . 52.53 112.982 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.465 ' HB3' HD12 ' A' ' 7' ' ' ILE . 15.2 m -96.06 102.02 13.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.978 0.418 . . . . 64.44 111.82 -172.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.649 ' HG3' ' H ' ' A' ' 68' ' ' LEU . 81.6 mmm -104.17 -32.16 9.28 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.215 -0.661 . . . . 74.33 109.215 165.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.401 ' OG ' ' HG2' ' A' ' 71' ' ' LYS . 49.8 m -145.85 123.64 11.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.25 -0.886 . . . . 74.2 109.622 175.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.558 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 45.4 mm -95.04 153.3 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 74.54 110.486 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.519 ' HB2' HH11 ' A' ' 64' ' ' ARG . 89.2 m-20 -106.3 85.83 1.85 Allowed Pre-proline 0 N--CA 1.465 0.278 0 N-CA-C 108.971 -0.751 . . . . 64.43 108.971 173.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.587 ' HG2' ' HB2' ' A' ' 12' ' ' ASP . 91.6 Cg_endo -95.86 141.65 0.99 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.316 2.677 . . . . 71.44 112.852 -174.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -62.78 -46.01 90.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.022 -0.535 . . . . 72.32 110.659 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.89 -46.21 2.84 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.23 -0.441 . . . . 75.4 111.336 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.587 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 28.5 t70 73.76 -10.8 1.03 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.466 0.706 . . . . 73.54 111.817 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.43 -60.71 2.12 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.669 0.271 . . . . 74.53 110.922 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -82.77 -29.93 29.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 73.33 109.85 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.05 -118.25 14.4 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.457 -0.792 . . . . 55.21 112.7 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.498 ' C ' ' HB3' ' A' ' 51' ' ' ALA . 20.2 m -160.6 -179.92 8.04 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.325 -0.62 . . . . 71.32 109.325 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.898 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 23.4 t80 -66.29 -165.5 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.094 -0.706 . . . . 74.22 109.094 172.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -124.49 136.32 53.92 Favored 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 121.366 -0.833 . . . . 74.44 110.65 -169.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.8 t -143.6 131.31 18.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 CA-C-N 114.802 -1.09 . . . . 65.33 110.574 -169.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.649 HD22 ' HB3' ' A' ' 30' ' ' TRP . 43.8 tp -112.78 123.37 50.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.575 -0.739 . . . . 74.02 110.168 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -109.35 177.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.614 -0.514 . . . . 73.44 109.614 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.667 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 27.7 t-20 -144.37 149.87 36.83 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.482 -0.192 . . . . 74.14 110.482 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.46 -28.49 30.69 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.295 0.372 . . . . 75.14 111.741 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.75 20.27 1.83 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.179 -0.464 . . . . 73.32 111.322 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 71.16 10.61 6.82 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.499 0.719 . . . . 73.3 112.211 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.667 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 43.2 mt-30 -74.62 153.36 39.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.601 -0.518 . . . . 70.43 109.601 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -157.36 133.96 9.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 74.11 110.591 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.1 t -171.53 -163.96 0.3 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.534 -0.913 . . . . 70.43 108.534 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.62 166.27 11.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.775 -0.454 . . . . 74.34 109.775 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.649 ' HB3' HD22 ' A' ' 20' ' ' LEU . 32.5 p-90 -128.14 144.73 52.75 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.542 -0.299 . . . . 75.52 110.272 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.76 104.72 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.596 2.197 . . . . 54.3 111.605 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.22 -18.72 59.72 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.181 -0.463 . . . . 64.13 111.738 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -92.17 10.66 28.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.107 -0.497 . . . . 72.43 110.866 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.71 179.32 6.65 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.794 0.331 . . . . 42.14 110.76 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -95.5 139.96 31.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.959 -0.564 . . . . 74.13 109.874 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.54 124.03 89.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.575 -0.284 . . . . 74.22 110.404 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.427 ' HG2' ' CD1' ' A' ' 40' ' ' TRP . 29.2 Cg_endo -63.64 146.65 92.65 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.379 2.052 . . . . 74.14 111.789 178.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.04 145.97 28.86 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.126 -0.488 . . . . 34.34 111.075 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.86 -23.39 34.9 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.152 -0.476 . . . . 60.32 111.944 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.517 ' CE3' ' HB2' ' A' ' 22' ' ' ASN . 65.7 m95 -97.04 160.59 14.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.712 0.292 . . . . 74.51 110.221 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -132.64 125.58 30.69 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.911 -0.774 . . . . 64.44 108.911 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.05 114.09 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.481 -0.563 . . . . 73.31 109.481 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.8 m -86.92 -21.37 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.368 0.604 . . . . 73.33 110.417 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -153.78 129.4 10.0 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.342 -0.845 . . . . 73.35 109.347 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.08 -178.85 45.82 Favored Glycine 0 C--N 1.336 0.546 0 O-C-N 124.15 0.907 . . . . 61.03 112.122 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.68 145.09 50.54 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.855 0.359 . . . . 74.34 111.623 -174.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.25 -178.34 6.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.782 -0.644 . . . . 73.41 110.54 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -79.3 167.98 20.17 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 116.2 -0.455 . . . . 61.52 111.452 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.683 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 41.0 ttm180 -55.88 -33.76 64.88 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 115.989 -0.55 . . . . 74.33 110.941 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -56.32 -48.15 77.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.134 0.493 . . . . 72.03 109.949 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.498 ' HB3' ' C ' ' A' ' 16' ' ' SER . . . -65.66 -31.04 71.83 Favored 'General case' 0 C--O 1.26 1.61 0 CA-C-N 115.176 -0.92 . . . . 52.32 111.133 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.898 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 24.9 m -62.05 -50.29 72.57 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.666 -1.152 . . . . 74.52 109.643 173.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.7 mt -59.61 -40.95 89.2 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.614 -0.721 . . . . 74.32 110.463 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 17.6 mm-40 -58.64 -52.81 64.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.441 . . . . 75.13 110.26 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -56.22 -55.35 34.35 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.794 0.294 . . . . 73.43 111.794 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 52' ' ' CYS . 8.8 tt -61.92 -42.83 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 121.076 -0.25 . . . . 72.14 111.539 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.32 -43.89 93.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.263 0.554 . . . . 72.01 110.127 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -72.63 -14.51 61.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.755 -0.657 . . . . 74.42 110.864 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 45.13 37.69 2.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.758 0.823 . . . . 71.52 111.23 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.494 ' CZ2' ' HA ' ' A' ' 63' ' ' ILE . 76.2 t-105 70.21 102.24 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 115.077 -0.965 . . . . 74.23 110.68 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.07 -62.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.505 2.136 . . . . 74.04 112.193 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -162.51 159.06 24.44 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.896 -0.409 . . . . 74.44 109.896 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.494 ' HA ' ' CZ2' ' A' ' 60' ' ' TRP . 14.1 tt -78.15 -7.5 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 65.41 111.59 -176.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.519 HH11 ' HB2' ' A' ' 8' ' ' ASN . 1.4 tpp180 53.49 76.65 0.51 Allowed Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.055 -0.52 . . . . 72.23 110.639 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.13 102.8 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.742 2.295 . . . . 62.12 112.335 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.645 ' HB2' ' HZ1' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -152.43 88.11 1.35 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.951 -0.568 . . . . 64.54 109.816 176.216 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.4 p -88.21 122.59 31.93 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.51 -0.768 . . . . 72.44 110.448 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.649 ' H ' ' HG3' ' A' ' 5' ' ' MET . 96.6 mt -137.5 164.13 29.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.55 -0.537 . . . . 74.14 109.55 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -52.27 -60.96 2.6 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.37 0.419 . . . . 72.54 110.608 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -160.31 143.67 13.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.087 0.47 . . . . 72.12 110.424 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 5' ' ' MET . 5.3 tppp? -157.38 13.06 0.23 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.472 -0.936 . . . . 73.4 108.472 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.75 60.28 0.7 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.486 -0.779 . . . . 75.41 109.985 -167.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.2 145.7 26.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.27 -0.877 . . . . 32.42 110.38 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.7 p -77.61 78.54 4.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.08 0.466 . . . . 74.24 110.603 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.59 7.32 5.89 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.946 -0.645 . . . . 72.52 113.135 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -73.85 93.2 2.13 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.138 0.494 . . . . 74.3 109.977 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.98 98.2 0.14 Allowed Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.301 -0.863 . . . . 61.11 111.078 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -92.31 -64.9 1.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.684 0.278 . . . . 74.31 110.974 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 23.7 t70 -122.65 94.88 4.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.887 0.375 . . . . 74.11 111.064 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-N 115.382 -0.827 . . . . 63.52 108.844 175.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.68 0 N-CA-C 112.233 -0.347 . . . . 64.54 112.233 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.32 69.55 6.88 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.73 2.287 . . . . 72.44 112.409 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.17 46.53 3.65 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.161 -0.543 . . . . 52.53 112.525 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.3 t -108.54 -167.76 1.27 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.647 0.379 . . . . 64.44 110.301 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 5.8 tpt -46.57 -42.34 15.81 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.317 0.647 . . . . 74.33 111.691 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.3 m -124.31 113.94 18.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.651 0.263 . . . . 74.2 110.646 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.1 mm -67.1 -67.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.995 -0.548 . . . . 74.54 110.572 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 14.5 m120 -125.84 135.91 27.69 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 64.43 109.955 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 8' ' ' ASN . 5.7 Cg_exo -77.9 87.86 1.48 Allowed 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.874 2.383 . . . . 71.44 112.642 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -128.11 -178.19 4.43 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.035 -0.53 . . . . 72.32 110.067 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -89.5 -176.88 5.17 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 110.099 -0.334 . . . . 75.4 110.099 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.12 61.16 1.54 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.323 -0.621 . . . . 73.54 109.323 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -55.26 -47.19 75.81 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.068 -0.515 . . . . 74.53 111.768 -171.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -96.86 14.98 23.43 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.405 -0.361 . . . . 73.33 111.073 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.74 82.52 0.09 OUTLIER Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.825 -0.51 . . . . 55.21 111.825 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.475 ' C ' ' HB3' ' A' ' 51' ' ' ALA . 3.0 p -101.43 170.11 8.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.176 0.512 . . . . 71.32 112.218 -171.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.776 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 3.3 t80 -67.13 -159.82 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.241 1.017 . . . . 74.22 110.663 178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.529 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 41.9 p90 -124.37 142.11 51.54 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.284 0.564 . . . . 74.44 110.813 -172.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.597 HG22 HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.37 142.49 5.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-N 115.012 -0.995 . . . . 65.33 110.858 -172.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 40' ' ' TRP . 43.1 tp -120.46 144.58 47.9 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.216 -0.902 . . . . 74.02 111.273 -171.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.35 141.82 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 115.997 -0.547 . . . . 73.44 109.94 173.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 25.3 t-20 -110.01 155.9 21.2 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.507 -0.553 . . . . 74.14 109.507 -176.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.0 -26.64 68.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.9 0.381 . . . . 75.14 111.152 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -86.43 22.88 1.73 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.279 0.562 . . . . 73.32 110.512 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 73.02 6.65 5.34 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.404 -0.816 . . . . 73.3 112.397 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.564 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 81.6 mm-40 -71.96 117.74 13.95 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.194 -0.669 . . . . 70.43 109.194 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -131.35 127.62 37.99 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.199 -0.313 . . . . 74.11 111.042 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.5 t -173.57 163.13 4.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 70.43 110.329 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.555 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.4 pt? -72.13 130.81 41.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.174 -1.047 . . . . 74.34 108.174 169.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.489 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 33.4 p-90 -95.87 141.84 23.73 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.529 -0.305 . . . . 75.52 110.917 -173.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 23.0 Cg_exo -64.98 105.32 0.66 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.616 2.21 . . . . 54.3 111.275 177.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.489 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -58.61 -26.89 64.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.965 -0.561 . . . . 64.13 111.66 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -98.63 23.75 8.29 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.096 -0.502 . . . . 72.43 110.968 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . . . -132.96 166.63 21.93 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.013 -0.54 . . . . 42.14 110.764 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -77.25 139.62 39.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 74.13 110.458 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.504 HG13 ' NE1' ' A' ' 40' ' ' TRP . 3.0 t -112.12 106.03 56.24 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.068 -0.515 . . . . 74.22 109.745 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 33.8 Cg_endo -64.85 116.28 3.73 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.124 2.549 . . . . 74.14 112.819 -174.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.84 152.25 0.38 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.12 0.785 . . . . 34.34 113.12 -174.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.13 18.62 6.69 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.827 -0.624 . . . . 60.32 111.817 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.504 ' NE1' HG13 ' A' ' 36' ' ' VAL . 12.3 p-90 -122.41 -173.28 2.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.141 0.496 . . . . 74.51 111.056 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -154.62 126.64 7.71 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.629 -0.878 . . . . 64.44 108.629 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.9 p -90.51 138.78 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.213 -0.449 . . . . 73.31 110.651 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.597 HG23 HG22 ' A' ' 19' ' ' VAL . 27.6 m -100.74 -22.85 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.909 0.385 . . . . 73.33 110.69 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.553 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 39.3 m80 -150.4 132.63 15.44 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.929 -0.578 . . . . 73.35 109.711 176.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.529 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -92.01 176.14 38.86 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 123.758 0.661 . . . . 61.03 112.784 -175.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.37 131.03 10.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.352 0.661 . . . . 74.34 111.232 -174.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.663 ' HB1' ' HA ' ' A' ' 17' ' ' PHE . . . -147.57 178.24 8.62 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.227 0.537 . . . . 73.41 111.566 -174.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -98.18 177.97 5.22 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.826 -0.625 . . . . 61.52 111.819 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.515 ' NH1' HD11 ' A' ' 53' ' ' LEU . 2.4 tmt_? -61.59 -44.71 96.5 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.697 -0.683 . . . . 74.33 110.493 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.45 -42.53 67.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.464 0.65 . . . . 72.03 110.028 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.475 ' HB3' ' C ' ' A' ' 16' ' ' SER . . . -65.98 -32.69 74.33 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.021 -0.991 . . . . 52.32 110.944 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.776 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 49.0 t -60.22 -51.06 71.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.045 -0.525 . . . . 74.52 109.918 173.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.515 HD11 ' NH1' ' A' ' 49' ' ' ARG . 82.0 mt -58.16 -40.16 80.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.522 -0.763 . . . . 74.32 110.8 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.94 -29.02 55.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.074 -0.512 . . . . 75.13 112.213 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.536 ' HB2' ' H ' ' A' ' 17' ' ' PHE . 54.9 t80 -65.43 -52.37 53.7 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.015 -0.428 . . . . 73.43 110.787 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 tt -59.34 -35.77 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 121.011 0.434 . . . . 72.14 110.574 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -70.99 -42.01 70.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.769 -0.65 . . . . 72.01 111.217 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -58.86 -30.22 67.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.713 0.292 . . . . 74.42 110.268 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 53.93 67.93 0.93 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.72 -0.673 . . . . 71.52 111.375 176.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 88.3 m95 50.7 78.84 0.38 Allowed Pre-proline 0 N--CA 1.465 0.286 0 CA-C-N 115.74 -0.664 . . . . 74.23 111.63 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 63' ' ' ILE . 57.6 Cg_endo -87.45 0.82 7.24 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.724 2.282 . . . . 74.04 112.188 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.2 t70 71.46 -26.0 0.17 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.374 0.67 . . . . 74.44 112.337 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.444 ' H ' ' C ' ' A' ' 61' ' ' PRO . 65.6 mt -50.73 106.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.161 0.505 . . . . 65.41 111.185 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.515 ' HG3' ' HA ' ' A' ' 43' ' ' VAL . 29.8 ttp180 -120.28 89.57 43.69 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.064 -0.971 . . . . 72.23 109.969 -177.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.58 -61.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.161 1.908 . . . . 62.12 111.741 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 59.7 tttm 61.98 9.82 3.26 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.231 0.538 . . . . 64.54 111.126 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.6 t -96.36 155.39 16.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.339 -0.391 . . . . 72.44 110.163 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.471 ' N ' HD21 ' A' ' 68' ' ' LEU . 2.1 pt? -147.7 16.39 1.12 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.889 -0.596 . . . . 74.14 109.728 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.404 ' HA ' ' CZ ' ' A' ' 69' ' ' ARG . 0.4 OUTLIER -90.68 -177.18 4.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.701 -0.681 . . . . 72.54 111.407 -177.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -141.17 -169.57 2.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.98 -1.009 . . . . 72.12 109.617 -174.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.55 18.77 2.71 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.954 -0.758 . . . . 73.4 108.954 175.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 72' ' ' LEU . 3.2 tm? -92.83 -24.34 18.53 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.132 -0.94 . . . . 75.41 109.225 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.9 102.76 2.05 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.669 -0.696 . . . . 32.42 110.083 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.8 t -100.09 -25.61 14.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.2 -0.455 . . . . 74.24 111.424 -175.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.91 -134.74 43.65 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.396 -0.43 . . . . 72.52 112.66 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -143.92 121.46 11.76 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 122.786 0.434 . . . . 74.3 110.172 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.92 96.62 1.25 Allowed Glycine 0 CA--C 1.518 0.275 0 CA-C-N 116.111 -0.495 . . . . 61.11 112.462 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.482 ' O ' ' HB3' ' A' ' 79' ' ' ASP . 84.7 t80 -167.71 142.0 3.6 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 122.419 0.287 . . . . 74.31 110.481 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.482 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 1.0 OUTLIER 169.42 132.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.363 -0.977 . . . . 74.11 108.363 176.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.101 -0.952 . . . . 63.52 109.868 173.167 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.528 -0.629 . . . . 64.54 111.528 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.74 -35.11 70.74 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.542 2.161 . . . . 72.44 112.116 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.29 78.94 0.22 Allowed Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.352 -0.699 . . . . 52.53 111.352 -175.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.0 p -107.23 125.79 51.58 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.218 0.451 . . . . 64.44 112.218 -172.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.588 ' HB2' ' HB3' ' A' ' 71' ' ' LYS . 22.3 tpp -68.82 -60.95 2.02 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 107.673 -1.232 . . . . 74.33 107.673 164.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 m -164.61 139.65 5.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 113.981 -1.463 . . . . 74.2 108.061 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.9 mt -79.75 73.73 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.361 0.6 . . . . 74.54 109.446 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.81 98.26 9.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.023 -0.99 . . . . 64.43 109.979 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.44 99.84 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.721 2.28 . . . . 71.44 113.093 -173.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -145.41 161.1 40.49 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.262 -0.644 . . . . 72.32 109.262 168.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -86.41 118.35 25.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.905 0.383 . . . . 75.4 111.564 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -84.75 -172.17 4.03 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.94 -0.763 . . . . 73.54 108.94 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -79.14 -52.01 8.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.976 0.417 . . . . 74.53 112.048 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -97.05 -3.32 41.6 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.381 0.511 . . . . 73.33 112.381 -167.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.32 -24.34 58.92 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 121.473 -0.394 . . . . 55.21 113.487 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.488 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 5.9 p -178.83 168.0 1.67 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.698 0.399 . . . . 71.32 110.088 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.727 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 34.5 t80 -66.43 -161.94 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.227 0.611 . . . . 74.22 109.865 173.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.542 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 33.8 p90 -124.58 134.43 52.95 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 121.325 -0.86 . . . . 74.44 110.177 -173.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.57 HG23 HG21 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.7 128.85 2.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 115.146 -0.934 . . . . 65.33 111.247 -171.034 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.7 tp -108.54 137.55 46.3 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.608 -1.178 . . . . 74.02 109.946 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 58.4 t -124.95 126.45 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 73.44 110.016 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.749 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 27.2 t-20 -87.41 158.81 18.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.89 -0.411 . . . . 74.14 109.89 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -50.25 -33.28 19.13 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.203 -0.453 . . . . 75.14 112.004 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.58 30.46 0.72 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.207 0.527 . . . . 73.32 111.145 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 67.3 6.58 4.94 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.049 0.539 . . . . 73.3 112.141 174.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.749 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 81.6 mm-40 -63.17 117.81 7.06 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 109.554 -0.535 . . . . 70.43 109.554 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -121.56 111.25 17.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.855 0.36 . . . . 74.11 110.321 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -153.32 156.08 37.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.317 -0.402 . . . . 70.43 110.168 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.54 ' H ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.56 154.27 39.17 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.545 -0.539 . . . . 74.34 109.545 172.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 27.9 p-90 -126.16 148.95 65.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.687 -0.233 . . . . 75.52 110.556 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.06 102.57 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.238 1.959 . . . . 54.3 111.112 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . . . -57.06 -18.0 12.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.847 -0.615 . . . . 64.13 111.863 -175.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -102.15 24.47 10.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 72.43 111.215 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.4 172.53 12.58 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.378 -0.373 . . . . 42.14 111.059 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -95.68 139.81 31.4 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.966 -0.561 . . . . 74.13 109.869 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.8 t -88.99 118.73 69.52 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 110.601 -0.148 . . . . 74.22 110.601 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.04 160.0 48.66 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.755 2.304 . . . . 74.14 112.243 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.51 144.7 50.77 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.265 -0.425 . . . . 34.34 110.622 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.25 -18.63 48.25 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 111.55 -0.62 . . . . 60.32 111.55 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -107.61 118.88 37.9 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.93 -0.396 . . . . 74.51 109.93 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -103.41 126.04 50.34 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.695 -0.484 . . . . 64.44 109.695 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.6 p -91.29 134.08 30.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 110.054 -0.35 . . . . 73.31 110.054 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.57 HG21 HG23 ' A' ' 19' ' ' VAL . 29.5 m -99.7 -5.2 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.031 0.443 . . . . 73.33 110.837 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -175.99 130.78 0.24 Allowed 'General case' 0 C--O 1.246 0.872 0 CA-C-N 115.183 -0.917 . . . . 73.35 109.453 167.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -79.0 -171.47 40.52 Favored Glycine 0 C--N 1.338 0.665 0 O-C-N 123.935 0.772 . . . . 61.03 112.846 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -50.66 151.55 2.33 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.509 0.559 . . . . 74.34 112.509 -173.189 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 17' ' ' PHE . . . -161.42 179.19 8.46 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.097 -0.501 . . . . 73.41 112.252 -173.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -97.96 179.43 4.79 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.581 -0.736 . . . . 61.52 112.308 -171.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -56.91 -51.08 70.52 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.702 -0.681 . . . . 74.33 110.406 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.39 -34.19 56.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.412 -0.813 . . . . 72.03 110.186 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -75.74 -31.59 59.65 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 115.284 -0.871 . . . . 52.32 111.098 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.727 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 56.2 m -58.94 -48.71 80.55 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.933 -0.766 . . . . 74.52 108.933 172.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.74 -36.37 82.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.989 -1.005 . . . . 74.32 110.539 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -62.27 -42.16 99.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.531 . . . . 75.13 110.566 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HB2' ' H ' ' A' ' 17' ' ' PHE . 59.9 t80 -64.51 -50.43 67.4 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.315 -0.402 . . . . 73.43 111.194 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 tt -64.24 -37.36 79.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 120.779 0.323 . . . . 72.14 110.371 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -73.25 -28.35 62.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 72.01 110.361 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.645 ' HG2' ' HD3' ' A' ' 61' ' ' PRO . 41.5 tt0 -61.14 -41.52 96.88 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.933 -0.576 . . . . 74.42 109.51 176.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 63.04 20.05 12.04 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.42 -0.809 . . . . 71.52 111.609 170.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 89.9 m95 58.09 87.0 0.15 Allowed Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.222 -0.445 . . . . 74.23 111.812 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.645 ' HD3' ' HG2' ' A' ' 58' ' ' GLU . 63.0 Cg_endo -90.55 178.05 2.13 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.021 2.48 . . . . 74.04 111.899 176.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -69.7 -50.03 47.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.39 0.614 . . . . 74.44 109.63 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.2 pt -116.57 127.0 74.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.168 -0.924 . . . . 65.41 110.277 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.36 92.7 40.96 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.222 -0.659 . . . . 72.23 109.222 175.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.9 74.58 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.222 2.615 . . . . 62.12 113.416 -172.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -70.59 91.44 0.79 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.101 -0.5 . . . . 64.54 109.718 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.4 p -159.51 175.84 12.79 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.207 -0.451 . . . . 72.44 110.948 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.445 ' N ' HD21 ' A' ' 68' ' ' LEU . 2.8 mm? -101.63 123.27 45.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.401 -0.363 . . . . 74.14 110.695 -177.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -87.85 143.25 27.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.269 -0.423 . . . . 72.54 111.128 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 36.81 37.01 0.06 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.771 1.229 . . . . 72.12 112.717 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.588 ' HB3' ' HB2' ' A' ' 5' ' ' MET . 0.0 OUTLIER -56.58 -28.9 61.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.601 -0.727 . . . . 73.4 111.943 -175.146 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 29.5 tp -87.89 -3.15 58.95 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.923 0.392 . . . . 75.41 111.193 -176.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.46 11.66 20.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.3 -0.409 . . . . 32.42 110.947 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.8 m -69.58 77.05 0.42 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.265 0.555 . . . . 74.24 110.487 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.64 86.57 1.47 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.731 -0.668 . . . . 72.52 111.564 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -80.39 77.32 7.17 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.216 -0.661 . . . . 74.3 109.216 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.06 46.89 3.04 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.677 -0.692 . . . . 61.11 113.261 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -77.92 -45.05 25.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.316 -0.624 . . . . 74.31 109.316 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.9 t70 56.16 95.33 0.02 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.939 -1.028 . . . . 74.11 110.559 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.246 0.912 0 CA-C-N 115.682 -0.69 . . . . 63.52 110.409 -173.705 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.81 0 CA-C-O 119.979 -0.345 . . . . 64.54 112.265 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.02 107.73 2.49 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.806 2.337 . . . . 72.44 111.772 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 104.76 111.76 3.64 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.319 -0.712 . . . . 52.53 111.319 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 t -108.27 161.17 15.25 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 110.048 -0.353 . . . . 64.44 110.048 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.5 ' HE1' ' HB3' ' A' ' 71' ' ' LYS . 29.8 tpp -61.53 -62.14 2.03 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.259 0.552 . . . . 74.33 110.465 177.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.1 p -113.15 116.86 30.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.836 -0.62 . . . . 74.2 110.116 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.553 HD11 ' H ' ' A' ' 67' ' ' SER . 58.2 mt -72.14 88.29 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.506 -0.553 . . . . 74.54 109.506 176.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.425 ' N ' ' HD2' ' A' ' 9' ' ' PRO . 17.1 m120 -66.99 -48.4 50.44 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.338 -0.846 . . . . 64.43 111.36 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 8' ' ' ASN . 74.2 Cg_endo -74.99 98.65 1.18 Allowed 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 121.908 1.739 . . . . 71.44 111.377 175.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -77.72 -23.33 49.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 72.32 110.444 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.0 t70 67.86 -69.68 0.14 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.432 -0.804 . . . . 75.4 111.616 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.8 83.81 0.65 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.277 0.56 . . . . 73.54 110.865 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -79.45 -22.62 43.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.057 0.932 . . . . 74.53 109.34 171.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -67.97 -28.46 67.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.514 -1.675 . . . . 73.33 112.087 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.96 70.92 1.19 Allowed Glycine 0 C--N 1.33 0.239 0 C-N-CA 121.068 -0.586 . . . . 55.21 112.347 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.464 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 7.0 p -77.38 -173.97 3.11 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.597 0.237 . . . . 71.32 111.196 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.832 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 3.8 t80 -67.42 -161.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 116.354 -0.384 . . . . 74.22 110.915 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.814 ' HB3' ' HA ' ' A' ' 46' ' ' GLU . 51.9 p90 -125.15 143.77 50.77 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.14 0.495 . . . . 74.44 111.357 -171.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 43' ' ' VAL . 48.2 t -146.49 133.04 13.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-N 115.077 -0.965 . . . . 65.33 110.331 -175.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.496 ' HB2' ' CE3' ' A' ' 30' ' ' TRP . 57.4 tp -109.2 133.88 52.46 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.694 -0.685 . . . . 74.02 109.847 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 m -120.6 126.27 75.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.705 0.765 . . . . 73.44 110.554 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.573 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 11.3 m120 -93.12 154.09 18.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.074 -0.966 . . . . 74.14 109.228 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -56.69 -24.3 48.09 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.032 0.444 . . . . 75.14 111.097 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -82.15 15.67 2.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.965 -0.562 . . . . 73.32 111.156 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 67.64 6.79 5.22 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.26 0.624 . . . . 73.3 111.477 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.573 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 15.4 mm100 -66.65 119.61 12.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.298 -0.63 . . . . 70.43 109.298 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -111.14 113.06 25.31 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.376 -0.602 . . . . 74.11 109.376 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -150.38 -162.26 1.51 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.16 -0.473 . . . . 70.43 109.985 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.586 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.3 pt? -127.93 172.21 11.1 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.633 -0.506 . . . . 74.34 109.633 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.526 ' CH2' ' HB2' ' A' ' 18' ' ' PHE . 13.1 p90 -135.67 157.8 75.49 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.411 -0.588 . . . . 75.52 109.411 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.653 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . 37.4 Cg_exo -57.66 100.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.959 1.772 . . . . 54.3 110.211 171.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.18 -13.59 19.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.636 0.606 . . . . 64.13 112.636 -171.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -103.13 2.72 34.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.837 0.351 . . . . 72.43 110.602 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.653 ' HB1' ' HB2' ' A' ' 31' ' ' PRO . . . -121.61 -175.85 3.18 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.099 -0.5 . . . . 42.14 111.316 -173.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -81.91 137.92 35.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.594 -0.73 . . . . 74.13 110.434 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.5 t -82.34 132.79 51.8 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.934 -0.576 . . . . 74.22 110.022 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.06 132.68 48.84 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.345 2.03 . . . . 74.14 111.293 173.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.23 152.32 45.14 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.256 0.55 . . . . 34.34 112.056 -173.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.02 -35.55 4.6 Favored Glycine 0 N--CA 1.453 -0.193 0 CA-C-N 115.595 -0.73 . . . . 60.32 113.478 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -81.87 175.97 9.96 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.752 0.31 . . . . 74.51 110.694 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -121.92 126.64 49.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.006 0.431 . . . . 64.44 110.967 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.56 126.43 40.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.682 -0.859 . . . . 73.31 108.682 170.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 19' ' ' VAL . 14.7 p -95.83 -23.24 4.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 120.698 -0.401 . . . . 73.33 110.345 -175.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.451 ' ND1' ' O ' ' A' ' 17' ' ' PHE . 45.0 t-80 -158.26 133.42 8.62 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.301 -0.409 . . . . 73.35 110.469 174.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.24 176.86 46.71 Favored Glycine 0 C--N 1.337 0.629 0 O-C-N 124.14 0.9 . . . . 61.03 113.438 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.814 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -78.69 154.84 29.79 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.003 0.742 . . . . 74.34 113.003 -170.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.32 -178.11 5.74 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.802 -0.635 . . . . 73.41 111.065 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.16 170.17 16.81 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.78 0.659 . . . . 61.52 112.78 -173.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 31.9 ttm180 -45.7 -45.72 14.43 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.577 0.751 . . . . 74.33 111.631 176.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.576 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -53.66 -45.0 70.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.351 0.595 . . . . 72.03 109.964 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.464 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -66.99 -30.96 71.22 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 115.172 -0.922 . . . . 52.32 111.102 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.832 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 42.7 t -58.19 -47.47 83.33 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.682 -0.69 . . . . 74.52 109.731 171.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.57 -39.72 94.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.878 -0.601 . . . . 74.32 110.118 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.576 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 13.8 mm-40 -59.4 -39.32 83.03 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.121 -0.491 . . . . 75.13 110.742 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -58.68 -47.94 82.79 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.776 0.322 . . . . 73.43 110.668 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.45 -48.7 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.703 0.763 . . . . 72.14 109.623 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -68.85 -26.64 65.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.357 -1.292 . . . . 72.01 111.072 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -65.99 -39.55 90.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.448 . . . . 74.42 109.834 175.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 67.12 22.72 9.78 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.756 -0.656 . . . . 71.52 111.027 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 34.6 m95 67.39 108.99 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.687 -0.688 . . . . 74.23 112.629 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.416 ' HG2' HG22 ' A' ' 63' ' ' ILE . 96.7 Cg_endo -91.59 -161.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.295 2.663 . . . . 74.04 111.668 173.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -82.18 -15.2 54.07 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.623 -0.262 . . . . 74.44 111.423 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.416 HG22 ' HG2' ' A' ' 61' ' ' PRO . 9.5 tp -41.31 132.15 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 113.364 0.875 . . . . 65.41 113.364 -172.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -95.09 151.06 38.55 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.27 -0.877 . . . . 72.23 109.715 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.475 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . 17.8 Cg_endo -58.5 139.84 92.28 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.642 2.228 . . . . 62.12 112.387 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -60.87 112.49 2.07 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.012 -0.54 . . . . 64.54 109.592 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.553 ' H ' HD11 ' A' ' 7' ' ' ILE . 32.7 t -126.15 154.01 43.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.134 -0.485 . . . . 72.44 110.133 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 70' ' ' ASP . 1.6 pp -150.56 155.04 38.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.52 -0.764 . . . . 74.14 109.399 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 69.01 -18.48 0.18 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.222 0.609 . . . . 72.54 112.56 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 68' ' ' LEU . 28.5 t0 -83.96 59.0 5.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.372 0.606 . . . . 72.12 111.389 -172.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.5 ' HB3' ' HE1' ' A' ' 5' ' ' MET . 60.8 tttm -172.43 38.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.611 -0.885 . . . . 73.4 108.611 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.6 tp -84.74 51.28 2.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.227 -0.897 . . . . 75.41 109.83 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.43 101.8 14.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.236 -0.893 . . . . 32.42 110.301 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.9 m -123.75 102.11 7.64 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.672 -0.492 . . . . 74.24 109.672 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.22 129.17 3.27 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.649 -0.786 . . . . 72.52 112.469 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.3 ttt85 -165.75 99.68 0.67 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.844 0.354 . . . . 74.3 110.139 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -151.05 80.98 0.19 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.331 -0.708 . . . . 61.11 111.331 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -94.26 -84.61 0.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.011 -0.366 . . . . 74.31 110.011 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -97.48 -29.33 13.54 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.446 -0.575 . . . . 74.11 109.446 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 . . . . . 0 C--O 1.247 0.964 0 CA-C-N 114.75 -1.114 . . . . 63.52 108.711 178.413 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.689 0 N-CA-C 111.973 -0.451 . . . . 64.54 111.973 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.62 79.62 2.18 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.582 2.188 . . . . 72.44 112.653 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.12 59.48 3.56 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 111.208 -0.757 . . . . 52.53 111.208 173.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.9 t -108.96 178.22 4.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.371 0.605 . . . . 64.44 111.861 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.476 ' HE3' ' HB3' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -85.13 -20.73 29.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.918 -1.037 . . . . 74.33 108.235 173.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.4 t -136.65 -169.05 2.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.861 -1.063 . . . . 74.2 109.735 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.26 -34.73 68.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.708 -0.678 . . . . 74.54 110.885 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -54.99 110.59 2.28 Favored Pre-proline 0 N--CA 1.468 0.46 0 CA-C-N 115.755 -0.657 . . . . 64.43 111.07 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.52 -39.07 78.82 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.167 1.911 . . . . 71.44 110.935 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -172.69 156.12 3.45 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.937 -1.029 . . . . 72.32 108.564 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.414 ' HB3' ' H ' ' A' ' 12' ' ' ASP . 55.0 m-20 -102.19 -153.2 0.46 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.256 -0.276 . . . . 75.4 110.256 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' H ' ' HB3' ' A' ' 11' ' ' ASP . 23.3 m-20 -75.19 18.81 0.18 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.382 0.512 . . . . 73.54 112.382 -175.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -67.81 -27.96 67.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.343 0.592 . . . . 74.53 109.771 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -95.98 10.9 35.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.301 -0.863 . . . . 73.33 111.088 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 52' ' ' CYS . . . -85.92 100.31 2.47 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 111.078 -0.809 . . . . 55.21 111.078 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.505 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 6.2 p -54.56 135.03 46.66 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 111.888 0.329 . . . . 71.32 111.888 -174.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.523 ' HD1' ' HB2' ' A' ' 55' ' ' TYR . 24.8 t80 -68.65 102.75 1.56 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.057 -0.719 . . . . 74.22 109.057 173.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.432 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 47.6 p90 -141.6 131.02 23.74 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.71 -1.589 . . . . 74.44 106.71 168.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.664 HG22 HG13 ' A' ' 43' ' ' VAL . 2.8 m -156.36 135.49 3.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.539 0.685 . . . . 65.33 110.522 -167.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 8.5 tt -117.31 131.44 56.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.374 -0.83 . . . . 74.02 110.038 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.3 t -104.17 126.08 58.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.397 -0.594 . . . . 73.44 109.397 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.697 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 14.3 m120 -79.94 170.45 16.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.039 -0.528 . . . . 74.14 109.82 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -51.82 -42.17 62.32 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.11 0.481 . . . . 75.14 111.466 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -88.95 28.06 1.24 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.866 -0.606 . . . . 73.32 111.677 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 65.63 15.51 10.07 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.117 0.567 . . . . 73.3 111.734 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.697 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 56.0 tt0 -68.58 131.11 44.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 70.43 110.072 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -90.52 118.24 29.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.642 0.258 . . . . 74.11 110.658 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 m -144.46 -175.51 4.67 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.15 -0.477 . . . . 70.43 110.149 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.452 ' N ' HD23 ' A' ' 29' ' ' LEU . 1.7 pt? -142.33 135.43 28.68 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.439 -0.578 . . . . 74.34 109.439 173.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.432 ' CH2' ' HB2' ' A' ' 18' ' ' PHE . 4.8 p90 -85.31 152.02 57.41 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 75.52 110.114 -176.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.98 104.72 0.4 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.95 1.767 . . . . 54.3 110.169 171.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.69 -15.43 7.8 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.099 0.407 . . . . 64.13 112.099 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -92.07 6.79 45.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 72.43 111.024 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.94 179.49 6.31 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.897 0.38 . . . . 42.14 111.122 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -87.05 139.79 30.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.668 -0.696 . . . . 74.13 110.125 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.5 129.39 94.19 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.114 -0.494 . . . . 74.22 110.899 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.86 141.04 93.55 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.697 2.265 . . . . 74.14 111.841 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.98 147.41 52.47 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.023 -0.535 . . . . 34.34 111.56 -175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.43 -25.95 25.79 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.757 -0.656 . . . . 60.32 112.981 176.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -82.86 -177.42 6.74 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.816 0.341 . . . . 74.51 110.111 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 41' ' ' ARG . 50.7 ttt-85 -145.27 126.5 14.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.335 -0.393 . . . . 64.44 110.008 173.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 54.8 t -80.42 123.37 37.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.264 -0.643 . . . . 73.31 109.264 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.664 HG13 HG22 ' A' ' 19' ' ' VAL . 7.1 p -88.77 -19.11 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.198 0.523 . . . . 73.33 110.107 -175.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -157.53 121.89 4.3 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.029 -0.73 . . . . 73.35 109.029 171.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.66 -179.34 52.81 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.29 -0.481 . . . . 61.03 112.986 -174.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -53.72 138.73 34.52 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.824 -0.436 . . . . 74.34 109.824 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.8 -178.01 6.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.873 1.064 . . . . 73.41 113.873 -167.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.401 ' CG ' ' N ' ' A' ' 49' ' ' ARG . 14.0 t70 -91.14 175.09 7.07 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.513 -1.222 . . . . 61.52 111.528 -176.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.91 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 59.1 ttt180 -57.88 -27.86 63.66 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 122.327 -0.233 . . . . 74.33 111.052 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.87 -41.37 67.44 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.278 -0.638 . . . . 72.03 109.278 173.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 17' ' ' PHE . . . -75.81 -31.17 59.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.352 -0.84 . . . . 52.32 111.018 175.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.91 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 61.3 m -54.8 -55.05 34.39 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.565 0.697 . . . . 74.52 110.253 172.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.3 mt -64.68 -23.16 67.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.989 -1.005 . . . . 74.32 110.557 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.404 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 40.7 tt0 -71.73 -49.82 35.8 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.069 -0.514 . . . . 75.13 111.257 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.523 ' HB2' ' HD1' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -52.53 -40.93 63.03 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 111.98 0.363 . . . . 73.43 111.98 -175.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.411 HD12 ' HG2' ' A' ' 65' ' ' PRO . 4.5 tt -69.57 -39.0 77.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 120.879 0.371 . . . . 72.14 110.887 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -71.64 -34.0 69.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 72.01 110.899 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 59' ' ' HIS . 7.4 mm-40 -67.07 -13.91 62.39 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.853 -0.612 . . . . 74.42 111.639 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.481 ' HB3' ' O ' ' A' ' 58' ' ' GLU . 21.6 t-80 75.08 71.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.6 0.714 . . . . 71.52 109.843 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.687 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 0.8 OUTLIER -145.24 24.07 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.056 0 CA-C-N 115.076 -0.966 . . . . 74.23 111.338 177.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.687 ' HD3' ' N ' ' A' ' 60' ' ' TRP . 60.3 Cg_endo -88.32 137.14 3.57 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 121.832 1.688 . . . . 74.04 112.593 -171.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -76.48 -45.38 31.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.2 -0.455 . . . . 74.44 109.89 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.38 132.87 65.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.801 -0.636 . . . . 65.41 109.987 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -71.19 122.09 86.04 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 110.197 -0.297 . . . . 72.23 110.197 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.411 ' HG2' HD12 ' A' ' 56' ' ' ILE . 36.1 Cg_exo -59.0 136.88 76.4 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.632 2.222 . . . . 62.12 112.204 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -124.3 0.39 8.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.123 -0.489 . . . . 64.54 110.534 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.2 t -107.29 91.48 3.67 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.926 -0.579 . . . . 72.44 110.447 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.7 tp -94.13 -58.51 2.21 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.337 -0.392 . . . . 74.14 110.065 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.597 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -148.18 -171.86 3.93 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.464 -0.335 . . . . 72.54 111.491 178.226 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.82 144.98 47.29 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.98 0.733 . . . . 72.12 112.98 -166.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.476 ' HB3' ' HE3' ' A' ' 5' ' ' MET . 16.9 pttp -64.55 87.01 0.05 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.813 -1.085 . . . . 73.4 111.482 171.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 32.4 tp 64.18 35.74 9.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.657 0.741 . . . . 75.41 110.528 174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.43 -170.79 3.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.797 -0.638 . . . . 32.42 110.58 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.4 m -145.4 114.62 7.06 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.38 -0.6 . . . . 74.24 109.38 174.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.8 56.74 3.48 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 116.439 -0.346 . . . . 72.52 112.258 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -81.26 108.25 14.73 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.612 -0.514 . . . . 74.3 109.612 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.15 -84.5 0.14 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.164 -0.541 . . . . 61.11 112.03 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -141.04 139.46 34.11 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.563 0.345 . . . . 74.31 110.672 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.53 -12.63 51.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.954 -0.566 . . . . 74.11 111.798 -176.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.726 -0.654 . . . . 63.52 110.85 -174.957 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 112.384 -0.286 . . . . 64.54 112.384 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.1 127.37 17.48 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.816 2.344 . . . . 72.44 111.997 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -93.84 47.61 2.27 Favored Glycine 0 C--N 1.331 0.302 0 N-CA-C 111.857 -0.497 . . . . 52.53 111.857 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.6 p -89.37 174.48 7.79 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.89 -0.182 . . . . 64.44 110.829 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.428 ' HE3' ' HB2' ' A' ' 5' ' ' MET . 10.9 ttm -50.72 -64.64 0.75 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.227 0.537 . . . . 74.33 110.351 176.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.9 p -151.93 139.86 20.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.461 -0.791 . . . . 74.2 110.086 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.7 mm -86.79 87.66 2.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 109.245 -0.65 . . . . 74.54 109.245 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.561 ' ND2' ' HA ' ' A' ' 11' ' ' ASP . 22.3 p-10 -153.06 141.77 14.23 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.116 -0.493 . . . . 64.43 110.731 -175.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.47 -40.3 4.34 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.537 2.158 . . . . 71.44 111.19 173.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -130.64 150.08 52.0 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.801 -0.814 . . . . 72.32 108.801 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.561 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 63.9 m-20 -77.87 172.9 12.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.131 0.491 . . . . 75.4 110.927 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -91.25 25.17 2.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.646 -0.706 . . . . 73.54 110.904 -170.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.93 -15.18 28.24 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.953 0.406 . . . . 74.53 111.199 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -96.06 15.11 21.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.03 -0.532 . . . . 73.33 110.507 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 51' ' ' ALA . . . -59.64 86.5 0.02 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 114.716 0.646 . . . . 55.21 114.716 -174.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 48.7 m -78.76 71.01 5.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.161 -1.052 . . . . 71.32 108.161 166.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.662 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 56.4 m-85 -162.13 138.8 8.03 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.007 -0.997 . . . . 74.22 113.063 -155.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -151.23 130.51 12.79 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.279 -1.378 . . . . 74.44 107.279 149.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.482 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 31.2 t -157.19 120.14 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.965 0 CA-C-O 121.081 0.467 . . . . 65.33 112.036 -173.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.436 HD13 HG23 ' A' ' 42' ' ' VAL . 64.6 tp -96.14 128.99 43.54 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.646 -0.706 . . . . 74.02 109.317 171.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 58.2 t -120.85 125.95 74.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.22 0.533 . . . . 73.44 110.302 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -85.66 153.2 22.52 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.168 -0.679 . . . . 74.14 109.168 175.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.34 -9.78 20.08 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.657 0.741 . . . . 75.14 109.535 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -79.79 7.58 8.39 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.943 -1.026 . . . . 73.32 110.174 173.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 72.23 7.02 5.66 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.47 0.708 . . . . 73.3 111.951 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 68.6 mt-30 -70.48 120.11 15.65 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 108.864 -0.791 . . . . 70.43 108.864 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -128.88 104.11 7.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.674 0.273 . . . . 74.11 110.688 -174.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.7 t -166.36 -169.43 1.41 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.722 0.296 . . . . 70.43 110.739 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 pp -71.12 172.88 8.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.12 -0.491 . . . . 74.34 111.511 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -153.21 156.13 32.35 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.552 -0.295 . . . . 75.52 110.739 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.22 93.46 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.432 2.088 . . . . 54.3 111.262 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.17 -1.71 3.52 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.23 0.455 . . . . 64.13 112.23 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -81.7 2.33 30.24 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.624 -0.262 . . . . 72.43 111.227 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.46 174.08 10.98 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.68 0.276 . . . . 42.14 110.782 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -87.99 139.98 29.96 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.058 -0.519 . . . . 74.13 109.981 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -59.39 119.93 43.8 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.964 -0.562 . . . . 74.22 111.412 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.85 138.82 82.96 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.611 2.207 . . . . 74.14 111.883 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.37 127.73 33.45 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.913 -0.585 . . . . 34.34 111.473 -177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.9 -23.43 13.05 Favored Glycine 0 C--N 1.33 0.223 0 CA-C-N 115.955 -0.566 . . . . 60.32 112.653 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -92.57 152.74 19.44 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.718 -0.283 . . . . 74.51 110.377 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.407 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 2.3 mmp_? -123.67 126.34 46.39 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.908 -0.405 . . . . 64.44 109.908 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.453 HG13 ' HA2' ' A' ' 45' ' ' GLY . 19.0 t -85.61 116.73 29.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.522 -0.918 . . . . 73.31 108.522 175.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.482 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 13.6 p -79.11 -29.98 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.411 0.624 . . . . 73.33 109.757 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -144.12 115.37 7.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.802 -1.184 . . . . 73.35 107.802 172.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.453 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . -61.77 163.67 23.49 Favored Glycine 0 CA--C 1.509 -0.314 0 O-C-N 123.7 0.625 . . . . 61.03 113.54 -172.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -61.67 137.73 58.26 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.683 -0.488 . . . . 74.34 109.683 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.32 -177.82 4.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.807 -0.633 . . . . 73.41 110.479 -173.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.6 151.33 6.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.073 -0.512 . . . . 61.52 110.343 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.746 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 18.6 ttm180 -48.51 -39.54 23.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.957 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 54' ' ' GLU . . . -63.96 -39.53 94.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.372 -0.376 . . . . 72.03 111.352 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 15' ' ' GLY . . . -76.24 -33.34 59.19 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 120.925 0.393 . . . . 52.32 111.943 -175.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.746 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 16.2 p -73.51 -42.83 61.28 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.796 -0.638 . . . . 74.52 110.501 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 57.2 mt -65.77 -28.68 69.2 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.09 0.472 . . . . 74.32 110.096 174.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 13.3 tp10 -75.27 -33.07 61.21 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.006 -0.543 . . . . 75.13 110.048 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.662 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 9.5 t80 -45.96 -60.19 2.4 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.415 0.524 . . . . 73.43 112.415 173.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.8 tt -56.28 -40.96 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 120.708 0.289 . . . . 72.14 111.319 -173.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.46 -30.68 63.34 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.028 0.442 . . . . 72.01 110.6 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.14 -34.48 77.71 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.873 -0.603 . . . . 74.42 109.85 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 71.15 6.68 5.91 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.445 -0.798 . . . . 71.52 112.259 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 65.75 102.21 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 120.876 0.369 . . . . 74.23 111.97 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.46 -157.73 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.702 2.268 . . . . 74.04 111.716 173.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -88.79 33.29 0.78 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.189 0.518 . . . . 74.44 110.566 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.6 tt -68.11 127.54 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.78 -0.646 . . . . 65.41 111.134 -176.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.644 ' H ' ' HD2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -57.77 155.96 20.13 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.522 -0.763 . . . . 72.23 111.88 -178.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.07 -11.9 32.87 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.725 2.283 . . . . 62.12 112.421 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -62.29 103.72 0.42 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.982 -0.553 . . . . 64.54 109.843 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.1 t -154.34 -61.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.803 -0.635 . . . . 72.44 109.982 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.429 HD13 ' CA ' ' A' ' 45' ' ' GLY . 80.8 mt -103.28 -164.0 1.04 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.883 -0.599 . . . . 74.14 110.626 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.6 ttp180 71.89 49.51 0.26 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.77 0.669 . . . . 72.54 109.573 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.65 -175.17 5.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.573 -0.74 . . . . 72.12 110.382 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -91.24 -28.51 17.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.278 -0.419 . . . . 73.4 110.693 -173.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.4 tp -80.48 -54.93 5.23 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.345 -0.389 . . . . 75.41 110.41 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 55.42 18.77 2.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.936 -0.574 . . . . 32.42 112.148 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.3 m -88.82 85.22 6.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.291 0.567 . . . . 74.24 110.844 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.25 103.49 0.23 Allowed Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 110.278 -1.129 . . . . 72.52 110.278 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -160.43 127.7 4.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.269 -0.271 . . . . 74.3 110.269 -172.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.83 -172.92 29.13 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.46 -0.656 . . . . 61.11 111.46 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -155.62 160.88 40.8 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.41 0.284 . . . . 74.31 110.48 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -162.92 115.52 1.59 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.932 -0.766 . . . . 74.11 108.932 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.657 -0.687 . . . . 63.52 109.169 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 N-CA-C 112.2 -0.36 . . . . 64.54 112.2 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.14 98.78 1.22 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.469 2.112 . . . . 72.44 112.467 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -145.38 133.01 4.88 Favored Glycine 0 C--O 1.227 -0.319 0 N-CA-C 111.092 -0.803 . . . . 52.53 111.092 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.9 m -64.5 167.96 6.43 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.967 0.413 . . . . 64.44 112.105 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.2 tpp -71.22 -64.9 0.82 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.305 0.574 . . . . 74.33 110.309 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.0 m -70.68 158.73 35.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.967 -1.015 . . . . 74.2 110.418 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.0 mm -62.33 92.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 121.219 0.533 . . . . 74.54 110.637 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -116.45 140.22 26.34 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.341 -0.845 . . . . 64.43 109.086 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -41.67 89.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 123.462 2.774 . . . . 71.44 114.265 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -142.58 106.51 4.7 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.819 -1.548 . . . . 72.32 106.819 170.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.412 ' HA ' HD13 ' A' ' 63' ' ' ILE . 5.0 m-20 61.52 83.01 0.16 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.446 -1.316 . . . . 75.4 107.446 -162.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -43.36 114.92 0.69 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.242 1.201 . . . . 73.54 114.242 -163.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.81 -17.57 55.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.885 -1.052 . . . . 74.53 109.142 168.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -67.98 11.62 0.14 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.699 -1.591 . . . . 73.33 112.922 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.15 96.47 0.09 OUTLIER Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.932 -0.867 . . . . 55.21 110.932 172.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.492 ' C ' ' HB3' ' A' ' 51' ' ' ALA . 9.4 m -64.57 -51.04 64.81 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.156 0.428 . . . . 71.32 112.156 -172.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.667 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 2.4 t80 -67.2 -159.89 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 110.151 -0.314 . . . . 74.22 110.151 172.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 27.5 p90 -123.94 136.73 54.51 Favored 'General case' 0 CA--C 1.509 -0.624 0 O-C-N 121.632 -0.668 . . . . 74.44 110.05 -170.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.557 HG22 ' HB ' ' A' ' 43' ' ' VAL . 23.4 m -144.56 129.18 13.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 114.88 -1.054 . . . . 65.33 111.551 -168.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.494 HD12 HG22 ' A' ' 36' ' ' VAL . 54.3 tp -106.78 132.5 52.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.005 -0.998 . . . . 74.02 109.163 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.02 126.38 75.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.925 0.393 . . . . 73.44 110.861 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -78.41 144.86 35.5 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.773 -0.825 . . . . 74.14 108.773 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -59.87 -18.27 43.11 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.891 0.377 . . . . 75.14 110.711 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.59 4.73 3.63 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.796 -0.638 . . . . 73.32 111.255 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.495 ' HG2' HH11 ' A' ' 64' ' ' ARG . 40.8 mt-10 72.0 56.05 0.17 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.099 0.56 . . . . 73.3 111.357 175.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -143.16 131.57 22.22 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.654 -0.703 . . . . 70.43 109.608 175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -100.92 139.24 36.89 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.784 0.326 . . . . 74.11 110.735 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.8 m -154.92 -172.72 4.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.293 -0.632 . . . . 70.43 109.293 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.75 162.51 15.67 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.741 -0.466 . . . . 74.34 109.741 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.41 ' HH2' ' HA2' ' A' ' 45' ' ' GLY . 3.7 p90 -137.32 160.22 66.45 Favored Pre-proline 0 C--O 1.234 0.264 0 N-CA-C 109.613 -0.514 . . . . 75.52 109.613 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.6 97.86 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.04 1.827 . . . . 54.3 111.024 172.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 46' ' ' GLU . . . -53.23 -24.28 10.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.009 -0.541 . . . . 64.13 112.341 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -92.83 29.86 1.71 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.271 -0.422 . . . . 72.43 111.043 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.5 158.85 43.77 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.296 -0.411 . . . . 42.14 110.546 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.56 129.82 36.66 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.191 -0.459 . . . . 74.13 110.402 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.494 HG22 HD12 ' A' ' 20' ' ' LEU . 7.7 p -91.87 131.31 35.79 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 116.273 -0.421 . . . . 74.22 111.317 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.17 177.91 4.71 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.909 2.406 . . . . 74.14 113.047 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.12 152.07 43.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.538 -0.755 . . . . 34.34 110.763 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.13 -35.33 4.63 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.303 -0.719 . . . . 60.32 111.303 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -100.88 100.76 11.45 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.782 -0.821 . . . . 74.51 108.782 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -93.3 126.57 38.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.868 0.365 . . . . 64.44 110.589 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.0 p -83.69 128.52 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.039 -0.356 . . . . 73.31 110.039 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.557 ' HB ' HG22 ' A' ' 19' ' ' VAL . 93.4 t -89.7 -43.33 14.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.9 0.381 . . . . 73.33 110.221 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -139.22 132.8 30.42 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 109.18 -0.674 . . . . 73.35 109.18 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -79.69 -176.26 48.95 Favored Glycine 0 C--N 1.335 0.507 0 O-C-N 124.334 1.022 . . . . 61.03 112.964 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -46.35 144.33 2.13 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.703 0.631 . . . . 74.34 112.703 -174.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.56 ' HB1' ' HA ' ' A' ' 17' ' ' PHE . . . -151.36 -178.04 6.42 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.326 0.491 . . . . 73.41 112.326 -170.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.412 ' O ' ' HB1' ' A' ' 51' ' ' ALA . 3.7 m-20 -96.67 171.4 8.56 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.911 0.863 . . . . 61.52 112.924 -171.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.73 ' HD3' ' SG ' ' A' ' 52' ' ' CYS . 6.4 tpp180 -56.67 -45.82 81.49 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 114.867 -1.06 . . . . 74.33 110.294 173.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -57.21 -34.23 68.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.463 0.649 . . . . 72.03 110.098 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.492 ' HB3' ' C ' ' A' ' 16' ' ' SER . . . -72.46 -33.06 66.77 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-N 115.277 -0.874 . . . . 52.32 111.622 -177.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.73 ' SG ' ' HD3' ' A' ' 49' ' ' ARG . 22.4 p -71.56 -38.83 70.95 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.308 -0.405 . . . . 74.52 110.387 172.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 92.0 mt -60.14 -35.85 76.21 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.981 -0.554 . . . . 74.32 110.449 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 42.1 mt-10 -77.07 -39.23 50.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.301 -0.409 . . . . 75.13 110.641 176.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -55.65 -48.19 75.39 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.69 0.256 . . . . 73.43 111.69 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.0 tt -62.92 -45.3 99.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 120.811 0.338 . . . . 72.14 111.145 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -60.98 -48.0 83.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.983 -0.553 . . . . 72.01 110.326 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -58.71 -34.66 71.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.822 -0.627 . . . . 74.42 110.25 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 62.19 93.34 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.596 -0.729 . . . . 71.52 110.226 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.41 ' CH2' HG21 ' A' ' 43' ' ' VAL . 3.4 t90 -109.52 105.2 56.89 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.229 -0.441 . . . . 74.23 110.012 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HG2' HG22 ' A' ' 63' ' ' ILE . 68.1 Cg_endo -84.79 -159.87 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.176 2.584 . . . . 74.04 112.146 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -85.74 89.97 7.9 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.265 -0.643 . . . . 74.44 109.265 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.458 HG22 ' HG2' ' A' ' 61' ' ' PRO . 21.8 pt -129.67 169.46 20.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.065 -0.516 . . . . 65.41 110.489 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.495 HH11 ' HG2' ' A' ' 25' ' ' GLU . 14.2 ptm180 -158.03 120.63 2.06 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 72.23 109.834 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.12 118.42 3.91 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.165 2.577 . . . . 62.12 113.134 -175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.494 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 10.4 mptt -78.91 -25.52 43.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.807 -0.633 . . . . 64.54 109.939 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.423 ' OG ' ' NZ ' ' A' ' 71' ' ' LYS . 33.9 t -80.89 81.85 7.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.764 -0.653 . . . . 72.44 110.232 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 pp -124.14 20.32 9.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.892 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.556 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -134.28 166.5 22.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.269 -0.423 . . . . 72.54 110.016 -178.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.502 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 4.7 m-20 -53.36 155.6 2.75 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.297 -0.411 . . . . 72.12 111.117 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.423 ' NZ ' ' OG ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -136.24 57.02 1.79 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.113 -0.494 . . . . 73.4 109.752 -177.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 tt -88.72 55.13 3.26 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.73 -0.841 . . . . 75.41 108.73 -175.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.59 135.55 53.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.805 -1.089 . . . . 32.42 110.299 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.6 m -108.08 110.26 21.9 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.459 -0.337 . . . . 74.24 110.77 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.55 73.4 0.23 Allowed Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.941 -0.463 . . . . 72.52 111.941 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -135.98 147.63 48.1 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.943 -0.762 . . . . 74.3 108.943 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -145.02 175.9 24.36 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.432 -0.667 . . . . 61.11 111.432 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -106.01 -177.94 3.51 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.206 -0.294 . . . . 74.31 110.206 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -148.34 106.67 3.76 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.313 -0.625 . . . . 74.11 109.313 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.401 -0.809 . . . . 63.52 110.055 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 CA-C-O 119.925 -0.375 . . . . 64.54 112.172 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.7 139.62 48.81 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.592 2.195 . . . . 72.44 112.073 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.19 47.65 1.01 Allowed Glycine 0 C--N 1.33 0.212 0 N-CA-C 111.496 -0.641 . . . . 52.53 111.496 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.646 ' H ' HD11 ' A' ' 7' ' ' ILE . 23.2 m -72.72 177.82 4.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.901 0.381 . . . . 64.44 111.669 -177.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 85.3 mmm -53.9 -46.79 71.52 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.527 -0.761 . . . . 74.33 111.563 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.4 m -138.99 115.85 10.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 74.2 110.537 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.646 HD11 ' H ' ' A' ' 4' ' ' SER . 49.6 mm -94.99 -75.01 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.889 0.376 . . . . 74.54 110.446 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -94.97 140.17 22.37 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 64.43 110.234 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.74 121.24 8.86 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.678 2.252 . . . . 71.44 111.456 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -54.92 149.87 10.95 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.312 0.577 . . . . 72.32 111.691 -174.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -146.06 178.28 8.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.442 -0.948 . . . . 75.4 108.442 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 61.05 31.92 19.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.788 0.328 . . . . 73.54 110.219 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -53.15 -43.79 67.27 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.94 -0.573 . . . . 74.53 111.793 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -96.54 15.1 22.52 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.003 -0.544 . . . . 73.33 110.623 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.17 116.15 4.34 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.981 -0.554 . . . . 55.21 111.758 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.776 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 5.0 p -84.86 179.32 7.35 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.449 -0.204 . . . . 71.32 110.449 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.457 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 65.1 t80 -67.91 102.67 1.31 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 119.731 -0.787 . . . . 74.22 109.963 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.447 ' HB2' ' HE1' ' A' ' 30' ' ' TRP . 48.0 p90 -136.36 131.42 34.23 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.931 -1.507 . . . . 74.44 106.931 167.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.7 t -146.33 138.66 19.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 CA-C-O 121.263 0.554 . . . . 65.33 111.229 -167.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.75 ' HB2' ' HB3' ' A' ' 30' ' ' TRP . 33.8 tp -117.06 130.44 56.67 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.872 -1.058 . . . . 74.02 110.273 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.72 126.4 72.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.157 0.503 . . . . 73.44 110.216 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 52.8 t-20 -85.52 149.48 25.35 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.211 -0.663 . . . . 74.14 109.211 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 22' ' ' ASN . 27.4 t70 -56.44 -26.49 53.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.218 0.533 . . . . 75.14 110.174 176.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -80.69 15.9 1.57 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.596 -0.729 . . . . 73.32 111.589 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 73.68 18.75 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.582 0.753 . . . . 73.3 112.452 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 14.9 mm100 -77.24 129.78 36.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.512 -0.551 . . . . 70.43 109.512 173.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.424 ' HB3' ' CZ2' ' A' ' 60' ' ' TRP . 72.9 m80 -123.88 108.53 12.55 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.564 0.221 . . . . 74.11 110.817 -175.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -154.91 -163.63 1.61 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.181 -0.303 . . . . 70.43 110.181 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.681 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.3 pt? -109.66 159.16 17.37 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.382 -0.599 . . . . 74.34 109.382 175.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.75 ' HB3' ' HB2' ' A' ' 20' ' ' LEU . 11.7 p-90 -112.05 148.26 38.65 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 120.557 0.218 . . . . 75.52 110.849 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.18 94.41 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.368 2.045 . . . . 54.3 110.847 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.88 -18.28 12.58 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.858 -0.61 . . . . 64.13 111.682 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -85.02 2.24 44.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 72.43 110.668 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.17 176.88 8.26 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.183 -0.462 . . . . 42.14 110.906 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.51 139.85 30.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.465 . . . . 74.13 110.067 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.7 124.41 90.87 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.308 -0.406 . . . . 74.22 110.052 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.42 -171.67 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.906 2.404 . . . . 74.14 112.797 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.48 145.63 30.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 34.34 110.974 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.23 -32.66 5.77 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.248 -0.433 . . . . 60.32 112.415 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.461 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 16.8 m95 -86.0 136.94 33.06 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.489 -0.56 . . . . 74.51 109.489 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.461 ' HD2' ' O ' ' A' ' 40' ' ' TRP . 16.0 mmm180 -121.51 126.48 49.33 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.257 -0.645 . . . . 64.44 109.257 176.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.0 p -85.9 132.78 31.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.343 -0.243 . . . . 73.31 110.343 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.95 -37.51 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.069 0.461 . . . . 73.33 110.069 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -148.19 132.14 17.15 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.652 -0.703 . . . . 73.35 109.682 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.0 -175.15 45.36 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.111 -0.796 . . . . 61.03 111.111 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -54.86 133.64 47.9 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.884 0.342 . . . . 74.34 110.281 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.63 -177.58 4.93 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.665 0.617 . . . . 73.41 112.665 -168.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.22 165.89 1.28 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.981 -1.009 . . . . 61.52 112.601 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 0.2 OUTLIER -60.75 -29.08 69.17 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.891 -0.595 . . . . 74.33 109.682 174.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.508 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -58.18 -46.89 84.97 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.348 -0.612 . . . . 72.03 109.348 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.83 -30.86 71.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.335 -0.848 . . . . 52.32 110.725 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.776 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 54.1 t -58.4 -49.04 78.7 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.849 -0.426 . . . . 74.52 109.849 170.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.9 mt -67.75 -27.15 66.54 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.799 -0.637 . . . . 74.32 110.494 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 43.5 mt-10 -76.89 -36.69 56.52 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 116.236 -0.438 . . . . 75.13 111.649 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.457 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 1.9 t80 -61.86 -47.8 83.37 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.956 0.343 . . . . 73.43 110.798 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.656 HG13 HD21 ' A' ' 68' ' ' LEU . 10.6 tt -63.78 -41.84 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.73 -0.214 . . . . 72.14 110.932 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.31 -34.19 65.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.762 0.315 . . . . 72.01 111.183 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.23 -25.5 68.09 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.307 0.575 . . . . 74.42 109.47 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 62.71 41.01 9.54 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.134 -0.939 . . . . 71.52 110.732 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.424 ' CZ2' ' HB3' ' A' ' 27' ' ' HIS . 32.5 t-105 -59.49 128.95 86.69 Favored Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 109.228 -0.656 . . . . 74.23 109.228 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.45 92.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.664 2.243 . . . . 74.04 113.148 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -85.74 126.41 33.96 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.217 -1.031 . . . . 74.44 108.217 172.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.697 ' H ' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -78.87 3.89 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.134 0.42 . . . . 65.41 112.134 -173.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.471 ' C ' ' H ' ' A' ' 66' ' ' LYS . 34.9 ttt180 -92.13 141.44 25.16 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.413 -0.588 . . . . 72.23 109.413 173.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.432 ' HD2' ' HG3' ' A' ' 64' ' ' ARG . 51.2 Cg_endo -69.13 34.47 0.19 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.76 2.306 . . . . 62.12 112.649 176.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.471 ' H ' ' C ' ' A' ' 64' ' ' ARG . 34.7 ttpt -74.23 99.71 3.51 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.501 0.72 . . . . 64.54 110.017 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.3 m -71.28 144.24 50.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.967 -0.561 . . . . 72.44 110.3 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.656 HD21 HG13 ' A' ' 56' ' ' ILE . 50.7 mt -63.91 -74.33 0.1 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.78 -0.452 . . . . 74.14 109.78 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER 176.25 -65.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.759 -0.83 . . . . 72.54 108.759 176.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -91.64 92.44 8.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.086 -0.506 . . . . 72.12 109.673 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -66.09 -47.15 75.18 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.34 -0.615 . . . . 73.4 109.34 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.99 47.02 1.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.085 -0.709 . . . . 75.41 109.085 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.02 94.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.63 -0.714 . . . . 32.42 110.646 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.2 p -77.46 -57.56 3.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.731 -0.668 . . . . 74.24 110.764 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.8 -168.83 22.73 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 111.558 -0.617 . . . . 72.52 111.558 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 4.2 mmp_? -116.73 29.1 8.14 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.941 0.4 . . . . 74.3 110.859 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.05 46.82 92.61 Favored Glycine 0 N--CA 1.454 -0.159 0 CA-C-N 116.012 -0.54 . . . . 61.11 112.093 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -78.32 143.21 37.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.72 0.295 . . . . 74.31 110.524 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -102.81 -62.88 1.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.887 -0.597 . . . . 74.11 109.684 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 . . . . . 0 C--O 1.248 1.013 0 CA-C-N 115.541 -0.754 . . . . 63.52 109.048 178.603 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.783 -0.527 . . . . 64.54 111.783 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.38 88.27 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.584 2.19 . . . . 72.44 111.518 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 149.59 93.54 0.11 Allowed Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.858 -0.61 . . . . 52.53 112.151 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.9 m -67.91 103.03 1.37 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.253 -0.647 . . . . 64.44 109.253 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.53 ' HA ' ' HB3' ' A' ' 71' ' ' LYS . 26.8 mmt -69.11 -8.28 43.89 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.989 -0.55 . . . . 74.33 111.86 -174.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.6 m -145.37 152.71 40.29 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 110.19 -0.3 . . . . 74.2 110.19 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.7 mm -88.18 81.74 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.129 0.49 . . . . 74.54 109.869 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.642 ' HB3' ' HB3' ' A' ' 11' ' ' ASP . 3.2 m-20 -106.52 133.12 20.39 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.821 -0.627 . . . . 64.43 110.632 -176.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -86.93 95.33 0.49 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.185 2.59 . . . . 71.44 111.163 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 69.9 t80 56.13 88.05 0.05 OUTLIER 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.689 -0.687 . . . . 72.32 110.187 -173.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.642 ' HB3' ' HB3' ' A' ' 8' ' ' ASN . 27.3 t70 -179.7 94.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.011 -1.107 . . . . 75.4 108.011 -177.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.67 131.84 36.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.232 0.539 . . . . 73.54 111.931 -171.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -51.34 -47.85 62.59 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.888 -1.051 . . . . 74.53 111.675 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -97.19 13.51 29.09 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.178 -0.465 . . . . 73.33 111.926 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.05 -175.26 46.41 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 121.186 -0.53 . . . . 55.21 113.344 177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.426 ' C ' ' HB3' ' A' ' 51' ' ' ALA . 5.8 p -93.5 -57.69 2.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.146 0.578 . . . . 71.32 111.974 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.745 ' CD1' ' HB2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -65.73 -159.03 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.444 0.535 . . . . 74.22 112.444 171.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.411 ' CB ' ' HA ' ' A' ' 46' ' ' GLU . 27.7 p90 -124.26 135.98 53.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.474 -0.784 . . . . 74.44 108.956 -173.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.426 HG22 ' CZ ' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -142.07 129.5 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.055 -0.52 . . . . 65.33 111.896 -167.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.599 HD23 ' HB3' ' A' ' 30' ' ' TRP . 49.5 tp -100.31 125.62 46.55 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.252 -0.886 . . . . 74.02 109.123 172.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 41' ' ' ARG . 12.2 p -109.26 126.34 66.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.24 0.543 . . . . 73.44 109.807 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -94.47 148.33 22.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.72 -0.673 . . . . 74.14 110.671 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' HB3' ' HZ3' ' A' ' 40' ' ' TRP . 15.3 t70 -56.06 -20.86 18.75 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.354 0.597 . . . . 75.14 110.199 174.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -73.55 3.72 5.83 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.262 -0.881 . . . . 73.32 111.531 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 63.31 56.83 1.63 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.37 0.605 . . . . 73.3 110.586 -175.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -137.93 132.55 32.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.251 -0.886 . . . . 70.43 109.171 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.415 ' HB2' ' HZ3' ' A' ' 60' ' ' TRP . 0.4 OUTLIER -116.8 109.12 16.7 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.13 0.491 . . . . 74.11 110.333 -178.361 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.3 t -145.96 -167.77 2.81 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.564 -0.532 . . . . 70.43 109.564 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 pp -107.61 158.63 17.08 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.27 -0.27 . . . . 74.34 110.27 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.599 ' HB3' HD23 ' A' ' 20' ' ' LEU . 18.2 p-90 -111.79 153.24 44.48 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.453 -0.34 . . . . 75.52 110.431 -175.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.73 102.83 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.157 1.905 . . . . 54.3 110.979 175.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.09 -7.01 2.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.522 0.934 . . . . 64.13 113.522 -171.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -107.23 10.13 29.97 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.256 -0.278 . . . . 72.43 110.962 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.453 ' O ' ' HZ3' ' A' ' 30' ' ' TRP . . . -124.48 169.89 11.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.426 -0.352 . . . . 42.14 110.574 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.45 139.56 30.59 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.124 -0.324 . . . . 74.13 110.124 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.0 t -74.64 120.93 83.9 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.557 -0.292 . . . . 74.22 110.513 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.65 137.67 70.33 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.461 2.108 . . . . 74.14 111.436 175.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.73 134.94 57.5 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.46 -0.336 . . . . 34.34 110.571 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.31 -35.15 4.59 Favored Glycine 0 CA--C 1.511 -0.211 0 N-CA-C 111.062 -0.815 . . . . 60.32 111.062 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.404 ' HZ3' ' HB3' ' A' ' 23' ' ' ASP . 3.7 m95 -92.5 143.89 25.9 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.043 -1.095 . . . . 74.51 108.043 173.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.406 ' O ' HG12 ' A' ' 21' ' ' VAL . 44.6 ttm105 -141.22 133.7 28.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.96 0.41 . . . . 64.44 111.517 -174.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.2 t -85.49 121.09 36.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.959 -0.564 . . . . 73.31 110.31 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.42 -37.18 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.8 0.334 . . . . 73.33 110.873 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.409 ' HD2' ' O ' ' A' ' 45' ' ' GLY . 3.6 t-160 -134.67 129.89 35.49 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.226 -0.657 . . . . 73.35 109.226 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.409 ' O ' ' HD2' ' A' ' 44' ' ' HIS . . . -72.47 167.29 53.52 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 124.455 1.097 . . . . 61.03 113.543 -176.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.6 mp0 -50.91 128.69 21.83 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.715 0.806 . . . . 74.34 112.488 -171.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -133.18 -178.23 4.88 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.509 -0.768 . . . . 73.41 110.727 -176.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.37 164.57 23.94 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.772 0.796 . . . . 61.52 112.653 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -52.57 -38.37 59.77 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 114.753 -1.112 . . . . 74.33 109.787 173.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.42 -47.6 83.39 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 115.756 -0.656 . . . . 72.03 110.216 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 17' ' ' PHE . . . -59.86 -31.35 69.69 Favored 'General case' 0 C--O 1.258 1.515 0 CA-C-O 121.71 0.766 . . . . 52.32 111.015 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 47.8 t -71.25 -40.88 70.75 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.724 -1.125 . . . . 74.52 110.839 172.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.5 mt -67.66 -26.93 66.45 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.317 0.58 . . . . 74.32 109.796 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -77.11 -37.39 54.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.526 -0.761 . . . . 75.13 110.141 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.745 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -46.53 -58.04 4.16 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 111.861 0.319 . . . . 73.43 111.861 171.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 tt -60.81 -37.96 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.242 0.544 . . . . 72.14 110.552 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.45 -43.55 93.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.249 -0.887 . . . . 72.01 110.571 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -73.76 -27.95 61.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.868 -0.605 . . . . 74.42 110.106 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 58.02 57.46 4.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.185 -0.916 . . . . 71.52 110.121 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.448 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 50.4 t90 -62.4 116.3 21.91 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-N 115.631 -0.713 . . . . 74.23 109.794 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 60' ' ' TRP . 1.2 Cg_endo -83.11 -153.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.406 2.737 . . . . 74.04 112.101 -176.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -98.73 -1.97 39.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 74.44 110.773 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.2 pt -108.93 141.31 24.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.094 -0.503 . . . . 65.41 110.893 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.0 ttt-85 -127.62 146.78 59.92 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.731 -0.668 . . . . 72.23 109.671 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -46.88 140.22 13.38 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.578 2.185 . . . . 62.12 112.182 171.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.698 ' HB3' ' HZ2' ' A' ' 66' ' ' LYS . 7.1 ttpm? -83.53 111.56 19.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.042 -0.526 . . . . 64.54 111.396 -174.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -61.41 146.87 46.9 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.155 -0.475 . . . . 72.44 110.433 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.3 tt -172.33 -60.01 0.02 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.933 0.397 . . . . 74.14 110.099 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.493 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 2.2 tpm_? -92.19 132.28 36.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.409 . . . . 72.54 110.528 -177.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.12 82.28 1.28 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.547 . . . . 72.12 110.605 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.53 ' HB3' ' HA ' ' A' ' 5' ' ' MET . 14.5 tppt? -94.12 171.21 8.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.674 -0.694 . . . . 73.4 109.341 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 56.5 tp -169.3 51.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.946 0.879 . . . . 75.41 108.924 -176.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.416 ' HB2' ' HG3' ' A' ' 76' ' ' ARG . . . 56.94 31.06 19.11 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.77 -1.105 . . . . 32.42 112.127 174.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.6 p -55.47 -33.89 64.05 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.309 -0.405 . . . . 74.24 111.865 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.72 6.47 58.39 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 116.094 -0.503 . . . . 72.52 113.558 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.589 ' HA ' ' HE ' ' A' ' 76' ' ' ARG . 3.1 mmp_? -83.25 105.15 13.98 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 117.23 0.515 . . . . 74.3 110.495 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -135.37 -76.76 0.09 OUTLIER Glycine 0 CA--C 1.509 -0.318 0 N-CA-C 110.543 -1.023 . . . . 61.11 110.543 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -139.81 138.25 35.65 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.24 -0.652 . . . . 74.31 109.24 170.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -143.76 105.15 4.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.397 -0.82 . . . . 74.11 110.324 -174.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 115.643 -0.708 . . . . 63.52 109.909 179.174 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.836 0 N-CA-C 112.347 -0.301 . . . . 64.54 112.347 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -80.26 141.49 14.47 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.997 2.465 . . . . 72.44 111.571 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.76 83.04 0.81 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.056 -0.592 . . . . 52.53 112.067 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.2 p -74.73 174.48 9.07 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.715 0.293 . . . . 64.44 110.869 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.4 mtp -77.8 -65.04 1.02 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.756 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.4 m -86.4 135.55 33.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.852 -0.613 . . . . 74.2 111.169 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 48.2 mm -101.43 134.09 42.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.427 -0.953 . . . . 74.54 108.427 170.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 7' ' ' ILE . 90.6 m-20 70.17 159.88 0.15 Allowed Pre-proline 0 N--CA 1.468 0.461 0 O-C-N 123.486 0.491 . . . . 64.43 109.993 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.8 -18.32 55.59 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.086 1.857 . . . . 71.44 112.082 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -113.77 110.75 20.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.512 . . . . 72.32 110.209 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -73.67 78.46 1.52 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.618 -0.882 . . . . 75.4 108.618 175.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -137.81 27.06 2.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.591 -0.731 . . . . 73.54 110.014 -174.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 15' ' ' GLY . 10.7 t70 -58.65 -19.17 36.81 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 114.66 -1.155 . . . . 74.53 111.573 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.823 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 8.9 p30 -68.54 14.6 0.07 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.002 -0.999 . . . . 73.33 113.118 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 13' ' ' ASP . . . -104.66 -10.43 33.07 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.102 -0.57 . . . . 55.21 112.442 177.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.485 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 4.5 m -73.47 140.27 46.35 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.643 0.609 . . . . 71.32 112.643 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.673 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -67.12 -158.02 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.897 0.379 . . . . 74.22 110.411 159.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.483 ' HB3' ' HA ' ' A' ' 46' ' ' GLU . 31.2 p90 -122.9 135.93 54.68 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.458 0.647 . . . . 74.44 109.66 -167.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.679 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 18.1 t -135.86 131.99 50.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.83 -1.077 . . . . 65.33 109.694 -167.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.488 ' HB2' ' CD1' ' A' ' 30' ' ' TRP . 29.6 tp -120.92 145.16 47.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.108 -0.497 . . . . 74.02 110.714 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 97.8 t -122.01 125.54 73.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.812 -0.811 . . . . 73.44 108.812 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -82.48 163.55 21.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.826 -0.435 . . . . 74.14 109.826 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -57.38 -31.17 65.53 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.929 0.395 . . . . 75.14 110.719 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -79.18 16.67 0.91 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.429 0.633 . . . . 73.32 110.338 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 65.44 24.62 11.95 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.473 -0.785 . . . . 73.3 111.538 173.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 93.7 mt-30 -78.73 121.19 24.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.789 -0.641 . . . . 70.43 110.104 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -99.15 116.8 32.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.265 -0.272 . . . . 74.11 110.265 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.4 t -166.33 -164.19 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.601 -0.518 . . . . 70.43 109.601 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.65 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.4 pt? -108.32 173.73 6.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.694 -0.484 . . . . 74.34 109.694 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.488 ' CD1' ' HB2' ' A' ' 20' ' ' LEU . 14.7 p-90 -134.6 149.34 70.63 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.693 -0.23 . . . . 75.52 111.163 -175.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.88 108.63 2.62 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.741 2.294 . . . . 54.3 111.703 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.28 -12.16 60.75 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.304 -0.407 . . . . 64.13 112.013 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -104.31 14.53 30.07 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.041 0.448 . . . . 72.43 110.749 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.68 179.96 6.27 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.022 -0.535 . . . . 42.14 110.51 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -79.16 118.9 21.54 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.509 -0.314 . . . . 74.13 110.443 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.613 HG21 ' NE1' ' A' ' 40' ' ' TRP . 7.7 p -96.19 110.38 51.95 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 109.02 -0.733 . . . . 74.22 109.02 173.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.463 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 36.5 Cg_endo -64.3 108.38 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.853 2.369 . . . . 74.14 114.043 -167.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.26 152.53 0.27 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.682 -0.69 . . . . 34.34 112.3 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.78 -8.1 21.83 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.735 -0.666 . . . . 60.32 111.702 -174.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.613 ' NE1' HG21 ' A' ' 36' ' ' VAL . 4.9 p-90 -87.72 -177.61 5.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 122.972 0.509 . . . . 74.51 110.746 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.608 ' HB3' HD11 ' A' ' 63' ' ' ILE . 49.0 mtt85 -128.95 125.38 37.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.288 -1.005 . . . . 64.44 108.288 171.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 p -91.47 116.63 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.962 0.41 . . . . 73.31 111.162 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.679 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 61.4 t -76.98 -35.36 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.095 0.474 . . . . 73.33 110.288 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.421 ' CD2' ' HB2' ' A' ' 16' ' ' SER . 2.1 m80 -157.02 132.2 9.05 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.632 -0.713 . . . . 73.35 109.828 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -71.31 167.66 51.62 Favored Glycine 0 C--N 1.34 0.773 0 O-C-N 124.337 1.023 . . . . 61.03 112.461 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.483 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -55.45 147.1 18.24 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.389 0.885 . . . . 74.34 113.389 -170.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.614 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -148.99 -178.31 6.3 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.735 -1.12 . . . . 73.41 109.24 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -91.89 172.28 8.57 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.001 0.429 . . . . 61.52 111.357 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -57.8 -32.25 67.37 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.137 -0.483 . . . . 74.33 110.117 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.7 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -52.35 -52.66 52.14 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 109.343 -0.614 . . . . 72.03 109.343 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.485 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -64.26 -31.56 72.8 Favored 'General case' 0 C--O 1.262 1.724 0 CA-C-N 115.439 -0.801 . . . . 52.32 111.274 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.673 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 53.0 t -66.14 -36.53 83.37 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 114.55 -1.204 . . . . 74.52 110.57 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.615 ' O ' HG21 ' A' ' 56' ' ' ILE . 76.0 mt -72.0 -44.39 63.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.52 -0.548 . . . . 74.32 109.52 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.7 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 4.3 mm-40 -62.34 -25.55 67.96 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.417 -0.356 . . . . 75.13 111.12 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.608 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -46.09 -27.17 0.89 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 111.715 0.265 . . . . 73.43 111.715 173.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.615 HG21 ' O ' ' A' ' 53' ' ' LEU . 19.7 tt -60.85 -47.83 91.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 121.477 0.656 . . . . 72.14 110.271 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -73.83 -35.47 64.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.098 -0.955 . . . . 72.01 110.364 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.647 ' HG3' ' HG3' ' A' ' 61' ' ' PRO . 4.6 tp10 -74.89 -36.35 62.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.0 -1.0 . . . . 74.42 111.361 -172.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 67.91 -87.36 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.845 -0.616 . . . . 71.52 111.63 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -159.08 91.34 1.96 Allowed Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 122.445 0.298 . . . . 74.23 110.669 -175.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.647 ' HG3' ' HG3' ' A' ' 58' ' ' GLU . 5.1 Cg_exo -79.94 -172.26 1.48 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.936 2.424 . . . . 74.04 111.674 175.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.56 168.51 19.16 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.293 0.568 . . . . 74.44 111.894 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.673 HG13 ' HA ' ' A' ' 43' ' ' VAL . 8.6 tt -101.82 124.47 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.253 -0.885 . . . . 65.41 112.344 -169.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.493 ' HB2' ' HD2' ' A' ' 65' ' ' PRO . 0.1 OUTLIER 178.71 163.34 0.68 Allowed Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.024 -0.535 . . . . 72.23 109.774 170.162 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 64' ' ' ARG . 33.7 Cg_endo -62.85 -170.39 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.126 2.551 . . . . 62.12 113.437 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HZ1' ' CD ' ' A' ' 46' ' ' GLU . 31.1 tttp -63.5 84.28 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.976 -0.556 . . . . 64.54 111.337 -174.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.3 p -135.41 47.36 2.31 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.727 -0.842 . . . . 72.44 108.727 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.823 ' HB2' ' HA ' ' A' ' 14' ' ' ASN . 2.3 pt? -65.0 -25.31 67.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.546 -1.206 . . . . 74.14 111.991 -174.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.594 ' HG3' ' HG ' ' A' ' 68' ' ' LEU . 59.9 mtm180 -117.59 111.72 19.59 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.747 -0.094 . . . . 72.54 110.747 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 61.66 121.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 O-C-N 124.0 0.813 . . . . 72.12 112.777 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -75.46 63.99 1.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.196 -0.668 . . . . 73.4 109.196 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -165.42 -49.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.842 -0.617 . . . . 75.41 109.728 -174.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -130.77 -164.41 1.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 32.42 110.506 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.5 m -143.25 -52.65 0.36 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.058 0.456 . . . . 74.24 110.279 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.84 -154.34 22.63 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.751 -0.659 . . . . 72.52 111.487 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -150.68 156.19 40.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.74 -0.467 . . . . 74.3 109.74 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.19 103.55 0.2 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.08 -0.581 . . . . 61.11 112.265 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -162.16 -179.93 7.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.181 -0.674 . . . . 74.31 109.181 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 t70 72.38 16.72 4.95 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.876 0.846 . . . . 74.11 110.097 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 C--O 1.247 0.936 0 CA-C-N 115.112 -0.949 . . . . 63.52 110.165 179.854 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 111.814 -0.515 . . . . 64.54 111.814 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.22 93.08 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.396 2.064 . . . . 72.44 111.43 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.27 111.45 4.13 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.883 -0.599 . . . . 52.53 112.314 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.9 p -65.45 130.33 42.93 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.294 -0.261 . . . . 64.44 110.294 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.413 ' HE1' ' HB2' ' A' ' 5' ' ' MET . 35.3 tpp -54.41 -51.94 63.31 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.306 0.574 . . . . 74.33 109.81 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.7 t -165.88 149.94 8.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.092 -0.958 . . . . 74.2 110.366 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.5 mt -142.74 147.46 20.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.244 -0.889 . . . . 74.54 109.013 176.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 8.0 t30 74.49 132.29 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.537 0 O-C-N 123.656 0.597 . . . . 64.43 110.823 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 8' ' ' ASN . 23.1 Cg_exo -65.32 160.64 41.43 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.797 2.331 . . . . 71.44 112.348 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -69.45 95.61 0.83 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.324 -0.621 . . . . 72.32 109.324 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.414 ' HB3' HH12 ' A' ' 64' ' ' ARG . 32.5 t70 -111.23 72.03 0.76 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.589 . . . . 75.4 111.162 -170.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 53.62 28.95 8.54 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.827 -0.624 . . . . 73.54 111.837 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HD3' ' A' ' 64' ' ' ARG . 11.1 m-20 -58.64 -44.16 89.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 74.53 110.368 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.472 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 7.4 m-20 -97.42 15.4 23.19 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.599 -0.728 . . . . 73.33 111.042 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.82 -46.57 75.56 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.371 -0.442 . . . . 55.21 113.27 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.8 m -139.83 58.38 1.6 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.972 -1.121 . . . . 71.32 107.972 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 14' ' ' ASN . 62.2 m-85 -162.21 109.8 1.35 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 114.424 -1.262 . . . . 74.22 114.351 -156.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -151.51 130.71 12.73 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.306 -0.998 . . . . 74.44 108.306 150.456 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.43 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 64.0 t -158.1 136.71 3.13 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 CA-C-O 121.128 0.489 . . . . 65.33 112.152 -169.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.4 tp -102.21 122.96 45.21 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.445 -0.798 . . . . 74.02 109.514 174.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.55 125.82 50.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.241 -0.651 . . . . 73.44 109.241 174.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.447 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 14.3 m120 -96.92 139.26 33.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.781 -0.645 . . . . 74.14 110.254 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.72 -15.92 59.75 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.087 0.47 . . . . 75.14 110.843 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -85.24 26.56 0.88 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.031 -0.531 . . . . 73.32 111.078 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 69.8 6.25 5.64 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.314 0.646 . . . . 73.3 111.803 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.447 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 15.7 mm100 -90.86 153.78 19.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.929 0.395 . . . . 70.43 110.45 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -133.37 109.09 9.11 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.394 -0.965 . . . . 74.11 108.394 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.3 t -128.38 177.21 7.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.772 0.796 . . . . 70.43 111.889 -170.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.3 tt -111.71 106.59 15.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.594 -1.185 . . . . 74.34 108.065 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.447 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 25.3 p-90 -77.67 149.49 77.86 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.059 -0.519 . . . . 75.52 111.206 -174.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.89 104.07 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.038 1.825 . . . . 54.3 111.085 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -63.42 -2.15 1.43 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.23 -0.441 . . . . 64.13 111.621 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -89.78 -0.72 57.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 72.43 110.789 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.2 178.0 7.24 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.05 0.452 . . . . 42.14 111.688 -175.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -95.92 140.11 31.15 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.593 -0.731 . . . . 74.13 111.028 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.3 t -91.48 123.95 62.38 Favored Pre-proline 0 C--O 1.236 0.383 0 CA-C-N 116.243 -0.435 . . . . 74.22 111.037 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.54 153.75 73.04 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.616 2.211 . . . . 74.14 111.708 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.05 152.18 38.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.94 0.4 . . . . 34.34 110.714 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.4 -35.53 4.91 Favored Glycine 0 N--CA 1.455 -0.073 0 N-CA-C 111.036 -0.826 . . . . 60.32 111.036 -174.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -95.01 129.21 42.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.757 -1.201 . . . . 74.51 107.757 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -100.12 125.64 46.25 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.622 -0.51 . . . . 64.44 109.622 -171.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.69 117.88 34.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.99 -0.744 . . . . 73.31 108.99 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.43 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 14.4 p -84.16 -23.35 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.681 0.753 . . . . 73.33 109.548 -174.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 64' ' ' ARG . 27.2 m80 -148.29 115.48 6.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.036 -0.984 . . . . 73.35 108.714 173.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -69.74 -171.51 8.73 Favored Glycine 0 N--CA 1.447 -0.583 0 O-C-N 123.864 0.728 . . . . 61.03 112.501 -175.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.44 133.88 34.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.146 0.498 . . . . 74.34 111.322 -178.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.87 175.89 9.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.541 -0.754 . . . . 73.41 110.017 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.74 159.58 21.96 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.984 -0.553 . . . . 61.52 111.273 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.557 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 15.7 ttm180 -58.38 -37.72 75.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.242 -0.651 . . . . 74.33 109.242 176.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.74 -36.82 84.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.028 -0.533 . . . . 72.03 110.468 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 14' ' ' ASN . . . -69.02 -38.47 79.22 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-N 115.855 -0.611 . . . . 52.32 111.389 -176.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.557 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 27.0 p -73.44 -47.26 43.06 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.411 -0.813 . . . . 74.52 110.995 174.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 72.8 mt -60.89 -34.5 74.74 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.503 -0.317 . . . . 74.32 110.594 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -76.82 -37.54 55.5 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.885 -0.326 . . . . 75.13 110.54 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.531 ' HE1' ' HB2' ' A' ' 60' ' ' TRP . 11.0 t80 -48.26 -58.12 5.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 120.438 -0.505 . . . . 73.43 111.588 170.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 52' ' ' CYS . 3.7 tt -61.65 -38.55 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 120.672 0.272 . . . . 72.14 111.032 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -60.54 -43.49 97.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 72.01 110.51 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -81.94 -14.89 55.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.895 -0.593 . . . . 74.42 111.428 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.4 t60 61.68 34.94 17.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.151 -0.477 . . . . 71.52 110.853 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.531 ' HB2' ' HE1' ' A' ' 55' ' ' TYR . 75.0 t-105 64.79 83.62 0.19 Allowed Pre-proline 0 N--CA 1.471 0.581 0 CA-C-O 120.962 0.411 . . . . 74.23 110.079 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -87.86 -33.81 0.13 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.917 2.411 . . . . 74.04 113.726 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -145.88 171.15 15.23 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.309 -0.245 . . . . 74.44 110.925 -170.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.649 HD13 ' H ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -122.52 136.71 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.184 0.516 . . . . 65.41 111.523 -173.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.451 ' HD3' ' OD1' ' A' ' 13' ' ' ASP . 59.5 mtt180 -149.68 153.6 36.71 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 115.632 -0.713 . . . . 72.23 109.277 176.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.6 171.49 17.09 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.968 2.445 . . . . 62.12 113.327 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -73.88 136.63 43.4 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.379 -0.828 . . . . 64.54 110.316 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.523 ' C ' HD12 ' A' ' 68' ' ' LEU . 13.7 m -64.98 81.45 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.44 -0.345 . . . . 72.44 110.854 176.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 67' ' ' SER . 0.0 OUTLIER 31.25 -167.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 116.248 1.944 . . . . 74.14 116.248 174.226 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.449 ' HG2' ' N ' ' A' ' 70' ' ' ASP . 57.0 ttt180 -175.25 161.74 2.85 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 113.803 -1.544 . . . . 72.54 108.11 172.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 8.5 p-10 -57.98 114.4 2.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.232 0.539 . . . . 72.12 111.463 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 70' ' ' ASP . 5.1 mptp? -124.34 27.09 7.14 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.042 -0.526 . . . . 73.4 110.377 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.7 tp -85.9 48.73 1.65 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.547 0.689 . . . . 75.41 109.964 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.73 24.29 2.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.59 -0.732 . . . . 32.42 111.029 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.4 p -66.44 127.77 33.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 74.24 111.018 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.86 120.93 0.96 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.244 -0.503 . . . . 72.52 112.035 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -134.91 128.4 32.5 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.506 -0.553 . . . . 74.3 109.506 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -147.14 -159.2 8.19 Favored Glycine 0 C--O 1.236 0.256 0 N-CA-C 111.496 -0.642 . . . . 61.11 111.496 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.9 t80 179.72 -84.06 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.809 -0.441 . . . . 74.31 109.809 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -82.19 -41.96 19.63 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.421 -0.585 . . . . 74.11 109.421 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.537 ' NE2' ' H ' ' A' ' 80' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.03 0 N-CA-C 108.466 -0.939 . . . . 63.52 108.466 169.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.867 0 N-CA-C 111.934 -0.466 . . . . 64.54 111.934 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.57 152.79 23.16 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.758 2.305 . . . . 72.44 112.225 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.7 70.31 2.89 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 116.022 -0.536 . . . . 52.53 112.421 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.7 m -69.93 102.87 2.08 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.068 -0.345 . . . . 64.44 110.068 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.532 ' CE ' ' HA ' ' A' ' 71' ' ' LYS . 81.8 mmm -57.23 -57.56 12.08 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.2 -0.454 . . . . 74.33 110.548 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.9 m -80.86 112.19 18.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.99 -0.55 . . . . 74.2 109.648 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.427 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 67.5 mt -75.47 102.59 2.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.219 -0.446 . . . . 74.54 110.808 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -101.31 91.13 1.93 Allowed Pre-proline 0 C--O 1.235 0.318 0 N-CA-C 108.408 -0.96 . . . . 64.43 108.408 169.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 7' ' ' ILE . 83.9 Cg_endo -85.35 151.94 10.59 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.759 2.306 . . . . 71.44 112.943 -171.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -131.63 -75.77 0.52 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.813 -0.631 . . . . 72.32 109.54 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -75.47 -24.06 56.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.12 0.486 . . . . 75.4 109.868 175.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.43 -30.36 60.33 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.378 -0.828 . . . . 73.54 110.939 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -58.05 -35.1 70.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.706 -0.679 . . . . 74.53 111.303 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -97.09 13.08 30.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.202 0.525 . . . . 73.33 110.263 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.1 60.84 4.56 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 116.149 -0.478 . . . . 55.21 112.871 -174.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 32.3 m -68.99 150.86 47.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.108 -0.33 . . . . 71.32 110.108 175.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.597 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 68.5 t80 -68.34 102.91 1.49 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.904 -0.718 . . . . 74.22 109.843 174.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -144.44 131.57 20.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.36 -1.348 . . . . 74.44 107.36 169.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -141.79 123.6 13.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.267 0.555 . . . . 65.33 111.003 -170.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.432 HD11 ' HB3' ' A' ' 40' ' ' TRP . 52.2 tp -93.48 127.99 39.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.202 -0.908 . . . . 74.02 109.64 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 61.8 t -121.44 129.16 75.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.232 0.539 . . . . 73.44 110.909 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 33.4 t30 -92.81 151.78 19.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.92 -0.77 . . . . 74.14 108.92 173.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -54.54 -19.94 6.86 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.159 0.504 . . . . 75.14 110.95 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -82.64 20.61 1.1 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.965 -0.561 . . . . 73.32 111.635 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 65.62 12.57 8.34 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.976 0.51 . . . . 73.3 111.849 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 34.6 tt0 -76.03 117.64 17.95 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.341 -0.615 . . . . 70.43 109.341 176.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -122.52 107.95 12.6 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.01 0.434 . . . . 74.11 111.298 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 m -132.38 -168.03 1.99 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.549 -0.75 . . . . 70.43 109.359 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.697 HD21 ' H ' ' A' ' 29' ' ' LEU . 1.9 pt? -106.38 161.63 14.4 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.238 -0.653 . . . . 74.34 109.238 174.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.463 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 20.0 p-90 -131.8 145.03 55.72 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.614 0.245 . . . . 75.52 111.31 -173.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 14.0 Cg_exo -69.86 103.67 1.21 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.727 2.285 . . . . 54.3 111.291 176.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.463 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -60.01 -22.52 62.7 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.14 -0.482 . . . . 64.13 112.03 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -84.88 4.26 34.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.615 -0.266 . . . . 72.43 111.436 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.99 162.44 22.33 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.806 0.336 . . . . 42.14 110.725 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -82.97 132.84 35.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 74.13 110.597 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.97 115.95 62.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 74.22 110.198 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.68 147.1 95.92 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.345 2.03 . . . . 74.14 112.169 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.37 137.76 57.0 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.203 -0.453 . . . . 34.34 110.685 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.42 -35.42 4.55 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.42 -0.672 . . . . 60.32 111.42 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.432 ' HB3' HD11 ' A' ' 20' ' ' LEU . 71.0 m95 -81.37 140.6 34.63 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.581 -0.526 . . . . 74.51 109.581 177.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -127.61 126.13 41.49 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.151 -0.314 . . . . 64.44 110.151 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.6 t -85.21 130.57 35.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.583 -0.525 . . . . 73.31 109.583 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -85.43 -31.33 6.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.228 0.537 . . . . 73.33 109.997 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -154.58 122.95 6.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.924 -0.769 . . . . 73.35 108.924 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.03 -172.41 42.18 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.28 -0.486 . . . . 61.03 112.522 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -61.73 154.52 25.3 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 110.244 -0.28 . . . . 74.34 110.244 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.44 ' HB1' ' CB ' ' A' ' 51' ' ' ALA . . . -160.71 -178.25 6.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.118 0.485 . . . . 73.41 111.762 -175.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -68.91 178.45 2.19 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.954 -1.021 . . . . 61.52 111.9 -175.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -61.15 -27.86 68.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.38 -0.827 . . . . 74.33 110.203 177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -51.84 -44.97 63.81 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.162 0.505 . . . . 72.03 110.01 172.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.44 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -75.81 -31.74 59.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.428 -0.806 . . . . 52.32 110.846 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 52.8 t -54.12 -42.01 68.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.042 -0.527 . . . . 74.52 110.067 170.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.06 -29.85 68.91 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.055 -0.52 . . . . 74.32 110.665 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 94.8 mt-10 -70.05 -51.65 30.3 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.445 -0.343 . . . . 75.13 111.039 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.597 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 2.7 t80 -58.48 -41.9 86.34 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.603 -0.271 . . . . 73.43 111.693 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.7 tt -71.03 -45.62 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 121.085 -0.246 . . . . 72.14 111.146 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -64.57 -52.6 56.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.418 -0.356 . . . . 72.01 110.302 -177.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -70.68 -33.14 70.6 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.948 -0.569 . . . . 74.42 110.337 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 41.55 61.2 1.91 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.829 0.852 . . . . 71.52 111.826 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.676 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 23.0 t90 -86.02 -52.84 0.45 Allowed Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 115.282 -0.872 . . . . 74.23 111.471 -178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' A' ' 60' ' ' TRP . 20.0 Cg_exo -67.33 -52.62 0.57 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.126 1.884 . . . . 74.04 112.029 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -105.81 132.63 51.69 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.755 -0.461 . . . . 74.44 109.755 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.515 ' N ' HD13 ' A' ' 63' ' ' ILE . 2.8 mp -83.5 90.58 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.277 -0.42 . . . . 65.41 110.905 -173.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.567 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 31.5 ttt85 -80.13 102.54 1.25 Allowed Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 108.228 -1.027 . . . . 72.23 108.228 168.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -70.64 144.21 48.75 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.907 2.405 . . . . 62.12 113.405 -167.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp 57.8 15.1 2.81 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.41 -0.814 . . . . 64.54 112.162 174.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.567 ' HB2' ' HG2' ' A' ' 64' ' ' ARG . 27.9 t -80.92 68.82 7.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.537 0.684 . . . . 72.44 110.305 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 mp -102.03 -73.67 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.474 -0.935 . . . . 74.14 108.474 173.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 60.2 mmt-85 -90.85 70.54 6.53 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.814 -0.81 . . . . 72.54 108.814 171.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -60.92 107.36 0.7 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.697 -0.683 . . . . 72.12 109.784 -175.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.532 ' HA ' ' CE ' ' A' ' 5' ' ' MET . 1.8 tmtp? 54.51 50.5 15.93 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.221 1.01 . . . . 73.4 110.263 -175.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 71.41 -0.01 3.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.906 -1.043 . . . . 75.41 111.269 171.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 69' ' ' ARG . . . -80.42 149.83 30.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.766 0.317 . . . . 32.42 110.729 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.1 p -75.19 121.52 22.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.528 -0.306 . . . . 74.24 110.739 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.84 170.17 43.3 Favored Glycine 0 C--O 1.237 0.323 0 C-N-CA 121.065 -0.588 . . . . 72.52 112.418 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -148.58 156.03 41.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.517 -0.549 . . . . 74.3 109.517 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -167.1 111.33 0.44 Allowed Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.629 -0.714 . . . . 61.11 111.674 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -169.52 163.55 10.32 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.98 -0.378 . . . . 74.31 109.98 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -152.41 111.24 3.8 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.789 0.328 . . . . 74.11 110.203 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.343 -0.837 . . . . 63.52 108.962 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.421 ' HA3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 112.105 -0.398 . . . . 64.54 112.105 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 1' ' ' GLY . 38.4 Cg_exo -60.73 92.92 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.819 2.346 . . . . 72.44 112.663 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.59 27.91 1.06 Allowed Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 111.377 -0.689 . . . . 52.53 111.377 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.9 m -78.18 -171.55 2.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.253 0.549 . . . . 64.44 111.845 -175.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.417 ' O ' ' HB2' ' A' ' 6' ' ' SER . 81.6 mmm -58.45 -32.65 68.91 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.616 -0.72 . . . . 74.33 111.438 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 5' ' ' MET . 20.1 m 74.55 19.74 2.6 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 123.711 1.719 . . . . 74.2 110.676 -175.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.36 83.03 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.673 0 CA-C-N 110.846 -2.888 . . . . 74.54 108.628 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.585 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 26.1 t-20 -169.19 -51.08 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.713 -1.13 . . . . 64.43 109.445 -176.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 8' ' ' ASN . 76.7 Cg_endo -88.07 143.11 5.69 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.007 1.805 . . . . 71.44 111.403 172.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -73.81 -26.7 60.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.322 0.582 . . . . 72.32 109.538 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -80.07 97.08 6.68 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.437 -0.802 . . . . 75.4 109.331 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -63.58 119.7 10.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 73.54 111.753 -175.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.87 -21.78 66.23 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.051 -0.522 . . . . 74.53 111.205 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.494 ' HA ' ' HB3' ' A' ' 65' ' ' PRO . 7.8 t30 -85.62 -11.26 54.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.041 0.448 . . . . 73.33 110.521 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.4 112.05 3.61 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 116.095 -0.502 . . . . 55.21 112.717 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.496 ' C ' ' HB2' ' A' ' 51' ' ' ALA . 46.6 t -162.92 141.26 8.34 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.304 0.242 . . . . 71.32 110.443 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.819 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 19.0 t80 -66.98 -160.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.066 -0.716 . . . . 74.22 109.066 171.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.643 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 46.1 p90 -125.22 138.15 54.12 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.366 -0.834 . . . . 74.44 111.652 -172.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -142.15 133.81 26.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 114.955 -1.02 . . . . 65.33 110.11 -173.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.633 ' HB2' ' CE3' ' A' ' 30' ' ' TRP . 17.8 tp -120.88 142.67 49.46 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 122.978 0.511 . . . . 74.02 110.754 -174.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.8 147.8 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.619 -0.264 . . . . 73.44 110.356 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -122.72 161.4 23.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.531 -0.304 . . . . 74.14 110.628 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -58.5 -25.46 62.39 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.889 -0.596 . . . . 75.14 111.202 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -83.49 22.93 0.99 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.627 -0.715 . . . . 73.32 111.512 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 65.53 14.25 9.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.879 0.471 . . . . 73.3 111.321 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -86.57 123.08 31.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.497 -0.319 . . . . 70.43 110.534 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -120.56 126.51 50.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.544 -0.539 . . . . 74.11 109.544 176.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 p -164.42 -154.44 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 70.43 110.346 -173.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.508 HD21 ' H ' ' A' ' 29' ' ' LEU . 2.2 pt? -131.85 164.9 25.03 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.122 -0.695 . . . . 74.34 109.122 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.643 ' CH2' ' HB2' ' A' ' 18' ' ' PHE . 20.1 p90 -125.91 147.8 60.32 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-O 120.46 0.172 . . . . 75.52 111.033 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 13.8 Cg_exo -70.0 99.25 0.76 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.552 2.168 . . . . 54.3 111.133 173.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.99 -7.38 8.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.309 -0.405 . . . . 64.13 111.22 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -81.45 -2.46 49.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.985 -0.552 . . . . 72.43 110.706 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.0 177.62 7.84 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.413 -0.358 . . . . 42.14 110.642 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -80.79 138.55 36.27 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.814 -0.439 . . . . 74.13 109.814 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 t -90.45 126.29 56.93 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.138 -0.483 . . . . 74.22 110.45 -175.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' O ' ' HD1' ' A' ' 40' ' ' TRP . 38.6 Cg_endo -66.27 110.92 1.9 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.882 2.388 . . . . 74.14 112.501 -176.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -44.73 150.85 0.32 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.199 0.814 . . . . 34.34 113.199 -172.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.98 23.93 4.75 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.541 -0.754 . . . . 60.32 111.85 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.419 ' HD1' ' O ' ' A' ' 37' ' ' PRO . 25.3 p-90 -130.2 160.08 34.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.897 0.379 . . . . 74.51 111.18 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.41 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 4.6 mmp_? -122.7 127.01 48.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.708 -0.849 . . . . 64.44 108.708 171.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.437 HG22 ' CH2' ' A' ' 30' ' ' TRP . 7.5 p -89.4 119.6 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 120.825 0.345 . . . . 73.31 110.423 -177.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.85 -38.18 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.455 0.645 . . . . 73.33 110.555 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.632 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 26.0 m80 -132.56 136.39 46.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.349 -0.841 . . . . 73.35 108.849 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.43 160.44 22.01 Favored Glycine 0 C--N 1.332 0.334 0 O-C-N 123.525 0.516 . . . . 61.03 112.892 -176.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.67 132.98 54.12 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.843 0.354 . . . . 74.34 111.031 -178.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.5 -177.89 6.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.137 0.494 . . . . 73.41 111.734 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.76 172.71 2.06 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.241 -0.89 . . . . 61.52 112.716 -174.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.439 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 14.6 ttp180 -58.63 -42.91 89.34 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.575 -0.739 . . . . 74.33 111.172 178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.493 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -52.5 -46.5 66.67 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.299 -0.63 . . . . 72.03 109.299 177.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.496 ' HB2' ' C ' ' A' ' 16' ' ' SER . . . -63.21 -34.7 78.21 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.019 -0.991 . . . . 52.32 111.081 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.819 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 36.7 m -60.39 -46.14 91.06 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.367 -0.833 . . . . 74.52 109.928 171.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.18 -24.78 62.3 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.486 -0.779 . . . . 74.32 110.561 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 42.1 mt-10 -76.93 -36.95 56.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 75.13 110.844 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -54.82 -50.46 68.53 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.659 0.244 . . . . 73.43 111.659 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.8 -34.89 49.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.032 0.444 . . . . 72.14 110.007 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -73.67 -25.59 60.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.762 -0.654 . . . . 72.01 110.819 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.493 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 53.7 mt-10 -65.88 -54.62 24.17 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.108 0.48 . . . . 74.42 109.985 173.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 77.0 t60 58.07 38.38 26.6 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.21 -0.904 . . . . 71.52 109.16 -174.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 70.05 92.78 0.06 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.006 -0.997 . . . . 74.23 109.924 -176.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 58' ' ' GLU . 24.1 Cg_endo -97.16 -158.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.528 2.819 . . . . 74.04 113.112 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -96.63 -35.62 10.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.506 -0.77 . . . . 74.44 110.823 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.08 139.35 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.783 -0.644 . . . . 65.41 111.119 -174.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -124.04 137.64 29.28 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 109.555 -0.535 . . . . 72.23 109.555 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 42.5 Cg_endo -66.07 104.6 0.73 Allowed 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.576 2.184 . . . . 62.12 112.933 -177.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -76.51 76.89 3.22 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.334 -0.987 . . . . 64.54 108.334 170.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.2 t -68.73 154.36 42.1 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.975 -1.011 . . . . 72.44 112.038 -170.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.1 tp -170.97 -69.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.778 -1.101 . . . . 74.14 108.443 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -179.74 153.92 0.56 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.86 -0.793 . . . . 72.54 108.86 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.595 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 27.9 t70 -68.29 160.48 29.29 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.886 -0.413 . . . . 72.12 109.886 175.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.701 ' HD2' ' H ' ' A' ' 71' ' ' LYS . 4.3 mptt -89.27 -13.17 38.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.411 -0.358 . . . . 73.4 111.022 -170.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.6 tp -119.75 7.59 11.04 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.187 0.517 . . . . 75.41 109.998 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 70' ' ' ASP . . . -72.06 86.4 1.03 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.166 -0.47 . . . . 32.42 110.899 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.4 p -87.57 102.17 14.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.469 . . . . 74.24 109.837 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.02 53.39 3.4 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.447 -0.406 . . . . 72.52 112.874 -177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -168.55 116.54 0.69 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.247 -0.649 . . . . 74.3 109.247 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.54 139.94 12.18 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.083 -0.579 . . . . 61.11 112.445 -176.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -76.37 -18.48 58.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.508 0.671 . . . . 74.31 109.458 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.26 80.75 0.09 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.507 -1.224 . . . . 74.11 109.854 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 . . . . . 0 C--O 1.247 0.94 0 CA-C-N 114.55 -1.205 . . . . 63.52 111.579 176.929 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 112.238 -0.345 . . . . 64.54 112.238 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.9 -68.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.694 2.263 . . . . 72.44 112.011 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.86 41.96 2.09 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.972 -0.558 . . . . 52.53 112.033 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.7 m -67.46 102.81 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 64.44 110.239 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.466 ' O ' ' HG2' ' A' ' 69' ' ' ARG . 31.5 mmt -88.48 -8.82 54.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.056 -0.52 . . . . 74.33 110.985 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.8 p -146.44 142.6 28.3 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.675 0.274 . . . . 74.2 111.233 -174.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.2 mt -101.53 95.58 4.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 109.352 -0.61 . . . . 74.54 109.352 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -70.37 114.32 25.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 64.43 110.956 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -85.37 173.34 7.7 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.893 2.395 . . . . 71.44 112.657 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -109.14 -174.5 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.9 -0.591 . . . . 72.32 110.373 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.47 155.27 18.72 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.208 0.527 . . . . 75.4 111.747 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.06 -24.49 66.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.174 -0.921 . . . . 73.54 111.836 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -51.21 -55.48 17.82 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.281 -0.418 . . . . 74.53 111.88 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -87.51 8.46 24.85 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.034 0.445 . . . . 73.33 111.35 -174.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.21 -31.93 63.35 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.726 -0.75 . . . . 55.21 113.435 -175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.801 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 23.7 m -93.01 149.93 20.89 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 117.051 0.425 . . . . 71.32 111.914 -172.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.541 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 1.7 t80 -68.42 103.31 1.61 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-O 120.968 0.413 . . . . 74.22 110.051 174.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -140.97 131.18 24.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.321 -1.363 . . . . 74.44 107.321 165.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 43' ' ' VAL . 98.7 t -147.91 129.86 6.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 121.002 0.429 . . . . 65.33 110.345 -170.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 40' ' ' TRP . 46.2 tp -105.42 139.29 40.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.566 -0.743 . . . . 74.02 110.124 -177.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.1 t -118.41 126.09 74.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 109.41 -0.589 . . . . 73.44 109.41 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -95.09 162.54 13.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.295 -0.411 . . . . 74.14 110.007 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.44 -11.9 37.98 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.236 0.541 . . . . 75.14 110.232 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -83.08 9.62 9.96 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.35 -0.841 . . . . 73.32 110.768 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 66.08 9.85 6.56 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.088 0.555 . . . . 73.3 110.65 -174.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.5 HE21 ' HB2' ' A' ' 28' ' ' SER . 48.4 tp60 -74.06 118.27 16.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.118 -0.492 . . . . 70.43 110.171 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.651 ' HB2' ' HZ2' ' A' ' 60' ' ' TRP . 19.6 p-80 -108.71 98.63 8.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.084 -0.507 . . . . 74.11 110.165 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.5 ' HB2' HE21 ' A' ' 26' ' ' GLN . 33.5 t -133.17 -173.17 3.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.354 -0.385 . . . . 70.43 110.06 -175.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.713 HD21 ' H ' ' A' ' 29' ' ' LEU . 2.1 pt? -107.57 147.84 30.06 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.423 -0.584 . . . . 74.34 109.423 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.446 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 43.2 p-90 -116.1 129.43 25.21 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.642 -0.254 . . . . 75.52 110.478 -177.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 33.3 Cg_exo -61.82 108.44 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.472 2.115 . . . . 54.3 111.67 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.446 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -60.59 -18.53 53.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.166 -0.47 . . . . 64.13 111.845 -178.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -93.05 9.41 35.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 72.43 111.285 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.57 175.8 7.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.224 -0.444 . . . . 42.14 110.754 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -95.94 128.49 42.88 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.248 -0.433 . . . . 74.13 110.799 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.499 HG12 ' NE1' ' A' ' 40' ' ' TRP . 3.2 t -91.87 110.78 46.09 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.263 -0.426 . . . . 74.22 110.138 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.43 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 38.5 Cg_endo -67.2 115.67 3.78 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 123.103 2.536 . . . . 74.14 112.582 -176.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -46.12 151.9 0.45 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.189 0.811 . . . . 34.34 113.189 -172.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.2 26.52 3.73 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.408 -0.814 . . . . 60.32 111.741 -175.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.499 ' NE1' HG12 ' A' ' 36' ' ' VAL . 17.2 p-90 -134.74 -178.82 5.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.151 0.5 . . . . 74.51 110.952 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -145.06 126.05 14.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.65 -0.871 . . . . 64.44 108.65 169.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.87 134.65 28.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.078 -0.341 . . . . 73.31 110.078 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 19' ' ' VAL . 9.8 p -89.79 -25.5 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.544 0.688 . . . . 73.33 109.965 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -155.05 121.51 5.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.213 -0.903 . . . . 73.35 109.095 175.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.45 -174.78 50.26 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.188 -0.529 . . . . 61.03 111.955 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.5 112.13 1.48 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.09 0.471 . . . . 74.34 109.857 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.21 -177.78 3.51 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.765 0.654 . . . . 73.41 112.765 -165.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -86.74 179.87 6.69 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.175 -0.92 . . . . 61.52 112.437 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.469 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 32.2 ttm180 -48.48 -41.44 29.75 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.629 -1.169 . . . . 74.33 111.393 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.518 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -52.82 -47.18 67.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.146 0.498 . . . . 72.03 110.094 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 17' ' ' PHE . . . -69.88 -31.17 68.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.564 -0.743 . . . . 52.32 110.838 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.801 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 53.9 t -56.84 -42.5 79.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.961 0.41 . . . . 74.52 110.164 171.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.44 -26.16 62.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.929 -0.578 . . . . 74.32 111.105 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 52.9 mt-10 -74.94 -53.17 9.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.362 -0.381 . . . . 75.13 111.468 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.541 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 39.7 t80 -60.84 -35.5 76.7 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 111.755 0.28 . . . . 73.43 111.755 -175.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.7 tt -71.23 -41.16 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 120.996 -0.282 . . . . 72.14 111.064 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -73.72 -57.25 4.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.901 0.381 . . . . 72.01 110.913 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -61.22 -31.86 71.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.747 -0.66 . . . . 74.42 110.926 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.8 m80 68.74 171.91 0.29 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.029 -0.532 . . . . 71.52 110.645 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.651 ' HZ2' ' HB2' ' A' ' 27' ' ' HIS . 21.2 t-105 -170.49 -48.68 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.684 -0.689 . . . . 74.23 109.377 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.473 ' HD2' ' H ' ' A' ' 60' ' ' TRP . 88.6 Cg_endo -81.54 -152.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 122.057 1.838 . . . . 74.04 111.225 172.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -75.99 -173.93 2.5 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.939 0.399 . . . . 74.44 111.127 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.8 pt -120.39 159.35 21.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 116.16 -0.473 . . . . 65.41 110.787 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -137.9 142.0 34.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.1 -0.704 . . . . 72.23 109.1 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -52.12 90.1 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.727 2.285 . . . . 62.12 112.487 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -74.09 96.69 2.75 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.693 -0.685 . . . . 64.54 109.876 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.6 t -111.89 119.24 37.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.619 -0.718 . . . . 72.44 110.015 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 68' ' ' LEU . 5.8 mp -73.33 165.81 24.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 74.14 110.318 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 5' ' ' MET . 62.4 mtp180 -67.29 159.68 28.73 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.001 -0.545 . . . . 72.54 110.602 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.0 t70 58.4 49.52 10.72 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.842 0.829 . . . . 72.12 109.289 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -79.34 9.68 4.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.543 -0.753 . . . . 73.4 110.18 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.0 tp -60.65 -44.62 96.2 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.595 -0.891 . . . . 75.41 108.595 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.75 83.15 7.19 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.058 -0.974 . . . . 32.42 108.868 171.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.9 p -62.17 -33.37 74.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.664 -0.698 . . . . 74.24 110.901 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.02 70.0 3.09 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.51 -0.636 . . . . 72.52 111.51 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -73.88 -9.25 58.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.714 0.768 . . . . 74.3 110.304 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -134.07 142.23 13.68 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.744 -1.117 . . . . 61.11 110.799 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -83.06 145.9 29.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.874 0.369 . . . . 74.31 110.889 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.44 -63.7 1.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.825 -0.625 . . . . 74.11 110.38 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.559 -0.734 . . . . 63.52 109.706 179.752 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 112.281 -0.327 . . . . 64.54 112.281 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.88 -13.6 15.87 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.519 2.146 . . . . 72.44 112.226 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.43 124.79 2.58 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.214 -0.754 . . . . 52.53 111.214 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.4 m -83.59 176.25 9.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.767 0.318 . . . . 64.44 110.521 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 74.2 mmm -74.82 -41.2 60.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.185 0.517 . . . . 74.33 109.712 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.3 p -171.22 153.99 3.84 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.234 -0.894 . . . . 74.2 109.639 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.5 mm -71.73 -63.93 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.121 -0.696 . . . . 74.54 109.121 175.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -168.82 155.02 6.58 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.331 -0.85 . . . . 64.43 108.989 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.89 106.2 1.28 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.563 2.176 . . . . 71.44 111.987 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.505 ' HD1' ' HB3' ' A' ' 67' ' ' SER . 96.5 m-85 -68.15 116.99 9.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.784 -0.45 . . . . 72.32 109.784 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -94.34 -159.06 0.68 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.88 -0.6 . . . . 75.4 111.495 -173.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 67.87 33.3 4.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.036 0.535 . . . . 73.54 110.581 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.27 -23.99 67.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.212 -0.904 . . . . 74.53 111.393 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -96.72 14.93 23.33 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.755 -0.657 . . . . 73.33 111.703 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.91 -167.08 3.74 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 114.37 0.508 . . . . 55.21 114.37 -173.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.559 ' HB3' ' CB ' ' A' ' 54' ' ' GLU . 40.4 m -98.3 82.22 2.88 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.296 0.638 . . . . 71.32 110.011 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.738 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -163.72 128.7 2.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.569 -0.741 . . . . 74.22 112.643 -161.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.414 ' H ' ' HB2' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -152.45 130.59 11.91 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.989 0.813 . . . . 74.44 109.834 153.229 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -162.85 138.3 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.053 0 CA-C-O 121.242 0.544 . . . . 65.33 111.045 170.546 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.572 ' HB2' ' CD1' ' A' ' 30' ' ' TRP . 32.3 tp -104.19 153.7 20.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.418 -0.81 . . . . 74.02 108.972 175.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.515 HG11 ' O ' ' A' ' 41' ' ' ARG . 9.7 p -136.67 134.23 48.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.952 0.406 . . . . 73.44 110.373 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -73.05 154.76 40.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.875 -0.787 . . . . 74.14 108.875 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -57.13 -23.91 50.53 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.082 0.468 . . . . 75.14 110.512 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.42 13.04 1.69 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.837 -0.619 . . . . 73.32 111.004 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 56.88 56.81 5.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.8 0.81 . . . . 73.3 110.696 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -114.74 119.89 38.21 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.709 -1.132 . . . . 70.43 108.896 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -76.08 132.29 39.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.673 -0.24 . . . . 74.11 110.502 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.8 m -153.74 178.12 10.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.012 0.434 . . . . 70.43 110.741 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.59 ' H ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -124.57 159.83 29.77 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.949 -0.76 . . . . 74.34 108.949 177.131 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.572 ' CD1' ' HB2' ' A' ' 20' ' ' LEU . 6.0 p-90 -145.13 139.49 15.15 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 121.041 -0.264 . . . . 75.52 111.59 -173.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 5.2 Cg_exo -80.14 104.9 1.71 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.072 2.515 . . . . 54.3 110.833 173.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.29 -2.08 1.98 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.467 0.543 . . . . 64.13 112.467 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -91.05 -0.14 57.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.474 0.178 . . . . 72.43 111.36 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.65 170.31 12.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.597 0.237 . . . . 42.14 110.903 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -69.44 126.39 29.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.887 -0.597 . . . . 74.13 110.08 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 t -97.61 113.25 63.22 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.756 -0.461 . . . . 74.22 109.756 -176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 21.0 Cg_endo -60.64 107.23 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.982 2.454 . . . . 74.14 113.334 -172.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.89 151.82 0.42 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.447 0.699 . . . . 34.34 112.655 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.98 5.91 21.3 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.869 -0.605 . . . . 60.32 112.065 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.446 ' CD1' ' O ' ' A' ' 37' ' ' PRO . 18.4 p-90 -107.41 175.66 5.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 74.51 110.867 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.515 ' O ' HG11 ' A' ' 21' ' ' VAL . 15.0 tpp180 -141.61 142.98 33.44 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.26 -1.015 . . . . 64.44 108.26 170.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.2 p -90.68 131.2 38.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.013 -0.366 . . . . 73.31 110.013 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.428 HG21 ' CH2' ' A' ' 60' ' ' TRP . 10.1 m -99.47 -22.42 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.313 0.578 . . . . 73.33 110.313 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.522 ' HB3' ' HB2' ' A' ' 17' ' ' PHE . 92.1 m-70 -147.63 118.72 7.72 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.224 -1.028 . . . . 73.35 108.224 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.04 165.4 7.1 Favored Glycine 0 C--N 1.332 0.35 0 O-C-N 123.807 0.692 . . . . 61.03 113.481 -172.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.45 151.35 24.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.143 0.497 . . . . 74.34 110.594 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -162.95 -177.98 5.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.948 -0.569 . . . . 73.41 110.465 -175.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -54.18 161.37 1.32 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.234 0.54 . . . . 61.52 112.01 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.685 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 46.1 ttt180 -57.12 -29.81 63.85 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.574 -0.739 . . . . 74.33 110.47 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.42 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -62.25 -47.3 84.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.939 0.4 . . . . 72.03 110.154 174.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.27 -31.4 71.7 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 116.173 -0.467 . . . . 52.32 111.544 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.685 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 16.6 p -73.51 -50.59 20.68 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.711 -0.677 . . . . 74.52 111.244 173.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 78.6 mt -59.09 -34.66 72.25 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.414 0.626 . . . . 74.32 110.346 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.559 ' CB ' ' HB3' ' A' ' 16' ' ' SER . 20.2 mm-40 -76.94 -35.19 57.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.72 -0.673 . . . . 75.13 110.485 176.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.738 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -46.33 -52.68 12.31 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 117.847 0.294 . . . . 73.43 111.599 171.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.6 tt -71.18 -36.58 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.661 0.267 . . . . 72.14 111.61 -173.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -73.31 -50.46 22.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.149 0.499 . . . . 72.01 110.498 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -61.47 -27.58 68.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.598 -0.728 . . . . 74.42 109.041 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 64.45 80.38 0.23 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.396 -1.275 . . . . 71.52 112.179 171.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.428 ' CH2' HG21 ' A' ' 43' ' ' VAL . 3.3 t-105 51.76 79.26 0.35 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.504 -0.771 . . . . 74.23 111.126 175.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.462 ' HB2' HG12 ' A' ' 63' ' ' ILE . 49.7 Cg_endo -69.08 174.34 9.07 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.242 1.961 . . . . 74.04 111.726 176.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -79.84 -28.81 40.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.422 -0.214 . . . . 74.44 110.422 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.501 ' O ' HG13 ' A' ' 63' ' ' ILE . 40.0 pt -54.17 106.62 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.601 0.715 . . . . 65.41 110.728 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.413 ' HD3' ' HD3' ' A' ' 66' ' ' LYS . 6.4 ptp180 -133.35 133.32 22.69 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.878 -0.601 . . . . 72.23 110.972 -170.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -72.85 4.49 3.59 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.623 2.215 . . . . 62.12 111.767 173.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.413 ' HD3' ' HD3' ' A' ' 64' ' ' ARG . 55.7 mtpt -63.72 93.68 0.08 Allowed 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 109.496 -0.557 . . . . 64.54 109.496 175.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' HD1' ' A' ' 10' ' ' PHE . 28.0 p -148.65 178.4 8.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.768 -0.651 . . . . 72.44 109.822 -176.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.466 HD23 ' HD3' ' A' ' 71' ' ' LYS . 55.7 tp -115.88 118.68 33.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.635 -0.505 . . . . 74.14 109.635 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.05 -171.86 2.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 72.54 110.12 176.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.13 90.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 72.12 110.867 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.508 ' HZ1' ' HB3' ' A' ' 71' ' ' LYS . 5.2 ttpm? -70.81 74.42 0.6 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.266 0.555 . . . . 73.4 109.51 176.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 29.4 tp -139.9 30.15 2.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.572 -0.74 . . . . 75.41 109.523 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.86 137.43 32.13 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.663 -0.699 . . . . 32.42 110.084 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.3 m -64.99 79.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.339 0.59 . . . . 74.24 111.615 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.27 103.61 1.24 Allowed Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 110.203 -1.159 . . . . 72.52 110.203 174.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.59 143.36 50.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.876 0.37 . . . . 74.3 110.404 -171.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -134.42 -169.34 11.97 Favored Glycine 0 C--N 1.316 -0.542 0 CA-C-N 115.485 -0.78 . . . . 61.11 111.187 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -130.7 151.21 51.4 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.154 0.502 . . . . 74.31 110.607 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -161.05 99.75 1.22 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.506 -0.77 . . . . 74.11 109.319 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.959 -0.543 . . . . 63.52 110.391 -174.973 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 111.945 -0.462 . . . . 64.54 111.945 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.43 145.5 30.09 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.979 2.453 . . . . 72.44 112.235 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.94 146.27 16.3 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.142 -0.783 . . . . 52.53 111.142 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.8 m -70.35 102.86 2.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.153 0.501 . . . . 64.44 110.723 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.462 ' HA ' ' HE3' ' A' ' 5' ' ' MET . 0.9 OUTLIER -98.86 -18.28 17.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.615 -0.72 . . . . 74.33 110.666 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 t -67.71 148.85 50.75 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.143 -0.481 . . . . 74.2 110.327 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.61 HD11 HD12 ' A' ' 72' ' ' LEU . 42.1 mm -80.31 73.99 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.992 -0.549 . . . . 74.54 111.059 -176.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.33 96.29 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.575 0 CA-C-N 115.547 -0.751 . . . . 64.43 111.39 173.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.85 55.77 2.83 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.186 2.591 . . . . 71.44 112.514 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -85.35 -6.65 59.22 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.821 0.344 . . . . 72.32 111.142 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -96.4 -28.79 14.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.021 0.438 . . . . 75.4 110.973 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -90.48 -35.7 14.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.894 -0.594 . . . . 73.54 111.823 -173.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -61.02 -26.84 67.9 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.316 0.579 . . . . 74.53 112.201 -173.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -73.15 -13.55 61.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.413 -0.812 . . . . 73.33 111.922 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.11 59.69 2.34 Favored Glycine 0 C--N 1.329 0.164 0 C-N-CA 121.073 -0.584 . . . . 55.21 112.152 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.591 ' C ' ' HB2' ' A' ' 51' ' ' ALA . 5.6 m -141.68 118.33 11.01 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.967 -0.137 . . . . 71.32 110.712 -177.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.8 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -66.12 -159.7 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.637 0.256 . . . . 74.22 111.543 172.58 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.481 ' HB3' ' HA ' ' A' ' 46' ' ' GLU . 28.3 p90 -125.12 137.45 54.18 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.92 0.39 . . . . 74.44 110.434 -173.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.407 HG12 ' CE2' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -155.14 142.86 12.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 121.567 0.699 . . . . 65.33 111.776 -178.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 30' ' ' TRP . 48.1 tp -105.25 147.99 27.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.194 -1.367 . . . . 74.02 108.8 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.6 144.42 28.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.13 0.49 . . . . 73.44 110.824 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -104.33 153.63 20.81 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.007 -0.738 . . . . 74.14 109.007 175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -57.59 -22.81 47.3 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.811 0.339 . . . . 75.14 111.087 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -77.9 15.4 0.88 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.15 -0.477 . . . . 73.32 111.577 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 67.11 15.81 10.15 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.135 0.574 . . . . 73.3 111.407 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -84.83 119.45 25.33 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.578 -0.527 . . . . 70.43 109.578 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -114.19 136.48 52.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.95 0.405 . . . . 74.11 111.191 -175.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -152.04 -172.12 4.13 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.213 -0.662 . . . . 70.43 109.213 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.664 HD21 ' H ' ' A' ' 29' ' ' LEU . 1.8 pt? -109.04 139.37 44.02 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.452 -0.573 . . . . 74.34 109.452 174.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 20' ' ' LEU . 21.4 p-90 -98.62 155.03 37.2 Favored Pre-proline 0 C--O 1.236 0.345 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.792 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.53 ' HB2' ' HB2' ' A' ' 34' ' ' ALA . 31.1 Cg_exo -62.2 96.16 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.45 2.1 . . . . 54.3 111.012 174.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.39 -23.76 62.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.884 -0.598 . . . . 64.13 111.692 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -95.3 17.44 14.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.112 -0.495 . . . . 72.43 110.894 -178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.53 ' HB2' ' HB2' ' A' ' 31' ' ' PRO . . . -143.39 174.62 10.58 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.8 0.333 . . . . 42.14 110.762 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -92.21 139.88 30.18 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.057 -0.52 . . . . 74.13 110.244 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -76.06 130.91 76.85 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 74.22 110.603 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.4 ' HG2' ' CD1' ' A' ' 40' ' ' TRP . 45.3 Cg_endo -68.52 167.02 23.75 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.454 2.102 . . . . 74.14 112.141 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.94 151.57 47.37 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.969 -0.56 . . . . 34.34 111.548 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.97 -35.85 4.13 Favored Glycine 0 C--N 1.33 0.232 0 CA-C-N 115.65 -0.705 . . . . 60.32 112.342 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.4 ' CD1' ' HG2' ' A' ' 37' ' ' PRO . 41.9 m95 -88.23 145.37 25.91 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.256 -0.276 . . . . 74.51 110.256 -177.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -127.87 128.82 45.85 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.147 -0.316 . . . . 64.44 110.147 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.9 t -80.98 137.6 21.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.985 -0.376 . . . . 73.31 109.985 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.401 HG12 HG23 ' A' ' 19' ' ' VAL . 8.1 p -107.15 -28.98 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.992 0.425 . . . . 73.33 110.839 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.659 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 1.7 m-70 -139.79 138.58 35.97 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.799 -0.445 . . . . 73.35 109.799 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.48 174.81 36.9 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 123.674 0.609 . . . . 61.03 113.367 -173.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -58.99 138.31 57.56 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.127 0.571 . . . . 74.34 111.185 -172.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.51 ' HB1' ' HA ' ' A' ' 17' ' ' PHE . . . -158.99 173.94 15.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.917 0.389 . . . . 73.41 111.493 -175.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -84.25 177.59 8.13 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.717 0.77 . . . . 61.52 112.894 -171.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.443 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 9.0 tpm_? -50.19 -44.29 52.9 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.331 -1.304 . . . . 74.33 111.143 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.31 -52.41 61.6 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 116.144 -0.48 . . . . 72.03 110.64 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.591 ' HB2' ' C ' ' A' ' 16' ' ' SER . . . -63.64 -31.04 72.09 Favored 'General case' 0 C--O 1.263 1.801 0 CA-C-O 121.819 0.818 . . . . 52.32 111.608 -178.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.8 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 73.2 m -72.58 -28.76 63.0 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 114.459 -1.246 . . . . 74.52 110.79 175.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.573 ' O ' HG21 ' A' ' 56' ' ' ILE . 92.6 mt -71.72 -51.96 20.2 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 108.81 -0.811 . . . . 74.32 108.81 169.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.17 -24.17 25.42 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.371 -0.831 . . . . 75.13 111.811 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.582 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -44.39 -31.25 1.0 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 121.118 -0.233 . . . . 73.43 111.276 171.27 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.573 HG21 ' O ' ' A' ' 53' ' ' LEU . 19.8 tt -60.16 -46.47 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.379 0.609 . . . . 72.14 110.455 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -74.37 -43.04 58.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.492 -0.776 . . . . 72.01 110.81 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -50.79 -58.89 4.84 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.302 -0.863 . . . . 74.42 111.956 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.2 m80 68.6 -72.24 0.1 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.671 -0.695 . . . . 71.52 111.285 -175.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.56 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 44.1 t-105 -172.64 -63.11 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 113.341 0.867 . . . . 74.23 113.341 -175.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 60' ' ' TRP . 50.2 Cg_endo -92.8 176.28 1.63 Allowed 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.47 2.113 . . . . 74.04 114.852 -164.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 69.39 9.83 7.46 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.834 -1.075 . . . . 74.44 112.626 172.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.3 pp -87.32 91.85 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.353 0.597 . . . . 65.41 112.006 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -115.45 92.67 33.59 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 109.44 -0.578 . . . . 72.23 109.44 173.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.01 -28.03 3.42 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.372 2.048 . . . . 62.12 113.607 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -79.67 108.3 13.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.472 0.653 . . . . 64.54 111.482 -173.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 p -142.96 112.45 6.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.946 -1.025 . . . . 72.44 109.201 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 68' ' ' LEU . 6.2 mp -69.46 -45.26 69.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.034 0.445 . . . . 74.14 111.035 -176.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -162.44 152.6 16.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.987 -0.745 . . . . 72.54 108.987 -177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.64 162.54 26.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.99 0.424 . . . . 72.12 110.41 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -108.54 16.5 22.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.425 0.631 . . . . 73.4 109.739 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.61 HD12 HD11 ' A' ' 7' ' ' ILE . 7.1 tt -85.75 -44.96 12.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.968 -0.56 . . . . 75.41 109.517 -179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.39 74.17 0.36 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.222 0.534 . . . . 32.42 110.522 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.4 m -86.03 -39.96 16.28 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.621 -0.718 . . . . 74.24 110.899 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.22 49.52 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.832 -0.699 . . . . 72.52 112.712 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -86.47 96.52 10.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.562 -0.533 . . . . 74.3 109.562 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.56 76.82 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.462 -0.655 . . . . 61.11 111.462 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -123.24 138.72 54.57 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.861 0.362 . . . . 74.31 110.102 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -148.72 99.7 3.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.919 -0.582 . . . . 74.11 109.902 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.453 -0.784 . . . . 63.52 109.546 179.529 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 112.15 -0.38 . . . . 64.54 112.15 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.56 -166.69 0.42 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.953 2.435 . . . . 72.44 112.309 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 111.78 2.53 27.08 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 116.229 -0.441 . . . . 52.53 112.114 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.5 m -78.73 161.77 26.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.711 0.291 . . . . 64.44 111.115 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 5' ' ' MET . 0.0 OUTLIER -75.03 -20.25 59.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.055 0.455 . . . . 74.33 110.176 176.188 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.7 p -144.15 121.14 11.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.46 -0.791 . . . . 74.2 109.782 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.492 HG21 HD21 ' A' ' 8' ' ' ASN . 53.7 mt -100.04 -90.99 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 110.325 -0.25 . . . . 74.54 110.325 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 58.2 m-80 -152.02 146.48 18.63 Favored Pre-proline 0 N--CA 1.468 0.465 0 N-CA-C 109.545 -0.539 . . . . 64.43 109.545 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.03 79.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.009 2.472 . . . . 71.44 113.508 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -131.94 97.53 4.2 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.013 -1.106 . . . . 72.32 108.013 171.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -142.22 141.8 32.57 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.945 0.72 . . . . 75.4 112.945 -170.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -162.57 80.27 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.156 -1.424 . . . . 73.54 107.156 168.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.537 ' HA ' ' NH1' ' A' ' 64' ' ' ARG . 12.1 t70 -65.78 -6.63 12.4 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.113 -0.949 . . . . 74.53 112.503 -167.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -68.51 -20.27 64.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.075 -0.512 . . . . 73.33 110.61 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -156.08 119.74 0.94 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.649 -0.58 . . . . 55.21 111.649 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.588 ' C ' ' HB2' ' A' ' 51' ' ' ALA . 30.2 m -151.31 123.13 8.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.536 0.168 . . . . 71.32 111.054 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.601 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -64.53 -174.05 0.12 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.596 1.332 . . . . 74.22 114.596 179.355 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -126.48 136.2 52.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 113.924 -1.489 . . . . 74.44 109.766 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.51 ' O ' HG11 ' A' ' 43' ' ' VAL . 54.3 t -147.75 131.44 8.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-O 121.053 0.454 . . . . 65.33 110.1 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.452 HD12 ' HB2' ' A' ' 40' ' ' TRP . 64.9 tp -102.97 137.66 40.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.753 -0.658 . . . . 74.02 110.851 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.1 t -113.04 152.78 14.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.127 -1.064 . . . . 73.44 108.127 171.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.674 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 34.6 t30 -123.57 144.72 49.4 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.572 -0.899 . . . . 74.14 108.572 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -68.5 -7.85 35.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.014 0.435 . . . . 75.14 110.504 -177.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 29.2 tt0 -75.39 4.09 7.93 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.329 -0.85 . . . . 73.32 109.893 168.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 47.6 mt-10 74.16 15.72 3.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.854 0.862 . . . . 73.3 111.693 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.674 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 6.2 tp-100 -76.6 148.75 36.77 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.212 -0.662 . . . . 70.43 109.212 172.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -150.77 114.36 4.93 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.661 0.267 . . . . 74.11 110.626 -177.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.5 t -171.75 175.72 3.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.143 -0.481 . . . . 70.43 109.752 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.637 HD21 ' H ' ' A' ' 29' ' ' LEU . 2.5 pt? -80.79 160.14 24.94 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.456 -0.572 . . . . 74.34 109.456 175.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 23.7 p-90 -126.46 132.84 24.47 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.65 0.262 . . . . 75.52 110.996 -174.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 12.6 Cg_exo -70.46 107.27 1.96 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.435 2.09 . . . . 54.3 111.549 177.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.04 -8.92 8.44 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.24 -0.436 . . . . 64.13 111.78 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -81.66 -10.86 59.3 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.307 -0.406 . . . . 72.43 110.606 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.36 166.33 11.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.231 -0.441 . . . . 42.14 110.577 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.64 134.29 35.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.055 -0.521 . . . . 74.13 109.705 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.458 HG12 ' NE1' ' A' ' 40' ' ' TRP . 2.5 t -95.47 104.09 14.63 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 110.078 -0.341 . . . . 74.22 110.078 -176.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 42.9 Cg_endo -67.2 114.42 3.21 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.982 2.455 . . . . 74.14 113.116 -174.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -44.48 152.49 0.2 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.727 0.811 . . . . 34.34 113.156 -173.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.1 12.65 10.81 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.747 -0.661 . . . . 60.32 111.468 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.458 ' NE1' HG12 ' A' ' 36' ' ' VAL . 10.4 p-90 -115.78 -172.53 2.18 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.912 0.485 . . . . 74.51 110.85 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -161.77 125.91 3.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.334 -0.848 . . . . 64.44 109.243 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.414 HG23 HD13 ' A' ' 20' ' ' LEU . 6.1 t -90.63 148.04 4.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.603 -0.271 . . . . 73.31 111.05 -171.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.637 ' HA ' ' HZ2' ' A' ' 71' ' ' LYS . 8.9 p -93.69 -34.26 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 109.508 -0.553 . . . . 73.33 109.508 173.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.441 ' ND1' ' O ' ' A' ' 17' ' ' PHE . 64.2 t-80 -158.31 132.14 7.8 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.434 -0.58 . . . . 73.35 109.434 173.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.739 ' HA3' ' HA2' ' A' ' 75' ' ' GLY . . . -76.66 -168.67 28.68 Favored Glycine 0 C--N 1.334 0.417 0 O-C-N 123.712 0.632 . . . . 61.03 114.021 -175.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 76' ' ' ARG . 6.7 mp0 -45.19 154.86 0.14 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.451 1.1 . . . . 74.34 113.449 -170.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . . . -157.79 162.49 38.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.597 -0.729 . . . . 73.41 111.707 -176.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.96 166.14 21.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.533 -0.758 . . . . 61.52 110.296 175.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.443 HH11 HD12 ' A' ' 53' ' ' LEU . 7.0 tmm_? -53.83 -45.3 70.83 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.311 -0.404 . . . . 74.33 110.499 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.92 -42.81 80.64 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 116.207 -0.451 . . . . 72.03 110.703 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.588 ' HB2' ' C ' ' A' ' 16' ' ' SER . . . -66.67 -34.46 77.91 Favored 'General case' 0 C--O 1.273 2.324 0 CA-C-O 122.295 1.045 . . . . 52.32 111.616 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.601 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 36.1 t -66.17 -36.77 83.97 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 113.528 -1.669 . . . . 74.52 109.773 175.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.574 ' O ' HG21 ' A' ' 56' ' ' ILE . 79.8 mt -71.76 -39.8 69.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 74.32 110.183 171.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -60.92 -25.2 66.58 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 122.905 0.482 . . . . 75.13 111.224 -176.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.581 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -45.63 -24.91 0.39 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.319 0.387 . . . . 73.43 111.344 170.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.574 HG21 ' O ' ' A' ' 53' ' ' LEU . 17.0 tt -64.62 -49.38 80.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.082 0.467 . . . . 72.14 110.277 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.454 ' N ' HG23 ' A' ' 56' ' ' ILE . 9.5 tp10 -74.01 -42.51 60.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.315 -0.857 . . . . 72.01 111.049 -175.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.484 ' OE2' ' HA ' ' A' ' 16' ' ' SER . 16.3 pt-20 -78.46 -37.98 42.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 74.42 111.269 -176.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.1 p80 36.57 75.19 0.07 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.772 0.829 . . . . 71.52 112.261 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 53.5 m95 59.89 81.06 0.25 Allowed Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.844 -0.616 . . . . 74.23 109.788 -175.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 58' ' ' GLU . 71.0 Cg_endo -80.53 177.2 8.36 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.004 2.469 . . . . 74.04 113.156 -174.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 8' ' ' ASN . 28.2 t70 -82.3 160.72 22.83 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.465 -0.789 . . . . 74.44 110.615 177.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.517 HD11 ' N ' ' A' ' 63' ' ' ILE . 2.4 mp -73.99 86.12 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.742 -0.836 . . . . 65.41 108.742 177.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.537 ' NH1' ' HA ' ' A' ' 13' ' ' ASP . 51.5 mtt180 -58.77 152.6 47.0 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 114.704 -1.135 . . . . 72.23 111.838 -173.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -41.61 -48.56 5.6 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.647 2.898 . . . . 62.12 114.187 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -75.94 -25.89 56.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.806 0.336 . . . . 64.54 111.306 -175.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -96.16 13.28 27.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.172 -0.467 . . . . 72.44 109.746 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.442 ' HA ' HG23 ' A' ' 63' ' ' ILE . 2.2 tm? -65.52 90.96 0.12 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.452 0.644 . . . . 74.14 109.333 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.592 ' HB3' ' HB1' ' A' ' 73' ' ' ALA . 1.9 mmp_? -133.77 30.39 3.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.09 -0.959 . . . . 72.54 108.873 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 72' ' ' LEU . 14.7 m-20 55.42 49.31 17.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.089 -0.96 . . . . 72.12 110.341 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.637 ' HZ2' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 60.31 -37.4 0.09 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.502 1.521 . . . . 73.4 113.513 -178.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 70' ' ' ASP . 49.3 tp -61.54 -40.79 95.96 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.131 -0.356 . . . . 75.41 111.47 -163.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.592 ' HB1' ' HB3' ' A' ' 69' ' ' ARG . . . -107.68 127.63 53.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.949 -0.568 . . . . 32.42 110.753 -177.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.418 HG22 ' HA ' ' A' ' 44' ' ' HIS . 4.8 t -176.09 103.64 0.07 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.985 -0.552 . . . . 74.24 109.935 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.739 ' HA2' ' HA3' ' A' ' 45' ' ' GLY . . . -142.61 -171.28 13.19 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 116.105 -0.498 . . . . 72.52 112.605 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.599 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 20.8 ttm-85 -143.36 132.95 23.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.735 0.302 . . . . 74.3 110.437 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -155.34 96.64 0.16 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 61.11 112.338 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -122.89 165.68 16.27 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.756 -0.461 . . . . 74.31 109.756 177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -144.0 108.42 4.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.45 0.643 . . . . 74.11 109.575 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 . . . . . 0 C--O 1.251 1.168 0 CA-C-N 115.455 -0.793 . . . . 63.52 109.461 177.801 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 111.917 -0.473 . . . . 64.54 111.917 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.38 163.84 26.97 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.039 2.493 . . . . 72.44 112.414 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.91 91.97 1.43 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 111.409 -0.676 . . . . 52.53 111.409 175.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.0 m -51.99 121.95 7.58 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.537 0.569 . . . . 64.44 112.537 -176.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.487 ' HE2' ' HB2' ' A' ' 71' ' ' LYS . 23.9 mtp -69.93 -36.06 75.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.725 -0.671 . . . . 74.33 109.609 171.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.9 p -55.1 159.07 2.63 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 114.415 -1.266 . . . . 74.2 113.013 -174.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.5 mt -104.42 105.54 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.846 -1.07 . . . . 74.54 108.704 172.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.563 ' N ' ' HD2' ' A' ' 9' ' ' PRO . 81.1 m-20 -79.26 -40.53 1.5 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.293 -0.412 . . . . 64.43 112.011 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 8' ' ' ASN . 52.1 Cg_endo -70.08 108.71 2.2 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.634 1.556 . . . . 71.44 112.375 175.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -85.47 -81.9 0.19 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.776 -0.453 . . . . 72.32 109.776 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -105.38 57.58 0.68 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.633 -1.247 . . . . 75.4 107.633 174.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.462 ' HA ' HD21 ' A' ' 29' ' ' LEU . 23.6 t70 -134.33 -108.71 0.22 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.798 -1.092 . . . . 73.54 110.911 -169.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -54.17 -31.78 53.67 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.274 0.63 . . . . 74.53 112.317 -177.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -93.13 15.07 16.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.089 -0.505 . . . . 73.33 111.682 -173.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.36 -176.11 40.4 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.101 -0.571 . . . . 55.21 112.177 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.661 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 49.4 m -62.17 157.94 18.07 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.731 0.265 . . . . 71.32 110.479 177.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.775 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 24.8 t80 -68.28 102.43 1.38 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 119.024 -1.07 . . . . 74.22 109.502 173.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 29' ' ' LEU . 54.2 p90 -150.39 131.51 14.42 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.004 -1.48 . . . . 74.44 107.004 169.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.557 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 48.9 t -143.06 131.77 20.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.84 -0.344 . . . . 65.33 110.256 -169.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -120.91 123.57 42.82 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.263 -0.643 . . . . 74.02 109.263 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.3 m -112.19 125.97 69.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.444 0.64 . . . . 73.44 109.778 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.664 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 14.4 m120 -84.06 146.65 27.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.598 -0.728 . . . . 74.14 109.485 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -56.33 -23.35 36.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.029 0.443 . . . . 75.14 111.203 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -87.36 23.2 1.93 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.045 -0.525 . . . . 73.32 110.906 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 67.84 21.01 9.21 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.74 0.816 . . . . 73.3 112.391 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.664 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 15.6 mm-40 -83.43 117.96 23.41 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.011 -0.366 . . . . 70.43 110.011 175.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -92.92 116.82 29.39 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.364 -0.606 . . . . 74.11 109.364 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -152.9 -172.84 4.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.231 0.539 . . . . 70.43 110.758 -174.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.462 HD21 ' HA ' ' A' ' 12' ' ' ASP . 2.4 pp -125.72 -174.78 3.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.69 -0.686 . . . . 74.34 109.196 174.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.4 p-90 -145.3 128.78 8.49 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 110.122 -0.325 . . . . 75.52 110.122 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.52 130.62 41.04 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.457 2.104 . . . . 54.3 111.369 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.67 12.48 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.9 0.704 . . . . 64.13 112.9 -173.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -81.72 -27.37 33.94 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.712 0.292 . . . . 72.43 111.052 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.04 155.12 37.59 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.996 0.427 . . . . 42.14 111.17 -176.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -94.91 139.71 30.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.057 -0.52 . . . . 74.13 109.823 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.2 t -79.9 111.37 21.12 Favored Pre-proline 0 C--O 1.235 0.305 0 N-CA-C 110.006 -0.368 . . . . 74.22 110.006 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.11 133.44 57.71 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.666 2.244 . . . . 74.14 112.03 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.9 135.7 57.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.999 -0.546 . . . . 34.34 110.763 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.02 -24.83 11.31 Favored Glycine 0 C--O 1.235 0.201 0 C-N-CA 121.315 -0.469 . . . . 60.32 112.171 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -91.27 154.67 19.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.839 -0.8 . . . . 74.51 108.839 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -110.02 125.97 53.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.919 0.39 . . . . 64.44 110.141 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.1 p -91.87 122.99 43.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.98 0.419 . . . . 73.31 110.68 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.557 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 58.4 t -72.94 -41.05 60.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.261 0.553 . . . . 73.33 109.561 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -160.96 141.89 11.57 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.492 -0.777 . . . . 73.35 109.24 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.08 -170.68 47.25 Favored Glycine 0 N--CA 1.452 -0.297 0 O-C-N 123.598 0.561 . . . . 61.03 112.617 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.17 140.31 21.38 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.063 0.545 . . . . 74.34 110.583 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.57 -178.32 5.83 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.429 0.529 . . . . 73.41 112.429 -170.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -91.66 179.72 5.57 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.324 -0.853 . . . . 61.52 112.213 -173.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.516 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 4.4 tmt_? -60.93 -40.82 94.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.428 -0.805 . . . . 74.33 111.734 -177.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.65 -36.05 81.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.144 0.497 . . . . 72.03 109.729 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 17' ' ' PHE . . . -68.31 -30.71 69.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.576 -0.738 . . . . 52.32 110.532 175.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.661 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 53.9 t -59.43 -47.59 84.88 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.356 -0.609 . . . . 74.52 109.356 170.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.489 HD13 ' NH1' ' A' ' 49' ' ' ARG . 85.5 mt -57.88 -32.76 68.02 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.6 -0.727 . . . . 74.32 110.689 177.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.54 -53.53 22.44 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.341 -0.39 . . . . 75.13 110.728 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.775 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 40.4 t80 -64.59 -43.83 92.59 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.991 0.367 . . . . 73.43 111.991 -173.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.564 HG21 ' O ' ' A' ' 52' ' ' CYS . 12.4 tt -64.11 -39.83 86.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.121 0.486 . . . . 72.14 110.978 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -73.52 -35.31 65.56 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.078 -0.51 . . . . 72.01 110.537 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -65.24 -38.72 91.24 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.285 -0.635 . . . . 74.42 109.285 171.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 54.3 54.86 8.88 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.711 -1.131 . . . . 71.52 110.584 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.464 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 1.7 t90 -53.24 -45.45 98.34 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.477 -0.783 . . . . 74.23 110.584 -178.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 60' ' ' TRP . 10.4 Cg_exo -72.24 102.52 1.38 Allowed 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.665 1.577 . . . . 74.04 110.637 170.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 64' ' ' ARG . 32.2 t70 -57.67 -54.03 51.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 74.44 110.399 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.692 HG13 ' H ' ' A' ' 64' ' ' ARG . 25.6 pt 42.39 -72.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.91 1.284 . . . . 65.41 113.637 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.692 ' H ' HG13 ' A' ' 63' ' ' ILE . 31.8 ttm-85 -160.95 92.22 1.53 Allowed Pre-proline 0 C--O 1.238 0.48 0 N-CA-C 109.688 -0.486 . . . . 72.23 109.688 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.22 85.47 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.841 2.361 . . . . 62.12 111.671 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -77.85 -5.62 51.51 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.998 -0.546 . . . . 64.54 111.016 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.3 m 62.28 -75.77 0.03 OUTLIER 'General case' 0 C--O 1.234 0.248 0 O-C-N 123.622 0.576 . . . . 72.44 109.572 -171.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.81 110.47 3.82 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.694 -0.854 . . . . 74.14 108.694 171.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -62.0 -35.61 79.04 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.937 -0.574 . . . . 72.54 110.385 -175.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -126.89 160.76 30.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.211 -0.663 . . . . 72.12 109.211 171.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.487 ' HB2' ' HE2' ' A' ' 5' ' ' MET . 28.2 mtpp -114.71 55.06 0.76 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.124 0.488 . . . . 73.4 110.085 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.6 tp -138.72 -36.24 0.56 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.102 -0.499 . . . . 75.41 110.723 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.34 92.93 0.82 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.154 0.502 . . . . 32.42 111.287 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.7 p -77.43 96.89 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.804 -0.635 . . . . 74.24 110.225 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.87 -173.71 23.26 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.107 -0.568 . . . . 72.52 112.049 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -70.0 83.13 0.5 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.72 0.295 . . . . 74.3 110.598 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.57 -55.73 4.9 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.512 -0.635 . . . . 61.11 111.512 177.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.9 t80 72.69 -38.23 0.41 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.714 0.806 . . . . 74.31 112.369 176.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.88 80.66 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 122.057 0.932 . . . . 74.11 110.836 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.166 -1.379 . . . . 63.52 109.72 174.191 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 111.998 -0.441 . . . . 64.54 111.998 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.56 -164.89 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.915 2.41 . . . . 72.44 112.117 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.87 -51.78 4.62 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.927 -0.654 . . . . 52.53 111.701 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.4 m -65.28 103.25 0.76 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.807 -0.442 . . . . 64.44 109.807 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 71' ' ' LYS . 39.3 tpp -54.2 -64.84 0.7 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.179 -0.464 . . . . 74.33 111.438 -176.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.6 m -157.51 115.75 3.16 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.828 -0.624 . . . . 74.2 109.722 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.53 88.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.11 0.481 . . . . 74.54 110.35 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -105.06 114.96 63.11 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.961 -0.563 . . . . 64.43 110.604 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.5 77.26 0.99 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.208 1.938 . . . . 71.44 110.483 171.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.431 ' HA ' HD12 ' A' ' 63' ' ' ILE . 42.6 p90 -75.46 158.1 33.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.371 -0.831 . . . . 72.32 110.753 -176.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 62' ' ' ASP . 27.0 t0 -99.95 152.41 20.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.208 -0.664 . . . . 75.4 109.208 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -90.73 45.58 1.27 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.485 0.66 . . . . 73.54 109.694 -174.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.59 -74.81 0.28 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.664 0.987 . . . . 74.53 113.664 -167.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.8 -30.37 68.93 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.045 0.387 . . . . 73.33 112.045 -167.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.596 ' HA2' ' CZ ' ' A' ' 17' ' ' PHE . . . 88.59 37.07 7.63 Favored Glycine 0 C--O 1.22 -0.763 0 C-N-CA 120.739 -0.743 . . . . 55.21 112.283 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.629 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 11.2 m -73.87 49.67 0.33 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.003 0.43 . . . . 71.32 110.606 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.663 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 3.4 p90 -162.82 143.25 9.52 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.278 1.214 . . . . 74.22 114.278 -162.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -151.15 130.5 12.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.333 -1.729 . . . . 74.44 106.333 148.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.59 HG22 ' CE1' ' A' ' 55' ' ' TYR . 17.3 t -151.87 122.25 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 112.373 0.509 . . . . 65.33 112.373 -168.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 54.5 tp -96.42 144.83 26.19 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.621 -0.718 . . . . 74.02 109.785 174.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.68 126.1 64.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.278 0.561 . . . . 73.44 110.008 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.402 ' ND2' ' HZ3' ' A' ' 40' ' ' TRP . 1.1 m-20 -77.47 144.77 37.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.439 -0.8 . . . . 74.14 109.633 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -58.4 -17.85 23.59 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.802 0.811 . . . . 75.14 109.683 172.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.56 0.96 9.06 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.76 -1.109 . . . . 73.32 111.04 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 72.69 14.36 5.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.411 0.684 . . . . 73.3 111.035 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -90.05 161.31 15.89 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.546 -0.909 . . . . 70.43 108.546 172.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -152.33 140.85 20.71 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.186 0.448 . . . . 74.11 111.253 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -168.22 -166.27 0.69 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.552 -0.536 . . . . 70.43 109.552 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.703 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.1 pt? -94.44 161.65 14.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.691 0.281 . . . . 74.34 110.461 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -138.25 147.3 55.19 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.43 -0.35 . . . . 75.52 110.65 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.15 116.9 4.72 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.488 2.125 . . . . 54.3 111.543 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.0 -21.29 64.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.279 -0.418 . . . . 64.13 111.655 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -81.43 -20.16 40.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.855 0.359 . . . . 72.43 110.524 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.97 150.62 23.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.367 -0.379 . . . . 42.14 110.439 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -95.37 111.64 23.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.659 -0.497 . . . . 74.13 109.659 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.469 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.1 p -81.49 120.4 78.0 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.361 -0.381 . . . . 74.22 110.936 -176.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 5.9 Cg_exo -75.57 173.1 15.07 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.401 2.734 . . . . 74.14 113.107 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.42 152.35 44.12 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.957 -0.565 . . . . 34.34 110.911 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.54 -28.55 11.85 Favored Glycine 0 C--N 1.329 0.186 0 N-CA-C 110.935 -0.866 . . . . 60.32 110.935 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.402 ' HZ3' ' ND2' ' A' ' 22' ' ' ASN . 11.7 m95 -105.09 98.67 8.35 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.075 -1.083 . . . . 74.51 108.075 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -99.59 126.34 45.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.855 0.36 . . . . 64.44 111.3 -172.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 8.5 p -82.94 119.76 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.117 -0.492 . . . . 73.31 109.907 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.08 -26.87 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.527 0.679 . . . . 73.33 110.059 -175.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -131.96 107.18 8.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.218 -0.901 . . . . 73.35 108.652 174.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.55 173.26 5.72 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.19 -0.914 . . . . 61.03 114.453 -169.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.92 137.27 58.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.772 -0.714 . . . . 74.34 110.061 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.85 -177.97 6.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.678 0.275 . . . . 73.41 111.138 -174.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -58.08 160.45 4.88 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.685 -0.689 . . . . 61.52 112.178 -175.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.573 ' O ' ' SG ' ' A' ' 52' ' ' CYS . 6.6 ttm180 -53.87 -44.18 70.2 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.477 -0.783 . . . . 74.33 110.004 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.69 -33.79 74.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.099 0.476 . . . . 72.03 110.539 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 15' ' ' GLY . . . -66.52 -42.22 87.6 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-N 115.751 -0.659 . . . . 52.32 111.059 -178.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 49' ' ' ARG . 30.0 p -73.54 -35.79 65.57 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.66 -1.154 . . . . 74.52 111.233 174.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 60.0 mt -65.12 -34.75 79.15 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.363 -0.381 . . . . 74.32 110.222 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 16' ' ' SER . 0.4 OUTLIER -77.19 -37.24 54.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.239 -0.437 . . . . 75.13 110.504 173.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.663 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 23.2 t80 -46.35 -45.24 17.53 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.324 0.49 . . . . 73.43 112.324 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.444 HG21 ' O ' ' A' ' 53' ' ' LEU . 11.5 tt -63.48 -39.35 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 120.491 -0.484 . . . . 72.14 111.326 -176.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -73.78 -43.21 59.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.625 0.25 . . . . 72.01 110.973 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 69.5 mm-40 -77.7 -41.12 39.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.151 -0.477 . . . . 74.42 111.758 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 95.2 m-70 83.06 -11.27 0.96 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.428 1.091 . . . . 71.52 113.076 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.458 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 43.1 t-105 -175.45 -55.39 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.06 0.393 . . . . 74.23 112.06 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HD3' ' HB3' ' A' ' 60' ' ' TRP . 74.0 Cg_endo -74.08 179.67 5.53 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.206 1.937 . . . . 74.04 112.657 -174.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 27.2 t70 -114.05 -46.61 3.0 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.942 -0.572 . . . . 74.44 110.988 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.458 ' O ' ' HD3' ' A' ' 65' ' ' PRO . 53.7 mt -61.09 114.59 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.44 -0.578 . . . . 65.41 109.44 177.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.87 113.72 60.54 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.717 -0.674 . . . . 72.23 111.371 -166.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 63' ' ' ILE . 15.8 Cg_exo -68.83 -27.43 31.14 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.108 1.872 . . . . 62.12 109.254 166.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.8 tptp 60.1 14.38 4.42 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 114.554 -1.203 . . . . 64.54 111.261 175.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.8 p -149.89 162.98 39.26 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.253 -0.43 . . . . 72.44 110.193 -177.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.9 tp -67.31 93.44 0.32 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.367 -0.379 . . . . 74.14 111.619 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -95.49 104.36 16.26 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.486 -0.931 . . . . 72.54 108.486 170.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -114.97 145.08 42.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.1 0.476 . . . . 72.12 111.138 -175.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.569 ' HE3' ' HA ' ' A' ' 71' ' ' LYS . 1.5 tpmt? -118.47 9.41 12.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.227 -0.897 . . . . 73.4 109.174 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.558 ' HG ' HG22 ' A' ' 74' ' ' THR . 42.8 tp -134.95 75.53 1.58 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.492 -0.776 . . . . 75.41 109.916 -170.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.35 80.87 7.66 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.457 -0.792 . . . . 32.42 109.917 174.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.558 HG22 ' HG ' ' A' ' 72' ' ' LEU . 22.7 p -67.52 -31.0 70.81 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.044 -0.525 . . . . 74.24 111.133 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.25 -144.23 34.26 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.927 -0.579 . . . . 72.52 112.11 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 40.4 ttt85 -139.59 25.15 2.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.428 0.632 . . . . 74.3 110.001 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.76 63.19 1.28 Allowed Glycine 0 CA--C 1.516 0.134 0 CA-C-N 115.796 -0.638 . . . . 61.11 111.775 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -90.61 147.68 23.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.625 0.25 . . . . 74.31 110.799 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.82 -53.58 14.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.906 -0.588 . . . . 74.11 110.35 177.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 C--O 1.252 1.235 0 CA-C-O 118.259 -0.877 . . . . 63.52 108.838 -178.428 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.807 0 N-CA-C 111.719 -0.552 . . . . 64.54 111.719 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.03 132.3 6.2 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.496 2.131 . . . . 72.44 112.848 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.95 56.57 3.32 Favored Glycine 0 CA--C 1.511 -0.182 0 N-CA-C 110.144 -1.182 . . . . 52.53 110.144 171.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.2 p -80.78 117.79 21.75 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.717 0.636 . . . . 64.44 112.717 -169.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.487 ' HE3' ' HB2' ' A' ' 5' ' ' MET . 13.2 ttm -81.88 -55.25 4.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.898 -1.149 . . . . 74.33 107.898 167.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 p -162.74 111.97 1.38 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.105 -1.407 . . . . 74.2 109.214 174.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.2 mt -80.85 -64.66 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.537 -0.301 . . . . 74.54 110.323 -176.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 3.6 t-20 179.27 -47.82 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 115.579 -0.737 . . . . 64.43 110.337 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 8' ' ' ASN . 96.0 Cg_endo -83.26 176.28 7.51 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.916 1.744 . . . . 71.44 111.41 172.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 68.17 91.23 0.09 Allowed 'General case' 0 C--O 1.24 0.561 0 O-C-N 123.58 0.55 . . . . 72.32 110.493 -177.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 174.41 161.66 0.19 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.859 -1.064 . . . . 75.4 109.497 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -170.19 148.32 3.3 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.195 -0.457 . . . . 73.54 110.41 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.91 -60.16 3.74 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.884 -0.598 . . . . 74.53 111.661 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -82.54 -21.74 35.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.371 0.605 . . . . 73.33 110.073 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.49 73.3 1.28 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.202 -1.159 . . . . 55.21 110.202 -173.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 58.0 m -58.15 105.86 0.32 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 122.267 1.032 . . . . 71.32 110.617 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.762 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 38.4 m-85 -166.8 100.94 0.56 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 112.902 -1.954 . . . . 74.22 107.93 -162.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.602 ' CE2' ' HB1' ' A' ' 51' ' ' ALA . 98.1 m-85 -151.83 130.54 12.35 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 121.843 2.11 . . . . 74.44 109.871 172.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -164.22 143.29 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 112.559 0.577 . . . . 65.33 112.559 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.8 tp -102.3 123.6 46.4 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.575 -0.898 . . . . 74.02 108.575 165.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.58 125.83 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 73.44 110.15 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 3.8 m-20 -97.53 158.34 15.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.419 -0.355 . . . . 74.14 110.435 -178.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.25 -20.54 59.37 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.705 0.764 . . . . 75.14 109.816 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -76.49 9.56 2.63 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.8 -1.091 . . . . 73.32 111.143 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 67.86 15.37 9.58 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.304 0.642 . . . . 73.3 111.09 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.427 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 80.6 mm-40 -78.06 146.42 35.28 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.789 -0.819 . . . . 70.43 108.789 173.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -153.48 102.54 2.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.022 -0.362 . . . . 74.11 110.022 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.3 t -170.86 -170.1 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.823 -0.626 . . . . 70.43 110.096 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.431 HD11 ' N ' ' A' ' 29' ' ' LEU . 6.4 mp -80.65 166.26 21.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.771 -0.65 . . . . 74.34 110.67 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.503 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 17.3 p-90 -143.36 155.29 61.13 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.521 -0.309 . . . . 75.52 111.11 -175.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.6 95.72 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.5 2.133 . . . . 54.3 111.585 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.503 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -67.42 -18.31 65.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.657 -0.701 . . . . 64.13 112.004 -175.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -81.58 -20.84 39.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 72.43 110.709 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.13 176.38 6.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 42.14 110.837 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.46 138.57 37.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.944 -0.571 . . . . 74.13 109.873 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.624 HG21 ' NE1' ' A' ' 40' ' ' TRP . 7.4 p -104.46 129.77 24.45 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 109.968 -0.382 . . . . 74.22 109.968 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.511 ' O ' ' NE1' ' A' ' 40' ' ' TRP . 77.7 Cg_endo -76.4 -169.43 0.7 Allowed 'Trans proline' 0 N--CA 1.481 0.778 0 C-N-CA 123.125 2.55 . . . . 74.14 114.299 -171.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.95 152.43 24.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.92 -0.582 . . . . 34.34 111.14 171.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.0 27.18 7.51 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.741 -0.743 . . . . 60.32 114.42 168.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.624 ' NE1' HG21 ' A' ' 36' ' ' VAL . 48.2 p-90 -130.36 174.63 9.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.337 0.589 . . . . 74.51 111.213 176.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -154.66 125.92 7.32 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.964 -1.124 . . . . 64.44 107.964 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.87 131.93 36.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.735 -0.469 . . . . 73.31 109.735 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.3 t -91.29 -23.99 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.655 0.74 . . . . 73.33 109.56 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.439 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -171.06 131.24 0.79 Allowed 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.605 -1.18 . . . . 73.35 107.928 174.244 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 18' ' ' PHE . . . -73.41 139.91 27.44 Favored Glycine 0 C--N 1.338 0.642 0 O-C-N 124.333 1.021 . . . . 61.03 114.089 -167.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -25.89 124.63 0.06 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.015 1.326 . . . . 74.34 114.539 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 18' ' ' PHE . . . -131.65 -176.98 4.22 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.015 -0.993 . . . . 73.41 109.419 175.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -52.57 153.01 3.29 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.267 0.556 . . . . 61.52 110.98 176.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.44 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 14.0 ttp180 -54.26 -31.28 53.18 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 115.293 -0.867 . . . . 74.33 110.248 -176.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.89 -45.05 83.42 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.09 0.471 . . . . 72.03 111.012 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.602 ' HB1' ' CE2' ' A' ' 18' ' ' PHE . . . -63.21 -40.18 96.73 Favored 'General case' 0 C--O 1.274 2.359 0 CA-C-O 121.683 0.754 . . . . 52.32 111.483 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.593 ' O ' ' HB3' ' A' ' 55' ' ' TYR . 64.9 m -73.46 -37.99 65.61 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 113.57 -1.65 . . . . 74.52 112.309 175.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 25.9 mt -70.11 -44.3 69.28 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.823 -0.436 . . . . 74.32 109.823 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.524 ' HB3' ' HB2' ' A' ' 16' ' ' SER . 0.8 OUTLIER -68.72 -25.98 65.03 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 118.911 -0.566 . . . . 75.13 110.353 175.353 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.762 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -45.39 -61.5 1.65 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 118.141 -1.424 . . . . 73.43 111.352 162.584 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 tt -68.59 -35.76 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.754 0.311 . . . . 72.14 111.302 -176.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.5 ' HB3' ' HA ' ' A' ' 54' ' ' GLU . 8.3 tp10 -62.53 -43.26 99.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.181 0.515 . . . . 72.01 110.244 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -66.97 -40.24 87.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.144 -0.935 . . . . 74.42 110.57 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.7 t60 70.86 11.18 7.1 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.621 -0.718 . . . . 71.52 111.2 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 16.8 m0 67.43 114.69 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.512 0 C-N-CA 123.249 0.62 . . . . 74.23 112.018 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.18 134.79 25.74 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.09 1.86 . . . . 74.04 109.997 167.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -71.8 16.09 0.13 Allowed 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.437 0.532 . . . . 74.44 112.437 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.497 HD11 ' HA ' ' A' ' 70' ' ' ASP . 40.6 mt -75.36 -89.91 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.368 -0.975 . . . . 65.41 108.368 170.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.455 ' HD2' ' O ' ' A' ' 63' ' ' ILE . 29.8 mmm180 -147.19 145.71 22.95 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 106.262 -1.755 . . . . 72.23 106.262 169.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.498 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 25.2 Cg_exo -64.42 70.22 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.761 2.308 . . . . 62.12 113.808 -175.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 56.8 tttp 169.38 116.63 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.962 0.905 . . . . 64.54 109.128 176.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.9 t -76.64 93.63 3.65 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.964 0.411 . . . . 72.44 110.644 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -154.66 16.03 0.44 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.775 -0.648 . . . . 74.14 109.325 176.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 17.6 ptp180 -173.51 167.82 4.57 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.748 -0.66 . . . . 72.54 109.612 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.497 ' HA ' HD11 ' A' ' 63' ' ' ILE . 4.2 p30 -122.31 -173.52 2.69 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.108 0.48 . . . . 72.12 112.204 -171.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.479 ' HB2' ' HE1' ' A' ' 5' ' ' MET . 29.7 mmtp -66.35 -28.43 68.65 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.558 -0.747 . . . . 73.4 112.286 -175.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.9 tp -84.28 -40.12 18.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.253 0.549 . . . . 75.41 109.588 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 69' ' ' ARG . . . -96.72 76.24 2.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.583 -0.735 . . . . 32.42 110.607 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.7 p -77.71 -55.41 5.37 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.788 -0.449 . . . . 74.24 109.788 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 48.67 63.67 3.67 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.416 -0.811 . . . . 72.52 113.256 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 84.7 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.196 0.522 . . . . 74.3 109.703 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.2 -151.96 22.09 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.667 -0.697 . . . . 61.11 111.387 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -138.87 143.73 38.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.102 0.477 . . . . 74.31 111.066 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -94.21 -28.78 15.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.361 -0.836 . . . . 74.11 109.223 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.226 0 CA-C-N 114.918 -1.037 . . . . 63.52 109.363 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.895 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 23.4 t80 . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 109.094 -0.706 . . . . 74.209999999999994 109.094 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -124.49 136.32 53.92 Favored 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 121.366 -0.833 . . . . 74.439999999999998 110.65 -169.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.8 t -143.6 131.31 18.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 CA-C-N 114.802 -1.09 . . . . 65.329999999999998 110.574 -169.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.709 HD22 ' HB3' ' A' ' 30' ' ' TRP . 43.8 tp -112.78 123.37 50.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.575 -0.739 . . . . 71.329999999999998 110.168 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -109.35 177.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.614 -0.514 . . . . 73.439999999999998 109.614 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 27.7 t-20 -144.37 149.87 36.83 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.482 -0.192 . . . . 74.140000000000001 110.482 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.46 -28.49 30.69 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.295 0.372 . . . . 71.409999999999997 111.741 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.75 20.27 1.83 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.179 -0.464 . . . . 73.319999999999993 111.322 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 71.16 10.61 6.82 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.499 0.719 . . . . 73.299999999999997 112.211 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.683 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 43.2 mt-30 -74.62 153.36 39.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.601 -0.518 . . . . 54.009999999999998 109.601 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -157.36 133.96 9.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 74.109999999999999 110.591 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.1 t -171.53 -163.96 0.3 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.534 -0.913 . . . . 70.430000000000007 108.534 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.62 166.27 11.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.775 -0.454 . . . . 62.520000000000003 109.775 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.709 ' HB3' HD22 ' A' ' 20' ' ' LEU . 32.5 p-90 -128.14 144.73 52.75 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.542 -0.299 . . . . 73.310000000000002 110.272 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.76 104.72 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.596 2.197 . . . . 52.539999999999999 111.605 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.22 -18.72 59.72 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.181 -0.463 . . . . 64.129999999999995 111.738 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -92.17 10.66 28.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.107 -0.497 . . . . 72.430000000000007 110.866 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.71 179.32 6.65 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.794 0.331 . . . . 42.140000000000001 110.76 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -95.5 139.96 31.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.959 -0.564 . . . . 74.129999999999995 109.874 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.54 124.03 89.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.575 -0.284 . . . . 74.219999999999999 110.404 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HG2' ' CD1' ' A' ' 40' ' ' TRP . 29.2 Cg_endo -63.64 146.65 92.65 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.379 2.052 . . . . 74.140000000000001 111.789 178.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.04 145.97 28.86 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.126 -0.488 . . . . 34.340000000000003 111.075 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.86 -23.39 34.9 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.152 -0.476 . . . . 60.32 111.944 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.525 ' CE3' ' HB2' ' A' ' 22' ' ' ASN . 65.7 m95 -97.04 160.59 14.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.712 0.292 . . . . 74.510000000000005 110.221 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -132.64 125.58 30.69 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.911 -0.774 . . . . 63.219999999999999 108.911 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.05 114.09 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.481 -0.563 . . . . 60.219999999999999 109.481 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.8 m -86.92 -21.37 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.368 0.604 . . . . 73.329999999999998 110.417 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.402 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 46.1 m80 -153.78 129.4 10.0 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.342 -0.845 . . . . 73.349999999999994 109.347 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.08 -178.85 45.82 Favored Glycine 0 C--N 1.336 0.546 0 O-C-N 124.15 0.907 . . . . 61.030000000000001 112.122 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.68 145.09 50.54 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.855 0.359 . . . . 74.340000000000003 111.623 -174.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.25 -178.34 6.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.782 -0.644 . . . . 73.409999999999997 110.54 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -79.3 167.98 20.17 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 116.2 -0.455 . . . . 61.520000000000003 111.452 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.689 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 41.0 ttm180 -55.88 -33.76 64.88 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 115.989 -0.55 . . . . 74.329999999999998 110.941 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -56.32 -48.15 77.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.134 0.493 . . . . 72.030000000000001 109.949 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.66 -31.04 71.83 Favored 'General case' 0 C--O 1.26 1.61 0 CA-C-N 115.176 -0.92 . . . . 52.32 111.133 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.895 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 24.9 m -62.05 -50.29 72.57 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.666 -1.152 . . . . 61.32 109.643 173.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.7 mt -59.61 -40.95 89.2 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.614 -0.721 . . . . 74.319999999999993 110.463 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 17.6 mm-40 -58.64 -52.81 64.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.441 . . . . 73.120000000000005 110.26 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -56.22 -55.35 34.35 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.794 0.294 . . . . 71.239999999999995 111.794 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 52' ' ' CYS . 8.8 tt -61.92 -42.83 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 121.076 -0.25 . . . . 72.140000000000001 111.539 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.32 -43.89 93.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.263 0.554 . . . . 72.010000000000005 110.127 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -72.63 -14.51 61.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.755 -0.657 . . . . 74.420000000000002 110.864 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 . . . . . 0 N--CA 1.471 0.583 0 C-N-CA 123.758 0.823 . . . . 71.519999999999996 111.23 179.393 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.781 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 3.3 t80 . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 110.663 -0.125 . . . . 74.209999999999994 110.663 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.543 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 41.9 p90 -124.37 142.11 51.54 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.284 0.564 . . . . 74.439999999999998 110.813 -172.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.663 HG23 HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.37 142.49 5.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-N 115.012 -0.995 . . . . 65.329999999999998 110.858 -172.297 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 40' ' ' TRP . 43.1 tp -120.46 144.58 47.9 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.216 -0.902 . . . . 71.329999999999998 111.273 -171.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.35 141.82 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 115.997 -0.547 . . . . 73.439999999999998 109.94 173.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.578 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 25.3 t-20 -110.01 155.9 21.2 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.507 -0.553 . . . . 74.140000000000001 109.507 -176.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.0 -26.64 68.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.9 0.381 . . . . 71.409999999999997 111.152 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -86.43 22.88 1.73 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.279 0.562 . . . . 73.319999999999993 110.512 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 73.02 6.65 5.34 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.404 -0.816 . . . . 73.299999999999997 112.397 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 81.6 mm-40 -71.96 117.74 13.95 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.194 -0.669 . . . . 54.009999999999998 109.194 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -131.35 127.62 37.99 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.199 -0.313 . . . . 74.109999999999999 111.042 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.5 t -173.57 163.13 4.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 70.430000000000007 110.329 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.4 pt? -72.13 130.81 41.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.174 -1.047 . . . . 62.520000000000003 108.174 169.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.501 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 33.4 p-90 -95.87 141.84 23.73 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.529 -0.305 . . . . 73.310000000000002 110.917 -173.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.592 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 23.0 Cg_exo -64.98 105.32 0.66 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.616 2.21 . . . . 52.539999999999999 111.275 177.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.501 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -58.61 -26.89 64.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.965 -0.561 . . . . 64.129999999999995 111.66 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -98.63 23.75 8.29 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.096 -0.502 . . . . 72.430000000000007 110.968 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.592 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . . . -132.96 166.63 21.93 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.013 -0.54 . . . . 42.140000000000001 110.764 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -77.25 139.62 39.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 74.129999999999995 110.458 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.511 HG12 ' NE1' ' A' ' 40' ' ' TRP . 3.0 t -112.12 106.03 56.24 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.068 -0.515 . . . . 74.219999999999999 109.745 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 33.8 Cg_endo -64.85 116.28 3.73 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.124 2.549 . . . . 74.140000000000001 112.819 -174.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.84 152.25 0.38 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.12 0.785 . . . . 34.340000000000003 113.12 -174.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.13 18.62 6.69 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.827 -0.624 . . . . 60.32 111.817 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.511 ' NE1' HG12 ' A' ' 36' ' ' VAL . 12.3 p-90 -122.41 -173.28 2.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.141 0.496 . . . . 74.510000000000005 111.056 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -154.62 126.64 7.71 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.629 -0.878 . . . . 63.219999999999999 108.629 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.9 p -90.51 138.78 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.213 -0.449 . . . . 60.219999999999999 110.651 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.663 HG23 HG23 ' A' ' 19' ' ' VAL . 27.6 m -100.74 -22.85 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.909 0.385 . . . . 73.329999999999998 110.69 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.572 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 39.3 m80 -150.4 132.63 15.44 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.929 -0.578 . . . . 73.349999999999994 109.711 176.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -92.01 176.14 38.86 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 123.758 0.661 . . . . 61.030000000000001 112.784 -175.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.37 131.03 10.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.352 0.661 . . . . 74.340000000000003 111.232 -174.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.684 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -147.57 178.24 8.62 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.227 0.537 . . . . 73.409999999999997 111.566 -174.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -98.18 177.97 5.22 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.826 -0.625 . . . . 61.520000000000003 111.819 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.525 ' NH1' HD11 ' A' ' 53' ' ' LEU . 2.4 tmt_? -61.59 -44.71 96.5 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.697 -0.683 . . . . 74.329999999999998 110.493 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.45 -42.53 67.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.464 0.65 . . . . 72.030000000000001 110.028 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.98 -32.69 74.33 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.021 -0.991 . . . . 52.32 110.944 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.781 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 49.0 t -60.22 -51.06 71.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.045 -0.525 . . . . 61.32 109.918 173.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.525 HD11 ' NH1' ' A' ' 49' ' ' ARG . 82.0 mt -58.16 -40.16 80.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.522 -0.763 . . . . 74.319999999999993 110.8 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.94 -29.02 55.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.074 -0.512 . . . . 73.120000000000005 112.213 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -65.43 -52.37 53.7 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.015 -0.428 . . . . 71.239999999999995 110.787 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 tt -59.34 -35.77 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 121.011 0.434 . . . . 72.140000000000001 110.574 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -70.99 -42.01 70.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.769 -0.65 . . . . 72.010000000000005 111.217 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -58.86 -30.22 67.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.713 0.292 . . . . 74.420000000000002 110.268 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 . . . . . 0 N--CA 1.466 0.362 0 CA-C-N 115.72 -0.673 . . . . 71.519999999999996 111.375 176.028 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.724 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 34.5 t80 . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 109.865 -0.42 . . . . 74.209999999999994 109.865 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.557 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 33.8 p90 -124.58 134.43 52.95 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 121.325 -0.86 . . . . 74.439999999999998 110.177 -173.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.639 HG23 HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.7 128.85 2.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 115.146 -0.934 . . . . 65.329999999999998 111.247 -171.034 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.7 tp -108.54 137.55 46.3 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.608 -1.178 . . . . 71.329999999999998 109.946 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 58.4 t -124.95 126.45 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 73.439999999999998 110.016 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.771 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 27.2 t-20 -87.41 158.81 18.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.89 -0.411 . . . . 74.140000000000001 109.89 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -50.25 -33.28 19.13 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.203 -0.453 . . . . 71.409999999999997 112.004 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.58 30.46 0.72 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.207 0.527 . . . . 73.319999999999993 111.145 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 67.3 6.58 4.94 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.049 0.539 . . . . 73.299999999999997 112.141 174.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.771 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 81.6 mm-40 -63.17 117.81 7.06 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 109.554 -0.535 . . . . 54.009999999999998 109.554 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -121.56 111.25 17.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.855 0.36 . . . . 74.109999999999999 110.321 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -153.32 156.08 37.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.317 -0.402 . . . . 70.430000000000007 110.168 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.652 ' H ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.56 154.27 39.17 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.545 -0.539 . . . . 62.520000000000003 109.545 172.088 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.4 ' HZ2' ' HA2' ' A' ' 45' ' ' GLY . 27.9 p-90 -126.16 148.95 65.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.687 -0.233 . . . . 73.310000000000002 110.556 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.06 102.57 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.238 1.959 . . . . 52.539999999999999 111.112 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 46' ' ' GLU . . . -57.06 -18.0 12.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.847 -0.615 . . . . 64.129999999999995 111.863 -175.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -102.15 24.47 10.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 72.430000000000007 111.215 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.4 172.53 12.58 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.378 -0.373 . . . . 42.140000000000001 111.059 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -95.68 139.81 31.4 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.966 -0.561 . . . . 74.129999999999995 109.869 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.8 t -88.99 118.73 69.52 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 110.601 -0.148 . . . . 74.219999999999999 110.601 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.04 160.0 48.66 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.755 2.304 . . . . 74.140000000000001 112.243 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.51 144.7 50.77 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.265 -0.425 . . . . 34.340000000000003 110.622 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.25 -18.63 48.25 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 111.55 -0.62 . . . . 60.32 111.55 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -107.61 118.88 37.9 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.93 -0.396 . . . . 74.510000000000005 109.93 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -103.41 126.04 50.34 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.695 -0.484 . . . . 63.219999999999999 109.695 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 44' ' ' HIS . 13.6 p -91.29 134.08 30.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 110.054 -0.35 . . . . 60.219999999999999 110.054 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.639 HG23 HG23 ' A' ' 19' ' ' VAL . 29.5 m -99.7 -5.2 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.031 0.443 . . . . 73.329999999999998 110.837 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.432 ' H ' HG22 ' A' ' 42' ' ' VAL . 65.4 t-80 -175.99 130.78 0.24 Allowed 'General case' 0 C--O 1.246 0.872 0 CA-C-N 115.183 -0.917 . . . . 73.349999999999994 109.453 167.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -79.0 -171.47 40.52 Favored Glycine 0 C--N 1.338 0.665 0 O-C-N 123.935 0.772 . . . . 61.030000000000001 112.846 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -50.66 151.55 2.33 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.509 0.559 . . . . 74.340000000000003 112.509 -173.189 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB1' ' CB ' ' A' ' 51' ' ' ALA . . . -161.42 179.19 8.46 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.097 -0.501 . . . . 73.409999999999997 112.252 -173.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -97.96 179.43 4.79 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.581 -0.736 . . . . 61.520000000000003 112.308 -171.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -56.91 -51.08 70.52 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.702 -0.681 . . . . 74.329999999999998 110.406 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.39 -34.19 56.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.412 -0.813 . . . . 72.030000000000001 110.186 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.45 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -75.74 -31.59 59.65 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 115.284 -0.871 . . . . 52.32 111.098 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.724 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 56.2 m -58.94 -48.71 80.55 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.933 -0.766 . . . . 61.32 108.933 172.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.74 -36.37 82.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.989 -1.005 . . . . 74.319999999999993 110.539 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -62.27 -42.16 99.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.531 . . . . 73.120000000000005 110.566 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -64.51 -50.43 67.4 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.315 -0.402 . . . . 71.239999999999995 111.194 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 tt -64.24 -37.36 79.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 120.779 0.323 . . . . 72.140000000000001 110.371 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -73.25 -28.35 62.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 72.010000000000005 110.361 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.14 -41.52 96.88 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.933 -0.576 . . . . 74.420000000000002 109.51 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 . . . . . 0 N--CA 1.467 0.424 0 CA-C-N 115.42 -0.809 . . . . 71.519999999999996 111.609 170.582 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.822 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 3.8 t80 . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.203 0.049 . . . . 74.209999999999994 110.915 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.81 ' HB3' ' HA ' ' A' ' 46' ' ' GLU . 51.9 p90 -125.15 143.77 50.77 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.14 0.495 . . . . 74.439999999999998 111.357 -171.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 43' ' ' VAL . 48.2 t -146.49 133.04 13.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-N 115.077 -0.965 . . . . 65.329999999999998 110.331 -175.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.508 ' HB2' ' CE3' ' A' ' 30' ' ' TRP . 57.4 tp -109.2 133.88 52.46 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.694 -0.685 . . . . 71.329999999999998 109.847 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 m -120.6 126.27 75.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.705 0.765 . . . . 73.439999999999998 110.554 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 11.3 m120 -93.12 154.09 18.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.074 -0.966 . . . . 74.140000000000001 109.228 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -56.69 -24.3 48.09 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.032 0.444 . . . . 71.409999999999997 111.097 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -82.15 15.67 2.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.965 -0.562 . . . . 73.319999999999993 111.156 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 67.64 6.79 5.22 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.26 0.624 . . . . 73.299999999999997 111.477 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 15.4 mm100 -66.65 119.61 12.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.298 -0.63 . . . . 54.009999999999998 109.298 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -111.14 113.06 25.31 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.376 -0.602 . . . . 74.109999999999999 109.376 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -150.38 -162.26 1.51 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.16 -0.473 . . . . 70.430000000000007 109.985 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.661 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.3 pt? -127.93 172.21 11.1 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.633 -0.506 . . . . 62.520000000000003 109.633 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.534 ' CH2' ' HB2' ' A' ' 18' ' ' PHE . 13.1 p90 -135.67 157.8 75.49 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.411 -0.588 . . . . 73.310000000000002 109.411 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.729 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 37.4 Cg_exo -57.66 100.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.959 1.772 . . . . 52.539999999999999 110.211 171.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.18 -13.59 19.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.636 0.606 . . . . 64.129999999999995 112.636 -171.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -103.13 2.72 34.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.837 0.351 . . . . 72.430000000000007 110.602 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.729 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . . . -121.61 -175.85 3.18 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.099 -0.5 . . . . 42.140000000000001 111.316 -173.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -81.91 137.92 35.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.594 -0.73 . . . . 74.129999999999995 110.434 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.402 HG22 ' CD1' ' A' ' 30' ' ' TRP . 56.5 t -82.34 132.79 51.8 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.934 -0.576 . . . . 74.219999999999999 110.022 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.06 132.68 48.84 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.345 2.03 . . . . 74.140000000000001 111.293 173.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.23 152.32 45.14 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.256 0.55 . . . . 34.340000000000003 112.056 -173.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.02 -35.55 4.6 Favored Glycine 0 N--CA 1.453 -0.193 0 CA-C-N 115.595 -0.73 . . . . 60.32 113.478 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -81.87 175.97 9.96 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.752 0.31 . . . . 74.510000000000005 110.694 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -121.92 126.64 49.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.006 0.431 . . . . 63.219999999999999 110.967 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.56 126.43 40.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.682 -0.859 . . . . 60.219999999999999 108.682 170.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 19' ' ' VAL . 14.7 p -95.83 -23.24 4.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 120.698 -0.401 . . . . 73.329999999999998 110.345 -175.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.451 ' ND1' ' O ' ' A' ' 17' ' ' PHE . 45.0 t-80 -158.26 133.42 8.62 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.301 -0.409 . . . . 73.349999999999994 110.469 174.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.24 176.86 46.71 Favored Glycine 0 C--N 1.337 0.629 0 O-C-N 124.14 0.9 . . . . 61.030000000000001 113.438 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.81 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -78.69 154.84 29.79 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.003 0.742 . . . . 74.340000000000003 113.003 -170.06 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.32 -178.11 5.74 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.802 -0.635 . . . . 73.409999999999997 111.065 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.16 170.17 16.81 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.78 0.659 . . . . 61.520000000000003 112.78 -173.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 31.9 ttm180 -45.7 -45.72 14.43 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.577 0.751 . . . . 74.329999999999998 111.631 176.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.581 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -53.66 -45.0 70.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.351 0.595 . . . . 72.030000000000001 109.964 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.99 -30.96 71.22 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 115.172 -0.922 . . . . 52.32 111.102 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.822 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 42.7 t -58.19 -47.47 83.33 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.682 -0.69 . . . . 61.32 109.731 171.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.57 -39.72 94.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.878 -0.601 . . . . 74.319999999999993 110.118 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 13.8 mm-40 -59.4 -39.32 83.03 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.121 -0.491 . . . . 73.120000000000005 110.742 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -58.68 -47.94 82.79 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.776 0.322 . . . . 71.239999999999995 110.668 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.416 HG13 ' H ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -64.45 -48.7 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.703 0.763 . . . . 72.140000000000001 109.623 -178.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -68.85 -26.64 65.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.357 -1.292 . . . . 72.010000000000005 111.072 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -65.99 -39.55 90.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.448 . . . . 74.420000000000002 109.834 175.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 . . . . . 0 CA--C 1.537 0.45 0 CA-C-N 115.756 -0.656 . . . . 71.519999999999996 111.027 177.063 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.506 ' HD1' ' HB2' ' A' ' 55' ' ' TYR . 24.8 t80 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.057 -0.719 . . . . 74.209999999999994 109.057 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.443 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 47.6 p90 -141.6 131.02 23.74 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.71 -1.589 . . . . 74.439999999999998 106.71 168.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.753 HG23 HG13 ' A' ' 43' ' ' VAL . 2.8 m -156.36 135.49 3.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.539 0.685 . . . . 65.329999999999998 110.522 -167.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 8.5 tt -117.31 131.44 56.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.374 -0.83 . . . . 71.329999999999998 110.038 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.3 t -104.17 126.08 58.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.397 -0.594 . . . . 73.439999999999998 109.397 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.711 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 14.3 m120 -79.94 170.45 16.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.039 -0.528 . . . . 74.140000000000001 109.82 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -51.82 -42.17 62.32 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.11 0.481 . . . . 71.409999999999997 111.466 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -88.95 28.06 1.24 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.866 -0.606 . . . . 73.319999999999993 111.677 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 65.63 15.51 10.07 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.117 0.567 . . . . 73.299999999999997 111.734 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.711 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 56.0 tt0 -68.58 131.11 44.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 54.009999999999998 110.072 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -90.52 118.24 29.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.642 0.258 . . . . 74.109999999999999 110.658 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 m -144.46 -175.51 4.67 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.15 -0.477 . . . . 70.430000000000007 110.149 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 29' ' ' LEU . 1.7 pt? -142.33 135.43 28.68 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.439 -0.578 . . . . 62.520000000000003 109.439 173.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.443 ' CH2' ' HB2' ' A' ' 18' ' ' PHE . 4.8 p90 -85.31 152.02 57.41 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 73.310000000000002 110.114 -176.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.98 104.72 0.4 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.95 1.767 . . . . 52.539999999999999 110.169 171.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.69 -15.43 7.8 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.099 0.407 . . . . 64.129999999999995 112.099 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -92.07 6.79 45.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 72.430000000000007 111.024 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.94 179.49 6.31 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.897 0.38 . . . . 42.140000000000001 111.122 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -87.05 139.79 30.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.668 -0.696 . . . . 74.129999999999995 110.125 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 70.5 t -64.5 129.39 94.19 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.114 -0.494 . . . . 74.219999999999999 110.899 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 35.3 Cg_exo -60.86 141.04 93.55 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.697 2.265 . . . . 74.140000000000001 111.841 175.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.98 147.41 52.47 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.023 -0.535 . . . . 34.340000000000003 111.56 -175.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.43 -25.95 25.79 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.757 -0.656 . . . . 60.32 112.981 176.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -82.86 -177.42 6.74 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.816 0.341 . . . . 74.510000000000005 110.111 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 41' ' ' ARG . 50.7 ttt-85 -145.27 126.5 14.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.335 -0.393 . . . . 63.219999999999999 110.008 173.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 54.8 t -80.42 123.37 37.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.264 -0.643 . . . . 60.219999999999999 109.264 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.753 HG13 HG23 ' A' ' 19' ' ' VAL . 7.1 p -88.77 -19.11 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.198 0.523 . . . . 73.329999999999998 110.107 -175.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -157.53 121.89 4.3 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.029 -0.73 . . . . 73.349999999999994 109.029 171.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.66 -179.34 52.81 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.29 -0.481 . . . . 61.030000000000001 112.986 -174.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -53.72 138.73 34.52 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.824 -0.436 . . . . 74.340000000000003 109.824 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.8 -178.01 6.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.873 1.064 . . . . 73.409999999999997 113.873 -167.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.401 ' CG ' ' N ' ' A' ' 49' ' ' ARG . 14.0 t70 -91.14 175.09 7.07 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.513 -1.222 . . . . 61.520000000000003 111.528 -176.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.923 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 59.1 ttt180 -57.88 -27.86 63.66 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 122.327 -0.233 . . . . 74.329999999999998 111.052 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.87 -41.37 67.44 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.278 -0.638 . . . . 72.030000000000001 109.278 173.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 17' ' ' PHE . . . -75.81 -31.17 59.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.352 -0.84 . . . . 52.32 111.018 175.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.923 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 61.3 m -54.8 -55.05 34.39 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.565 0.697 . . . . 61.32 110.253 172.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.3 mt -64.68 -23.16 67.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.989 -1.005 . . . . 74.319999999999993 110.557 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.431 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 40.7 tt0 -71.73 -49.82 35.8 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.069 -0.514 . . . . 73.120000000000005 111.257 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.506 ' HB2' ' HD1' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -52.53 -40.93 63.03 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 111.98 0.363 . . . . 71.239999999999995 111.98 -175.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 tt -69.57 -39.0 77.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 120.879 0.371 . . . . 72.140000000000001 110.887 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -71.64 -34.0 69.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 72.010000000000005 110.899 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 59' ' ' HIS . 7.4 mm-40 -67.07 -13.91 62.39 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.853 -0.612 . . . . 74.420000000000002 111.639 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.494 ' HB3' ' O ' ' A' ' 58' ' ' GLU . 21.6 t-80 . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 121.6 0.714 . . . . 71.519999999999996 109.843 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.686 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 56.4 m-85 . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 113.063 0.764 . . . . 74.209999999999994 113.063 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -151.23 130.51 12.79 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.279 -1.378 . . . . 74.439999999999998 107.279 149.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.467 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 31.2 t -157.19 120.14 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.965 0 CA-C-O 121.081 0.467 . . . . 65.329999999999998 112.036 -173.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.462 HD13 HG22 ' A' ' 42' ' ' VAL . 64.6 tp -96.14 128.99 43.54 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.646 -0.706 . . . . 71.329999999999998 109.317 171.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 58.2 t -120.85 125.95 74.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.22 0.533 . . . . 73.439999999999998 110.302 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -85.66 153.2 22.52 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.168 -0.679 . . . . 74.140000000000001 109.168 175.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.34 -9.78 20.08 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.657 0.741 . . . . 71.409999999999997 109.535 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -79.79 7.58 8.39 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.943 -1.026 . . . . 73.319999999999993 110.174 173.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 72.23 7.02 5.66 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.47 0.708 . . . . 73.299999999999997 111.951 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 68.6 mt-30 -70.48 120.11 15.65 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 108.864 -0.791 . . . . 54.009999999999998 108.864 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -128.88 104.11 7.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.674 0.273 . . . . 74.109999999999999 110.688 -174.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.7 t -166.36 -169.43 1.41 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.722 0.296 . . . . 70.430000000000007 110.739 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 pp -71.12 172.88 8.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.12 -0.491 . . . . 62.520000000000003 111.511 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -153.21 156.13 32.35 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.552 -0.295 . . . . 73.310000000000002 110.739 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.22 93.46 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.432 2.088 . . . . 52.539999999999999 111.262 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.17 -1.71 3.52 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.23 0.455 . . . . 64.129999999999995 112.23 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -81.7 2.33 30.24 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.624 -0.262 . . . . 72.430000000000007 111.227 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.46 174.08 10.98 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.68 0.276 . . . . 42.140000000000001 110.782 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -87.99 139.98 29.96 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.058 -0.519 . . . . 74.129999999999995 109.981 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -59.39 119.93 43.8 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.964 -0.562 . . . . 74.219999999999999 111.412 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.85 138.82 82.96 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.611 2.207 . . . . 74.140000000000001 111.883 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.37 127.73 33.45 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.913 -0.585 . . . . 34.340000000000003 111.473 -177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.9 -23.43 13.05 Favored Glycine 0 C--N 1.33 0.223 0 CA-C-N 115.955 -0.566 . . . . 60.32 112.653 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -92.57 152.74 19.44 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.718 -0.283 . . . . 74.510000000000005 110.377 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.413 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 2.3 mmp_? -123.67 126.34 46.39 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.908 -0.405 . . . . 63.219999999999999 109.908 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.462 HG22 HD13 ' A' ' 20' ' ' LEU . 19.0 t -85.61 116.73 29.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.522 -0.918 . . . . 60.219999999999999 108.522 175.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.467 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 13.6 p -79.11 -29.98 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.411 0.624 . . . . 73.329999999999998 109.757 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -144.12 115.37 7.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.802 -1.184 . . . . 73.349999999999994 107.802 172.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.445 ' HA2' HG11 ' A' ' 42' ' ' VAL . . . -61.77 163.67 23.49 Favored Glycine 0 CA--C 1.509 -0.314 0 O-C-N 123.7 0.625 . . . . 61.030000000000001 113.54 -172.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -61.67 137.73 58.26 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.683 -0.488 . . . . 74.340000000000003 109.683 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.32 -177.82 4.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.807 -0.633 . . . . 73.409999999999997 110.479 -173.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.6 151.33 6.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.073 -0.512 . . . . 61.520000000000003 110.343 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.756 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 18.6 ttm180 -48.51 -39.54 23.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 110.957 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 54' ' ' GLU . . . -63.96 -39.53 94.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.372 -0.376 . . . . 72.030000000000001 111.352 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.24 -33.34 59.19 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 120.925 0.393 . . . . 52.32 111.943 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.756 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 16.2 p -73.51 -42.83 61.28 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.796 -0.638 . . . . 61.32 110.501 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 57.2 mt -65.77 -28.68 69.2 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.09 0.472 . . . . 74.319999999999993 110.096 174.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 13.3 tp10 -75.27 -33.07 61.21 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.006 -0.543 . . . . 73.120000000000005 110.048 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.686 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 9.5 t80 -45.96 -60.19 2.4 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.415 0.524 . . . . 71.239999999999995 112.415 173.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.8 tt -56.28 -40.96 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 120.708 0.289 . . . . 72.140000000000001 111.319 -173.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.46 -30.68 63.34 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.028 0.442 . . . . 72.010000000000005 110.6 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.14 -34.48 77.71 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.873 -0.603 . . . . 74.420000000000002 109.85 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 . . . . . 0 N--CA 1.47 0.56 0 CA-C-N 115.445 -0.798 . . . . 71.519999999999996 112.259 175.092 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.662 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 2.4 t80 . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 110.151 -0.314 . . . . 74.209999999999994 110.151 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 27.5 p90 -123.94 136.73 54.51 Favored 'General case' 0 CA--C 1.509 -0.624 0 O-C-N 121.632 -0.668 . . . . 74.439999999999998 110.05 -170.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.58 HG23 ' HB ' ' A' ' 43' ' ' VAL . 23.4 m -144.56 129.18 13.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 114.88 -1.054 . . . . 65.329999999999998 111.551 -168.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.498 HD11 HG21 ' A' ' 36' ' ' VAL . 54.3 tp -106.78 132.5 52.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.005 -0.998 . . . . 71.329999999999998 109.163 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.02 126.38 75.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.925 0.393 . . . . 73.439999999999998 110.861 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -78.41 144.86 35.5 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.773 -0.825 . . . . 74.140000000000001 108.773 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -59.87 -18.27 43.11 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.891 0.377 . . . . 71.409999999999997 110.711 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.59 4.73 3.63 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.796 -0.638 . . . . 73.319999999999993 111.255 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 72.0 56.05 0.17 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.099 0.56 . . . . 73.299999999999997 111.357 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -143.16 131.57 22.22 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.654 -0.703 . . . . 54.009999999999998 109.608 175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -100.92 139.24 36.89 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.784 0.326 . . . . 74.109999999999999 110.735 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.8 m -154.92 -172.72 4.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.293 -0.632 . . . . 70.430000000000007 109.293 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.75 162.51 15.67 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.741 -0.466 . . . . 62.520000000000003 109.741 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.417 ' HH2' ' HA2' ' A' ' 45' ' ' GLY . 3.7 p90 -137.32 160.22 66.45 Favored Pre-proline 0 C--O 1.234 0.264 0 N-CA-C 109.613 -0.514 . . . . 73.310000000000002 109.613 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.6 97.86 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.04 1.827 . . . . 52.539999999999999 111.024 172.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.463 ' HB1' ' HB3' ' A' ' 46' ' ' GLU . . . -53.23 -24.28 10.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.009 -0.541 . . . . 64.129999999999995 112.341 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -92.83 29.86 1.71 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.271 -0.422 . . . . 72.430000000000007 111.043 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.5 158.85 43.77 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.296 -0.411 . . . . 42.140000000000001 110.546 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.56 129.82 36.66 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.191 -0.459 . . . . 74.129999999999995 110.402 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.498 HG21 HD11 ' A' ' 20' ' ' LEU . 7.7 p -91.87 131.31 35.79 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 116.273 -0.421 . . . . 74.219999999999999 111.317 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 13.5 Cg_exo -69.17 177.91 4.71 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.909 2.406 . . . . 74.140000000000001 113.047 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.12 152.07 43.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.538 -0.755 . . . . 34.340000000000003 110.763 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.13 -35.33 4.63 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.303 -0.719 . . . . 60.32 111.303 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -100.88 100.76 11.45 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.782 -0.821 . . . . 74.510000000000005 108.782 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -93.3 126.57 38.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.868 0.365 . . . . 63.219999999999999 110.589 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.0 p -83.69 128.52 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.039 -0.356 . . . . 60.219999999999999 110.039 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.58 ' HB ' HG23 ' A' ' 19' ' ' VAL . 93.4 t -89.7 -43.33 14.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.9 0.381 . . . . 73.329999999999998 110.221 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -139.22 132.8 30.42 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 109.18 -0.674 . . . . 73.349999999999994 109.18 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -79.69 -176.26 48.95 Favored Glycine 0 C--N 1.335 0.507 0 O-C-N 124.334 1.022 . . . . 61.030000000000001 112.964 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -46.35 144.33 2.13 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.703 0.631 . . . . 74.340000000000003 112.703 -174.26 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.572 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -151.36 -178.04 6.42 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.326 0.491 . . . . 73.409999999999997 112.326 -170.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 3.7 m-20 -96.67 171.4 8.56 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.911 0.863 . . . . 61.520000000000003 112.924 -171.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.737 ' HD3' ' SG ' ' A' ' 52' ' ' CYS . 6.4 tpp180 -56.67 -45.82 81.49 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 114.867 -1.06 . . . . 74.329999999999998 110.294 173.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -57.21 -34.23 68.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.463 0.649 . . . . 72.030000000000001 110.098 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 48' ' ' ASP . . . -72.46 -33.06 66.77 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-N 115.277 -0.874 . . . . 52.32 111.622 -177.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.737 ' SG ' ' HD3' ' A' ' 49' ' ' ARG . 22.4 p -71.56 -38.83 70.95 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.308 -0.405 . . . . 61.32 110.387 172.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 92.0 mt -60.14 -35.85 76.21 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.981 -0.554 . . . . 74.319999999999993 110.449 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 42.1 mt-10 -77.07 -39.23 50.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.301 -0.409 . . . . 73.120000000000005 110.641 176.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -55.65 -48.19 75.39 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.69 0.256 . . . . 71.239999999999995 111.69 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.0 tt -62.92 -45.3 99.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 120.811 0.338 . . . . 72.140000000000001 111.145 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -60.98 -48.0 83.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.983 -0.553 . . . . 72.010000000000005 110.326 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -58.71 -34.66 71.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.822 -0.627 . . . . 74.420000000000002 110.25 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 N--CA 1.463 0.195 0 CA-C-N 115.596 -0.729 . . . . 71.519999999999996 110.226 -178.535 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.477 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 65.1 t80 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 121.311 0.577 . . . . 74.209999999999994 109.963 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.483 ' HB2' ' HE1' ' A' ' 30' ' ' TRP . 48.0 p90 -136.36 131.42 34.23 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.931 -1.507 . . . . 74.439999999999998 106.931 167.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.7 t -146.33 138.66 19.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 CA-C-O 121.263 0.554 . . . . 65.329999999999998 111.229 -167.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.765 ' HB2' ' HB3' ' A' ' 30' ' ' TRP . 33.8 tp -117.06 130.44 56.67 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.872 -1.058 . . . . 71.329999999999998 110.273 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.72 126.4 72.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.157 0.503 . . . . 73.439999999999998 110.216 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.528 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 52.8 t-20 -85.52 149.48 25.35 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.211 -0.663 . . . . 74.140000000000001 109.211 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 22' ' ' ASN . 27.4 t70 -56.44 -26.49 53.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.218 0.533 . . . . 71.409999999999997 110.174 176.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -80.69 15.9 1.57 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.596 -0.729 . . . . 73.319999999999993 111.589 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 73.68 18.75 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.582 0.753 . . . . 73.299999999999997 112.452 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 14.9 mm100 -77.24 129.78 36.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.512 -0.551 . . . . 54.009999999999998 109.512 173.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -123.88 108.53 12.55 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.564 0.221 . . . . 74.109999999999999 110.817 -175.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -154.91 -163.63 1.61 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.181 -0.303 . . . . 70.430000000000007 110.181 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.776 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.3 pt? -109.66 159.16 17.37 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.382 -0.599 . . . . 62.520000000000003 109.382 175.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.765 ' HB3' ' HB2' ' A' ' 20' ' ' LEU . 11.7 p-90 -112.05 148.26 38.65 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 120.557 0.218 . . . . 73.310000000000002 110.849 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.18 94.41 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.368 2.045 . . . . 52.539999999999999 110.847 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.402 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -56.88 -18.28 12.58 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.858 -0.61 . . . . 64.129999999999995 111.682 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -85.02 2.24 44.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 72.430000000000007 110.668 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.17 176.88 8.26 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.183 -0.462 . . . . 42.140000000000001 110.906 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.51 139.85 30.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.465 . . . . 74.129999999999995 110.067 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.7 124.41 90.87 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.308 -0.406 . . . . 74.219999999999999 110.052 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.42 -171.67 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.906 2.404 . . . . 74.140000000000001 112.797 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.48 145.63 30.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 34.340000000000003 110.974 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.23 -32.66 5.77 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.248 -0.433 . . . . 60.32 112.415 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.466 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 16.8 m95 -86.0 136.94 33.06 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.489 -0.56 . . . . 74.510000000000005 109.489 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 40' ' ' TRP . 16.0 mmm180 -121.51 126.48 49.33 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.257 -0.645 . . . . 63.219999999999999 109.257 176.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.0 p -85.9 132.78 31.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.343 -0.243 . . . . 60.219999999999999 110.343 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.95 -37.51 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.069 0.461 . . . . 73.329999999999998 110.069 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -148.19 132.14 17.15 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.652 -0.703 . . . . 73.349999999999994 109.682 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.0 -175.15 45.36 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.111 -0.796 . . . . 61.030000000000001 111.111 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -54.86 133.64 47.9 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.884 0.342 . . . . 74.340000000000003 110.281 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.63 -177.58 4.93 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.665 0.617 . . . . 73.409999999999997 112.665 -168.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.22 165.89 1.28 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.981 -1.009 . . . . 61.520000000000003 112.601 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.519 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 0.2 OUTLIER -60.75 -29.08 69.17 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.891 -0.595 . . . . 74.329999999999998 109.682 174.304 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.509 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -58.18 -46.89 84.97 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.348 -0.612 . . . . 72.030000000000001 109.348 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' PHE . . . -65.83 -30.86 71.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.335 -0.848 . . . . 52.32 110.725 177.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 49' ' ' ARG . 54.1 t -58.4 -49.04 78.7 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.849 -0.426 . . . . 61.32 109.849 170.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.9 mt -67.75 -27.15 66.54 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.799 -0.637 . . . . 74.319999999999993 110.494 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 43.5 mt-10 -76.89 -36.69 56.52 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 116.236 -0.438 . . . . 73.120000000000005 111.649 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.477 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 1.9 t80 -61.86 -47.8 83.37 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.956 0.343 . . . . 71.239999999999995 110.798 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 tt -63.78 -41.84 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.73 -0.214 . . . . 72.140000000000001 110.932 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.31 -34.19 65.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.762 0.315 . . . . 72.010000000000005 111.183 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.23 -25.5 68.09 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.307 0.575 . . . . 74.420000000000002 109.47 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 . . . . . 0 C--O 1.233 0.187 0 CA-C-N 115.134 -0.939 . . . . 71.519999999999996 110.732 176.513 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.764 ' CD1' ' HB2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 112.444 0.535 . . . . 74.209999999999994 112.444 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.422 ' CB ' ' HA ' ' A' ' 46' ' ' GLU . 27.7 p90 -124.26 135.98 53.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.474 -0.784 . . . . 74.439999999999998 108.956 -173.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.07 129.5 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.055 -0.52 . . . . 65.329999999999998 111.896 -167.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 30' ' ' TRP . 49.5 tp -100.31 125.62 46.55 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.252 -0.886 . . . . 71.329999999999998 109.123 172.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 p -109.26 126.34 66.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.24 0.543 . . . . 73.439999999999998 109.807 176.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -94.47 148.33 22.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.72 -0.673 . . . . 74.140000000000001 110.671 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.417 ' HB3' ' HZ3' ' A' ' 40' ' ' TRP . 15.3 t70 -56.06 -20.86 18.75 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.354 0.597 . . . . 71.409999999999997 110.199 174.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -73.55 3.72 5.83 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.262 -0.881 . . . . 73.319999999999993 111.531 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 63.31 56.83 1.63 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.37 0.605 . . . . 73.299999999999997 110.586 -175.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -137.93 132.55 32.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.251 -0.886 . . . . 54.009999999999998 109.171 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -116.8 109.12 16.7 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.13 0.491 . . . . 74.109999999999999 110.333 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.3 t -145.96 -167.77 2.81 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.564 -0.532 . . . . 70.430000000000007 109.564 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 pp -107.61 158.63 17.08 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.27 -0.27 . . . . 62.520000000000003 110.27 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.632 ' HB3' HD22 ' A' ' 20' ' ' LEU . 18.2 p-90 -111.79 153.24 44.48 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.453 -0.34 . . . . 73.310000000000002 110.431 -175.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.73 102.83 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.157 1.905 . . . . 52.539999999999999 110.979 175.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.09 -7.01 2.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.522 0.934 . . . . 64.129999999999995 113.522 -171.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -107.23 10.13 29.97 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.256 -0.278 . . . . 72.430000000000007 110.962 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.456 ' O ' ' HZ3' ' A' ' 30' ' ' TRP . . . -124.48 169.89 11.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.426 -0.352 . . . . 42.140000000000001 110.574 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.45 139.56 30.59 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.124 -0.324 . . . . 74.129999999999995 110.124 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.0 t -74.64 120.93 83.9 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.557 -0.292 . . . . 74.219999999999999 110.513 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.65 137.67 70.33 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.461 2.108 . . . . 74.140000000000001 111.436 175.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.73 134.94 57.5 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.46 -0.336 . . . . 34.340000000000003 110.571 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.31 -35.15 4.59 Favored Glycine 0 CA--C 1.511 -0.211 0 N-CA-C 111.062 -0.815 . . . . 60.32 111.062 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.417 ' HZ3' ' HB3' ' A' ' 23' ' ' ASP . 3.7 m95 -92.5 143.89 25.9 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.043 -1.095 . . . . 74.510000000000005 108.043 173.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 41' ' ' ARG . 44.6 ttm105 -141.22 133.7 28.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.96 0.41 . . . . 63.219999999999999 111.517 -174.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.2 t -85.49 121.09 36.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.959 -0.564 . . . . 60.219999999999999 110.31 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.42 -37.18 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.8 0.334 . . . . 73.329999999999998 110.873 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -134.67 129.89 35.49 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.226 -0.657 . . . . 73.349999999999994 109.226 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -72.47 167.29 53.52 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 124.455 1.097 . . . . 61.030000000000001 113.543 -176.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.6 mp0 -50.91 128.69 21.83 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.715 0.806 . . . . 74.340000000000003 112.488 -171.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -133.18 -178.23 4.88 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.509 -0.768 . . . . 73.409999999999997 110.727 -176.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.37 164.57 23.94 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.772 0.796 . . . . 61.520000000000003 112.653 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -52.57 -38.37 59.77 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 114.753 -1.112 . . . . 74.329999999999998 109.787 173.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.42 -47.6 83.39 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 115.756 -0.656 . . . . 72.030000000000001 110.216 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 17' ' ' PHE . . . -59.86 -31.35 69.69 Favored 'General case' 0 C--O 1.258 1.515 0 CA-C-O 121.71 0.766 . . . . 52.32 111.015 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.608 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 47.8 t -71.25 -40.88 70.75 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.724 -1.125 . . . . 61.32 110.839 172.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.5 mt -67.66 -26.93 66.45 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.317 0.58 . . . . 74.319999999999993 109.796 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -77.11 -37.39 54.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.526 -0.761 . . . . 73.120000000000005 110.141 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.764 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -46.53 -58.04 4.16 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 111.861 0.319 . . . . 71.239999999999995 111.861 171.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 tt -60.81 -37.96 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.242 0.544 . . . . 72.140000000000001 110.552 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.45 -43.55 93.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.249 -0.887 . . . . 72.010000000000005 110.571 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -73.76 -27.95 61.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.868 -0.605 . . . . 74.420000000000002 110.106 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 . . . . . 0 CA--C 1.533 0.301 0 CA-C-N 115.185 -0.916 . . . . 71.519999999999996 110.121 -176.865 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.685 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.581 0 CA-C-O 120.897 0.379 . . . . 74.209999999999994 110.411 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.505 ' HB3' ' HA ' ' A' ' 46' ' ' GLU . 31.2 p90 -122.9 135.93 54.68 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.458 0.647 . . . . 74.439999999999998 109.66 -167.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.686 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 18.1 t -135.86 131.99 50.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.83 -1.077 . . . . 65.329999999999998 109.694 -167.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.501 ' HB2' ' CD1' ' A' ' 30' ' ' TRP . 29.6 tp -120.92 145.16 47.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.108 -0.497 . . . . 71.329999999999998 110.714 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 97.8 t -122.01 125.54 73.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.812 -0.811 . . . . 73.439999999999998 108.812 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -82.48 163.55 21.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.826 -0.435 . . . . 74.140000000000001 109.826 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -57.38 -31.17 65.53 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.929 0.395 . . . . 71.409999999999997 110.719 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -79.18 16.67 0.91 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.429 0.633 . . . . 73.319999999999993 110.338 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 65.44 24.62 11.95 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.473 -0.785 . . . . 73.299999999999997 111.538 173.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 93.7 mt-30 -78.73 121.19 24.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.789 -0.641 . . . . 54.009999999999998 110.104 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -99.15 116.8 32.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.265 -0.272 . . . . 74.109999999999999 110.265 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.4 t -166.33 -164.19 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.601 -0.518 . . . . 70.430000000000007 109.601 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.763 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.4 pt? -108.32 173.73 6.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.694 -0.484 . . . . 62.520000000000003 109.694 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.501 ' CD1' ' HB2' ' A' ' 20' ' ' LEU . 14.7 p-90 -134.6 149.34 70.63 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.693 -0.23 . . . . 73.310000000000002 111.163 -175.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.88 108.63 2.62 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.741 2.294 . . . . 52.539999999999999 111.703 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.28 -12.16 60.75 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.304 -0.407 . . . . 64.129999999999995 112.013 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -104.31 14.53 30.07 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.041 0.448 . . . . 72.430000000000007 110.749 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.68 179.96 6.27 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.022 -0.535 . . . . 42.140000000000001 110.51 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -79.16 118.9 21.54 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.509 -0.314 . . . . 74.129999999999995 110.443 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.619 HG22 ' NE1' ' A' ' 40' ' ' TRP . 7.7 p -96.19 110.38 51.95 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 109.02 -0.733 . . . . 74.219999999999999 109.02 173.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.463 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 36.5 Cg_endo -64.3 108.38 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.853 2.369 . . . . 74.140000000000001 114.043 -167.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.26 152.53 0.27 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.682 -0.69 . . . . 34.340000000000003 112.3 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.78 -8.1 21.83 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.735 -0.666 . . . . 60.32 111.702 -174.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.619 ' NE1' HG22 ' A' ' 36' ' ' VAL . 4.9 p-90 -87.72 -177.61 5.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 122.972 0.509 . . . . 74.510000000000005 110.746 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.0 mtt85 -128.95 125.38 37.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.288 -1.005 . . . . 63.219999999999999 108.288 171.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 p -91.47 116.63 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.962 0.41 . . . . 60.219999999999999 111.162 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.686 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 61.4 t -76.98 -35.36 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.095 0.474 . . . . 73.329999999999998 110.288 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -157.02 132.2 9.05 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.632 -0.713 . . . . 73.349999999999994 109.828 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -71.31 167.66 51.62 Favored Glycine 0 C--N 1.34 0.773 0 O-C-N 124.337 1.023 . . . . 61.030000000000001 112.461 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -55.45 147.1 18.24 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.389 0.885 . . . . 74.340000000000003 113.389 -170.247 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -148.99 -178.31 6.3 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.735 -1.12 . . . . 73.409999999999997 109.24 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -91.89 172.28 8.57 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.001 0.429 . . . . 61.520000000000003 111.357 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -57.8 -32.25 67.37 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.137 -0.483 . . . . 74.329999999999998 110.117 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.712 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -52.35 -52.66 52.14 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 109.343 -0.614 . . . . 72.030000000000001 109.343 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.495 ' C ' ' HB3' ' A' ' 17' ' ' PHE . . . -64.26 -31.56 72.8 Favored 'General case' 0 C--O 1.262 1.724 0 CA-C-N 115.439 -0.801 . . . . 52.32 111.274 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.685 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 53.0 t -66.14 -36.53 83.37 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 114.55 -1.204 . . . . 61.32 110.57 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.677 ' O ' HG22 ' A' ' 56' ' ' ILE . 76.0 mt -72.0 -44.39 63.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.52 -0.548 . . . . 74.319999999999993 109.52 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.712 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 4.3 mm-40 -62.34 -25.55 67.96 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.417 -0.356 . . . . 73.120000000000005 111.12 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.604 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -46.09 -27.17 0.89 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 111.715 0.265 . . . . 71.239999999999995 111.715 173.518 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 53' ' ' LEU . 19.7 tt -60.85 -47.83 91.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 121.477 0.656 . . . . 72.140000000000001 110.271 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.475 ' N ' HG23 ' A' ' 56' ' ' ILE . 12.5 tp10 -73.83 -35.47 64.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.098 -0.955 . . . . 72.010000000000005 110.364 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -74.89 -36.35 62.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.0 -1.0 . . . . 74.420000000000002 111.361 -172.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 . . . . . 0 N--CA 1.47 0.548 0 CA-C-N 115.845 -0.616 . . . . 71.519999999999996 111.63 -179.032 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 114.351 1.241 . . . . 74.209999999999994 114.351 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -151.51 130.71 12.73 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.306 -0.998 . . . . 74.439999999999998 108.306 150.456 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.435 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 64.0 t -158.1 136.71 3.13 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 CA-C-O 121.128 0.489 . . . . 65.329999999999998 112.152 -169.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.423 HD13 HG22 ' A' ' 42' ' ' VAL . 63.4 tp -102.21 122.96 45.21 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.445 -0.798 . . . . 71.329999999999998 109.514 174.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.55 125.82 50.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.241 -0.651 . . . . 73.439999999999998 109.241 174.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 14.3 m120 -96.92 139.26 33.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.781 -0.645 . . . . 74.140000000000001 110.254 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.72 -15.92 59.75 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.087 0.47 . . . . 71.409999999999997 110.843 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -85.24 26.56 0.88 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.031 -0.531 . . . . 73.319999999999993 111.078 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 69.8 6.25 5.64 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.314 0.646 . . . . 73.299999999999997 111.803 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 15.7 mm100 -90.86 153.78 19.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.929 0.395 . . . . 54.009999999999998 110.45 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -133.37 109.09 9.11 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.394 -0.965 . . . . 74.109999999999999 108.394 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.3 t -128.38 177.21 7.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.772 0.796 . . . . 70.430000000000007 111.889 -170.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.3 tt -111.71 106.59 15.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.594 -1.185 . . . . 62.520000000000003 108.065 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.457 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 25.3 p-90 -77.67 149.49 77.86 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.059 -0.519 . . . . 73.310000000000002 111.206 -174.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.89 104.07 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.038 1.825 . . . . 52.539999999999999 111.085 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.457 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -63.42 -2.15 1.43 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.23 -0.441 . . . . 64.129999999999995 111.621 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -89.78 -0.72 57.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 72.430000000000007 110.789 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.2 178.0 7.24 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.05 0.452 . . . . 42.140000000000001 111.688 -175.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -95.92 140.11 31.15 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.593 -0.731 . . . . 74.129999999999995 111.028 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.3 t -91.48 123.95 62.38 Favored Pre-proline 0 C--O 1.236 0.383 0 CA-C-N 116.243 -0.435 . . . . 74.219999999999999 111.037 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.54 153.75 73.04 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.616 2.211 . . . . 74.140000000000001 111.708 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.05 152.18 38.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.94 0.4 . . . . 34.340000000000003 110.714 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.4 -35.53 4.91 Favored Glycine 0 N--CA 1.455 -0.073 0 N-CA-C 111.036 -0.826 . . . . 60.32 111.036 -174.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -95.01 129.21 42.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.757 -1.201 . . . . 74.510000000000005 107.757 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -100.12 125.64 46.25 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.622 -0.51 . . . . 63.219999999999999 109.622 -171.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.423 HG22 HD13 ' A' ' 20' ' ' LEU . 21.6 t -90.69 117.88 34.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.99 -0.744 . . . . 60.219999999999999 108.99 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.435 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 14.4 p -84.16 -23.35 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.681 0.753 . . . . 73.329999999999998 109.548 -174.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -148.29 115.48 6.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.036 -0.984 . . . . 73.349999999999994 108.714 173.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -69.74 -171.51 8.73 Favored Glycine 0 N--CA 1.447 -0.583 0 O-C-N 123.864 0.728 . . . . 61.030000000000001 112.501 -175.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -52.44 133.88 34.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.146 0.498 . . . . 74.340000000000003 111.322 -178.716 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.87 175.89 9.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.541 -0.754 . . . . 73.409999999999997 110.017 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.74 159.58 21.96 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.984 -0.553 . . . . 61.520000000000003 111.273 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.556 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 15.7 ttm180 -58.38 -37.72 75.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.242 -0.651 . . . . 74.329999999999998 109.242 176.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.74 -36.82 84.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.028 -0.533 . . . . 72.030000000000001 110.468 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.02 -38.47 79.22 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-N 115.855 -0.611 . . . . 52.32 111.389 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.556 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 27.0 p -73.44 -47.26 43.06 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.411 -0.813 . . . . 61.32 110.995 174.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 72.8 mt -60.89 -34.5 74.74 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.503 -0.317 . . . . 74.319999999999993 110.594 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -76.82 -37.54 55.5 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.885 -0.326 . . . . 73.120000000000005 110.54 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -48.26 -58.12 5.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 120.438 -0.505 . . . . 71.239999999999995 111.588 170.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 52' ' ' CYS . 3.7 tt -61.65 -38.55 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 120.672 0.272 . . . . 72.140000000000001 111.032 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -60.54 -43.49 97.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 72.010000000000005 110.51 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -81.94 -14.89 55.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.895 -0.593 . . . . 74.420000000000002 111.428 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 . . . . . 0 N--CA 1.467 0.378 0 CA-C-N 116.151 -0.477 . . . . 71.519999999999996 110.853 174.936 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.632 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 68.5 t80 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.363 0.601 . . . . 74.209999999999994 109.843 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -144.44 131.57 20.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.36 -1.348 . . . . 74.439999999999998 107.36 169.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -141.79 123.6 13.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.267 0.555 . . . . 65.329999999999998 111.003 -170.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 40' ' ' TRP . 52.2 tp -93.48 127.99 39.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.202 -0.908 . . . . 71.329999999999998 109.64 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 61.8 t -121.44 129.16 75.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.232 0.539 . . . . 73.439999999999998 110.909 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 33.4 t30 -92.81 151.78 19.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.92 -0.77 . . . . 74.140000000000001 108.92 173.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -54.54 -19.94 6.86 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.159 0.504 . . . . 71.409999999999997 110.95 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -82.64 20.61 1.1 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.965 -0.561 . . . . 73.319999999999993 111.635 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 65.62 12.57 8.34 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.976 0.51 . . . . 73.299999999999997 111.849 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 34.6 tt0 -76.03 117.64 17.95 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.341 -0.615 . . . . 54.009999999999998 109.341 176.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -122.52 107.95 12.6 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.01 0.434 . . . . 74.109999999999999 111.298 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 m -132.38 -168.03 1.99 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.549 -0.75 . . . . 70.430000000000007 109.359 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.787 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.9 pt? -106.38 161.63 14.4 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.238 -0.653 . . . . 62.520000000000003 109.238 174.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.467 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 20.0 p-90 -131.8 145.03 55.72 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.614 0.245 . . . . 73.310000000000002 111.31 -173.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 14.0 Cg_exo -69.86 103.67 1.21 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.727 2.285 . . . . 52.539999999999999 111.291 176.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.467 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -60.01 -22.52 62.7 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.14 -0.482 . . . . 64.129999999999995 112.03 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -84.88 4.26 34.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.615 -0.266 . . . . 72.430000000000007 111.436 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.99 162.44 22.33 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.806 0.336 . . . . 42.140000000000001 110.725 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -82.97 132.84 35.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 74.129999999999995 110.597 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.97 115.95 62.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 74.219999999999999 110.198 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.68 147.1 95.92 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.345 2.03 . . . . 74.140000000000001 112.169 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.37 137.76 57.0 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.203 -0.453 . . . . 34.340000000000003 110.685 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.42 -35.42 4.55 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.42 -0.672 . . . . 60.32 111.42 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.469 ' HB3' HD11 ' A' ' 20' ' ' LEU . 71.0 m95 -81.37 140.6 34.63 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.581 -0.526 . . . . 74.510000000000005 109.581 177.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -127.61 126.13 41.49 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.151 -0.314 . . . . 63.219999999999999 110.151 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.6 t -85.21 130.57 35.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.583 -0.525 . . . . 60.219999999999999 109.583 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -85.43 -31.33 6.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.228 0.537 . . . . 73.329999999999998 109.997 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -154.58 122.95 6.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.924 -0.769 . . . . 73.349999999999994 108.924 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.03 -172.41 42.18 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.28 -0.486 . . . . 61.030000000000001 112.522 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -61.73 154.52 25.3 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 110.244 -0.28 . . . . 74.340000000000003 110.244 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.436 ' HB3' ' CB ' ' A' ' 51' ' ' ALA . . . -160.71 -178.25 6.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.118 0.485 . . . . 73.409999999999997 111.762 -175.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -68.91 178.45 2.19 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.954 -1.021 . . . . 61.520000000000003 111.9 -175.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 44.5 ttm180 -61.15 -27.86 68.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.38 -0.827 . . . . 74.329999999999998 110.203 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -51.84 -44.97 63.81 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.162 0.505 . . . . 72.030000000000001 110.01 172.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 47' ' ' ALA . . . -75.81 -31.74 59.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.428 -0.806 . . . . 52.32 110.846 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.42 ' O ' HG22 ' A' ' 56' ' ' ILE . 52.8 t -54.12 -42.01 68.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.042 -0.527 . . . . 61.32 110.067 170.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.06 -29.85 68.91 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.055 -0.52 . . . . 74.319999999999993 110.665 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 94.8 mt-10 -70.05 -51.65 30.3 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.445 -0.343 . . . . 73.120000000000005 111.039 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.632 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 2.7 t80 -58.48 -41.9 86.34 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.603 -0.271 . . . . 71.239999999999995 111.693 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 52' ' ' CYS . 9.7 tt -71.03 -45.62 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 121.085 -0.246 . . . . 72.140000000000001 111.146 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -64.57 -52.6 56.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.418 -0.356 . . . . 72.010000000000005 110.302 -177.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -70.68 -33.14 70.6 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.948 -0.569 . . . . 74.420000000000002 110.337 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 . . . . . 0 N--CA 1.472 0.644 0 C-N-CA 123.829 0.852 . . . . 71.519999999999996 111.826 -178.873 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.817 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 19.0 t80 . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 109.066 -0.716 . . . . 74.209999999999994 109.066 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.653 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 46.1 p90 -125.22 138.15 54.12 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.366 -0.834 . . . . 74.439999999999998 111.652 -172.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -142.15 133.81 26.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 114.955 -1.02 . . . . 65.329999999999998 110.11 -173.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.643 ' HB2' ' CE3' ' A' ' 30' ' ' TRP . 17.8 tp -120.88 142.67 49.46 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 122.978 0.511 . . . . 71.329999999999998 110.754 -174.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.8 147.8 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.619 -0.264 . . . . 73.439999999999998 110.356 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 17.2 m120 -122.72 161.4 23.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.531 -0.304 . . . . 74.140000000000001 110.628 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -58.5 -25.46 62.39 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.889 -0.596 . . . . 71.409999999999997 111.202 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -83.49 22.93 0.99 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.627 -0.715 . . . . 73.319999999999993 111.512 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 65.53 14.25 9.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.879 0.471 . . . . 73.299999999999997 111.321 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 74.7 mt-30 -86.57 123.08 31.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.497 -0.319 . . . . 54.009999999999998 110.534 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -120.56 126.51 50.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.544 -0.539 . . . . 74.109999999999999 109.544 176.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 p -164.42 -154.44 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 70.430000000000007 110.346 -173.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.625 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.2 pt? -131.85 164.9 25.03 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.122 -0.695 . . . . 62.520000000000003 109.122 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.653 ' CH2' ' HB2' ' A' ' 18' ' ' PHE . 20.1 p90 -125.91 147.8 60.32 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-O 120.46 0.172 . . . . 73.310000000000002 111.033 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 13.8 Cg_exo -70.0 99.25 0.76 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.552 2.168 . . . . 52.539999999999999 111.133 173.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.99 -7.38 8.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.309 -0.405 . . . . 64.129999999999995 111.22 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -81.45 -2.46 49.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.985 -0.552 . . . . 72.430000000000007 110.706 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.0 177.62 7.84 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.413 -0.358 . . . . 42.140000000000001 110.642 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -80.79 138.55 36.27 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.814 -0.439 . . . . 74.129999999999995 109.814 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 t -90.45 126.29 56.93 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.138 -0.483 . . . . 74.219999999999999 110.45 -175.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.429 ' O ' ' HD1' ' A' ' 40' ' ' TRP . 38.6 Cg_endo -66.27 110.92 1.9 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.882 2.388 . . . . 74.140000000000001 112.501 -176.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -44.73 150.85 0.32 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.199 0.814 . . . . 34.340000000000003 113.199 -172.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.98 23.93 4.75 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.541 -0.754 . . . . 60.32 111.85 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.431 ' HB2' HD11 ' A' ' 20' ' ' LEU . 25.3 p-90 -130.2 160.08 34.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.897 0.379 . . . . 74.510000000000005 111.18 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 4.6 mmp_? -122.7 127.01 48.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.708 -0.849 . . . . 63.219999999999999 108.708 171.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.515 HG23 ' CH2' ' A' ' 30' ' ' TRP . 7.5 p -89.4 119.6 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 120.825 0.345 . . . . 60.219999999999999 110.423 -177.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.85 -38.18 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.455 0.645 . . . . 73.329999999999998 110.555 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.647 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 26.0 m80 -132.56 136.39 46.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.349 -0.841 . . . . 73.349999999999994 108.849 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.43 160.44 22.01 Favored Glycine 0 C--N 1.332 0.334 0 O-C-N 123.525 0.516 . . . . 61.030000000000001 112.892 -176.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.47 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -62.67 132.98 54.12 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.843 0.354 . . . . 74.340000000000003 111.031 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.5 -177.89 6.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.137 0.494 . . . . 73.409999999999997 111.734 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.76 172.71 2.06 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.241 -0.89 . . . . 61.520000000000003 112.716 -174.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.446 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 14.6 ttp180 -58.63 -42.91 89.34 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.575 -0.739 . . . . 74.329999999999998 111.172 178.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -52.5 -46.5 66.67 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.299 -0.63 . . . . 72.030000000000001 109.299 177.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.21 -34.7 78.21 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.019 -0.991 . . . . 52.32 111.081 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.817 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 36.7 m -60.39 -46.14 91.06 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.367 -0.833 . . . . 61.32 109.928 171.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.18 -24.78 62.3 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.486 -0.779 . . . . 74.319999999999993 110.561 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 42.1 mt-10 -76.93 -36.95 56.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 73.120000000000005 110.844 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -54.82 -50.46 68.53 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.659 0.244 . . . . 71.239999999999995 111.659 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.8 -34.89 49.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.032 0.444 . . . . 72.140000000000001 110.007 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -73.67 -25.59 60.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.762 -0.654 . . . . 72.010000000000005 110.819 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -65.88 -54.62 24.17 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.108 0.48 . . . . 74.420000000000002 109.985 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 77.0 t60 . . . . . 0 CA--C 1.534 0.334 0 CA-C-N 115.21 -0.904 . . . . 71.519999999999996 109.16 -174.585 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 1.7 t80 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.968 0.413 . . . . 74.209999999999994 110.051 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -140.97 131.18 24.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.321 -1.363 . . . . 74.439999999999998 107.321 165.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 43' ' ' VAL . 98.7 t -147.91 129.86 6.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 121.002 0.429 . . . . 65.329999999999998 110.345 -170.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 40' ' ' TRP . 46.2 tp -105.42 139.29 40.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.566 -0.743 . . . . 71.329999999999998 110.124 -177.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.1 t -118.41 126.09 74.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 109.41 -0.589 . . . . 73.439999999999998 109.41 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -95.09 162.54 13.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.295 -0.411 . . . . 74.140000000000001 110.007 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.44 -11.9 37.98 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.236 0.541 . . . . 71.409999999999997 110.232 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -83.08 9.62 9.96 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.35 -0.841 . . . . 73.319999999999993 110.768 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 66.08 9.85 6.56 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.088 0.555 . . . . 73.299999999999997 110.65 -174.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -74.06 118.27 16.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.118 -0.492 . . . . 54.009999999999998 110.171 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -108.71 98.63 8.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.084 -0.507 . . . . 74.109999999999999 110.165 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -133.17 -173.17 3.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.354 -0.385 . . . . 70.430000000000007 110.06 -175.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.814 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.1 pt? -107.57 147.84 30.06 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.423 -0.584 . . . . 62.520000000000003 109.423 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.449 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 43.2 p-90 -116.1 129.43 25.21 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.642 -0.254 . . . . 73.310000000000002 110.478 -177.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 33.3 Cg_exo -61.82 108.44 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.472 2.115 . . . . 52.539999999999999 111.67 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.449 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -60.59 -18.53 53.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.166 -0.47 . . . . 64.129999999999995 111.845 -178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -93.05 9.41 35.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 72.430000000000007 111.285 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.57 175.8 7.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.224 -0.444 . . . . 42.140000000000001 110.754 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -95.94 128.49 42.88 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.248 -0.433 . . . . 74.129999999999995 110.799 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.498 HG12 ' NE1' ' A' ' 40' ' ' TRP . 3.2 t -91.87 110.78 46.09 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.263 -0.426 . . . . 74.219999999999999 110.138 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.43 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 38.5 Cg_endo -67.2 115.67 3.78 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 123.103 2.536 . . . . 74.140000000000001 112.582 -176.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -46.12 151.9 0.45 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.189 0.811 . . . . 34.340000000000003 113.189 -172.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.2 26.52 3.73 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.408 -0.814 . . . . 60.32 111.741 -175.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.498 ' NE1' HG12 ' A' ' 36' ' ' VAL . 17.2 p-90 -134.74 -178.82 5.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.151 0.5 . . . . 74.510000000000005 110.952 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -145.06 126.05 14.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.65 -0.871 . . . . 63.219999999999999 108.65 169.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.87 134.65 28.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.078 -0.341 . . . . 60.219999999999999 110.078 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 19' ' ' VAL . 9.8 p -89.79 -25.5 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.544 0.688 . . . . 73.329999999999998 109.965 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -155.05 121.51 5.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.213 -0.903 . . . . 73.349999999999994 109.095 175.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.45 -174.78 50.26 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.188 -0.529 . . . . 61.030000000000001 111.955 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.5 112.13 1.48 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.09 0.471 . . . . 74.340000000000003 109.857 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.21 -177.78 3.51 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.765 0.654 . . . . 73.409999999999997 112.765 -165.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -86.74 179.87 6.69 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.175 -0.92 . . . . 61.520000000000003 112.437 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 32.2 ttm180 -48.48 -41.44 29.75 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.629 -1.169 . . . . 74.329999999999998 111.393 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -52.82 -47.18 67.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.146 0.498 . . . . 72.030000000000001 110.094 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 17' ' ' PHE . . . -69.88 -31.17 68.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.564 -0.743 . . . . 52.32 110.838 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 49' ' ' ARG . 53.9 t -56.84 -42.5 79.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.961 0.41 . . . . 61.32 110.164 171.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.44 -26.16 62.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.929 -0.578 . . . . 74.319999999999993 111.105 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 52.9 mt-10 -74.94 -53.17 9.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.362 -0.381 . . . . 73.120000000000005 111.468 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.572 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 39.7 t80 -60.84 -35.5 76.7 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 111.755 0.28 . . . . 71.239999999999995 111.755 -175.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.7 tt -71.23 -41.16 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 120.996 -0.282 . . . . 72.140000000000001 111.064 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -73.72 -57.25 4.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.901 0.381 . . . . 72.010000000000005 110.913 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -61.22 -31.86 71.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.747 -0.66 . . . . 74.420000000000002 110.926 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.8 m80 . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 116.029 -0.532 . . . . 71.519999999999996 110.645 -177.849 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.759 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 112.643 0.608 . . . . 74.209999999999994 112.643 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.45 130.59 11.91 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.989 0.813 . . . . 74.439999999999998 109.834 153.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -162.85 138.3 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.053 0 CA-C-O 121.242 0.544 . . . . 65.329999999999998 111.045 170.546 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.586 ' HB2' ' CD1' ' A' ' 30' ' ' TRP . 32.3 tp -104.19 153.7 20.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.418 -0.81 . . . . 71.329999999999998 108.972 175.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 41' ' ' ARG . 9.7 p -136.67 134.23 48.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.952 0.406 . . . . 73.439999999999998 110.373 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -73.05 154.76 40.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.875 -0.787 . . . . 74.140000000000001 108.875 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -57.13 -23.91 50.53 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.082 0.468 . . . . 71.409999999999997 110.512 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.42 13.04 1.69 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.837 -0.619 . . . . 73.319999999999993 111.004 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 56.88 56.81 5.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.8 0.81 . . . . 73.299999999999997 110.696 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -114.74 119.89 38.21 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.709 -1.132 . . . . 54.009999999999998 108.896 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -76.08 132.29 39.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.673 -0.24 . . . . 74.109999999999999 110.502 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.8 m -153.74 178.12 10.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.012 0.434 . . . . 70.430000000000007 110.741 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.704 ' H ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -124.57 159.83 29.77 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.949 -0.76 . . . . 62.520000000000003 108.949 177.131 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.586 ' CD1' ' HB2' ' A' ' 20' ' ' LEU . 6.0 p-90 -145.13 139.49 15.15 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 121.041 -0.264 . . . . 73.310000000000002 111.59 -173.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 5.2 Cg_exo -80.14 104.9 1.71 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.072 2.515 . . . . 52.539999999999999 110.833 173.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.29 -2.08 1.98 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.467 0.543 . . . . 64.129999999999995 112.467 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -91.05 -0.14 57.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.474 0.178 . . . . 72.430000000000007 111.36 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.65 170.31 12.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.597 0.237 . . . . 42.140000000000001 110.903 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -69.44 126.39 29.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.887 -0.597 . . . . 74.129999999999995 110.08 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 t -97.61 113.25 63.22 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.756 -0.461 . . . . 74.219999999999999 109.756 -176.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 21.0 Cg_endo -60.64 107.23 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.982 2.454 . . . . 74.140000000000001 113.334 -172.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.89 151.82 0.42 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.447 0.699 . . . . 34.340000000000003 112.655 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.98 5.91 21.3 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.869 -0.605 . . . . 60.32 112.065 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.446 ' CD1' ' O ' ' A' ' 37' ' ' PRO . 18.4 p-90 -107.41 175.66 5.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 74.510000000000005 110.867 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.527 ' O ' HG12 ' A' ' 21' ' ' VAL . 15.0 tpp180 -141.61 142.98 33.44 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.26 -1.015 . . . . 63.219999999999999 108.26 170.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.2 p -90.68 131.2 38.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.013 -0.366 . . . . 60.219999999999999 110.013 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.1 m -99.47 -22.42 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.313 0.578 . . . . 73.329999999999998 110.313 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 17' ' ' PHE . 92.1 m-70 -147.63 118.72 7.72 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.224 -1.028 . . . . 73.349999999999994 108.224 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.04 165.4 7.1 Favored Glycine 0 C--N 1.332 0.35 0 O-C-N 123.807 0.692 . . . . 61.030000000000001 113.481 -172.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.45 151.35 24.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.143 0.497 . . . . 74.340000000000003 110.594 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -162.95 -177.98 5.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.948 -0.569 . . . . 73.409999999999997 110.465 -175.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -54.18 161.37 1.32 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.234 0.54 . . . . 61.520000000000003 112.01 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.687 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 46.1 ttt180 -57.12 -29.81 63.85 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.574 -0.739 . . . . 74.329999999999998 110.47 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -62.25 -47.3 84.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.939 0.4 . . . . 72.030000000000001 110.154 174.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.27 -31.4 71.7 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 116.173 -0.467 . . . . 52.32 111.544 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.687 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 16.6 p -73.51 -50.59 20.68 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.711 -0.677 . . . . 61.32 111.244 173.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.508 ' H ' ' HG ' ' A' ' 52' ' ' CYS . 78.6 mt -59.09 -34.66 72.25 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.414 0.626 . . . . 74.319999999999993 110.346 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 20.2 mm-40 -76.94 -35.19 57.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.72 -0.673 . . . . 73.120000000000005 110.485 176.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.759 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -46.33 -52.68 12.31 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 117.847 0.294 . . . . 71.239999999999995 111.599 171.241 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.6 tt -71.18 -36.58 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.661 0.267 . . . . 72.140000000000001 111.61 -173.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -73.31 -50.46 22.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.149 0.499 . . . . 72.010000000000005 110.498 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -61.47 -27.58 68.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.598 -0.728 . . . . 74.420000000000002 109.041 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 . . . . . 0 N--CA 1.463 0.196 0 CA-C-N 114.396 -1.275 . . . . 71.519999999999996 112.179 171.697 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.813 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.637 0.256 . . . . 74.209999999999994 111.543 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.472 ' HB3' ' HA ' ' A' ' 46' ' ' GLU . 28.3 p90 -125.12 137.45 54.18 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.92 0.39 . . . . 74.439999999999998 110.434 -173.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.445 HG23 HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -155.14 142.86 12.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 121.567 0.699 . . . . 65.329999999999998 111.776 -178.73 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 30' ' ' TRP . 48.1 tp -105.25 147.99 27.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.194 -1.367 . . . . 71.329999999999998 108.8 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.6 144.42 28.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.13 0.49 . . . . 73.439999999999998 110.824 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -104.33 153.63 20.81 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.007 -0.738 . . . . 74.140000000000001 109.007 175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -57.59 -22.81 47.3 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.811 0.339 . . . . 71.409999999999997 111.087 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -77.9 15.4 0.88 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.15 -0.477 . . . . 73.319999999999993 111.577 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 67.11 15.81 10.15 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.135 0.574 . . . . 73.299999999999997 111.407 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -84.83 119.45 25.33 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.578 -0.527 . . . . 54.009999999999998 109.578 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -114.19 136.48 52.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.95 0.405 . . . . 74.109999999999999 111.191 -175.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -152.04 -172.12 4.13 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.213 -0.662 . . . . 70.430000000000007 109.213 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.8 pt? -109.04 139.37 44.02 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.452 -0.573 . . . . 62.520000000000003 109.452 174.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 20' ' ' LEU . 21.4 p-90 -98.62 155.03 37.2 Favored Pre-proline 0 C--O 1.236 0.345 0 CA-C-N 116.151 -0.477 . . . . 73.310000000000002 110.792 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.578 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 31.1 Cg_exo -62.2 96.16 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.45 2.1 . . . . 52.539999999999999 111.012 174.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.39 -23.76 62.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.884 -0.598 . . . . 64.129999999999995 111.692 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -95.3 17.44 14.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.112 -0.495 . . . . 72.430000000000007 110.894 -178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . . . -143.39 174.62 10.58 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.8 0.333 . . . . 42.140000000000001 110.762 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -92.21 139.88 30.18 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.057 -0.52 . . . . 74.129999999999995 110.244 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -76.06 130.91 76.85 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 74.219999999999999 110.603 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HG2' ' CD1' ' A' ' 40' ' ' TRP . 45.3 Cg_endo -68.52 167.02 23.75 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.454 2.102 . . . . 74.140000000000001 112.141 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.94 151.57 47.37 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.969 -0.56 . . . . 34.340000000000003 111.548 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.97 -35.85 4.13 Favored Glycine 0 C--N 1.33 0.232 0 CA-C-N 115.65 -0.705 . . . . 60.32 112.342 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.406 ' CD1' ' HG2' ' A' ' 37' ' ' PRO . 41.9 m95 -88.23 145.37 25.91 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.256 -0.276 . . . . 74.510000000000005 110.256 -177.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -127.87 128.82 45.85 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.147 -0.316 . . . . 63.219999999999999 110.147 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.9 t -80.98 137.6 21.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.985 -0.376 . . . . 60.219999999999999 109.985 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.445 HG13 HG23 ' A' ' 19' ' ' VAL . 8.1 p -107.15 -28.98 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.992 0.425 . . . . 73.329999999999998 110.839 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.674 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 1.7 m-70 -139.79 138.58 35.97 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.799 -0.445 . . . . 73.349999999999994 109.799 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.48 174.81 36.9 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 123.674 0.609 . . . . 61.030000000000001 113.367 -173.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -58.99 138.31 57.56 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.127 0.571 . . . . 74.340000000000003 111.185 -172.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -158.99 173.94 15.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.917 0.389 . . . . 73.409999999999997 111.493 -175.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -84.25 177.59 8.13 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.717 0.77 . . . . 61.520000000000003 112.894 -171.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.457 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 9.0 tpm_? -50.19 -44.29 52.9 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.331 -1.304 . . . . 74.329999999999998 111.143 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.31 -52.41 61.6 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 116.144 -0.48 . . . . 72.030000000000001 110.64 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.04 72.09 Favored 'General case' 0 C--O 1.263 1.801 0 CA-C-O 121.819 0.818 . . . . 52.32 111.608 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.813 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 73.2 m -72.58 -28.76 63.0 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 114.459 -1.246 . . . . 61.32 110.79 175.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.654 ' O ' HG22 ' A' ' 56' ' ' ILE . 92.6 mt -71.72 -51.96 20.2 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 108.81 -0.811 . . . . 74.319999999999993 108.81 169.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.17 -24.17 25.42 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.371 -0.831 . . . . 73.120000000000005 111.811 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.587 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -44.39 -31.25 1.0 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 121.118 -0.233 . . . . 71.239999999999995 111.276 171.27 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.654 HG22 ' O ' ' A' ' 53' ' ' LEU . 19.8 tt -60.16 -46.47 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.379 0.609 . . . . 72.140000000000001 110.455 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.458 ' N ' HG23 ' A' ' 56' ' ' ILE . 6.2 tp10 -74.37 -43.04 58.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.492 -0.776 . . . . 72.010000000000005 110.81 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -50.79 -58.89 4.84 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.302 -0.863 . . . . 74.420000000000002 111.956 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.2 m80 . . . . . 0 CA--C 1.533 0.292 0 CA-C-N 115.671 -0.695 . . . . 71.519999999999996 111.285 -175.879 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.626 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 114.596 1.332 . . . . 74.209999999999994 114.596 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 38.9 p90 -126.48 136.2 52.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 113.924 -1.489 . . . . 74.439999999999998 109.766 -176.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 43' ' ' VAL . 54.3 t -147.75 131.44 8.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-O 121.053 0.454 . . . . 65.329999999999998 110.1 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 40' ' ' TRP . 64.9 tp -102.97 137.66 40.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.753 -0.658 . . . . 71.329999999999998 110.851 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.1 t -113.04 152.78 14.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.127 -1.064 . . . . 73.439999999999998 108.127 171.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.696 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 34.6 t30 -123.57 144.72 49.4 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.572 -0.899 . . . . 74.140000000000001 108.572 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -68.5 -7.85 35.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.014 0.435 . . . . 71.409999999999997 110.504 -177.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 29.2 tt0 -75.39 4.09 7.93 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.329 -0.85 . . . . 73.319999999999993 109.893 168.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 47.6 mt-10 74.16 15.72 3.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.854 0.862 . . . . 73.299999999999997 111.693 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.696 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 6.2 tp-100 -76.6 148.75 36.77 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.212 -0.662 . . . . 54.009999999999998 109.212 172.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -150.77 114.36 4.93 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.661 0.267 . . . . 74.109999999999999 110.626 -177.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.5 t -171.75 175.72 3.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.143 -0.481 . . . . 70.430000000000007 109.752 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.689 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.5 pt? -80.79 160.14 24.94 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.456 -0.572 . . . . 62.520000000000003 109.456 175.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 23.7 p-90 -126.46 132.84 24.47 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.65 0.262 . . . . 73.310000000000002 110.996 -174.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 12.6 Cg_exo -70.46 107.27 1.96 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.435 2.09 . . . . 52.539999999999999 111.549 177.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.04 -8.92 8.44 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.24 -0.436 . . . . 64.129999999999995 111.78 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -81.66 -10.86 59.3 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.307 -0.406 . . . . 72.430000000000007 110.606 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.36 166.33 11.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.231 -0.441 . . . . 42.140000000000001 110.577 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.64 134.29 35.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.055 -0.521 . . . . 74.129999999999995 109.705 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.508 HG12 ' NE1' ' A' ' 40' ' ' TRP . 2.5 t -95.47 104.09 14.63 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 110.078 -0.341 . . . . 74.219999999999999 110.078 -176.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 42.9 Cg_endo -67.2 114.42 3.21 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.982 2.455 . . . . 74.140000000000001 113.116 -174.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -44.48 152.49 0.2 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.727 0.811 . . . . 34.340000000000003 113.156 -173.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.1 12.65 10.81 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.747 -0.661 . . . . 60.32 111.468 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.508 ' NE1' HG12 ' A' ' 36' ' ' VAL . 10.4 p-90 -115.78 -172.53 2.18 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.912 0.485 . . . . 74.510000000000005 110.85 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -161.77 125.91 3.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.334 -0.848 . . . . 63.219999999999999 109.243 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.419 HG22 HD13 ' A' ' 20' ' ' LEU . 6.1 t -90.63 148.04 4.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.603 -0.271 . . . . 60.219999999999999 111.05 -171.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 19' ' ' VAL . 8.9 p -93.69 -34.26 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 109.508 -0.553 . . . . 73.329999999999998 109.508 173.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.441 ' ND1' ' O ' ' A' ' 17' ' ' PHE . 64.2 t-80 -158.31 132.14 7.8 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.434 -0.58 . . . . 73.349999999999994 109.434 173.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -76.66 -168.67 28.68 Favored Glycine 0 C--N 1.334 0.417 0 O-C-N 123.712 0.632 . . . . 61.030000000000001 114.021 -175.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -45.19 154.86 0.14 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.451 1.1 . . . . 74.340000000000003 113.449 -170.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' A' ' 51' ' ' ALA . . . -157.79 162.49 38.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.597 -0.729 . . . . 73.409999999999997 111.707 -176.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.96 166.14 21.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.533 -0.758 . . . . 61.520000000000003 110.296 175.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.464 HH11 HD12 ' A' ' 53' ' ' LEU . 7.0 tmm_? -53.83 -45.3 70.83 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.311 -0.404 . . . . 74.329999999999998 110.499 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.92 -42.81 80.64 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 116.207 -0.451 . . . . 72.030000000000001 110.703 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . . . -66.67 -34.46 77.91 Favored 'General case' 0 C--O 1.273 2.324 0 CA-C-O 122.295 1.045 . . . . 52.32 111.616 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.626 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 36.1 t -66.17 -36.77 83.97 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 113.528 -1.669 . . . . 61.32 109.773 175.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.617 ' O ' HG22 ' A' ' 56' ' ' ILE . 79.8 mt -71.76 -39.8 69.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 74.319999999999993 110.183 171.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -60.92 -25.2 66.58 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 122.905 0.482 . . . . 73.120000000000005 111.224 -176.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.588 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -45.63 -24.91 0.39 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.319 0.387 . . . . 71.239999999999995 111.344 170.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 53' ' ' LEU . 17.0 tt -64.62 -49.38 80.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.082 0.467 . . . . 72.140000000000001 110.277 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.517 ' N ' HG23 ' A' ' 56' ' ' ILE . 9.5 tp10 -74.01 -42.51 60.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.315 -0.857 . . . . 72.010000000000005 111.049 -175.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.512 ' HG2' ' HA ' ' A' ' 55' ' ' TYR . 16.3 pt-20 -78.46 -37.98 42.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 74.420000000000002 111.269 -176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.1 p80 . . . . . 0 N--CA 1.475 0.802 0 C-N-CA 123.772 0.829 . . . . 71.519999999999996 112.261 179.152 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.81 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 24.8 t80 . . . . . 0 N--CA 1.451 -0.41 0 CA-C-O 121.872 0.844 . . . . 74.209999999999994 109.502 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 29' ' ' LEU . 54.2 p90 -150.39 131.51 14.42 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.004 -1.48 . . . . 74.439999999999998 107.004 169.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 48.9 t -143.06 131.77 20.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.84 -0.344 . . . . 65.329999999999998 110.256 -169.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -120.91 123.57 42.82 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.263 -0.643 . . . . 71.329999999999998 109.263 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.3 m -112.19 125.97 69.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.444 0.64 . . . . 73.439999999999998 109.778 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.675 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 14.4 m120 -84.06 146.65 27.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.598 -0.728 . . . . 74.140000000000001 109.485 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -56.33 -23.35 36.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.029 0.443 . . . . 71.409999999999997 111.203 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -87.36 23.2 1.93 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.045 -0.525 . . . . 73.319999999999993 110.906 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 67.84 21.01 9.21 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.74 0.816 . . . . 73.299999999999997 112.391 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.675 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 15.6 mm-40 -83.43 117.96 23.41 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.011 -0.366 . . . . 54.009999999999998 110.011 175.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -92.92 116.82 29.39 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.364 -0.606 . . . . 74.109999999999999 109.364 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -152.9 -172.84 4.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.231 0.539 . . . . 70.430000000000007 110.758 -174.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.442 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 2.4 pp -125.72 -174.78 3.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.69 -0.686 . . . . 62.520000000000003 109.196 174.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.4 p-90 -145.3 128.78 8.49 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 110.122 -0.325 . . . . 73.310000000000002 110.122 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.52 130.62 41.04 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.457 2.104 . . . . 52.539999999999999 111.369 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.67 12.48 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.9 0.704 . . . . 64.129999999999995 112.9 -173.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -81.72 -27.37 33.94 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.712 0.292 . . . . 72.430000000000007 111.052 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.04 155.12 37.59 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.996 0.427 . . . . 42.140000000000001 111.17 -176.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -94.91 139.71 30.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.057 -0.52 . . . . 74.129999999999995 109.823 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.2 t -79.9 111.37 21.12 Favored Pre-proline 0 C--O 1.235 0.305 0 N-CA-C 110.006 -0.368 . . . . 74.219999999999999 110.006 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.11 133.44 57.71 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.666 2.244 . . . . 74.140000000000001 112.03 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.9 135.7 57.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.999 -0.546 . . . . 34.340000000000003 110.763 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.02 -24.83 11.31 Favored Glycine 0 C--O 1.235 0.201 0 C-N-CA 121.315 -0.469 . . . . 60.32 112.171 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -91.27 154.67 19.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.839 -0.8 . . . . 74.510000000000005 108.839 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -110.02 125.97 53.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.919 0.39 . . . . 63.219999999999999 110.141 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.1 p -91.87 122.99 43.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.98 0.419 . . . . 60.219999999999999 110.68 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 58.4 t -72.94 -41.05 60.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.261 0.553 . . . . 73.329999999999998 109.561 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.425 ' HE1' ' HB2' ' A' ' 47' ' ' ALA . 49.2 t-80 -160.96 141.89 11.57 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.492 -0.777 . . . . 73.349999999999994 109.24 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.08 -170.68 47.25 Favored Glycine 0 N--CA 1.452 -0.297 0 O-C-N 123.598 0.561 . . . . 61.030000000000001 112.617 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.17 140.31 21.38 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.063 0.545 . . . . 74.340000000000003 110.583 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.425 ' HB2' ' HE1' ' A' ' 44' ' ' HIS . . . -143.57 -178.32 5.83 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.429 0.529 . . . . 73.409999999999997 112.429 -170.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -91.66 179.72 5.57 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.324 -0.853 . . . . 61.520000000000003 112.213 -173.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.534 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 4.4 tmt_? -60.93 -40.82 94.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.428 -0.805 . . . . 74.329999999999998 111.734 -177.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.65 -36.05 81.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.144 0.497 . . . . 72.030000000000001 109.729 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 17' ' ' PHE . . . -68.31 -30.71 69.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.576 -0.738 . . . . 52.32 110.532 175.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.598 ' O ' HG22 ' A' ' 56' ' ' ILE . 53.9 t -59.43 -47.59 84.88 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.356 -0.609 . . . . 61.32 109.356 170.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.503 HD11 ' NH1' ' A' ' 49' ' ' ARG . 85.5 mt -57.88 -32.76 68.02 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.6 -0.727 . . . . 74.319999999999993 110.689 177.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.54 -53.53 22.44 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.341 -0.39 . . . . 73.120000000000005 110.728 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.81 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 40.4 t80 -64.59 -43.83 92.59 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.991 0.367 . . . . 71.239999999999995 111.991 -173.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 52' ' ' CYS . 12.4 tt -64.11 -39.83 86.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.121 0.486 . . . . 72.140000000000001 110.978 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -73.52 -35.31 65.56 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.078 -0.51 . . . . 72.010000000000005 110.537 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -65.24 -38.72 91.24 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.285 -0.635 . . . . 74.420000000000002 109.285 171.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 . . . . . 0 C--O 1.236 0.38 0 CA-C-N 114.711 -1.131 . . . . 71.519999999999996 110.584 179.166 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.687 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 3.4 p90 . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 114.278 1.214 . . . . 74.209999999999994 114.278 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -151.15 130.5 12.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.333 -1.729 . . . . 74.439999999999998 106.333 148.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.6 HG22 ' CE1' ' A' ' 55' ' ' TYR . 17.3 t -151.87 122.25 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 112.373 0.509 . . . . 65.329999999999998 112.373 -168.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 54.5 tp -96.42 144.83 26.19 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.621 -0.718 . . . . 71.329999999999998 109.785 174.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.68 126.1 64.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.278 0.561 . . . . 73.439999999999998 110.008 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.406 ' ND2' ' HZ3' ' A' ' 40' ' ' TRP . 1.1 m-20 -77.47 144.77 37.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.439 -0.8 . . . . 74.140000000000001 109.633 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -58.4 -17.85 23.59 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.802 0.811 . . . . 71.409999999999997 109.683 172.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.56 0.96 9.06 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.76 -1.109 . . . . 73.319999999999993 111.04 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 72.69 14.36 5.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.411 0.684 . . . . 73.299999999999997 111.035 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -90.05 161.31 15.89 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.546 -0.909 . . . . 54.009999999999998 108.546 172.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -152.33 140.85 20.71 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.186 0.448 . . . . 74.109999999999999 111.253 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -168.22 -166.27 0.69 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.552 -0.536 . . . . 70.430000000000007 109.552 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.809 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.1 pt? -94.44 161.65 14.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.691 0.281 . . . . 62.520000000000003 110.461 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -138.25 147.3 55.19 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.43 -0.35 . . . . 73.310000000000002 110.65 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.15 116.9 4.72 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.488 2.125 . . . . 52.539999999999999 111.543 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.0 -21.29 64.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.279 -0.418 . . . . 64.129999999999995 111.655 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -81.43 -20.16 40.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.855 0.359 . . . . 72.430000000000007 110.524 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.97 150.62 23.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.367 -0.379 . . . . 42.140000000000001 110.439 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -95.37 111.64 23.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.659 -0.497 . . . . 74.129999999999995 109.659 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.482 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.1 p -81.49 120.4 78.0 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.361 -0.381 . . . . 74.219999999999999 110.936 -176.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 5.9 Cg_exo -75.57 173.1 15.07 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.401 2.734 . . . . 74.140000000000001 113.107 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.42 152.35 44.12 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.957 -0.565 . . . . 34.340000000000003 110.911 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.54 -28.55 11.85 Favored Glycine 0 C--N 1.329 0.186 0 N-CA-C 110.935 -0.866 . . . . 60.32 110.935 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.406 ' HZ3' ' ND2' ' A' ' 22' ' ' ASN . 11.7 m95 -105.09 98.67 8.35 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.075 -1.083 . . . . 74.510000000000005 108.075 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -99.59 126.34 45.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.855 0.36 . . . . 63.219999999999999 111.3 -172.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 8.5 p -82.94 119.76 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.117 -0.492 . . . . 60.219999999999999 109.907 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.08 -26.87 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.527 0.679 . . . . 73.329999999999998 110.059 -175.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -131.96 107.18 8.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.218 -0.901 . . . . 73.349999999999994 108.652 174.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.55 173.26 5.72 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.19 -0.914 . . . . 61.030000000000001 114.453 -169.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.92 137.27 58.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.772 -0.714 . . . . 74.340000000000003 110.061 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.85 -177.97 6.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.678 0.275 . . . . 73.409999999999997 111.138 -174.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 7.7 m-20 -58.08 160.45 4.88 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.685 -0.689 . . . . 61.520000000000003 112.178 -175.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.514 ' O ' ' SG ' ' A' ' 52' ' ' CYS . 6.6 ttm180 -53.87 -44.18 70.2 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.477 -0.783 . . . . 74.329999999999998 110.004 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.69 -33.79 74.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.099 0.476 . . . . 72.030000000000001 110.539 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 48' ' ' ASP . . . -66.52 -42.22 87.6 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-N 115.751 -0.659 . . . . 52.32 111.059 -178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 49' ' ' ARG . 30.0 p -73.54 -35.79 65.57 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.66 -1.154 . . . . 61.32 111.233 174.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 60.0 mt -65.12 -34.75 79.15 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.363 -0.381 . . . . 74.319999999999993 110.222 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.19 -37.24 54.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.239 -0.437 . . . . 73.120000000000005 110.504 173.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.687 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 23.2 t80 -46.35 -45.24 17.53 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.324 0.49 . . . . 71.239999999999995 112.324 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 53' ' ' LEU . 11.5 tt -63.48 -39.35 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 120.491 -0.484 . . . . 72.140000000000001 111.326 -176.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -73.78 -43.21 59.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.625 0.25 . . . . 72.010000000000005 110.973 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 69.5 mm-40 -77.7 -41.12 39.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 111.758 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 95.2 m-70 . . . . . 0 N--CA 1.477 0.897 0 C-N-CA 124.428 1.091 . . . . 71.519999999999996 113.076 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.736 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 38.4 m-85 . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 117.049 -1.453 . . . . 74.209999999999994 107.93 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.63 ' CE2' ' HB1' ' A' ' 51' ' ' ALA . 98.1 m-85 -151.83 130.54 12.35 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 121.843 2.11 . . . . 74.439999999999998 109.871 172.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -164.22 143.29 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 112.559 0.577 . . . . 65.329999999999998 112.559 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.8 tp -102.3 123.6 46.4 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.575 -0.898 . . . . 71.329999999999998 108.575 165.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.58 125.83 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 73.439999999999998 110.15 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 3.8 m-20 -97.53 158.34 15.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.419 -0.355 . . . . 74.140000000000001 110.435 -178.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.25 -20.54 59.37 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.705 0.764 . . . . 71.409999999999997 109.816 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -76.49 9.56 2.63 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.8 -1.091 . . . . 73.319999999999993 111.143 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 67.86 15.37 9.58 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.304 0.642 . . . . 73.299999999999997 111.09 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.411 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 80.6 mm-40 -78.06 146.42 35.28 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.789 -0.819 . . . . 54.009999999999998 108.789 173.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -153.48 102.54 2.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.022 -0.362 . . . . 74.109999999999999 110.022 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.3 t -170.86 -170.1 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.823 -0.626 . . . . 70.430000000000007 110.096 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.452 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.4 mp -80.65 166.26 21.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.771 -0.65 . . . . 62.520000000000003 110.67 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.504 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 17.3 p-90 -143.36 155.29 61.13 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.521 -0.309 . . . . 73.310000000000002 111.11 -175.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.6 95.72 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.5 2.133 . . . . 52.539999999999999 111.585 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -67.42 -18.31 65.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.657 -0.701 . . . . 64.129999999999995 112.004 -175.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -81.58 -20.84 39.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 72.430000000000007 110.709 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.13 176.38 6.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 42.140000000000001 110.837 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.46 138.57 37.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.944 -0.571 . . . . 74.129999999999995 109.873 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.617 HG22 ' NE1' ' A' ' 40' ' ' TRP . 7.4 p -104.46 129.77 24.45 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 109.968 -0.382 . . . . 74.219999999999999 109.968 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.511 ' O ' ' NE1' ' A' ' 40' ' ' TRP . 77.7 Cg_endo -76.4 -169.43 0.7 Allowed 'Trans proline' 0 N--CA 1.481 0.778 0 C-N-CA 123.125 2.55 . . . . 74.140000000000001 114.299 -171.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.95 152.43 24.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.92 -0.582 . . . . 34.340000000000003 111.14 171.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.0 27.18 7.51 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.741 -0.743 . . . . 60.32 114.42 168.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.617 ' NE1' HG22 ' A' ' 36' ' ' VAL . 48.2 p-90 -130.36 174.63 9.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.337 0.589 . . . . 74.510000000000005 111.213 176.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -154.66 125.92 7.32 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.964 -1.124 . . . . 63.219999999999999 107.964 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.87 131.93 36.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.735 -0.469 . . . . 60.219999999999999 109.735 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.3 t -91.29 -23.99 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.655 0.74 . . . . 73.329999999999998 109.56 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.443 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -171.06 131.24 0.79 Allowed 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.605 -1.18 . . . . 73.349999999999994 107.928 174.244 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 18' ' ' PHE . . . -73.41 139.91 27.44 Favored Glycine 0 C--N 1.338 0.642 0 O-C-N 124.333 1.021 . . . . 61.030000000000001 114.089 -167.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -25.89 124.63 0.06 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.015 1.326 . . . . 74.340000000000003 114.539 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.492 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . . . -131.65 -176.98 4.22 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.015 -0.993 . . . . 73.409999999999997 109.419 175.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -52.57 153.01 3.29 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.267 0.556 . . . . 61.520000000000003 110.98 176.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.45 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 14.0 ttp180 -54.26 -31.28 53.18 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 115.293 -0.867 . . . . 74.329999999999998 110.248 -176.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.89 -45.05 83.42 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.09 0.471 . . . . 72.030000000000001 111.012 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.63 ' HB1' ' CE2' ' A' ' 18' ' ' PHE . . . -63.21 -40.18 96.73 Favored 'General case' 0 C--O 1.274 2.359 0 CA-C-O 121.683 0.754 . . . . 52.32 111.483 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.595 ' O ' ' HB3' ' A' ' 55' ' ' TYR . 64.9 m -73.46 -37.99 65.61 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 113.57 -1.65 . . . . 61.32 112.309 175.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 25.9 mt -70.11 -44.3 69.28 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.823 -0.436 . . . . 74.319999999999993 109.823 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.511 ' HA ' ' HB3' ' A' ' 57' ' ' GLU . 0.8 OUTLIER -68.72 -25.98 65.03 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 118.911 -0.566 . . . . 73.120000000000005 110.353 175.353 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.736 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -45.39 -61.5 1.65 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 118.141 -1.424 . . . . 71.239999999999995 111.352 162.584 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 tt -68.59 -35.76 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.754 0.311 . . . . 72.140000000000001 111.302 -176.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 54' ' ' GLU . 8.3 tp10 -62.53 -43.26 99.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.181 0.515 . . . . 72.010000000000005 110.244 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -66.97 -40.24 87.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.144 -0.935 . . . . 74.420000000000002 110.57 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 . . . . . 0 N--CA 1.469 0.515 0 CA-C-N 115.621 -0.718 . . . . 71.519999999999996 111.2 175.653 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.805 0 N-CA-C 111.697 -0.561 . . . . 64.540000000000006 111.697 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.82 140.52 11.58 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.579 2.186 . . . . 72.439999999999998 112.702 -175.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.89 -111.92 3.4 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.849 -0.614 . . . . 52.530000000000001 112.982 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.479 ' HB3' HD11 ' A' ' 7' ' ' ILE . 15.2 m -96.06 102.02 13.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.978 0.418 . . . . 64.439999999999998 111.82 -172.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.717 ' HG3' ' H ' ' A' ' 68' ' ' LEU . 81.6 mmm -104.17 -32.16 9.28 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.215 -0.661 . . . . 72.430000000000007 109.215 165.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.421 ' HG ' ' HG2' ' A' ' 71' ' ' LYS . 49.8 m -145.85 123.64 11.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.25 -0.886 . . . . 74.200000000000003 109.622 175.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.572 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 45.4 mm -95.04 153.3 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 65.329999999999998 110.486 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.544 ' HB2' HH11 ' A' ' 64' ' ' ARG . 89.2 m-20 -106.3 85.83 1.85 Allowed Pre-proline 0 N--CA 1.465 0.278 0 N-CA-C 108.971 -0.751 . . . . 64.430000000000007 108.971 173.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.61 ' HG2' ' HB2' ' A' ' 12' ' ' ASP . 91.6 Cg_endo -95.86 141.65 0.99 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.316 2.677 . . . . 71.439999999999998 112.852 -174.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -62.78 -46.01 90.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.022 -0.535 . . . . 72.319999999999993 110.659 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.89 -46.21 2.84 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.23 -0.441 . . . . 75.400000000000006 111.336 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.61 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 28.5 t70 73.76 -10.8 1.03 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.466 0.706 . . . . 73.540000000000006 111.817 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.43 -60.71 2.12 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.669 0.271 . . . . 74.530000000000001 110.922 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -82.77 -29.93 29.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 73.329999999999998 109.85 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.05 -118.25 14.4 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.457 -0.792 . . . . 55.210000000000001 112.7 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.556 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 20.2 m -160.6 -179.92 8.04 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.325 -0.62 . . . . 71.319999999999993 109.325 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.895 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 23.4 t80 -66.29 -165.5 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.094 -0.706 . . . . 74.209999999999994 109.094 172.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -124.49 136.32 53.92 Favored 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 121.366 -0.833 . . . . 74.439999999999998 110.65 -169.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.8 t -143.6 131.31 18.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 CA-C-N 114.802 -1.09 . . . . 65.329999999999998 110.574 -169.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.709 HD22 ' HB3' ' A' ' 30' ' ' TRP . 43.8 tp -112.78 123.37 50.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.575 -0.739 . . . . 71.329999999999998 110.168 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -109.35 177.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.614 -0.514 . . . . 73.439999999999998 109.614 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 27.7 t-20 -144.37 149.87 36.83 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.482 -0.192 . . . . 74.140000000000001 110.482 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.46 -28.49 30.69 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.295 0.372 . . . . 71.409999999999997 111.741 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.75 20.27 1.83 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.179 -0.464 . . . . 73.319999999999993 111.322 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 71.16 10.61 6.82 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.499 0.719 . . . . 73.299999999999997 112.211 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.683 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 43.2 mt-30 -74.62 153.36 39.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.601 -0.518 . . . . 54.009999999999998 109.601 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -157.36 133.96 9.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 74.109999999999999 110.591 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.1 t -171.53 -163.96 0.3 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.534 -0.913 . . . . 70.430000000000007 108.534 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.62 166.27 11.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.775 -0.454 . . . . 62.520000000000003 109.775 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.709 ' HB3' HD22 ' A' ' 20' ' ' LEU . 32.5 p-90 -128.14 144.73 52.75 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.542 -0.299 . . . . 73.310000000000002 110.272 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.76 104.72 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.596 2.197 . . . . 52.539999999999999 111.605 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.22 -18.72 59.72 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.181 -0.463 . . . . 64.129999999999995 111.738 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -92.17 10.66 28.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.107 -0.497 . . . . 72.430000000000007 110.866 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.71 179.32 6.65 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.794 0.331 . . . . 42.140000000000001 110.76 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -95.5 139.96 31.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.959 -0.564 . . . . 74.129999999999995 109.874 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.54 124.03 89.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.575 -0.284 . . . . 74.219999999999999 110.404 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HG2' ' CD1' ' A' ' 40' ' ' TRP . 29.2 Cg_endo -63.64 146.65 92.65 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.379 2.052 . . . . 74.140000000000001 111.789 178.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.04 145.97 28.86 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.126 -0.488 . . . . 34.340000000000003 111.075 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.86 -23.39 34.9 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.152 -0.476 . . . . 60.32 111.944 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.525 ' CE3' ' HB2' ' A' ' 22' ' ' ASN . 65.7 m95 -97.04 160.59 14.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.712 0.292 . . . . 74.510000000000005 110.221 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -132.64 125.58 30.69 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.911 -0.774 . . . . 63.219999999999999 108.911 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.05 114.09 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.481 -0.563 . . . . 60.219999999999999 109.481 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.41 HG21 ' CH2' ' A' ' 60' ' ' TRP . 34.8 m -86.92 -21.37 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.368 0.604 . . . . 73.329999999999998 110.417 -174.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.402 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 46.1 m80 -153.78 129.4 10.0 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.342 -0.845 . . . . 73.349999999999994 109.347 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.08 -178.85 45.82 Favored Glycine 0 C--N 1.336 0.546 0 O-C-N 124.15 0.907 . . . . 61.030000000000001 112.122 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.68 145.09 50.54 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.855 0.359 . . . . 74.340000000000003 111.623 -174.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.25 -178.34 6.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.782 -0.644 . . . . 73.409999999999997 110.54 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -79.3 167.98 20.17 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 116.2 -0.455 . . . . 61.520000000000003 111.452 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.689 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 41.0 ttm180 -55.88 -33.76 64.88 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 115.989 -0.55 . . . . 74.329999999999998 110.941 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -56.32 -48.15 77.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.134 0.493 . . . . 72.030000000000001 109.949 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.556 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -65.66 -31.04 71.83 Favored 'General case' 0 C--O 1.26 1.61 0 CA-C-N 115.176 -0.92 . . . . 52.32 111.133 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.895 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 24.9 m -62.05 -50.29 72.57 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.666 -1.152 . . . . 61.32 109.643 173.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.7 mt -59.61 -40.95 89.2 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.614 -0.721 . . . . 74.319999999999993 110.463 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 17.6 mm-40 -58.64 -52.81 64.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.441 . . . . 73.120000000000005 110.26 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -56.22 -55.35 34.35 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.794 0.294 . . . . 71.239999999999995 111.794 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 52' ' ' CYS . 8.8 tt -61.92 -42.83 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 121.076 -0.25 . . . . 72.140000000000001 111.539 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.32 -43.89 93.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.263 0.554 . . . . 72.010000000000005 110.127 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -72.63 -14.51 61.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.755 -0.657 . . . . 74.420000000000002 110.864 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 45.13 37.69 2.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.758 0.823 . . . . 71.519999999999996 111.23 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.499 ' CZ2' ' HA ' ' A' ' 63' ' ' ILE . 76.2 t-105 70.21 102.24 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 115.077 -0.965 . . . . 74.230000000000004 110.68 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.07 -62.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.505 2.136 . . . . 74.040000000000006 112.193 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -162.51 159.06 24.44 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.896 -0.409 . . . . 74.439999999999998 109.896 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.499 ' HA ' ' CZ2' ' A' ' 60' ' ' TRP . 14.1 tt -78.15 -7.5 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 44.5 111.59 -176.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.544 HH11 ' HB2' ' A' ' 8' ' ' ASN . 1.4 tpp180 53.49 76.65 0.51 Allowed Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.055 -0.52 . . . . 72.230000000000004 110.639 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.13 102.8 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.742 2.295 . . . . 62.119999999999997 112.335 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 5' ' ' MET . 0.1 OUTLIER -152.43 88.11 1.35 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.951 -0.568 . . . . 64.540000000000006 109.816 176.216 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.4 p -88.21 122.59 31.93 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.51 -0.768 . . . . 72.439999999999998 110.448 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.717 ' H ' ' HG3' ' A' ' 5' ' ' MET . 96.6 mt -137.5 164.13 29.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.55 -0.537 . . . . 74.140000000000001 109.55 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -52.27 -60.96 2.6 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.37 0.419 . . . . 72.540000000000006 110.608 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -160.31 143.67 13.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.087 0.47 . . . . 72.120000000000005 110.424 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 5' ' ' MET . 5.3 tppp? -157.38 13.06 0.23 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.472 -0.936 . . . . 71.420000000000002 108.472 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.75 60.28 0.7 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.486 -0.779 . . . . 75.409999999999997 109.985 -167.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.2 145.7 26.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.27 -0.877 . . . . 32.420000000000002 110.38 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.7 p -77.61 78.54 4.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.08 0.466 . . . . 74.239999999999995 110.603 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.59 7.32 5.89 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.946 -0.645 . . . . 72.519999999999996 113.135 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -73.85 93.2 2.13 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.138 0.494 . . . . 73.200000000000003 109.977 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.98 98.2 0.14 Allowed Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.301 -0.863 . . . . 61.109999999999999 111.078 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -92.31 -64.9 1.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.684 0.278 . . . . 73.439999999999998 110.974 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 23.7 t70 -122.65 94.88 4.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.887 0.375 . . . . 74.109999999999999 111.064 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-N 115.382 -0.827 . . . . 63.520000000000003 108.844 175.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.68 0 N-CA-C 112.233 -0.347 . . . . 64.540000000000006 112.233 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.32 69.55 6.88 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.73 2.287 . . . . 72.439999999999998 112.409 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.17 46.53 3.65 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.161 -0.543 . . . . 52.530000000000001 112.525 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.3 t -108.54 -167.76 1.27 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.647 0.379 . . . . 64.439999999999998 110.301 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 5.8 tpt -46.57 -42.34 15.81 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.317 0.647 . . . . 72.430000000000007 111.691 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.3 m -124.31 113.94 18.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.651 0.263 . . . . 74.200000000000003 110.646 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.1 mm -67.1 -67.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.995 -0.548 . . . . 65.329999999999998 110.572 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.5 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 88.5 m-20 -125.84 135.91 27.69 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 64.430000000000007 109.955 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 8' ' ' ASN . 5.7 Cg_exo -77.9 87.86 1.48 Allowed 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.874 2.383 . . . . 71.439999999999998 112.642 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -128.11 -178.19 4.43 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.035 -0.53 . . . . 72.319999999999993 110.067 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -89.5 -176.88 5.17 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 110.099 -0.334 . . . . 75.400000000000006 110.099 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.12 61.16 1.54 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.323 -0.621 . . . . 73.540000000000006 109.323 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -55.26 -47.19 75.81 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.068 -0.515 . . . . 74.530000000000001 111.768 -171.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -96.86 14.98 23.43 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.405 -0.361 . . . . 73.329999999999998 111.073 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.74 82.52 0.09 OUTLIER Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.825 -0.51 . . . . 55.210000000000001 111.825 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.491 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 3.0 p -101.43 170.11 8.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.176 0.512 . . . . 71.319999999999993 112.218 -171.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.781 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 3.3 t80 -67.13 -159.82 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.241 1.017 . . . . 74.209999999999994 110.663 178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.543 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 41.9 p90 -124.37 142.11 51.54 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.284 0.564 . . . . 74.439999999999998 110.813 -172.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.663 HG23 HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.37 142.49 5.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-N 115.012 -0.995 . . . . 65.329999999999998 110.858 -172.297 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 40' ' ' TRP . 43.1 tp -120.46 144.58 47.9 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.216 -0.902 . . . . 71.329999999999998 111.273 -171.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.35 141.82 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 115.997 -0.547 . . . . 73.439999999999998 109.94 173.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.578 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 25.3 t-20 -110.01 155.9 21.2 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.507 -0.553 . . . . 74.140000000000001 109.507 -176.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.0 -26.64 68.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.9 0.381 . . . . 71.409999999999997 111.152 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -86.43 22.88 1.73 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.279 0.562 . . . . 73.319999999999993 110.512 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 73.02 6.65 5.34 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.404 -0.816 . . . . 73.299999999999997 112.397 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 81.6 mm-40 -71.96 117.74 13.95 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.194 -0.669 . . . . 54.009999999999998 109.194 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -131.35 127.62 37.99 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.199 -0.313 . . . . 74.109999999999999 111.042 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.5 t -173.57 163.13 4.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 70.430000000000007 110.329 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.4 pt? -72.13 130.81 41.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.174 -1.047 . . . . 62.520000000000003 108.174 169.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.501 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 33.4 p-90 -95.87 141.84 23.73 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.529 -0.305 . . . . 73.310000000000002 110.917 -173.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.592 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 23.0 Cg_exo -64.98 105.32 0.66 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.616 2.21 . . . . 52.539999999999999 111.275 177.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.501 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -58.61 -26.89 64.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.965 -0.561 . . . . 64.129999999999995 111.66 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -98.63 23.75 8.29 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.096 -0.502 . . . . 72.430000000000007 110.968 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.592 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . . . -132.96 166.63 21.93 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.013 -0.54 . . . . 42.140000000000001 110.764 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -77.25 139.62 39.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 74.129999999999995 110.458 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.511 HG12 ' NE1' ' A' ' 40' ' ' TRP . 3.0 t -112.12 106.03 56.24 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.068 -0.515 . . . . 74.219999999999999 109.745 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 33.8 Cg_endo -64.85 116.28 3.73 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.124 2.549 . . . . 74.140000000000001 112.819 -174.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.84 152.25 0.38 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.12 0.785 . . . . 34.340000000000003 113.12 -174.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.13 18.62 6.69 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.827 -0.624 . . . . 60.32 111.817 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.511 ' NE1' HG12 ' A' ' 36' ' ' VAL . 12.3 p-90 -122.41 -173.28 2.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.141 0.496 . . . . 74.510000000000005 111.056 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -154.62 126.64 7.71 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.629 -0.878 . . . . 63.219999999999999 108.629 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.9 p -90.51 138.78 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.213 -0.449 . . . . 60.219999999999999 110.651 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.663 HG23 HG23 ' A' ' 19' ' ' VAL . 27.6 m -100.74 -22.85 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.909 0.385 . . . . 73.329999999999998 110.69 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.572 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 39.3 m80 -150.4 132.63 15.44 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.929 -0.578 . . . . 73.349999999999994 109.711 176.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -92.01 176.14 38.86 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 123.758 0.661 . . . . 61.030000000000001 112.784 -175.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.37 131.03 10.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.352 0.661 . . . . 74.340000000000003 111.232 -174.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.684 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -147.57 178.24 8.62 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.227 0.537 . . . . 73.409999999999997 111.566 -174.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -98.18 177.97 5.22 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.826 -0.625 . . . . 61.520000000000003 111.819 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.525 ' NH1' HD11 ' A' ' 53' ' ' LEU . 2.4 tmt_? -61.59 -44.71 96.5 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.697 -0.683 . . . . 74.329999999999998 110.493 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.45 -42.53 67.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.464 0.65 . . . . 72.030000000000001 110.028 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.491 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -65.98 -32.69 74.33 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.021 -0.991 . . . . 52.32 110.944 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.781 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 49.0 t -60.22 -51.06 71.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.045 -0.525 . . . . 61.32 109.918 173.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.525 HD11 ' NH1' ' A' ' 49' ' ' ARG . 82.0 mt -58.16 -40.16 80.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.522 -0.763 . . . . 74.319999999999993 110.8 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.94 -29.02 55.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.074 -0.512 . . . . 73.120000000000005 112.213 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.661 ' HB2' ' H ' ' A' ' 17' ' ' PHE . 54.9 t80 -65.43 -52.37 53.7 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.015 -0.428 . . . . 71.239999999999995 110.787 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 tt -59.34 -35.77 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 121.011 0.434 . . . . 72.140000000000001 110.574 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -70.99 -42.01 70.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.769 -0.65 . . . . 72.010000000000005 111.217 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -58.86 -30.22 67.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.713 0.292 . . . . 74.420000000000002 110.268 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 53.93 67.93 0.93 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.72 -0.673 . . . . 71.519999999999996 111.375 176.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 88.3 m95 50.7 78.84 0.38 Allowed Pre-proline 0 N--CA 1.465 0.286 0 CA-C-N 115.74 -0.664 . . . . 74.230000000000004 111.63 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 63' ' ' ILE . 57.6 Cg_endo -87.45 0.82 7.24 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.724 2.282 . . . . 74.040000000000006 112.188 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.2 t70 71.46 -26.0 0.17 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.374 0.67 . . . . 74.439999999999998 112.337 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.425 ' H ' ' C ' ' A' ' 61' ' ' PRO . 65.6 mt -50.73 106.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.161 0.505 . . . . 44.5 111.185 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.504 ' HG3' ' HA ' ' A' ' 43' ' ' VAL . 29.8 ttp180 -120.28 89.57 43.69 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.064 -0.971 . . . . 72.230000000000004 109.969 -177.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.58 -61.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.161 1.908 . . . . 62.119999999999997 111.741 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 59.7 tttm 61.98 9.82 3.26 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.231 0.538 . . . . 64.540000000000006 111.126 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.6 t -96.36 155.39 16.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.339 -0.391 . . . . 72.439999999999998 110.163 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 68' ' ' LEU . 2.1 pt? -147.7 16.39 1.12 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.889 -0.596 . . . . 74.140000000000001 109.728 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 69' ' ' ARG . 0.4 OUTLIER -90.68 -177.18 4.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.701 -0.681 . . . . 72.540000000000006 111.407 -177.555 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -141.17 -169.57 2.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.98 -1.009 . . . . 72.120000000000005 109.617 -174.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.41 ' HA ' ' HE3' ' A' ' 71' ' ' LYS . 0.1 OUTLIER -138.55 18.77 2.71 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.954 -0.758 . . . . 71.420000000000002 108.954 175.206 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.482 ' O ' HD13 ' A' ' 72' ' ' LEU . 3.2 tm? -92.83 -24.34 18.53 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.132 -0.94 . . . . 75.409999999999997 109.225 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.9 102.76 2.05 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.669 -0.696 . . . . 32.420000000000002 110.083 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.8 t -100.09 -25.61 14.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.2 -0.455 . . . . 74.239999999999995 111.424 -175.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.91 -134.74 43.65 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.396 -0.43 . . . . 72.519999999999996 112.66 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.401 ' HD3' ' HA ' ' A' ' 76' ' ' ARG . 16.9 mmt180 -143.92 121.46 11.76 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 122.786 0.434 . . . . 73.200000000000003 110.172 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.92 96.62 1.25 Allowed Glycine 0 CA--C 1.518 0.275 0 CA-C-N 116.111 -0.495 . . . . 61.109999999999999 112.462 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.487 ' O ' ' HB3' ' A' ' 79' ' ' ASP . 84.7 t80 -167.71 142.0 3.6 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 122.419 0.287 . . . . 73.439999999999998 110.481 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.487 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 1.0 OUTLIER 169.42 132.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.363 -0.977 . . . . 74.109999999999999 108.363 176.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.101 -0.952 . . . . 63.520000000000003 109.868 173.167 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.528 -0.629 . . . . 64.540000000000006 111.528 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.74 -35.11 70.74 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.542 2.161 . . . . 72.439999999999998 112.116 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.29 78.94 0.22 Allowed Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.352 -0.699 . . . . 52.530000000000001 111.352 -175.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.0 p -107.23 125.79 51.58 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.218 0.451 . . . . 64.439999999999998 112.218 -172.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.592 ' HB2' ' HB3' ' A' ' 71' ' ' LYS . 22.3 tpp -68.82 -60.95 2.02 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 107.673 -1.232 . . . . 72.430000000000007 107.673 164.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 m -164.61 139.65 5.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 113.981 -1.463 . . . . 74.200000000000003 108.061 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.9 mt -79.75 73.73 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.361 0.6 . . . . 65.329999999999998 109.446 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -101.81 98.26 9.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.023 -0.99 . . . . 64.430000000000007 109.979 177.664 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 8' ' ' ASN . 10.8 Cg_exo -70.44 99.84 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.721 2.28 . . . . 71.439999999999998 113.093 -173.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 10.1 p90 -145.41 161.1 40.49 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.262 -0.644 . . . . 72.319999999999993 109.262 168.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -86.41 118.35 25.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.905 0.383 . . . . 75.400000000000006 111.564 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -84.75 -172.17 4.03 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.94 -0.763 . . . . 73.540000000000006 108.94 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -79.14 -52.01 8.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.976 0.417 . . . . 74.530000000000001 112.048 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -97.05 -3.32 41.6 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.381 0.511 . . . . 73.329999999999998 112.381 -167.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.32 -24.34 58.92 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 121.473 -0.394 . . . . 55.210000000000001 113.487 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.513 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 5.9 p -178.83 168.0 1.67 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.698 0.399 . . . . 71.319999999999993 110.088 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.724 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 34.5 t80 -66.43 -161.94 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.227 0.611 . . . . 74.209999999999994 109.865 173.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.557 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 33.8 p90 -124.58 134.43 52.95 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 121.325 -0.86 . . . . 74.439999999999998 110.177 -173.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.639 HG23 HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.7 128.85 2.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 115.146 -0.934 . . . . 65.329999999999998 111.247 -171.034 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.7 tp -108.54 137.55 46.3 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.608 -1.178 . . . . 71.329999999999998 109.946 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 58.4 t -124.95 126.45 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 73.439999999999998 110.016 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.771 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 27.2 t-20 -87.41 158.81 18.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.89 -0.411 . . . . 74.140000000000001 109.89 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -50.25 -33.28 19.13 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.203 -0.453 . . . . 71.409999999999997 112.004 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.58 30.46 0.72 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.207 0.527 . . . . 73.319999999999993 111.145 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 67.3 6.58 4.94 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.049 0.539 . . . . 73.299999999999997 112.141 174.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.771 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 81.6 mm-40 -63.17 117.81 7.06 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 109.554 -0.535 . . . . 54.009999999999998 109.554 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -121.56 111.25 17.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.855 0.36 . . . . 74.109999999999999 110.321 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -153.32 156.08 37.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.317 -0.402 . . . . 70.430000000000007 110.168 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.652 HD13 ' H ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.56 154.27 39.17 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.545 -0.539 . . . . 62.520000000000003 109.545 172.088 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.4 ' HZ2' ' HA2' ' A' ' 45' ' ' GLY . 27.9 p-90 -126.16 148.95 65.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.687 -0.233 . . . . 73.310000000000002 110.556 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.06 102.57 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.238 1.959 . . . . 52.539999999999999 111.112 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 46' ' ' GLU . . . -57.06 -18.0 12.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.847 -0.615 . . . . 64.129999999999995 111.863 -175.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -102.15 24.47 10.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 72.430000000000007 111.215 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.4 172.53 12.58 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.378 -0.373 . . . . 42.140000000000001 111.059 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -95.68 139.81 31.4 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.966 -0.561 . . . . 74.129999999999995 109.869 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.8 t -88.99 118.73 69.52 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 110.601 -0.148 . . . . 74.219999999999999 110.601 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.04 160.0 48.66 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.755 2.304 . . . . 74.140000000000001 112.243 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.51 144.7 50.77 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.265 -0.425 . . . . 34.340000000000003 110.622 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.25 -18.63 48.25 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 111.55 -0.62 . . . . 60.32 111.55 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -107.61 118.88 37.9 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.93 -0.396 . . . . 74.510000000000005 109.93 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -103.41 126.04 50.34 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.695 -0.484 . . . . 63.219999999999999 109.695 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 44' ' ' HIS . 13.6 p -91.29 134.08 30.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 110.054 -0.35 . . . . 60.219999999999999 110.054 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.639 HG23 HG23 ' A' ' 19' ' ' VAL . 29.5 m -99.7 -5.2 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.031 0.443 . . . . 73.329999999999998 110.837 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.432 ' H ' HG22 ' A' ' 42' ' ' VAL . 65.4 t-80 -175.99 130.78 0.24 Allowed 'General case' 0 C--O 1.246 0.872 0 CA-C-N 115.183 -0.917 . . . . 73.349999999999994 109.453 167.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -79.0 -171.47 40.52 Favored Glycine 0 C--N 1.338 0.665 0 O-C-N 123.935 0.772 . . . . 61.030000000000001 112.846 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -50.66 151.55 2.33 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.509 0.559 . . . . 74.340000000000003 112.509 -173.189 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB1' ' CB ' ' A' ' 51' ' ' ALA . . . -161.42 179.19 8.46 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.097 -0.501 . . . . 73.409999999999997 112.252 -173.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -97.96 179.43 4.79 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.581 -0.736 . . . . 61.520000000000003 112.308 -171.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -56.91 -51.08 70.52 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.702 -0.681 . . . . 74.329999999999998 110.406 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.39 -34.19 56.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.412 -0.813 . . . . 72.030000000000001 110.186 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.513 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -75.74 -31.59 59.65 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 115.284 -0.871 . . . . 52.32 111.098 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.724 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 56.2 m -58.94 -48.71 80.55 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.933 -0.766 . . . . 61.32 108.933 172.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.74 -36.37 82.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.989 -1.005 . . . . 74.319999999999993 110.539 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -62.27 -42.16 99.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.531 . . . . 73.120000000000005 110.566 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.564 ' HB2' ' H ' ' A' ' 17' ' ' PHE . 59.9 t80 -64.51 -50.43 67.4 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.315 -0.402 . . . . 71.239999999999995 111.194 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 tt -64.24 -37.36 79.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 120.779 0.323 . . . . 72.140000000000001 110.371 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -73.25 -28.35 62.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 72.010000000000005 110.361 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.682 ' HG2' ' HD3' ' A' ' 61' ' ' PRO . 41.5 tt0 -61.14 -41.52 96.88 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.933 -0.576 . . . . 74.420000000000002 109.51 176.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 63.04 20.05 12.04 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.42 -0.809 . . . . 71.519999999999996 111.609 170.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 89.9 m95 58.09 87.0 0.15 Allowed Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.222 -0.445 . . . . 74.230000000000004 111.812 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.682 ' HD3' ' HG2' ' A' ' 58' ' ' GLU . 63.0 Cg_endo -90.55 178.05 2.13 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.021 2.48 . . . . 74.040000000000006 111.899 176.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -69.7 -50.03 47.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.39 0.614 . . . . 74.439999999999998 109.63 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.2 pt -116.57 127.0 74.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.168 -0.924 . . . . 44.5 110.277 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.36 92.7 40.96 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.222 -0.659 . . . . 72.230000000000004 109.222 175.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.9 74.58 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.222 2.615 . . . . 62.119999999999997 113.416 -172.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 10' ' ' PHE . 53.2 mtmt -70.59 91.44 0.79 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.101 -0.5 . . . . 64.540000000000006 109.718 174.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.4 p -159.51 175.84 12.79 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.207 -0.451 . . . . 72.439999999999998 110.948 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.461 ' N ' HD22 ' A' ' 68' ' ' LEU . 2.8 mm? -101.63 123.27 45.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.401 -0.363 . . . . 74.140000000000001 110.695 -177.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -87.85 143.25 27.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.269 -0.423 . . . . 72.540000000000006 111.128 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 36.81 37.01 0.06 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.771 1.229 . . . . 72.120000000000005 112.717 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.592 ' HB3' ' HB2' ' A' ' 5' ' ' MET . 0.0 OUTLIER -56.58 -28.9 61.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.601 -0.727 . . . . 71.420000000000002 111.943 -175.146 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 29.5 tp -87.89 -3.15 58.95 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.923 0.392 . . . . 75.409999999999997 111.193 -176.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.46 11.66 20.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.3 -0.409 . . . . 32.420000000000002 110.947 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.8 m -69.58 77.05 0.42 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.265 0.555 . . . . 74.239999999999995 110.487 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.64 86.57 1.47 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.731 -0.668 . . . . 72.519999999999996 111.564 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -80.39 77.32 7.17 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.216 -0.661 . . . . 73.200000000000003 109.216 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.06 46.89 3.04 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.677 -0.692 . . . . 61.109999999999999 113.261 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -77.92 -45.05 25.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.316 -0.624 . . . . 73.439999999999998 109.316 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.9 t70 56.16 95.33 0.02 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.939 -1.028 . . . . 74.109999999999999 110.559 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.246 0.912 0 CA-C-N 115.682 -0.69 . . . . 63.520000000000003 110.409 -173.705 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.81 0 CA-C-O 119.979 -0.345 . . . . 64.540000000000006 112.265 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.02 107.73 2.49 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.806 2.337 . . . . 72.439999999999998 111.772 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 104.76 111.76 3.64 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.319 -0.712 . . . . 52.530000000000001 111.319 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 t -108.27 161.17 15.25 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 110.048 -0.353 . . . . 64.439999999999998 110.048 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.8 tpp -61.53 -62.14 2.03 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.259 0.552 . . . . 72.430000000000007 110.465 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.1 p -113.15 116.86 30.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.836 -0.62 . . . . 74.200000000000003 110.116 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.57 HD12 ' H ' ' A' ' 67' ' ' SER . 58.2 mt -72.14 88.29 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.506 -0.553 . . . . 65.329999999999998 109.506 176.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.439 ' N ' ' HD2' ' A' ' 9' ' ' PRO . 17.1 m120 -66.99 -48.4 50.44 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.338 -0.846 . . . . 64.430000000000007 111.36 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 8' ' ' ASN . 74.2 Cg_endo -74.99 98.65 1.18 Allowed 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 121.908 1.739 . . . . 71.439999999999998 111.377 175.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -77.72 -23.33 49.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 72.319999999999993 110.444 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.0 t70 67.86 -69.68 0.14 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.432 -0.804 . . . . 75.400000000000006 111.616 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.8 83.81 0.65 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.277 0.56 . . . . 73.540000000000006 110.865 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -79.45 -22.62 43.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.057 0.932 . . . . 74.530000000000001 109.34 171.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -67.97 -28.46 67.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.514 -1.675 . . . . 73.329999999999998 112.087 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.96 70.92 1.19 Allowed Glycine 0 C--N 1.33 0.239 0 C-N-CA 121.068 -0.586 . . . . 55.210000000000001 112.347 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.483 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 7.0 p -77.38 -173.97 3.11 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.597 0.237 . . . . 71.319999999999993 111.196 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.822 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 3.8 t80 -67.42 -161.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 116.354 -0.384 . . . . 74.209999999999994 110.915 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.81 ' HB3' ' HA ' ' A' ' 46' ' ' GLU . 51.9 p90 -125.15 143.77 50.77 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.14 0.495 . . . . 74.439999999999998 111.357 -171.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 43' ' ' VAL . 48.2 t -146.49 133.04 13.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-N 115.077 -0.965 . . . . 65.329999999999998 110.331 -175.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.508 ' HB2' ' CE3' ' A' ' 30' ' ' TRP . 57.4 tp -109.2 133.88 52.46 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.694 -0.685 . . . . 71.329999999999998 109.847 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 m -120.6 126.27 75.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.705 0.765 . . . . 73.439999999999998 110.554 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 11.3 m120 -93.12 154.09 18.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.074 -0.966 . . . . 74.140000000000001 109.228 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -56.69 -24.3 48.09 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.032 0.444 . . . . 71.409999999999997 111.097 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -82.15 15.67 2.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.965 -0.562 . . . . 73.319999999999993 111.156 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 67.64 6.79 5.22 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.26 0.624 . . . . 73.299999999999997 111.477 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 15.4 mm100 -66.65 119.61 12.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.298 -0.63 . . . . 54.009999999999998 109.298 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -111.14 113.06 25.31 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.376 -0.602 . . . . 74.109999999999999 109.376 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -150.38 -162.26 1.51 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.16 -0.473 . . . . 70.430000000000007 109.985 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.661 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.3 pt? -127.93 172.21 11.1 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.633 -0.506 . . . . 62.520000000000003 109.633 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.534 ' CH2' ' HB2' ' A' ' 18' ' ' PHE . 13.1 p90 -135.67 157.8 75.49 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.411 -0.588 . . . . 73.310000000000002 109.411 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.729 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 37.4 Cg_exo -57.66 100.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.959 1.772 . . . . 52.539999999999999 110.211 171.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.18 -13.59 19.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.636 0.606 . . . . 64.129999999999995 112.636 -171.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -103.13 2.72 34.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.837 0.351 . . . . 72.430000000000007 110.602 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.729 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . . . -121.61 -175.85 3.18 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.099 -0.5 . . . . 42.140000000000001 111.316 -173.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -81.91 137.92 35.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.594 -0.73 . . . . 74.129999999999995 110.434 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.402 HG22 ' CD1' ' A' ' 30' ' ' TRP . 56.5 t -82.34 132.79 51.8 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.934 -0.576 . . . . 74.219999999999999 110.022 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.06 132.68 48.84 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.345 2.03 . . . . 74.140000000000001 111.293 173.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.23 152.32 45.14 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.256 0.55 . . . . 34.340000000000003 112.056 -173.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.02 -35.55 4.6 Favored Glycine 0 N--CA 1.453 -0.193 0 CA-C-N 115.595 -0.73 . . . . 60.32 113.478 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -81.87 175.97 9.96 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.752 0.31 . . . . 74.510000000000005 110.694 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -121.92 126.64 49.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.006 0.431 . . . . 63.219999999999999 110.967 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.56 126.43 40.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.682 -0.859 . . . . 60.219999999999999 108.682 170.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 19' ' ' VAL . 14.7 p -95.83 -23.24 4.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 120.698 -0.401 . . . . 73.329999999999998 110.345 -175.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.451 ' ND1' ' O ' ' A' ' 17' ' ' PHE . 45.0 t-80 -158.26 133.42 8.62 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.301 -0.409 . . . . 73.349999999999994 110.469 174.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.24 176.86 46.71 Favored Glycine 0 C--N 1.337 0.629 0 O-C-N 124.14 0.9 . . . . 61.030000000000001 113.438 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.81 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -78.69 154.84 29.79 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.003 0.742 . . . . 74.340000000000003 113.003 -170.06 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.32 -178.11 5.74 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.802 -0.635 . . . . 73.409999999999997 111.065 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.16 170.17 16.81 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.78 0.659 . . . . 61.520000000000003 112.78 -173.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 31.9 ttm180 -45.7 -45.72 14.43 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.577 0.751 . . . . 74.329999999999998 111.631 176.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.581 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -53.66 -45.0 70.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.351 0.595 . . . . 72.030000000000001 109.964 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.483 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -66.99 -30.96 71.22 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 115.172 -0.922 . . . . 52.32 111.102 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.822 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 42.7 t -58.19 -47.47 83.33 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.682 -0.69 . . . . 61.32 109.731 171.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.57 -39.72 94.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.878 -0.601 . . . . 74.319999999999993 110.118 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 13.8 mm-40 -59.4 -39.32 83.03 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.121 -0.491 . . . . 73.120000000000005 110.742 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -58.68 -47.94 82.79 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.776 0.322 . . . . 71.239999999999995 110.668 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.416 HG13 ' H ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -64.45 -48.7 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.703 0.763 . . . . 72.140000000000001 109.623 -178.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -68.85 -26.64 65.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.357 -1.292 . . . . 72.010000000000005 111.072 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -65.99 -39.55 90.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.448 . . . . 74.420000000000002 109.834 175.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 67.12 22.72 9.78 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.756 -0.656 . . . . 71.519999999999996 111.027 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 34.6 m95 67.39 108.99 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.687 -0.688 . . . . 74.230000000000004 112.629 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HG2' HG22 ' A' ' 63' ' ' ILE . 96.7 Cg_endo -91.59 -161.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.295 2.663 . . . . 74.040000000000006 111.668 173.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -82.18 -15.2 54.07 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.623 -0.262 . . . . 74.439999999999998 111.423 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.472 HG22 ' HG2' ' A' ' 61' ' ' PRO . 9.5 tp -41.31 132.15 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 113.364 0.875 . . . . 44.5 113.364 -172.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -95.09 151.06 38.55 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.27 -0.877 . . . . 72.230000000000004 109.715 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . 17.8 Cg_endo -58.5 139.84 92.28 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.642 2.228 . . . . 62.119999999999997 112.387 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -60.87 112.49 2.07 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.012 -0.54 . . . . 64.540000000000006 109.592 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.57 ' H ' HD12 ' A' ' 7' ' ' ILE . 32.7 t -126.15 154.01 43.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.134 -0.485 . . . . 72.439999999999998 110.133 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 pp -150.56 155.04 38.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.52 -0.764 . . . . 74.140000000000001 109.399 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 69.01 -18.48 0.18 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.222 0.609 . . . . 72.540000000000006 112.56 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -83.96 59.0 5.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.372 0.606 . . . . 72.120000000000005 111.389 -172.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -172.43 38.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.611 -0.885 . . . . 71.420000000000002 108.611 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.6 tp -84.74 51.28 2.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.227 -0.897 . . . . 75.409999999999997 109.83 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.43 101.8 14.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.236 -0.893 . . . . 32.420000000000002 110.301 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.9 m -123.75 102.11 7.64 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.672 -0.492 . . . . 74.239999999999995 109.672 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.22 129.17 3.27 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.649 -0.786 . . . . 72.519999999999996 112.469 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.3 ttt85 -165.75 99.68 0.67 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.844 0.354 . . . . 73.200000000000003 110.139 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -151.05 80.98 0.19 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.331 -0.708 . . . . 61.109999999999999 111.331 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -94.26 -84.61 0.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.011 -0.366 . . . . 73.439999999999998 110.011 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -97.48 -29.33 13.54 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.446 -0.575 . . . . 74.109999999999999 109.446 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 . . . . . 0 C--O 1.247 0.964 0 CA-C-N 114.75 -1.114 . . . . 63.520000000000003 108.711 178.413 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.689 0 N-CA-C 111.973 -0.451 . . . . 64.540000000000006 111.973 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.62 79.62 2.18 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.582 2.188 . . . . 72.439999999999998 112.653 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.12 59.48 3.56 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 111.208 -0.757 . . . . 52.530000000000001 111.208 173.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.9 t -108.96 178.22 4.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.371 0.605 . . . . 64.439999999999998 111.861 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.632 ' HE2' ' HA ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -85.13 -20.73 29.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.918 -1.037 . . . . 72.430000000000007 108.235 173.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.4 t -136.65 -169.05 2.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.861 -1.063 . . . . 74.200000000000003 109.735 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.26 -34.73 68.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.708 -0.678 . . . . 65.329999999999998 110.885 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 2.3 m-20 -54.99 110.59 2.28 Favored Pre-proline 0 N--CA 1.468 0.46 0 CA-C-N 115.755 -0.657 . . . . 64.430000000000007 111.07 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 8' ' ' ASN . 19.4 Cg_endo -59.52 -39.07 78.82 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.167 1.911 . . . . 71.439999999999998 110.935 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -172.69 156.12 3.45 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.937 -1.029 . . . . 72.319999999999993 108.564 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -102.19 -153.2 0.46 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.256 -0.276 . . . . 75.400000000000006 110.256 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -75.19 18.81 0.18 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.382 0.512 . . . . 73.540000000000006 112.382 -175.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -67.81 -27.96 67.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.343 0.592 . . . . 74.530000000000001 109.771 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -95.98 10.9 35.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.301 -0.863 . . . . 73.329999999999998 111.088 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 52' ' ' CYS . . . -85.92 100.31 2.47 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 111.078 -0.809 . . . . 55.210000000000001 111.078 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 6.2 p -54.56 135.03 46.66 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 111.888 0.329 . . . . 71.319999999999993 111.888 -174.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.506 ' HD1' ' HB2' ' A' ' 55' ' ' TYR . 24.8 t80 -68.65 102.75 1.56 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.057 -0.719 . . . . 74.209999999999994 109.057 173.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.443 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 47.6 p90 -141.6 131.02 23.74 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.71 -1.589 . . . . 74.439999999999998 106.71 168.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.753 HG23 HG13 ' A' ' 43' ' ' VAL . 2.8 m -156.36 135.49 3.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.539 0.685 . . . . 65.329999999999998 110.522 -167.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 8.5 tt -117.31 131.44 56.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.374 -0.83 . . . . 71.329999999999998 110.038 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.3 t -104.17 126.08 58.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.397 -0.594 . . . . 73.439999999999998 109.397 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.711 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 14.3 m120 -79.94 170.45 16.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.039 -0.528 . . . . 74.140000000000001 109.82 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -51.82 -42.17 62.32 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.11 0.481 . . . . 71.409999999999997 111.466 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -88.95 28.06 1.24 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.866 -0.606 . . . . 73.319999999999993 111.677 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 65.63 15.51 10.07 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.117 0.567 . . . . 73.299999999999997 111.734 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.711 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 56.0 tt0 -68.58 131.11 44.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 54.009999999999998 110.072 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -90.52 118.24 29.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.642 0.258 . . . . 74.109999999999999 110.658 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 m -144.46 -175.51 4.67 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.15 -0.477 . . . . 70.430000000000007 110.149 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 29' ' ' LEU . 1.7 pt? -142.33 135.43 28.68 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.439 -0.578 . . . . 62.520000000000003 109.439 173.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.443 ' CH2' ' HB2' ' A' ' 18' ' ' PHE . 4.8 p90 -85.31 152.02 57.41 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 73.310000000000002 110.114 -176.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.98 104.72 0.4 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.95 1.767 . . . . 52.539999999999999 110.169 171.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.69 -15.43 7.8 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.099 0.407 . . . . 64.129999999999995 112.099 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -92.07 6.79 45.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 72.430000000000007 111.024 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.94 179.49 6.31 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.897 0.38 . . . . 42.140000000000001 111.122 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -87.05 139.79 30.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.668 -0.696 . . . . 74.129999999999995 110.125 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 70.5 t -64.5 129.39 94.19 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.114 -0.494 . . . . 74.219999999999999 110.899 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 35.3 Cg_exo -60.86 141.04 93.55 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.697 2.265 . . . . 74.140000000000001 111.841 175.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.98 147.41 52.47 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.023 -0.535 . . . . 34.340000000000003 111.56 -175.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.43 -25.95 25.79 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.757 -0.656 . . . . 60.32 112.981 176.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -82.86 -177.42 6.74 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.816 0.341 . . . . 74.510000000000005 110.111 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 41' ' ' ARG . 50.7 ttt-85 -145.27 126.5 14.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.335 -0.393 . . . . 63.219999999999999 110.008 173.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 54.8 t -80.42 123.37 37.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.264 -0.643 . . . . 60.219999999999999 109.264 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.753 HG13 HG23 ' A' ' 19' ' ' VAL . 7.1 p -88.77 -19.11 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.198 0.523 . . . . 73.329999999999998 110.107 -175.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -157.53 121.89 4.3 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.029 -0.73 . . . . 73.349999999999994 109.029 171.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.66 -179.34 52.81 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.29 -0.481 . . . . 61.030000000000001 112.986 -174.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -53.72 138.73 34.52 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.824 -0.436 . . . . 74.340000000000003 109.824 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.8 -178.01 6.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.873 1.064 . . . . 73.409999999999997 113.873 -167.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.401 ' CG ' ' N ' ' A' ' 49' ' ' ARG . 14.0 t70 -91.14 175.09 7.07 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.513 -1.222 . . . . 61.520000000000003 111.528 -176.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.923 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 59.1 ttt180 -57.88 -27.86 63.66 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 122.327 -0.233 . . . . 74.329999999999998 111.052 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.87 -41.37 67.44 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.278 -0.638 . . . . 72.030000000000001 109.278 173.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 17' ' ' PHE . . . -75.81 -31.17 59.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.352 -0.84 . . . . 52.32 111.018 175.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.923 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 61.3 m -54.8 -55.05 34.39 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.565 0.697 . . . . 61.32 110.253 172.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.3 mt -64.68 -23.16 67.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.989 -1.005 . . . . 74.319999999999993 110.557 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.431 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 40.7 tt0 -71.73 -49.82 35.8 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.069 -0.514 . . . . 73.120000000000005 111.257 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.506 ' HB2' ' HD1' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -52.53 -40.93 63.03 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 111.98 0.363 . . . . 71.239999999999995 111.98 -175.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.482 HD12 ' HG2' ' A' ' 65' ' ' PRO . 4.5 tt -69.57 -39.0 77.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 120.879 0.371 . . . . 72.140000000000001 110.887 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -71.64 -34.0 69.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 72.010000000000005 110.899 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 59' ' ' HIS . 7.4 mm-40 -67.07 -13.91 62.39 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.853 -0.612 . . . . 74.420000000000002 111.639 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.494 ' HB3' ' O ' ' A' ' 58' ' ' GLU . 21.6 t-80 75.08 71.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.6 0.714 . . . . 71.519999999999996 109.843 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.701 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 0.8 OUTLIER -145.24 24.07 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.056 0 CA-C-N 115.076 -0.966 . . . . 74.230000000000004 111.338 177.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.701 ' HD3' ' N ' ' A' ' 60' ' ' TRP . 60.3 Cg_endo -88.32 137.14 3.57 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 121.832 1.688 . . . . 74.040000000000006 112.593 -171.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -76.48 -45.38 31.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 109.89 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.38 132.87 65.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.801 -0.636 . . . . 44.5 109.987 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -71.19 122.09 86.04 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 110.197 -0.297 . . . . 72.230000000000004 110.197 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.482 ' HG2' HD12 ' A' ' 56' ' ' ILE . 36.1 Cg_exo -59.0 136.88 76.4 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.632 2.222 . . . . 62.119999999999997 112.204 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -124.3 0.39 8.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.123 -0.489 . . . . 64.540000000000006 110.534 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.2 t -107.29 91.48 3.67 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.926 -0.579 . . . . 72.439999999999998 110.447 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.7 tp -94.13 -58.51 2.21 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.337 -0.392 . . . . 74.140000000000001 110.065 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.612 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -148.18 -171.86 3.93 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.464 -0.335 . . . . 72.540000000000006 111.491 178.226 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.82 144.98 47.29 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.98 0.733 . . . . 72.120000000000005 112.98 -166.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.632 ' HA ' ' HE2' ' A' ' 5' ' ' MET . 16.9 pttp -64.55 87.01 0.05 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.813 -1.085 . . . . 71.420000000000002 111.482 171.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.4 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 32.4 tp 64.18 35.74 9.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.657 0.741 . . . . 75.409999999999997 110.528 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.43 -170.79 3.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.797 -0.638 . . . . 32.420000000000002 110.58 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.4 m -145.4 114.62 7.06 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.38 -0.6 . . . . 74.239999999999995 109.38 174.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.8 56.74 3.48 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 116.439 -0.346 . . . . 72.519999999999996 112.258 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -81.26 108.25 14.73 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.612 -0.514 . . . . 73.200000000000003 109.612 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.15 -84.5 0.14 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.164 -0.541 . . . . 61.109999999999999 112.03 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -141.04 139.46 34.11 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.563 0.345 . . . . 73.439999999999998 110.672 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.53 -12.63 51.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.954 -0.566 . . . . 74.109999999999999 111.798 -176.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.726 -0.654 . . . . 63.520000000000003 110.85 -174.957 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 112.384 -0.286 . . . . 64.540000000000006 112.384 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.1 127.37 17.48 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.816 2.344 . . . . 72.439999999999998 111.997 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -93.84 47.61 2.27 Favored Glycine 0 C--N 1.331 0.302 0 N-CA-C 111.857 -0.497 . . . . 52.530000000000001 111.857 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.6 p -89.37 174.48 7.79 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.89 -0.182 . . . . 64.439999999999998 110.829 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 10.9 ttm -50.72 -64.64 0.75 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.227 0.537 . . . . 72.430000000000007 110.351 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.9 p -151.93 139.86 20.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.461 -0.791 . . . . 74.200000000000003 110.086 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.7 mm -86.79 87.66 2.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 109.245 -0.65 . . . . 65.329999999999998 109.245 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.569 ' ND2' ' HA ' ' A' ' 11' ' ' ASP . 22.3 p-10 -153.06 141.77 14.23 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.116 -0.493 . . . . 64.430000000000007 110.731 -175.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.47 -40.3 4.34 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.537 2.158 . . . . 71.439999999999998 111.19 173.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -130.64 150.08 52.0 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.801 -0.814 . . . . 72.319999999999993 108.801 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.569 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 63.9 m-20 -77.87 172.9 12.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.131 0.491 . . . . 75.400000000000006 110.927 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -91.25 25.17 2.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.646 -0.706 . . . . 73.540000000000006 110.904 -170.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.93 -15.18 28.24 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.953 0.406 . . . . 74.530000000000001 111.199 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -96.06 15.11 21.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.03 -0.532 . . . . 73.329999999999998 110.507 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.434 ' O ' ' HB1' ' A' ' 51' ' ' ALA . . . -59.64 86.5 0.02 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 114.716 0.646 . . . . 55.210000000000001 114.716 -174.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 48.7 m -78.76 71.01 5.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.161 -1.052 . . . . 71.319999999999993 108.161 166.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.686 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 56.4 m-85 -162.13 138.8 8.03 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.007 -0.997 . . . . 74.209999999999994 113.063 -155.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -151.23 130.51 12.79 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.279 -1.378 . . . . 74.439999999999998 107.279 149.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.467 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 31.2 t -157.19 120.14 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.965 0 CA-C-O 121.081 0.467 . . . . 65.329999999999998 112.036 -173.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.462 HD13 HG22 ' A' ' 42' ' ' VAL . 64.6 tp -96.14 128.99 43.54 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.646 -0.706 . . . . 71.329999999999998 109.317 171.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 58.2 t -120.85 125.95 74.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.22 0.533 . . . . 73.439999999999998 110.302 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -85.66 153.2 22.52 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.168 -0.679 . . . . 74.140000000000001 109.168 175.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.34 -9.78 20.08 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.657 0.741 . . . . 71.409999999999997 109.535 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -79.79 7.58 8.39 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.943 -1.026 . . . . 73.319999999999993 110.174 173.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 72.23 7.02 5.66 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.47 0.708 . . . . 73.299999999999997 111.951 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 68.6 mt-30 -70.48 120.11 15.65 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 108.864 -0.791 . . . . 54.009999999999998 108.864 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -128.88 104.11 7.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.674 0.273 . . . . 74.109999999999999 110.688 -174.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.7 t -166.36 -169.43 1.41 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.722 0.296 . . . . 70.430000000000007 110.739 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 pp -71.12 172.88 8.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.12 -0.491 . . . . 62.520000000000003 111.511 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -153.21 156.13 32.35 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.552 -0.295 . . . . 73.310000000000002 110.739 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.22 93.46 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.432 2.088 . . . . 52.539999999999999 111.262 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.17 -1.71 3.52 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.23 0.455 . . . . 64.129999999999995 112.23 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -81.7 2.33 30.24 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.624 -0.262 . . . . 72.430000000000007 111.227 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.46 174.08 10.98 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.68 0.276 . . . . 42.140000000000001 110.782 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -87.99 139.98 29.96 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.058 -0.519 . . . . 74.129999999999995 109.981 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -59.39 119.93 43.8 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.964 -0.562 . . . . 74.219999999999999 111.412 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.85 138.82 82.96 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.611 2.207 . . . . 74.140000000000001 111.883 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.37 127.73 33.45 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.913 -0.585 . . . . 34.340000000000003 111.473 -177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.9 -23.43 13.05 Favored Glycine 0 C--N 1.33 0.223 0 CA-C-N 115.955 -0.566 . . . . 60.32 112.653 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -92.57 152.74 19.44 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.718 -0.283 . . . . 74.510000000000005 110.377 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.413 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 2.3 mmp_? -123.67 126.34 46.39 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.908 -0.405 . . . . 63.219999999999999 109.908 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.462 HG22 HD13 ' A' ' 20' ' ' LEU . 19.0 t -85.61 116.73 29.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.522 -0.918 . . . . 60.219999999999999 108.522 175.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.467 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 13.6 p -79.11 -29.98 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.411 0.624 . . . . 73.329999999999998 109.757 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -144.12 115.37 7.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.802 -1.184 . . . . 73.349999999999994 107.802 172.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.445 ' HA2' HG11 ' A' ' 42' ' ' VAL . . . -61.77 163.67 23.49 Favored Glycine 0 CA--C 1.509 -0.314 0 O-C-N 123.7 0.625 . . . . 61.030000000000001 113.54 -172.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -61.67 137.73 58.26 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.683 -0.488 . . . . 74.340000000000003 109.683 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.32 -177.82 4.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.807 -0.633 . . . . 73.409999999999997 110.479 -173.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.6 151.33 6.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.073 -0.512 . . . . 61.520000000000003 110.343 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.756 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 18.6 ttm180 -48.51 -39.54 23.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 110.957 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 54' ' ' GLU . . . -63.96 -39.53 94.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.372 -0.376 . . . . 72.030000000000001 111.352 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 15' ' ' GLY . . . -76.24 -33.34 59.19 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 120.925 0.393 . . . . 52.32 111.943 -175.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.756 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 16.2 p -73.51 -42.83 61.28 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.796 -0.638 . . . . 61.32 110.501 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 57.2 mt -65.77 -28.68 69.2 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.09 0.472 . . . . 74.319999999999993 110.096 174.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 13.3 tp10 -75.27 -33.07 61.21 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.006 -0.543 . . . . 73.120000000000005 110.048 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.686 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 9.5 t80 -45.96 -60.19 2.4 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.415 0.524 . . . . 71.239999999999995 112.415 173.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.8 tt -56.28 -40.96 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 120.708 0.289 . . . . 72.140000000000001 111.319 -173.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.46 -30.68 63.34 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.028 0.442 . . . . 72.010000000000005 110.6 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.14 -34.48 77.71 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.873 -0.603 . . . . 74.420000000000002 109.85 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 71.15 6.68 5.91 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.445 -0.798 . . . . 71.519999999999996 112.259 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 65.75 102.21 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 120.876 0.369 . . . . 74.230000000000004 111.97 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.46 -157.73 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.702 2.268 . . . . 74.040000000000006 111.716 173.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -88.79 33.29 0.78 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.189 0.518 . . . . 74.439999999999998 110.566 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.6 tt -68.11 127.54 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.78 -0.646 . . . . 44.5 111.134 -176.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.708 ' HD2' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -57.77 155.96 20.13 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.522 -0.763 . . . . 72.230000000000004 111.88 -178.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.07 -11.9 32.87 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.725 2.283 . . . . 62.119999999999997 112.421 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -62.29 103.72 0.42 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.982 -0.553 . . . . 64.540000000000006 109.843 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.1 t -154.34 -61.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.803 -0.635 . . . . 72.439999999999998 109.982 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.441 HD11 ' CA ' ' A' ' 45' ' ' GLY . 80.8 mt -103.28 -164.0 1.04 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.883 -0.599 . . . . 74.140000000000001 110.626 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.6 ttp180 71.89 49.51 0.26 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.77 0.669 . . . . 72.540000000000006 109.573 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.65 -175.17 5.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.573 -0.74 . . . . 72.120000000000005 110.382 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -91.24 -28.51 17.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.278 -0.419 . . . . 71.420000000000002 110.693 -173.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.4 tp -80.48 -54.93 5.23 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.345 -0.389 . . . . 75.409999999999997 110.41 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 55.42 18.77 2.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.936 -0.574 . . . . 32.420000000000002 112.148 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.3 m -88.82 85.22 6.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.291 0.567 . . . . 74.239999999999995 110.844 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.25 103.49 0.23 Allowed Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 110.278 -1.129 . . . . 72.519999999999996 110.278 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -160.43 127.7 4.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.269 -0.271 . . . . 73.200000000000003 110.269 -172.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.83 -172.92 29.13 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.46 -0.656 . . . . 61.109999999999999 111.46 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -155.62 160.88 40.8 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.41 0.284 . . . . 73.439999999999998 110.48 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -162.92 115.52 1.59 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.932 -0.766 . . . . 74.109999999999999 108.932 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.657 -0.687 . . . . 63.520000000000003 109.169 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 N-CA-C 112.2 -0.36 . . . . 64.540000000000006 112.2 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.14 98.78 1.22 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.469 2.112 . . . . 72.439999999999998 112.467 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -145.38 133.01 4.88 Favored Glycine 0 C--O 1.227 -0.319 0 N-CA-C 111.092 -0.803 . . . . 52.530000000000001 111.092 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.9 m -64.5 167.96 6.43 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.967 0.413 . . . . 64.439999999999998 112.105 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.2 tpp -71.22 -64.9 0.82 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.305 0.574 . . . . 72.430000000000007 110.309 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.0 m -70.68 158.73 35.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.967 -1.015 . . . . 74.200000000000003 110.418 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.0 mm -62.33 92.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 121.219 0.533 . . . . 65.329999999999998 110.637 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -116.45 140.22 26.34 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.341 -0.845 . . . . 64.430000000000007 109.086 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -41.67 89.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 123.462 2.774 . . . . 71.439999999999998 114.265 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -142.58 106.51 4.7 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.819 -1.548 . . . . 72.319999999999993 106.819 170.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.445 ' HA ' HD12 ' A' ' 63' ' ' ILE . 5.0 m-20 61.52 83.01 0.16 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.446 -1.316 . . . . 75.400000000000006 107.446 -162.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -43.36 114.92 0.69 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.242 1.201 . . . . 73.540000000000006 114.242 -163.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.81 -17.57 55.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.885 -1.052 . . . . 74.530000000000001 109.142 168.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -67.98 11.62 0.14 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.699 -1.591 . . . . 73.329999999999998 112.922 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.15 96.47 0.09 OUTLIER Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.932 -0.867 . . . . 55.210000000000001 110.932 172.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.499 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 9.4 m -64.57 -51.04 64.81 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.156 0.428 . . . . 71.319999999999993 112.156 -172.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.662 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 2.4 t80 -67.2 -159.89 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 110.151 -0.314 . . . . 74.209999999999994 110.151 172.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 27.5 p90 -123.94 136.73 54.51 Favored 'General case' 0 CA--C 1.509 -0.624 0 O-C-N 121.632 -0.668 . . . . 74.439999999999998 110.05 -170.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.58 HG23 ' HB ' ' A' ' 43' ' ' VAL . 23.4 m -144.56 129.18 13.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 114.88 -1.054 . . . . 65.329999999999998 111.551 -168.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.498 HD11 HG21 ' A' ' 36' ' ' VAL . 54.3 tp -106.78 132.5 52.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.005 -0.998 . . . . 71.329999999999998 109.163 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.02 126.38 75.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.925 0.393 . . . . 73.439999999999998 110.861 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -78.41 144.86 35.5 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.773 -0.825 . . . . 74.140000000000001 108.773 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -59.87 -18.27 43.11 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.891 0.377 . . . . 71.409999999999997 110.711 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.59 4.73 3.63 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.796 -0.638 . . . . 73.319999999999993 111.255 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.531 ' HG2' HH11 ' A' ' 64' ' ' ARG . 40.8 mt-10 72.0 56.05 0.17 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.099 0.56 . . . . 73.299999999999997 111.357 175.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -143.16 131.57 22.22 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.654 -0.703 . . . . 54.009999999999998 109.608 175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -100.92 139.24 36.89 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.784 0.326 . . . . 74.109999999999999 110.735 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.8 m -154.92 -172.72 4.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.293 -0.632 . . . . 70.430000000000007 109.293 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.75 162.51 15.67 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.741 -0.466 . . . . 62.520000000000003 109.741 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.417 ' HH2' ' HA2' ' A' ' 45' ' ' GLY . 3.7 p90 -137.32 160.22 66.45 Favored Pre-proline 0 C--O 1.234 0.264 0 N-CA-C 109.613 -0.514 . . . . 73.310000000000002 109.613 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.6 97.86 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.04 1.827 . . . . 52.539999999999999 111.024 172.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.463 ' HB1' ' HB3' ' A' ' 46' ' ' GLU . . . -53.23 -24.28 10.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.009 -0.541 . . . . 64.129999999999995 112.341 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -92.83 29.86 1.71 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.271 -0.422 . . . . 72.430000000000007 111.043 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.5 158.85 43.77 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.296 -0.411 . . . . 42.140000000000001 110.546 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.56 129.82 36.66 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.191 -0.459 . . . . 74.129999999999995 110.402 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.498 HG21 HD11 ' A' ' 20' ' ' LEU . 7.7 p -91.87 131.31 35.79 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 116.273 -0.421 . . . . 74.219999999999999 111.317 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 13.5 Cg_exo -69.17 177.91 4.71 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.909 2.406 . . . . 74.140000000000001 113.047 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.12 152.07 43.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.538 -0.755 . . . . 34.340000000000003 110.763 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.13 -35.33 4.63 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.303 -0.719 . . . . 60.32 111.303 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -100.88 100.76 11.45 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.782 -0.821 . . . . 74.510000000000005 108.782 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -93.3 126.57 38.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.868 0.365 . . . . 63.219999999999999 110.589 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.0 p -83.69 128.52 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.039 -0.356 . . . . 60.219999999999999 110.039 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.58 ' HB ' HG23 ' A' ' 19' ' ' VAL . 93.4 t -89.7 -43.33 14.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.9 0.381 . . . . 73.329999999999998 110.221 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -139.22 132.8 30.42 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 109.18 -0.674 . . . . 73.349999999999994 109.18 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -79.69 -176.26 48.95 Favored Glycine 0 C--N 1.335 0.507 0 O-C-N 124.334 1.022 . . . . 61.030000000000001 112.964 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -46.35 144.33 2.13 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.703 0.631 . . . . 74.340000000000003 112.703 -174.26 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.572 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -151.36 -178.04 6.42 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.326 0.491 . . . . 73.409999999999997 112.326 -170.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 3.7 m-20 -96.67 171.4 8.56 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.911 0.863 . . . . 61.520000000000003 112.924 -171.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.737 ' HD3' ' SG ' ' A' ' 52' ' ' CYS . 6.4 tpp180 -56.67 -45.82 81.49 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 114.867 -1.06 . . . . 74.329999999999998 110.294 173.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -57.21 -34.23 68.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.463 0.649 . . . . 72.030000000000001 110.098 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -72.46 -33.06 66.77 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-N 115.277 -0.874 . . . . 52.32 111.622 -177.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.737 ' SG ' ' HD3' ' A' ' 49' ' ' ARG . 22.4 p -71.56 -38.83 70.95 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.308 -0.405 . . . . 61.32 110.387 172.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 92.0 mt -60.14 -35.85 76.21 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.981 -0.554 . . . . 74.319999999999993 110.449 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 42.1 mt-10 -77.07 -39.23 50.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.301 -0.409 . . . . 73.120000000000005 110.641 176.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -55.65 -48.19 75.39 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.69 0.256 . . . . 71.239999999999995 111.69 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.0 tt -62.92 -45.3 99.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 120.811 0.338 . . . . 72.140000000000001 111.145 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -60.98 -48.0 83.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.983 -0.553 . . . . 72.010000000000005 110.326 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -58.71 -34.66 71.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.822 -0.627 . . . . 74.420000000000002 110.25 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 62.19 93.34 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.596 -0.729 . . . . 71.519999999999996 110.226 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.418 ' CH2' HG21 ' A' ' 43' ' ' VAL . 3.4 t90 -109.52 105.2 56.89 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.229 -0.441 . . . . 74.230000000000004 110.012 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HG2' HG23 ' A' ' 63' ' ' ILE . 68.1 Cg_endo -84.79 -159.87 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.176 2.584 . . . . 74.040000000000006 112.146 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -85.74 89.97 7.9 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.265 -0.643 . . . . 74.439999999999998 109.265 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.455 HG23 ' HG2' ' A' ' 61' ' ' PRO . 21.8 pt -129.67 169.46 20.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.065 -0.516 . . . . 44.5 110.489 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.531 HH11 ' HG2' ' A' ' 25' ' ' GLU . 14.2 ptm180 -158.03 120.63 2.06 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 72.230000000000004 109.834 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.12 118.42 3.91 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.165 2.577 . . . . 62.119999999999997 113.134 -175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.501 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 10.4 mptt -78.91 -25.52 43.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.807 -0.633 . . . . 64.540000000000006 109.939 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.9 t -80.89 81.85 7.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.764 -0.653 . . . . 72.439999999999998 110.232 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 pp -124.14 20.32 9.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.119 -0.491 . . . . 74.140000000000001 110.892 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.613 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -134.28 166.5 22.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.269 -0.423 . . . . 72.540000000000006 110.016 -178.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.49 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 4.7 m-20 -53.36 155.6 2.75 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.297 -0.411 . . . . 72.120000000000005 111.117 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.24 57.02 1.79 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.113 -0.494 . . . . 71.420000000000002 109.752 -177.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 tt -88.72 55.13 3.26 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.73 -0.841 . . . . 75.409999999999997 108.73 -175.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.59 135.55 53.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.805 -1.089 . . . . 32.420000000000002 110.299 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.6 m -108.08 110.26 21.9 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.459 -0.337 . . . . 74.239999999999995 110.77 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.55 73.4 0.23 Allowed Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.941 -0.463 . . . . 72.519999999999996 111.941 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -135.98 147.63 48.1 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.943 -0.762 . . . . 73.200000000000003 108.943 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -145.02 175.9 24.36 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.432 -0.667 . . . . 61.109999999999999 111.432 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -106.01 -177.94 3.51 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.206 -0.294 . . . . 73.439999999999998 110.206 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -148.34 106.67 3.76 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.313 -0.625 . . . . 74.109999999999999 109.313 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.1 tm0? . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.401 -0.809 . . . . 63.520000000000003 110.055 -176.437 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 CA-C-O 119.925 -0.375 . . . . 64.540000000000006 112.172 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.7 139.62 48.81 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.592 2.195 . . . . 72.439999999999998 112.073 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.19 47.65 1.01 Allowed Glycine 0 C--N 1.33 0.212 0 N-CA-C 111.496 -0.641 . . . . 52.530000000000001 111.496 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.693 ' H ' HD11 ' A' ' 7' ' ' ILE . 23.2 m -72.72 177.82 4.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.901 0.381 . . . . 64.439999999999998 111.669 -177.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.431 ' HA ' ' HB2' ' A' ' 71' ' ' LYS . 85.3 mmm -53.9 -46.79 71.52 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.527 -0.761 . . . . 72.430000000000007 111.563 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.4 m -138.99 115.85 10.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 74.200000000000003 110.537 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.693 HD11 ' H ' ' A' ' 4' ' ' SER . 49.6 mm -94.99 -75.01 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.889 0.376 . . . . 65.329999999999998 110.446 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -94.97 140.17 22.37 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 64.430000000000007 110.234 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.74 121.24 8.86 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.678 2.252 . . . . 71.439999999999998 111.456 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -54.92 149.87 10.95 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.312 0.577 . . . . 72.319999999999993 111.691 -174.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -146.06 178.28 8.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.442 -0.948 . . . . 75.400000000000006 108.442 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 61.05 31.92 19.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.788 0.328 . . . . 73.540000000000006 110.219 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -53.15 -43.79 67.27 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.94 -0.573 . . . . 74.530000000000001 111.793 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -96.54 15.1 22.52 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.003 -0.544 . . . . 73.329999999999998 110.623 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.17 116.15 4.34 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.981 -0.554 . . . . 55.210000000000001 111.758 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.806 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 5.0 p -84.86 179.32 7.35 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.449 -0.204 . . . . 71.319999999999993 110.449 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.477 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 65.1 t80 -67.91 102.67 1.31 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 119.731 -0.787 . . . . 74.209999999999994 109.963 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.483 ' HB2' ' HE1' ' A' ' 30' ' ' TRP . 48.0 p90 -136.36 131.42 34.23 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.931 -1.507 . . . . 74.439999999999998 106.931 167.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.7 t -146.33 138.66 19.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 CA-C-O 121.263 0.554 . . . . 65.329999999999998 111.229 -167.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.765 ' HB2' ' HB3' ' A' ' 30' ' ' TRP . 33.8 tp -117.06 130.44 56.67 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.872 -1.058 . . . . 71.329999999999998 110.273 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.72 126.4 72.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.157 0.503 . . . . 73.439999999999998 110.216 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.528 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 52.8 t-20 -85.52 149.48 25.35 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.211 -0.663 . . . . 74.140000000000001 109.211 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 22' ' ' ASN . 27.4 t70 -56.44 -26.49 53.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.218 0.533 . . . . 71.409999999999997 110.174 176.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -80.69 15.9 1.57 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.596 -0.729 . . . . 73.319999999999993 111.589 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 73.68 18.75 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.582 0.753 . . . . 73.299999999999997 112.452 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 14.9 mm100 -77.24 129.78 36.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.512 -0.551 . . . . 54.009999999999998 109.512 173.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.427 ' HB3' ' CZ2' ' A' ' 60' ' ' TRP . 72.9 m80 -123.88 108.53 12.55 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.564 0.221 . . . . 74.109999999999999 110.817 -175.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -154.91 -163.63 1.61 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.181 -0.303 . . . . 70.430000000000007 110.181 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.776 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.3 pt? -109.66 159.16 17.37 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.382 -0.599 . . . . 62.520000000000003 109.382 175.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.765 ' HB3' ' HB2' ' A' ' 20' ' ' LEU . 11.7 p-90 -112.05 148.26 38.65 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 120.557 0.218 . . . . 73.310000000000002 110.849 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.18 94.41 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.368 2.045 . . . . 52.539999999999999 110.847 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.402 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -56.88 -18.28 12.58 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.858 -0.61 . . . . 64.129999999999995 111.682 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -85.02 2.24 44.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 72.430000000000007 110.668 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.17 176.88 8.26 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.183 -0.462 . . . . 42.140000000000001 110.906 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.51 139.85 30.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.465 . . . . 74.129999999999995 110.067 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.7 124.41 90.87 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.308 -0.406 . . . . 74.219999999999999 110.052 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.42 -171.67 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.906 2.404 . . . . 74.140000000000001 112.797 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.48 145.63 30.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 34.340000000000003 110.974 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.23 -32.66 5.77 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.248 -0.433 . . . . 60.32 112.415 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.466 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 16.8 m95 -86.0 136.94 33.06 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.489 -0.56 . . . . 74.510000000000005 109.489 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 40' ' ' TRP . 16.0 mmm180 -121.51 126.48 49.33 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.257 -0.645 . . . . 63.219999999999999 109.257 176.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.0 p -85.9 132.78 31.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.343 -0.243 . . . . 60.219999999999999 110.343 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.95 -37.51 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.069 0.461 . . . . 73.329999999999998 110.069 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -148.19 132.14 17.15 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.652 -0.703 . . . . 73.349999999999994 109.682 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.0 -175.15 45.36 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.111 -0.796 . . . . 61.030000000000001 111.111 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -54.86 133.64 47.9 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.884 0.342 . . . . 74.340000000000003 110.281 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.63 -177.58 4.93 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.665 0.617 . . . . 73.409999999999997 112.665 -168.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.22 165.89 1.28 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.981 -1.009 . . . . 61.520000000000003 112.601 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.519 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 0.2 OUTLIER -60.75 -29.08 69.17 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.891 -0.595 . . . . 74.329999999999998 109.682 174.304 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.509 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -58.18 -46.89 84.97 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.348 -0.612 . . . . 72.030000000000001 109.348 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' PHE . . . -65.83 -30.86 71.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.335 -0.848 . . . . 52.32 110.725 177.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.806 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 54.1 t -58.4 -49.04 78.7 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.849 -0.426 . . . . 61.32 109.849 170.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.9 mt -67.75 -27.15 66.54 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.799 -0.637 . . . . 74.319999999999993 110.494 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 43.5 mt-10 -76.89 -36.69 56.52 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 116.236 -0.438 . . . . 73.120000000000005 111.649 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.477 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 1.9 t80 -61.86 -47.8 83.37 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.956 0.343 . . . . 71.239999999999995 110.798 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.672 HG13 HD22 ' A' ' 68' ' ' LEU . 10.6 tt -63.78 -41.84 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.73 -0.214 . . . . 72.140000000000001 110.932 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.31 -34.19 65.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.762 0.315 . . . . 72.010000000000005 111.183 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.23 -25.5 68.09 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.307 0.575 . . . . 74.420000000000002 109.47 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 62.71 41.01 9.54 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.134 -0.939 . . . . 71.519999999999996 110.732 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' A' ' 27' ' ' HIS . 32.5 t-105 -59.49 128.95 86.69 Favored Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 109.228 -0.656 . . . . 74.230000000000004 109.228 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.45 92.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.664 2.243 . . . . 74.040000000000006 113.148 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -85.74 126.41 33.96 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.217 -1.031 . . . . 74.439999999999998 108.217 172.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.785 ' H ' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -78.87 3.89 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.134 0.42 . . . . 44.5 112.134 -173.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.456 ' C ' ' H ' ' A' ' 66' ' ' LYS . 34.9 ttt180 -92.13 141.44 25.16 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.413 -0.588 . . . . 72.230000000000004 109.413 173.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.435 ' HD2' ' HG3' ' A' ' 64' ' ' ARG . 51.2 Cg_endo -69.13 34.47 0.19 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.76 2.306 . . . . 62.119999999999997 112.649 176.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 64' ' ' ARG . 34.7 ttpt -74.23 99.71 3.51 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.501 0.72 . . . . 64.540000000000006 110.017 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.3 m -71.28 144.24 50.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.967 -0.561 . . . . 72.439999999999998 110.3 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.672 HD22 HG13 ' A' ' 56' ' ' ILE . 50.7 mt -63.91 -74.33 0.1 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.78 -0.452 . . . . 74.140000000000001 109.78 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER 176.25 -65.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.759 -0.83 . . . . 72.540000000000006 108.759 176.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -91.64 92.44 8.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.086 -0.506 . . . . 72.120000000000005 109.673 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 5' ' ' MET . 2.5 tmtp? -66.09 -47.15 75.18 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.34 -0.615 . . . . 71.420000000000002 109.34 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.99 47.02 1.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.085 -0.709 . . . . 75.409999999999997 109.085 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.02 94.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.63 -0.714 . . . . 32.420000000000002 110.646 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.2 p -77.46 -57.56 3.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.731 -0.668 . . . . 74.239999999999995 110.764 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.8 -168.83 22.73 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 111.558 -0.617 . . . . 72.519999999999996 111.558 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.502 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 4.2 mmp_? -116.73 29.1 8.14 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.941 0.4 . . . . 73.200000000000003 110.859 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.05 46.82 92.61 Favored Glycine 0 N--CA 1.454 -0.159 0 CA-C-N 116.012 -0.54 . . . . 61.109999999999999 112.093 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -78.32 143.21 37.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.72 0.295 . . . . 73.439999999999998 110.524 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -102.81 -62.88 1.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.887 -0.597 . . . . 74.109999999999999 109.684 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 . . . . . 0 C--O 1.248 1.013 0 CA-C-N 115.541 -0.754 . . . . 63.520000000000003 109.048 178.603 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.783 -0.527 . . . . 64.540000000000006 111.783 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.38 88.27 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.584 2.19 . . . . 72.439999999999998 111.518 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 149.59 93.54 0.11 Allowed Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.858 -0.61 . . . . 52.530000000000001 112.151 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.9 m -67.91 103.03 1.37 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.253 -0.647 . . . . 64.439999999999998 109.253 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.576 ' HA ' ' HE2' ' A' ' 5' ' ' MET . 26.8 mmt -69.11 -8.28 43.89 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.989 -0.55 . . . . 72.430000000000007 111.86 -174.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.6 m -145.37 152.71 40.29 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 110.19 -0.3 . . . . 74.200000000000003 110.19 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.7 mm -88.18 81.74 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.129 0.49 . . . . 65.329999999999998 109.869 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.661 ' HB3' ' HB3' ' A' ' 11' ' ' ASP . 3.2 m-20 -106.52 133.12 20.39 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.821 -0.627 . . . . 64.430000000000007 110.632 -176.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -86.93 95.33 0.49 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.185 2.59 . . . . 71.439999999999998 111.163 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 69.9 t80 56.13 88.05 0.05 OUTLIER 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.689 -0.687 . . . . 72.319999999999993 110.187 -173.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.661 ' HB3' ' HB3' ' A' ' 8' ' ' ASN . 27.3 t70 -179.7 94.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.011 -1.107 . . . . 75.400000000000006 108.011 -177.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.67 131.84 36.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.232 0.539 . . . . 73.540000000000006 111.931 -171.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -51.34 -47.85 62.59 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.888 -1.051 . . . . 74.530000000000001 111.675 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -97.19 13.51 29.09 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.178 -0.465 . . . . 73.329999999999998 111.926 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.05 -175.26 46.41 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 121.186 -0.53 . . . . 55.210000000000001 113.344 177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.431 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 5.8 p -93.5 -57.69 2.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.146 0.578 . . . . 71.319999999999993 111.974 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.764 ' CD1' ' HB2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -65.73 -159.03 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.444 0.535 . . . . 74.209999999999994 112.444 171.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.422 ' CB ' ' HA ' ' A' ' 46' ' ' GLU . 27.7 p90 -124.26 135.98 53.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.474 -0.784 . . . . 74.439999999999998 108.956 -173.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.07 129.5 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.055 -0.52 . . . . 65.329999999999998 111.896 -167.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 30' ' ' TRP . 49.5 tp -100.31 125.62 46.55 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.252 -0.886 . . . . 71.329999999999998 109.123 172.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 p -109.26 126.34 66.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.24 0.543 . . . . 73.439999999999998 109.807 176.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -94.47 148.33 22.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.72 -0.673 . . . . 74.140000000000001 110.671 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' HB3' ' HZ3' ' A' ' 40' ' ' TRP . 15.3 t70 -56.06 -20.86 18.75 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.354 0.597 . . . . 71.409999999999997 110.199 174.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -73.55 3.72 5.83 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.262 -0.881 . . . . 73.319999999999993 111.531 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 63.31 56.83 1.63 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.37 0.605 . . . . 73.299999999999997 110.586 -175.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -137.93 132.55 32.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.251 -0.886 . . . . 54.009999999999998 109.171 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.436 ' HB2' ' HZ3' ' A' ' 60' ' ' TRP . 0.4 OUTLIER -116.8 109.12 16.7 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.13 0.491 . . . . 74.109999999999999 110.333 -178.361 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.3 t -145.96 -167.77 2.81 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.564 -0.532 . . . . 70.430000000000007 109.564 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 pp -107.61 158.63 17.08 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.27 -0.27 . . . . 62.520000000000003 110.27 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.632 ' HB3' HD22 ' A' ' 20' ' ' LEU . 18.2 p-90 -111.79 153.24 44.48 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.453 -0.34 . . . . 73.310000000000002 110.431 -175.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.73 102.83 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.157 1.905 . . . . 52.539999999999999 110.979 175.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.09 -7.01 2.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.522 0.934 . . . . 64.129999999999995 113.522 -171.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -107.23 10.13 29.97 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.256 -0.278 . . . . 72.430000000000007 110.962 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.456 ' O ' ' HZ3' ' A' ' 30' ' ' TRP . . . -124.48 169.89 11.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.426 -0.352 . . . . 42.140000000000001 110.574 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.45 139.56 30.59 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.124 -0.324 . . . . 74.129999999999995 110.124 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.0 t -74.64 120.93 83.9 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.557 -0.292 . . . . 74.219999999999999 110.513 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.65 137.67 70.33 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.461 2.108 . . . . 74.140000000000001 111.436 175.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.73 134.94 57.5 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.46 -0.336 . . . . 34.340000000000003 110.571 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.31 -35.15 4.59 Favored Glycine 0 CA--C 1.511 -0.211 0 N-CA-C 111.062 -0.815 . . . . 60.32 111.062 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.417 ' HZ3' ' HB3' ' A' ' 23' ' ' ASP . 3.7 m95 -92.5 143.89 25.9 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.043 -1.095 . . . . 74.510000000000005 108.043 173.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 41' ' ' ARG . 44.6 ttm105 -141.22 133.7 28.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.96 0.41 . . . . 63.219999999999999 111.517 -174.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.2 t -85.49 121.09 36.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.959 -0.564 . . . . 60.219999999999999 110.31 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.42 -37.18 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.8 0.334 . . . . 73.329999999999998 110.873 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.415 ' HD2' ' O ' ' A' ' 45' ' ' GLY . 3.6 t-160 -134.67 129.89 35.49 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.226 -0.657 . . . . 73.349999999999994 109.226 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -72.47 167.29 53.52 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 124.455 1.097 . . . . 61.030000000000001 113.543 -176.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.595 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 2.6 mp0 -50.91 128.69 21.83 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.715 0.806 . . . . 74.340000000000003 112.488 -171.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -133.18 -178.23 4.88 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.509 -0.768 . . . . 73.409999999999997 110.727 -176.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.37 164.57 23.94 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.772 0.796 . . . . 61.520000000000003 112.653 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -52.57 -38.37 59.77 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 114.753 -1.112 . . . . 74.329999999999998 109.787 173.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.42 -47.6 83.39 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 115.756 -0.656 . . . . 72.030000000000001 110.216 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 17' ' ' PHE . . . -59.86 -31.35 69.69 Favored 'General case' 0 C--O 1.258 1.515 0 CA-C-O 121.71 0.766 . . . . 52.32 111.015 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.608 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 47.8 t -71.25 -40.88 70.75 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.724 -1.125 . . . . 61.32 110.839 172.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.5 mt -67.66 -26.93 66.45 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.317 0.58 . . . . 74.319999999999993 109.796 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -77.11 -37.39 54.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.526 -0.761 . . . . 73.120000000000005 110.141 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.764 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -46.53 -58.04 4.16 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 111.861 0.319 . . . . 71.239999999999995 111.861 171.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 tt -60.81 -37.96 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.242 0.544 . . . . 72.140000000000001 110.552 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.45 -43.55 93.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.249 -0.887 . . . . 72.010000000000005 110.571 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -73.76 -27.95 61.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.868 -0.605 . . . . 74.420000000000002 110.106 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 58.02 57.46 4.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.185 -0.916 . . . . 71.519999999999996 110.121 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.452 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 50.4 t90 -62.4 116.3 21.91 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-N 115.631 -0.713 . . . . 74.230000000000004 109.794 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 60' ' ' TRP . 1.2 Cg_endo -83.11 -153.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.406 2.737 . . . . 74.040000000000006 112.101 -176.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -98.73 -1.97 39.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.773 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.2 pt -108.93 141.31 24.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.094 -0.503 . . . . 44.5 110.893 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.0 ttt-85 -127.62 146.78 59.92 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.731 -0.668 . . . . 72.230000000000004 109.671 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -46.88 140.22 13.38 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.578 2.185 . . . . 62.119999999999997 112.182 171.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 66' ' ' LYS . 7.1 ttpm? -83.53 111.56 19.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.042 -0.526 . . . . 64.540000000000006 111.396 -174.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -61.41 146.87 46.9 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.155 -0.475 . . . . 72.439999999999998 110.433 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.3 tt -172.33 -60.01 0.02 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.933 0.397 . . . . 74.140000000000001 110.099 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.534 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 2.2 tpm_? -92.19 132.28 36.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.409 . . . . 72.540000000000006 110.528 -177.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.12 82.28 1.28 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.547 . . . . 72.120000000000005 110.605 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.567 ' HB3' ' HA ' ' A' ' 5' ' ' MET . 14.5 tppt? -94.12 171.21 8.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.674 -0.694 . . . . 71.420000000000002 109.341 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 56.5 tp -169.3 51.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.946 0.879 . . . . 75.409999999999997 108.924 -176.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.45 ' HB1' ' HG3' ' A' ' 76' ' ' ARG . . . 56.94 31.06 19.11 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.77 -1.105 . . . . 32.420000000000002 112.127 174.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.6 p -55.47 -33.89 64.05 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.309 -0.405 . . . . 74.239999999999995 111.865 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.72 6.47 58.39 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 116.094 -0.503 . . . . 72.519999999999996 113.558 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.633 ' HE ' ' HA ' ' A' ' 76' ' ' ARG . 3.1 mmp_? -83.25 105.15 13.98 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 117.23 0.515 . . . . 73.200000000000003 110.495 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -135.37 -76.76 0.09 OUTLIER Glycine 0 CA--C 1.509 -0.318 0 N-CA-C 110.543 -1.023 . . . . 61.109999999999999 110.543 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -139.81 138.25 35.65 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.24 -0.652 . . . . 73.439999999999998 109.24 170.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -143.76 105.15 4.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.397 -0.82 . . . . 74.109999999999999 110.324 -174.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 115.643 -0.708 . . . . 63.520000000000003 109.909 179.174 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.836 0 N-CA-C 112.347 -0.301 . . . . 64.540000000000006 112.347 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -80.26 141.49 14.47 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.997 2.465 . . . . 72.439999999999998 111.571 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.76 83.04 0.81 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.056 -0.592 . . . . 52.530000000000001 112.067 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.2 p -74.73 174.48 9.07 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.715 0.293 . . . . 64.439999999999998 110.869 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.4 mtp -77.8 -65.04 1.02 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 72.430000000000007 110.756 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.4 m -86.4 135.55 33.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.852 -0.613 . . . . 74.200000000000003 111.169 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 48.2 mm -101.43 134.09 42.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.427 -0.953 . . . . 65.329999999999998 108.427 170.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 7' ' ' ILE . 90.6 m-20 70.17 159.88 0.15 Allowed Pre-proline 0 N--CA 1.468 0.461 0 O-C-N 123.486 0.491 . . . . 64.430000000000007 109.993 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.8 -18.32 55.59 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.086 1.857 . . . . 71.439999999999998 112.082 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -113.77 110.75 20.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.512 . . . . 72.319999999999993 110.209 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -73.67 78.46 1.52 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.618 -0.882 . . . . 75.400000000000006 108.618 175.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -137.81 27.06 2.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.591 -0.731 . . . . 73.540000000000006 110.014 -174.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.65 -19.17 36.81 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 114.66 -1.155 . . . . 74.530000000000001 111.573 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.833 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 8.9 p30 -68.54 14.6 0.07 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.002 -0.999 . . . . 73.329999999999998 113.118 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.66 -10.43 33.07 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.102 -0.57 . . . . 55.210000000000001 112.442 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.497 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 4.5 m -73.47 140.27 46.35 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.643 0.609 . . . . 71.319999999999993 112.643 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.685 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -67.12 -158.02 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.897 0.379 . . . . 74.209999999999994 110.411 159.735 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.505 ' HB3' ' HA ' ' A' ' 46' ' ' GLU . 31.2 p90 -122.9 135.93 54.68 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.458 0.647 . . . . 74.439999999999998 109.66 -167.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.686 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 18.1 t -135.86 131.99 50.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.83 -1.077 . . . . 65.329999999999998 109.694 -167.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.501 ' HB2' ' CD1' ' A' ' 30' ' ' TRP . 29.6 tp -120.92 145.16 47.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.108 -0.497 . . . . 71.329999999999998 110.714 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 97.8 t -122.01 125.54 73.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.812 -0.811 . . . . 73.439999999999998 108.812 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -82.48 163.55 21.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.826 -0.435 . . . . 74.140000000000001 109.826 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -57.38 -31.17 65.53 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.929 0.395 . . . . 71.409999999999997 110.719 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -79.18 16.67 0.91 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.429 0.633 . . . . 73.319999999999993 110.338 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 65.44 24.62 11.95 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.473 -0.785 . . . . 73.299999999999997 111.538 173.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 93.7 mt-30 -78.73 121.19 24.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.789 -0.641 . . . . 54.009999999999998 110.104 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -99.15 116.8 32.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.265 -0.272 . . . . 74.109999999999999 110.265 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.4 t -166.33 -164.19 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.601 -0.518 . . . . 70.430000000000007 109.601 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.763 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.4 pt? -108.32 173.73 6.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.694 -0.484 . . . . 62.520000000000003 109.694 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.501 ' CD1' ' HB2' ' A' ' 20' ' ' LEU . 14.7 p-90 -134.6 149.34 70.63 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.693 -0.23 . . . . 73.310000000000002 111.163 -175.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.88 108.63 2.62 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.741 2.294 . . . . 52.539999999999999 111.703 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.28 -12.16 60.75 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.304 -0.407 . . . . 64.129999999999995 112.013 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -104.31 14.53 30.07 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.041 0.448 . . . . 72.430000000000007 110.749 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.68 179.96 6.27 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.022 -0.535 . . . . 42.140000000000001 110.51 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -79.16 118.9 21.54 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.509 -0.314 . . . . 74.129999999999995 110.443 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.619 HG22 ' NE1' ' A' ' 40' ' ' TRP . 7.7 p -96.19 110.38 51.95 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 109.02 -0.733 . . . . 74.219999999999999 109.02 173.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.463 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 36.5 Cg_endo -64.3 108.38 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.853 2.369 . . . . 74.140000000000001 114.043 -167.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.26 152.53 0.27 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.682 -0.69 . . . . 34.340000000000003 112.3 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.78 -8.1 21.83 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.735 -0.666 . . . . 60.32 111.702 -174.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.619 ' NE1' HG22 ' A' ' 36' ' ' VAL . 4.9 p-90 -87.72 -177.61 5.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 122.972 0.509 . . . . 74.510000000000005 110.746 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.631 ' HB3' HD11 ' A' ' 63' ' ' ILE . 49.0 mtt85 -128.95 125.38 37.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.288 -1.005 . . . . 63.219999999999999 108.288 171.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 p -91.47 116.63 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.962 0.41 . . . . 60.219999999999999 111.162 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.699 ' HA ' HG13 ' A' ' 63' ' ' ILE . 61.4 t -76.98 -35.36 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.095 0.474 . . . . 73.329999999999998 110.288 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.433 ' CD2' ' HB2' ' A' ' 16' ' ' SER . 2.1 m80 -157.02 132.2 9.05 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.632 -0.713 . . . . 73.349999999999994 109.828 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -71.31 167.66 51.62 Favored Glycine 0 C--N 1.34 0.773 0 O-C-N 124.337 1.023 . . . . 61.030000000000001 112.461 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -55.45 147.1 18.24 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.389 0.885 . . . . 74.340000000000003 113.389 -170.247 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -148.99 -178.31 6.3 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.735 -1.12 . . . . 73.409999999999997 109.24 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -91.89 172.28 8.57 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.001 0.429 . . . . 61.520000000000003 111.357 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -57.8 -32.25 67.37 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.137 -0.483 . . . . 74.329999999999998 110.117 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.712 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -52.35 -52.66 52.14 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 109.343 -0.614 . . . . 72.030000000000001 109.343 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.497 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -64.26 -31.56 72.8 Favored 'General case' 0 C--O 1.262 1.724 0 CA-C-N 115.439 -0.801 . . . . 52.32 111.274 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.685 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 53.0 t -66.14 -36.53 83.37 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 114.55 -1.204 . . . . 61.32 110.57 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.677 ' O ' HG22 ' A' ' 56' ' ' ILE . 76.0 mt -72.0 -44.39 63.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.52 -0.548 . . . . 74.319999999999993 109.52 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.712 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 4.3 mm-40 -62.34 -25.55 67.96 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.417 -0.356 . . . . 73.120000000000005 111.12 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.604 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -46.09 -27.17 0.89 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 111.715 0.265 . . . . 71.239999999999995 111.715 173.518 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 53' ' ' LEU . 19.7 tt -60.85 -47.83 91.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 121.477 0.656 . . . . 72.140000000000001 110.271 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.475 ' N ' HG23 ' A' ' 56' ' ' ILE . 12.5 tp10 -73.83 -35.47 64.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.098 -0.955 . . . . 72.010000000000005 110.364 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.688 ' HG3' ' HG3' ' A' ' 61' ' ' PRO . 4.6 tp10 -74.89 -36.35 62.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.0 -1.0 . . . . 74.420000000000002 111.361 -172.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 67.91 -87.36 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.845 -0.616 . . . . 71.519999999999996 111.63 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -159.08 91.34 1.96 Allowed Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 122.445 0.298 . . . . 74.230000000000004 110.669 -175.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.688 ' HG3' ' HG3' ' A' ' 58' ' ' GLU . 5.1 Cg_exo -79.94 -172.26 1.48 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.936 2.424 . . . . 74.040000000000006 111.674 175.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.56 168.51 19.16 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.293 0.568 . . . . 74.439999999999998 111.894 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.699 HG13 ' HA ' ' A' ' 43' ' ' VAL . 8.6 tt -101.82 124.47 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.253 -0.885 . . . . 44.5 112.344 -169.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.503 ' HB2' ' HD2' ' A' ' 65' ' ' PRO . 0.1 OUTLIER 178.71 163.34 0.68 Allowed Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.024 -0.535 . . . . 72.230000000000004 109.774 170.162 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 64' ' ' ARG . 33.7 Cg_endo -62.85 -170.39 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.126 2.551 . . . . 62.119999999999997 113.437 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.1 tttp -63.5 84.28 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.976 -0.556 . . . . 64.540000000000006 111.337 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.3 p -135.41 47.36 2.31 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.727 -0.842 . . . . 72.439999999999998 108.727 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.833 ' HB2' ' HA ' ' A' ' 14' ' ' ASN . 2.3 pt? -65.0 -25.31 67.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.546 -1.206 . . . . 74.140000000000001 111.991 -174.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.617 ' HG3' ' HG ' ' A' ' 68' ' ' LEU . 59.9 mtm180 -117.59 111.72 19.59 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.747 -0.094 . . . . 72.540000000000006 110.747 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 61.66 121.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 O-C-N 124.0 0.813 . . . . 72.120000000000005 112.777 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -75.46 63.99 1.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.196 -0.668 . . . . 71.420000000000002 109.196 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -165.42 -49.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.842 -0.617 . . . . 75.409999999999997 109.728 -174.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -130.77 -164.41 1.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 32.420000000000002 110.506 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.5 m -143.25 -52.65 0.36 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.058 0.456 . . . . 74.239999999999995 110.279 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.84 -154.34 22.63 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.751 -0.659 . . . . 72.519999999999996 111.487 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -150.68 156.19 40.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.74 -0.467 . . . . 73.200000000000003 109.74 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.19 103.55 0.2 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.08 -0.581 . . . . 61.109999999999999 112.265 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -162.16 -179.93 7.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.181 -0.674 . . . . 73.439999999999998 109.181 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 t70 72.38 16.72 4.95 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.876 0.846 . . . . 74.109999999999999 110.097 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 C--O 1.247 0.936 0 CA-C-N 115.112 -0.949 . . . . 63.520000000000003 110.165 179.854 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 111.814 -0.515 . . . . 64.540000000000006 111.814 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.22 93.08 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.396 2.064 . . . . 72.439999999999998 111.43 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.27 111.45 4.13 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.883 -0.599 . . . . 52.530000000000001 112.314 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.9 p -65.45 130.33 42.93 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.294 -0.261 . . . . 64.439999999999998 110.294 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.3 tpp -54.41 -51.94 63.31 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.306 0.574 . . . . 72.430000000000007 109.81 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.7 t -165.88 149.94 8.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.092 -0.958 . . . . 74.200000000000003 110.366 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.5 mt -142.74 147.46 20.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.244 -0.889 . . . . 65.329999999999998 109.013 176.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.464 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 27.0 t-20 74.49 132.29 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.537 0 O-C-N 123.656 0.597 . . . . 64.430000000000007 110.823 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 8' ' ' ASN . 23.1 Cg_exo -65.32 160.64 41.43 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.797 2.331 . . . . 71.439999999999998 112.348 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -69.45 95.61 0.83 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.324 -0.621 . . . . 72.319999999999993 109.324 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.439 ' HB3' HH12 ' A' ' 64' ' ' ARG . 32.5 t70 -111.23 72.03 0.76 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.589 . . . . 75.400000000000006 111.162 -170.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 53.62 28.95 8.54 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.827 -0.624 . . . . 73.540000000000006 111.837 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.463 ' OD1' ' HD3' ' A' ' 64' ' ' ARG . 11.1 m-20 -58.64 -44.16 89.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 74.530000000000001 110.368 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.46 ' O ' ' HB1' ' A' ' 51' ' ' ALA . 7.4 m-20 -97.42 15.4 23.19 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.599 -0.728 . . . . 73.329999999999998 111.042 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.82 -46.57 75.56 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.371 -0.442 . . . . 55.210000000000001 113.27 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.8 m -139.83 58.38 1.6 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.972 -1.121 . . . . 71.319999999999993 107.972 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.436 ' HB2' ' HA ' ' A' ' 14' ' ' ASN . 62.2 m-85 -162.21 109.8 1.35 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 114.424 -1.262 . . . . 74.209999999999994 114.351 -156.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -151.51 130.71 12.73 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.306 -0.998 . . . . 74.439999999999998 108.306 150.456 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.435 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 64.0 t -158.1 136.71 3.13 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 CA-C-O 121.128 0.489 . . . . 65.329999999999998 112.152 -169.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.423 HD13 HG22 ' A' ' 42' ' ' VAL . 63.4 tp -102.21 122.96 45.21 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.445 -0.798 . . . . 71.329999999999998 109.514 174.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.55 125.82 50.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.241 -0.651 . . . . 73.439999999999998 109.241 174.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 14.3 m120 -96.92 139.26 33.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.781 -0.645 . . . . 74.140000000000001 110.254 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.72 -15.92 59.75 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.087 0.47 . . . . 71.409999999999997 110.843 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -85.24 26.56 0.88 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.031 -0.531 . . . . 73.319999999999993 111.078 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 69.8 6.25 5.64 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.314 0.646 . . . . 73.299999999999997 111.803 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 15.7 mm100 -90.86 153.78 19.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.929 0.395 . . . . 54.009999999999998 110.45 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -133.37 109.09 9.11 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.394 -0.965 . . . . 74.109999999999999 108.394 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.3 t -128.38 177.21 7.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.772 0.796 . . . . 70.430000000000007 111.889 -170.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.3 tt -111.71 106.59 15.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.594 -1.185 . . . . 62.520000000000003 108.065 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.457 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 25.3 p-90 -77.67 149.49 77.86 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.059 -0.519 . . . . 73.310000000000002 111.206 -174.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.89 104.07 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.038 1.825 . . . . 52.539999999999999 111.085 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.457 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -63.42 -2.15 1.43 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.23 -0.441 . . . . 64.129999999999995 111.621 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -89.78 -0.72 57.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 72.430000000000007 110.789 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.2 178.0 7.24 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.05 0.452 . . . . 42.140000000000001 111.688 -175.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -95.92 140.11 31.15 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.593 -0.731 . . . . 74.129999999999995 111.028 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.3 t -91.48 123.95 62.38 Favored Pre-proline 0 C--O 1.236 0.383 0 CA-C-N 116.243 -0.435 . . . . 74.219999999999999 111.037 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.54 153.75 73.04 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.616 2.211 . . . . 74.140000000000001 111.708 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.05 152.18 38.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.94 0.4 . . . . 34.340000000000003 110.714 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.4 -35.53 4.91 Favored Glycine 0 N--CA 1.455 -0.073 0 N-CA-C 111.036 -0.826 . . . . 60.32 111.036 -174.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -95.01 129.21 42.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.757 -1.201 . . . . 74.510000000000005 107.757 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -100.12 125.64 46.25 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.622 -0.51 . . . . 63.219999999999999 109.622 -171.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.423 HG22 HD13 ' A' ' 20' ' ' LEU . 21.6 t -90.69 117.88 34.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.99 -0.744 . . . . 60.219999999999999 108.99 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.435 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 14.4 p -84.16 -23.35 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.681 0.753 . . . . 73.329999999999998 109.548 -174.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.429 ' NE2' ' HB2' ' A' ' 64' ' ' ARG . 27.2 m80 -148.29 115.48 6.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.036 -0.984 . . . . 73.349999999999994 108.714 173.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -69.74 -171.51 8.73 Favored Glycine 0 N--CA 1.447 -0.583 0 O-C-N 123.864 0.728 . . . . 61.030000000000001 112.501 -175.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -52.44 133.88 34.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.146 0.498 . . . . 74.340000000000003 111.322 -178.716 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.87 175.89 9.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.541 -0.754 . . . . 73.409999999999997 110.017 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.74 159.58 21.96 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.984 -0.553 . . . . 61.520000000000003 111.273 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.556 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 15.7 ttm180 -58.38 -37.72 75.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.242 -0.651 . . . . 74.329999999999998 109.242 176.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.74 -36.82 84.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.028 -0.533 . . . . 72.030000000000001 110.468 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 14' ' ' ASN . . . -69.02 -38.47 79.22 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-N 115.855 -0.611 . . . . 52.32 111.389 -176.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.556 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 27.0 p -73.44 -47.26 43.06 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.411 -0.813 . . . . 61.32 110.995 174.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 72.8 mt -60.89 -34.5 74.74 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.503 -0.317 . . . . 74.319999999999993 110.594 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -76.82 -37.54 55.5 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.885 -0.326 . . . . 73.120000000000005 110.54 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.537 ' HE1' ' HB2' ' A' ' 60' ' ' TRP . 11.0 t80 -48.26 -58.12 5.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 120.438 -0.505 . . . . 71.239999999999995 111.588 170.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 52' ' ' CYS . 3.7 tt -61.65 -38.55 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 120.672 0.272 . . . . 72.140000000000001 111.032 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -60.54 -43.49 97.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 72.010000000000005 110.51 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -81.94 -14.89 55.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.895 -0.593 . . . . 74.420000000000002 111.428 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 61.68 34.94 17.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.151 -0.477 . . . . 71.519999999999996 110.853 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.537 ' HB2' ' HE1' ' A' ' 55' ' ' TYR . 75.0 t-105 64.79 83.62 0.19 Allowed Pre-proline 0 N--CA 1.471 0.581 0 CA-C-O 120.962 0.411 . . . . 74.230000000000004 110.079 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -87.86 -33.81 0.13 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.917 2.411 . . . . 74.040000000000006 113.726 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -145.88 171.15 15.23 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.309 -0.245 . . . . 74.439999999999998 110.925 -170.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.711 ' H ' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -122.52 136.71 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.184 0.516 . . . . 44.5 111.523 -173.5 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.463 ' HD3' ' OD1' ' A' ' 13' ' ' ASP . 59.5 mtt180 -149.68 153.6 36.71 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 115.632 -0.713 . . . . 72.230000000000004 109.277 176.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.6 171.49 17.09 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.968 2.445 . . . . 62.119999999999997 113.327 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -73.88 136.63 43.4 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.379 -0.828 . . . . 64.540000000000006 110.316 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' HD13 ' A' ' 68' ' ' LEU . 13.7 m -64.98 81.45 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.44 -0.345 . . . . 72.439999999999998 110.854 176.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.545 HD13 ' C ' ' A' ' 67' ' ' SER . 0.0 OUTLIER 31.25 -167.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 116.248 1.944 . . . . 74.140000000000001 116.248 174.226 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.462 ' HG2' ' N ' ' A' ' 70' ' ' ASP . 57.0 ttt180 -175.25 161.74 2.85 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 113.803 -1.544 . . . . 72.540000000000006 108.11 172.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.462 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 8.5 p-10 -57.98 114.4 2.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.232 0.539 . . . . 72.120000000000005 111.463 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HD2' ' O ' ' A' ' 70' ' ' ASP . 5.1 mptp? -124.34 27.09 7.14 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.042 -0.526 . . . . 71.420000000000002 110.377 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.7 tp -85.9 48.73 1.65 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.547 0.689 . . . . 75.409999999999997 109.964 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.73 24.29 2.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.59 -0.732 . . . . 32.420000000000002 111.029 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.4 p -66.44 127.77 33.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 74.239999999999995 111.018 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.86 120.93 0.96 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.244 -0.503 . . . . 72.519999999999996 112.035 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -134.91 128.4 32.5 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.506 -0.553 . . . . 73.200000000000003 109.506 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -147.14 -159.2 8.19 Favored Glycine 0 C--O 1.236 0.256 0 N-CA-C 111.496 -0.642 . . . . 61.109999999999999 111.496 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.9 t80 179.72 -84.06 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.809 -0.441 . . . . 73.439999999999998 109.809 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -82.19 -41.96 19.63 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.421 -0.585 . . . . 74.109999999999999 109.421 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.03 0 N-CA-C 108.466 -0.939 . . . . 63.520000000000003 108.466 169.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.867 0 N-CA-C 111.934 -0.466 . . . . 64.540000000000006 111.934 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.57 152.79 23.16 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.758 2.305 . . . . 72.439999999999998 112.225 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.7 70.31 2.89 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 116.022 -0.536 . . . . 52.530000000000001 112.421 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.7 m -69.93 102.87 2.08 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.068 -0.345 . . . . 64.439999999999998 110.068 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.59 ' HE1' ' HA ' ' A' ' 71' ' ' LYS . 81.8 mmm -57.23 -57.56 12.08 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.2 -0.454 . . . . 72.430000000000007 110.548 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.9 m -80.86 112.19 18.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.99 -0.55 . . . . 74.200000000000003 109.648 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.446 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 67.5 mt -75.47 102.59 2.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.219 -0.446 . . . . 65.329999999999998 110.808 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -101.31 91.13 1.93 Allowed Pre-proline 0 C--O 1.235 0.318 0 N-CA-C 108.408 -0.96 . . . . 64.430000000000007 108.408 169.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 7' ' ' ILE . 83.9 Cg_endo -85.35 151.94 10.59 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.759 2.306 . . . . 71.439999999999998 112.943 -171.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -131.63 -75.77 0.52 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.813 -0.631 . . . . 72.319999999999993 109.54 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -75.47 -24.06 56.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.12 0.486 . . . . 75.400000000000006 109.868 175.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.43 -30.36 60.33 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.378 -0.828 . . . . 73.540000000000006 110.939 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -58.05 -35.1 70.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.706 -0.679 . . . . 74.530000000000001 111.303 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -97.09 13.08 30.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.202 0.525 . . . . 73.329999999999998 110.263 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.1 60.84 4.56 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 116.149 -0.478 . . . . 55.210000000000001 112.871 -174.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 32.3 m -68.99 150.86 47.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.108 -0.33 . . . . 71.319999999999993 110.108 175.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.632 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 68.5 t80 -68.34 102.91 1.49 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.904 -0.718 . . . . 74.209999999999994 109.843 174.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -144.44 131.57 20.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.36 -1.348 . . . . 74.439999999999998 107.36 169.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -141.79 123.6 13.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.267 0.555 . . . . 65.329999999999998 111.003 -170.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 40' ' ' TRP . 52.2 tp -93.48 127.99 39.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.202 -0.908 . . . . 71.329999999999998 109.64 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 61.8 t -121.44 129.16 75.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.232 0.539 . . . . 73.439999999999998 110.909 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 33.4 t30 -92.81 151.78 19.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.92 -0.77 . . . . 74.140000000000001 108.92 173.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -54.54 -19.94 6.86 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.159 0.504 . . . . 71.409999999999997 110.95 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -82.64 20.61 1.1 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.965 -0.561 . . . . 73.319999999999993 111.635 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 65.62 12.57 8.34 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.976 0.51 . . . . 73.299999999999997 111.849 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 34.6 tt0 -76.03 117.64 17.95 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.341 -0.615 . . . . 54.009999999999998 109.341 176.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -122.52 107.95 12.6 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.01 0.434 . . . . 74.109999999999999 111.298 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 m -132.38 -168.03 1.99 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.549 -0.75 . . . . 70.430000000000007 109.359 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.787 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.9 pt? -106.38 161.63 14.4 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.238 -0.653 . . . . 62.520000000000003 109.238 174.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.467 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 20.0 p-90 -131.8 145.03 55.72 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.614 0.245 . . . . 73.310000000000002 111.31 -173.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 14.0 Cg_exo -69.86 103.67 1.21 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.727 2.285 . . . . 52.539999999999999 111.291 176.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.467 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -60.01 -22.52 62.7 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.14 -0.482 . . . . 64.129999999999995 112.03 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -84.88 4.26 34.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.615 -0.266 . . . . 72.430000000000007 111.436 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.99 162.44 22.33 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.806 0.336 . . . . 42.140000000000001 110.725 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -82.97 132.84 35.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 74.129999999999995 110.597 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.97 115.95 62.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 74.219999999999999 110.198 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.68 147.1 95.92 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.345 2.03 . . . . 74.140000000000001 112.169 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.37 137.76 57.0 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.203 -0.453 . . . . 34.340000000000003 110.685 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.42 -35.42 4.55 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.42 -0.672 . . . . 60.32 111.42 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.469 ' HB3' HD11 ' A' ' 20' ' ' LEU . 71.0 m95 -81.37 140.6 34.63 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.581 -0.526 . . . . 74.510000000000005 109.581 177.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -127.61 126.13 41.49 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.151 -0.314 . . . . 63.219999999999999 110.151 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.6 t -85.21 130.57 35.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.583 -0.525 . . . . 60.219999999999999 109.583 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -85.43 -31.33 6.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.228 0.537 . . . . 73.329999999999998 109.997 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -154.58 122.95 6.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.924 -0.769 . . . . 73.349999999999994 108.924 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.03 -172.41 42.18 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.28 -0.486 . . . . 61.030000000000001 112.522 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -61.73 154.52 25.3 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 110.244 -0.28 . . . . 74.340000000000003 110.244 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.436 ' HB3' ' CB ' ' A' ' 51' ' ' ALA . . . -160.71 -178.25 6.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.118 0.485 . . . . 73.409999999999997 111.762 -175.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -68.91 178.45 2.19 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.954 -1.021 . . . . 61.520000000000003 111.9 -175.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 44.5 ttm180 -61.15 -27.86 68.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.38 -0.827 . . . . 74.329999999999998 110.203 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -51.84 -44.97 63.81 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.162 0.505 . . . . 72.030000000000001 110.01 172.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 47' ' ' ALA . . . -75.81 -31.74 59.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.428 -0.806 . . . . 52.32 110.846 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.679 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 52.8 t -54.12 -42.01 68.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.042 -0.527 . . . . 61.32 110.067 170.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.06 -29.85 68.91 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.055 -0.52 . . . . 74.319999999999993 110.665 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 94.8 mt-10 -70.05 -51.65 30.3 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.445 -0.343 . . . . 73.120000000000005 111.039 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.632 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 2.7 t80 -58.48 -41.9 86.34 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.603 -0.271 . . . . 71.239999999999995 111.693 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 52' ' ' CYS . 9.7 tt -71.03 -45.62 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 121.085 -0.246 . . . . 72.140000000000001 111.146 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -64.57 -52.6 56.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.418 -0.356 . . . . 72.010000000000005 110.302 -177.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -70.68 -33.14 70.6 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.948 -0.569 . . . . 74.420000000000002 110.337 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 41.55 61.2 1.91 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.829 0.852 . . . . 71.519999999999996 111.826 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.685 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 23.0 t90 -86.02 -52.84 0.45 Allowed Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 115.282 -0.872 . . . . 74.230000000000004 111.471 -178.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.685 ' HD3' ' HB3' ' A' ' 60' ' ' TRP . 20.0 Cg_exo -67.33 -52.62 0.57 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.126 1.884 . . . . 74.040000000000006 112.029 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -105.81 132.63 51.69 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.755 -0.461 . . . . 74.439999999999998 109.755 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.527 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.8 mp -83.5 90.58 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.277 -0.42 . . . . 44.5 110.905 -173.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.575 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 31.5 ttt85 -80.13 102.54 1.25 Allowed Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 108.228 -1.027 . . . . 72.230000000000004 108.228 168.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -70.64 144.21 48.75 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.907 2.405 . . . . 62.119999999999997 113.405 -167.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp 57.8 15.1 2.81 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.41 -0.814 . . . . 64.540000000000006 112.162 174.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.575 ' HB2' ' HG2' ' A' ' 64' ' ' ARG . 27.9 t -80.92 68.82 7.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.537 0.684 . . . . 72.439999999999998 110.305 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 mp -102.03 -73.67 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.474 -0.935 . . . . 74.140000000000001 108.474 173.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 60.2 mmt-85 -90.85 70.54 6.53 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.814 -0.81 . . . . 72.540000000000006 108.814 171.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -60.92 107.36 0.7 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.697 -0.683 . . . . 72.120000000000005 109.784 -175.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.59 ' HA ' ' HE1' ' A' ' 5' ' ' MET . 1.8 tmtp? 54.51 50.5 15.93 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.221 1.01 . . . . 71.420000000000002 110.263 -175.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 71.41 -0.01 3.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.906 -1.043 . . . . 75.409999999999997 111.269 171.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 69' ' ' ARG . . . -80.42 149.83 30.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.766 0.317 . . . . 32.420000000000002 110.729 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.1 p -75.19 121.52 22.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.528 -0.306 . . . . 74.239999999999995 110.739 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.84 170.17 43.3 Favored Glycine 0 C--O 1.237 0.323 0 C-N-CA 121.065 -0.588 . . . . 72.519999999999996 112.418 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -148.58 156.03 41.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.517 -0.549 . . . . 73.200000000000003 109.517 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -167.1 111.33 0.44 Allowed Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.629 -0.714 . . . . 61.109999999999999 111.674 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -169.52 163.55 10.32 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.98 -0.378 . . . . 73.439999999999998 109.98 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -152.41 111.24 3.8 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.789 0.328 . . . . 74.109999999999999 110.203 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.343 -0.837 . . . . 63.520000000000003 108.962 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.431 ' HA3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 112.105 -0.398 . . . . 64.540000000000006 112.105 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' HD3' ' HA3' ' A' ' 1' ' ' GLY . 38.4 Cg_exo -60.73 92.92 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.819 2.346 . . . . 72.439999999999998 112.663 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.59 27.91 1.06 Allowed Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 111.377 -0.689 . . . . 52.530000000000001 111.377 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.9 m -78.18 -171.55 2.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.253 0.549 . . . . 64.439999999999998 111.845 -175.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 81.6 mmm -58.45 -32.65 68.91 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.616 -0.72 . . . . 72.430000000000007 111.438 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.1 m 74.55 19.74 2.6 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 123.711 1.719 . . . . 74.200000000000003 110.676 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.36 83.03 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.673 0 CA-C-N 110.846 -2.888 . . . . 65.329999999999998 108.628 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.603 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 26.1 t-20 -169.19 -51.08 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.713 -1.13 . . . . 64.430000000000007 109.445 -176.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 8' ' ' ASN . 76.7 Cg_endo -88.07 143.11 5.69 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.007 1.805 . . . . 71.439999999999998 111.403 172.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -73.81 -26.7 60.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.322 0.582 . . . . 72.319999999999993 109.538 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -80.07 97.08 6.68 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.437 -0.802 . . . . 75.400000000000006 109.331 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -63.58 119.7 10.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 73.540000000000006 111.753 -175.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.87 -21.78 66.23 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.051 -0.522 . . . . 74.530000000000001 111.205 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 65' ' ' PRO . 7.8 t30 -85.62 -11.26 54.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.041 0.448 . . . . 73.329999999999998 110.521 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.4 112.05 3.61 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 116.095 -0.502 . . . . 55.210000000000001 112.717 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.532 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 46.6 t -162.92 141.26 8.34 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.304 0.242 . . . . 71.319999999999993 110.443 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.817 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 19.0 t80 -66.98 -160.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.066 -0.716 . . . . 74.209999999999994 109.066 171.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.653 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 46.1 p90 -125.22 138.15 54.12 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.366 -0.834 . . . . 74.439999999999998 111.652 -172.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -142.15 133.81 26.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 114.955 -1.02 . . . . 65.329999999999998 110.11 -173.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.643 ' HB2' ' CE3' ' A' ' 30' ' ' TRP . 17.8 tp -120.88 142.67 49.46 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 122.978 0.511 . . . . 71.329999999999998 110.754 -174.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.8 147.8 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.619 -0.264 . . . . 73.439999999999998 110.356 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 17.2 m120 -122.72 161.4 23.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.531 -0.304 . . . . 74.140000000000001 110.628 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -58.5 -25.46 62.39 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.889 -0.596 . . . . 71.409999999999997 111.202 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -83.49 22.93 0.99 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.627 -0.715 . . . . 73.319999999999993 111.512 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 65.53 14.25 9.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.879 0.471 . . . . 73.299999999999997 111.321 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 74.7 mt-30 -86.57 123.08 31.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.497 -0.319 . . . . 54.009999999999998 110.534 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -120.56 126.51 50.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.544 -0.539 . . . . 74.109999999999999 109.544 176.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 p -164.42 -154.44 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 70.430000000000007 110.346 -173.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.625 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.2 pt? -131.85 164.9 25.03 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.122 -0.695 . . . . 62.520000000000003 109.122 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.653 ' CH2' ' HB2' ' A' ' 18' ' ' PHE . 20.1 p90 -125.91 147.8 60.32 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-O 120.46 0.172 . . . . 73.310000000000002 111.033 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 13.8 Cg_exo -70.0 99.25 0.76 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.552 2.168 . . . . 52.539999999999999 111.133 173.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.99 -7.38 8.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.309 -0.405 . . . . 64.129999999999995 111.22 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -81.45 -2.46 49.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.985 -0.552 . . . . 72.430000000000007 110.706 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.0 177.62 7.84 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.413 -0.358 . . . . 42.140000000000001 110.642 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -80.79 138.55 36.27 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.814 -0.439 . . . . 74.129999999999995 109.814 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 t -90.45 126.29 56.93 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.138 -0.483 . . . . 74.219999999999999 110.45 -175.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.429 ' O ' ' HD1' ' A' ' 40' ' ' TRP . 38.6 Cg_endo -66.27 110.92 1.9 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.882 2.388 . . . . 74.140000000000001 112.501 -176.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -44.73 150.85 0.32 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.199 0.814 . . . . 34.340000000000003 113.199 -172.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.98 23.93 4.75 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.541 -0.754 . . . . 60.32 111.85 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.431 ' HB2' HD11 ' A' ' 20' ' ' LEU . 25.3 p-90 -130.2 160.08 34.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.897 0.379 . . . . 74.510000000000005 111.18 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.435 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 4.6 mmp_? -122.7 127.01 48.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.708 -0.849 . . . . 63.219999999999999 108.708 171.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.515 HG23 ' CH2' ' A' ' 30' ' ' TRP . 7.5 p -89.4 119.6 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 120.825 0.345 . . . . 60.219999999999999 110.423 -177.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.85 -38.18 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.455 0.645 . . . . 73.329999999999998 110.555 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.647 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 72.0 m-70 -132.56 136.39 46.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.349 -0.841 . . . . 73.349999999999994 108.849 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.43 160.44 22.01 Favored Glycine 0 C--N 1.332 0.334 0 O-C-N 123.525 0.516 . . . . 61.030000000000001 112.892 -176.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -62.67 132.98 54.12 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.843 0.354 . . . . 74.340000000000003 111.031 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.5 -177.89 6.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.137 0.494 . . . . 73.409999999999997 111.734 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.76 172.71 2.06 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.241 -0.89 . . . . 61.520000000000003 112.716 -174.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.446 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 14.6 ttp180 -58.63 -42.91 89.34 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.575 -0.739 . . . . 74.329999999999998 111.172 178.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -52.5 -46.5 66.67 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.299 -0.63 . . . . 72.030000000000001 109.299 177.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.532 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -63.21 -34.7 78.21 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.019 -0.991 . . . . 52.32 111.081 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.817 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 36.7 m -60.39 -46.14 91.06 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.367 -0.833 . . . . 61.32 109.928 171.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.18 -24.78 62.3 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.486 -0.779 . . . . 74.319999999999993 110.561 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 42.1 mt-10 -76.93 -36.95 56.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 73.120000000000005 110.844 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -54.82 -50.46 68.53 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.659 0.244 . . . . 71.239999999999995 111.659 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.8 -34.89 49.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.032 0.444 . . . . 72.140000000000001 110.007 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -73.67 -25.59 60.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.762 -0.654 . . . . 72.010000000000005 110.819 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.483 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 53.7 mt-10 -65.88 -54.62 24.17 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.108 0.48 . . . . 74.420000000000002 109.985 173.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 77.0 t60 58.07 38.38 26.6 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.21 -0.904 . . . . 71.519999999999996 109.16 -174.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 70.05 92.78 0.06 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.006 -0.997 . . . . 74.230000000000004 109.924 -176.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 58' ' ' GLU . 24.1 Cg_endo -97.16 -158.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.528 2.819 . . . . 74.040000000000006 113.112 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -96.63 -35.62 10.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.506 -0.77 . . . . 74.439999999999998 110.823 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.08 139.35 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.783 -0.644 . . . . 44.5 111.119 -174.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -124.04 137.64 29.28 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 109.555 -0.535 . . . . 72.230000000000004 109.555 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 42.5 Cg_endo -66.07 104.6 0.73 Allowed 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.576 2.184 . . . . 62.119999999999997 112.933 -177.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -76.51 76.89 3.22 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.334 -0.987 . . . . 64.540000000000006 108.334 170.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.2 t -68.73 154.36 42.1 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.975 -1.011 . . . . 72.439999999999998 112.038 -170.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.1 tp -170.97 -69.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.778 -1.101 . . . . 74.140000000000001 108.443 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -179.74 153.92 0.56 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.86 -0.793 . . . . 72.540000000000006 108.86 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 27.9 t70 -68.29 160.48 29.29 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.886 -0.413 . . . . 72.120000000000005 109.886 175.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.777 ' HD2' ' H ' ' A' ' 71' ' ' LYS . 4.3 mptt -89.27 -13.17 38.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.411 -0.358 . . . . 71.420000000000002 111.022 -170.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.6 tp -119.75 7.59 11.04 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.187 0.517 . . . . 75.409999999999997 109.998 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' A' ' 70' ' ' ASP . . . -72.06 86.4 1.03 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.166 -0.47 . . . . 32.420000000000002 110.899 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.4 p -87.57 102.17 14.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.469 . . . . 74.239999999999995 109.837 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.02 53.39 3.4 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.447 -0.406 . . . . 72.519999999999996 112.874 -177.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -168.55 116.54 0.69 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.247 -0.649 . . . . 73.200000000000003 109.247 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.54 139.94 12.18 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.083 -0.579 . . . . 61.109999999999999 112.445 -176.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -76.37 -18.48 58.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.508 0.671 . . . . 73.439999999999998 109.458 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.26 80.75 0.09 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.507 -1.224 . . . . 74.109999999999999 109.854 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 . . . . . 0 C--O 1.247 0.94 0 CA-C-N 114.55 -1.205 . . . . 63.520000000000003 111.579 176.929 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 112.238 -0.345 . . . . 64.540000000000006 112.238 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.9 -68.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.694 2.263 . . . . 72.439999999999998 112.011 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.86 41.96 2.09 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.972 -0.558 . . . . 52.530000000000001 112.033 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.7 m -67.46 102.81 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 64.439999999999998 110.239 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.472 ' O ' ' HG2' ' A' ' 69' ' ' ARG . 31.5 mmt -88.48 -8.82 54.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.056 -0.52 . . . . 72.430000000000007 110.985 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.8 p -146.44 142.6 28.3 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.675 0.274 . . . . 74.200000000000003 111.233 -174.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.2 mt -101.53 95.58 4.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 109.352 -0.61 . . . . 65.329999999999998 109.352 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -70.37 114.32 25.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 64.430000000000007 110.956 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -85.37 173.34 7.7 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.893 2.395 . . . . 71.439999999999998 112.657 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -109.14 -174.5 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.9 -0.591 . . . . 72.319999999999993 110.373 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.47 155.27 18.72 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.208 0.527 . . . . 75.400000000000006 111.747 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.06 -24.49 66.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.174 -0.921 . . . . 73.540000000000006 111.836 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -51.21 -55.48 17.82 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.281 -0.418 . . . . 74.530000000000001 111.88 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -87.51 8.46 24.85 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.034 0.445 . . . . 73.329999999999998 111.35 -174.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.21 -31.93 63.35 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.726 -0.75 . . . . 55.210000000000001 113.435 -175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.828 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 23.7 m -93.01 149.93 20.89 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 117.051 0.425 . . . . 71.319999999999993 111.914 -172.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 1.7 t80 -68.42 103.31 1.61 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-O 120.968 0.413 . . . . 74.209999999999994 110.051 174.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -140.97 131.18 24.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.321 -1.363 . . . . 74.439999999999998 107.321 165.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 43' ' ' VAL . 98.7 t -147.91 129.86 6.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 121.002 0.429 . . . . 65.329999999999998 110.345 -170.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 40' ' ' TRP . 46.2 tp -105.42 139.29 40.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.566 -0.743 . . . . 71.329999999999998 110.124 -177.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.1 t -118.41 126.09 74.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 109.41 -0.589 . . . . 73.439999999999998 109.41 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -95.09 162.54 13.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.295 -0.411 . . . . 74.140000000000001 110.007 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.44 -11.9 37.98 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.236 0.541 . . . . 71.409999999999997 110.232 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -83.08 9.62 9.96 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.35 -0.841 . . . . 73.319999999999993 110.768 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 66.08 9.85 6.56 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.088 0.555 . . . . 73.299999999999997 110.65 -174.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -74.06 118.27 16.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.118 -0.492 . . . . 54.009999999999998 110.171 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.671 ' HB2' ' HZ2' ' A' ' 60' ' ' TRP . 18.6 p80 -108.71 98.63 8.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.084 -0.507 . . . . 74.109999999999999 110.165 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -133.17 -173.17 3.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.354 -0.385 . . . . 70.430000000000007 110.06 -175.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.814 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.1 pt? -107.57 147.84 30.06 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.423 -0.584 . . . . 62.520000000000003 109.423 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.449 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 43.2 p-90 -116.1 129.43 25.21 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.642 -0.254 . . . . 73.310000000000002 110.478 -177.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 33.3 Cg_exo -61.82 108.44 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.472 2.115 . . . . 52.539999999999999 111.67 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.449 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -60.59 -18.53 53.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.166 -0.47 . . . . 64.129999999999995 111.845 -178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -93.05 9.41 35.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 72.430000000000007 111.285 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.57 175.8 7.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.224 -0.444 . . . . 42.140000000000001 110.754 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -95.94 128.49 42.88 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.248 -0.433 . . . . 74.129999999999995 110.799 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.498 HG12 ' NE1' ' A' ' 40' ' ' TRP . 3.2 t -91.87 110.78 46.09 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.263 -0.426 . . . . 74.219999999999999 110.138 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.43 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 38.5 Cg_endo -67.2 115.67 3.78 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 123.103 2.536 . . . . 74.140000000000001 112.582 -176.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -46.12 151.9 0.45 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.189 0.811 . . . . 34.340000000000003 113.189 -172.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.2 26.52 3.73 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.408 -0.814 . . . . 60.32 111.741 -175.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.498 ' NE1' HG12 ' A' ' 36' ' ' VAL . 17.2 p-90 -134.74 -178.82 5.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.151 0.5 . . . . 74.510000000000005 110.952 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -145.06 126.05 14.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.65 -0.871 . . . . 63.219999999999999 108.65 169.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.87 134.65 28.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.078 -0.341 . . . . 60.219999999999999 110.078 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 19' ' ' VAL . 9.8 p -89.79 -25.5 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.544 0.688 . . . . 73.329999999999998 109.965 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -155.05 121.51 5.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.213 -0.903 . . . . 73.349999999999994 109.095 175.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.45 -174.78 50.26 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.188 -0.529 . . . . 61.030000000000001 111.955 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.5 112.13 1.48 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.09 0.471 . . . . 74.340000000000003 109.857 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.21 -177.78 3.51 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.765 0.654 . . . . 73.409999999999997 112.765 -165.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -86.74 179.87 6.69 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.175 -0.92 . . . . 61.520000000000003 112.437 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 32.2 ttm180 -48.48 -41.44 29.75 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.629 -1.169 . . . . 74.329999999999998 111.393 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -52.82 -47.18 67.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.146 0.498 . . . . 72.030000000000001 110.094 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 17' ' ' PHE . . . -69.88 -31.17 68.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.564 -0.743 . . . . 52.32 110.838 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.828 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 53.9 t -56.84 -42.5 79.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.961 0.41 . . . . 61.32 110.164 171.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.44 -26.16 62.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.929 -0.578 . . . . 74.319999999999993 111.105 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 52.9 mt-10 -74.94 -53.17 9.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.362 -0.381 . . . . 73.120000000000005 111.468 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.572 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 39.7 t80 -60.84 -35.5 76.7 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 111.755 0.28 . . . . 71.239999999999995 111.755 -175.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.7 tt -71.23 -41.16 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 120.996 -0.282 . . . . 72.140000000000001 111.064 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -73.72 -57.25 4.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.901 0.381 . . . . 72.010000000000005 110.913 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -61.22 -31.86 71.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.747 -0.66 . . . . 74.420000000000002 110.926 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.8 m80 68.74 171.91 0.29 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.029 -0.532 . . . . 71.519999999999996 110.645 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.671 ' HZ2' ' HB2' ' A' ' 27' ' ' HIS . 21.2 t-105 -170.49 -48.68 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.684 -0.689 . . . . 74.230000000000004 109.377 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.527 ' HD2' ' H ' ' A' ' 60' ' ' TRP . 88.6 Cg_endo -81.54 -152.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 122.057 1.838 . . . . 74.040000000000006 111.225 172.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -75.99 -173.93 2.5 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.939 0.399 . . . . 74.439999999999998 111.127 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.8 pt -120.39 159.35 21.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 116.16 -0.473 . . . . 44.5 110.787 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -137.9 142.0 34.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.1 -0.704 . . . . 72.230000000000004 109.1 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -52.12 90.1 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.727 2.285 . . . . 62.119999999999997 112.487 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -74.09 96.69 2.75 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.693 -0.685 . . . . 64.540000000000006 109.876 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.6 t -111.89 119.24 37.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.619 -0.718 . . . . 72.439999999999998 110.015 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 68' ' ' LEU . 5.8 mp -73.33 165.81 24.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 74.140000000000001 110.318 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 5' ' ' MET . 62.4 mtp180 -67.29 159.68 28.73 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.001 -0.545 . . . . 72.540000000000006 110.602 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.0 t70 58.4 49.52 10.72 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.842 0.829 . . . . 72.120000000000005 109.289 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -79.34 9.68 4.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.543 -0.753 . . . . 71.420000000000002 110.18 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.0 tp -60.65 -44.62 96.2 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.595 -0.891 . . . . 75.409999999999997 108.595 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.75 83.15 7.19 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.058 -0.974 . . . . 32.420000000000002 108.868 171.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.9 p -62.17 -33.37 74.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.664 -0.698 . . . . 74.239999999999995 110.901 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.02 70.0 3.09 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.51 -0.636 . . . . 72.519999999999996 111.51 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -73.88 -9.25 58.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.714 0.768 . . . . 73.200000000000003 110.304 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -134.07 142.23 13.68 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.744 -1.117 . . . . 61.109999999999999 110.799 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -83.06 145.9 29.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.874 0.369 . . . . 73.439999999999998 110.889 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.44 -63.7 1.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.825 -0.625 . . . . 74.109999999999999 110.38 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.559 -0.734 . . . . 63.520000000000003 109.706 179.752 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 112.281 -0.327 . . . . 64.540000000000006 112.281 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.88 -13.6 15.87 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.519 2.146 . . . . 72.439999999999998 112.226 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.43 124.79 2.58 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.214 -0.754 . . . . 52.530000000000001 111.214 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.4 m -83.59 176.25 9.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.767 0.318 . . . . 64.439999999999998 110.521 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 74.2 mmm -74.82 -41.2 60.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.185 0.517 . . . . 72.430000000000007 109.712 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.3 p -171.22 153.99 3.84 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.234 -0.894 . . . . 74.200000000000003 109.639 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.5 mm -71.73 -63.93 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.121 -0.696 . . . . 65.329999999999998 109.121 175.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -168.82 155.02 6.58 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.331 -0.85 . . . . 64.430000000000007 108.989 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.89 106.2 1.28 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.563 2.176 . . . . 71.439999999999998 111.987 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.524 ' HD1' ' HB3' ' A' ' 67' ' ' SER . 96.5 m-85 -68.15 116.99 9.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.784 -0.45 . . . . 72.319999999999993 109.784 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -94.34 -159.06 0.68 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.88 -0.6 . . . . 75.400000000000006 111.495 -173.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 67.87 33.3 4.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.036 0.535 . . . . 73.540000000000006 110.581 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.27 -23.99 67.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.212 -0.904 . . . . 74.530000000000001 111.393 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -96.72 14.93 23.33 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.755 -0.657 . . . . 73.329999999999998 111.703 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.91 -167.08 3.74 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 114.37 0.508 . . . . 55.210000000000001 114.37 -173.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.561 ' HB3' ' CB ' ' A' ' 54' ' ' GLU . 40.4 m -98.3 82.22 2.88 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.296 0.638 . . . . 71.319999999999993 110.011 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.759 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -163.72 128.7 2.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.569 -0.741 . . . . 74.209999999999994 112.643 -161.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.45 130.59 11.91 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.989 0.813 . . . . 74.439999999999998 109.834 153.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -162.85 138.3 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.053 0 CA-C-O 121.242 0.544 . . . . 65.329999999999998 111.045 170.546 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.586 ' HB2' ' CD1' ' A' ' 30' ' ' TRP . 32.3 tp -104.19 153.7 20.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.418 -0.81 . . . . 71.329999999999998 108.972 175.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 41' ' ' ARG . 9.7 p -136.67 134.23 48.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.952 0.406 . . . . 73.439999999999998 110.373 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -73.05 154.76 40.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.875 -0.787 . . . . 74.140000000000001 108.875 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -57.13 -23.91 50.53 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.082 0.468 . . . . 71.409999999999997 110.512 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.42 13.04 1.69 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.837 -0.619 . . . . 73.319999999999993 111.004 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 56.88 56.81 5.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.8 0.81 . . . . 73.299999999999997 110.696 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -114.74 119.89 38.21 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.709 -1.132 . . . . 54.009999999999998 108.896 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -76.08 132.29 39.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.673 -0.24 . . . . 74.109999999999999 110.502 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.8 m -153.74 178.12 10.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.012 0.434 . . . . 70.430000000000007 110.741 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.704 HD13 ' H ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -124.57 159.83 29.77 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.949 -0.76 . . . . 62.520000000000003 108.949 177.131 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.586 ' CD1' ' HB2' ' A' ' 20' ' ' LEU . 6.0 p-90 -145.13 139.49 15.15 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 121.041 -0.264 . . . . 73.310000000000002 111.59 -173.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 5.2 Cg_exo -80.14 104.9 1.71 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.072 2.515 . . . . 52.539999999999999 110.833 173.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.29 -2.08 1.98 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.467 0.543 . . . . 64.129999999999995 112.467 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -91.05 -0.14 57.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.474 0.178 . . . . 72.430000000000007 111.36 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.65 170.31 12.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.597 0.237 . . . . 42.140000000000001 110.903 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -69.44 126.39 29.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.887 -0.597 . . . . 74.129999999999995 110.08 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 t -97.61 113.25 63.22 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.756 -0.461 . . . . 74.219999999999999 109.756 -176.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 21.0 Cg_endo -60.64 107.23 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.982 2.454 . . . . 74.140000000000001 113.334 -172.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.89 151.82 0.42 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.447 0.699 . . . . 34.340000000000003 112.655 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.98 5.91 21.3 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.869 -0.605 . . . . 60.32 112.065 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.446 ' CD1' ' O ' ' A' ' 37' ' ' PRO . 18.4 p-90 -107.41 175.66 5.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 74.510000000000005 110.867 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.527 ' O ' HG12 ' A' ' 21' ' ' VAL . 15.0 tpp180 -141.61 142.98 33.44 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.26 -1.015 . . . . 63.219999999999999 108.26 170.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.2 p -90.68 131.2 38.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.013 -0.366 . . . . 60.219999999999999 110.013 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.448 HG21 ' CH2' ' A' ' 60' ' ' TRP . 10.1 m -99.47 -22.42 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.313 0.578 . . . . 73.329999999999998 110.313 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 17' ' ' PHE . 92.1 m-70 -147.63 118.72 7.72 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.224 -1.028 . . . . 73.349999999999994 108.224 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.04 165.4 7.1 Favored Glycine 0 C--N 1.332 0.35 0 O-C-N 123.807 0.692 . . . . 61.030000000000001 113.481 -172.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.45 151.35 24.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.143 0.497 . . . . 74.340000000000003 110.594 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -162.95 -177.98 5.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.948 -0.569 . . . . 73.409999999999997 110.465 -175.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -54.18 161.37 1.32 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.234 0.54 . . . . 61.520000000000003 112.01 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.687 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 46.1 ttt180 -57.12 -29.81 63.85 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.574 -0.739 . . . . 74.329999999999998 110.47 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -62.25 -47.3 84.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.939 0.4 . . . . 72.030000000000001 110.154 174.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.27 -31.4 71.7 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 116.173 -0.467 . . . . 52.32 111.544 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.687 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 16.6 p -73.51 -50.59 20.68 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.711 -0.677 . . . . 61.32 111.244 173.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.508 ' H ' ' HG ' ' A' ' 52' ' ' CYS . 78.6 mt -59.09 -34.66 72.25 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.414 0.626 . . . . 74.319999999999993 110.346 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.561 ' CB ' ' HB3' ' A' ' 16' ' ' SER . 20.2 mm-40 -76.94 -35.19 57.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.72 -0.673 . . . . 73.120000000000005 110.485 176.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.759 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -46.33 -52.68 12.31 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 117.847 0.294 . . . . 71.239999999999995 111.599 171.241 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.6 tt -71.18 -36.58 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.661 0.267 . . . . 72.140000000000001 111.61 -173.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -73.31 -50.46 22.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.149 0.499 . . . . 72.010000000000005 110.498 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -61.47 -27.58 68.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.598 -0.728 . . . . 74.420000000000002 109.041 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 64.45 80.38 0.23 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.396 -1.275 . . . . 71.519999999999996 112.179 171.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.448 ' CH2' HG21 ' A' ' 43' ' ' VAL . 3.3 t-105 51.76 79.26 0.35 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.504 -0.771 . . . . 74.230000000000004 111.126 175.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.496 ' HB2' HG12 ' A' ' 63' ' ' ILE . 49.7 Cg_endo -69.08 174.34 9.07 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.242 1.961 . . . . 74.040000000000006 111.726 176.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -79.84 -28.81 40.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.422 -0.214 . . . . 74.439999999999998 110.422 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.519 ' O ' HG13 ' A' ' 63' ' ' ILE . 40.0 pt -54.17 106.62 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.601 0.715 . . . . 44.5 110.728 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.423 ' HD3' ' HD3' ' A' ' 66' ' ' LYS . 6.4 ptp180 -133.35 133.32 22.69 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.878 -0.601 . . . . 72.230000000000004 110.972 -170.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -72.85 4.49 3.59 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.623 2.215 . . . . 62.119999999999997 111.767 173.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.423 ' HD3' ' HD3' ' A' ' 64' ' ' ARG . 55.7 mtpt -63.72 93.68 0.08 Allowed 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 109.496 -0.557 . . . . 64.540000000000006 109.496 175.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.524 ' HB3' ' HD1' ' A' ' 10' ' ' PHE . 28.0 p -148.65 178.4 8.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.768 -0.651 . . . . 72.439999999999998 109.822 -176.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.487 HD21 ' HD3' ' A' ' 71' ' ' LYS . 55.7 tp -115.88 118.68 33.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.635 -0.505 . . . . 74.140000000000001 109.635 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.05 -171.86 2.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 72.540000000000006 110.12 176.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.13 90.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 72.120000000000005 110.867 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.487 ' HD3' HD21 ' A' ' 68' ' ' LEU . 5.2 ttpm? -70.81 74.42 0.6 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.266 0.555 . . . . 71.420000000000002 109.51 176.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 29.4 tp -139.9 30.15 2.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.572 -0.74 . . . . 75.409999999999997 109.523 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.86 137.43 32.13 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.663 -0.699 . . . . 32.420000000000002 110.084 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.3 m -64.99 79.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.339 0.59 . . . . 74.239999999999995 111.615 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.27 103.61 1.24 Allowed Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 110.203 -1.159 . . . . 72.519999999999996 110.203 174.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.59 143.36 50.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.876 0.37 . . . . 73.200000000000003 110.404 -171.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -134.42 -169.34 11.97 Favored Glycine 0 C--N 1.316 -0.542 0 CA-C-N 115.485 -0.78 . . . . 61.109999999999999 111.187 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -130.7 151.21 51.4 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.154 0.502 . . . . 73.439999999999998 110.607 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -161.05 99.75 1.22 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.506 -0.77 . . . . 74.109999999999999 109.319 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.959 -0.543 . . . . 63.520000000000003 110.391 -174.973 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 111.945 -0.462 . . . . 64.540000000000006 111.945 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.43 145.5 30.09 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.979 2.453 . . . . 72.439999999999998 112.235 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.94 146.27 16.3 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.142 -0.783 . . . . 52.530000000000001 111.142 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.8 m -70.35 102.86 2.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.153 0.501 . . . . 64.439999999999998 110.723 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.402 ' CE ' ' HA ' ' A' ' 5' ' ' MET . 0.9 OUTLIER -98.86 -18.28 17.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.615 -0.72 . . . . 72.430000000000007 110.666 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 t -67.71 148.85 50.75 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.143 -0.481 . . . . 74.200000000000003 110.327 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.637 HD11 HD13 ' A' ' 72' ' ' LEU . 42.1 mm -80.31 73.99 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.992 -0.549 . . . . 65.329999999999998 111.059 -176.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 53.33 96.29 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.575 0 CA-C-N 115.547 -0.751 . . . . 64.430000000000007 111.39 173.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.85 55.77 2.83 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.186 2.591 . . . . 71.439999999999998 112.514 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -85.35 -6.65 59.22 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.821 0.344 . . . . 72.319999999999993 111.142 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -96.4 -28.79 14.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.021 0.438 . . . . 75.400000000000006 110.973 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -90.48 -35.7 14.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.894 -0.594 . . . . 73.540000000000006 111.823 -173.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -61.02 -26.84 67.9 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.316 0.579 . . . . 74.530000000000001 112.201 -173.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -73.15 -13.55 61.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.413 -0.812 . . . . 73.329999999999998 111.922 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.11 59.69 2.34 Favored Glycine 0 C--N 1.329 0.164 0 C-N-CA 121.073 -0.584 . . . . 55.210000000000001 112.152 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.626 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 5.6 m -141.68 118.33 11.01 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.967 -0.137 . . . . 71.319999999999993 110.712 -177.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.813 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -66.12 -159.7 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.637 0.256 . . . . 74.209999999999994 111.543 172.58 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.472 ' HB3' ' HA ' ' A' ' 46' ' ' GLU . 28.3 p90 -125.12 137.45 54.18 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.92 0.39 . . . . 74.439999999999998 110.434 -173.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.445 HG23 HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -155.14 142.86 12.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 121.567 0.699 . . . . 65.329999999999998 111.776 -178.73 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 30' ' ' TRP . 48.1 tp -105.25 147.99 27.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.194 -1.367 . . . . 71.329999999999998 108.8 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.6 144.42 28.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.13 0.49 . . . . 73.439999999999998 110.824 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -104.33 153.63 20.81 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.007 -0.738 . . . . 74.140000000000001 109.007 175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -57.59 -22.81 47.3 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.811 0.339 . . . . 71.409999999999997 111.087 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -77.9 15.4 0.88 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.15 -0.477 . . . . 73.319999999999993 111.577 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 67.11 15.81 10.15 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.135 0.574 . . . . 73.299999999999997 111.407 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -84.83 119.45 25.33 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.578 -0.527 . . . . 54.009999999999998 109.578 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -114.19 136.48 52.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.95 0.405 . . . . 74.109999999999999 111.191 -175.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -152.04 -172.12 4.13 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.213 -0.662 . . . . 70.430000000000007 109.213 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.8 pt? -109.04 139.37 44.02 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.452 -0.573 . . . . 62.520000000000003 109.452 174.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 20' ' ' LEU . 21.4 p-90 -98.62 155.03 37.2 Favored Pre-proline 0 C--O 1.236 0.345 0 CA-C-N 116.151 -0.477 . . . . 73.310000000000002 110.792 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.578 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 31.1 Cg_exo -62.2 96.16 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.45 2.1 . . . . 52.539999999999999 111.012 174.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.39 -23.76 62.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.884 -0.598 . . . . 64.129999999999995 111.692 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -95.3 17.44 14.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.112 -0.495 . . . . 72.430000000000007 110.894 -178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . . . -143.39 174.62 10.58 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.8 0.333 . . . . 42.140000000000001 110.762 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -92.21 139.88 30.18 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.057 -0.52 . . . . 74.129999999999995 110.244 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -76.06 130.91 76.85 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 74.219999999999999 110.603 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HG2' ' CD1' ' A' ' 40' ' ' TRP . 45.3 Cg_endo -68.52 167.02 23.75 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.454 2.102 . . . . 74.140000000000001 112.141 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.94 151.57 47.37 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.969 -0.56 . . . . 34.340000000000003 111.548 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.97 -35.85 4.13 Favored Glycine 0 C--N 1.33 0.232 0 CA-C-N 115.65 -0.705 . . . . 60.32 112.342 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.406 ' CD1' ' HG2' ' A' ' 37' ' ' PRO . 41.9 m95 -88.23 145.37 25.91 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.256 -0.276 . . . . 74.510000000000005 110.256 -177.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -127.87 128.82 45.85 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.147 -0.316 . . . . 63.219999999999999 110.147 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.9 t -80.98 137.6 21.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.985 -0.376 . . . . 60.219999999999999 109.985 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.445 HG13 HG23 ' A' ' 19' ' ' VAL . 8.1 p -107.15 -28.98 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.992 0.425 . . . . 73.329999999999998 110.839 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.674 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 1.7 m-70 -139.79 138.58 35.97 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.799 -0.445 . . . . 73.349999999999994 109.799 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.48 174.81 36.9 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 123.674 0.609 . . . . 61.030000000000001 113.367 -173.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -58.99 138.31 57.56 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.127 0.571 . . . . 74.340000000000003 111.185 -172.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -158.99 173.94 15.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.917 0.389 . . . . 73.409999999999997 111.493 -175.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -84.25 177.59 8.13 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.717 0.77 . . . . 61.520000000000003 112.894 -171.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.457 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 9.0 tpm_? -50.19 -44.29 52.9 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.331 -1.304 . . . . 74.329999999999998 111.143 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.31 -52.41 61.6 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 116.144 -0.48 . . . . 72.030000000000001 110.64 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.626 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -63.64 -31.04 72.09 Favored 'General case' 0 C--O 1.263 1.801 0 CA-C-O 121.819 0.818 . . . . 52.32 111.608 -178.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.813 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 73.2 m -72.58 -28.76 63.0 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 114.459 -1.246 . . . . 61.32 110.79 175.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.654 ' O ' HG22 ' A' ' 56' ' ' ILE . 92.6 mt -71.72 -51.96 20.2 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 108.81 -0.811 . . . . 74.319999999999993 108.81 169.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.17 -24.17 25.42 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.371 -0.831 . . . . 73.120000000000005 111.811 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.587 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -44.39 -31.25 1.0 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 121.118 -0.233 . . . . 71.239999999999995 111.276 171.27 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.654 HG22 ' O ' ' A' ' 53' ' ' LEU . 19.8 tt -60.16 -46.47 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.379 0.609 . . . . 72.140000000000001 110.455 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.458 ' N ' HG23 ' A' ' 56' ' ' ILE . 6.2 tp10 -74.37 -43.04 58.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.492 -0.776 . . . . 72.010000000000005 110.81 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -50.79 -58.89 4.84 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.302 -0.863 . . . . 74.420000000000002 111.956 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.2 m80 68.6 -72.24 0.1 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.671 -0.695 . . . . 71.519999999999996 111.285 -175.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.554 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 44.1 t-105 -172.64 -63.11 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 113.341 0.867 . . . . 74.230000000000004 113.341 -175.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 60' ' ' TRP . 50.2 Cg_endo -92.8 176.28 1.63 Allowed 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.47 2.113 . . . . 74.040000000000006 114.852 -164.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 69.39 9.83 7.46 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.834 -1.075 . . . . 74.439999999999998 112.626 172.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.3 pp -87.32 91.85 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.353 0.597 . . . . 44.5 112.006 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -115.45 92.67 33.59 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 109.44 -0.578 . . . . 72.230000000000004 109.44 173.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.01 -28.03 3.42 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.372 2.048 . . . . 62.119999999999997 113.607 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -79.67 108.3 13.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.472 0.653 . . . . 64.540000000000006 111.482 -173.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 p -142.96 112.45 6.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.946 -1.025 . . . . 72.439999999999998 109.201 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 68' ' ' LEU . 6.2 mp -69.46 -45.26 69.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.034 0.445 . . . . 74.140000000000001 111.035 -176.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -162.44 152.6 16.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.987 -0.745 . . . . 72.540000000000006 108.987 -177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.64 162.54 26.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.99 0.424 . . . . 72.120000000000005 110.41 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -108.54 16.5 22.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.425 0.631 . . . . 71.420000000000002 109.739 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.637 HD13 HD11 ' A' ' 7' ' ' ILE . 7.1 tt -85.75 -44.96 12.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.968 -0.56 . . . . 75.409999999999997 109.517 -179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.39 74.17 0.36 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.222 0.534 . . . . 32.420000000000002 110.522 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.4 m -86.03 -39.96 16.28 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.621 -0.718 . . . . 74.239999999999995 110.899 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.22 49.52 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.832 -0.699 . . . . 72.519999999999996 112.712 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -86.47 96.52 10.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.562 -0.533 . . . . 73.200000000000003 109.562 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.56 76.82 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.462 -0.655 . . . . 61.109999999999999 111.462 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -123.24 138.72 54.57 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.861 0.362 . . . . 73.439999999999998 110.102 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -148.72 99.7 3.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.919 -0.582 . . . . 74.109999999999999 109.902 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.453 -0.784 . . . . 63.520000000000003 109.546 179.529 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 112.15 -0.38 . . . . 64.540000000000006 112.15 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.56 -166.69 0.42 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.953 2.435 . . . . 72.439999999999998 112.309 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 111.78 2.53 27.08 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 116.229 -0.441 . . . . 52.530000000000001 112.114 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.5 m -78.73 161.77 26.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.711 0.291 . . . . 64.439999999999998 111.115 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 5' ' ' MET . 0.0 OUTLIER -75.03 -20.25 59.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.055 0.455 . . . . 72.430000000000007 110.176 176.188 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.7 p -144.15 121.14 11.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.46 -0.791 . . . . 74.200000000000003 109.782 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.7 mt -100.04 -90.99 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 110.325 -0.25 . . . . 65.329999999999998 110.325 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 24.8 m120 -152.02 146.48 18.63 Favored Pre-proline 0 N--CA 1.468 0.465 0 N-CA-C 109.545 -0.539 . . . . 64.430000000000007 109.545 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.03 79.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.009 2.472 . . . . 71.439999999999998 113.508 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -131.94 97.53 4.2 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.013 -1.106 . . . . 72.319999999999993 108.013 171.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -142.22 141.8 32.57 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.945 0.72 . . . . 75.400000000000006 112.945 -170.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -162.57 80.27 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.156 -1.424 . . . . 73.540000000000006 107.156 168.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.528 ' HA ' ' NH1' ' A' ' 64' ' ' ARG . 12.1 t70 -65.78 -6.63 12.4 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.113 -0.949 . . . . 74.530000000000001 112.503 -167.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -68.51 -20.27 64.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.075 -0.512 . . . . 73.329999999999998 110.61 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -156.08 119.74 0.94 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.649 -0.58 . . . . 55.210000000000001 111.649 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.601 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 30.2 m -151.31 123.13 8.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.536 0.168 . . . . 71.319999999999993 111.054 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.626 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -64.53 -174.05 0.12 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.596 1.332 . . . . 74.209999999999994 114.596 179.355 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 38.9 p90 -126.48 136.2 52.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 113.924 -1.489 . . . . 74.439999999999998 109.766 -176.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 43' ' ' VAL . 54.3 t -147.75 131.44 8.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-O 121.053 0.454 . . . . 65.329999999999998 110.1 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 40' ' ' TRP . 64.9 tp -102.97 137.66 40.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.753 -0.658 . . . . 71.329999999999998 110.851 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.1 t -113.04 152.78 14.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.127 -1.064 . . . . 73.439999999999998 108.127 171.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.696 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 34.6 t30 -123.57 144.72 49.4 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.572 -0.899 . . . . 74.140000000000001 108.572 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -68.5 -7.85 35.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.014 0.435 . . . . 71.409999999999997 110.504 -177.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 29.2 tt0 -75.39 4.09 7.93 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.329 -0.85 . . . . 73.319999999999993 109.893 168.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 47.6 mt-10 74.16 15.72 3.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.854 0.862 . . . . 73.299999999999997 111.693 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.696 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 6.2 tp-100 -76.6 148.75 36.77 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.212 -0.662 . . . . 54.009999999999998 109.212 172.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -150.77 114.36 4.93 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.661 0.267 . . . . 74.109999999999999 110.626 -177.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.5 t -171.75 175.72 3.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.143 -0.481 . . . . 70.430000000000007 109.752 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.689 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.5 pt? -80.79 160.14 24.94 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.456 -0.572 . . . . 62.520000000000003 109.456 175.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 23.7 p-90 -126.46 132.84 24.47 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.65 0.262 . . . . 73.310000000000002 110.996 -174.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 12.6 Cg_exo -70.46 107.27 1.96 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.435 2.09 . . . . 52.539999999999999 111.549 177.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.04 -8.92 8.44 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.24 -0.436 . . . . 64.129999999999995 111.78 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -81.66 -10.86 59.3 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.307 -0.406 . . . . 72.430000000000007 110.606 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.36 166.33 11.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.231 -0.441 . . . . 42.140000000000001 110.577 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.64 134.29 35.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.055 -0.521 . . . . 74.129999999999995 109.705 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.508 HG12 ' NE1' ' A' ' 40' ' ' TRP . 2.5 t -95.47 104.09 14.63 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 110.078 -0.341 . . . . 74.219999999999999 110.078 -176.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 42.9 Cg_endo -67.2 114.42 3.21 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.982 2.455 . . . . 74.140000000000001 113.116 -174.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -44.48 152.49 0.2 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.727 0.811 . . . . 34.340000000000003 113.156 -173.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.1 12.65 10.81 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.747 -0.661 . . . . 60.32 111.468 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.508 ' NE1' HG12 ' A' ' 36' ' ' VAL . 10.4 p-90 -115.78 -172.53 2.18 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.912 0.485 . . . . 74.510000000000005 110.85 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -161.77 125.91 3.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.334 -0.848 . . . . 63.219999999999999 109.243 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.419 HG22 HD13 ' A' ' 20' ' ' LEU . 6.1 t -90.63 148.04 4.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.603 -0.271 . . . . 60.219999999999999 111.05 -171.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 19' ' ' VAL . 8.9 p -93.69 -34.26 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 109.508 -0.553 . . . . 73.329999999999998 109.508 173.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.441 ' ND1' ' O ' ' A' ' 17' ' ' PHE . 64.2 t-80 -158.31 132.14 7.8 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.434 -0.58 . . . . 73.349999999999994 109.434 173.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.754 ' HA3' ' HA2' ' A' ' 75' ' ' GLY . . . -76.66 -168.67 28.68 Favored Glycine 0 C--N 1.334 0.417 0 O-C-N 123.712 0.632 . . . . 61.030000000000001 114.021 -175.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 76' ' ' ARG . 6.7 mp0 -45.19 154.86 0.14 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.451 1.1 . . . . 74.340000000000003 113.449 -170.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' A' ' 51' ' ' ALA . . . -157.79 162.49 38.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.597 -0.729 . . . . 73.409999999999997 111.707 -176.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.96 166.14 21.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.533 -0.758 . . . . 61.520000000000003 110.296 175.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.464 HH11 HD12 ' A' ' 53' ' ' LEU . 7.0 tmm_? -53.83 -45.3 70.83 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.311 -0.404 . . . . 74.329999999999998 110.499 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.92 -42.81 80.64 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 116.207 -0.451 . . . . 72.030000000000001 110.703 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.601 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -66.67 -34.46 77.91 Favored 'General case' 0 C--O 1.273 2.324 0 CA-C-O 122.295 1.045 . . . . 52.32 111.616 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.626 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 36.1 t -66.17 -36.77 83.97 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 113.528 -1.669 . . . . 61.32 109.773 175.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.617 ' O ' HG22 ' A' ' 56' ' ' ILE . 79.8 mt -71.76 -39.8 69.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 74.319999999999993 110.183 171.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -60.92 -25.2 66.58 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 122.905 0.482 . . . . 73.120000000000005 111.224 -176.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.588 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -45.63 -24.91 0.39 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.319 0.387 . . . . 71.239999999999995 111.344 170.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 53' ' ' LEU . 17.0 tt -64.62 -49.38 80.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.082 0.467 . . . . 72.140000000000001 110.277 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.517 ' N ' HG23 ' A' ' 56' ' ' ILE . 9.5 tp10 -74.01 -42.51 60.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.315 -0.857 . . . . 72.010000000000005 111.049 -175.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.512 ' HG2' ' HA ' ' A' ' 55' ' ' TYR . 16.3 pt-20 -78.46 -37.98 42.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 74.420000000000002 111.269 -176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.1 p80 36.57 75.19 0.07 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.772 0.829 . . . . 71.519999999999996 112.261 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 53.5 m95 59.89 81.06 0.25 Allowed Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.844 -0.616 . . . . 74.230000000000004 109.788 -175.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.486 ' HB3' ' HB2' ' A' ' 58' ' ' GLU . 71.0 Cg_endo -80.53 177.2 8.36 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.004 2.469 . . . . 74.040000000000006 113.156 -174.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 8' ' ' ASN . 28.2 t70 -82.3 160.72 22.83 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.465 -0.789 . . . . 74.439999999999998 110.615 177.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.559 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.4 mp -73.99 86.12 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.742 -0.836 . . . . 44.5 108.742 177.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.528 ' NH1' ' HA ' ' A' ' 13' ' ' ASP . 51.5 mtt180 -58.77 152.6 47.0 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 114.704 -1.135 . . . . 72.230000000000004 111.838 -173.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -41.61 -48.56 5.6 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.647 2.898 . . . . 62.119999999999997 114.187 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -75.94 -25.89 56.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.806 0.336 . . . . 64.540000000000006 111.306 -175.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -96.16 13.28 27.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.172 -0.467 . . . . 72.439999999999998 109.746 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.431 ' HA ' HG22 ' A' ' 63' ' ' ILE . 2.2 tm? -65.52 90.96 0.12 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.452 0.644 . . . . 74.140000000000001 109.333 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . 1.9 mmp_? -133.77 30.39 3.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.09 -0.959 . . . . 72.540000000000006 108.873 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 72' ' ' LEU . 14.7 m-20 55.42 49.31 17.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.089 -0.96 . . . . 72.120000000000005 110.341 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.468 ' NZ ' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 60.31 -37.4 0.09 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.502 1.521 . . . . 71.420000000000002 113.513 -178.219 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.428 ' H ' ' C ' ' A' ' 70' ' ' ASP . 49.3 tp -61.54 -40.79 95.96 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.131 -0.356 . . . . 75.409999999999997 111.47 -163.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . . . -107.68 127.63 53.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.949 -0.568 . . . . 32.420000000000002 110.753 -177.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.8 t -176.09 103.64 0.07 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.985 -0.552 . . . . 74.239999999999995 109.935 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.754 ' HA2' ' HA3' ' A' ' 45' ' ' GLY . . . -142.61 -171.28 13.19 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 116.105 -0.498 . . . . 72.519999999999996 112.605 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.622 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 20.8 ttm-85 -143.36 132.95 23.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.735 0.302 . . . . 73.200000000000003 110.437 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -155.34 96.64 0.16 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 61.109999999999999 112.338 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -122.89 165.68 16.27 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.756 -0.461 . . . . 73.439999999999998 109.756 177.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -144.0 108.42 4.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.45 0.643 . . . . 74.109999999999999 109.575 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 . . . . . 0 C--O 1.251 1.168 0 CA-C-N 115.455 -0.793 . . . . 63.520000000000003 109.461 177.801 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 111.917 -0.473 . . . . 64.540000000000006 111.917 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.38 163.84 26.97 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.039 2.493 . . . . 72.439999999999998 112.414 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.91 91.97 1.43 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 111.409 -0.676 . . . . 52.530000000000001 111.409 175.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.0 m -51.99 121.95 7.58 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.537 0.569 . . . . 64.439999999999998 112.537 -176.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 23.9 mtp -69.93 -36.06 75.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.725 -0.671 . . . . 72.430000000000007 109.609 171.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.9 p -55.1 159.07 2.63 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 114.415 -1.266 . . . . 74.200000000000003 113.013 -174.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.5 mt -104.42 105.54 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.846 -1.07 . . . . 65.329999999999998 108.704 172.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.576 ' N ' ' HD2' ' A' ' 9' ' ' PRO . 81.1 m-20 -79.26 -40.53 1.5 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.293 -0.412 . . . . 64.430000000000007 112.011 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 8' ' ' ASN . 52.1 Cg_endo -70.08 108.71 2.2 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.634 1.556 . . . . 71.439999999999998 112.375 175.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -85.47 -81.9 0.19 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.776 -0.453 . . . . 72.319999999999993 109.776 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -105.38 57.58 0.68 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.633 -1.247 . . . . 75.400000000000006 107.633 174.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.486 ' HA ' HD21 ' A' ' 29' ' ' LEU . 23.6 t70 -134.33 -108.71 0.22 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.798 -1.092 . . . . 73.540000000000006 110.911 -169.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -54.17 -31.78 53.67 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.274 0.63 . . . . 74.530000000000001 112.317 -177.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -93.13 15.07 16.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.089 -0.505 . . . . 73.329999999999998 111.682 -173.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.36 -176.11 40.4 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.101 -0.571 . . . . 55.210000000000001 112.177 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.684 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 49.4 m -62.17 157.94 18.07 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.731 0.265 . . . . 71.319999999999993 110.479 177.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.81 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 24.8 t80 -68.28 102.43 1.38 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 119.024 -1.07 . . . . 74.209999999999994 109.502 173.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 29' ' ' LEU . 54.2 p90 -150.39 131.51 14.42 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.004 -1.48 . . . . 74.439999999999998 107.004 169.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 48.9 t -143.06 131.77 20.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.84 -0.344 . . . . 65.329999999999998 110.256 -169.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -120.91 123.57 42.82 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.263 -0.643 . . . . 71.329999999999998 109.263 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.3 m -112.19 125.97 69.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.444 0.64 . . . . 73.439999999999998 109.778 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.675 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 14.4 m120 -84.06 146.65 27.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.598 -0.728 . . . . 74.140000000000001 109.485 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -56.33 -23.35 36.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.029 0.443 . . . . 71.409999999999997 111.203 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -87.36 23.2 1.93 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.045 -0.525 . . . . 73.319999999999993 110.906 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 67.84 21.01 9.21 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.74 0.816 . . . . 73.299999999999997 112.391 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.675 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 15.6 mm-40 -83.43 117.96 23.41 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.011 -0.366 . . . . 54.009999999999998 110.011 175.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -92.92 116.82 29.39 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.364 -0.606 . . . . 74.109999999999999 109.364 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -152.9 -172.84 4.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.231 0.539 . . . . 70.430000000000007 110.758 -174.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.486 HD21 ' HA ' ' A' ' 12' ' ' ASP . 2.4 pp -125.72 -174.78 3.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.69 -0.686 . . . . 62.520000000000003 109.196 174.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.4 p-90 -145.3 128.78 8.49 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 110.122 -0.325 . . . . 73.310000000000002 110.122 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.52 130.62 41.04 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.457 2.104 . . . . 52.539999999999999 111.369 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.67 12.48 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.9 0.704 . . . . 64.129999999999995 112.9 -173.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -81.72 -27.37 33.94 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.712 0.292 . . . . 72.430000000000007 111.052 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.04 155.12 37.59 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.996 0.427 . . . . 42.140000000000001 111.17 -176.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -94.91 139.71 30.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.057 -0.52 . . . . 74.129999999999995 109.823 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.2 t -79.9 111.37 21.12 Favored Pre-proline 0 C--O 1.235 0.305 0 N-CA-C 110.006 -0.368 . . . . 74.219999999999999 110.006 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.11 133.44 57.71 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.666 2.244 . . . . 74.140000000000001 112.03 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.9 135.7 57.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.999 -0.546 . . . . 34.340000000000003 110.763 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.02 -24.83 11.31 Favored Glycine 0 C--O 1.235 0.201 0 C-N-CA 121.315 -0.469 . . . . 60.32 112.171 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -91.27 154.67 19.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.839 -0.8 . . . . 74.510000000000005 108.839 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -110.02 125.97 53.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.919 0.39 . . . . 63.219999999999999 110.141 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.1 p -91.87 122.99 43.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.98 0.419 . . . . 60.219999999999999 110.68 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 58.4 t -72.94 -41.05 60.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.261 0.553 . . . . 73.329999999999998 109.561 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.425 ' HE1' ' HB2' ' A' ' 47' ' ' ALA . 49.2 t-80 -160.96 141.89 11.57 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.492 -0.777 . . . . 73.349999999999994 109.24 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.08 -170.68 47.25 Favored Glycine 0 N--CA 1.452 -0.297 0 O-C-N 123.598 0.561 . . . . 61.030000000000001 112.617 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.17 140.31 21.38 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.063 0.545 . . . . 74.340000000000003 110.583 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.425 ' HB2' ' HE1' ' A' ' 44' ' ' HIS . . . -143.57 -178.32 5.83 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.429 0.529 . . . . 73.409999999999997 112.429 -170.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -91.66 179.72 5.57 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.324 -0.853 . . . . 61.520000000000003 112.213 -173.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.534 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 4.4 tmt_? -60.93 -40.82 94.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.428 -0.805 . . . . 74.329999999999998 111.734 -177.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.65 -36.05 81.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.144 0.497 . . . . 72.030000000000001 109.729 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 17' ' ' PHE . . . -68.31 -30.71 69.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.576 -0.738 . . . . 52.32 110.532 175.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 53.9 t -59.43 -47.59 84.88 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.356 -0.609 . . . . 61.32 109.356 170.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.503 HD11 ' NH1' ' A' ' 49' ' ' ARG . 85.5 mt -57.88 -32.76 68.02 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.6 -0.727 . . . . 74.319999999999993 110.689 177.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.54 -53.53 22.44 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.341 -0.39 . . . . 73.120000000000005 110.728 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.81 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 40.4 t80 -64.59 -43.83 92.59 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.991 0.367 . . . . 71.239999999999995 111.991 -173.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 52' ' ' CYS . 12.4 tt -64.11 -39.83 86.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.121 0.486 . . . . 72.140000000000001 110.978 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -73.52 -35.31 65.56 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.078 -0.51 . . . . 72.010000000000005 110.537 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -65.24 -38.72 91.24 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.285 -0.635 . . . . 74.420000000000002 109.285 171.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 54.3 54.86 8.88 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.711 -1.131 . . . . 71.519999999999996 110.584 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.471 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 1.7 t90 -53.24 -45.45 98.34 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.477 -0.783 . . . . 74.230000000000004 110.584 -178.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 60' ' ' TRP . 10.4 Cg_exo -72.24 102.52 1.38 Allowed 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.665 1.577 . . . . 74.040000000000006 110.637 170.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 64' ' ' ARG . 32.2 t70 -57.67 -54.03 51.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 74.439999999999998 110.399 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.731 HG13 ' H ' ' A' ' 64' ' ' ARG . 25.6 pt 42.39 -72.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.91 1.284 . . . . 44.5 113.637 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.731 ' H ' HG13 ' A' ' 63' ' ' ILE . 31.8 ttm-85 -160.95 92.22 1.53 Allowed Pre-proline 0 C--O 1.238 0.48 0 N-CA-C 109.688 -0.486 . . . . 72.230000000000004 109.688 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.22 85.47 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.841 2.361 . . . . 62.119999999999997 111.671 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -77.85 -5.62 51.51 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.998 -0.546 . . . . 64.540000000000006 111.016 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.3 m 62.28 -75.77 0.03 OUTLIER 'General case' 0 C--O 1.234 0.248 0 O-C-N 123.622 0.576 . . . . 72.439999999999998 109.572 -171.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.81 110.47 3.82 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.694 -0.854 . . . . 74.140000000000001 108.694 171.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -62.0 -35.61 79.04 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.937 -0.574 . . . . 72.540000000000006 110.385 -175.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -126.89 160.76 30.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.211 -0.663 . . . . 72.120000000000005 109.211 171.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -114.71 55.06 0.76 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.124 0.488 . . . . 71.420000000000002 110.085 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.6 tp -138.72 -36.24 0.56 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.102 -0.499 . . . . 75.409999999999997 110.723 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.34 92.93 0.82 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.154 0.502 . . . . 32.420000000000002 111.287 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.7 p -77.43 96.89 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.804 -0.635 . . . . 74.239999999999995 110.225 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.87 -173.71 23.26 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.107 -0.568 . . . . 72.519999999999996 112.049 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -70.0 83.13 0.5 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.72 0.295 . . . . 73.200000000000003 110.598 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.57 -55.73 4.9 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.512 -0.635 . . . . 61.109999999999999 111.512 177.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.9 t80 72.69 -38.23 0.41 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.714 0.806 . . . . 73.439999999999998 112.369 176.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.88 80.66 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 122.057 0.932 . . . . 74.109999999999999 110.836 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.166 -1.379 . . . . 63.520000000000003 109.72 174.191 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 111.998 -0.441 . . . . 64.540000000000006 111.998 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.56 -164.89 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.915 2.41 . . . . 72.439999999999998 112.117 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.87 -51.78 4.62 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.927 -0.654 . . . . 52.530000000000001 111.701 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.4 m -65.28 103.25 0.76 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.807 -0.442 . . . . 64.439999999999998 109.807 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 71' ' ' LYS . 39.3 tpp -54.2 -64.84 0.7 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.179 -0.464 . . . . 72.430000000000007 111.438 -176.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.6 m -157.51 115.75 3.16 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.828 -0.624 . . . . 74.200000000000003 109.722 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.53 88.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.11 0.481 . . . . 65.329999999999998 110.35 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -105.06 114.96 63.11 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.961 -0.563 . . . . 64.430000000000007 110.604 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.5 77.26 0.99 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.208 1.938 . . . . 71.439999999999998 110.483 171.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.505 ' HA ' HD12 ' A' ' 63' ' ' ILE . 42.6 p90 -75.46 158.1 33.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.371 -0.831 . . . . 72.319999999999993 110.753 -176.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 62' ' ' ASP . 27.0 t0 -99.95 152.41 20.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.208 -0.664 . . . . 75.400000000000006 109.208 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -90.73 45.58 1.27 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.485 0.66 . . . . 73.540000000000006 109.694 -174.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.59 -74.81 0.28 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.664 0.987 . . . . 74.530000000000001 113.664 -167.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -68.8 -30.37 68.93 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.045 0.387 . . . . 73.329999999999998 112.045 -167.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.612 ' HA2' ' CZ ' ' A' ' 17' ' ' PHE . . . 88.59 37.07 7.63 Favored Glycine 0 C--O 1.22 -0.763 0 C-N-CA 120.739 -0.743 . . . . 55.210000000000001 112.283 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.629 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 11.2 m -73.87 49.67 0.33 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.003 0.43 . . . . 71.319999999999993 110.606 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.687 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 3.4 p90 -162.82 143.25 9.52 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.278 1.214 . . . . 74.209999999999994 114.278 -162.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -151.15 130.5 12.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.333 -1.729 . . . . 74.439999999999998 106.333 148.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.6 HG22 ' CE1' ' A' ' 55' ' ' TYR . 17.3 t -151.87 122.25 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 112.373 0.509 . . . . 65.329999999999998 112.373 -168.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 54.5 tp -96.42 144.83 26.19 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.621 -0.718 . . . . 71.329999999999998 109.785 174.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.68 126.1 64.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.278 0.561 . . . . 73.439999999999998 110.008 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.406 ' ND2' ' HZ3' ' A' ' 40' ' ' TRP . 1.1 m-20 -77.47 144.77 37.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.439 -0.8 . . . . 74.140000000000001 109.633 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -58.4 -17.85 23.59 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.802 0.811 . . . . 71.409999999999997 109.683 172.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.56 0.96 9.06 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.76 -1.109 . . . . 73.319999999999993 111.04 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 72.69 14.36 5.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.411 0.684 . . . . 73.299999999999997 111.035 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -90.05 161.31 15.89 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.546 -0.909 . . . . 54.009999999999998 108.546 172.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -152.33 140.85 20.71 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.186 0.448 . . . . 74.109999999999999 111.253 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -168.22 -166.27 0.69 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.552 -0.536 . . . . 70.430000000000007 109.552 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.809 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.1 pt? -94.44 161.65 14.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.691 0.281 . . . . 62.520000000000003 110.461 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -138.25 147.3 55.19 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.43 -0.35 . . . . 73.310000000000002 110.65 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.15 116.9 4.72 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.488 2.125 . . . . 52.539999999999999 111.543 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.0 -21.29 64.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.279 -0.418 . . . . 64.129999999999995 111.655 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -81.43 -20.16 40.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.855 0.359 . . . . 72.430000000000007 110.524 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.97 150.62 23.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.367 -0.379 . . . . 42.140000000000001 110.439 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -95.37 111.64 23.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.659 -0.497 . . . . 74.129999999999995 109.659 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.482 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.1 p -81.49 120.4 78.0 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.361 -0.381 . . . . 74.219999999999999 110.936 -176.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 5.9 Cg_exo -75.57 173.1 15.07 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.401 2.734 . . . . 74.140000000000001 113.107 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.42 152.35 44.12 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.957 -0.565 . . . . 34.340000000000003 110.911 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.54 -28.55 11.85 Favored Glycine 0 C--N 1.329 0.186 0 N-CA-C 110.935 -0.866 . . . . 60.32 110.935 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.406 ' HZ3' ' ND2' ' A' ' 22' ' ' ASN . 11.7 m95 -105.09 98.67 8.35 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.075 -1.083 . . . . 74.510000000000005 108.075 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -99.59 126.34 45.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.855 0.36 . . . . 63.219999999999999 111.3 -172.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 8.5 p -82.94 119.76 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.117 -0.492 . . . . 60.219999999999999 109.907 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.08 -26.87 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.527 0.679 . . . . 73.329999999999998 110.059 -175.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -131.96 107.18 8.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.218 -0.901 . . . . 73.349999999999994 108.652 174.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.55 173.26 5.72 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.19 -0.914 . . . . 61.030000000000001 114.453 -169.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.92 137.27 58.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.772 -0.714 . . . . 74.340000000000003 110.061 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.85 -177.97 6.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.678 0.275 . . . . 73.409999999999997 111.138 -174.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 7.7 m-20 -58.08 160.45 4.88 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.685 -0.689 . . . . 61.520000000000003 112.178 -175.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.514 ' O ' ' SG ' ' A' ' 52' ' ' CYS . 6.6 ttm180 -53.87 -44.18 70.2 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.477 -0.783 . . . . 74.329999999999998 110.004 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.69 -33.79 74.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.099 0.476 . . . . 72.030000000000001 110.539 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 15' ' ' GLY . . . -66.52 -42.22 87.6 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-N 115.751 -0.659 . . . . 52.32 111.059 -178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 49' ' ' ARG . 30.0 p -73.54 -35.79 65.57 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.66 -1.154 . . . . 61.32 111.233 174.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 60.0 mt -65.12 -34.75 79.15 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.363 -0.381 . . . . 74.319999999999993 110.222 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 16' ' ' SER . 0.4 OUTLIER -77.19 -37.24 54.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.239 -0.437 . . . . 73.120000000000005 110.504 173.754 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.687 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 23.2 t80 -46.35 -45.24 17.53 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.324 0.49 . . . . 71.239999999999995 112.324 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 53' ' ' LEU . 11.5 tt -63.48 -39.35 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 120.491 -0.484 . . . . 72.140000000000001 111.326 -176.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -73.78 -43.21 59.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.625 0.25 . . . . 72.010000000000005 110.973 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 69.5 mm-40 -77.7 -41.12 39.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 111.758 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 95.2 m-70 83.06 -11.27 0.96 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.428 1.091 . . . . 71.519999999999996 113.076 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.479 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 43.1 t-105 -175.45 -55.39 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.06 0.393 . . . . 74.230000000000004 112.06 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 60' ' ' TRP . 74.0 Cg_endo -74.08 179.67 5.53 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.206 1.937 . . . . 74.040000000000006 112.657 -174.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 27.2 t70 -114.05 -46.61 3.0 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.942 -0.572 . . . . 74.439999999999998 110.988 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 10' ' ' PHE . 53.7 mt -61.09 114.59 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.44 -0.578 . . . . 44.5 109.44 177.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.433 ' H ' ' CD ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -92.87 113.72 60.54 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.717 -0.674 . . . . 72.230000000000004 111.371 -166.404 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 63' ' ' ILE . 15.8 Cg_exo -68.83 -27.43 31.14 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.108 1.872 . . . . 62.119999999999997 109.254 166.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.8 tptp 60.1 14.38 4.42 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 114.554 -1.203 . . . . 64.540000000000006 111.261 175.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.8 p -149.89 162.98 39.26 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.253 -0.43 . . . . 72.439999999999998 110.193 -177.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.9 tp -67.31 93.44 0.32 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.367 -0.379 . . . . 74.140000000000001 111.619 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -95.49 104.36 16.26 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.486 -0.931 . . . . 72.540000000000006 108.486 170.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -114.97 145.08 42.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.1 0.476 . . . . 72.120000000000005 111.138 -175.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.605 ' HA ' ' HE3' ' A' ' 71' ' ' LYS . 1.5 tpmt? -118.47 9.41 12.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.227 -0.897 . . . . 71.420000000000002 109.174 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.564 ' HG ' HG23 ' A' ' 74' ' ' THR . 42.8 tp -134.95 75.53 1.58 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.492 -0.776 . . . . 75.409999999999997 109.916 -170.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.35 80.87 7.66 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.457 -0.792 . . . . 32.420000000000002 109.917 174.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.564 HG23 ' HG ' ' A' ' 72' ' ' LEU . 22.7 p -67.52 -31.0 70.81 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.044 -0.525 . . . . 74.239999999999995 111.133 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.25 -144.23 34.26 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.927 -0.579 . . . . 72.519999999999996 112.11 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 40.4 ttt85 -139.59 25.15 2.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.428 0.632 . . . . 73.200000000000003 110.001 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.76 63.19 1.28 Allowed Glycine 0 CA--C 1.516 0.134 0 CA-C-N 115.796 -0.638 . . . . 61.109999999999999 111.775 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -90.61 147.68 23.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.625 0.25 . . . . 73.439999999999998 110.799 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.82 -53.58 14.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.906 -0.588 . . . . 74.109999999999999 110.35 177.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 C--O 1.252 1.235 0 CA-C-O 118.259 -0.877 . . . . 63.520000000000003 108.838 -178.428 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.807 0 N-CA-C 111.719 -0.552 . . . . 64.540000000000006 111.719 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.03 132.3 6.2 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.496 2.131 . . . . 72.439999999999998 112.848 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.95 56.57 3.32 Favored Glycine 0 CA--C 1.511 -0.182 0 N-CA-C 110.144 -1.182 . . . . 52.530000000000001 110.144 171.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.2 p -80.78 117.79 21.75 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.717 0.636 . . . . 64.439999999999998 112.717 -169.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.2 ttm -81.88 -55.25 4.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.898 -1.149 . . . . 72.430000000000007 107.898 167.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 p -162.74 111.97 1.38 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.105 -1.407 . . . . 74.200000000000003 109.214 174.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.2 mt -80.85 -64.66 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.537 -0.301 . . . . 65.329999999999998 110.323 -176.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.48 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 58.1 t30 179.27 -47.82 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 115.579 -0.737 . . . . 64.430000000000007 110.337 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 8' ' ' ASN . 96.0 Cg_endo -83.26 176.28 7.51 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.916 1.744 . . . . 71.439999999999998 111.41 172.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 68.17 91.23 0.09 Allowed 'General case' 0 C--O 1.24 0.561 0 O-C-N 123.58 0.55 . . . . 72.319999999999993 110.493 -177.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 174.41 161.66 0.19 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.859 -1.064 . . . . 75.400000000000006 109.497 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -170.19 148.32 3.3 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.195 -0.457 . . . . 73.540000000000006 110.41 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.91 -60.16 3.74 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.884 -0.598 . . . . 74.530000000000001 111.661 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -82.54 -21.74 35.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.371 0.605 . . . . 73.329999999999998 110.073 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.49 73.3 1.28 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.202 -1.159 . . . . 55.210000000000001 110.202 -173.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.562 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 58.0 m -58.15 105.86 0.32 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 122.267 1.032 . . . . 71.319999999999993 110.617 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.736 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 38.4 m-85 -166.8 100.94 0.56 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 112.902 -1.954 . . . . 74.209999999999994 107.93 -162.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.63 ' CE2' ' HB1' ' A' ' 51' ' ' ALA . 98.1 m-85 -151.83 130.54 12.35 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 121.843 2.11 . . . . 74.439999999999998 109.871 172.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -164.22 143.29 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 112.559 0.577 . . . . 65.329999999999998 112.559 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.8 tp -102.3 123.6 46.4 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.575 -0.898 . . . . 71.329999999999998 108.575 165.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.58 125.83 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 73.439999999999998 110.15 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 3.8 m-20 -97.53 158.34 15.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.419 -0.355 . . . . 74.140000000000001 110.435 -178.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.25 -20.54 59.37 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.705 0.764 . . . . 71.409999999999997 109.816 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -76.49 9.56 2.63 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.8 -1.091 . . . . 73.319999999999993 111.143 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 67.86 15.37 9.58 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.304 0.642 . . . . 73.299999999999997 111.09 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.411 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 80.6 mm-40 -78.06 146.42 35.28 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.789 -0.819 . . . . 54.009999999999998 108.789 173.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -153.48 102.54 2.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.022 -0.362 . . . . 74.109999999999999 110.022 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.3 t -170.86 -170.1 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.823 -0.626 . . . . 70.430000000000007 110.096 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.452 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.4 mp -80.65 166.26 21.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.771 -0.65 . . . . 62.520000000000003 110.67 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.504 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 17.3 p-90 -143.36 155.29 61.13 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.521 -0.309 . . . . 73.310000000000002 111.11 -175.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.6 95.72 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.5 2.133 . . . . 52.539999999999999 111.585 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -67.42 -18.31 65.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.657 -0.701 . . . . 64.129999999999995 112.004 -175.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -81.58 -20.84 39.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 72.430000000000007 110.709 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.13 176.38 6.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 42.140000000000001 110.837 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.46 138.57 37.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.944 -0.571 . . . . 74.129999999999995 109.873 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.617 HG22 ' NE1' ' A' ' 40' ' ' TRP . 7.4 p -104.46 129.77 24.45 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 109.968 -0.382 . . . . 74.219999999999999 109.968 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.511 ' O ' ' NE1' ' A' ' 40' ' ' TRP . 77.7 Cg_endo -76.4 -169.43 0.7 Allowed 'Trans proline' 0 N--CA 1.481 0.778 0 C-N-CA 123.125 2.55 . . . . 74.140000000000001 114.299 -171.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.95 152.43 24.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.92 -0.582 . . . . 34.340000000000003 111.14 171.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.0 27.18 7.51 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.741 -0.743 . . . . 60.32 114.42 168.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.617 ' NE1' HG22 ' A' ' 36' ' ' VAL . 48.2 p-90 -130.36 174.63 9.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.337 0.589 . . . . 74.510000000000005 111.213 176.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -154.66 125.92 7.32 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.964 -1.124 . . . . 63.219999999999999 107.964 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.87 131.93 36.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.735 -0.469 . . . . 60.219999999999999 109.735 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.3 t -91.29 -23.99 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.655 0.74 . . . . 73.329999999999998 109.56 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.443 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -171.06 131.24 0.79 Allowed 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.605 -1.18 . . . . 73.349999999999994 107.928 174.244 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 18' ' ' PHE . . . -73.41 139.91 27.44 Favored Glycine 0 C--N 1.338 0.642 0 O-C-N 124.333 1.021 . . . . 61.030000000000001 114.089 -167.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -25.89 124.63 0.06 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.015 1.326 . . . . 74.340000000000003 114.539 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.492 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . . . -131.65 -176.98 4.22 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.015 -0.993 . . . . 73.409999999999997 109.419 175.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -52.57 153.01 3.29 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.267 0.556 . . . . 61.520000000000003 110.98 176.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.45 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 14.0 ttp180 -54.26 -31.28 53.18 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 115.293 -0.867 . . . . 74.329999999999998 110.248 -176.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.89 -45.05 83.42 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.09 0.471 . . . . 72.030000000000001 111.012 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.63 ' HB1' ' CE2' ' A' ' 18' ' ' PHE . . . -63.21 -40.18 96.73 Favored 'General case' 0 C--O 1.274 2.359 0 CA-C-O 121.683 0.754 . . . . 52.32 111.483 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.595 ' O ' ' HB3' ' A' ' 55' ' ' TYR . 64.9 m -73.46 -37.99 65.61 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 113.57 -1.65 . . . . 61.32 112.309 175.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 25.9 mt -70.11 -44.3 69.28 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.823 -0.436 . . . . 74.319999999999993 109.823 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 16' ' ' SER . 0.8 OUTLIER -68.72 -25.98 65.03 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 118.911 -0.566 . . . . 73.120000000000005 110.353 175.353 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.736 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -45.39 -61.5 1.65 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 118.141 -1.424 . . . . 71.239999999999995 111.352 162.584 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 tt -68.59 -35.76 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.754 0.311 . . . . 72.140000000000001 111.302 -176.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 54' ' ' GLU . 8.3 tp10 -62.53 -43.26 99.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.181 0.515 . . . . 72.010000000000005 110.244 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -66.97 -40.24 87.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.144 -0.935 . . . . 74.420000000000002 110.57 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 70.86 11.18 7.1 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.621 -0.718 . . . . 71.519999999999996 111.2 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 16.8 m0 67.43 114.69 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.512 0 C-N-CA 123.249 0.62 . . . . 74.230000000000004 112.018 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.18 134.79 25.74 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.09 1.86 . . . . 74.040000000000006 109.997 167.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -71.8 16.09 0.13 Allowed 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.437 0.532 . . . . 74.439999999999998 112.437 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.537 HD13 ' HA ' ' A' ' 70' ' ' ASP . 40.6 mt -75.36 -89.91 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.368 -0.975 . . . . 44.5 108.368 170.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 63' ' ' ILE . 29.8 mmm180 -147.19 145.71 22.95 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 106.262 -1.755 . . . . 72.230000000000004 106.262 169.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.506 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 25.2 Cg_exo -64.42 70.22 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.761 2.308 . . . . 62.119999999999997 113.808 -175.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 56.8 tttp 169.38 116.63 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.962 0.905 . . . . 64.540000000000006 109.128 176.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.9 t -76.64 93.63 3.65 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.964 0.411 . . . . 72.439999999999998 110.644 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -154.66 16.03 0.44 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.775 -0.648 . . . . 74.140000000000001 109.325 176.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 17.6 ptp180 -173.51 167.82 4.57 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.748 -0.66 . . . . 72.540000000000006 109.612 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.537 ' HA ' HD13 ' A' ' 63' ' ' ILE . 4.2 p30 -122.31 -173.52 2.69 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.108 0.48 . . . . 72.120000000000005 112.204 -171.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HE3' HG12 ' A' ' 63' ' ' ILE . 29.7 mmtp -66.35 -28.43 68.65 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.558 -0.747 . . . . 71.420000000000002 112.286 -175.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.9 tp -84.28 -40.12 18.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.253 0.549 . . . . 75.409999999999997 109.588 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 69' ' ' ARG . . . -96.72 76.24 2.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.583 -0.735 . . . . 32.420000000000002 110.607 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.7 p -77.71 -55.41 5.37 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.788 -0.449 . . . . 74.239999999999995 109.788 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 48.67 63.67 3.67 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.416 -0.811 . . . . 72.519999999999996 113.256 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 84.7 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.196 0.522 . . . . 73.200000000000003 109.703 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.2 -151.96 22.09 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.667 -0.697 . . . . 61.109999999999999 111.387 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -138.87 143.73 38.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.102 0.477 . . . . 73.439999999999998 111.066 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -94.21 -28.78 15.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.361 -0.836 . . . . 74.109999999999999 109.223 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? . . . . . 0 C--O 1.252 1.226 0 CA-C-N 114.918 -1.037 . . . . 63.520000000000003 109.363 177.53 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.895 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 23.4 t80 . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 109.094 -0.706 . . . . 74.209999999999994 109.094 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -124.49 136.32 53.92 Favored 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 121.366 -0.833 . . . . 74.439999999999998 110.65 -169.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.8 t -143.6 131.31 18.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 CA-C-N 114.802 -1.09 . . . . 65.329999999999998 110.574 -169.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.709 HD22 ' HB3' ' A' ' 30' ' ' TRP . 43.8 tp -112.78 123.37 50.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.575 -0.739 . . . . 71.329999999999998 110.168 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -109.35 177.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.614 -0.514 . . . . 73.439999999999998 109.614 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 27.7 t-20 -144.37 149.87 36.83 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.482 -0.192 . . . . 74.140000000000001 110.482 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.46 -28.49 30.69 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.295 0.372 . . . . 71.409999999999997 111.741 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.75 20.27 1.83 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.179 -0.464 . . . . 73.319999999999993 111.322 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 71.16 10.61 6.82 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.499 0.719 . . . . 73.299999999999997 112.211 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.683 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 43.2 mt-30 -74.62 153.36 39.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.601 -0.518 . . . . 54.009999999999998 109.601 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -157.36 133.96 9.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 74.109999999999999 110.591 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.1 t -171.53 -163.96 0.3 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.534 -0.913 . . . . 70.430000000000007 108.534 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.62 166.27 11.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.775 -0.454 . . . . 62.520000000000003 109.775 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.709 ' HB3' HD22 ' A' ' 20' ' ' LEU . 32.5 p-90 -128.14 144.73 52.75 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.542 -0.299 . . . . 73.310000000000002 110.272 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.76 104.72 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.596 2.197 . . . . 52.539999999999999 111.605 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.22 -18.72 59.72 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.181 -0.463 . . . . 64.129999999999995 111.738 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -92.17 10.66 28.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.107 -0.497 . . . . 72.430000000000007 110.866 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.71 179.32 6.65 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.794 0.331 . . . . 42.140000000000001 110.76 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -95.5 139.96 31.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.959 -0.564 . . . . 74.129999999999995 109.874 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.54 124.03 89.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.575 -0.284 . . . . 74.219999999999999 110.404 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HG2' ' CD1' ' A' ' 40' ' ' TRP . 29.2 Cg_endo -63.64 146.65 92.65 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.379 2.052 . . . . 74.140000000000001 111.789 178.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.04 145.97 28.86 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.126 -0.488 . . . . 34.340000000000003 111.075 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.86 -23.39 34.9 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.152 -0.476 . . . . 60.32 111.944 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.525 ' CE3' ' HB2' ' A' ' 22' ' ' ASN . 65.7 m95 -97.04 160.59 14.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.712 0.292 . . . . 74.510000000000005 110.221 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -132.64 125.58 30.69 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.911 -0.774 . . . . 63.219999999999999 108.911 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.05 114.09 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.481 -0.563 . . . . 60.219999999999999 109.481 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.8 m -86.92 -21.37 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.368 0.604 . . . . 73.329999999999998 110.417 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.402 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 46.1 m80 -153.78 129.4 10.0 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.342 -0.845 . . . . 73.349999999999994 109.347 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.08 -178.85 45.82 Favored Glycine 0 C--N 1.336 0.546 0 O-C-N 124.15 0.907 . . . . 61.030000000000001 112.122 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.68 145.09 50.54 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.855 0.359 . . . . 74.340000000000003 111.623 -174.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.25 -178.34 6.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.782 -0.644 . . . . 73.409999999999997 110.54 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -79.3 167.98 20.17 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 116.2 -0.455 . . . . 61.520000000000003 111.452 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.689 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 41.0 ttm180 -55.88 -33.76 64.88 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 115.989 -0.55 . . . . 74.329999999999998 110.941 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -56.32 -48.15 77.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.134 0.493 . . . . 72.030000000000001 109.949 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.66 -31.04 71.83 Favored 'General case' 0 C--O 1.26 1.61 0 CA-C-N 115.176 -0.92 . . . . 52.32 111.133 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.895 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 24.9 m -62.05 -50.29 72.57 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.666 -1.152 . . . . 61.32 109.643 173.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.7 mt -59.61 -40.95 89.2 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.614 -0.721 . . . . 74.319999999999993 110.463 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 17.6 mm-40 -58.64 -52.81 64.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.441 . . . . 73.120000000000005 110.26 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -56.22 -55.35 34.35 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.794 0.294 . . . . 71.239999999999995 111.794 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 52' ' ' CYS . 8.8 tt -61.92 -42.83 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 121.076 -0.25 . . . . 72.140000000000001 111.539 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.32 -43.89 93.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.263 0.554 . . . . 72.010000000000005 110.127 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -72.63 -14.51 61.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.755 -0.657 . . . . 74.420000000000002 110.864 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 . . . . . 0 N--CA 1.471 0.583 0 C-N-CA 123.758 0.823 . . . . 71.519999999999996 111.23 179.393 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.781 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 3.3 t80 . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 110.663 -0.125 . . . . 74.209999999999994 110.663 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.543 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 41.9 p90 -124.37 142.11 51.54 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.284 0.564 . . . . 74.439999999999998 110.813 -172.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.663 HG23 HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.37 142.49 5.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-N 115.012 -0.995 . . . . 65.329999999999998 110.858 -172.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 40' ' ' TRP . 43.1 tp -120.46 144.58 47.9 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.216 -0.902 . . . . 71.329999999999998 111.273 -171.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.35 141.82 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 115.997 -0.547 . . . . 73.439999999999998 109.94 173.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.578 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 25.3 t-20 -110.01 155.9 21.2 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.507 -0.553 . . . . 74.140000000000001 109.507 -176.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.0 -26.64 68.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.9 0.381 . . . . 71.409999999999997 111.152 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -86.43 22.88 1.73 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.279 0.562 . . . . 73.319999999999993 110.512 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 73.02 6.65 5.34 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.404 -0.816 . . . . 73.299999999999997 112.397 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 81.6 mm-40 -71.96 117.74 13.95 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.194 -0.669 . . . . 54.009999999999998 109.194 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -131.35 127.62 37.99 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.199 -0.313 . . . . 74.109999999999999 111.042 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.5 t -173.57 163.13 4.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 70.430000000000007 110.329 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.4 pt? -72.13 130.81 41.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.174 -1.047 . . . . 62.520000000000003 108.174 169.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.501 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 33.4 p-90 -95.87 141.84 23.73 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.529 -0.305 . . . . 73.310000000000002 110.917 -173.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.592 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 23.0 Cg_exo -64.98 105.32 0.66 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.616 2.21 . . . . 52.539999999999999 111.275 177.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.501 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -58.61 -26.89 64.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.965 -0.561 . . . . 64.129999999999995 111.66 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -98.63 23.75 8.29 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.096 -0.502 . . . . 72.430000000000007 110.968 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.592 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . . . -132.96 166.63 21.93 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.013 -0.54 . . . . 42.140000000000001 110.764 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -77.25 139.62 39.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 74.129999999999995 110.458 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.511 HG12 ' NE1' ' A' ' 40' ' ' TRP . 3.0 t -112.12 106.03 56.24 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.068 -0.515 . . . . 74.219999999999999 109.745 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 33.8 Cg_endo -64.85 116.28 3.73 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.124 2.549 . . . . 74.140000000000001 112.819 -174.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.84 152.25 0.38 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.12 0.785 . . . . 34.340000000000003 113.12 -174.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.13 18.62 6.69 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.827 -0.624 . . . . 60.32 111.817 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.511 ' NE1' HG12 ' A' ' 36' ' ' VAL . 12.3 p-90 -122.41 -173.28 2.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.141 0.496 . . . . 74.510000000000005 111.056 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -154.62 126.64 7.71 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.629 -0.878 . . . . 63.219999999999999 108.629 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.9 p -90.51 138.78 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.213 -0.449 . . . . 60.219999999999999 110.651 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.663 HG23 HG23 ' A' ' 19' ' ' VAL . 27.6 m -100.74 -22.85 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.909 0.385 . . . . 73.329999999999998 110.69 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.572 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 39.3 m80 -150.4 132.63 15.44 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.929 -0.578 . . . . 73.349999999999994 109.711 176.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -92.01 176.14 38.86 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 123.758 0.661 . . . . 61.030000000000001 112.784 -175.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.37 131.03 10.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.352 0.661 . . . . 74.340000000000003 111.232 -174.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.684 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -147.57 178.24 8.62 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.227 0.537 . . . . 73.409999999999997 111.566 -174.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -98.18 177.97 5.22 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.826 -0.625 . . . . 61.520000000000003 111.819 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.525 ' NH1' HD11 ' A' ' 53' ' ' LEU . 2.4 tmt_? -61.59 -44.71 96.5 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.697 -0.683 . . . . 74.329999999999998 110.493 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.45 -42.53 67.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.464 0.65 . . . . 72.030000000000001 110.028 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.98 -32.69 74.33 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.021 -0.991 . . . . 52.32 110.944 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.781 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 49.0 t -60.22 -51.06 71.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.045 -0.525 . . . . 61.32 109.918 173.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.525 HD11 ' NH1' ' A' ' 49' ' ' ARG . 82.0 mt -58.16 -40.16 80.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.522 -0.763 . . . . 74.319999999999993 110.8 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.94 -29.02 55.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.074 -0.512 . . . . 73.120000000000005 112.213 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -65.43 -52.37 53.7 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.015 -0.428 . . . . 71.239999999999995 110.787 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 tt -59.34 -35.77 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 121.011 0.434 . . . . 72.140000000000001 110.574 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -70.99 -42.01 70.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.769 -0.65 . . . . 72.010000000000005 111.217 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -58.86 -30.22 67.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.713 0.292 . . . . 74.420000000000002 110.268 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 . . . . . 0 N--CA 1.466 0.362 0 CA-C-N 115.72 -0.673 . . . . 71.519999999999996 111.375 176.028 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.724 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 34.5 t80 . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 109.865 -0.42 . . . . 74.209999999999994 109.865 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.557 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 33.8 p90 -124.58 134.43 52.95 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 121.325 -0.86 . . . . 74.439999999999998 110.177 -173.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.639 HG23 HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.7 128.85 2.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 115.146 -0.934 . . . . 65.329999999999998 111.247 -171.034 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.7 tp -108.54 137.55 46.3 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.608 -1.178 . . . . 71.329999999999998 109.946 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 58.4 t -124.95 126.45 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 73.439999999999998 110.016 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.771 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 27.2 t-20 -87.41 158.81 18.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.89 -0.411 . . . . 74.140000000000001 109.89 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -50.25 -33.28 19.13 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.203 -0.453 . . . . 71.409999999999997 112.004 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.58 30.46 0.72 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.207 0.527 . . . . 73.319999999999993 111.145 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 67.3 6.58 4.94 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.049 0.539 . . . . 73.299999999999997 112.141 174.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.771 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 81.6 mm-40 -63.17 117.81 7.06 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 109.554 -0.535 . . . . 54.009999999999998 109.554 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -121.56 111.25 17.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.855 0.36 . . . . 74.109999999999999 110.321 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -153.32 156.08 37.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.317 -0.402 . . . . 70.430000000000007 110.168 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.652 ' H ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.56 154.27 39.17 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.545 -0.539 . . . . 62.520000000000003 109.545 172.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.4 ' HZ2' ' HA2' ' A' ' 45' ' ' GLY . 27.9 p-90 -126.16 148.95 65.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.687 -0.233 . . . . 73.310000000000002 110.556 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.06 102.57 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.238 1.959 . . . . 52.539999999999999 111.112 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 46' ' ' GLU . . . -57.06 -18.0 12.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.847 -0.615 . . . . 64.129999999999995 111.863 -175.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -102.15 24.47 10.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 72.430000000000007 111.215 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.4 172.53 12.58 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.378 -0.373 . . . . 42.140000000000001 111.059 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -95.68 139.81 31.4 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.966 -0.561 . . . . 74.129999999999995 109.869 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.8 t -88.99 118.73 69.52 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 110.601 -0.148 . . . . 74.219999999999999 110.601 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.04 160.0 48.66 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.755 2.304 . . . . 74.140000000000001 112.243 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.51 144.7 50.77 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.265 -0.425 . . . . 34.340000000000003 110.622 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.25 -18.63 48.25 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 111.55 -0.62 . . . . 60.32 111.55 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -107.61 118.88 37.9 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.93 -0.396 . . . . 74.510000000000005 109.93 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -103.41 126.04 50.34 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.695 -0.484 . . . . 63.219999999999999 109.695 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 44' ' ' HIS . 13.6 p -91.29 134.08 30.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 110.054 -0.35 . . . . 60.219999999999999 110.054 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.639 HG23 HG23 ' A' ' 19' ' ' VAL . 29.5 m -99.7 -5.2 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.031 0.443 . . . . 73.329999999999998 110.837 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.432 ' H ' HG22 ' A' ' 42' ' ' VAL . 65.4 t-80 -175.99 130.78 0.24 Allowed 'General case' 0 C--O 1.246 0.872 0 CA-C-N 115.183 -0.917 . . . . 73.349999999999994 109.453 167.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -79.0 -171.47 40.52 Favored Glycine 0 C--N 1.338 0.665 0 O-C-N 123.935 0.772 . . . . 61.030000000000001 112.846 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -50.66 151.55 2.33 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.509 0.559 . . . . 74.340000000000003 112.509 -173.189 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB1' ' CB ' ' A' ' 51' ' ' ALA . . . -161.42 179.19 8.46 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.097 -0.501 . . . . 73.409999999999997 112.252 -173.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -97.96 179.43 4.79 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.581 -0.736 . . . . 61.520000000000003 112.308 -171.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -56.91 -51.08 70.52 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.702 -0.681 . . . . 74.329999999999998 110.406 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.39 -34.19 56.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.412 -0.813 . . . . 72.030000000000001 110.186 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.45 ' CB ' ' HB1' ' A' ' 47' ' ' ALA . . . -75.74 -31.59 59.65 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 115.284 -0.871 . . . . 52.32 111.098 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.724 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 56.2 m -58.94 -48.71 80.55 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.933 -0.766 . . . . 61.32 108.933 172.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.74 -36.37 82.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.989 -1.005 . . . . 74.319999999999993 110.539 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -62.27 -42.16 99.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.531 . . . . 73.120000000000005 110.566 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -64.51 -50.43 67.4 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.315 -0.402 . . . . 71.239999999999995 111.194 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 tt -64.24 -37.36 79.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 120.779 0.323 . . . . 72.140000000000001 110.371 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -73.25 -28.35 62.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 72.010000000000005 110.361 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.14 -41.52 96.88 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.933 -0.576 . . . . 74.420000000000002 109.51 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 . . . . . 0 N--CA 1.467 0.424 0 CA-C-N 115.42 -0.809 . . . . 71.519999999999996 111.609 170.582 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.822 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 3.8 t80 . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.203 0.049 . . . . 74.209999999999994 110.915 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.81 ' HB3' ' HA ' ' A' ' 46' ' ' GLU . 51.9 p90 -125.15 143.77 50.77 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.14 0.495 . . . . 74.439999999999998 111.357 -171.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 43' ' ' VAL . 48.2 t -146.49 133.04 13.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-N 115.077 -0.965 . . . . 65.329999999999998 110.331 -175.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.508 ' HB2' ' CE3' ' A' ' 30' ' ' TRP . 57.4 tp -109.2 133.88 52.46 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.694 -0.685 . . . . 71.329999999999998 109.847 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 m -120.6 126.27 75.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.705 0.765 . . . . 73.439999999999998 110.554 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 11.3 m120 -93.12 154.09 18.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.074 -0.966 . . . . 74.140000000000001 109.228 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -56.69 -24.3 48.09 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.032 0.444 . . . . 71.409999999999997 111.097 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -82.15 15.67 2.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.965 -0.562 . . . . 73.319999999999993 111.156 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 67.64 6.79 5.22 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.26 0.624 . . . . 73.299999999999997 111.477 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 15.4 mm100 -66.65 119.61 12.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.298 -0.63 . . . . 54.009999999999998 109.298 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -111.14 113.06 25.31 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.376 -0.602 . . . . 74.109999999999999 109.376 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -150.38 -162.26 1.51 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.16 -0.473 . . . . 70.430000000000007 109.985 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.661 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.3 pt? -127.93 172.21 11.1 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.633 -0.506 . . . . 62.520000000000003 109.633 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.534 ' CH2' ' HB2' ' A' ' 18' ' ' PHE . 13.1 p90 -135.67 157.8 75.49 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.411 -0.588 . . . . 73.310000000000002 109.411 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.729 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 37.4 Cg_exo -57.66 100.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.959 1.772 . . . . 52.539999999999999 110.211 171.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.18 -13.59 19.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.636 0.606 . . . . 64.129999999999995 112.636 -171.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -103.13 2.72 34.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.837 0.351 . . . . 72.430000000000007 110.602 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.729 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . . . -121.61 -175.85 3.18 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.099 -0.5 . . . . 42.140000000000001 111.316 -173.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -81.91 137.92 35.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.594 -0.73 . . . . 74.129999999999995 110.434 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.402 HG22 ' CD1' ' A' ' 30' ' ' TRP . 56.5 t -82.34 132.79 51.8 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.934 -0.576 . . . . 74.219999999999999 110.022 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.06 132.68 48.84 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.345 2.03 . . . . 74.140000000000001 111.293 173.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.23 152.32 45.14 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.256 0.55 . . . . 34.340000000000003 112.056 -173.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.02 -35.55 4.6 Favored Glycine 0 N--CA 1.453 -0.193 0 CA-C-N 115.595 -0.73 . . . . 60.32 113.478 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -81.87 175.97 9.96 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.752 0.31 . . . . 74.510000000000005 110.694 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -121.92 126.64 49.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.006 0.431 . . . . 63.219999999999999 110.967 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.56 126.43 40.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.682 -0.859 . . . . 60.219999999999999 108.682 170.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 19' ' ' VAL . 14.7 p -95.83 -23.24 4.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 120.698 -0.401 . . . . 73.329999999999998 110.345 -175.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.451 ' ND1' ' O ' ' A' ' 17' ' ' PHE . 45.0 t-80 -158.26 133.42 8.62 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.301 -0.409 . . . . 73.349999999999994 110.469 174.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.24 176.86 46.71 Favored Glycine 0 C--N 1.337 0.629 0 O-C-N 124.14 0.9 . . . . 61.030000000000001 113.438 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.81 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -78.69 154.84 29.79 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.003 0.742 . . . . 74.340000000000003 113.003 -170.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.32 -178.11 5.74 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.802 -0.635 . . . . 73.409999999999997 111.065 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.16 170.17 16.81 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.78 0.659 . . . . 61.520000000000003 112.78 -173.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 31.9 ttm180 -45.7 -45.72 14.43 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.577 0.751 . . . . 74.329999999999998 111.631 176.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.581 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -53.66 -45.0 70.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.351 0.595 . . . . 72.030000000000001 109.964 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.99 -30.96 71.22 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 115.172 -0.922 . . . . 52.32 111.102 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.822 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 42.7 t -58.19 -47.47 83.33 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.682 -0.69 . . . . 61.32 109.731 171.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.57 -39.72 94.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.878 -0.601 . . . . 74.319999999999993 110.118 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 13.8 mm-40 -59.4 -39.32 83.03 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.121 -0.491 . . . . 73.120000000000005 110.742 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -58.68 -47.94 82.79 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.776 0.322 . . . . 71.239999999999995 110.668 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.416 HG13 ' H ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -64.45 -48.7 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.703 0.763 . . . . 72.140000000000001 109.623 -178.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -68.85 -26.64 65.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.357 -1.292 . . . . 72.010000000000005 111.072 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -65.99 -39.55 90.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.448 . . . . 74.420000000000002 109.834 175.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 . . . . . 0 CA--C 1.537 0.45 0 CA-C-N 115.756 -0.656 . . . . 71.519999999999996 111.027 177.063 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.506 ' HD1' ' HB2' ' A' ' 55' ' ' TYR . 24.8 t80 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.057 -0.719 . . . . 74.209999999999994 109.057 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.443 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 47.6 p90 -141.6 131.02 23.74 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.71 -1.589 . . . . 74.439999999999998 106.71 168.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.753 HG23 HG13 ' A' ' 43' ' ' VAL . 2.8 m -156.36 135.49 3.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.539 0.685 . . . . 65.329999999999998 110.522 -167.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 8.5 tt -117.31 131.44 56.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.374 -0.83 . . . . 71.329999999999998 110.038 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.3 t -104.17 126.08 58.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.397 -0.594 . . . . 73.439999999999998 109.397 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.711 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 14.3 m120 -79.94 170.45 16.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.039 -0.528 . . . . 74.140000000000001 109.82 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -51.82 -42.17 62.32 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.11 0.481 . . . . 71.409999999999997 111.466 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -88.95 28.06 1.24 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.866 -0.606 . . . . 73.319999999999993 111.677 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 65.63 15.51 10.07 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.117 0.567 . . . . 73.299999999999997 111.734 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.711 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 56.0 tt0 -68.58 131.11 44.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 54.009999999999998 110.072 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -90.52 118.24 29.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.642 0.258 . . . . 74.109999999999999 110.658 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 m -144.46 -175.51 4.67 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.15 -0.477 . . . . 70.430000000000007 110.149 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 29' ' ' LEU . 1.7 pt? -142.33 135.43 28.68 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.439 -0.578 . . . . 62.520000000000003 109.439 173.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.443 ' CH2' ' HB2' ' A' ' 18' ' ' PHE . 4.8 p90 -85.31 152.02 57.41 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 73.310000000000002 110.114 -176.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.98 104.72 0.4 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.95 1.767 . . . . 52.539999999999999 110.169 171.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.69 -15.43 7.8 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.099 0.407 . . . . 64.129999999999995 112.099 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -92.07 6.79 45.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 72.430000000000007 111.024 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.94 179.49 6.31 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.897 0.38 . . . . 42.140000000000001 111.122 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -87.05 139.79 30.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.668 -0.696 . . . . 74.129999999999995 110.125 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 70.5 t -64.5 129.39 94.19 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.114 -0.494 . . . . 74.219999999999999 110.899 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 35.3 Cg_exo -60.86 141.04 93.55 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.697 2.265 . . . . 74.140000000000001 111.841 175.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.98 147.41 52.47 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.023 -0.535 . . . . 34.340000000000003 111.56 -175.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.43 -25.95 25.79 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.757 -0.656 . . . . 60.32 112.981 176.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -82.86 -177.42 6.74 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.816 0.341 . . . . 74.510000000000005 110.111 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 41' ' ' ARG . 50.7 ttt-85 -145.27 126.5 14.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.335 -0.393 . . . . 63.219999999999999 110.008 173.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 54.8 t -80.42 123.37 37.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.264 -0.643 . . . . 60.219999999999999 109.264 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.753 HG13 HG23 ' A' ' 19' ' ' VAL . 7.1 p -88.77 -19.11 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.198 0.523 . . . . 73.329999999999998 110.107 -175.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -157.53 121.89 4.3 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.029 -0.73 . . . . 73.349999999999994 109.029 171.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.66 -179.34 52.81 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.29 -0.481 . . . . 61.030000000000001 112.986 -174.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -53.72 138.73 34.52 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.824 -0.436 . . . . 74.340000000000003 109.824 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.8 -178.01 6.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.873 1.064 . . . . 73.409999999999997 113.873 -167.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.401 ' CG ' ' N ' ' A' ' 49' ' ' ARG . 14.0 t70 -91.14 175.09 7.07 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.513 -1.222 . . . . 61.520000000000003 111.528 -176.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.923 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 59.1 ttt180 -57.88 -27.86 63.66 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 122.327 -0.233 . . . . 74.329999999999998 111.052 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.87 -41.37 67.44 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.278 -0.638 . . . . 72.030000000000001 109.278 173.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 17' ' ' PHE . . . -75.81 -31.17 59.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.352 -0.84 . . . . 52.32 111.018 175.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.923 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 61.3 m -54.8 -55.05 34.39 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.565 0.697 . . . . 61.32 110.253 172.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.3 mt -64.68 -23.16 67.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.989 -1.005 . . . . 74.319999999999993 110.557 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.431 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 40.7 tt0 -71.73 -49.82 35.8 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.069 -0.514 . . . . 73.120000000000005 111.257 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.506 ' HB2' ' HD1' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -52.53 -40.93 63.03 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 111.98 0.363 . . . . 71.239999999999995 111.98 -175.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 tt -69.57 -39.0 77.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 120.879 0.371 . . . . 72.140000000000001 110.887 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -71.64 -34.0 69.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 72.010000000000005 110.899 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 59' ' ' HIS . 7.4 mm-40 -67.07 -13.91 62.39 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.853 -0.612 . . . . 74.420000000000002 111.639 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.494 ' HB3' ' O ' ' A' ' 58' ' ' GLU . 21.6 t-80 . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 121.6 0.714 . . . . 71.519999999999996 109.843 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.686 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 56.4 m-85 . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 113.063 0.764 . . . . 74.209999999999994 113.063 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -151.23 130.51 12.79 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.279 -1.378 . . . . 74.439999999999998 107.279 149.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.467 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 31.2 t -157.19 120.14 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.965 0 CA-C-O 121.081 0.467 . . . . 65.329999999999998 112.036 -173.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.462 HD13 HG22 ' A' ' 42' ' ' VAL . 64.6 tp -96.14 128.99 43.54 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.646 -0.706 . . . . 71.329999999999998 109.317 171.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 58.2 t -120.85 125.95 74.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.22 0.533 . . . . 73.439999999999998 110.302 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -85.66 153.2 22.52 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.168 -0.679 . . . . 74.140000000000001 109.168 175.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.34 -9.78 20.08 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.657 0.741 . . . . 71.409999999999997 109.535 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -79.79 7.58 8.39 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.943 -1.026 . . . . 73.319999999999993 110.174 173.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 72.23 7.02 5.66 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.47 0.708 . . . . 73.299999999999997 111.951 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 68.6 mt-30 -70.48 120.11 15.65 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 108.864 -0.791 . . . . 54.009999999999998 108.864 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -128.88 104.11 7.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.674 0.273 . . . . 74.109999999999999 110.688 -174.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.7 t -166.36 -169.43 1.41 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.722 0.296 . . . . 70.430000000000007 110.739 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 pp -71.12 172.88 8.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.12 -0.491 . . . . 62.520000000000003 111.511 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -153.21 156.13 32.35 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.552 -0.295 . . . . 73.310000000000002 110.739 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.22 93.46 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.432 2.088 . . . . 52.539999999999999 111.262 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.17 -1.71 3.52 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.23 0.455 . . . . 64.129999999999995 112.23 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -81.7 2.33 30.24 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.624 -0.262 . . . . 72.430000000000007 111.227 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.46 174.08 10.98 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.68 0.276 . . . . 42.140000000000001 110.782 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -87.99 139.98 29.96 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.058 -0.519 . . . . 74.129999999999995 109.981 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -59.39 119.93 43.8 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.964 -0.562 . . . . 74.219999999999999 111.412 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.85 138.82 82.96 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.611 2.207 . . . . 74.140000000000001 111.883 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.37 127.73 33.45 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.913 -0.585 . . . . 34.340000000000003 111.473 -177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.9 -23.43 13.05 Favored Glycine 0 C--N 1.33 0.223 0 CA-C-N 115.955 -0.566 . . . . 60.32 112.653 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -92.57 152.74 19.44 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.718 -0.283 . . . . 74.510000000000005 110.377 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.413 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 2.3 mmp_? -123.67 126.34 46.39 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.908 -0.405 . . . . 63.219999999999999 109.908 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.462 HG22 HD13 ' A' ' 20' ' ' LEU . 19.0 t -85.61 116.73 29.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.522 -0.918 . . . . 60.219999999999999 108.522 175.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.467 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 13.6 p -79.11 -29.98 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.411 0.624 . . . . 73.329999999999998 109.757 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -144.12 115.37 7.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.802 -1.184 . . . . 73.349999999999994 107.802 172.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.445 ' HA2' HG11 ' A' ' 42' ' ' VAL . . . -61.77 163.67 23.49 Favored Glycine 0 CA--C 1.509 -0.314 0 O-C-N 123.7 0.625 . . . . 61.030000000000001 113.54 -172.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -61.67 137.73 58.26 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.683 -0.488 . . . . 74.340000000000003 109.683 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.32 -177.82 4.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.807 -0.633 . . . . 73.409999999999997 110.479 -173.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.6 151.33 6.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.073 -0.512 . . . . 61.520000000000003 110.343 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.756 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 18.6 ttm180 -48.51 -39.54 23.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 110.957 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 54' ' ' GLU . . . -63.96 -39.53 94.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.372 -0.376 . . . . 72.030000000000001 111.352 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.24 -33.34 59.19 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 120.925 0.393 . . . . 52.32 111.943 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.756 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 16.2 p -73.51 -42.83 61.28 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.796 -0.638 . . . . 61.32 110.501 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 57.2 mt -65.77 -28.68 69.2 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.09 0.472 . . . . 74.319999999999993 110.096 174.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 13.3 tp10 -75.27 -33.07 61.21 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.006 -0.543 . . . . 73.120000000000005 110.048 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.686 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 9.5 t80 -45.96 -60.19 2.4 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.415 0.524 . . . . 71.239999999999995 112.415 173.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.8 tt -56.28 -40.96 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 120.708 0.289 . . . . 72.140000000000001 111.319 -173.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.46 -30.68 63.34 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.028 0.442 . . . . 72.010000000000005 110.6 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.14 -34.48 77.71 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.873 -0.603 . . . . 74.420000000000002 109.85 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 . . . . . 0 N--CA 1.47 0.56 0 CA-C-N 115.445 -0.798 . . . . 71.519999999999996 112.259 175.092 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.662 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 2.4 t80 . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 110.151 -0.314 . . . . 74.209999999999994 110.151 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 27.5 p90 -123.94 136.73 54.51 Favored 'General case' 0 CA--C 1.509 -0.624 0 O-C-N 121.632 -0.668 . . . . 74.439999999999998 110.05 -170.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.58 HG23 ' HB ' ' A' ' 43' ' ' VAL . 23.4 m -144.56 129.18 13.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 114.88 -1.054 . . . . 65.329999999999998 111.551 -168.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.498 HD11 HG21 ' A' ' 36' ' ' VAL . 54.3 tp -106.78 132.5 52.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.005 -0.998 . . . . 71.329999999999998 109.163 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.02 126.38 75.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.925 0.393 . . . . 73.439999999999998 110.861 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -78.41 144.86 35.5 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.773 -0.825 . . . . 74.140000000000001 108.773 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -59.87 -18.27 43.11 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.891 0.377 . . . . 71.409999999999997 110.711 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.59 4.73 3.63 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.796 -0.638 . . . . 73.319999999999993 111.255 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 72.0 56.05 0.17 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.099 0.56 . . . . 73.299999999999997 111.357 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -143.16 131.57 22.22 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.654 -0.703 . . . . 54.009999999999998 109.608 175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -100.92 139.24 36.89 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.784 0.326 . . . . 74.109999999999999 110.735 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.8 m -154.92 -172.72 4.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.293 -0.632 . . . . 70.430000000000007 109.293 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.75 162.51 15.67 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.741 -0.466 . . . . 62.520000000000003 109.741 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.417 ' HH2' ' HA2' ' A' ' 45' ' ' GLY . 3.7 p90 -137.32 160.22 66.45 Favored Pre-proline 0 C--O 1.234 0.264 0 N-CA-C 109.613 -0.514 . . . . 73.310000000000002 109.613 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.6 97.86 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.04 1.827 . . . . 52.539999999999999 111.024 172.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.463 ' HB1' ' HB3' ' A' ' 46' ' ' GLU . . . -53.23 -24.28 10.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.009 -0.541 . . . . 64.129999999999995 112.341 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -92.83 29.86 1.71 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.271 -0.422 . . . . 72.430000000000007 111.043 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.5 158.85 43.77 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.296 -0.411 . . . . 42.140000000000001 110.546 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.56 129.82 36.66 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.191 -0.459 . . . . 74.129999999999995 110.402 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.498 HG21 HD11 ' A' ' 20' ' ' LEU . 7.7 p -91.87 131.31 35.79 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 116.273 -0.421 . . . . 74.219999999999999 111.317 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 13.5 Cg_exo -69.17 177.91 4.71 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.909 2.406 . . . . 74.140000000000001 113.047 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.12 152.07 43.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.538 -0.755 . . . . 34.340000000000003 110.763 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.13 -35.33 4.63 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.303 -0.719 . . . . 60.32 111.303 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -100.88 100.76 11.45 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.782 -0.821 . . . . 74.510000000000005 108.782 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -93.3 126.57 38.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.868 0.365 . . . . 63.219999999999999 110.589 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.0 p -83.69 128.52 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.039 -0.356 . . . . 60.219999999999999 110.039 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.58 ' HB ' HG23 ' A' ' 19' ' ' VAL . 93.4 t -89.7 -43.33 14.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.9 0.381 . . . . 73.329999999999998 110.221 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -139.22 132.8 30.42 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 109.18 -0.674 . . . . 73.349999999999994 109.18 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -79.69 -176.26 48.95 Favored Glycine 0 C--N 1.335 0.507 0 O-C-N 124.334 1.022 . . . . 61.030000000000001 112.964 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -46.35 144.33 2.13 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.703 0.631 . . . . 74.340000000000003 112.703 -174.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.572 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -151.36 -178.04 6.42 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.326 0.491 . . . . 73.409999999999997 112.326 -170.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 3.7 m-20 -96.67 171.4 8.56 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.911 0.863 . . . . 61.520000000000003 112.924 -171.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.737 ' HD3' ' SG ' ' A' ' 52' ' ' CYS . 6.4 tpp180 -56.67 -45.82 81.49 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 114.867 -1.06 . . . . 74.329999999999998 110.294 173.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -57.21 -34.23 68.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.463 0.649 . . . . 72.030000000000001 110.098 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 48' ' ' ASP . . . -72.46 -33.06 66.77 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-N 115.277 -0.874 . . . . 52.32 111.622 -177.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.737 ' SG ' ' HD3' ' A' ' 49' ' ' ARG . 22.4 p -71.56 -38.83 70.95 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.308 -0.405 . . . . 61.32 110.387 172.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 92.0 mt -60.14 -35.85 76.21 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.981 -0.554 . . . . 74.319999999999993 110.449 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 42.1 mt-10 -77.07 -39.23 50.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.301 -0.409 . . . . 73.120000000000005 110.641 176.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -55.65 -48.19 75.39 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.69 0.256 . . . . 71.239999999999995 111.69 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.0 tt -62.92 -45.3 99.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 120.811 0.338 . . . . 72.140000000000001 111.145 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -60.98 -48.0 83.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.983 -0.553 . . . . 72.010000000000005 110.326 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -58.71 -34.66 71.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.822 -0.627 . . . . 74.420000000000002 110.25 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 N--CA 1.463 0.195 0 CA-C-N 115.596 -0.729 . . . . 71.519999999999996 110.226 -178.535 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.477 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 65.1 t80 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 121.311 0.577 . . . . 74.209999999999994 109.963 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.483 ' HB2' ' HE1' ' A' ' 30' ' ' TRP . 48.0 p90 -136.36 131.42 34.23 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.931 -1.507 . . . . 74.439999999999998 106.931 167.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.7 t -146.33 138.66 19.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 CA-C-O 121.263 0.554 . . . . 65.329999999999998 111.229 -167.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.765 ' HB2' ' HB3' ' A' ' 30' ' ' TRP . 33.8 tp -117.06 130.44 56.67 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.872 -1.058 . . . . 71.329999999999998 110.273 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.72 126.4 72.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.157 0.503 . . . . 73.439999999999998 110.216 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.528 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 52.8 t-20 -85.52 149.48 25.35 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.211 -0.663 . . . . 74.140000000000001 109.211 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 22' ' ' ASN . 27.4 t70 -56.44 -26.49 53.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.218 0.533 . . . . 71.409999999999997 110.174 176.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -80.69 15.9 1.57 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.596 -0.729 . . . . 73.319999999999993 111.589 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 73.68 18.75 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.582 0.753 . . . . 73.299999999999997 112.452 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 14.9 mm100 -77.24 129.78 36.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.512 -0.551 . . . . 54.009999999999998 109.512 173.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -123.88 108.53 12.55 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.564 0.221 . . . . 74.109999999999999 110.817 -175.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -154.91 -163.63 1.61 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.181 -0.303 . . . . 70.430000000000007 110.181 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.776 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.3 pt? -109.66 159.16 17.37 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.382 -0.599 . . . . 62.520000000000003 109.382 175.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.765 ' HB3' ' HB2' ' A' ' 20' ' ' LEU . 11.7 p-90 -112.05 148.26 38.65 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 120.557 0.218 . . . . 73.310000000000002 110.849 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.18 94.41 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.368 2.045 . . . . 52.539999999999999 110.847 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.402 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -56.88 -18.28 12.58 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.858 -0.61 . . . . 64.129999999999995 111.682 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -85.02 2.24 44.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 72.430000000000007 110.668 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.17 176.88 8.26 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.183 -0.462 . . . . 42.140000000000001 110.906 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.51 139.85 30.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.465 . . . . 74.129999999999995 110.067 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.7 124.41 90.87 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.308 -0.406 . . . . 74.219999999999999 110.052 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.42 -171.67 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.906 2.404 . . . . 74.140000000000001 112.797 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.48 145.63 30.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 34.340000000000003 110.974 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.23 -32.66 5.77 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.248 -0.433 . . . . 60.32 112.415 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.466 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 16.8 m95 -86.0 136.94 33.06 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.489 -0.56 . . . . 74.510000000000005 109.489 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 40' ' ' TRP . 16.0 mmm180 -121.51 126.48 49.33 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.257 -0.645 . . . . 63.219999999999999 109.257 176.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.0 p -85.9 132.78 31.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.343 -0.243 . . . . 60.219999999999999 110.343 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.95 -37.51 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.069 0.461 . . . . 73.329999999999998 110.069 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -148.19 132.14 17.15 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.652 -0.703 . . . . 73.349999999999994 109.682 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.0 -175.15 45.36 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.111 -0.796 . . . . 61.030000000000001 111.111 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -54.86 133.64 47.9 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.884 0.342 . . . . 74.340000000000003 110.281 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.63 -177.58 4.93 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.665 0.617 . . . . 73.409999999999997 112.665 -168.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.22 165.89 1.28 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.981 -1.009 . . . . 61.520000000000003 112.601 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.519 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 0.2 OUTLIER -60.75 -29.08 69.17 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.891 -0.595 . . . . 74.329999999999998 109.682 174.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.509 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -58.18 -46.89 84.97 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.348 -0.612 . . . . 72.030000000000001 109.348 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' PHE . . . -65.83 -30.86 71.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.335 -0.848 . . . . 52.32 110.725 177.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 49' ' ' ARG . 54.1 t -58.4 -49.04 78.7 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.849 -0.426 . . . . 61.32 109.849 170.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.9 mt -67.75 -27.15 66.54 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.799 -0.637 . . . . 74.319999999999993 110.494 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 43.5 mt-10 -76.89 -36.69 56.52 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 116.236 -0.438 . . . . 73.120000000000005 111.649 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.477 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 1.9 t80 -61.86 -47.8 83.37 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.956 0.343 . . . . 71.239999999999995 110.798 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 tt -63.78 -41.84 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.73 -0.214 . . . . 72.140000000000001 110.932 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.31 -34.19 65.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.762 0.315 . . . . 72.010000000000005 111.183 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.23 -25.5 68.09 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.307 0.575 . . . . 74.420000000000002 109.47 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 . . . . . 0 C--O 1.233 0.187 0 CA-C-N 115.134 -0.939 . . . . 71.519999999999996 110.732 176.513 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.764 ' CD1' ' HB2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 112.444 0.535 . . . . 74.209999999999994 112.444 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.422 ' CB ' ' HA ' ' A' ' 46' ' ' GLU . 27.7 p90 -124.26 135.98 53.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.474 -0.784 . . . . 74.439999999999998 108.956 -173.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.07 129.5 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.055 -0.52 . . . . 65.329999999999998 111.896 -167.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 30' ' ' TRP . 49.5 tp -100.31 125.62 46.55 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.252 -0.886 . . . . 71.329999999999998 109.123 172.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 p -109.26 126.34 66.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.24 0.543 . . . . 73.439999999999998 109.807 176.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -94.47 148.33 22.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.72 -0.673 . . . . 74.140000000000001 110.671 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.417 ' HB3' ' HZ3' ' A' ' 40' ' ' TRP . 15.3 t70 -56.06 -20.86 18.75 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.354 0.597 . . . . 71.409999999999997 110.199 174.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -73.55 3.72 5.83 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.262 -0.881 . . . . 73.319999999999993 111.531 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 63.31 56.83 1.63 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.37 0.605 . . . . 73.299999999999997 110.586 -175.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -137.93 132.55 32.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.251 -0.886 . . . . 54.009999999999998 109.171 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.8 109.12 16.7 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.13 0.491 . . . . 74.109999999999999 110.333 -178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.3 t -145.96 -167.77 2.81 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.564 -0.532 . . . . 70.430000000000007 109.564 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 pp -107.61 158.63 17.08 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.27 -0.27 . . . . 62.520000000000003 110.27 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.632 ' HB3' HD22 ' A' ' 20' ' ' LEU . 18.2 p-90 -111.79 153.24 44.48 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.453 -0.34 . . . . 73.310000000000002 110.431 -175.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.73 102.83 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.157 1.905 . . . . 52.539999999999999 110.979 175.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.09 -7.01 2.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.522 0.934 . . . . 64.129999999999995 113.522 -171.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -107.23 10.13 29.97 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.256 -0.278 . . . . 72.430000000000007 110.962 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.456 ' O ' ' HZ3' ' A' ' 30' ' ' TRP . . . -124.48 169.89 11.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.426 -0.352 . . . . 42.140000000000001 110.574 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.45 139.56 30.59 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.124 -0.324 . . . . 74.129999999999995 110.124 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.0 t -74.64 120.93 83.9 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.557 -0.292 . . . . 74.219999999999999 110.513 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.65 137.67 70.33 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.461 2.108 . . . . 74.140000000000001 111.436 175.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.73 134.94 57.5 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.46 -0.336 . . . . 34.340000000000003 110.571 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.31 -35.15 4.59 Favored Glycine 0 CA--C 1.511 -0.211 0 N-CA-C 111.062 -0.815 . . . . 60.32 111.062 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.417 ' HZ3' ' HB3' ' A' ' 23' ' ' ASP . 3.7 m95 -92.5 143.89 25.9 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.043 -1.095 . . . . 74.510000000000005 108.043 173.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 41' ' ' ARG . 44.6 ttm105 -141.22 133.7 28.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.96 0.41 . . . . 63.219999999999999 111.517 -174.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.2 t -85.49 121.09 36.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.959 -0.564 . . . . 60.219999999999999 110.31 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.42 -37.18 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.8 0.334 . . . . 73.329999999999998 110.873 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.415 ' HD2' ' O ' ' A' ' 45' ' ' GLY . 3.6 t-160 -134.67 129.89 35.49 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.226 -0.657 . . . . 73.349999999999994 109.226 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -72.47 167.29 53.52 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 124.455 1.097 . . . . 61.030000000000001 113.543 -176.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.6 mp0 -50.91 128.69 21.83 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.715 0.806 . . . . 74.340000000000003 112.488 -171.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -133.18 -178.23 4.88 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.509 -0.768 . . . . 73.409999999999997 110.727 -176.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.37 164.57 23.94 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.772 0.796 . . . . 61.520000000000003 112.653 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -52.57 -38.37 59.77 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 114.753 -1.112 . . . . 74.329999999999998 109.787 173.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.42 -47.6 83.39 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 115.756 -0.656 . . . . 72.030000000000001 110.216 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 17' ' ' PHE . . . -59.86 -31.35 69.69 Favored 'General case' 0 C--O 1.258 1.515 0 CA-C-O 121.71 0.766 . . . . 52.32 111.015 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.608 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 47.8 t -71.25 -40.88 70.75 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.724 -1.125 . . . . 61.32 110.839 172.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.5 mt -67.66 -26.93 66.45 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.317 0.58 . . . . 74.319999999999993 109.796 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -77.11 -37.39 54.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.526 -0.761 . . . . 73.120000000000005 110.141 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.764 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -46.53 -58.04 4.16 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 111.861 0.319 . . . . 71.239999999999995 111.861 171.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 tt -60.81 -37.96 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.242 0.544 . . . . 72.140000000000001 110.552 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.45 -43.55 93.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.249 -0.887 . . . . 72.010000000000005 110.571 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -73.76 -27.95 61.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.868 -0.605 . . . . 74.420000000000002 110.106 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 . . . . . 0 CA--C 1.533 0.301 0 CA-C-N 115.185 -0.916 . . . . 71.519999999999996 110.121 -176.865 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.685 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.581 0 CA-C-O 120.897 0.379 . . . . 74.209999999999994 110.411 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.505 ' HB3' ' HA ' ' A' ' 46' ' ' GLU . 31.2 p90 -122.9 135.93 54.68 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.458 0.647 . . . . 74.439999999999998 109.66 -167.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.686 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 18.1 t -135.86 131.99 50.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.83 -1.077 . . . . 65.329999999999998 109.694 -167.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.501 ' HB2' ' CD1' ' A' ' 30' ' ' TRP . 29.6 tp -120.92 145.16 47.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.108 -0.497 . . . . 71.329999999999998 110.714 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 97.8 t -122.01 125.54 73.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.812 -0.811 . . . . 73.439999999999998 108.812 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -82.48 163.55 21.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.826 -0.435 . . . . 74.140000000000001 109.826 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -57.38 -31.17 65.53 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.929 0.395 . . . . 71.409999999999997 110.719 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -79.18 16.67 0.91 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.429 0.633 . . . . 73.319999999999993 110.338 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 65.44 24.62 11.95 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.473 -0.785 . . . . 73.299999999999997 111.538 173.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 93.7 mt-30 -78.73 121.19 24.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.789 -0.641 . . . . 54.009999999999998 110.104 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -99.15 116.8 32.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.265 -0.272 . . . . 74.109999999999999 110.265 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.4 t -166.33 -164.19 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.601 -0.518 . . . . 70.430000000000007 109.601 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.763 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.4 pt? -108.32 173.73 6.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.694 -0.484 . . . . 62.520000000000003 109.694 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.501 ' CD1' ' HB2' ' A' ' 20' ' ' LEU . 14.7 p-90 -134.6 149.34 70.63 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.693 -0.23 . . . . 73.310000000000002 111.163 -175.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.88 108.63 2.62 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.741 2.294 . . . . 52.539999999999999 111.703 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.28 -12.16 60.75 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.304 -0.407 . . . . 64.129999999999995 112.013 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -104.31 14.53 30.07 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.041 0.448 . . . . 72.430000000000007 110.749 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.68 179.96 6.27 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.022 -0.535 . . . . 42.140000000000001 110.51 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -79.16 118.9 21.54 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.509 -0.314 . . . . 74.129999999999995 110.443 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.619 HG22 ' NE1' ' A' ' 40' ' ' TRP . 7.7 p -96.19 110.38 51.95 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 109.02 -0.733 . . . . 74.219999999999999 109.02 173.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.463 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 36.5 Cg_endo -64.3 108.38 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.853 2.369 . . . . 74.140000000000001 114.043 -167.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.26 152.53 0.27 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.682 -0.69 . . . . 34.340000000000003 112.3 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.78 -8.1 21.83 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.735 -0.666 . . . . 60.32 111.702 -174.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.619 ' NE1' HG22 ' A' ' 36' ' ' VAL . 4.9 p-90 -87.72 -177.61 5.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 122.972 0.509 . . . . 74.510000000000005 110.746 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.0 mtt85 -128.95 125.38 37.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.288 -1.005 . . . . 63.219999999999999 108.288 171.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 p -91.47 116.63 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.962 0.41 . . . . 60.219999999999999 111.162 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.686 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 61.4 t -76.98 -35.36 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.095 0.474 . . . . 73.329999999999998 110.288 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -157.02 132.2 9.05 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.632 -0.713 . . . . 73.349999999999994 109.828 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -71.31 167.66 51.62 Favored Glycine 0 C--N 1.34 0.773 0 O-C-N 124.337 1.023 . . . . 61.030000000000001 112.461 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -55.45 147.1 18.24 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.389 0.885 . . . . 74.340000000000003 113.389 -170.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -148.99 -178.31 6.3 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.735 -1.12 . . . . 73.409999999999997 109.24 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -91.89 172.28 8.57 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.001 0.429 . . . . 61.520000000000003 111.357 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -57.8 -32.25 67.37 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.137 -0.483 . . . . 74.329999999999998 110.117 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.712 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -52.35 -52.66 52.14 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 109.343 -0.614 . . . . 72.030000000000001 109.343 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.495 ' C ' ' HB3' ' A' ' 17' ' ' PHE . . . -64.26 -31.56 72.8 Favored 'General case' 0 C--O 1.262 1.724 0 CA-C-N 115.439 -0.801 . . . . 52.32 111.274 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.685 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 53.0 t -66.14 -36.53 83.37 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 114.55 -1.204 . . . . 61.32 110.57 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.677 ' O ' HG22 ' A' ' 56' ' ' ILE . 76.0 mt -72.0 -44.39 63.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.52 -0.548 . . . . 74.319999999999993 109.52 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.712 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 4.3 mm-40 -62.34 -25.55 67.96 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.417 -0.356 . . . . 73.120000000000005 111.12 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.604 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -46.09 -27.17 0.89 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 111.715 0.265 . . . . 71.239999999999995 111.715 173.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 53' ' ' LEU . 19.7 tt -60.85 -47.83 91.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 121.477 0.656 . . . . 72.140000000000001 110.271 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.475 ' N ' HG23 ' A' ' 56' ' ' ILE . 12.5 tp10 -73.83 -35.47 64.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.098 -0.955 . . . . 72.010000000000005 110.364 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -74.89 -36.35 62.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.0 -1.0 . . . . 74.420000000000002 111.361 -172.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 . . . . . 0 N--CA 1.47 0.548 0 CA-C-N 115.845 -0.616 . . . . 71.519999999999996 111.63 -179.032 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 114.351 1.241 . . . . 74.209999999999994 114.351 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -151.51 130.71 12.73 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.306 -0.998 . . . . 74.439999999999998 108.306 150.456 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.435 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 64.0 t -158.1 136.71 3.13 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 CA-C-O 121.128 0.489 . . . . 65.329999999999998 112.152 -169.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.423 HD13 HG22 ' A' ' 42' ' ' VAL . 63.4 tp -102.21 122.96 45.21 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.445 -0.798 . . . . 71.329999999999998 109.514 174.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.55 125.82 50.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.241 -0.651 . . . . 73.439999999999998 109.241 174.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 14.3 m120 -96.92 139.26 33.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.781 -0.645 . . . . 74.140000000000001 110.254 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.72 -15.92 59.75 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.087 0.47 . . . . 71.409999999999997 110.843 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -85.24 26.56 0.88 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.031 -0.531 . . . . 73.319999999999993 111.078 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 69.8 6.25 5.64 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.314 0.646 . . . . 73.299999999999997 111.803 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 15.7 mm100 -90.86 153.78 19.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.929 0.395 . . . . 54.009999999999998 110.45 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -133.37 109.09 9.11 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.394 -0.965 . . . . 74.109999999999999 108.394 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.3 t -128.38 177.21 7.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.772 0.796 . . . . 70.430000000000007 111.889 -170.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.3 tt -111.71 106.59 15.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.594 -1.185 . . . . 62.520000000000003 108.065 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.457 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 25.3 p-90 -77.67 149.49 77.86 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.059 -0.519 . . . . 73.310000000000002 111.206 -174.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.89 104.07 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.038 1.825 . . . . 52.539999999999999 111.085 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.457 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -63.42 -2.15 1.43 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.23 -0.441 . . . . 64.129999999999995 111.621 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -89.78 -0.72 57.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 72.430000000000007 110.789 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.2 178.0 7.24 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.05 0.452 . . . . 42.140000000000001 111.688 -175.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -95.92 140.11 31.15 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.593 -0.731 . . . . 74.129999999999995 111.028 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.3 t -91.48 123.95 62.38 Favored Pre-proline 0 C--O 1.236 0.383 0 CA-C-N 116.243 -0.435 . . . . 74.219999999999999 111.037 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.54 153.75 73.04 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.616 2.211 . . . . 74.140000000000001 111.708 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.05 152.18 38.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.94 0.4 . . . . 34.340000000000003 110.714 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.4 -35.53 4.91 Favored Glycine 0 N--CA 1.455 -0.073 0 N-CA-C 111.036 -0.826 . . . . 60.32 111.036 -174.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -95.01 129.21 42.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.757 -1.201 . . . . 74.510000000000005 107.757 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -100.12 125.64 46.25 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.622 -0.51 . . . . 63.219999999999999 109.622 -171.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.423 HG22 HD13 ' A' ' 20' ' ' LEU . 21.6 t -90.69 117.88 34.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.99 -0.744 . . . . 60.219999999999999 108.99 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.435 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 14.4 p -84.16 -23.35 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.681 0.753 . . . . 73.329999999999998 109.548 -174.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -148.29 115.48 6.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.036 -0.984 . . . . 73.349999999999994 108.714 173.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -69.74 -171.51 8.73 Favored Glycine 0 N--CA 1.447 -0.583 0 O-C-N 123.864 0.728 . . . . 61.030000000000001 112.501 -175.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -52.44 133.88 34.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.146 0.498 . . . . 74.340000000000003 111.322 -178.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.87 175.89 9.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.541 -0.754 . . . . 73.409999999999997 110.017 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.74 159.58 21.96 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.984 -0.553 . . . . 61.520000000000003 111.273 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.556 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 15.7 ttm180 -58.38 -37.72 75.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.242 -0.651 . . . . 74.329999999999998 109.242 176.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.74 -36.82 84.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.028 -0.533 . . . . 72.030000000000001 110.468 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.02 -38.47 79.22 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-N 115.855 -0.611 . . . . 52.32 111.389 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.556 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 27.0 p -73.44 -47.26 43.06 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.411 -0.813 . . . . 61.32 110.995 174.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 72.8 mt -60.89 -34.5 74.74 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.503 -0.317 . . . . 74.319999999999993 110.594 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -76.82 -37.54 55.5 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.885 -0.326 . . . . 73.120000000000005 110.54 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -48.26 -58.12 5.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 120.438 -0.505 . . . . 71.239999999999995 111.588 170.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 52' ' ' CYS . 3.7 tt -61.65 -38.55 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 120.672 0.272 . . . . 72.140000000000001 111.032 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -60.54 -43.49 97.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 72.010000000000005 110.51 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -81.94 -14.89 55.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.895 -0.593 . . . . 74.420000000000002 111.428 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.4 t60 . . . . . 0 N--CA 1.467 0.378 0 CA-C-N 116.151 -0.477 . . . . 71.519999999999996 110.853 174.936 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.632 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 68.5 t80 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.363 0.601 . . . . 74.209999999999994 109.843 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -144.44 131.57 20.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.36 -1.348 . . . . 74.439999999999998 107.36 169.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -141.79 123.6 13.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.267 0.555 . . . . 65.329999999999998 111.003 -170.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 40' ' ' TRP . 52.2 tp -93.48 127.99 39.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.202 -0.908 . . . . 71.329999999999998 109.64 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 61.8 t -121.44 129.16 75.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.232 0.539 . . . . 73.439999999999998 110.909 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 33.4 t30 -92.81 151.78 19.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.92 -0.77 . . . . 74.140000000000001 108.92 173.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -54.54 -19.94 6.86 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.159 0.504 . . . . 71.409999999999997 110.95 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -82.64 20.61 1.1 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.965 -0.561 . . . . 73.319999999999993 111.635 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 65.62 12.57 8.34 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.976 0.51 . . . . 73.299999999999997 111.849 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 34.6 tt0 -76.03 117.64 17.95 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.341 -0.615 . . . . 54.009999999999998 109.341 176.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -122.52 107.95 12.6 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.01 0.434 . . . . 74.109999999999999 111.298 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 m -132.38 -168.03 1.99 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.549 -0.75 . . . . 70.430000000000007 109.359 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.787 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.9 pt? -106.38 161.63 14.4 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.238 -0.653 . . . . 62.520000000000003 109.238 174.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.467 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 20.0 p-90 -131.8 145.03 55.72 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.614 0.245 . . . . 73.310000000000002 111.31 -173.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 14.0 Cg_exo -69.86 103.67 1.21 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.727 2.285 . . . . 52.539999999999999 111.291 176.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.467 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -60.01 -22.52 62.7 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.14 -0.482 . . . . 64.129999999999995 112.03 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -84.88 4.26 34.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.615 -0.266 . . . . 72.430000000000007 111.436 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.99 162.44 22.33 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.806 0.336 . . . . 42.140000000000001 110.725 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -82.97 132.84 35.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 74.129999999999995 110.597 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.97 115.95 62.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 74.219999999999999 110.198 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.68 147.1 95.92 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.345 2.03 . . . . 74.140000000000001 112.169 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.37 137.76 57.0 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.203 -0.453 . . . . 34.340000000000003 110.685 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.42 -35.42 4.55 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.42 -0.672 . . . . 60.32 111.42 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.469 ' HB3' HD11 ' A' ' 20' ' ' LEU . 71.0 m95 -81.37 140.6 34.63 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.581 -0.526 . . . . 74.510000000000005 109.581 177.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -127.61 126.13 41.49 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.151 -0.314 . . . . 63.219999999999999 110.151 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.6 t -85.21 130.57 35.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.583 -0.525 . . . . 60.219999999999999 109.583 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -85.43 -31.33 6.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.228 0.537 . . . . 73.329999999999998 109.997 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -154.58 122.95 6.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.924 -0.769 . . . . 73.349999999999994 108.924 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.03 -172.41 42.18 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.28 -0.486 . . . . 61.030000000000001 112.522 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -61.73 154.52 25.3 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 110.244 -0.28 . . . . 74.340000000000003 110.244 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.436 ' HB3' ' CB ' ' A' ' 51' ' ' ALA . . . -160.71 -178.25 6.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.118 0.485 . . . . 73.409999999999997 111.762 -175.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -68.91 178.45 2.19 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.954 -1.021 . . . . 61.520000000000003 111.9 -175.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 44.5 ttm180 -61.15 -27.86 68.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.38 -0.827 . . . . 74.329999999999998 110.203 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -51.84 -44.97 63.81 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.162 0.505 . . . . 72.030000000000001 110.01 172.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 47' ' ' ALA . . . -75.81 -31.74 59.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.428 -0.806 . . . . 52.32 110.846 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.42 ' O ' HG22 ' A' ' 56' ' ' ILE . 52.8 t -54.12 -42.01 68.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.042 -0.527 . . . . 61.32 110.067 170.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.06 -29.85 68.91 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.055 -0.52 . . . . 74.319999999999993 110.665 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 94.8 mt-10 -70.05 -51.65 30.3 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.445 -0.343 . . . . 73.120000000000005 111.039 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.632 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 2.7 t80 -58.48 -41.9 86.34 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.603 -0.271 . . . . 71.239999999999995 111.693 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 52' ' ' CYS . 9.7 tt -71.03 -45.62 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 121.085 -0.246 . . . . 72.140000000000001 111.146 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -64.57 -52.6 56.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.418 -0.356 . . . . 72.010000000000005 110.302 -177.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -70.68 -33.14 70.6 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.948 -0.569 . . . . 74.420000000000002 110.337 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 . . . . . 0 N--CA 1.472 0.644 0 C-N-CA 123.829 0.852 . . . . 71.519999999999996 111.826 -178.873 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.817 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 19.0 t80 . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 109.066 -0.716 . . . . 74.209999999999994 109.066 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.653 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 46.1 p90 -125.22 138.15 54.12 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.366 -0.834 . . . . 74.439999999999998 111.652 -172.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -142.15 133.81 26.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 114.955 -1.02 . . . . 65.329999999999998 110.11 -173.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.643 ' HB2' ' CE3' ' A' ' 30' ' ' TRP . 17.8 tp -120.88 142.67 49.46 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 122.978 0.511 . . . . 71.329999999999998 110.754 -174.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.8 147.8 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.619 -0.264 . . . . 73.439999999999998 110.356 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 17.2 m120 -122.72 161.4 23.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.531 -0.304 . . . . 74.140000000000001 110.628 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -58.5 -25.46 62.39 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.889 -0.596 . . . . 71.409999999999997 111.202 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -83.49 22.93 0.99 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.627 -0.715 . . . . 73.319999999999993 111.512 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 65.53 14.25 9.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.879 0.471 . . . . 73.299999999999997 111.321 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 74.7 mt-30 -86.57 123.08 31.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.497 -0.319 . . . . 54.009999999999998 110.534 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -120.56 126.51 50.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.544 -0.539 . . . . 74.109999999999999 109.544 176.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 p -164.42 -154.44 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 70.430000000000007 110.346 -173.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.625 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.2 pt? -131.85 164.9 25.03 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.122 -0.695 . . . . 62.520000000000003 109.122 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.653 ' CH2' ' HB2' ' A' ' 18' ' ' PHE . 20.1 p90 -125.91 147.8 60.32 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-O 120.46 0.172 . . . . 73.310000000000002 111.033 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 13.8 Cg_exo -70.0 99.25 0.76 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.552 2.168 . . . . 52.539999999999999 111.133 173.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.99 -7.38 8.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.309 -0.405 . . . . 64.129999999999995 111.22 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -81.45 -2.46 49.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.985 -0.552 . . . . 72.430000000000007 110.706 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.0 177.62 7.84 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.413 -0.358 . . . . 42.140000000000001 110.642 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -80.79 138.55 36.27 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.814 -0.439 . . . . 74.129999999999995 109.814 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 t -90.45 126.29 56.93 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.138 -0.483 . . . . 74.219999999999999 110.45 -175.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.429 ' O ' ' HD1' ' A' ' 40' ' ' TRP . 38.6 Cg_endo -66.27 110.92 1.9 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.882 2.388 . . . . 74.140000000000001 112.501 -176.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -44.73 150.85 0.32 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.199 0.814 . . . . 34.340000000000003 113.199 -172.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.98 23.93 4.75 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.541 -0.754 . . . . 60.32 111.85 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.431 ' HB2' HD11 ' A' ' 20' ' ' LEU . 25.3 p-90 -130.2 160.08 34.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.897 0.379 . . . . 74.510000000000005 111.18 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 4.6 mmp_? -122.7 127.01 48.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.708 -0.849 . . . . 63.219999999999999 108.708 171.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.515 HG23 ' CH2' ' A' ' 30' ' ' TRP . 7.5 p -89.4 119.6 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 120.825 0.345 . . . . 60.219999999999999 110.423 -177.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.85 -38.18 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.455 0.645 . . . . 73.329999999999998 110.555 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.647 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 26.0 m80 -132.56 136.39 46.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.349 -0.841 . . . . 73.349999999999994 108.849 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.43 160.44 22.01 Favored Glycine 0 C--N 1.332 0.334 0 O-C-N 123.525 0.516 . . . . 61.030000000000001 112.892 -176.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.47 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -62.67 132.98 54.12 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.843 0.354 . . . . 74.340000000000003 111.031 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.5 -177.89 6.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.137 0.494 . . . . 73.409999999999997 111.734 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.76 172.71 2.06 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.241 -0.89 . . . . 61.520000000000003 112.716 -174.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.446 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 14.6 ttp180 -58.63 -42.91 89.34 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.575 -0.739 . . . . 74.329999999999998 111.172 178.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -52.5 -46.5 66.67 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.299 -0.63 . . . . 72.030000000000001 109.299 177.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.21 -34.7 78.21 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.019 -0.991 . . . . 52.32 111.081 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.817 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 36.7 m -60.39 -46.14 91.06 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.367 -0.833 . . . . 61.32 109.928 171.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.18 -24.78 62.3 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.486 -0.779 . . . . 74.319999999999993 110.561 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 42.1 mt-10 -76.93 -36.95 56.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 73.120000000000005 110.844 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -54.82 -50.46 68.53 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.659 0.244 . . . . 71.239999999999995 111.659 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.8 -34.89 49.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.032 0.444 . . . . 72.140000000000001 110.007 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -73.67 -25.59 60.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.762 -0.654 . . . . 72.010000000000005 110.819 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -65.88 -54.62 24.17 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.108 0.48 . . . . 74.420000000000002 109.985 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 77.0 t60 . . . . . 0 CA--C 1.534 0.334 0 CA-C-N 115.21 -0.904 . . . . 71.519999999999996 109.16 -174.585 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 1.7 t80 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.968 0.413 . . . . 74.209999999999994 110.051 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -140.97 131.18 24.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.321 -1.363 . . . . 74.439999999999998 107.321 165.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 43' ' ' VAL . 98.7 t -147.91 129.86 6.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 121.002 0.429 . . . . 65.329999999999998 110.345 -170.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 40' ' ' TRP . 46.2 tp -105.42 139.29 40.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.566 -0.743 . . . . 71.329999999999998 110.124 -177.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.1 t -118.41 126.09 74.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 109.41 -0.589 . . . . 73.439999999999998 109.41 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -95.09 162.54 13.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.295 -0.411 . . . . 74.140000000000001 110.007 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.44 -11.9 37.98 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.236 0.541 . . . . 71.409999999999997 110.232 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -83.08 9.62 9.96 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.35 -0.841 . . . . 73.319999999999993 110.768 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 66.08 9.85 6.56 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.088 0.555 . . . . 73.299999999999997 110.65 -174.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.559 HE21 ' HB2' ' A' ' 28' ' ' SER . 48.4 tp60 -74.06 118.27 16.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.118 -0.492 . . . . 54.009999999999998 110.171 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -108.71 98.63 8.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.084 -0.507 . . . . 74.109999999999999 110.165 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.559 ' HB2' HE21 ' A' ' 26' ' ' GLN . 33.5 t -133.17 -173.17 3.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.354 -0.385 . . . . 70.430000000000007 110.06 -175.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.814 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.1 pt? -107.57 147.84 30.06 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.423 -0.584 . . . . 62.520000000000003 109.423 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.449 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 43.2 p-90 -116.1 129.43 25.21 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.642 -0.254 . . . . 73.310000000000002 110.478 -177.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 33.3 Cg_exo -61.82 108.44 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.472 2.115 . . . . 52.539999999999999 111.67 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.449 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -60.59 -18.53 53.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.166 -0.47 . . . . 64.129999999999995 111.845 -178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -93.05 9.41 35.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 72.430000000000007 111.285 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.57 175.8 7.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.224 -0.444 . . . . 42.140000000000001 110.754 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -95.94 128.49 42.88 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.248 -0.433 . . . . 74.129999999999995 110.799 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.498 HG12 ' NE1' ' A' ' 40' ' ' TRP . 3.2 t -91.87 110.78 46.09 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.263 -0.426 . . . . 74.219999999999999 110.138 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.43 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 38.5 Cg_endo -67.2 115.67 3.78 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 123.103 2.536 . . . . 74.140000000000001 112.582 -176.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -46.12 151.9 0.45 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.189 0.811 . . . . 34.340000000000003 113.189 -172.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.2 26.52 3.73 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.408 -0.814 . . . . 60.32 111.741 -175.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.498 ' NE1' HG12 ' A' ' 36' ' ' VAL . 17.2 p-90 -134.74 -178.82 5.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.151 0.5 . . . . 74.510000000000005 110.952 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -145.06 126.05 14.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.65 -0.871 . . . . 63.219999999999999 108.65 169.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.87 134.65 28.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.078 -0.341 . . . . 60.219999999999999 110.078 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 19' ' ' VAL . 9.8 p -89.79 -25.5 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.544 0.688 . . . . 73.329999999999998 109.965 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -155.05 121.51 5.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.213 -0.903 . . . . 73.349999999999994 109.095 175.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.45 -174.78 50.26 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.188 -0.529 . . . . 61.030000000000001 111.955 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.5 112.13 1.48 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.09 0.471 . . . . 74.340000000000003 109.857 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.21 -177.78 3.51 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.765 0.654 . . . . 73.409999999999997 112.765 -165.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -86.74 179.87 6.69 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.175 -0.92 . . . . 61.520000000000003 112.437 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 32.2 ttm180 -48.48 -41.44 29.75 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.629 -1.169 . . . . 74.329999999999998 111.393 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -52.82 -47.18 67.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.146 0.498 . . . . 72.030000000000001 110.094 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 17' ' ' PHE . . . -69.88 -31.17 68.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.564 -0.743 . . . . 52.32 110.838 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 49' ' ' ARG . 53.9 t -56.84 -42.5 79.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.961 0.41 . . . . 61.32 110.164 171.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.44 -26.16 62.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.929 -0.578 . . . . 74.319999999999993 111.105 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 52.9 mt-10 -74.94 -53.17 9.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.362 -0.381 . . . . 73.120000000000005 111.468 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.572 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 39.7 t80 -60.84 -35.5 76.7 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 111.755 0.28 . . . . 71.239999999999995 111.755 -175.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.7 tt -71.23 -41.16 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 120.996 -0.282 . . . . 72.140000000000001 111.064 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -73.72 -57.25 4.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.901 0.381 . . . . 72.010000000000005 110.913 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -61.22 -31.86 71.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.747 -0.66 . . . . 74.420000000000002 110.926 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.8 m80 . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 116.029 -0.532 . . . . 71.519999999999996 110.645 -177.849 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.759 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 112.643 0.608 . . . . 74.209999999999994 112.643 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.45 130.59 11.91 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.989 0.813 . . . . 74.439999999999998 109.834 153.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -162.85 138.3 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.053 0 CA-C-O 121.242 0.544 . . . . 65.329999999999998 111.045 170.546 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.586 ' HB2' ' CD1' ' A' ' 30' ' ' TRP . 32.3 tp -104.19 153.7 20.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.418 -0.81 . . . . 71.329999999999998 108.972 175.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 41' ' ' ARG . 9.7 p -136.67 134.23 48.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.952 0.406 . . . . 73.439999999999998 110.373 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -73.05 154.76 40.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.875 -0.787 . . . . 74.140000000000001 108.875 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -57.13 -23.91 50.53 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.082 0.468 . . . . 71.409999999999997 110.512 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.42 13.04 1.69 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.837 -0.619 . . . . 73.319999999999993 111.004 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 56.88 56.81 5.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.8 0.81 . . . . 73.299999999999997 110.696 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -114.74 119.89 38.21 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.709 -1.132 . . . . 54.009999999999998 108.896 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -76.08 132.29 39.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.673 -0.24 . . . . 74.109999999999999 110.502 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.8 m -153.74 178.12 10.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.012 0.434 . . . . 70.430000000000007 110.741 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.704 ' H ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -124.57 159.83 29.77 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.949 -0.76 . . . . 62.520000000000003 108.949 177.131 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.586 ' CD1' ' HB2' ' A' ' 20' ' ' LEU . 6.0 p-90 -145.13 139.49 15.15 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 121.041 -0.264 . . . . 73.310000000000002 111.59 -173.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 5.2 Cg_exo -80.14 104.9 1.71 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.072 2.515 . . . . 52.539999999999999 110.833 173.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.29 -2.08 1.98 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.467 0.543 . . . . 64.129999999999995 112.467 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -91.05 -0.14 57.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.474 0.178 . . . . 72.430000000000007 111.36 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.65 170.31 12.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.597 0.237 . . . . 42.140000000000001 110.903 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -69.44 126.39 29.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.887 -0.597 . . . . 74.129999999999995 110.08 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 t -97.61 113.25 63.22 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.756 -0.461 . . . . 74.219999999999999 109.756 -176.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.446 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 21.0 Cg_endo -60.64 107.23 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.982 2.454 . . . . 74.140000000000001 113.334 -172.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.89 151.82 0.42 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.447 0.699 . . . . 34.340000000000003 112.655 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.98 5.91 21.3 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.869 -0.605 . . . . 60.32 112.065 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.446 ' CD1' ' O ' ' A' ' 37' ' ' PRO . 18.4 p-90 -107.41 175.66 5.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 74.510000000000005 110.867 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.527 ' O ' HG12 ' A' ' 21' ' ' VAL . 15.0 tpp180 -141.61 142.98 33.44 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.26 -1.015 . . . . 63.219999999999999 108.26 170.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.2 p -90.68 131.2 38.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.013 -0.366 . . . . 60.219999999999999 110.013 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.1 m -99.47 -22.42 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.313 0.578 . . . . 73.329999999999998 110.313 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 17' ' ' PHE . 92.1 m-70 -147.63 118.72 7.72 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.224 -1.028 . . . . 73.349999999999994 108.224 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.04 165.4 7.1 Favored Glycine 0 C--N 1.332 0.35 0 O-C-N 123.807 0.692 . . . . 61.030000000000001 113.481 -172.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.45 151.35 24.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.143 0.497 . . . . 74.340000000000003 110.594 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -162.95 -177.98 5.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.948 -0.569 . . . . 73.409999999999997 110.465 -175.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -54.18 161.37 1.32 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.234 0.54 . . . . 61.520000000000003 112.01 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.687 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 46.1 ttt180 -57.12 -29.81 63.85 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.574 -0.739 . . . . 74.329999999999998 110.47 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -62.25 -47.3 84.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.939 0.4 . . . . 72.030000000000001 110.154 174.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.27 -31.4 71.7 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 116.173 -0.467 . . . . 52.32 111.544 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.687 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 16.6 p -73.51 -50.59 20.68 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.711 -0.677 . . . . 61.32 111.244 173.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.508 ' H ' ' HG ' ' A' ' 52' ' ' CYS . 78.6 mt -59.09 -34.66 72.25 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.414 0.626 . . . . 74.319999999999993 110.346 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 20.2 mm-40 -76.94 -35.19 57.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.72 -0.673 . . . . 73.120000000000005 110.485 176.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.759 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -46.33 -52.68 12.31 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 117.847 0.294 . . . . 71.239999999999995 111.599 171.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.6 tt -71.18 -36.58 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.661 0.267 . . . . 72.140000000000001 111.61 -173.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -73.31 -50.46 22.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.149 0.499 . . . . 72.010000000000005 110.498 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -61.47 -27.58 68.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.598 -0.728 . . . . 74.420000000000002 109.041 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 . . . . . 0 N--CA 1.463 0.196 0 CA-C-N 114.396 -1.275 . . . . 71.519999999999996 112.179 171.697 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.813 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.637 0.256 . . . . 74.209999999999994 111.543 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.472 ' HB3' ' HA ' ' A' ' 46' ' ' GLU . 28.3 p90 -125.12 137.45 54.18 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.92 0.39 . . . . 74.439999999999998 110.434 -173.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.445 HG23 HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -155.14 142.86 12.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 121.567 0.699 . . . . 65.329999999999998 111.776 -178.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 30' ' ' TRP . 48.1 tp -105.25 147.99 27.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.194 -1.367 . . . . 71.329999999999998 108.8 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.6 144.42 28.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.13 0.49 . . . . 73.439999999999998 110.824 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -104.33 153.63 20.81 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.007 -0.738 . . . . 74.140000000000001 109.007 175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -57.59 -22.81 47.3 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.811 0.339 . . . . 71.409999999999997 111.087 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -77.9 15.4 0.88 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.15 -0.477 . . . . 73.319999999999993 111.577 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 67.11 15.81 10.15 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.135 0.574 . . . . 73.299999999999997 111.407 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -84.83 119.45 25.33 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.578 -0.527 . . . . 54.009999999999998 109.578 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -114.19 136.48 52.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.95 0.405 . . . . 74.109999999999999 111.191 -175.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -152.04 -172.12 4.13 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.213 -0.662 . . . . 70.430000000000007 109.213 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.8 pt? -109.04 139.37 44.02 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.452 -0.573 . . . . 62.520000000000003 109.452 174.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 20' ' ' LEU . 21.4 p-90 -98.62 155.03 37.2 Favored Pre-proline 0 C--O 1.236 0.345 0 CA-C-N 116.151 -0.477 . . . . 73.310000000000002 110.792 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.578 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 31.1 Cg_exo -62.2 96.16 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.45 2.1 . . . . 52.539999999999999 111.012 174.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.39 -23.76 62.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.884 -0.598 . . . . 64.129999999999995 111.692 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -95.3 17.44 14.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.112 -0.495 . . . . 72.430000000000007 110.894 -178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . . . -143.39 174.62 10.58 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.8 0.333 . . . . 42.140000000000001 110.762 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -92.21 139.88 30.18 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.057 -0.52 . . . . 74.129999999999995 110.244 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -76.06 130.91 76.85 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 74.219999999999999 110.603 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HG2' ' CD1' ' A' ' 40' ' ' TRP . 45.3 Cg_endo -68.52 167.02 23.75 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.454 2.102 . . . . 74.140000000000001 112.141 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.94 151.57 47.37 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.969 -0.56 . . . . 34.340000000000003 111.548 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.97 -35.85 4.13 Favored Glycine 0 C--N 1.33 0.232 0 CA-C-N 115.65 -0.705 . . . . 60.32 112.342 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.406 ' CD1' ' HG2' ' A' ' 37' ' ' PRO . 41.9 m95 -88.23 145.37 25.91 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.256 -0.276 . . . . 74.510000000000005 110.256 -177.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -127.87 128.82 45.85 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.147 -0.316 . . . . 63.219999999999999 110.147 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.9 t -80.98 137.6 21.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.985 -0.376 . . . . 60.219999999999999 109.985 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.445 HG13 HG23 ' A' ' 19' ' ' VAL . 8.1 p -107.15 -28.98 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.992 0.425 . . . . 73.329999999999998 110.839 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.674 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 1.7 m-70 -139.79 138.58 35.97 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.799 -0.445 . . . . 73.349999999999994 109.799 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.48 174.81 36.9 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 123.674 0.609 . . . . 61.030000000000001 113.367 -173.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -58.99 138.31 57.56 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.127 0.571 . . . . 74.340000000000003 111.185 -172.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -158.99 173.94 15.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.917 0.389 . . . . 73.409999999999997 111.493 -175.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -84.25 177.59 8.13 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.717 0.77 . . . . 61.520000000000003 112.894 -171.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.457 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 9.0 tpm_? -50.19 -44.29 52.9 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.331 -1.304 . . . . 74.329999999999998 111.143 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.31 -52.41 61.6 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 116.144 -0.48 . . . . 72.030000000000001 110.64 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.64 -31.04 72.09 Favored 'General case' 0 C--O 1.263 1.801 0 CA-C-O 121.819 0.818 . . . . 52.32 111.608 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.813 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 73.2 m -72.58 -28.76 63.0 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 114.459 -1.246 . . . . 61.32 110.79 175.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.654 ' O ' HG22 ' A' ' 56' ' ' ILE . 92.6 mt -71.72 -51.96 20.2 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 108.81 -0.811 . . . . 74.319999999999993 108.81 169.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.17 -24.17 25.42 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.371 -0.831 . . . . 73.120000000000005 111.811 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.587 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -44.39 -31.25 1.0 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 121.118 -0.233 . . . . 71.239999999999995 111.276 171.27 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.654 HG22 ' O ' ' A' ' 53' ' ' LEU . 19.8 tt -60.16 -46.47 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.379 0.609 . . . . 72.140000000000001 110.455 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.458 ' N ' HG23 ' A' ' 56' ' ' ILE . 6.2 tp10 -74.37 -43.04 58.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.492 -0.776 . . . . 72.010000000000005 110.81 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -50.79 -58.89 4.84 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.302 -0.863 . . . . 74.420000000000002 111.956 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.2 m80 . . . . . 0 CA--C 1.533 0.292 0 CA-C-N 115.671 -0.695 . . . . 71.519999999999996 111.285 -175.879 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.626 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 114.596 1.332 . . . . 74.209999999999994 114.596 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 38.9 p90 -126.48 136.2 52.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 113.924 -1.489 . . . . 74.439999999999998 109.766 -176.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 43' ' ' VAL . 54.3 t -147.75 131.44 8.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-O 121.053 0.454 . . . . 65.329999999999998 110.1 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 40' ' ' TRP . 64.9 tp -102.97 137.66 40.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.753 -0.658 . . . . 71.329999999999998 110.851 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.1 t -113.04 152.78 14.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.127 -1.064 . . . . 73.439999999999998 108.127 171.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.696 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 34.6 t30 -123.57 144.72 49.4 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.572 -0.899 . . . . 74.140000000000001 108.572 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -68.5 -7.85 35.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.014 0.435 . . . . 71.409999999999997 110.504 -177.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 29.2 tt0 -75.39 4.09 7.93 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.329 -0.85 . . . . 73.319999999999993 109.893 168.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 47.6 mt-10 74.16 15.72 3.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.854 0.862 . . . . 73.299999999999997 111.693 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.696 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 6.2 tp-100 -76.6 148.75 36.77 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.212 -0.662 . . . . 54.009999999999998 109.212 172.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -150.77 114.36 4.93 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.661 0.267 . . . . 74.109999999999999 110.626 -177.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.5 t -171.75 175.72 3.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.143 -0.481 . . . . 70.430000000000007 109.752 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.689 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.5 pt? -80.79 160.14 24.94 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.456 -0.572 . . . . 62.520000000000003 109.456 175.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 23.7 p-90 -126.46 132.84 24.47 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.65 0.262 . . . . 73.310000000000002 110.996 -174.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 12.6 Cg_exo -70.46 107.27 1.96 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.435 2.09 . . . . 52.539999999999999 111.549 177.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.04 -8.92 8.44 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.24 -0.436 . . . . 64.129999999999995 111.78 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -81.66 -10.86 59.3 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.307 -0.406 . . . . 72.430000000000007 110.606 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.36 166.33 11.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.231 -0.441 . . . . 42.140000000000001 110.577 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.64 134.29 35.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.055 -0.521 . . . . 74.129999999999995 109.705 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.508 HG12 ' NE1' ' A' ' 40' ' ' TRP . 2.5 t -95.47 104.09 14.63 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 110.078 -0.341 . . . . 74.219999999999999 110.078 -176.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 42.9 Cg_endo -67.2 114.42 3.21 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.982 2.455 . . . . 74.140000000000001 113.116 -174.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -44.48 152.49 0.2 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.727 0.811 . . . . 34.340000000000003 113.156 -173.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.1 12.65 10.81 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.747 -0.661 . . . . 60.32 111.468 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.508 ' NE1' HG12 ' A' ' 36' ' ' VAL . 10.4 p-90 -115.78 -172.53 2.18 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.912 0.485 . . . . 74.510000000000005 110.85 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -161.77 125.91 3.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.334 -0.848 . . . . 63.219999999999999 109.243 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.419 HG22 HD13 ' A' ' 20' ' ' LEU . 6.1 t -90.63 148.04 4.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.603 -0.271 . . . . 60.219999999999999 111.05 -171.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 19' ' ' VAL . 8.9 p -93.69 -34.26 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 109.508 -0.553 . . . . 73.329999999999998 109.508 173.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.441 ' ND1' ' O ' ' A' ' 17' ' ' PHE . 64.2 t-80 -158.31 132.14 7.8 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.434 -0.58 . . . . 73.349999999999994 109.434 173.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -76.66 -168.67 28.68 Favored Glycine 0 C--N 1.334 0.417 0 O-C-N 123.712 0.632 . . . . 61.030000000000001 114.021 -175.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -45.19 154.86 0.14 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.451 1.1 . . . . 74.340000000000003 113.449 -170.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' A' ' 51' ' ' ALA . . . -157.79 162.49 38.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.597 -0.729 . . . . 73.409999999999997 111.707 -176.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.96 166.14 21.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.533 -0.758 . . . . 61.520000000000003 110.296 175.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.464 HH11 HD12 ' A' ' 53' ' ' LEU . 7.0 tmm_? -53.83 -45.3 70.83 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.311 -0.404 . . . . 74.329999999999998 110.499 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.92 -42.81 80.64 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 116.207 -0.451 . . . . 72.030000000000001 110.703 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . . . -66.67 -34.46 77.91 Favored 'General case' 0 C--O 1.273 2.324 0 CA-C-O 122.295 1.045 . . . . 52.32 111.616 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.626 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 36.1 t -66.17 -36.77 83.97 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 113.528 -1.669 . . . . 61.32 109.773 175.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.617 ' O ' HG22 ' A' ' 56' ' ' ILE . 79.8 mt -71.76 -39.8 69.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 74.319999999999993 110.183 171.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -60.92 -25.2 66.58 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 122.905 0.482 . . . . 73.120000000000005 111.224 -176.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.588 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -45.63 -24.91 0.39 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.319 0.387 . . . . 71.239999999999995 111.344 170.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 53' ' ' LEU . 17.0 tt -64.62 -49.38 80.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.082 0.467 . . . . 72.140000000000001 110.277 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.517 ' N ' HG23 ' A' ' 56' ' ' ILE . 9.5 tp10 -74.01 -42.51 60.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.315 -0.857 . . . . 72.010000000000005 111.049 -175.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.512 ' HG2' ' HA ' ' A' ' 55' ' ' TYR . 16.3 pt-20 -78.46 -37.98 42.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 74.420000000000002 111.269 -176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.1 p80 . . . . . 0 N--CA 1.475 0.802 0 C-N-CA 123.772 0.829 . . . . 71.519999999999996 112.261 179.152 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.81 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 24.8 t80 . . . . . 0 N--CA 1.451 -0.41 0 CA-C-O 121.872 0.844 . . . . 74.209999999999994 109.502 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 29' ' ' LEU . 54.2 p90 -150.39 131.51 14.42 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.004 -1.48 . . . . 74.439999999999998 107.004 169.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 48.9 t -143.06 131.77 20.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.84 -0.344 . . . . 65.329999999999998 110.256 -169.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -120.91 123.57 42.82 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.263 -0.643 . . . . 71.329999999999998 109.263 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.3 m -112.19 125.97 69.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.444 0.64 . . . . 73.439999999999998 109.778 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.675 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 14.4 m120 -84.06 146.65 27.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.598 -0.728 . . . . 74.140000000000001 109.485 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -56.33 -23.35 36.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.029 0.443 . . . . 71.409999999999997 111.203 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -87.36 23.2 1.93 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.045 -0.525 . . . . 73.319999999999993 110.906 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 67.84 21.01 9.21 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.74 0.816 . . . . 73.299999999999997 112.391 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.675 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 15.6 mm-40 -83.43 117.96 23.41 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.011 -0.366 . . . . 54.009999999999998 110.011 175.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -92.92 116.82 29.39 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.364 -0.606 . . . . 74.109999999999999 109.364 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -152.9 -172.84 4.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.231 0.539 . . . . 70.430000000000007 110.758 -174.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.442 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 2.4 pp -125.72 -174.78 3.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.69 -0.686 . . . . 62.520000000000003 109.196 174.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.4 p-90 -145.3 128.78 8.49 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 110.122 -0.325 . . . . 73.310000000000002 110.122 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.52 130.62 41.04 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.457 2.104 . . . . 52.539999999999999 111.369 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.67 12.48 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.9 0.704 . . . . 64.129999999999995 112.9 -173.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -81.72 -27.37 33.94 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.712 0.292 . . . . 72.430000000000007 111.052 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.04 155.12 37.59 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.996 0.427 . . . . 42.140000000000001 111.17 -176.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -94.91 139.71 30.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.057 -0.52 . . . . 74.129999999999995 109.823 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.2 t -79.9 111.37 21.12 Favored Pre-proline 0 C--O 1.235 0.305 0 N-CA-C 110.006 -0.368 . . . . 74.219999999999999 110.006 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.11 133.44 57.71 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.666 2.244 . . . . 74.140000000000001 112.03 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.9 135.7 57.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.999 -0.546 . . . . 34.340000000000003 110.763 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.02 -24.83 11.31 Favored Glycine 0 C--O 1.235 0.201 0 C-N-CA 121.315 -0.469 . . . . 60.32 112.171 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -91.27 154.67 19.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.839 -0.8 . . . . 74.510000000000005 108.839 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -110.02 125.97 53.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.919 0.39 . . . . 63.219999999999999 110.141 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.1 p -91.87 122.99 43.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.98 0.419 . . . . 60.219999999999999 110.68 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 58.4 t -72.94 -41.05 60.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.261 0.553 . . . . 73.329999999999998 109.561 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.425 ' HE1' ' HB2' ' A' ' 47' ' ' ALA . 49.2 t-80 -160.96 141.89 11.57 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.492 -0.777 . . . . 73.349999999999994 109.24 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.08 -170.68 47.25 Favored Glycine 0 N--CA 1.452 -0.297 0 O-C-N 123.598 0.561 . . . . 61.030000000000001 112.617 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.17 140.31 21.38 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.063 0.545 . . . . 74.340000000000003 110.583 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.425 ' HB2' ' HE1' ' A' ' 44' ' ' HIS . . . -143.57 -178.32 5.83 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.429 0.529 . . . . 73.409999999999997 112.429 -170.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -91.66 179.72 5.57 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.324 -0.853 . . . . 61.520000000000003 112.213 -173.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.534 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 4.4 tmt_? -60.93 -40.82 94.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.428 -0.805 . . . . 74.329999999999998 111.734 -177.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.65 -36.05 81.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.144 0.497 . . . . 72.030000000000001 109.729 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 17' ' ' PHE . . . -68.31 -30.71 69.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.576 -0.738 . . . . 52.32 110.532 175.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.598 ' O ' HG22 ' A' ' 56' ' ' ILE . 53.9 t -59.43 -47.59 84.88 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.356 -0.609 . . . . 61.32 109.356 170.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.503 HD11 ' NH1' ' A' ' 49' ' ' ARG . 85.5 mt -57.88 -32.76 68.02 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.6 -0.727 . . . . 74.319999999999993 110.689 177.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.54 -53.53 22.44 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.341 -0.39 . . . . 73.120000000000005 110.728 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.81 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 40.4 t80 -64.59 -43.83 92.59 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.991 0.367 . . . . 71.239999999999995 111.991 -173.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 52' ' ' CYS . 12.4 tt -64.11 -39.83 86.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.121 0.486 . . . . 72.140000000000001 110.978 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -73.52 -35.31 65.56 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.078 -0.51 . . . . 72.010000000000005 110.537 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -65.24 -38.72 91.24 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.285 -0.635 . . . . 74.420000000000002 109.285 171.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 . . . . . 0 C--O 1.236 0.38 0 CA-C-N 114.711 -1.131 . . . . 71.519999999999996 110.584 179.166 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.687 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 3.4 p90 . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 114.278 1.214 . . . . 74.209999999999994 114.278 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -151.15 130.5 12.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.333 -1.729 . . . . 74.439999999999998 106.333 148.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.6 HG22 ' CE1' ' A' ' 55' ' ' TYR . 17.3 t -151.87 122.25 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 112.373 0.509 . . . . 65.329999999999998 112.373 -168.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 54.5 tp -96.42 144.83 26.19 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.621 -0.718 . . . . 71.329999999999998 109.785 174.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.68 126.1 64.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.278 0.561 . . . . 73.439999999999998 110.008 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.406 ' ND2' ' HZ3' ' A' ' 40' ' ' TRP . 1.1 m-20 -77.47 144.77 37.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.439 -0.8 . . . . 74.140000000000001 109.633 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -58.4 -17.85 23.59 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.802 0.811 . . . . 71.409999999999997 109.683 172.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.56 0.96 9.06 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.76 -1.109 . . . . 73.319999999999993 111.04 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 72.69 14.36 5.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.411 0.684 . . . . 73.299999999999997 111.035 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -90.05 161.31 15.89 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.546 -0.909 . . . . 54.009999999999998 108.546 172.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -152.33 140.85 20.71 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.186 0.448 . . . . 74.109999999999999 111.253 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -168.22 -166.27 0.69 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.552 -0.536 . . . . 70.430000000000007 109.552 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.809 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.1 pt? -94.44 161.65 14.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.691 0.281 . . . . 62.520000000000003 110.461 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -138.25 147.3 55.19 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.43 -0.35 . . . . 73.310000000000002 110.65 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.15 116.9 4.72 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.488 2.125 . . . . 52.539999999999999 111.543 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.0 -21.29 64.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.279 -0.418 . . . . 64.129999999999995 111.655 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -81.43 -20.16 40.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.855 0.359 . . . . 72.430000000000007 110.524 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.97 150.62 23.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.367 -0.379 . . . . 42.140000000000001 110.439 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -95.37 111.64 23.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.659 -0.497 . . . . 74.129999999999995 109.659 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.482 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.1 p -81.49 120.4 78.0 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.361 -0.381 . . . . 74.219999999999999 110.936 -176.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 5.9 Cg_exo -75.57 173.1 15.07 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.401 2.734 . . . . 74.140000000000001 113.107 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.42 152.35 44.12 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.957 -0.565 . . . . 34.340000000000003 110.911 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.54 -28.55 11.85 Favored Glycine 0 C--N 1.329 0.186 0 N-CA-C 110.935 -0.866 . . . . 60.32 110.935 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.406 ' HZ3' ' ND2' ' A' ' 22' ' ' ASN . 11.7 m95 -105.09 98.67 8.35 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.075 -1.083 . . . . 74.510000000000005 108.075 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -99.59 126.34 45.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.855 0.36 . . . . 63.219999999999999 111.3 -172.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 8.5 p -82.94 119.76 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.117 -0.492 . . . . 60.219999999999999 109.907 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.08 -26.87 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.527 0.679 . . . . 73.329999999999998 110.059 -175.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -131.96 107.18 8.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.218 -0.901 . . . . 73.349999999999994 108.652 174.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.55 173.26 5.72 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.19 -0.914 . . . . 61.030000000000001 114.453 -169.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.92 137.27 58.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.772 -0.714 . . . . 74.340000000000003 110.061 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.85 -177.97 6.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.678 0.275 . . . . 73.409999999999997 111.138 -174.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 7.7 m-20 -58.08 160.45 4.88 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.685 -0.689 . . . . 61.520000000000003 112.178 -175.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.514 ' O ' ' SG ' ' A' ' 52' ' ' CYS . 6.6 ttm180 -53.87 -44.18 70.2 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.477 -0.783 . . . . 74.329999999999998 110.004 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.69 -33.79 74.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.099 0.476 . . . . 72.030000000000001 110.539 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 48' ' ' ASP . . . -66.52 -42.22 87.6 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-N 115.751 -0.659 . . . . 52.32 111.059 -178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 49' ' ' ARG . 30.0 p -73.54 -35.79 65.57 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.66 -1.154 . . . . 61.32 111.233 174.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 60.0 mt -65.12 -34.75 79.15 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.363 -0.381 . . . . 74.319999999999993 110.222 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.19 -37.24 54.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.239 -0.437 . . . . 73.120000000000005 110.504 173.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.687 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 23.2 t80 -46.35 -45.24 17.53 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.324 0.49 . . . . 71.239999999999995 112.324 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 53' ' ' LEU . 11.5 tt -63.48 -39.35 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 120.491 -0.484 . . . . 72.140000000000001 111.326 -176.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -73.78 -43.21 59.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.625 0.25 . . . . 72.010000000000005 110.973 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 69.5 mm-40 -77.7 -41.12 39.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 111.758 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 95.2 m-70 . . . . . 0 N--CA 1.477 0.897 0 C-N-CA 124.428 1.091 . . . . 71.519999999999996 113.076 175.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.736 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 38.4 m-85 . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 117.049 -1.453 . . . . 74.209999999999994 107.93 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.63 ' CE2' ' HB1' ' A' ' 51' ' ' ALA . 98.1 m-85 -151.83 130.54 12.35 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 121.843 2.11 . . . . 74.439999999999998 109.871 172.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -164.22 143.29 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 112.559 0.577 . . . . 65.329999999999998 112.559 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.8 tp -102.3 123.6 46.4 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.575 -0.898 . . . . 71.329999999999998 108.575 165.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.58 125.83 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 73.439999999999998 110.15 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 3.8 m-20 -97.53 158.34 15.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.419 -0.355 . . . . 74.140000000000001 110.435 -178.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.25 -20.54 59.37 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.705 0.764 . . . . 71.409999999999997 109.816 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -76.49 9.56 2.63 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.8 -1.091 . . . . 73.319999999999993 111.143 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 67.86 15.37 9.58 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.304 0.642 . . . . 73.299999999999997 111.09 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.411 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 80.6 mm-40 -78.06 146.42 35.28 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.789 -0.819 . . . . 54.009999999999998 108.789 173.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -153.48 102.54 2.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.022 -0.362 . . . . 74.109999999999999 110.022 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.3 t -170.86 -170.1 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.823 -0.626 . . . . 70.430000000000007 110.096 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.452 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.4 mp -80.65 166.26 21.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.771 -0.65 . . . . 62.520000000000003 110.67 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.504 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 17.3 p-90 -143.36 155.29 61.13 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.521 -0.309 . . . . 73.310000000000002 111.11 -175.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.6 95.72 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.5 2.133 . . . . 52.539999999999999 111.585 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -67.42 -18.31 65.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.657 -0.701 . . . . 64.129999999999995 112.004 -175.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -81.58 -20.84 39.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 72.430000000000007 110.709 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.13 176.38 6.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 42.140000000000001 110.837 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.46 138.57 37.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.944 -0.571 . . . . 74.129999999999995 109.873 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.617 HG22 ' NE1' ' A' ' 40' ' ' TRP . 7.4 p -104.46 129.77 24.45 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 109.968 -0.382 . . . . 74.219999999999999 109.968 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.511 ' O ' ' NE1' ' A' ' 40' ' ' TRP . 77.7 Cg_endo -76.4 -169.43 0.7 Allowed 'Trans proline' 0 N--CA 1.481 0.778 0 C-N-CA 123.125 2.55 . . . . 74.140000000000001 114.299 -171.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.95 152.43 24.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.92 -0.582 . . . . 34.340000000000003 111.14 171.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.0 27.18 7.51 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.741 -0.743 . . . . 60.32 114.42 168.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.617 ' NE1' HG22 ' A' ' 36' ' ' VAL . 48.2 p-90 -130.36 174.63 9.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.337 0.589 . . . . 74.510000000000005 111.213 176.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -154.66 125.92 7.32 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.964 -1.124 . . . . 63.219999999999999 107.964 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.87 131.93 36.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.735 -0.469 . . . . 60.219999999999999 109.735 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.3 t -91.29 -23.99 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.655 0.74 . . . . 73.329999999999998 109.56 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.443 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -171.06 131.24 0.79 Allowed 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.605 -1.18 . . . . 73.349999999999994 107.928 174.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 18' ' ' PHE . . . -73.41 139.91 27.44 Favored Glycine 0 C--N 1.338 0.642 0 O-C-N 124.333 1.021 . . . . 61.030000000000001 114.089 -167.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -25.89 124.63 0.06 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.015 1.326 . . . . 74.340000000000003 114.539 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.492 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . . . -131.65 -176.98 4.22 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.015 -0.993 . . . . 73.409999999999997 109.419 175.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -52.57 153.01 3.29 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.267 0.556 . . . . 61.520000000000003 110.98 176.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.45 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 14.0 ttp180 -54.26 -31.28 53.18 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 115.293 -0.867 . . . . 74.329999999999998 110.248 -176.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.89 -45.05 83.42 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.09 0.471 . . . . 72.030000000000001 111.012 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.63 ' HB1' ' CE2' ' A' ' 18' ' ' PHE . . . -63.21 -40.18 96.73 Favored 'General case' 0 C--O 1.274 2.359 0 CA-C-O 121.683 0.754 . . . . 52.32 111.483 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.595 ' O ' ' HB3' ' A' ' 55' ' ' TYR . 64.9 m -73.46 -37.99 65.61 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 113.57 -1.65 . . . . 61.32 112.309 175.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 25.9 mt -70.11 -44.3 69.28 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.823 -0.436 . . . . 74.319999999999993 109.823 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.511 ' HA ' ' HB3' ' A' ' 57' ' ' GLU . 0.8 OUTLIER -68.72 -25.98 65.03 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 118.911 -0.566 . . . . 73.120000000000005 110.353 175.353 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.736 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -45.39 -61.5 1.65 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 118.141 -1.424 . . . . 71.239999999999995 111.352 162.584 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 tt -68.59 -35.76 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.754 0.311 . . . . 72.140000000000001 111.302 -176.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 54' ' ' GLU . 8.3 tp10 -62.53 -43.26 99.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.181 0.515 . . . . 72.010000000000005 110.244 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -66.97 -40.24 87.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.144 -0.935 . . . . 74.420000000000002 110.57 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.7 t60 . . . . . 0 N--CA 1.469 0.515 0 CA-C-N 115.621 -0.718 . . . . 71.519999999999996 111.2 175.653 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.805 0 N-CA-C 111.697 -0.561 . . . . 64.540000000000006 111.697 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.82 140.52 11.58 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.579 2.186 . . . . 72.439999999999998 112.702 -175.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.89 -111.92 3.4 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.849 -0.614 . . . . 52.530000000000001 112.982 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.479 ' HB3' HD11 ' A' ' 7' ' ' ILE . 15.2 m -96.06 102.02 13.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.978 0.418 . . . . 64.439999999999998 111.82 -172.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.717 ' HG3' ' H ' ' A' ' 68' ' ' LEU . 81.6 mmm -104.17 -32.16 9.28 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.215 -0.661 . . . . 72.430000000000007 109.215 165.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.421 ' HG ' ' HG2' ' A' ' 71' ' ' LYS . 49.8 m -145.85 123.64 11.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.25 -0.886 . . . . 74.200000000000003 109.622 175.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.572 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 45.4 mm -95.04 153.3 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 65.329999999999998 110.486 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.544 ' HB2' HH11 ' A' ' 64' ' ' ARG . 89.2 m-20 -106.3 85.83 1.85 Allowed Pre-proline 0 N--CA 1.465 0.278 0 N-CA-C 108.971 -0.751 . . . . 64.430000000000007 108.971 173.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.61 ' HG2' ' HB2' ' A' ' 12' ' ' ASP . 91.6 Cg_endo -95.86 141.65 0.99 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.316 2.677 . . . . 71.439999999999998 112.852 -174.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -62.78 -46.01 90.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.022 -0.535 . . . . 72.319999999999993 110.659 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.89 -46.21 2.84 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.23 -0.441 . . . . 75.400000000000006 111.336 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.61 ' HB2' ' HG2' ' A' ' 9' ' ' PRO . 28.5 t70 73.76 -10.8 1.03 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.466 0.706 . . . . 73.540000000000006 111.817 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.43 -60.71 2.12 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.669 0.271 . . . . 74.530000000000001 110.922 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -82.77 -29.93 29.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.03 -0.532 . . . . 73.329999999999998 109.85 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 61.05 -118.25 14.4 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.457 -0.792 . . . . 55.210000000000001 112.7 177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.556 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 20.2 m -160.6 -179.92 8.04 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.325 -0.62 . . . . 71.319999999999993 109.325 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.895 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 23.4 t80 -66.29 -165.5 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.094 -0.706 . . . . 74.209999999999994 109.094 172.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -124.49 136.32 53.92 Favored 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 121.366 -0.833 . . . . 74.439999999999998 110.65 -169.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.8 t -143.6 131.31 18.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.787 0 CA-C-N 114.802 -1.09 . . . . 65.329999999999998 110.574 -169.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.709 HD22 ' HB3' ' A' ' 30' ' ' TRP . 43.8 tp -112.78 123.37 50.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.575 -0.739 . . . . 71.329999999999998 110.168 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.9 m -109.35 177.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.614 -0.514 . . . . 73.439999999999998 109.614 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.683 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 27.7 t-20 -144.37 149.87 36.83 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.482 -0.192 . . . . 74.140000000000001 110.482 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.46 -28.49 30.69 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.295 0.372 . . . . 71.409999999999997 111.741 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.75 20.27 1.83 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.179 -0.464 . . . . 73.319999999999993 111.322 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 71.16 10.61 6.82 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.499 0.719 . . . . 73.299999999999997 112.211 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.683 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 43.2 mt-30 -74.62 153.36 39.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.601 -0.518 . . . . 54.009999999999998 109.601 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -157.36 133.96 9.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 74.109999999999999 110.591 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.1 t -171.53 -163.96 0.3 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.534 -0.913 . . . . 70.430000000000007 108.534 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.62 166.27 11.58 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.775 -0.454 . . . . 62.520000000000003 109.775 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.709 ' HB3' HD22 ' A' ' 20' ' ' LEU . 32.5 p-90 -128.14 144.73 52.75 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.542 -0.299 . . . . 73.310000000000002 110.272 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.76 104.72 0.58 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.596 2.197 . . . . 52.539999999999999 111.605 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.22 -18.72 59.72 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.181 -0.463 . . . . 64.129999999999995 111.738 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -92.17 10.66 28.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.107 -0.497 . . . . 72.430000000000007 110.866 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.71 179.32 6.65 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.794 0.331 . . . . 42.140000000000001 110.76 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -95.5 139.96 31.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.959 -0.564 . . . . 74.129999999999995 109.874 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.54 124.03 89.07 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.575 -0.284 . . . . 74.219999999999999 110.404 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HG2' ' CD1' ' A' ' 40' ' ' TRP . 29.2 Cg_endo -63.64 146.65 92.65 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.379 2.052 . . . . 74.140000000000001 111.789 178.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.04 145.97 28.86 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.126 -0.488 . . . . 34.340000000000003 111.075 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.86 -23.39 34.9 Favored Glycine 0 C--N 1.33 0.209 0 CA-C-N 116.152 -0.476 . . . . 60.32 111.944 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.525 ' CE3' ' HB2' ' A' ' 22' ' ' ASN . 65.7 m95 -97.04 160.59 14.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.712 0.292 . . . . 74.510000000000005 110.221 177.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -132.64 125.58 30.69 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.911 -0.774 . . . . 63.219999999999999 108.911 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.05 114.09 27.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.481 -0.563 . . . . 60.219999999999999 109.481 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.41 HG21 ' CH2' ' A' ' 60' ' ' TRP . 34.8 m -86.92 -21.37 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.368 0.604 . . . . 73.329999999999998 110.417 -174.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.402 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 46.1 m80 -153.78 129.4 10.0 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.342 -0.845 . . . . 73.349999999999994 109.347 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.08 -178.85 45.82 Favored Glycine 0 C--N 1.336 0.546 0 O-C-N 124.15 0.907 . . . . 61.030000000000001 112.122 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.68 145.09 50.54 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.855 0.359 . . . . 74.340000000000003 111.623 -174.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.25 -178.34 6.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.782 -0.644 . . . . 73.409999999999997 110.54 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -79.3 167.98 20.17 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 116.2 -0.455 . . . . 61.520000000000003 111.452 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.689 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 41.0 ttm180 -55.88 -33.76 64.88 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 115.989 -0.55 . . . . 74.329999999999998 110.941 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -56.32 -48.15 77.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.134 0.493 . . . . 72.030000000000001 109.949 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.556 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -65.66 -31.04 71.83 Favored 'General case' 0 C--O 1.26 1.61 0 CA-C-N 115.176 -0.92 . . . . 52.32 111.133 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.895 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 24.9 m -62.05 -50.29 72.57 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.666 -1.152 . . . . 61.32 109.643 173.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.7 mt -59.61 -40.95 89.2 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.614 -0.721 . . . . 74.319999999999993 110.463 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 17.6 mm-40 -58.64 -52.81 64.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.231 -0.441 . . . . 73.120000000000005 110.26 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -56.22 -55.35 34.35 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.794 0.294 . . . . 71.239999999999995 111.794 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 52' ' ' CYS . 8.8 tt -61.92 -42.83 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 121.076 -0.25 . . . . 72.140000000000001 111.539 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -64.32 -43.89 93.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.263 0.554 . . . . 72.010000000000005 110.127 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -72.63 -14.51 61.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.755 -0.657 . . . . 74.420000000000002 110.864 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 45.13 37.69 2.76 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.758 0.823 . . . . 71.519999999999996 111.23 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.499 ' CZ2' ' HA ' ' A' ' 63' ' ' ILE . 76.2 t-105 70.21 102.24 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 115.077 -0.965 . . . . 74.230000000000004 110.68 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.07 -62.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.505 2.136 . . . . 74.040000000000006 112.193 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -162.51 159.06 24.44 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.896 -0.409 . . . . 74.439999999999998 109.896 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.499 ' HA ' ' CZ2' ' A' ' 60' ' ' TRP . 14.1 tt -78.15 -7.5 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 44.5 111.59 -176.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.544 HH11 ' HB2' ' A' ' 8' ' ' ASN . 1.4 tpp180 53.49 76.65 0.51 Allowed Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.055 -0.52 . . . . 72.230000000000004 110.639 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.13 102.8 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.742 2.295 . . . . 62.119999999999997 112.335 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 5' ' ' MET . 0.1 OUTLIER -152.43 88.11 1.35 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.951 -0.568 . . . . 64.540000000000006 109.816 176.216 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.4 p -88.21 122.59 31.93 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.51 -0.768 . . . . 72.439999999999998 110.448 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.717 ' H ' ' HG3' ' A' ' 5' ' ' MET . 96.6 mt -137.5 164.13 29.46 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.55 -0.537 . . . . 74.140000000000001 109.55 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -52.27 -60.96 2.6 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.37 0.419 . . . . 72.540000000000006 110.608 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -160.31 143.67 13.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.087 0.47 . . . . 72.120000000000005 110.424 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 5' ' ' MET . 5.3 tppp? -157.38 13.06 0.23 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.472 -0.936 . . . . 71.420000000000002 108.472 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.75 60.28 0.7 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.486 -0.779 . . . . 75.409999999999997 109.985 -167.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.2 145.7 26.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.27 -0.877 . . . . 32.420000000000002 110.38 175.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.7 p -77.61 78.54 4.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.08 0.466 . . . . 74.239999999999995 110.603 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.59 7.32 5.89 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.946 -0.645 . . . . 72.519999999999996 113.135 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -73.85 93.2 2.13 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.138 0.494 . . . . 73.200000000000003 109.977 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.98 98.2 0.14 Allowed Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.301 -0.863 . . . . 61.109999999999999 111.078 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -92.31 -64.9 1.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.684 0.278 . . . . 73.439999999999998 110.974 -175.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 23.7 t70 -122.65 94.88 4.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.887 0.375 . . . . 74.109999999999999 111.064 -174.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 79' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-N 115.382 -0.827 . . . . 63.520000000000003 108.844 175.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.68 0 N-CA-C 112.233 -0.347 . . . . 64.540000000000006 112.233 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.32 69.55 6.88 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.73 2.287 . . . . 72.439999999999998 112.409 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.17 46.53 3.65 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 121.161 -0.543 . . . . 52.530000000000001 112.525 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.3 t -108.54 -167.76 1.27 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 122.647 0.379 . . . . 64.439999999999998 110.301 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 5.8 tpt -46.57 -42.34 15.81 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.317 0.647 . . . . 72.430000000000007 111.691 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.3 m -124.31 113.94 18.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.651 0.263 . . . . 74.200000000000003 110.646 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.1 mm -67.1 -67.76 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.995 -0.548 . . . . 65.329999999999998 110.572 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.5 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 14.5 m120 -125.84 135.91 27.69 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 64.430000000000007 109.955 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 8' ' ' ASN . 5.7 Cg_exo -77.9 87.86 1.48 Allowed 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.874 2.383 . . . . 71.439999999999998 112.642 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -128.11 -178.19 4.43 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.035 -0.53 . . . . 72.319999999999993 110.067 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -89.5 -176.88 5.17 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 110.099 -0.334 . . . . 75.400000000000006 110.099 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -76.12 61.16 1.54 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.323 -0.621 . . . . 73.540000000000006 109.323 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -55.26 -47.19 75.81 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.068 -0.515 . . . . 74.530000000000001 111.768 -171.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -96.86 14.98 23.43 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.405 -0.361 . . . . 73.329999999999998 111.073 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.74 82.52 0.09 OUTLIER Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.825 -0.51 . . . . 55.210000000000001 111.825 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.491 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 3.0 p -101.43 170.11 8.43 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.176 0.512 . . . . 71.319999999999993 112.218 -171.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.781 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 3.3 t80 -67.13 -159.82 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.241 1.017 . . . . 74.209999999999994 110.663 178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.543 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 41.9 p90 -124.37 142.11 51.54 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.284 0.564 . . . . 74.439999999999998 110.813 -172.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.663 HG23 HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -159.37 142.49 5.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-N 115.012 -0.995 . . . . 65.329999999999998 110.858 -172.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' A' ' 40' ' ' TRP . 43.1 tp -120.46 144.58 47.9 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.216 -0.902 . . . . 71.329999999999998 111.273 -171.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.35 141.82 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 115.997 -0.547 . . . . 73.439999999999998 109.94 173.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.578 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 25.3 t-20 -110.01 155.9 21.2 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.507 -0.553 . . . . 74.140000000000001 109.507 -176.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.0 -26.64 68.35 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.9 0.381 . . . . 71.409999999999997 111.152 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -86.43 22.88 1.73 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.279 0.562 . . . . 73.319999999999993 110.512 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 73.02 6.65 5.34 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.404 -0.816 . . . . 73.299999999999997 112.397 173.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 81.6 mm-40 -71.96 117.74 13.95 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.194 -0.669 . . . . 54.009999999999998 109.194 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -131.35 127.62 37.99 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.199 -0.313 . . . . 74.109999999999999 111.042 -174.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.5 t -173.57 163.13 4.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.484 . . . . 70.430000000000007 110.329 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.4 pt? -72.13 130.81 41.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.174 -1.047 . . . . 62.520000000000003 108.174 169.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.501 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 33.4 p-90 -95.87 141.84 23.73 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.529 -0.305 . . . . 73.310000000000002 110.917 -173.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.592 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 23.0 Cg_exo -64.98 105.32 0.66 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.616 2.21 . . . . 52.539999999999999 111.275 177.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.501 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -58.61 -26.89 64.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.965 -0.561 . . . . 64.129999999999995 111.66 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -98.63 23.75 8.29 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.096 -0.502 . . . . 72.430000000000007 110.968 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.592 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . . . -132.96 166.63 21.93 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.013 -0.54 . . . . 42.140000000000001 110.764 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -77.25 139.62 39.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 74.129999999999995 110.458 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.511 HG12 ' NE1' ' A' ' 40' ' ' TRP . 3.0 t -112.12 106.03 56.24 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 116.068 -0.515 . . . . 74.219999999999999 109.745 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 33.8 Cg_endo -64.85 116.28 3.73 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.124 2.549 . . . . 74.140000000000001 112.819 -174.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.84 152.25 0.38 Allowed 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.12 0.785 . . . . 34.340000000000003 113.12 -174.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.13 18.62 6.69 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 115.827 -0.624 . . . . 60.32 111.817 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.511 ' NE1' HG12 ' A' ' 36' ' ' VAL . 12.3 p-90 -122.41 -173.28 2.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.141 0.496 . . . . 74.510000000000005 111.056 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -154.62 126.64 7.71 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.629 -0.878 . . . . 63.219999999999999 108.629 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.9 p -90.51 138.78 18.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.213 -0.449 . . . . 60.219999999999999 110.651 -175.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.663 HG23 HG23 ' A' ' 19' ' ' VAL . 27.6 m -100.74 -22.85 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.909 0.385 . . . . 73.329999999999998 110.69 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.572 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 39.3 m80 -150.4 132.63 15.44 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.929 -0.578 . . . . 73.349999999999994 109.711 176.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -92.01 176.14 38.86 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 123.758 0.661 . . . . 61.030000000000001 112.784 -175.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.37 131.03 10.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.352 0.661 . . . . 74.340000000000003 111.232 -174.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.684 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -147.57 178.24 8.62 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.227 0.537 . . . . 73.409999999999997 111.566 -174.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -98.18 177.97 5.22 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.826 -0.625 . . . . 61.520000000000003 111.819 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.525 ' NH1' HD11 ' A' ' 53' ' ' LEU . 2.4 tmt_? -61.59 -44.71 96.5 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.697 -0.683 . . . . 74.329999999999998 110.493 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.45 -42.53 67.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.464 0.65 . . . . 72.030000000000001 110.028 174.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.491 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -65.98 -32.69 74.33 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.021 -0.991 . . . . 52.32 110.944 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.781 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 49.0 t -60.22 -51.06 71.16 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.045 -0.525 . . . . 61.32 109.918 173.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.525 HD11 ' NH1' ' A' ' 49' ' ' ARG . 82.0 mt -58.16 -40.16 80.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.522 -0.763 . . . . 74.319999999999993 110.8 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.94 -29.02 55.44 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.074 -0.512 . . . . 73.120000000000005 112.213 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.661 ' HB2' ' H ' ' A' ' 17' ' ' PHE . 54.9 t80 -65.43 -52.37 53.7 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.015 -0.428 . . . . 71.239999999999995 110.787 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 tt -59.34 -35.77 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 121.011 0.434 . . . . 72.140000000000001 110.574 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -70.99 -42.01 70.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.769 -0.65 . . . . 72.010000000000005 111.217 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -58.86 -30.22 67.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.713 0.292 . . . . 74.420000000000002 110.268 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 53.93 67.93 0.93 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.72 -0.673 . . . . 71.519999999999996 111.375 176.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 88.3 m95 50.7 78.84 0.38 Allowed Pre-proline 0 N--CA 1.465 0.286 0 CA-C-N 115.74 -0.664 . . . . 74.230000000000004 111.63 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 63' ' ' ILE . 57.6 Cg_endo -87.45 0.82 7.24 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.724 2.282 . . . . 74.040000000000006 112.188 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.2 t70 71.46 -26.0 0.17 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.374 0.67 . . . . 74.439999999999998 112.337 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.425 ' H ' ' C ' ' A' ' 61' ' ' PRO . 65.6 mt -50.73 106.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-O 121.161 0.505 . . . . 44.5 111.185 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.504 ' HG3' ' HA ' ' A' ' 43' ' ' VAL . 29.8 ttp180 -120.28 89.57 43.69 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.064 -0.971 . . . . 72.230000000000004 109.969 -177.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.58 -61.67 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.161 1.908 . . . . 62.119999999999997 111.741 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 59.7 tttm 61.98 9.82 3.26 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.231 0.538 . . . . 64.540000000000006 111.126 178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.6 t -96.36 155.39 16.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.339 -0.391 . . . . 72.439999999999998 110.163 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 68' ' ' LEU . 2.1 pt? -147.7 16.39 1.12 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.889 -0.596 . . . . 74.140000000000001 109.728 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 69' ' ' ARG . 0.4 OUTLIER -90.68 -177.18 4.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.701 -0.681 . . . . 72.540000000000006 111.407 -177.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -141.17 -169.57 2.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.98 -1.009 . . . . 72.120000000000005 109.617 -174.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.41 ' HA ' ' HE3' ' A' ' 71' ' ' LYS . 0.1 OUTLIER -138.55 18.77 2.71 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.954 -0.758 . . . . 71.420000000000002 108.954 175.206 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.482 ' O ' HD13 ' A' ' 72' ' ' LEU . 3.2 tm? -92.83 -24.34 18.53 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.132 -0.94 . . . . 75.409999999999997 109.225 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.9 102.76 2.05 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.669 -0.696 . . . . 32.420000000000002 110.083 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.8 t -100.09 -25.61 14.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.2 -0.455 . . . . 74.239999999999995 111.424 -175.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.91 -134.74 43.65 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.396 -0.43 . . . . 72.519999999999996 112.66 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.401 ' HD3' ' HA ' ' A' ' 76' ' ' ARG . 16.9 mmt180 -143.92 121.46 11.76 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 122.786 0.434 . . . . 73.200000000000003 110.172 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.92 96.62 1.25 Allowed Glycine 0 CA--C 1.518 0.275 0 CA-C-N 116.111 -0.495 . . . . 61.109999999999999 112.462 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.487 ' O ' ' HB3' ' A' ' 79' ' ' ASP . 84.7 t80 -167.71 142.0 3.6 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 122.419 0.287 . . . . 73.439999999999998 110.481 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.487 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 1.0 OUTLIER 169.42 132.67 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.363 -0.977 . . . . 74.109999999999999 108.363 176.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.101 -0.952 . . . . 63.520000000000003 109.868 173.167 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.528 -0.629 . . . . 64.540000000000006 111.528 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.74 -35.11 70.74 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.542 2.161 . . . . 72.439999999999998 112.116 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.29 78.94 0.22 Allowed Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.352 -0.699 . . . . 52.530000000000001 111.352 -175.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.0 p -107.23 125.79 51.58 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.218 0.451 . . . . 64.439999999999998 112.218 -172.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.592 ' HB2' ' HB3' ' A' ' 71' ' ' LYS . 22.3 tpp -68.82 -60.95 2.02 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 107.673 -1.232 . . . . 72.430000000000007 107.673 164.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 m -164.61 139.65 5.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 113.981 -1.463 . . . . 74.200000000000003 108.061 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.9 mt -79.75 73.73 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.361 0.6 . . . . 65.329999999999998 109.446 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -101.81 98.26 9.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.023 -0.99 . . . . 64.430000000000007 109.979 177.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 8' ' ' ASN . 10.8 Cg_exo -70.44 99.84 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.721 2.28 . . . . 71.439999999999998 113.093 -173.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 10.1 p90 -145.41 161.1 40.49 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.262 -0.644 . . . . 72.319999999999993 109.262 168.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -86.41 118.35 25.79 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.905 0.383 . . . . 75.400000000000006 111.564 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -84.75 -172.17 4.03 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.94 -0.763 . . . . 73.540000000000006 108.94 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -79.14 -52.01 8.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.976 0.417 . . . . 74.530000000000001 112.048 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -97.05 -3.32 41.6 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.381 0.511 . . . . 73.329999999999998 112.381 -167.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.32 -24.34 58.92 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 121.473 -0.394 . . . . 55.210000000000001 113.487 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.513 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 5.9 p -178.83 168.0 1.67 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.698 0.399 . . . . 71.319999999999993 110.088 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.724 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 34.5 t80 -66.43 -161.94 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.227 0.611 . . . . 74.209999999999994 109.865 173.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.557 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 33.8 p90 -124.58 134.43 52.95 Favored 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 121.325 -0.86 . . . . 74.439999999999998 110.177 -173.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.639 HG23 HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -151.7 128.85 2.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 115.146 -0.934 . . . . 65.329999999999998 111.247 -171.034 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.7 tp -108.54 137.55 46.3 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.608 -1.178 . . . . 71.329999999999998 109.946 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 58.4 t -124.95 126.45 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 73.439999999999998 110.016 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.771 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 27.2 t-20 -87.41 158.81 18.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.89 -0.411 . . . . 74.140000000000001 109.89 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -50.25 -33.28 19.13 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.203 -0.453 . . . . 71.409999999999997 112.004 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.58 30.46 0.72 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.207 0.527 . . . . 73.319999999999993 111.145 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 67.3 6.58 4.94 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.049 0.539 . . . . 73.299999999999997 112.141 174.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.771 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 81.6 mm-40 -63.17 117.81 7.06 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 109.554 -0.535 . . . . 54.009999999999998 109.554 177.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -121.56 111.25 17.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.855 0.36 . . . . 74.109999999999999 110.321 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.9 m -153.32 156.08 37.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.317 -0.402 . . . . 70.430000000000007 110.168 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.652 HD13 ' H ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.56 154.27 39.17 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.545 -0.539 . . . . 62.520000000000003 109.545 172.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.4 ' HZ2' ' HA2' ' A' ' 45' ' ' GLY . 27.9 p-90 -126.16 148.95 65.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.687 -0.233 . . . . 73.310000000000002 110.556 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.06 102.57 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.238 1.959 . . . . 52.539999999999999 111.112 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 46' ' ' GLU . . . -57.06 -18.0 12.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.847 -0.615 . . . . 64.129999999999995 111.863 -175.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -102.15 24.47 10.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 72.430000000000007 111.215 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.4 172.53 12.58 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.378 -0.373 . . . . 42.140000000000001 111.059 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -95.68 139.81 31.4 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.966 -0.561 . . . . 74.129999999999995 109.869 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.8 t -88.99 118.73 69.52 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 110.601 -0.148 . . . . 74.219999999999999 110.601 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.04 160.0 48.66 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.755 2.304 . . . . 74.140000000000001 112.243 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.51 144.7 50.77 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.265 -0.425 . . . . 34.340000000000003 110.622 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.25 -18.63 48.25 Favored Glycine 0 C--N 1.331 0.253 0 N-CA-C 111.55 -0.62 . . . . 60.32 111.55 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -107.61 118.88 37.9 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.93 -0.396 . . . . 74.510000000000005 109.93 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -103.41 126.04 50.34 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.695 -0.484 . . . . 63.219999999999999 109.695 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 44' ' ' HIS . 13.6 p -91.29 134.08 30.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 110.054 -0.35 . . . . 60.219999999999999 110.054 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.639 HG23 HG23 ' A' ' 19' ' ' VAL . 29.5 m -99.7 -5.2 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.031 0.443 . . . . 73.329999999999998 110.837 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.432 ' H ' HG22 ' A' ' 42' ' ' VAL . 65.4 t-80 -175.99 130.78 0.24 Allowed 'General case' 0 C--O 1.246 0.872 0 CA-C-N 115.183 -0.917 . . . . 73.349999999999994 109.453 167.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -79.0 -171.47 40.52 Favored Glycine 0 C--N 1.338 0.665 0 O-C-N 123.935 0.772 . . . . 61.030000000000001 112.846 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -50.66 151.55 2.33 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.509 0.559 . . . . 74.340000000000003 112.509 -173.189 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB1' ' CB ' ' A' ' 51' ' ' ALA . . . -161.42 179.19 8.46 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.097 -0.501 . . . . 73.409999999999997 112.252 -173.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -97.96 179.43 4.79 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.581 -0.736 . . . . 61.520000000000003 112.308 -171.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -56.91 -51.08 70.52 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.702 -0.681 . . . . 74.329999999999998 110.406 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.39 -34.19 56.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.412 -0.813 . . . . 72.030000000000001 110.186 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.513 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -75.74 -31.59 59.65 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 115.284 -0.871 . . . . 52.32 111.098 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.724 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 56.2 m -58.94 -48.71 80.55 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.933 -0.766 . . . . 61.32 108.933 172.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.74 -36.37 82.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.989 -1.005 . . . . 74.319999999999993 110.539 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -62.27 -42.16 99.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.033 -0.531 . . . . 73.120000000000005 110.566 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.564 ' HB2' ' H ' ' A' ' 17' ' ' PHE . 59.9 t80 -64.51 -50.43 67.4 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.315 -0.402 . . . . 71.239999999999995 111.194 -178.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 tt -64.24 -37.36 79.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 120.779 0.323 . . . . 72.140000000000001 110.371 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -73.25 -28.35 62.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 72.010000000000005 110.361 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.682 ' HG2' ' HD3' ' A' ' 61' ' ' PRO . 41.5 tt0 -61.14 -41.52 96.88 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.933 -0.576 . . . . 74.420000000000002 109.51 176.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 63.04 20.05 12.04 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.42 -0.809 . . . . 71.519999999999996 111.609 170.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 89.9 m95 58.09 87.0 0.15 Allowed Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.222 -0.445 . . . . 74.230000000000004 111.812 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.682 ' HD3' ' HG2' ' A' ' 58' ' ' GLU . 63.0 Cg_endo -90.55 178.05 2.13 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.021 2.48 . . . . 74.040000000000006 111.899 176.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -69.7 -50.03 47.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.39 0.614 . . . . 74.439999999999998 109.63 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.2 pt -116.57 127.0 74.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.168 -0.924 . . . . 44.5 110.277 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -117.36 92.7 40.96 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.222 -0.659 . . . . 72.230000000000004 109.222 175.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.9 74.58 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.222 2.615 . . . . 62.119999999999997 113.416 -172.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 10' ' ' PHE . 53.2 mtmt -70.59 91.44 0.79 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.101 -0.5 . . . . 64.540000000000006 109.718 174.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.4 p -159.51 175.84 12.79 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.207 -0.451 . . . . 72.439999999999998 110.948 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.461 ' N ' HD22 ' A' ' 68' ' ' LEU . 2.8 mm? -101.63 123.27 45.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.401 -0.363 . . . . 74.140000000000001 110.695 -177.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -87.85 143.25 27.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.269 -0.423 . . . . 72.540000000000006 111.128 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 36.81 37.01 0.06 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.771 1.229 . . . . 72.120000000000005 112.717 175.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.592 ' HB3' ' HB2' ' A' ' 5' ' ' MET . 0.0 OUTLIER -56.58 -28.9 61.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.601 -0.727 . . . . 71.420000000000002 111.943 -175.146 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 29.5 tp -87.89 -3.15 58.95 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.923 0.392 . . . . 75.409999999999997 111.193 -176.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.46 11.66 20.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.3 -0.409 . . . . 32.420000000000002 110.947 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.8 m -69.58 77.05 0.42 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.265 0.555 . . . . 74.239999999999995 110.487 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.64 86.57 1.47 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.731 -0.668 . . . . 72.519999999999996 111.564 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -80.39 77.32 7.17 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.216 -0.661 . . . . 73.200000000000003 109.216 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.06 46.89 3.04 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.677 -0.692 . . . . 61.109999999999999 113.261 -174.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -77.92 -45.05 25.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.316 -0.624 . . . . 73.439999999999998 109.316 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.9 t70 56.16 95.33 0.02 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.939 -1.028 . . . . 74.109999999999999 110.559 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.246 0.912 0 CA-C-N 115.682 -0.69 . . . . 63.520000000000003 110.409 -173.705 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.81 0 CA-C-O 119.979 -0.345 . . . . 64.540000000000006 112.265 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.02 107.73 2.49 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.806 2.337 . . . . 72.439999999999998 111.772 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 104.76 111.76 3.64 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.319 -0.712 . . . . 52.530000000000001 111.319 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 t -108.27 161.17 15.25 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 110.048 -0.353 . . . . 64.439999999999998 110.048 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 29.8 tpp -61.53 -62.14 2.03 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.259 0.552 . . . . 72.430000000000007 110.465 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.1 p -113.15 116.86 30.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.836 -0.62 . . . . 74.200000000000003 110.116 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.57 HD12 ' H ' ' A' ' 67' ' ' SER . 58.2 mt -72.14 88.29 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.506 -0.553 . . . . 65.329999999999998 109.506 176.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.439 ' N ' ' HD2' ' A' ' 9' ' ' PRO . 17.1 m120 -66.99 -48.4 50.44 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.338 -0.846 . . . . 64.430000000000007 111.36 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 8' ' ' ASN . 74.2 Cg_endo -74.99 98.65 1.18 Allowed 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 121.908 1.739 . . . . 71.439999999999998 111.377 175.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -77.72 -23.33 49.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.197 -0.456 . . . . 72.319999999999993 110.444 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.0 t70 67.86 -69.68 0.14 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.432 -0.804 . . . . 75.400000000000006 111.616 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -70.8 83.81 0.65 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.277 0.56 . . . . 73.540000000000006 110.865 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -79.45 -22.62 43.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.057 0.932 . . . . 74.530000000000001 109.34 171.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -67.97 -28.46 67.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.514 -1.675 . . . . 73.329999999999998 112.087 -172.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.96 70.92 1.19 Allowed Glycine 0 C--N 1.33 0.239 0 C-N-CA 121.068 -0.586 . . . . 55.210000000000001 112.347 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.483 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 7.0 p -77.38 -173.97 3.11 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.597 0.237 . . . . 71.319999999999993 111.196 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.822 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 3.8 t80 -67.42 -161.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 116.354 -0.384 . . . . 74.209999999999994 110.915 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.81 ' HB3' ' HA ' ' A' ' 46' ' ' GLU . 51.9 p90 -125.15 143.77 50.77 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.14 0.495 . . . . 74.439999999999998 111.357 -171.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 43' ' ' VAL . 48.2 t -146.49 133.04 13.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-N 115.077 -0.965 . . . . 65.329999999999998 110.331 -175.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.508 ' HB2' ' CE3' ' A' ' 30' ' ' TRP . 57.4 tp -109.2 133.88 52.46 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.694 -0.685 . . . . 71.329999999999998 109.847 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 m -120.6 126.27 75.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.705 0.765 . . . . 73.439999999999998 110.554 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 11.3 m120 -93.12 154.09 18.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.074 -0.966 . . . . 74.140000000000001 109.228 177.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -56.69 -24.3 48.09 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.032 0.444 . . . . 71.409999999999997 111.097 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -82.15 15.67 2.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.965 -0.562 . . . . 73.319999999999993 111.156 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 67.64 6.79 5.22 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.26 0.624 . . . . 73.299999999999997 111.477 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 15.4 mm100 -66.65 119.61 12.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.298 -0.63 . . . . 54.009999999999998 109.298 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -111.14 113.06 25.31 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.376 -0.602 . . . . 74.109999999999999 109.376 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -150.38 -162.26 1.51 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.16 -0.473 . . . . 70.430000000000007 109.985 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.661 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.3 pt? -127.93 172.21 11.1 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.633 -0.506 . . . . 62.520000000000003 109.633 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.534 ' CH2' ' HB2' ' A' ' 18' ' ' PHE . 13.1 p90 -135.67 157.8 75.49 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.411 -0.588 . . . . 73.310000000000002 109.411 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.729 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 37.4 Cg_exo -57.66 100.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.959 1.772 . . . . 52.539999999999999 110.211 171.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.18 -13.59 19.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.636 0.606 . . . . 64.129999999999995 112.636 -171.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -103.13 2.72 34.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.837 0.351 . . . . 72.430000000000007 110.602 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.729 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . . . -121.61 -175.85 3.18 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.099 -0.5 . . . . 42.140000000000001 111.316 -173.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -81.91 137.92 35.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.594 -0.73 . . . . 74.129999999999995 110.434 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.402 HG22 ' CD1' ' A' ' 30' ' ' TRP . 56.5 t -82.34 132.79 51.8 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.934 -0.576 . . . . 74.219999999999999 110.022 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.06 132.68 48.84 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.345 2.03 . . . . 74.140000000000001 111.293 173.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.23 152.32 45.14 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.256 0.55 . . . . 34.340000000000003 112.056 -173.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.02 -35.55 4.6 Favored Glycine 0 N--CA 1.453 -0.193 0 CA-C-N 115.595 -0.73 . . . . 60.32 113.478 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -81.87 175.97 9.96 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.752 0.31 . . . . 74.510000000000005 110.694 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -121.92 126.64 49.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.006 0.431 . . . . 63.219999999999999 110.967 -176.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.56 126.43 40.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.682 -0.859 . . . . 60.219999999999999 108.682 170.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 19' ' ' VAL . 14.7 p -95.83 -23.24 4.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 120.698 -0.401 . . . . 73.329999999999998 110.345 -175.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.451 ' ND1' ' O ' ' A' ' 17' ' ' PHE . 45.0 t-80 -158.26 133.42 8.62 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 116.301 -0.409 . . . . 73.349999999999994 110.469 174.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.24 176.86 46.71 Favored Glycine 0 C--N 1.337 0.629 0 O-C-N 124.14 0.9 . . . . 61.030000000000001 113.438 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.81 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -78.69 154.84 29.79 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.003 0.742 . . . . 74.340000000000003 113.003 -170.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -163.32 -178.11 5.74 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.802 -0.635 . . . . 73.409999999999997 111.065 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -80.16 170.17 16.81 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.78 0.659 . . . . 61.520000000000003 112.78 -173.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 31.9 ttm180 -45.7 -45.72 14.43 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.577 0.751 . . . . 74.329999999999998 111.631 176.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.581 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -53.66 -45.0 70.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.351 0.595 . . . . 72.030000000000001 109.964 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.483 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -66.99 -30.96 71.22 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 115.172 -0.922 . . . . 52.32 111.102 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.822 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 42.7 t -58.19 -47.47 83.33 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.682 -0.69 . . . . 61.32 109.731 171.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.57 -39.72 94.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.878 -0.601 . . . . 74.319999999999993 110.118 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.581 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 13.8 mm-40 -59.4 -39.32 83.03 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.121 -0.491 . . . . 73.120000000000005 110.742 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -58.68 -47.94 82.79 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.776 0.322 . . . . 71.239999999999995 110.668 177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.416 HG13 ' H ' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -64.45 -48.7 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.703 0.763 . . . . 72.140000000000001 109.623 -178.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -68.85 -26.64 65.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.357 -1.292 . . . . 72.010000000000005 111.072 -173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -65.99 -39.55 90.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.213 -0.448 . . . . 74.420000000000002 109.834 175.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 67.12 22.72 9.78 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.756 -0.656 . . . . 71.519999999999996 111.027 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 34.6 m95 67.39 108.99 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.687 -0.688 . . . . 74.230000000000004 112.629 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HG2' HG22 ' A' ' 63' ' ' ILE . 96.7 Cg_endo -91.59 -161.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.295 2.663 . . . . 74.040000000000006 111.668 173.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -82.18 -15.2 54.07 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.623 -0.262 . . . . 74.439999999999998 111.423 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.472 HG22 ' HG2' ' A' ' 61' ' ' PRO . 9.5 tp -41.31 132.15 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 113.364 0.875 . . . . 44.5 113.364 -172.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -95.09 151.06 38.55 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.27 -0.877 . . . . 72.230000000000004 109.715 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . 17.8 Cg_endo -58.5 139.84 92.28 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.642 2.228 . . . . 62.119999999999997 112.387 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -60.87 112.49 2.07 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.012 -0.54 . . . . 64.540000000000006 109.592 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.57 ' H ' HD12 ' A' ' 7' ' ' ILE . 32.7 t -126.15 154.01 43.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.134 -0.485 . . . . 72.439999999999998 110.133 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 pp -150.56 155.04 38.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.52 -0.764 . . . . 74.140000000000001 109.399 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 69.01 -18.48 0.18 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.222 0.609 . . . . 72.540000000000006 112.56 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -83.96 59.0 5.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.372 0.606 . . . . 72.120000000000005 111.389 -172.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -172.43 38.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.611 -0.885 . . . . 71.420000000000002 108.611 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.6 tp -84.74 51.28 2.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.227 -0.897 . . . . 75.409999999999997 109.83 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.43 101.8 14.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.236 -0.893 . . . . 32.420000000000002 110.301 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.9 m -123.75 102.11 7.64 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.672 -0.492 . . . . 74.239999999999995 109.672 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.22 129.17 3.27 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.649 -0.786 . . . . 72.519999999999996 112.469 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.3 ttt85 -165.75 99.68 0.67 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.844 0.354 . . . . 73.200000000000003 110.139 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -151.05 80.98 0.19 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.331 -0.708 . . . . 61.109999999999999 111.331 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -94.26 -84.61 0.31 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.011 -0.366 . . . . 73.439999999999998 110.011 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -97.48 -29.33 13.54 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.446 -0.575 . . . . 74.109999999999999 109.446 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 . . . . . 0 C--O 1.247 0.964 0 CA-C-N 114.75 -1.114 . . . . 63.520000000000003 108.711 178.413 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.689 0 N-CA-C 111.973 -0.451 . . . . 64.540000000000006 111.973 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.62 79.62 2.18 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.582 2.188 . . . . 72.439999999999998 112.653 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.12 59.48 3.56 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 111.208 -0.757 . . . . 52.530000000000001 111.208 173.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.9 t -108.96 178.22 4.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.371 0.605 . . . . 64.439999999999998 111.861 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.632 ' HE2' ' HA ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -85.13 -20.73 29.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.918 -1.037 . . . . 72.430000000000007 108.235 173.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.4 t -136.65 -169.05 2.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.861 -1.063 . . . . 74.200000000000003 109.735 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.26 -34.73 68.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.708 -0.678 . . . . 65.329999999999998 110.885 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 2.3 m-20 -54.99 110.59 2.28 Favored Pre-proline 0 N--CA 1.468 0.46 0 CA-C-N 115.755 -0.657 . . . . 64.430000000000007 111.07 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 8' ' ' ASN . 19.4 Cg_endo -59.52 -39.07 78.82 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.167 1.911 . . . . 71.439999999999998 110.935 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -172.69 156.12 3.45 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.937 -1.029 . . . . 72.319999999999993 108.564 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -102.19 -153.2 0.46 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.256 -0.276 . . . . 75.400000000000006 110.256 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -75.19 18.81 0.18 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.382 0.512 . . . . 73.540000000000006 112.382 -175.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -67.81 -27.96 67.18 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.343 0.592 . . . . 74.530000000000001 109.771 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -95.98 10.9 35.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.301 -0.863 . . . . 73.329999999999998 111.088 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 52' ' ' CYS . . . -85.92 100.31 2.47 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 111.078 -0.809 . . . . 55.210000000000001 111.078 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 6.2 p -54.56 135.03 46.66 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 111.888 0.329 . . . . 71.319999999999993 111.888 -174.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.506 ' HD1' ' HB2' ' A' ' 55' ' ' TYR . 24.8 t80 -68.65 102.75 1.56 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.057 -0.719 . . . . 74.209999999999994 109.057 173.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.443 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 47.6 p90 -141.6 131.02 23.74 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.71 -1.589 . . . . 74.439999999999998 106.71 168.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.753 HG23 HG13 ' A' ' 43' ' ' VAL . 2.8 m -156.36 135.49 3.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.539 0.685 . . . . 65.329999999999998 110.522 -167.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 8.5 tt -117.31 131.44 56.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.374 -0.83 . . . . 71.329999999999998 110.038 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.3 t -104.17 126.08 58.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.397 -0.594 . . . . 73.439999999999998 109.397 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.711 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 14.3 m120 -79.94 170.45 16.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.039 -0.528 . . . . 74.140000000000001 109.82 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -51.82 -42.17 62.32 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.11 0.481 . . . . 71.409999999999997 111.466 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -88.95 28.06 1.24 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.866 -0.606 . . . . 73.319999999999993 111.677 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 65.63 15.51 10.07 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.117 0.567 . . . . 73.299999999999997 111.734 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.711 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 56.0 tt0 -68.58 131.11 44.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 54.009999999999998 110.072 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 50.9 m170 -90.52 118.24 29.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.642 0.258 . . . . 74.109999999999999 110.658 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.2 m -144.46 -175.51 4.67 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.15 -0.477 . . . . 70.430000000000007 110.149 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 29' ' ' LEU . 1.7 pt? -142.33 135.43 28.68 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.439 -0.578 . . . . 62.520000000000003 109.439 173.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.443 ' CH2' ' HB2' ' A' ' 18' ' ' PHE . 4.8 p90 -85.31 152.02 57.41 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 73.310000000000002 110.114 -176.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.98 104.72 0.4 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.95 1.767 . . . . 52.539999999999999 110.169 171.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.69 -15.43 7.8 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.099 0.407 . . . . 64.129999999999995 112.099 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -92.07 6.79 45.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 72.430000000000007 111.024 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.94 179.49 6.31 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.897 0.38 . . . . 42.140000000000001 111.122 -176.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -87.05 139.79 30.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.668 -0.696 . . . . 74.129999999999995 110.125 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 70.5 t -64.5 129.39 94.19 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.114 -0.494 . . . . 74.219999999999999 110.899 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 35.3 Cg_exo -60.86 141.04 93.55 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.697 2.265 . . . . 74.140000000000001 111.841 175.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.98 147.41 52.47 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.023 -0.535 . . . . 34.340000000000003 111.56 -175.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.43 -25.95 25.79 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.757 -0.656 . . . . 60.32 112.981 176.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -82.86 -177.42 6.74 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.816 0.341 . . . . 74.510000000000005 110.111 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 41' ' ' ARG . 50.7 ttt-85 -145.27 126.5 14.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.335 -0.393 . . . . 63.219999999999999 110.008 173.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 54.8 t -80.42 123.37 37.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.264 -0.643 . . . . 60.219999999999999 109.264 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.753 HG13 HG23 ' A' ' 19' ' ' VAL . 7.1 p -88.77 -19.11 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 121.198 0.523 . . . . 73.329999999999998 110.107 -175.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -157.53 121.89 4.3 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.029 -0.73 . . . . 73.349999999999994 109.029 171.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.66 -179.34 52.81 Favored Glycine 0 C--N 1.33 0.25 0 C-N-CA 121.29 -0.481 . . . . 61.030000000000001 112.986 -174.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -53.72 138.73 34.52 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.824 -0.436 . . . . 74.340000000000003 109.824 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.8 -178.01 6.22 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.873 1.064 . . . . 73.409999999999997 113.873 -167.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.401 ' CG ' ' N ' ' A' ' 49' ' ' ARG . 14.0 t70 -91.14 175.09 7.07 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.513 -1.222 . . . . 61.520000000000003 111.528 -176.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.923 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 59.1 ttt180 -57.88 -27.86 63.66 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 122.327 -0.233 . . . . 74.329999999999998 111.052 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.87 -41.37 67.44 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.278 -0.638 . . . . 72.030000000000001 109.278 173.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 17' ' ' PHE . . . -75.81 -31.17 59.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.352 -0.84 . . . . 52.32 111.018 175.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.923 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 61.3 m -54.8 -55.05 34.39 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.565 0.697 . . . . 61.32 110.253 172.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.3 mt -64.68 -23.16 67.16 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.989 -1.005 . . . . 74.319999999999993 110.557 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.431 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 40.7 tt0 -71.73 -49.82 35.8 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.069 -0.514 . . . . 73.120000000000005 111.257 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.506 ' HB2' ' HD1' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -52.53 -40.93 63.03 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 111.98 0.363 . . . . 71.239999999999995 111.98 -175.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.482 HD12 ' HG2' ' A' ' 65' ' ' PRO . 4.5 tt -69.57 -39.0 77.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 120.879 0.371 . . . . 72.140000000000001 110.887 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -71.64 -34.0 69.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 72.010000000000005 110.899 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 59' ' ' HIS . 7.4 mm-40 -67.07 -13.91 62.39 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.853 -0.612 . . . . 74.420000000000002 111.639 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.494 ' HB3' ' O ' ' A' ' 58' ' ' GLU . 21.6 t-80 75.08 71.54 0.09 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.6 0.714 . . . . 71.519999999999996 109.843 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.701 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 0.8 OUTLIER -145.24 24.07 0.05 OUTLIER Pre-proline 0 CA--C 1.552 1.056 0 CA-C-N 115.076 -0.966 . . . . 74.230000000000004 111.338 177.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.701 ' HD3' ' N ' ' A' ' 60' ' ' TRP . 60.3 Cg_endo -88.32 137.14 3.57 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 121.832 1.688 . . . . 74.040000000000006 112.593 -171.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -76.48 -45.38 31.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 109.89 177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.38 132.87 65.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 CA-C-N 115.801 -0.636 . . . . 44.5 109.987 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -71.19 122.09 86.04 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 110.197 -0.297 . . . . 72.230000000000004 110.197 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.482 ' HG2' HD12 ' A' ' 56' ' ' ILE . 36.1 Cg_exo -59.0 136.88 76.4 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.632 2.222 . . . . 62.119999999999997 112.204 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -124.3 0.39 8.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.123 -0.489 . . . . 64.540000000000006 110.534 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.2 t -107.29 91.48 3.67 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.926 -0.579 . . . . 72.439999999999998 110.447 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.7 tp -94.13 -58.51 2.21 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.337 -0.392 . . . . 74.140000000000001 110.065 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.612 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -148.18 -171.86 3.93 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.464 -0.335 . . . . 72.540000000000006 111.491 178.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.82 144.98 47.29 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.98 0.733 . . . . 72.120000000000005 112.98 -166.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.632 ' HA ' ' HE2' ' A' ' 5' ' ' MET . 16.9 pttp -64.55 87.01 0.05 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 114.813 -1.085 . . . . 71.420000000000002 111.482 171.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.4 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 32.4 tp 64.18 35.74 9.99 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.657 0.741 . . . . 75.409999999999997 110.528 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.43 -170.79 3.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.797 -0.638 . . . . 32.420000000000002 110.58 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.4 m -145.4 114.62 7.06 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.38 -0.6 . . . . 74.239999999999995 109.38 174.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.8 56.74 3.48 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 116.439 -0.346 . . . . 72.519999999999996 112.258 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -81.26 108.25 14.73 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.612 -0.514 . . . . 73.200000000000003 109.612 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.15 -84.5 0.14 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.164 -0.541 . . . . 61.109999999999999 112.03 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -141.04 139.46 34.11 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.563 0.345 . . . . 73.439999999999998 110.672 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -85.53 -12.63 51.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.954 -0.566 . . . . 74.109999999999999 111.798 -176.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.726 -0.654 . . . . 63.520000000000003 110.85 -174.957 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 112.384 -0.286 . . . . 64.540000000000006 112.384 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.1 127.37 17.48 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.816 2.344 . . . . 72.439999999999998 111.997 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -93.84 47.61 2.27 Favored Glycine 0 C--N 1.331 0.302 0 N-CA-C 111.857 -0.497 . . . . 52.530000000000001 111.857 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.6 p -89.37 174.48 7.79 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.89 -0.182 . . . . 64.439999999999998 110.829 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 10.9 ttm -50.72 -64.64 0.75 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.227 0.537 . . . . 72.430000000000007 110.351 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.9 p -151.93 139.86 20.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.461 -0.791 . . . . 74.200000000000003 110.086 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.7 mm -86.79 87.66 2.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 109.245 -0.65 . . . . 65.329999999999998 109.245 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.569 ' ND2' ' HA ' ' A' ' 11' ' ' ASP . 22.3 p-10 -153.06 141.77 14.23 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.116 -0.493 . . . . 64.430000000000007 110.731 -175.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.47 -40.3 4.34 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.537 2.158 . . . . 71.439999999999998 111.19 173.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -130.64 150.08 52.0 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.801 -0.814 . . . . 72.319999999999993 108.801 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.569 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . 63.9 m-20 -77.87 172.9 12.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.131 0.491 . . . . 75.400000000000006 110.927 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -91.25 25.17 2.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.646 -0.706 . . . . 73.540000000000006 110.904 -170.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.93 -15.18 28.24 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.953 0.406 . . . . 74.530000000000001 111.199 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -96.06 15.11 21.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.03 -0.532 . . . . 73.329999999999998 110.507 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.434 ' O ' ' HB1' ' A' ' 51' ' ' ALA . . . -59.64 86.5 0.02 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 114.716 0.646 . . . . 55.210000000000001 114.716 -174.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 48.7 m -78.76 71.01 5.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.161 -1.052 . . . . 71.319999999999993 108.161 166.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.686 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 56.4 m-85 -162.13 138.8 8.03 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.007 -0.997 . . . . 74.209999999999994 113.063 -155.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -151.23 130.51 12.79 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.279 -1.378 . . . . 74.439999999999998 107.279 149.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.467 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 31.2 t -157.19 120.14 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.965 0 CA-C-O 121.081 0.467 . . . . 65.329999999999998 112.036 -173.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.462 HD13 HG22 ' A' ' 42' ' ' VAL . 64.6 tp -96.14 128.99 43.54 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.646 -0.706 . . . . 71.329999999999998 109.317 171.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 58.2 t -120.85 125.95 74.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.22 0.533 . . . . 73.439999999999998 110.302 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -85.66 153.2 22.52 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.168 -0.679 . . . . 74.140000000000001 109.168 175.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.34 -9.78 20.08 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.657 0.741 . . . . 71.409999999999997 109.535 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -79.79 7.58 8.39 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.943 -1.026 . . . . 73.319999999999993 110.174 173.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 72.23 7.02 5.66 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.47 0.708 . . . . 73.299999999999997 111.951 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 68.6 mt-30 -70.48 120.11 15.65 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 108.864 -0.791 . . . . 54.009999999999998 108.864 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -128.88 104.11 7.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.674 0.273 . . . . 74.109999999999999 110.688 -174.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.7 t -166.36 -169.43 1.41 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.722 0.296 . . . . 70.430000000000007 110.739 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 pp -71.12 172.88 8.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.12 -0.491 . . . . 62.520000000000003 111.511 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -153.21 156.13 32.35 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.552 -0.295 . . . . 73.310000000000002 110.739 -176.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.22 93.46 0.65 Allowed 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.432 2.088 . . . . 52.539999999999999 111.262 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.17 -1.71 3.52 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.23 0.455 . . . . 64.129999999999995 112.23 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -81.7 2.33 30.24 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.624 -0.262 . . . . 72.430000000000007 111.227 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.46 174.08 10.98 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.68 0.276 . . . . 42.140000000000001 110.782 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -87.99 139.98 29.96 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.058 -0.519 . . . . 74.129999999999995 109.981 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -59.39 119.93 43.8 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.964 -0.562 . . . . 74.219999999999999 111.412 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.85 138.82 82.96 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.611 2.207 . . . . 74.140000000000001 111.883 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.37 127.73 33.45 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.913 -0.585 . . . . 34.340000000000003 111.473 -177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.9 -23.43 13.05 Favored Glycine 0 C--N 1.33 0.223 0 CA-C-N 115.955 -0.566 . . . . 60.32 112.653 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -92.57 152.74 19.44 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 122.718 -0.283 . . . . 74.510000000000005 110.377 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.413 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 2.3 mmp_? -123.67 126.34 46.39 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.908 -0.405 . . . . 63.219999999999999 109.908 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.462 HG22 HD13 ' A' ' 20' ' ' LEU . 19.0 t -85.61 116.73 29.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.522 -0.918 . . . . 60.219999999999999 108.522 175.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.467 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 13.6 p -79.11 -29.98 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.411 0.624 . . . . 73.329999999999998 109.757 -172.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -144.12 115.37 7.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.802 -1.184 . . . . 73.349999999999994 107.802 172.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.445 ' HA2' HG11 ' A' ' 42' ' ' VAL . . . -61.77 163.67 23.49 Favored Glycine 0 CA--C 1.509 -0.314 0 O-C-N 123.7 0.625 . . . . 61.030000000000001 113.54 -172.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -61.67 137.73 58.26 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.683 -0.488 . . . . 74.340000000000003 109.683 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.32 -177.82 4.11 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.807 -0.633 . . . . 73.409999999999997 110.479 -173.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.6 151.33 6.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.073 -0.512 . . . . 61.520000000000003 110.343 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.756 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 18.6 ttm180 -48.51 -39.54 23.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 110.957 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 54' ' ' GLU . . . -63.96 -39.53 94.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.372 -0.376 . . . . 72.030000000000001 111.352 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 15' ' ' GLY . . . -76.24 -33.34 59.19 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 120.925 0.393 . . . . 52.32 111.943 -175.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.756 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 16.2 p -73.51 -42.83 61.28 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.796 -0.638 . . . . 61.32 110.501 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 57.2 mt -65.77 -28.68 69.2 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.09 0.472 . . . . 74.319999999999993 110.096 174.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 13.3 tp10 -75.27 -33.07 61.21 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.006 -0.543 . . . . 73.120000000000005 110.048 177.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.686 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 9.5 t80 -45.96 -60.19 2.4 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.415 0.524 . . . . 71.239999999999995 112.415 173.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.8 tt -56.28 -40.96 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 120.708 0.289 . . . . 72.140000000000001 111.319 -173.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.46 -30.68 63.34 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.028 0.442 . . . . 72.010000000000005 110.6 -179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.14 -34.48 77.71 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.873 -0.603 . . . . 74.420000000000002 109.85 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 71.15 6.68 5.91 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.445 -0.798 . . . . 71.519999999999996 112.259 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 65.75 102.21 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 120.876 0.369 . . . . 74.230000000000004 111.97 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.46 -157.73 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.702 2.268 . . . . 74.040000000000006 111.716 173.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -88.79 33.29 0.78 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.189 0.518 . . . . 74.439999999999998 110.566 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.6 tt -68.11 127.54 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.78 -0.646 . . . . 44.5 111.134 -176.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.708 ' HD2' ' H ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -57.77 155.96 20.13 Favored Pre-proline 0 CA--C 1.536 0.418 0 CA-C-N 115.522 -0.763 . . . . 72.230000000000004 111.88 -178.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.07 -11.9 32.87 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.725 2.283 . . . . 62.119999999999997 112.421 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -62.29 103.72 0.42 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.982 -0.553 . . . . 64.540000000000006 109.843 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.1 t -154.34 -61.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.803 -0.635 . . . . 72.439999999999998 109.982 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.441 HD11 ' CA ' ' A' ' 45' ' ' GLY . 80.8 mt -103.28 -164.0 1.04 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.883 -0.599 . . . . 74.140000000000001 110.626 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.6 ttp180 71.89 49.51 0.26 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.77 0.669 . . . . 72.540000000000006 109.573 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.65 -175.17 5.11 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.573 -0.74 . . . . 72.120000000000005 110.382 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -91.24 -28.51 17.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.278 -0.419 . . . . 71.420000000000002 110.693 -173.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.4 tp -80.48 -54.93 5.23 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.345 -0.389 . . . . 75.409999999999997 110.41 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 55.42 18.77 2.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.936 -0.574 . . . . 32.420000000000002 112.148 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.3 m -88.82 85.22 6.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.291 0.567 . . . . 74.239999999999995 110.844 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.25 103.49 0.23 Allowed Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 110.278 -1.129 . . . . 72.519999999999996 110.278 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -160.43 127.7 4.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.269 -0.271 . . . . 73.200000000000003 110.269 -172.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.83 -172.92 29.13 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.46 -0.656 . . . . 61.109999999999999 111.46 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -155.62 160.88 40.8 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 122.41 0.284 . . . . 73.439999999999998 110.48 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -162.92 115.52 1.59 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.932 -0.766 . . . . 74.109999999999999 108.932 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.657 -0.687 . . . . 63.520000000000003 109.169 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 N-CA-C 112.2 -0.36 . . . . 64.540000000000006 112.2 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.14 98.78 1.22 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.469 2.112 . . . . 72.439999999999998 112.467 -178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -145.38 133.01 4.88 Favored Glycine 0 C--O 1.227 -0.319 0 N-CA-C 111.092 -0.803 . . . . 52.530000000000001 111.092 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.9 m -64.5 167.96 6.43 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.967 0.413 . . . . 64.439999999999998 112.105 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 39.2 tpp -71.22 -64.9 0.82 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.305 0.574 . . . . 72.430000000000007 110.309 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.0 m -70.68 158.73 35.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.967 -1.015 . . . . 74.200000000000003 110.418 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.0 mm -62.33 92.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 121.219 0.533 . . . . 65.329999999999998 110.637 -178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -116.45 140.22 26.34 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.341 -0.845 . . . . 64.430000000000007 109.086 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -41.67 89.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 123.462 2.774 . . . . 71.439999999999998 114.265 -177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -142.58 106.51 4.7 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.819 -1.548 . . . . 72.319999999999993 106.819 170.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.445 ' HA ' HD12 ' A' ' 63' ' ' ILE . 5.0 m-20 61.52 83.01 0.16 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.446 -1.316 . . . . 75.400000000000006 107.446 -162.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -43.36 114.92 0.69 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.242 1.201 . . . . 73.540000000000006 114.242 -163.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.81 -17.57 55.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.885 -1.052 . . . . 74.530000000000001 109.142 168.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -67.98 11.62 0.14 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 113.699 -1.591 . . . . 73.329999999999998 112.922 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.15 96.47 0.09 OUTLIER Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.932 -0.867 . . . . 55.210000000000001 110.932 172.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.499 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 9.4 m -64.57 -51.04 64.81 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.156 0.428 . . . . 71.319999999999993 112.156 -172.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.662 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 2.4 t80 -67.2 -159.89 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 110.151 -0.314 . . . . 74.209999999999994 110.151 172.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 27.5 p90 -123.94 136.73 54.51 Favored 'General case' 0 CA--C 1.509 -0.624 0 O-C-N 121.632 -0.668 . . . . 74.439999999999998 110.05 -170.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.58 HG23 ' HB ' ' A' ' 43' ' ' VAL . 23.4 m -144.56 129.18 13.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 CA-C-N 114.88 -1.054 . . . . 65.329999999999998 111.551 -168.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.498 HD11 HG21 ' A' ' 36' ' ' VAL . 54.3 tp -106.78 132.5 52.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.005 -0.998 . . . . 71.329999999999998 109.163 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.02 126.38 75.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.925 0.393 . . . . 73.439999999999998 110.861 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -78.41 144.86 35.5 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.773 -0.825 . . . . 74.140000000000001 108.773 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -59.87 -18.27 43.11 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 120.891 0.377 . . . . 71.409999999999997 110.711 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.59 4.73 3.63 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.796 -0.638 . . . . 73.319999999999993 111.255 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.531 ' HG2' HH11 ' A' ' 64' ' ' ARG . 40.8 mt-10 72.0 56.05 0.17 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.099 0.56 . . . . 73.299999999999997 111.357 175.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -143.16 131.57 22.22 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.654 -0.703 . . . . 54.009999999999998 109.608 175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -100.92 139.24 36.89 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.784 0.326 . . . . 74.109999999999999 110.735 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.8 m -154.92 -172.72 4.29 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.293 -0.632 . . . . 70.430000000000007 109.293 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.75 162.51 15.67 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.741 -0.466 . . . . 62.520000000000003 109.741 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.417 ' HH2' ' HA2' ' A' ' 45' ' ' GLY . 3.7 p90 -137.32 160.22 66.45 Favored Pre-proline 0 C--O 1.234 0.264 0 N-CA-C 109.613 -0.514 . . . . 73.310000000000002 109.613 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.6 97.86 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.04 1.827 . . . . 52.539999999999999 111.024 172.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.463 ' HB1' ' HB3' ' A' ' 46' ' ' GLU . . . -53.23 -24.28 10.78 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.009 -0.541 . . . . 64.129999999999995 112.341 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -92.83 29.86 1.71 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.271 -0.422 . . . . 72.430000000000007 111.043 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.5 158.85 43.77 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.296 -0.411 . . . . 42.140000000000001 110.546 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.56 129.82 36.66 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.191 -0.459 . . . . 74.129999999999995 110.402 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.498 HG21 HD11 ' A' ' 20' ' ' LEU . 7.7 p -91.87 131.31 35.79 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 116.273 -0.421 . . . . 74.219999999999999 111.317 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 13.5 Cg_exo -69.17 177.91 4.71 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.909 2.406 . . . . 74.140000000000001 113.047 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.12 152.07 43.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.538 -0.755 . . . . 34.340000000000003 110.763 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.13 -35.33 4.63 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.303 -0.719 . . . . 60.32 111.303 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -100.88 100.76 11.45 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.782 -0.821 . . . . 74.510000000000005 108.782 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -93.3 126.57 38.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.868 0.365 . . . . 63.219999999999999 110.589 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.0 p -83.69 128.52 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.039 -0.356 . . . . 60.219999999999999 110.039 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.58 ' HB ' HG23 ' A' ' 19' ' ' VAL . 93.4 t -89.7 -43.33 14.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.9 0.381 . . . . 73.329999999999998 110.221 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -139.22 132.8 30.42 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 109.18 -0.674 . . . . 73.349999999999994 109.18 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -79.69 -176.26 48.95 Favored Glycine 0 C--N 1.335 0.507 0 O-C-N 124.334 1.022 . . . . 61.030000000000001 112.964 -175.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -46.35 144.33 2.13 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.703 0.631 . . . . 74.340000000000003 112.703 -174.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.572 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -151.36 -178.04 6.42 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.326 0.491 . . . . 73.409999999999997 112.326 -170.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 3.7 m-20 -96.67 171.4 8.56 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.911 0.863 . . . . 61.520000000000003 112.924 -171.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.737 ' HD3' ' SG ' ' A' ' 52' ' ' CYS . 6.4 tpp180 -56.67 -45.82 81.49 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 114.867 -1.06 . . . . 74.329999999999998 110.294 173.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -57.21 -34.23 68.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.463 0.649 . . . . 72.030000000000001 110.098 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -72.46 -33.06 66.77 Favored 'General case' 0 C--O 1.25 1.111 0 CA-C-N 115.277 -0.874 . . . . 52.32 111.622 -177.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.737 ' SG ' ' HD3' ' A' ' 49' ' ' ARG . 22.4 p -71.56 -38.83 70.95 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.308 -0.405 . . . . 61.32 110.387 172.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 92.0 mt -60.14 -35.85 76.21 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.981 -0.554 . . . . 74.319999999999993 110.449 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 42.1 mt-10 -77.07 -39.23 50.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.301 -0.409 . . . . 73.120000000000005 110.641 176.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -55.65 -48.19 75.39 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.69 0.256 . . . . 71.239999999999995 111.69 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.0 tt -62.92 -45.3 99.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 120.811 0.338 . . . . 72.140000000000001 111.145 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -60.98 -48.0 83.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.983 -0.553 . . . . 72.010000000000005 110.326 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -58.71 -34.66 71.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.822 -0.627 . . . . 74.420000000000002 110.25 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 62.19 93.34 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.596 -0.729 . . . . 71.519999999999996 110.226 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.418 ' CH2' HG21 ' A' ' 43' ' ' VAL . 3.4 t90 -109.52 105.2 56.89 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.229 -0.441 . . . . 74.230000000000004 110.012 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HG2' HG23 ' A' ' 63' ' ' ILE . 68.1 Cg_endo -84.79 -159.87 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.176 2.584 . . . . 74.040000000000006 112.146 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -85.74 89.97 7.9 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.265 -0.643 . . . . 74.439999999999998 109.265 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.455 HG23 ' HG2' ' A' ' 61' ' ' PRO . 21.8 pt -129.67 169.46 20.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.065 -0.516 . . . . 44.5 110.489 -178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.531 HH11 ' HG2' ' A' ' 25' ' ' GLU . 14.2 ptm180 -158.03 120.63 2.06 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 72.230000000000004 109.834 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.12 118.42 3.91 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.165 2.577 . . . . 62.119999999999997 113.134 -175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.501 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 10.4 mptt -78.91 -25.52 43.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.807 -0.633 . . . . 64.540000000000006 109.939 176.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.9 t -80.89 81.85 7.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.764 -0.653 . . . . 72.439999999999998 110.232 -178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.0 pp -124.14 20.32 9.02 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.119 -0.491 . . . . 74.140000000000001 110.892 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.613 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -134.28 166.5 22.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.269 -0.423 . . . . 72.540000000000006 110.016 -178.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.49 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 4.7 m-20 -53.36 155.6 2.75 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.297 -0.411 . . . . 72.120000000000005 111.117 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.24 57.02 1.79 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.113 -0.494 . . . . 71.420000000000002 109.752 -177.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 tt -88.72 55.13 3.26 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.73 -0.841 . . . . 75.409999999999997 108.73 -175.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.59 135.55 53.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.805 -1.089 . . . . 32.420000000000002 110.299 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.6 m -108.08 110.26 21.9 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.459 -0.337 . . . . 74.239999999999995 110.77 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.55 73.4 0.23 Allowed Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.941 -0.463 . . . . 72.519999999999996 111.941 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -135.98 147.63 48.1 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.943 -0.762 . . . . 73.200000000000003 108.943 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -145.02 175.9 24.36 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.432 -0.667 . . . . 61.109999999999999 111.432 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -106.01 -177.94 3.51 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.206 -0.294 . . . . 73.439999999999998 110.206 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -148.34 106.67 3.76 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.313 -0.625 . . . . 74.109999999999999 109.313 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.401 -0.809 . . . . 63.520000000000003 110.055 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 CA-C-O 119.925 -0.375 . . . . 64.540000000000006 112.172 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.7 139.62 48.81 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.592 2.195 . . . . 72.439999999999998 112.073 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.19 47.65 1.01 Allowed Glycine 0 C--N 1.33 0.212 0 N-CA-C 111.496 -0.641 . . . . 52.530000000000001 111.496 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.693 ' H ' HD11 ' A' ' 7' ' ' ILE . 23.2 m -72.72 177.82 4.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.901 0.381 . . . . 64.439999999999998 111.669 -177.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.431 ' HA ' ' HB2' ' A' ' 71' ' ' LYS . 85.3 mmm -53.9 -46.79 71.52 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.527 -0.761 . . . . 72.430000000000007 111.563 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.4 m -138.99 115.85 10.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 74.200000000000003 110.537 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.693 HD11 ' H ' ' A' ' 4' ' ' SER . 49.6 mm -94.99 -75.01 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.889 0.376 . . . . 65.329999999999998 110.446 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -94.97 140.17 22.37 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 64.430000000000007 110.234 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -52.74 121.24 8.86 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.678 2.252 . . . . 71.439999999999998 111.456 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -54.92 149.87 10.95 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.312 0.577 . . . . 72.319999999999993 111.691 -174.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -146.06 178.28 8.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.442 -0.948 . . . . 75.400000000000006 108.442 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 61.05 31.92 19.8 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.788 0.328 . . . . 73.540000000000006 110.219 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -53.15 -43.79 67.27 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.94 -0.573 . . . . 74.530000000000001 111.793 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -96.54 15.1 22.52 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.003 -0.544 . . . . 73.329999999999998 110.623 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.17 116.15 4.34 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.981 -0.554 . . . . 55.210000000000001 111.758 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.806 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 5.0 p -84.86 179.32 7.35 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.449 -0.204 . . . . 71.319999999999993 110.449 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.477 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 65.1 t80 -67.91 102.67 1.31 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 119.731 -0.787 . . . . 74.209999999999994 109.963 173.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.483 ' HB2' ' HE1' ' A' ' 30' ' ' TRP . 48.0 p90 -136.36 131.42 34.23 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.931 -1.507 . . . . 74.439999999999998 106.931 167.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 70.7 t -146.33 138.66 19.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 CA-C-O 121.263 0.554 . . . . 65.329999999999998 111.229 -167.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.765 ' HB2' ' HB3' ' A' ' 30' ' ' TRP . 33.8 tp -117.06 130.44 56.67 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.872 -1.058 . . . . 71.329999999999998 110.273 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.72 126.4 72.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.157 0.503 . . . . 73.439999999999998 110.216 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.528 ' HB3' ' HB2' ' A' ' 26' ' ' GLN . 52.8 t-20 -85.52 149.48 25.35 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.211 -0.663 . . . . 74.140000000000001 109.211 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 22' ' ' ASN . 27.4 t70 -56.44 -26.49 53.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.218 0.533 . . . . 71.409999999999997 110.174 176.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -80.69 15.9 1.57 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.596 -0.729 . . . . 73.319999999999993 111.589 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 73.68 18.75 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.582 0.753 . . . . 73.299999999999997 112.452 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' A' ' 22' ' ' ASN . 14.9 mm100 -77.24 129.78 36.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.512 -0.551 . . . . 54.009999999999998 109.512 173.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.427 ' HB3' ' CZ2' ' A' ' 60' ' ' TRP . 72.9 m80 -123.88 108.53 12.55 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.564 0.221 . . . . 74.109999999999999 110.817 -175.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.6 m -154.91 -163.63 1.61 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.181 -0.303 . . . . 70.430000000000007 110.181 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.776 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.3 pt? -109.66 159.16 17.37 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.382 -0.599 . . . . 62.520000000000003 109.382 175.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.765 ' HB3' ' HB2' ' A' ' 20' ' ' LEU . 11.7 p-90 -112.05 148.26 38.65 Favored Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 120.557 0.218 . . . . 73.310000000000002 110.849 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.18 94.41 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.368 2.045 . . . . 52.539999999999999 110.847 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.402 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -56.88 -18.28 12.58 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.858 -0.61 . . . . 64.129999999999995 111.682 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -85.02 2.24 44.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.928 -0.578 . . . . 72.430000000000007 110.668 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.17 176.88 8.26 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.183 -0.462 . . . . 42.140000000000001 110.906 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.51 139.85 30.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.465 . . . . 74.129999999999995 110.067 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.7 124.41 90.87 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.308 -0.406 . . . . 74.219999999999999 110.052 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.42 -171.67 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.906 2.404 . . . . 74.140000000000001 112.797 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.48 145.63 30.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.066 -0.515 . . . . 34.340000000000003 110.974 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.23 -32.66 5.77 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 116.248 -0.433 . . . . 60.32 112.415 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.466 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 16.8 m95 -86.0 136.94 33.06 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.489 -0.56 . . . . 74.510000000000005 109.489 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 40' ' ' TRP . 16.0 mmm180 -121.51 126.48 49.33 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.257 -0.645 . . . . 63.219999999999999 109.257 176.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.0 p -85.9 132.78 31.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.343 -0.243 . . . . 60.219999999999999 110.343 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.9 m -88.95 -37.51 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.069 0.461 . . . . 73.329999999999998 110.069 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -148.19 132.14 17.15 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.652 -0.703 . . . . 73.349999999999994 109.682 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.0 -175.15 45.36 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.111 -0.796 . . . . 61.030000000000001 111.111 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -54.86 133.64 47.9 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.884 0.342 . . . . 74.340000000000003 110.281 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.63 -177.58 4.93 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.665 0.617 . . . . 73.409999999999997 112.665 -168.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.22 165.89 1.28 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.981 -1.009 . . . . 61.520000000000003 112.601 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.519 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 0.2 OUTLIER -60.75 -29.08 69.17 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.891 -0.595 . . . . 74.329999999999998 109.682 174.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.509 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -58.18 -46.89 84.97 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.348 -0.612 . . . . 72.030000000000001 109.348 174.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' PHE . . . -65.83 -30.86 71.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.335 -0.848 . . . . 52.32 110.725 177.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.806 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 54.1 t -58.4 -49.04 78.7 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.849 -0.426 . . . . 61.32 109.849 170.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.9 mt -67.75 -27.15 66.54 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.799 -0.637 . . . . 74.319999999999993 110.494 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 43.5 mt-10 -76.89 -36.69 56.52 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-N 116.236 -0.438 . . . . 73.120000000000005 111.649 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.477 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 1.9 t80 -61.86 -47.8 83.37 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.956 0.343 . . . . 71.239999999999995 110.798 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.672 HG13 HD22 ' A' ' 68' ' ' LEU . 10.6 tt -63.78 -41.84 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.73 -0.214 . . . . 72.140000000000001 110.932 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.31 -34.19 65.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.762 0.315 . . . . 72.010000000000005 111.183 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.23 -25.5 68.09 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.307 0.575 . . . . 74.420000000000002 109.47 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 62.71 41.01 9.54 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.134 -0.939 . . . . 71.519999999999996 110.732 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' A' ' 27' ' ' HIS . 32.5 t-105 -59.49 128.95 86.69 Favored Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 109.228 -0.656 . . . . 74.230000000000004 109.228 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.45 92.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.664 2.243 . . . . 74.040000000000006 113.148 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -85.74 126.41 33.96 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.217 -1.031 . . . . 74.439999999999998 108.217 172.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.785 ' H ' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -78.87 3.89 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.134 0.42 . . . . 44.5 112.134 -173.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.456 ' C ' ' H ' ' A' ' 66' ' ' LYS . 34.9 ttt180 -92.13 141.44 25.16 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.413 -0.588 . . . . 72.230000000000004 109.413 173.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.435 ' HD2' ' HG3' ' A' ' 64' ' ' ARG . 51.2 Cg_endo -69.13 34.47 0.19 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.76 2.306 . . . . 62.119999999999997 112.649 176.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 64' ' ' ARG . 34.7 ttpt -74.23 99.71 3.51 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.501 0.72 . . . . 64.540000000000006 110.017 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.3 m -71.28 144.24 50.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.967 -0.561 . . . . 72.439999999999998 110.3 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.672 HD22 HG13 ' A' ' 56' ' ' ILE . 50.7 mt -63.91 -74.33 0.1 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.78 -0.452 . . . . 74.140000000000001 109.78 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER 176.25 -65.7 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.759 -0.83 . . . . 72.540000000000006 108.759 176.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -91.64 92.44 8.46 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.086 -0.506 . . . . 72.120000000000005 109.673 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 5' ' ' MET . 2.5 tmtp? -66.09 -47.15 75.18 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.34 -0.615 . . . . 71.420000000000002 109.34 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.99 47.02 1.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.085 -0.709 . . . . 75.409999999999997 109.085 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.02 94.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.63 -0.714 . . . . 32.420000000000002 110.646 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 19.2 p -77.46 -57.56 3.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.731 -0.668 . . . . 74.239999999999995 110.764 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.8 -168.83 22.73 Favored Glycine 0 C--N 1.331 0.269 0 N-CA-C 111.558 -0.617 . . . . 72.519999999999996 111.558 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.502 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 4.2 mmp_? -116.73 29.1 8.14 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.941 0.4 . . . . 73.200000000000003 110.859 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.05 46.82 92.61 Favored Glycine 0 N--CA 1.454 -0.159 0 CA-C-N 116.012 -0.54 . . . . 61.109999999999999 112.093 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -78.32 143.21 37.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.72 0.295 . . . . 73.439999999999998 110.524 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -102.81 -62.88 1.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.887 -0.597 . . . . 74.109999999999999 109.684 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 . . . . . 0 C--O 1.248 1.013 0 CA-C-N 115.541 -0.754 . . . . 63.520000000000003 109.048 178.603 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.783 -0.527 . . . . 64.540000000000006 111.783 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.38 88.27 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.584 2.19 . . . . 72.439999999999998 111.518 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 149.59 93.54 0.11 Allowed Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.858 -0.61 . . . . 52.530000000000001 112.151 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.9 m -67.91 103.03 1.37 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.253 -0.647 . . . . 64.439999999999998 109.253 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.576 ' HA ' ' HE2' ' A' ' 5' ' ' MET . 26.8 mmt -69.11 -8.28 43.89 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.989 -0.55 . . . . 72.430000000000007 111.86 -174.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.6 m -145.37 152.71 40.29 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 110.19 -0.3 . . . . 74.200000000000003 110.19 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.7 mm -88.18 81.74 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.129 0.49 . . . . 65.329999999999998 109.869 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.661 ' HB3' ' HB3' ' A' ' 11' ' ' ASP . 3.2 m-20 -106.52 133.12 20.39 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.821 -0.627 . . . . 64.430000000000007 110.632 -176.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -86.93 95.33 0.49 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.185 2.59 . . . . 71.439999999999998 111.163 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 69.9 t80 56.13 88.05 0.05 OUTLIER 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.689 -0.687 . . . . 72.319999999999993 110.187 -173.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.661 ' HB3' ' HB3' ' A' ' 8' ' ' ASN . 27.3 t70 -179.7 94.92 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.011 -1.107 . . . . 75.400000000000006 108.011 -177.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.67 131.84 36.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.232 0.539 . . . . 73.540000000000006 111.931 -171.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -51.34 -47.85 62.59 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.888 -1.051 . . . . 74.530000000000001 111.675 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -97.19 13.51 29.09 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.178 -0.465 . . . . 73.329999999999998 111.926 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.05 -175.26 46.41 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 121.186 -0.53 . . . . 55.210000000000001 113.344 177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.431 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 5.8 p -93.5 -57.69 2.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.146 0.578 . . . . 71.319999999999993 111.974 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.764 ' CD1' ' HB2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -65.73 -159.03 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.444 0.535 . . . . 74.209999999999994 112.444 171.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.422 ' CB ' ' HA ' ' A' ' 46' ' ' GLU . 27.7 p90 -124.26 135.98 53.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.474 -0.784 . . . . 74.439999999999998 108.956 -173.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.07 129.5 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.055 -0.52 . . . . 65.329999999999998 111.896 -167.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 30' ' ' TRP . 49.5 tp -100.31 125.62 46.55 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.252 -0.886 . . . . 71.329999999999998 109.123 172.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 p -109.26 126.34 66.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.24 0.543 . . . . 73.439999999999998 109.807 176.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -94.47 148.33 22.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.72 -0.673 . . . . 74.140000000000001 110.671 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' HB3' ' HZ3' ' A' ' 40' ' ' TRP . 15.3 t70 -56.06 -20.86 18.75 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.354 0.597 . . . . 71.409999999999997 110.199 174.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -73.55 3.72 5.83 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.262 -0.881 . . . . 73.319999999999993 111.531 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 63.31 56.83 1.63 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.37 0.605 . . . . 73.299999999999997 110.586 -175.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -137.93 132.55 32.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.251 -0.886 . . . . 54.009999999999998 109.171 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.436 ' HB2' ' HZ3' ' A' ' 60' ' ' TRP . 0.4 OUTLIER -116.8 109.12 16.7 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.13 0.491 . . . . 74.109999999999999 110.333 -178.361 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.3 t -145.96 -167.77 2.81 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.564 -0.532 . . . . 70.430000000000007 109.564 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 pp -107.61 158.63 17.08 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.27 -0.27 . . . . 62.520000000000003 110.27 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.632 ' HB3' HD22 ' A' ' 20' ' ' LEU . 18.2 p-90 -111.79 153.24 44.48 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.453 -0.34 . . . . 73.310000000000002 110.431 -175.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.73 102.83 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.157 1.905 . . . . 52.539999999999999 110.979 175.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.09 -7.01 2.25 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.522 0.934 . . . . 64.129999999999995 113.522 -171.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -107.23 10.13 29.97 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 122.256 -0.278 . . . . 72.430000000000007 110.962 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.456 ' O ' ' HZ3' ' A' ' 30' ' ' TRP . . . -124.48 169.89 11.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.426 -0.352 . . . . 42.140000000000001 110.574 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.45 139.56 30.59 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 110.124 -0.324 . . . . 74.129999999999995 110.124 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.0 t -74.64 120.93 83.9 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.557 -0.292 . . . . 74.219999999999999 110.513 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.65 137.67 70.33 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.461 2.108 . . . . 74.140000000000001 111.436 175.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.73 134.94 57.5 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.46 -0.336 . . . . 34.340000000000003 110.571 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.31 -35.15 4.59 Favored Glycine 0 CA--C 1.511 -0.211 0 N-CA-C 111.062 -0.815 . . . . 60.32 111.062 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.417 ' HZ3' ' HB3' ' A' ' 23' ' ' ASP . 3.7 m95 -92.5 143.89 25.9 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.043 -1.095 . . . . 74.510000000000005 108.043 173.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 41' ' ' ARG . 44.6 ttm105 -141.22 133.7 28.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.96 0.41 . . . . 63.219999999999999 111.517 -174.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.2 t -85.49 121.09 36.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.959 -0.564 . . . . 60.219999999999999 110.31 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.42 -37.18 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 120.8 0.334 . . . . 73.329999999999998 110.873 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.415 ' HD2' ' O ' ' A' ' 45' ' ' GLY . 3.6 t-160 -134.67 129.89 35.49 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.226 -0.657 . . . . 73.349999999999994 109.226 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -72.47 167.29 53.52 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 124.455 1.097 . . . . 61.030000000000001 113.543 -176.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.595 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 2.6 mp0 -50.91 128.69 21.83 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.715 0.806 . . . . 74.340000000000003 112.488 -171.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -133.18 -178.23 4.88 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.509 -0.768 . . . . 73.409999999999997 110.727 -176.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.37 164.57 23.94 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.772 0.796 . . . . 61.520000000000003 112.653 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -52.57 -38.37 59.77 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 114.753 -1.112 . . . . 74.329999999999998 109.787 173.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.42 -47.6 83.39 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 115.756 -0.656 . . . . 72.030000000000001 110.216 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 17' ' ' PHE . . . -59.86 -31.35 69.69 Favored 'General case' 0 C--O 1.258 1.515 0 CA-C-O 121.71 0.766 . . . . 52.32 111.015 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.608 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 47.8 t -71.25 -40.88 70.75 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.724 -1.125 . . . . 61.32 110.839 172.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.5 mt -67.66 -26.93 66.45 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.317 0.58 . . . . 74.319999999999993 109.796 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -77.11 -37.39 54.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.526 -0.761 . . . . 73.120000000000005 110.141 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.764 ' HB2' ' CD1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -46.53 -58.04 4.16 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 111.861 0.319 . . . . 71.239999999999995 111.861 171.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 tt -60.81 -37.96 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.242 0.544 . . . . 72.140000000000001 110.552 -176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.45 -43.55 93.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.249 -0.887 . . . . 72.010000000000005 110.571 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -73.76 -27.95 61.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.868 -0.605 . . . . 74.420000000000002 110.106 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 58.02 57.46 4.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.185 -0.916 . . . . 71.519999999999996 110.121 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.452 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 50.4 t90 -62.4 116.3 21.91 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-N 115.631 -0.713 . . . . 74.230000000000004 109.794 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 60' ' ' TRP . 1.2 Cg_endo -83.11 -153.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.406 2.737 . . . . 74.040000000000006 112.101 -176.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -98.73 -1.97 39.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.773 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 32.2 pt -108.93 141.31 24.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.094 -0.503 . . . . 44.5 110.893 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.0 ttt-85 -127.62 146.78 59.92 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.731 -0.668 . . . . 72.230000000000004 109.671 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -46.88 140.22 13.38 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.578 2.185 . . . . 62.119999999999997 112.182 171.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 66' ' ' LYS . 7.1 ttpm? -83.53 111.56 19.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.042 -0.526 . . . . 64.540000000000006 111.396 -174.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -61.41 146.87 46.9 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.155 -0.475 . . . . 72.439999999999998 110.433 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.3 tt -172.33 -60.01 0.02 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.933 0.397 . . . . 74.140000000000001 110.099 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.534 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 2.2 tpm_? -92.19 132.28 36.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.409 . . . . 72.540000000000006 110.528 -177.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -73.12 82.28 1.28 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.547 . . . . 72.120000000000005 110.605 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.567 ' HB3' ' HA ' ' A' ' 5' ' ' MET . 14.5 tppt? -94.12 171.21 8.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.674 -0.694 . . . . 71.420000000000002 109.341 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 72' ' ' LEU . 56.5 tp -169.3 51.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.946 0.879 . . . . 75.409999999999997 108.924 -176.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.45 ' HB1' ' HG3' ' A' ' 76' ' ' ARG . . . 56.94 31.06 19.11 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 114.77 -1.105 . . . . 32.420000000000002 112.127 174.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.6 p -55.47 -33.89 64.05 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.309 -0.405 . . . . 74.239999999999995 111.865 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.72 6.47 58.39 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 116.094 -0.503 . . . . 72.519999999999996 113.558 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.633 ' HE ' ' HA ' ' A' ' 76' ' ' ARG . 3.1 mmp_? -83.25 105.15 13.98 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 117.23 0.515 . . . . 73.200000000000003 110.495 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -135.37 -76.76 0.09 OUTLIER Glycine 0 CA--C 1.509 -0.318 0 N-CA-C 110.543 -1.023 . . . . 61.109999999999999 110.543 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -139.81 138.25 35.65 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.24 -0.652 . . . . 73.439999999999998 109.24 170.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -143.76 105.15 4.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.397 -0.82 . . . . 74.109999999999999 110.324 -174.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 115.643 -0.708 . . . . 63.520000000000003 109.909 179.174 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.836 0 N-CA-C 112.347 -0.301 . . . . 64.540000000000006 112.347 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -80.26 141.49 14.47 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.997 2.465 . . . . 72.439999999999998 111.571 178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.76 83.04 0.81 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.056 -0.592 . . . . 52.530000000000001 112.067 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.2 p -74.73 174.48 9.07 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.715 0.293 . . . . 64.439999999999998 110.869 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.4 mtp -77.8 -65.04 1.02 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 72.430000000000007 110.756 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.4 m -86.4 135.55 33.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.852 -0.613 . . . . 74.200000000000003 111.169 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 48.2 mm -101.43 134.09 42.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.427 -0.953 . . . . 65.329999999999998 108.427 170.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 7' ' ' ILE . 90.6 m-20 70.17 159.88 0.15 Allowed Pre-proline 0 N--CA 1.468 0.461 0 O-C-N 123.486 0.491 . . . . 64.430000000000007 109.993 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.8 -18.32 55.59 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.086 1.857 . . . . 71.439999999999998 112.082 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -113.77 110.75 20.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.512 . . . . 72.319999999999993 110.209 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -73.67 78.46 1.52 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.618 -0.882 . . . . 75.400000000000006 108.618 175.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -137.81 27.06 2.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.591 -0.731 . . . . 73.540000000000006 110.014 -174.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.65 -19.17 36.81 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 114.66 -1.155 . . . . 74.530000000000001 111.573 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.833 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 8.9 p30 -68.54 14.6 0.07 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.002 -0.999 . . . . 73.329999999999998 113.118 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.66 -10.43 33.07 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.102 -0.57 . . . . 55.210000000000001 112.442 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.497 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 4.5 m -73.47 140.27 46.35 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.643 0.609 . . . . 71.319999999999993 112.643 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.685 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -67.12 -158.02 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.897 0.379 . . . . 74.209999999999994 110.411 159.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.505 ' HB3' ' HA ' ' A' ' 46' ' ' GLU . 31.2 p90 -122.9 135.93 54.68 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.458 0.647 . . . . 74.439999999999998 109.66 -167.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.686 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 18.1 t -135.86 131.99 50.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.83 -1.077 . . . . 65.329999999999998 109.694 -167.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.501 ' HB2' ' CD1' ' A' ' 30' ' ' TRP . 29.6 tp -120.92 145.16 47.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.108 -0.497 . . . . 71.329999999999998 110.714 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 97.8 t -122.01 125.54 73.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.812 -0.811 . . . . 73.439999999999998 108.812 170.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -82.48 163.55 21.51 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.826 -0.435 . . . . 74.140000000000001 109.826 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -57.38 -31.17 65.53 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.929 0.395 . . . . 71.409999999999997 110.719 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -79.18 16.67 0.91 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.429 0.633 . . . . 73.319999999999993 110.338 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 65.44 24.62 11.95 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.473 -0.785 . . . . 73.299999999999997 111.538 173.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 93.7 mt-30 -78.73 121.19 24.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.789 -0.641 . . . . 54.009999999999998 110.104 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -99.15 116.8 32.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.265 -0.272 . . . . 74.109999999999999 110.265 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.4 t -166.33 -164.19 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.601 -0.518 . . . . 70.430000000000007 109.601 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.763 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.4 pt? -108.32 173.73 6.19 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.694 -0.484 . . . . 62.520000000000003 109.694 176.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.501 ' CD1' ' HB2' ' A' ' 20' ' ' LEU . 14.7 p-90 -134.6 149.34 70.63 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.693 -0.23 . . . . 73.310000000000002 111.163 -175.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.88 108.63 2.62 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.741 2.294 . . . . 52.539999999999999 111.703 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -73.28 -12.16 60.75 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.304 -0.407 . . . . 64.129999999999995 112.013 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -104.31 14.53 30.07 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.041 0.448 . . . . 72.430000000000007 110.749 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.68 179.96 6.27 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.022 -0.535 . . . . 42.140000000000001 110.51 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -79.16 118.9 21.54 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.509 -0.314 . . . . 74.129999999999995 110.443 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.619 HG22 ' NE1' ' A' ' 40' ' ' TRP . 7.7 p -96.19 110.38 51.95 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 109.02 -0.733 . . . . 74.219999999999999 109.02 173.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.463 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 36.5 Cg_endo -64.3 108.38 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.853 2.369 . . . . 74.140000000000001 114.043 -167.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.26 152.53 0.27 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.682 -0.69 . . . . 34.340000000000003 112.3 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.78 -8.1 21.83 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.735 -0.666 . . . . 60.32 111.702 -174.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.619 ' NE1' HG22 ' A' ' 36' ' ' VAL . 4.9 p-90 -87.72 -177.61 5.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 122.972 0.509 . . . . 74.510000000000005 110.746 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.631 ' HB3' HD11 ' A' ' 63' ' ' ILE . 49.0 mtt85 -128.95 125.38 37.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.288 -1.005 . . . . 63.219999999999999 108.288 171.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.9 p -91.47 116.63 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.962 0.41 . . . . 60.219999999999999 111.162 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.699 ' HA ' HG13 ' A' ' 63' ' ' ILE . 61.4 t -76.98 -35.36 23.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.095 0.474 . . . . 73.329999999999998 110.288 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.433 ' CD2' ' HB2' ' A' ' 16' ' ' SER . 2.1 m80 -157.02 132.2 9.05 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.632 -0.713 . . . . 73.349999999999994 109.828 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 18' ' ' PHE . . . -71.31 167.66 51.62 Favored Glycine 0 C--N 1.34 0.773 0 O-C-N 124.337 1.023 . . . . 61.030000000000001 112.461 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -55.45 147.1 18.24 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.389 0.885 . . . . 74.340000000000003 113.389 -170.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -148.99 -178.31 6.3 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 114.735 -1.12 . . . . 73.409999999999997 109.24 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -91.89 172.28 8.57 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.001 0.429 . . . . 61.520000000000003 111.357 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -57.8 -32.25 67.37 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.137 -0.483 . . . . 74.329999999999998 110.117 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.712 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -52.35 -52.66 52.14 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 109.343 -0.614 . . . . 72.030000000000001 109.343 175.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.497 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -64.26 -31.56 72.8 Favored 'General case' 0 C--O 1.262 1.724 0 CA-C-N 115.439 -0.801 . . . . 52.32 111.274 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.685 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 53.0 t -66.14 -36.53 83.37 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 114.55 -1.204 . . . . 61.32 110.57 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.677 ' O ' HG22 ' A' ' 56' ' ' ILE . 76.0 mt -72.0 -44.39 63.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.52 -0.548 . . . . 74.319999999999993 109.52 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.712 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 4.3 mm-40 -62.34 -25.55 67.96 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.417 -0.356 . . . . 73.120000000000005 111.12 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.604 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -46.09 -27.17 0.89 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 111.715 0.265 . . . . 71.239999999999995 111.715 173.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 53' ' ' LEU . 19.7 tt -60.85 -47.83 91.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 121.477 0.656 . . . . 72.140000000000001 110.271 177.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.475 ' N ' HG23 ' A' ' 56' ' ' ILE . 12.5 tp10 -73.83 -35.47 64.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.098 -0.955 . . . . 72.010000000000005 110.364 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.688 ' HG3' ' HG3' ' A' ' 61' ' ' PRO . 4.6 tp10 -74.89 -36.35 62.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.0 -1.0 . . . . 74.420000000000002 111.361 -172.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 67.91 -87.36 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.845 -0.616 . . . . 71.519999999999996 111.63 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -159.08 91.34 1.96 Allowed Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 122.445 0.298 . . . . 74.230000000000004 110.669 -175.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.688 ' HG3' ' HG3' ' A' ' 58' ' ' GLU . 5.1 Cg_exo -79.94 -172.26 1.48 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.936 2.424 . . . . 74.040000000000006 111.674 175.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.56 168.51 19.16 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.293 0.568 . . . . 74.439999999999998 111.894 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.699 HG13 ' HA ' ' A' ' 43' ' ' VAL . 8.6 tt -101.82 124.47 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.253 -0.885 . . . . 44.5 112.344 -169.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.503 ' HB2' ' HD2' ' A' ' 65' ' ' PRO . 0.1 OUTLIER 178.71 163.34 0.68 Allowed Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.024 -0.535 . . . . 72.230000000000004 109.774 170.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 64' ' ' ARG . 33.7 Cg_endo -62.85 -170.39 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 123.126 2.551 . . . . 62.119999999999997 113.437 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.1 tttp -63.5 84.28 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.976 -0.556 . . . . 64.540000000000006 111.337 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.3 p -135.41 47.36 2.31 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.727 -0.842 . . . . 72.439999999999998 108.727 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.833 ' HB2' ' HA ' ' A' ' 14' ' ' ASN . 2.3 pt? -65.0 -25.31 67.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.546 -1.206 . . . . 74.140000000000001 111.991 -174.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.617 ' HG3' ' HG ' ' A' ' 68' ' ' LEU . 59.9 mtm180 -117.59 111.72 19.59 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 110.747 -0.094 . . . . 72.540000000000006 110.747 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 61.66 121.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 O-C-N 124.0 0.813 . . . . 72.120000000000005 112.777 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -75.46 63.99 1.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.196 -0.668 . . . . 71.420000000000002 109.196 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -165.42 -49.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.842 -0.617 . . . . 75.409999999999997 109.728 -174.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -130.77 -164.41 1.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 32.420000000000002 110.506 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 64.5 m -143.25 -52.65 0.36 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.058 0.456 . . . . 74.239999999999995 110.279 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 137.84 -154.34 22.63 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.751 -0.659 . . . . 72.519999999999996 111.487 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -150.68 156.19 40.84 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.74 -0.467 . . . . 73.200000000000003 109.74 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.19 103.55 0.2 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.08 -0.581 . . . . 61.109999999999999 112.265 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -162.16 -179.93 7.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.181 -0.674 . . . . 73.439999999999998 109.181 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.5 t70 72.38 16.72 4.95 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.876 0.846 . . . . 74.109999999999999 110.097 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 C--O 1.247 0.936 0 CA-C-N 115.112 -0.949 . . . . 63.520000000000003 110.165 179.854 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 111.814 -0.515 . . . . 64.540000000000006 111.814 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.22 93.08 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.396 2.064 . . . . 72.439999999999998 111.43 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.27 111.45 4.13 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.883 -0.599 . . . . 52.530000000000001 112.314 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.9 p -65.45 130.33 42.93 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.294 -0.261 . . . . 64.439999999999998 110.294 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 35.3 tpp -54.41 -51.94 63.31 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.306 0.574 . . . . 72.430000000000007 109.81 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.7 t -165.88 149.94 8.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.092 -0.958 . . . . 74.200000000000003 110.366 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.5 mt -142.74 147.46 20.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.244 -0.889 . . . . 65.329999999999998 109.013 176.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.464 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 8.0 t30 74.49 132.29 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.537 0 O-C-N 123.656 0.597 . . . . 64.430000000000007 110.823 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 8' ' ' ASN . 23.1 Cg_exo -65.32 160.64 41.43 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.797 2.331 . . . . 71.439999999999998 112.348 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -69.45 95.61 0.83 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.324 -0.621 . . . . 72.319999999999993 109.324 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.439 ' HB3' HH12 ' A' ' 64' ' ' ARG . 32.5 t70 -111.23 72.03 0.76 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.905 -0.589 . . . . 75.400000000000006 111.162 -170.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 53.62 28.95 8.54 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.827 -0.624 . . . . 73.540000000000006 111.837 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.463 ' OD1' ' HD3' ' A' ' 64' ' ' ARG . 11.1 m-20 -58.64 -44.16 89.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 74.530000000000001 110.368 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.46 ' O ' ' HB1' ' A' ' 51' ' ' ALA . 7.4 m-20 -97.42 15.4 23.19 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.599 -0.728 . . . . 73.329999999999998 111.042 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.82 -46.57 75.56 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.371 -0.442 . . . . 55.210000000000001 113.27 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.8 m -139.83 58.38 1.6 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.972 -1.121 . . . . 71.319999999999993 107.972 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.436 ' HB2' ' HA ' ' A' ' 14' ' ' ASN . 62.2 m-85 -162.21 109.8 1.35 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 114.424 -1.262 . . . . 74.209999999999994 114.351 -156.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.448 ' HB2' ' O ' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -151.51 130.71 12.73 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.306 -0.998 . . . . 74.439999999999998 108.306 150.456 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.435 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 64.0 t -158.1 136.71 3.13 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 CA-C-O 121.128 0.489 . . . . 65.329999999999998 112.152 -169.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.423 HD13 HG22 ' A' ' 42' ' ' VAL . 63.4 tp -102.21 122.96 45.21 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.445 -0.798 . . . . 71.329999999999998 109.514 174.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.55 125.82 50.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.241 -0.651 . . . . 73.439999999999998 109.241 174.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 14.3 m120 -96.92 139.26 33.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.781 -0.645 . . . . 74.140000000000001 110.254 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.72 -15.92 59.75 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.087 0.47 . . . . 71.409999999999997 110.843 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -85.24 26.56 0.88 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.031 -0.531 . . . . 73.319999999999993 111.078 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 69.8 6.25 5.64 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.314 0.646 . . . . 73.299999999999997 111.803 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 15.7 mm100 -90.86 153.78 19.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.929 0.395 . . . . 54.009999999999998 110.45 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -133.37 109.09 9.11 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.394 -0.965 . . . . 74.109999999999999 108.394 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.3 t -128.38 177.21 7.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.772 0.796 . . . . 70.430000000000007 111.889 -170.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.3 tt -111.71 106.59 15.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.594 -1.185 . . . . 62.520000000000003 108.065 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.457 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 25.3 p-90 -77.67 149.49 77.86 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.059 -0.519 . . . . 73.310000000000002 111.206 -174.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.89 104.07 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.038 1.825 . . . . 52.539999999999999 111.085 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.457 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -63.42 -2.15 1.43 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.23 -0.441 . . . . 64.129999999999995 111.621 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -89.78 -0.72 57.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 72.430000000000007 110.789 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.2 178.0 7.24 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.05 0.452 . . . . 42.140000000000001 111.688 -175.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -95.92 140.11 31.15 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.593 -0.731 . . . . 74.129999999999995 111.028 178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.3 t -91.48 123.95 62.38 Favored Pre-proline 0 C--O 1.236 0.383 0 CA-C-N 116.243 -0.435 . . . . 74.219999999999999 111.037 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.54 153.75 73.04 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.616 2.211 . . . . 74.140000000000001 111.708 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.05 152.18 38.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.94 0.4 . . . . 34.340000000000003 110.714 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.4 -35.53 4.91 Favored Glycine 0 N--CA 1.455 -0.073 0 N-CA-C 111.036 -0.826 . . . . 60.32 111.036 -174.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -95.01 129.21 42.18 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.757 -1.201 . . . . 74.510000000000005 107.757 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -100.12 125.64 46.25 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.622 -0.51 . . . . 63.219999999999999 109.622 -171.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.423 HG22 HD13 ' A' ' 20' ' ' LEU . 21.6 t -90.69 117.88 34.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.99 -0.744 . . . . 60.219999999999999 108.99 178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.435 ' CG1' ' HB ' ' A' ' 19' ' ' VAL . 14.4 p -84.16 -23.35 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.681 0.753 . . . . 73.329999999999998 109.548 -174.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.429 ' NE2' ' HB2' ' A' ' 64' ' ' ARG . 27.2 m80 -148.29 115.48 6.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.036 -0.984 . . . . 73.349999999999994 108.714 173.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -69.74 -171.51 8.73 Favored Glycine 0 N--CA 1.447 -0.583 0 O-C-N 123.864 0.728 . . . . 61.030000000000001 112.501 -175.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -52.44 133.88 34.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.146 0.498 . . . . 74.340000000000003 111.322 -178.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.87 175.89 9.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.541 -0.754 . . . . 73.409999999999997 110.017 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.74 159.58 21.96 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.984 -0.553 . . . . 61.520000000000003 111.273 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.556 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 15.7 ttm180 -58.38 -37.72 75.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.242 -0.651 . . . . 74.329999999999998 109.242 176.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.74 -36.82 84.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.028 -0.533 . . . . 72.030000000000001 110.468 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 14' ' ' ASN . . . -69.02 -38.47 79.22 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-N 115.855 -0.611 . . . . 52.32 111.389 -176.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.556 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 27.0 p -73.44 -47.26 43.06 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.411 -0.813 . . . . 61.32 110.995 174.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 72.8 mt -60.89 -34.5 74.74 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.503 -0.317 . . . . 74.319999999999993 110.594 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -76.82 -37.54 55.5 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.885 -0.326 . . . . 73.120000000000005 110.54 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.537 ' HE1' ' HB2' ' A' ' 60' ' ' TRP . 11.0 t80 -48.26 -58.12 5.0 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 120.438 -0.505 . . . . 71.239999999999995 111.588 170.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 52' ' ' CYS . 3.7 tt -61.65 -38.55 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 120.672 0.272 . . . . 72.140000000000001 111.032 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -60.54 -43.49 97.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 72.010000000000005 110.51 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -81.94 -14.89 55.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.895 -0.593 . . . . 74.420000000000002 111.428 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.4 t60 61.68 34.94 17.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.151 -0.477 . . . . 71.519999999999996 110.853 174.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.537 ' HB2' ' HE1' ' A' ' 55' ' ' TYR . 75.0 t-105 64.79 83.62 0.19 Allowed Pre-proline 0 N--CA 1.471 0.581 0 CA-C-O 120.962 0.411 . . . . 74.230000000000004 110.079 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -87.86 -33.81 0.13 Allowed 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.917 2.411 . . . . 74.040000000000006 113.726 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -145.88 171.15 15.23 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 122.309 -0.245 . . . . 74.439999999999998 110.925 -170.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.711 ' H ' HD13 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -122.52 136.71 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 121.184 0.516 . . . . 44.5 111.523 -173.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.463 ' HD3' ' OD1' ' A' ' 13' ' ' ASP . 59.5 mtt180 -149.68 153.6 36.71 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-N 115.632 -0.713 . . . . 72.230000000000004 109.277 176.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.6 171.49 17.09 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.968 2.445 . . . . 62.119999999999997 113.327 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -73.88 136.63 43.4 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.379 -0.828 . . . . 64.540000000000006 110.316 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' HD13 ' A' ' 68' ' ' LEU . 13.7 m -64.98 81.45 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.44 -0.345 . . . . 72.439999999999998 110.854 176.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.545 HD13 ' C ' ' A' ' 67' ' ' SER . 0.0 OUTLIER 31.25 -167.01 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 116.248 1.944 . . . . 74.140000000000001 116.248 174.226 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.462 ' HG2' ' N ' ' A' ' 70' ' ' ASP . 57.0 ttt180 -175.25 161.74 2.85 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 113.803 -1.544 . . . . 72.540000000000006 108.11 172.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.462 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 8.5 p-10 -57.98 114.4 2.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.232 0.539 . . . . 72.120000000000005 111.463 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HD2' ' O ' ' A' ' 70' ' ' ASP . 5.1 mptp? -124.34 27.09 7.14 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.042 -0.526 . . . . 71.420000000000002 110.377 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.7 tp -85.9 48.73 1.65 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.547 0.689 . . . . 75.409999999999997 109.964 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.73 24.29 2.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.59 -0.732 . . . . 32.420000000000002 111.029 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.4 p -66.44 127.77 33.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 74.239999999999995 111.018 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.86 120.93 0.96 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.244 -0.503 . . . . 72.519999999999996 112.035 179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -134.91 128.4 32.5 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.506 -0.553 . . . . 73.200000000000003 109.506 178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -147.14 -159.2 8.19 Favored Glycine 0 C--O 1.236 0.256 0 N-CA-C 111.496 -0.642 . . . . 61.109999999999999 111.496 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 87.9 t80 179.72 -84.06 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.809 -0.441 . . . . 73.439999999999998 109.809 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -82.19 -41.96 19.63 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.421 -0.585 . . . . 74.109999999999999 109.421 175.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.602 ' NE2' ' H ' ' A' ' 80' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.03 0 N-CA-C 108.466 -0.939 . . . . 63.520000000000003 108.466 169.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.867 0 N-CA-C 111.934 -0.466 . . . . 64.540000000000006 111.934 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.57 152.79 23.16 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.758 2.305 . . . . 72.439999999999998 112.225 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.7 70.31 2.89 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 116.022 -0.536 . . . . 52.530000000000001 112.421 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.7 m -69.93 102.87 2.08 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.068 -0.345 . . . . 64.439999999999998 110.068 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.59 ' HE1' ' HA ' ' A' ' 71' ' ' LYS . 81.8 mmm -57.23 -57.56 12.08 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.2 -0.454 . . . . 72.430000000000007 110.548 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.9 m -80.86 112.19 18.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.99 -0.55 . . . . 74.200000000000003 109.648 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.446 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 67.5 mt -75.47 102.59 2.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.219 -0.446 . . . . 65.329999999999998 110.808 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -101.31 91.13 1.93 Allowed Pre-proline 0 C--O 1.235 0.318 0 N-CA-C 108.408 -0.96 . . . . 64.430000000000007 108.408 169.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 7' ' ' ILE . 83.9 Cg_endo -85.35 151.94 10.59 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.759 2.306 . . . . 71.439999999999998 112.943 -171.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -131.63 -75.77 0.52 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.813 -0.631 . . . . 72.319999999999993 109.54 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -75.47 -24.06 56.91 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.12 0.486 . . . . 75.400000000000006 109.868 175.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.43 -30.36 60.33 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.378 -0.828 . . . . 73.540000000000006 110.939 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -58.05 -35.1 70.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.706 -0.679 . . . . 74.530000000000001 111.303 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -97.09 13.08 30.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.202 0.525 . . . . 73.329999999999998 110.263 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.1 60.84 4.56 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 116.149 -0.478 . . . . 55.210000000000001 112.871 -174.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 32.3 m -68.99 150.86 47.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.108 -0.33 . . . . 71.319999999999993 110.108 175.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.632 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 68.5 t80 -68.34 102.91 1.49 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.904 -0.718 . . . . 74.209999999999994 109.843 174.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -144.44 131.57 20.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.36 -1.348 . . . . 74.439999999999998 107.36 169.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.3 t -141.79 123.6 13.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.267 0.555 . . . . 65.329999999999998 111.003 -170.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 40' ' ' TRP . 52.2 tp -93.48 127.99 39.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.202 -0.908 . . . . 71.329999999999998 109.64 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 26' ' ' GLN . 61.8 t -121.44 129.16 75.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.232 0.539 . . . . 73.439999999999998 110.909 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 33.4 t30 -92.81 151.78 19.81 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.92 -0.77 . . . . 74.140000000000001 108.92 173.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -54.54 -19.94 6.86 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.159 0.504 . . . . 71.409999999999997 110.95 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -82.64 20.61 1.1 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.965 -0.561 . . . . 73.319999999999993 111.635 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 65.62 12.57 8.34 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.976 0.51 . . . . 73.299999999999997 111.849 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.533 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 34.6 tt0 -76.03 117.64 17.95 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.341 -0.615 . . . . 54.009999999999998 109.341 176.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -122.52 107.95 12.6 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.01 0.434 . . . . 74.109999999999999 111.298 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 m -132.38 -168.03 1.99 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.549 -0.75 . . . . 70.430000000000007 109.359 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.787 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.9 pt? -106.38 161.63 14.4 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.238 -0.653 . . . . 62.520000000000003 109.238 174.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.467 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 20.0 p-90 -131.8 145.03 55.72 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-O 120.614 0.245 . . . . 73.310000000000002 111.31 -173.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 14.0 Cg_exo -69.86 103.67 1.21 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.727 2.285 . . . . 52.539999999999999 111.291 176.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.467 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -60.01 -22.52 62.7 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.14 -0.482 . . . . 64.129999999999995 112.03 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -84.88 4.26 34.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.615 -0.266 . . . . 72.430000000000007 111.436 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.99 162.44 22.33 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.806 0.336 . . . . 42.140000000000001 110.725 -179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -82.97 132.84 35.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 74.129999999999995 110.597 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.7 t -83.97 115.95 62.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 74.219999999999999 110.198 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -60.68 147.1 95.92 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.345 2.03 . . . . 74.140000000000001 112.169 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.37 137.76 57.0 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.203 -0.453 . . . . 34.340000000000003 110.685 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.42 -35.42 4.55 Favored Glycine 0 N--CA 1.452 -0.249 0 N-CA-C 111.42 -0.672 . . . . 60.32 111.42 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.469 ' HB3' HD11 ' A' ' 20' ' ' LEU . 71.0 m95 -81.37 140.6 34.63 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.581 -0.526 . . . . 74.510000000000005 109.581 177.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -127.61 126.13 41.49 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.151 -0.314 . . . . 63.219999999999999 110.151 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.6 t -85.21 130.57 35.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.583 -0.525 . . . . 60.219999999999999 109.583 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -85.43 -31.33 6.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.228 0.537 . . . . 73.329999999999998 109.997 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -154.58 122.95 6.04 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.924 -0.769 . . . . 73.349999999999994 108.924 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.03 -172.41 42.18 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.28 -0.486 . . . . 61.030000000000001 112.522 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -61.73 154.52 25.3 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 110.244 -0.28 . . . . 74.340000000000003 110.244 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.436 ' HB3' ' CB ' ' A' ' 51' ' ' ALA . . . -160.71 -178.25 6.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.118 0.485 . . . . 73.409999999999997 111.762 -175.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -68.91 178.45 2.19 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.954 -1.021 . . . . 61.520000000000003 111.9 -175.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 44.5 ttm180 -61.15 -27.86 68.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.38 -0.827 . . . . 74.329999999999998 110.203 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -51.84 -44.97 63.81 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.162 0.505 . . . . 72.030000000000001 110.01 172.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 47' ' ' ALA . . . -75.81 -31.74 59.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.428 -0.806 . . . . 52.32 110.846 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.679 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 52.8 t -54.12 -42.01 68.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.042 -0.527 . . . . 61.32 110.067 170.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.06 -29.85 68.91 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.055 -0.52 . . . . 74.319999999999993 110.665 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 94.8 mt-10 -70.05 -51.65 30.3 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.445 -0.343 . . . . 73.120000000000005 111.039 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.632 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 2.7 t80 -58.48 -41.9 86.34 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.603 -0.271 . . . . 71.239999999999995 111.693 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 52' ' ' CYS . 9.7 tt -71.03 -45.62 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 121.085 -0.246 . . . . 72.140000000000001 111.146 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -64.57 -52.6 56.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.418 -0.356 . . . . 72.010000000000005 110.302 -177.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -70.68 -33.14 70.6 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.948 -0.569 . . . . 74.420000000000002 110.337 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 41.55 61.2 1.91 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.829 0.852 . . . . 71.519999999999996 111.826 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.685 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 23.0 t90 -86.02 -52.84 0.45 Allowed Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 115.282 -0.872 . . . . 74.230000000000004 111.471 -178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.685 ' HD3' ' HB3' ' A' ' 60' ' ' TRP . 20.0 Cg_exo -67.33 -52.62 0.57 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 122.126 1.884 . . . . 74.040000000000006 112.029 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -105.81 132.63 51.69 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.755 -0.461 . . . . 74.439999999999998 109.755 178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.527 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.8 mp -83.5 90.58 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.277 -0.42 . . . . 44.5 110.905 -173.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.575 ' HG2' ' HB2' ' A' ' 67' ' ' SER . 31.5 ttt85 -80.13 102.54 1.25 Allowed Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 108.228 -1.027 . . . . 72.230000000000004 108.228 168.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -70.64 144.21 48.75 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.907 2.405 . . . . 62.119999999999997 113.405 -167.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp 57.8 15.1 2.81 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.41 -0.814 . . . . 64.540000000000006 112.162 174.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.575 ' HB2' ' HG2' ' A' ' 64' ' ' ARG . 27.9 t -80.92 68.82 7.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.537 0.684 . . . . 72.439999999999998 110.305 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 mp -102.03 -73.67 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.474 -0.935 . . . . 74.140000000000001 108.474 173.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 73' ' ' ALA . 60.2 mmt-85 -90.85 70.54 6.53 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.814 -0.81 . . . . 72.540000000000006 108.814 171.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -60.92 107.36 0.7 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.697 -0.683 . . . . 72.120000000000005 109.784 -175.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.59 ' HA ' ' HE1' ' A' ' 5' ' ' MET . 1.8 tmtp? 54.51 50.5 15.93 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.221 1.01 . . . . 71.420000000000002 110.263 -175.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 71.41 -0.01 3.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.906 -1.043 . . . . 75.409999999999997 111.269 171.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 69' ' ' ARG . . . -80.42 149.83 30.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.766 0.317 . . . . 32.420000000000002 110.729 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.1 p -75.19 121.52 22.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.528 -0.306 . . . . 74.239999999999995 110.739 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.84 170.17 43.3 Favored Glycine 0 C--O 1.237 0.323 0 C-N-CA 121.065 -0.588 . . . . 72.519999999999996 112.418 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -148.58 156.03 41.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.517 -0.549 . . . . 73.200000000000003 109.517 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -167.1 111.33 0.44 Allowed Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.629 -0.714 . . . . 61.109999999999999 111.674 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -169.52 163.55 10.32 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.98 -0.378 . . . . 73.439999999999998 109.98 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -152.41 111.24 3.8 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.789 0.328 . . . . 74.109999999999999 110.203 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.343 -0.837 . . . . 63.520000000000003 108.962 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.431 ' HA3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 112.105 -0.398 . . . . 64.540000000000006 112.105 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' HD3' ' HA3' ' A' ' 1' ' ' GLY . 38.4 Cg_exo -60.73 92.92 0.1 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.819 2.346 . . . . 72.439999999999998 112.663 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.59 27.91 1.06 Allowed Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 111.377 -0.689 . . . . 52.530000000000001 111.377 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.9 m -78.18 -171.55 2.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.253 0.549 . . . . 64.439999999999998 111.845 -175.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 81.6 mmm -58.45 -32.65 68.91 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.616 -0.72 . . . . 72.430000000000007 111.438 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.1 m 74.55 19.74 2.6 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 123.711 1.719 . . . . 74.200000000000003 110.676 -175.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.36 83.03 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.673 0 CA-C-N 110.846 -2.888 . . . . 65.329999999999998 108.628 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.603 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 26.1 t-20 -169.19 -51.08 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 114.713 -1.13 . . . . 64.430000000000007 109.445 -176.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.603 ' HD3' ' HB3' ' A' ' 8' ' ' ASN . 76.7 Cg_endo -88.07 143.11 5.69 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.007 1.805 . . . . 71.439999999999998 111.403 172.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -73.81 -26.7 60.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.322 0.582 . . . . 72.319999999999993 109.538 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -80.07 97.08 6.68 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.437 -0.802 . . . . 75.400000000000006 109.331 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -63.58 119.7 10.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 73.540000000000006 111.753 -175.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -62.87 -21.78 66.23 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.051 -0.522 . . . . 74.530000000000001 111.205 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 65' ' ' PRO . 7.8 t30 -85.62 -11.26 54.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.041 0.448 . . . . 73.329999999999998 110.521 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.4 112.05 3.61 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 116.095 -0.502 . . . . 55.210000000000001 112.717 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.532 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 46.6 t -162.92 141.26 8.34 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.304 0.242 . . . . 71.319999999999993 110.443 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.817 ' HB2' ' HA ' ' A' ' 52' ' ' CYS . 19.0 t80 -66.98 -160.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.066 -0.716 . . . . 74.209999999999994 109.066 171.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.653 ' HB2' ' CH2' ' A' ' 30' ' ' TRP . 46.1 p90 -125.22 138.15 54.12 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.366 -0.834 . . . . 74.439999999999998 111.652 -172.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -142.15 133.81 26.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 114.955 -1.02 . . . . 65.329999999999998 110.11 -173.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.643 ' HB2' ' CE3' ' A' ' 30' ' ' TRP . 17.8 tp -120.88 142.67 49.46 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 122.978 0.511 . . . . 71.329999999999998 110.754 -174.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.8 147.8 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.619 -0.264 . . . . 73.439999999999998 110.356 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 17.2 m120 -122.72 161.4 23.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.531 -0.304 . . . . 74.140000000000001 110.628 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -58.5 -25.46 62.39 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.889 -0.596 . . . . 71.409999999999997 111.202 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -83.49 22.93 0.99 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.627 -0.715 . . . . 73.319999999999993 111.512 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 65.53 14.25 9.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.879 0.471 . . . . 73.299999999999997 111.321 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 74.7 mt-30 -86.57 123.08 31.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.497 -0.319 . . . . 54.009999999999998 110.534 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -120.56 126.51 50.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.544 -0.539 . . . . 74.109999999999999 109.544 176.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.2 p -164.42 -154.44 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 70.430000000000007 110.346 -173.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.625 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.2 pt? -131.85 164.9 25.03 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.122 -0.695 . . . . 62.520000000000003 109.122 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.653 ' CH2' ' HB2' ' A' ' 18' ' ' PHE . 20.1 p90 -125.91 147.8 60.32 Favored Pre-proline 0 N--CA 1.464 0.251 0 CA-C-O 120.46 0.172 . . . . 73.310000000000002 111.033 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 13.8 Cg_exo -70.0 99.25 0.76 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.552 2.168 . . . . 52.539999999999999 111.133 173.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.99 -7.38 8.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.309 -0.405 . . . . 64.129999999999995 111.22 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -81.45 -2.46 49.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.985 -0.552 . . . . 72.430000000000007 110.706 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.0 177.62 7.84 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.413 -0.358 . . . . 42.140000000000001 110.642 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -80.79 138.55 36.27 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 109.814 -0.439 . . . . 74.129999999999995 109.814 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 t -90.45 126.29 56.93 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.138 -0.483 . . . . 74.219999999999999 110.45 -175.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.429 ' O ' ' HD1' ' A' ' 40' ' ' TRP . 38.6 Cg_endo -66.27 110.92 1.9 Allowed 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.882 2.388 . . . . 74.140000000000001 112.501 -176.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -44.73 150.85 0.32 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.199 0.814 . . . . 34.340000000000003 113.199 -172.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.98 23.93 4.75 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.541 -0.754 . . . . 60.32 111.85 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.431 ' HB2' HD11 ' A' ' 20' ' ' LEU . 25.3 p-90 -130.2 160.08 34.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.897 0.379 . . . . 74.510000000000005 111.18 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.435 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 4.6 mmp_? -122.7 127.01 48.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.708 -0.849 . . . . 63.219999999999999 108.708 171.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.515 HG23 ' CH2' ' A' ' 30' ' ' TRP . 7.5 p -89.4 119.6 36.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 120.825 0.345 . . . . 60.219999999999999 110.423 -177.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.85 -38.18 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.455 0.645 . . . . 73.329999999999998 110.555 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.647 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 26.0 m80 -132.56 136.39 46.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.349 -0.841 . . . . 73.349999999999994 108.849 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.43 160.44 22.01 Favored Glycine 0 C--N 1.332 0.334 0 O-C-N 123.525 0.516 . . . . 61.030000000000001 112.892 -176.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -62.67 132.98 54.12 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.843 0.354 . . . . 74.340000000000003 111.031 -178.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.5 -177.89 6.51 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.137 0.494 . . . . 73.409999999999997 111.734 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.76 172.71 2.06 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.241 -0.89 . . . . 61.520000000000003 112.716 -174.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.446 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 14.6 ttp180 -58.63 -42.91 89.34 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.575 -0.739 . . . . 74.329999999999998 111.172 178.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.49 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -52.5 -46.5 66.67 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.299 -0.63 . . . . 72.030000000000001 109.299 177.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.532 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -63.21 -34.7 78.21 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.019 -0.991 . . . . 52.32 111.081 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.817 ' HA ' ' HB2' ' A' ' 17' ' ' PHE . 36.7 m -60.39 -46.14 91.06 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.367 -0.833 . . . . 61.32 109.928 171.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.18 -24.78 62.3 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.486 -0.779 . . . . 74.319999999999993 110.561 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 42.1 mt-10 -76.93 -36.95 56.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 73.120000000000005 110.844 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -54.82 -50.46 68.53 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.659 0.244 . . . . 71.239999999999995 111.659 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.8 -34.89 49.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.032 0.444 . . . . 72.140000000000001 110.007 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -73.67 -25.59 60.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.762 -0.654 . . . . 72.010000000000005 110.819 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.483 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 53.7 mt-10 -65.88 -54.62 24.17 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.108 0.48 . . . . 74.420000000000002 109.985 173.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 77.0 t60 58.07 38.38 26.6 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.21 -0.904 . . . . 71.519999999999996 109.16 -174.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 70.05 92.78 0.06 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 115.006 -0.997 . . . . 74.230000000000004 109.924 -176.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 58' ' ' GLU . 24.1 Cg_endo -97.16 -158.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.528 2.819 . . . . 74.040000000000006 113.112 -176.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -96.63 -35.62 10.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.506 -0.77 . . . . 74.439999999999998 110.823 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.08 139.35 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.783 -0.644 . . . . 44.5 111.119 -174.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -124.04 137.64 29.28 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 109.555 -0.535 . . . . 72.230000000000004 109.555 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.522 ' HB3' ' HA ' ' A' ' 14' ' ' ASN . 42.5 Cg_endo -66.07 104.6 0.73 Allowed 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.576 2.184 . . . . 62.119999999999997 112.933 -177.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -76.51 76.89 3.22 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.334 -0.987 . . . . 64.540000000000006 108.334 170.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.2 t -68.73 154.36 42.1 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.975 -1.011 . . . . 72.439999999999998 112.038 -170.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.1 tp -170.97 -69.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.778 -1.101 . . . . 74.140000000000001 108.443 177.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -179.74 153.92 0.56 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 108.86 -0.793 . . . . 72.540000000000006 108.86 176.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 27.9 t70 -68.29 160.48 29.29 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.886 -0.413 . . . . 72.120000000000005 109.886 175.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.777 ' HD2' ' H ' ' A' ' 71' ' ' LYS . 4.3 mptt -89.27 -13.17 38.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.411 -0.358 . . . . 71.420000000000002 111.022 -170.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.6 tp -119.75 7.59 11.04 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.187 0.517 . . . . 75.409999999999997 109.998 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' A' ' 70' ' ' ASP . . . -72.06 86.4 1.03 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.166 -0.47 . . . . 32.420000000000002 110.899 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.4 p -87.57 102.17 14.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.469 . . . . 74.239999999999995 109.837 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.02 53.39 3.4 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 121.447 -0.406 . . . . 72.519999999999996 112.874 -177.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -168.55 116.54 0.69 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.247 -0.649 . . . . 73.200000000000003 109.247 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.54 139.94 12.18 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.083 -0.579 . . . . 61.109999999999999 112.445 -176.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -76.37 -18.48 58.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.508 0.671 . . . . 73.439999999999998 109.458 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.26 80.75 0.09 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.507 -1.224 . . . . 74.109999999999999 109.854 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 . . . . . 0 C--O 1.247 0.94 0 CA-C-N 114.55 -1.205 . . . . 63.520000000000003 111.579 176.929 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 112.238 -0.345 . . . . 64.540000000000006 112.238 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.9 -68.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.694 2.263 . . . . 72.439999999999998 112.011 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.86 41.96 2.09 Favored Glycine 0 C--N 1.332 0.35 0 CA-C-N 115.972 -0.558 . . . . 52.530000000000001 112.033 -178.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.7 m -67.46 102.81 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.842 0.353 . . . . 64.439999999999998 110.239 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.472 ' O ' ' HG2' ' A' ' 69' ' ' ARG . 31.5 mmt -88.48 -8.82 54.25 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.056 -0.52 . . . . 72.430000000000007 110.985 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.8 p -146.44 142.6 28.3 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.675 0.274 . . . . 74.200000000000003 111.233 -174.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.2 mt -101.53 95.58 4.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 109.352 -0.61 . . . . 65.329999999999998 109.352 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -70.37 114.32 25.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 64.430000000000007 110.956 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -85.37 173.34 7.7 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.893 2.395 . . . . 71.439999999999998 112.657 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -109.14 -174.5 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.9 -0.591 . . . . 72.319999999999993 110.373 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.47 155.27 18.72 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.208 0.527 . . . . 75.400000000000006 111.747 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.06 -24.49 66.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.174 -0.921 . . . . 73.540000000000006 111.836 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -51.21 -55.48 17.82 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.281 -0.418 . . . . 74.530000000000001 111.88 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -87.51 8.46 24.85 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.034 0.445 . . . . 73.329999999999998 111.35 -174.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.21 -31.93 63.35 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.726 -0.75 . . . . 55.210000000000001 113.435 -175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.828 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 23.7 m -93.01 149.93 20.89 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 117.051 0.425 . . . . 71.319999999999993 111.914 -172.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 1.7 t80 -68.42 103.31 1.61 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-O 120.968 0.413 . . . . 74.209999999999994 110.051 174.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -140.97 131.18 24.88 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.321 -1.363 . . . . 74.439999999999998 107.321 165.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 43' ' ' VAL . 98.7 t -147.91 129.86 6.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-O 121.002 0.429 . . . . 65.329999999999998 110.345 -170.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 40' ' ' TRP . 46.2 tp -105.42 139.29 40.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.566 -0.743 . . . . 71.329999999999998 110.124 -177.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.1 t -118.41 126.09 74.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 109.41 -0.589 . . . . 73.439999999999998 109.41 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -95.09 162.54 13.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.295 -0.411 . . . . 74.140000000000001 110.007 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.44 -11.9 37.98 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.236 0.541 . . . . 71.409999999999997 110.232 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -83.08 9.62 9.96 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.35 -0.841 . . . . 73.319999999999993 110.768 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 66.08 9.85 6.56 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.088 0.555 . . . . 73.299999999999997 110.65 -174.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.559 HE21 ' HB2' ' A' ' 28' ' ' SER . 48.4 tp60 -74.06 118.27 16.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.118 -0.492 . . . . 54.009999999999998 110.171 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.671 ' HB2' ' HZ2' ' A' ' 60' ' ' TRP . 19.6 p-80 -108.71 98.63 8.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.084 -0.507 . . . . 74.109999999999999 110.165 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.559 ' HB2' HE21 ' A' ' 26' ' ' GLN . 33.5 t -133.17 -173.17 3.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.354 -0.385 . . . . 70.430000000000007 110.06 -175.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.814 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.1 pt? -107.57 147.84 30.06 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.423 -0.584 . . . . 62.520000000000003 109.423 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.449 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 43.2 p-90 -116.1 129.43 25.21 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.642 -0.254 . . . . 73.310000000000002 110.478 -177.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 33.3 Cg_exo -61.82 108.44 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.472 2.115 . . . . 52.539999999999999 111.67 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.449 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -60.59 -18.53 53.5 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.166 -0.47 . . . . 64.129999999999995 111.845 -178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -93.05 9.41 35.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 72.430000000000007 111.285 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.57 175.8 7.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.224 -0.444 . . . . 42.140000000000001 110.754 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -95.94 128.49 42.88 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.248 -0.433 . . . . 74.129999999999995 110.799 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.498 HG12 ' NE1' ' A' ' 40' ' ' TRP . 3.2 t -91.87 110.78 46.09 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.263 -0.426 . . . . 74.219999999999999 110.138 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.43 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 38.5 Cg_endo -67.2 115.67 3.78 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 123.103 2.536 . . . . 74.140000000000001 112.582 -176.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -46.12 151.9 0.45 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.189 0.811 . . . . 34.340000000000003 113.189 -172.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.2 26.52 3.73 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.408 -0.814 . . . . 60.32 111.741 -175.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.498 ' NE1' HG12 ' A' ' 36' ' ' VAL . 17.2 p-90 -134.74 -178.82 5.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.151 0.5 . . . . 74.510000000000005 110.952 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -145.06 126.05 14.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.65 -0.871 . . . . 63.219999999999999 108.65 169.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.87 134.65 28.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 110.078 -0.341 . . . . 60.219999999999999 110.078 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 19' ' ' VAL . 9.8 p -89.79 -25.5 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.544 0.688 . . . . 73.329999999999998 109.965 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -155.05 121.51 5.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.213 -0.903 . . . . 73.349999999999994 109.095 175.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.45 -174.78 50.26 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.188 -0.529 . . . . 61.030000000000001 111.955 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -58.5 112.13 1.48 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.09 0.471 . . . . 74.340000000000003 109.857 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.21 -177.78 3.51 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.765 0.654 . . . . 73.409999999999997 112.765 -165.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -86.74 179.87 6.69 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.175 -0.92 . . . . 61.520000000000003 112.437 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 32.2 ttm180 -48.48 -41.44 29.75 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.629 -1.169 . . . . 74.329999999999998 111.393 177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 54' ' ' GLU . . . -52.82 -47.18 67.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.146 0.498 . . . . 72.030000000000001 110.094 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 17' ' ' PHE . . . -69.88 -31.17 68.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.564 -0.743 . . . . 52.32 110.838 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.828 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 53.9 t -56.84 -42.5 79.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.961 0.41 . . . . 61.32 110.164 171.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.44 -26.16 62.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.929 -0.578 . . . . 74.319999999999993 111.105 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 52.9 mt-10 -74.94 -53.17 9.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.362 -0.381 . . . . 73.120000000000005 111.468 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.572 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 39.7 t80 -60.84 -35.5 76.7 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 111.755 0.28 . . . . 71.239999999999995 111.755 -175.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.7 tt -71.23 -41.16 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 120.996 -0.282 . . . . 72.140000000000001 111.064 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -73.72 -57.25 4.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.901 0.381 . . . . 72.010000000000005 110.913 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -61.22 -31.86 71.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.747 -0.66 . . . . 74.420000000000002 110.926 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.8 m80 68.74 171.91 0.29 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.029 -0.532 . . . . 71.519999999999996 110.645 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.671 ' HZ2' ' HB2' ' A' ' 27' ' ' HIS . 21.2 t-105 -170.49 -48.68 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.684 -0.689 . . . . 74.230000000000004 109.377 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.527 ' HD2' ' H ' ' A' ' 60' ' ' TRP . 88.6 Cg_endo -81.54 -152.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 122.057 1.838 . . . . 74.040000000000006 111.225 172.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -75.99 -173.93 2.5 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.939 0.399 . . . . 74.439999999999998 111.127 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 33.8 pt -120.39 159.35 21.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 116.16 -0.473 . . . . 44.5 110.787 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -137.9 142.0 34.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.1 -0.704 . . . . 72.230000000000004 109.1 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -52.12 90.1 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.727 2.285 . . . . 62.119999999999997 112.487 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -74.09 96.69 2.75 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.693 -0.685 . . . . 64.540000000000006 109.876 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.6 t -111.89 119.24 37.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.619 -0.718 . . . . 72.439999999999998 110.015 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 68' ' ' LEU . 5.8 mp -73.33 165.81 24.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 74.140000000000001 110.318 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 5' ' ' MET . 62.4 mtp180 -67.29 159.68 28.73 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.001 -0.545 . . . . 72.540000000000006 110.602 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.0 t70 58.4 49.52 10.72 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.842 0.829 . . . . 72.120000000000005 109.289 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -79.34 9.68 4.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.543 -0.753 . . . . 71.420000000000002 110.18 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.0 tp -60.65 -44.62 96.2 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.595 -0.891 . . . . 75.409999999999997 108.595 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.75 83.15 7.19 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.058 -0.974 . . . . 32.420000000000002 108.868 171.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 16.9 p -62.17 -33.37 74.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.664 -0.698 . . . . 74.239999999999995 110.901 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.02 70.0 3.09 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.51 -0.636 . . . . 72.519999999999996 111.51 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.7 tpp180 -73.88 -9.25 58.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.714 0.768 . . . . 73.200000000000003 110.304 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -134.07 142.23 13.68 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.744 -1.117 . . . . 61.109999999999999 110.799 175.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -83.06 145.9 29.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.874 0.369 . . . . 73.439999999999998 110.889 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -71.44 -63.7 1.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.825 -0.625 . . . . 74.109999999999999 110.38 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.559 -0.734 . . . . 63.520000000000003 109.706 179.752 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 112.281 -0.327 . . . . 64.540000000000006 112.281 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.88 -13.6 15.87 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.519 2.146 . . . . 72.439999999999998 112.226 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.43 124.79 2.58 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.214 -0.754 . . . . 52.530000000000001 111.214 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.4 m -83.59 176.25 9.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.767 0.318 . . . . 64.439999999999998 110.521 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 74.2 mmm -74.82 -41.2 60.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.185 0.517 . . . . 72.430000000000007 109.712 175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.3 p -171.22 153.99 3.84 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.234 -0.894 . . . . 74.200000000000003 109.639 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.5 mm -71.73 -63.93 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.121 -0.696 . . . . 65.329999999999998 109.121 175.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -168.82 155.02 6.58 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.331 -0.85 . . . . 64.430000000000007 108.989 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.89 106.2 1.28 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.563 2.176 . . . . 71.439999999999998 111.987 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.524 ' HD1' ' HB3' ' A' ' 67' ' ' SER . 96.5 m-85 -68.15 116.99 9.4 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.784 -0.45 . . . . 72.319999999999993 109.784 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -94.34 -159.06 0.68 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.88 -0.6 . . . . 75.400000000000006 111.495 -173.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 67.87 33.3 4.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.036 0.535 . . . . 73.540000000000006 110.581 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.27 -23.99 67.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.212 -0.904 . . . . 74.530000000000001 111.393 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -96.72 14.93 23.33 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.755 -0.657 . . . . 73.329999999999998 111.703 174.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.91 -167.08 3.74 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 114.37 0.508 . . . . 55.210000000000001 114.37 -173.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.561 ' HB3' ' CB ' ' A' ' 54' ' ' GLU . 40.4 m -98.3 82.22 2.88 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.296 0.638 . . . . 71.319999999999993 110.011 -179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.759 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 0.1 OUTLIER -163.72 128.7 2.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.569 -0.741 . . . . 74.209999999999994 112.643 -161.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.45 130.59 11.91 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.989 0.813 . . . . 74.439999999999998 109.834 153.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 44' ' ' HIS . 0.1 OUTLIER -162.85 138.3 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.053 0 CA-C-O 121.242 0.544 . . . . 65.329999999999998 111.045 170.546 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.586 ' HB2' ' CD1' ' A' ' 30' ' ' TRP . 32.3 tp -104.19 153.7 20.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.418 -0.81 . . . . 71.329999999999998 108.972 175.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.527 HG12 ' O ' ' A' ' 41' ' ' ARG . 9.7 p -136.67 134.23 48.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.952 0.406 . . . . 73.439999999999998 110.373 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -73.05 154.76 40.32 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.875 -0.787 . . . . 74.140000000000001 108.875 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -57.13 -23.91 50.53 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.082 0.468 . . . . 71.409999999999997 110.512 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -78.42 13.04 1.69 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.837 -0.619 . . . . 73.319999999999993 111.004 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 56.88 56.81 5.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.8 0.81 . . . . 73.299999999999997 110.696 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -114.74 119.89 38.21 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.709 -1.132 . . . . 54.009999999999998 108.896 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -76.08 132.29 39.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.673 -0.24 . . . . 74.109999999999999 110.502 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.8 m -153.74 178.12 10.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.012 0.434 . . . . 70.430000000000007 110.741 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.704 HD13 ' H ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -124.57 159.83 29.77 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.949 -0.76 . . . . 62.520000000000003 108.949 177.131 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.586 ' CD1' ' HB2' ' A' ' 20' ' ' LEU . 6.0 p-90 -145.13 139.49 15.15 Favored Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 121.041 -0.264 . . . . 73.310000000000002 111.59 -173.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 5.2 Cg_exo -80.14 104.9 1.71 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.072 2.515 . . . . 52.539999999999999 110.833 173.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.29 -2.08 1.98 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.467 0.543 . . . . 64.129999999999995 112.467 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -91.05 -0.14 57.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.474 0.178 . . . . 72.430000000000007 111.36 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.65 170.31 12.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.597 0.237 . . . . 42.140000000000001 110.903 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -69.44 126.39 29.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.887 -0.597 . . . . 74.129999999999995 110.08 177.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.3 t -97.61 113.25 63.22 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.756 -0.461 . . . . 74.219999999999999 109.756 -176.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 21.0 Cg_endo -60.64 107.23 0.41 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.982 2.454 . . . . 74.140000000000001 113.334 -172.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -45.89 151.82 0.42 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.447 0.699 . . . . 34.340000000000003 112.655 -174.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.98 5.91 21.3 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.869 -0.605 . . . . 60.32 112.065 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.446 ' CD1' ' O ' ' A' ' 37' ' ' PRO . 18.4 p-90 -107.41 175.66 5.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 74.510000000000005 110.867 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.527 ' O ' HG12 ' A' ' 21' ' ' VAL . 15.0 tpp180 -141.61 142.98 33.44 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.26 -1.015 . . . . 63.219999999999999 108.26 170.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.2 p -90.68 131.2 38.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.013 -0.366 . . . . 60.219999999999999 110.013 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.448 HG21 ' CH2' ' A' ' 60' ' ' TRP . 10.1 m -99.47 -22.42 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.313 0.578 . . . . 73.329999999999998 110.313 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 17' ' ' PHE . 92.1 m-70 -147.63 118.72 7.72 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.224 -1.028 . . . . 73.349999999999994 108.224 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.04 165.4 7.1 Favored Glycine 0 C--N 1.332 0.35 0 O-C-N 123.807 0.692 . . . . 61.030000000000001 113.481 -172.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.45 151.35 24.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.143 0.497 . . . . 74.340000000000003 110.594 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -162.95 -177.98 5.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.948 -0.569 . . . . 73.409999999999997 110.465 -175.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -54.18 161.37 1.32 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.234 0.54 . . . . 61.520000000000003 112.01 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.687 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 46.1 ttt180 -57.12 -29.81 63.85 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.574 -0.739 . . . . 74.329999999999998 110.47 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -62.25 -47.3 84.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.939 0.4 . . . . 72.030000000000001 110.154 174.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.27 -31.4 71.7 Favored 'General case' 0 C--O 1.249 1.04 0 CA-C-N 116.173 -0.467 . . . . 52.32 111.544 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.687 ' SG ' ' HA ' ' A' ' 49' ' ' ARG . 16.6 p -73.51 -50.59 20.68 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.711 -0.677 . . . . 61.32 111.244 173.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.508 ' H ' ' HG ' ' A' ' 52' ' ' CYS . 78.6 mt -59.09 -34.66 72.25 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.414 0.626 . . . . 74.319999999999993 110.346 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.561 ' CB ' ' HB3' ' A' ' 16' ' ' SER . 20.2 mm-40 -76.94 -35.19 57.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.72 -0.673 . . . . 73.120000000000005 110.485 176.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.759 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -46.33 -52.68 12.31 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 117.847 0.294 . . . . 71.239999999999995 111.599 171.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.6 tt -71.18 -36.58 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.661 0.267 . . . . 72.140000000000001 111.61 -173.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -73.31 -50.46 22.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.149 0.499 . . . . 72.010000000000005 110.498 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -61.47 -27.58 68.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.598 -0.728 . . . . 74.420000000000002 109.041 174.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 64.45 80.38 0.23 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.396 -1.275 . . . . 71.519999999999996 112.179 171.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.448 ' CH2' HG21 ' A' ' 43' ' ' VAL . 3.3 t-105 51.76 79.26 0.35 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 115.504 -0.771 . . . . 74.230000000000004 111.126 175.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.496 ' HB2' HG12 ' A' ' 63' ' ' ILE . 49.7 Cg_endo -69.08 174.34 9.07 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.242 1.961 . . . . 74.040000000000006 111.726 176.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -79.84 -28.81 40.03 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.422 -0.214 . . . . 74.439999999999998 110.422 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.519 ' O ' HG13 ' A' ' 63' ' ' ILE . 40.0 pt -54.17 106.62 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.601 0.715 . . . . 44.5 110.728 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.423 ' HD3' ' HD3' ' A' ' 66' ' ' LYS . 6.4 ptp180 -133.35 133.32 22.69 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.878 -0.601 . . . . 72.230000000000004 110.972 -170.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -72.85 4.49 3.59 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.623 2.215 . . . . 62.119999999999997 111.767 173.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.423 ' HD3' ' HD3' ' A' ' 64' ' ' ARG . 55.7 mtpt -63.72 93.68 0.08 Allowed 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 109.496 -0.557 . . . . 64.540000000000006 109.496 175.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.524 ' HB3' ' HD1' ' A' ' 10' ' ' PHE . 28.0 p -148.65 178.4 8.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.768 -0.651 . . . . 72.439999999999998 109.822 -176.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.487 HD21 ' HD3' ' A' ' 71' ' ' LYS . 55.7 tp -115.88 118.68 33.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.635 -0.505 . . . . 74.140000000000001 109.635 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.05 -171.86 2.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 72.540000000000006 110.12 176.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -56.13 90.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 72.120000000000005 110.867 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.487 ' HD3' HD21 ' A' ' 68' ' ' LEU . 5.2 ttpm? -70.81 74.42 0.6 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.266 0.555 . . . . 71.420000000000002 109.51 176.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 29.4 tp -139.9 30.15 2.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.572 -0.74 . . . . 75.409999999999997 109.523 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.86 137.43 32.13 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.663 -0.699 . . . . 32.420000000000002 110.084 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.3 m -64.99 79.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.339 0.59 . . . . 74.239999999999995 111.615 -175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.27 103.61 1.24 Allowed Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 110.203 -1.159 . . . . 72.519999999999996 110.203 174.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.59 143.36 50.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.876 0.37 . . . . 73.200000000000003 110.404 -171.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -134.42 -169.34 11.97 Favored Glycine 0 C--N 1.316 -0.542 0 CA-C-N 115.485 -0.78 . . . . 61.109999999999999 111.187 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -130.7 151.21 51.4 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.154 0.502 . . . . 73.439999999999998 110.607 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -161.05 99.75 1.22 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.506 -0.77 . . . . 74.109999999999999 109.319 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.959 -0.543 . . . . 63.520000000000003 110.391 -174.973 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 111.945 -0.462 . . . . 64.540000000000006 111.945 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.43 145.5 30.09 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.979 2.453 . . . . 72.439999999999998 112.235 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.94 146.27 16.3 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.142 -0.783 . . . . 52.530000000000001 111.142 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.8 m -70.35 102.86 2.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.153 0.501 . . . . 64.439999999999998 110.723 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.402 ' CE ' ' HA ' ' A' ' 5' ' ' MET . 0.9 OUTLIER -98.86 -18.28 17.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.615 -0.72 . . . . 72.430000000000007 110.666 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 t -67.71 148.85 50.75 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.143 -0.481 . . . . 74.200000000000003 110.327 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.637 HD11 HD13 ' A' ' 72' ' ' LEU . 42.1 mm -80.31 73.99 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.992 -0.549 . . . . 65.329999999999998 111.059 -176.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.33 96.29 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.575 0 CA-C-N 115.547 -0.751 . . . . 64.430000000000007 111.39 173.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -72.85 55.77 2.83 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.186 2.591 . . . . 71.439999999999998 112.514 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -85.35 -6.65 59.22 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.821 0.344 . . . . 72.319999999999993 111.142 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -96.4 -28.79 14.29 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.021 0.438 . . . . 75.400000000000006 110.973 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -90.48 -35.7 14.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.894 -0.594 . . . . 73.540000000000006 111.823 -173.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -61.02 -26.84 67.9 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.316 0.579 . . . . 74.530000000000001 112.201 -173.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -73.15 -13.55 61.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.413 -0.812 . . . . 73.329999999999998 111.922 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.11 59.69 2.34 Favored Glycine 0 C--N 1.329 0.164 0 C-N-CA 121.073 -0.584 . . . . 55.210000000000001 112.152 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.626 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 5.6 m -141.68 118.33 11.01 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.967 -0.137 . . . . 71.319999999999993 110.712 -177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.813 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -66.12 -159.7 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 120.637 0.256 . . . . 74.209999999999994 111.543 172.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.472 ' HB3' ' HA ' ' A' ' 46' ' ' GLU . 28.3 p90 -125.12 137.45 54.18 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.92 0.39 . . . . 74.439999999999998 110.434 -173.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.445 HG23 HG13 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -155.14 142.86 12.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 CA-C-O 121.567 0.699 . . . . 65.329999999999998 111.776 -178.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 30' ' ' TRP . 48.1 tp -105.25 147.99 27.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.194 -1.367 . . . . 71.329999999999998 108.8 177.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.6 144.42 28.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.13 0.49 . . . . 73.439999999999998 110.824 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -104.33 153.63 20.81 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.007 -0.738 . . . . 74.140000000000001 109.007 175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -57.59 -22.81 47.3 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.811 0.339 . . . . 71.409999999999997 111.087 -175.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -77.9 15.4 0.88 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.15 -0.477 . . . . 73.319999999999993 111.577 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 67.11 15.81 10.15 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.135 0.574 . . . . 73.299999999999997 111.407 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -84.83 119.45 25.33 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.578 -0.527 . . . . 54.009999999999998 109.578 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -114.19 136.48 52.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.95 0.405 . . . . 74.109999999999999 111.191 -175.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -152.04 -172.12 4.13 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.213 -0.662 . . . . 70.430000000000007 109.213 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.8 pt? -109.04 139.37 44.02 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.452 -0.573 . . . . 62.520000000000003 109.452 174.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 20' ' ' LEU . 21.4 p-90 -98.62 155.03 37.2 Favored Pre-proline 0 C--O 1.236 0.345 0 CA-C-N 116.151 -0.477 . . . . 73.310000000000002 110.792 -176.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.578 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 31.1 Cg_exo -62.2 96.16 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.45 2.1 . . . . 52.539999999999999 111.012 174.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.39 -23.76 62.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.884 -0.598 . . . . 64.129999999999995 111.692 -175.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -95.3 17.44 14.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.112 -0.495 . . . . 72.430000000000007 110.894 -178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 31' ' ' PRO . . . -143.39 174.62 10.58 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.8 0.333 . . . . 42.140000000000001 110.762 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -92.21 139.88 30.18 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.057 -0.52 . . . . 74.129999999999995 110.244 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -76.06 130.91 76.85 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 74.219999999999999 110.603 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HG2' ' CD1' ' A' ' 40' ' ' TRP . 45.3 Cg_endo -68.52 167.02 23.75 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.454 2.102 . . . . 74.140000000000001 112.141 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.94 151.57 47.37 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.969 -0.56 . . . . 34.340000000000003 111.548 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.97 -35.85 4.13 Favored Glycine 0 C--N 1.33 0.232 0 CA-C-N 115.65 -0.705 . . . . 60.32 112.342 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.406 ' CD1' ' HG2' ' A' ' 37' ' ' PRO . 41.9 m95 -88.23 145.37 25.91 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.256 -0.276 . . . . 74.510000000000005 110.256 -177.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.5 tpt180 -127.87 128.82 45.85 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.147 -0.316 . . . . 63.219999999999999 110.147 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.9 t -80.98 137.6 21.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.985 -0.376 . . . . 60.219999999999999 109.985 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.445 HG13 HG23 ' A' ' 19' ' ' VAL . 8.1 p -107.15 -28.98 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.992 0.425 . . . . 73.329999999999998 110.839 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.674 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 1.7 m-70 -139.79 138.58 35.97 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.799 -0.445 . . . . 73.349999999999994 109.799 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.48 174.81 36.9 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 123.674 0.609 . . . . 61.030000000000001 113.367 -173.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -58.99 138.31 57.56 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.127 0.571 . . . . 74.340000000000003 111.185 -172.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HB3' ' HA ' ' A' ' 17' ' ' PHE . . . -158.99 173.94 15.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.917 0.389 . . . . 73.409999999999997 111.493 -175.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -84.25 177.59 8.13 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.717 0.77 . . . . 61.520000000000003 112.894 -171.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.457 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 9.0 tpm_? -50.19 -44.29 52.9 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 114.331 -1.304 . . . . 74.329999999999998 111.143 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.31 -52.41 61.6 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 116.144 -0.48 . . . . 72.030000000000001 110.64 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.626 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -63.64 -31.04 72.09 Favored 'General case' 0 C--O 1.263 1.801 0 CA-C-O 121.819 0.818 . . . . 52.32 111.608 -178.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.813 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 73.2 m -72.58 -28.76 63.0 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 114.459 -1.246 . . . . 61.32 110.79 175.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.654 ' O ' HG22 ' A' ' 56' ' ' ILE . 92.6 mt -71.72 -51.96 20.2 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 108.81 -0.811 . . . . 74.319999999999993 108.81 169.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.17 -24.17 25.42 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.371 -0.831 . . . . 73.120000000000005 111.811 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.587 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -44.39 -31.25 1.0 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 121.118 -0.233 . . . . 71.239999999999995 111.276 171.27 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.654 HG22 ' O ' ' A' ' 53' ' ' LEU . 19.8 tt -60.16 -46.47 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.379 0.609 . . . . 72.140000000000001 110.455 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.458 ' N ' HG23 ' A' ' 56' ' ' ILE . 6.2 tp10 -74.37 -43.04 58.19 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.492 -0.776 . . . . 72.010000000000005 110.81 -178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -50.79 -58.89 4.84 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.302 -0.863 . . . . 74.420000000000002 111.956 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.2 m80 68.6 -72.24 0.1 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.671 -0.695 . . . . 71.519999999999996 111.285 -175.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.554 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 44.1 t-105 -172.64 -63.11 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 113.341 0.867 . . . . 74.230000000000004 113.341 -175.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 60' ' ' TRP . 50.2 Cg_endo -92.8 176.28 1.63 Allowed 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.47 2.113 . . . . 74.040000000000006 114.852 -164.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 69.39 9.83 7.46 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.834 -1.075 . . . . 74.439999999999998 112.626 172.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.3 pp -87.32 91.85 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.353 0.597 . . . . 44.5 112.006 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.3 ttt180 -115.45 92.67 33.59 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 109.44 -0.578 . . . . 72.230000000000004 109.44 173.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.01 -28.03 3.42 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.372 2.048 . . . . 62.119999999999997 113.607 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -79.67 108.3 13.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.472 0.653 . . . . 64.540000000000006 111.482 -173.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.5 p -142.96 112.45 6.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.946 -1.025 . . . . 72.439999999999998 109.201 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 68' ' ' LEU . 6.2 mp -69.46 -45.26 69.46 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.034 0.445 . . . . 74.140000000000001 111.035 -176.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -162.44 152.6 16.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.987 -0.745 . . . . 72.540000000000006 108.987 -177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.64 162.54 26.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.99 0.424 . . . . 72.120000000000005 110.41 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -108.54 16.5 22.93 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.425 0.631 . . . . 71.420000000000002 109.739 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.637 HD13 HD11 ' A' ' 7' ' ' ILE . 7.1 tt -85.75 -44.96 12.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.968 -0.56 . . . . 75.409999999999997 109.517 -179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.39 74.17 0.36 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.222 0.534 . . . . 32.420000000000002 110.522 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.4 m -86.03 -39.96 16.28 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.621 -0.718 . . . . 74.239999999999995 110.899 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.22 49.52 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.832 -0.699 . . . . 72.519999999999996 112.712 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -86.47 96.52 10.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.562 -0.533 . . . . 73.200000000000003 109.562 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.56 76.82 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.462 -0.655 . . . . 61.109999999999999 111.462 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -123.24 138.72 54.57 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.861 0.362 . . . . 73.439999999999998 110.102 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -148.72 99.7 3.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.919 -0.582 . . . . 74.109999999999999 109.902 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.453 -0.784 . . . . 63.520000000000003 109.546 179.529 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 112.15 -0.38 . . . . 64.540000000000006 112.15 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.56 -166.69 0.42 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.953 2.435 . . . . 72.439999999999998 112.309 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 111.78 2.53 27.08 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 116.229 -0.441 . . . . 52.530000000000001 112.114 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.5 m -78.73 161.77 26.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.711 0.291 . . . . 64.439999999999998 111.115 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 5' ' ' MET . 0.0 OUTLIER -75.03 -20.25 59.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.055 0.455 . . . . 72.430000000000007 110.176 176.188 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.7 p -144.15 121.14 11.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.46 -0.791 . . . . 74.200000000000003 109.782 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.54 HG22 HD22 ' A' ' 8' ' ' ASN . 53.7 mt -100.04 -90.99 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 110.325 -0.25 . . . . 65.329999999999998 110.325 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.54 HD22 HG22 ' A' ' 7' ' ' ILE . 58.2 m-80 -152.02 146.48 18.63 Favored Pre-proline 0 N--CA 1.468 0.465 0 N-CA-C 109.545 -0.539 . . . . 64.430000000000007 109.545 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.03 79.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.009 2.472 . . . . 71.439999999999998 113.508 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -131.94 97.53 4.2 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.013 -1.106 . . . . 72.319999999999993 108.013 171.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -142.22 141.8 32.57 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.945 0.72 . . . . 75.400000000000006 112.945 -170.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -162.57 80.27 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.156 -1.424 . . . . 73.540000000000006 107.156 168.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.528 ' HA ' ' NH1' ' A' ' 64' ' ' ARG . 12.1 t70 -65.78 -6.63 12.4 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.113 -0.949 . . . . 74.530000000000001 112.503 -167.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -68.51 -20.27 64.56 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.075 -0.512 . . . . 73.329999999999998 110.61 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -156.08 119.74 0.94 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.649 -0.58 . . . . 55.210000000000001 111.649 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.601 ' C ' ' HB1' ' A' ' 51' ' ' ALA . 30.2 m -151.31 123.13 8.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.536 0.168 . . . . 71.319999999999993 111.054 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.626 ' HB3' ' HA ' ' A' ' 52' ' ' CYS . 0.1 OUTLIER -64.53 -174.05 0.12 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.596 1.332 . . . . 74.209999999999994 114.596 179.355 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 38.9 p90 -126.48 136.2 52.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 113.924 -1.489 . . . . 74.439999999999998 109.766 -176.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 43' ' ' VAL . 54.3 t -147.75 131.44 8.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-O 121.053 0.454 . . . . 65.329999999999998 110.1 178.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 40' ' ' TRP . 64.9 tp -102.97 137.66 40.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.753 -0.658 . . . . 71.329999999999998 110.851 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.1 t -113.04 152.78 14.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.127 -1.064 . . . . 73.439999999999998 108.127 171.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.696 ' HB3' ' HB3' ' A' ' 26' ' ' GLN . 34.6 t30 -123.57 144.72 49.4 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.572 -0.899 . . . . 74.140000000000001 108.572 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -68.5 -7.85 35.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.014 0.435 . . . . 71.409999999999997 110.504 -177.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 29.2 tt0 -75.39 4.09 7.93 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.329 -0.85 . . . . 73.319999999999993 109.893 168.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 47.6 mt-10 74.16 15.72 3.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.854 0.862 . . . . 73.299999999999997 111.693 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.696 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 6.2 tp-100 -76.6 148.75 36.77 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.212 -0.662 . . . . 54.009999999999998 109.212 172.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -150.77 114.36 4.93 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.661 0.267 . . . . 74.109999999999999 110.626 -177.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.5 t -171.75 175.72 3.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.143 -0.481 . . . . 70.430000000000007 109.752 -177.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.689 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.5 pt? -80.79 160.14 24.94 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.456 -0.572 . . . . 62.520000000000003 109.456 175.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 23.7 p-90 -126.46 132.84 24.47 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.65 0.262 . . . . 73.310000000000002 110.996 -174.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 30' ' ' TRP . 12.6 Cg_exo -70.46 107.27 1.96 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.435 2.09 . . . . 52.539999999999999 111.549 177.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.04 -8.92 8.44 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.24 -0.436 . . . . 64.129999999999995 111.78 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -81.66 -10.86 59.3 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.307 -0.406 . . . . 72.430000000000007 110.606 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.36 166.33 11.79 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.231 -0.441 . . . . 42.140000000000001 110.577 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.64 134.29 35.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.055 -0.521 . . . . 74.129999999999995 109.705 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.508 HG12 ' NE1' ' A' ' 40' ' ' TRP . 2.5 t -95.47 104.09 14.63 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 110.078 -0.341 . . . . 74.219999999999999 110.078 -176.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 42.9 Cg_endo -67.2 114.42 3.21 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.982 2.455 . . . . 74.140000000000001 113.116 -174.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -44.48 152.49 0.2 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.727 0.811 . . . . 34.340000000000003 113.156 -173.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.1 12.65 10.81 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.747 -0.661 . . . . 60.32 111.468 -174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.508 ' NE1' HG12 ' A' ' 36' ' ' VAL . 10.4 p-90 -115.78 -172.53 2.18 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.912 0.485 . . . . 74.510000000000005 110.85 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.8 ttp180 -161.77 125.91 3.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.334 -0.848 . . . . 63.219999999999999 109.243 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.419 HG22 HD13 ' A' ' 20' ' ' LEU . 6.1 t -90.63 148.04 4.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.603 -0.271 . . . . 60.219999999999999 111.05 -171.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 19' ' ' VAL . 8.9 p -93.69 -34.26 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 109.508 -0.553 . . . . 73.329999999999998 109.508 173.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.441 ' ND1' ' O ' ' A' ' 17' ' ' PHE . 64.2 t-80 -158.31 132.14 7.8 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.434 -0.58 . . . . 73.349999999999994 109.434 173.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.754 ' HA3' ' HA2' ' A' ' 75' ' ' GLY . . . -76.66 -168.67 28.68 Favored Glycine 0 C--N 1.334 0.417 0 O-C-N 123.712 0.632 . . . . 61.030000000000001 114.021 -175.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 76' ' ' ARG . 6.7 mp0 -45.19 154.86 0.14 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.451 1.1 . . . . 74.340000000000003 113.449 -170.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' A' ' 51' ' ' ALA . . . -157.79 162.49 38.47 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.597 -0.729 . . . . 73.409999999999997 111.707 -176.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.96 166.14 21.11 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.533 -0.758 . . . . 61.520000000000003 110.296 175.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.464 HH11 HD12 ' A' ' 53' ' ' LEU . 7.0 tmm_? -53.83 -45.3 70.83 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.311 -0.404 . . . . 74.329999999999998 110.499 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.92 -42.81 80.64 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 116.207 -0.451 . . . . 72.030000000000001 110.703 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.601 ' HB1' ' C ' ' A' ' 16' ' ' SER . . . -66.67 -34.46 77.91 Favored 'General case' 0 C--O 1.273 2.324 0 CA-C-O 122.295 1.045 . . . . 52.32 111.616 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.626 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 36.1 t -66.17 -36.77 83.97 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 113.528 -1.669 . . . . 61.32 109.773 175.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.617 ' O ' HG22 ' A' ' 56' ' ' ILE . 79.8 mt -71.76 -39.8 69.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.234 -0.439 . . . . 74.319999999999993 110.183 171.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.586 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -60.92 -25.2 66.58 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 122.905 0.482 . . . . 73.120000000000005 111.224 -176.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.588 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -45.63 -24.91 0.39 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.319 0.387 . . . . 71.239999999999995 111.344 170.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 53' ' ' LEU . 17.0 tt -64.62 -49.38 80.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.082 0.467 . . . . 72.140000000000001 110.277 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.517 ' N ' HG23 ' A' ' 56' ' ' ILE . 9.5 tp10 -74.01 -42.51 60.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.315 -0.857 . . . . 72.010000000000005 111.049 -175.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.512 ' HG2' ' HA ' ' A' ' 55' ' ' TYR . 16.3 pt-20 -78.46 -37.98 42.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 74.420000000000002 111.269 -176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 16.1 p80 36.57 75.19 0.07 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.772 0.829 . . . . 71.519999999999996 112.261 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 53.5 m95 59.89 81.06 0.25 Allowed Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.844 -0.616 . . . . 74.230000000000004 109.788 -175.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.486 ' HB3' ' HB2' ' A' ' 58' ' ' GLU . 71.0 Cg_endo -80.53 177.2 8.36 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.004 2.469 . . . . 74.040000000000006 113.156 -174.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 8' ' ' ASN . 28.2 t70 -82.3 160.72 22.83 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.465 -0.789 . . . . 74.439999999999998 110.615 177.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.559 HD12 ' N ' ' A' ' 63' ' ' ILE . 2.4 mp -73.99 86.12 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.742 -0.836 . . . . 44.5 108.742 177.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.528 ' NH1' ' HA ' ' A' ' 13' ' ' ASP . 51.5 mtt180 -58.77 152.6 47.0 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 114.704 -1.135 . . . . 72.230000000000004 111.838 -173.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -41.61 -48.56 5.6 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 123.647 2.898 . . . . 62.119999999999997 114.187 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -75.94 -25.89 56.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.806 0.336 . . . . 64.540000000000006 111.306 -175.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -96.16 13.28 27.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.172 -0.467 . . . . 72.439999999999998 109.746 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.431 ' HA ' HG22 ' A' ' 63' ' ' ILE . 2.2 tm? -65.52 90.96 0.12 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.452 0.644 . . . . 74.140000000000001 109.333 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . 1.9 mmp_? -133.77 30.39 3.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.09 -0.959 . . . . 72.540000000000006 108.873 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 72' ' ' LEU . 14.7 m-20 55.42 49.31 17.12 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.089 -0.96 . . . . 72.120000000000005 110.341 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.468 ' NZ ' ' HA ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 60.31 -37.4 0.09 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.502 1.521 . . . . 71.420000000000002 113.513 -178.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.428 ' H ' ' C ' ' A' ' 70' ' ' ASP . 49.3 tp -61.54 -40.79 95.96 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 122.131 -0.356 . . . . 75.409999999999997 111.47 -163.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . . . -107.68 127.63 53.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.949 -0.568 . . . . 32.420000000000002 110.753 -177.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.8 t -176.09 103.64 0.07 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.985 -0.552 . . . . 74.239999999999995 109.935 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.754 ' HA2' ' HA3' ' A' ' 45' ' ' GLY . . . -142.61 -171.28 13.19 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 116.105 -0.498 . . . . 72.519999999999996 112.605 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.622 ' HB3' ' HB2' ' A' ' 46' ' ' GLU . 20.8 ttm-85 -143.36 132.95 23.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.735 0.302 . . . . 73.200000000000003 110.437 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -155.34 96.64 0.16 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 61.109999999999999 112.338 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -122.89 165.68 16.27 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.756 -0.461 . . . . 73.439999999999998 109.756 177.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -144.0 108.42 4.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.45 0.643 . . . . 74.109999999999999 109.575 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 . . . . . 0 C--O 1.251 1.168 0 CA-C-N 115.455 -0.793 . . . . 63.520000000000003 109.461 177.801 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 111.917 -0.473 . . . . 64.540000000000006 111.917 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.38 163.84 26.97 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.039 2.493 . . . . 72.439999999999998 112.414 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.91 91.97 1.43 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 111.409 -0.676 . . . . 52.530000000000001 111.409 175.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.0 m -51.99 121.95 7.58 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.537 0.569 . . . . 64.439999999999998 112.537 -176.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 23.9 mtp -69.93 -36.06 75.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.725 -0.671 . . . . 72.430000000000007 109.609 171.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.9 p -55.1 159.07 2.63 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 114.415 -1.266 . . . . 74.200000000000003 113.013 -174.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.5 mt -104.42 105.54 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 114.846 -1.07 . . . . 65.329999999999998 108.704 172.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.576 ' N ' ' HD2' ' A' ' 9' ' ' PRO . 81.1 m-20 -79.26 -40.53 1.5 Allowed Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 116.293 -0.412 . . . . 64.430000000000007 112.011 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 8' ' ' ASN . 52.1 Cg_endo -70.08 108.71 2.2 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.634 1.556 . . . . 71.439999999999998 112.375 175.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -85.47 -81.9 0.19 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.776 -0.453 . . . . 72.319999999999993 109.776 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -105.38 57.58 0.68 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.633 -1.247 . . . . 75.400000000000006 107.633 174.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.486 ' HA ' HD21 ' A' ' 29' ' ' LEU . 23.6 t70 -134.33 -108.71 0.22 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.798 -1.092 . . . . 73.540000000000006 110.911 -169.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -54.17 -31.78 53.67 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.274 0.63 . . . . 74.530000000000001 112.317 -177.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -93.13 15.07 16.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.089 -0.505 . . . . 73.329999999999998 111.682 -173.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.36 -176.11 40.4 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.101 -0.571 . . . . 55.210000000000001 112.177 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.684 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 49.4 m -62.17 157.94 18.07 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.731 0.265 . . . . 71.319999999999993 110.479 177.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.81 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 24.8 t80 -68.28 102.43 1.38 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 119.024 -1.07 . . . . 74.209999999999994 109.502 173.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 29' ' ' LEU . 54.2 p90 -150.39 131.51 14.42 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.004 -1.48 . . . . 74.439999999999998 107.004 169.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 43' ' ' VAL . 48.9 t -143.06 131.77 20.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.84 -0.344 . . . . 65.329999999999998 110.256 -169.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -120.91 123.57 42.82 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.263 -0.643 . . . . 71.329999999999998 109.263 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.3 m -112.19 125.97 69.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 121.444 0.64 . . . . 73.439999999999998 109.778 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.675 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 14.4 m120 -84.06 146.65 27.82 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.598 -0.728 . . . . 74.140000000000001 109.485 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -56.33 -23.35 36.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.029 0.443 . . . . 71.409999999999997 111.203 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -87.36 23.2 1.93 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.045 -0.525 . . . . 73.319999999999993 110.906 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 67.84 21.01 9.21 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.74 0.816 . . . . 73.299999999999997 112.391 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.675 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 15.6 mm-40 -83.43 117.96 23.41 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.011 -0.366 . . . . 54.009999999999998 110.011 175.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -92.92 116.82 29.39 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.364 -0.606 . . . . 74.109999999999999 109.364 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -152.9 -172.84 4.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.231 0.539 . . . . 70.430000000000007 110.758 -174.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.486 HD21 ' HA ' ' A' ' 12' ' ' ASP . 2.4 pp -125.72 -174.78 3.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.69 -0.686 . . . . 62.520000000000003 109.196 174.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.4 p-90 -145.3 128.78 8.49 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 110.122 -0.325 . . . . 73.310000000000002 110.122 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.52 130.62 41.04 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.457 2.104 . . . . 52.539999999999999 111.369 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.67 12.48 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.9 0.704 . . . . 64.129999999999995 112.9 -173.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -81.72 -27.37 33.94 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.712 0.292 . . . . 72.430000000000007 111.052 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.04 155.12 37.59 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.996 0.427 . . . . 42.140000000000001 111.17 -176.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -94.91 139.71 30.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.057 -0.52 . . . . 74.129999999999995 109.823 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.2 t -79.9 111.37 21.12 Favored Pre-proline 0 C--O 1.235 0.305 0 N-CA-C 110.006 -0.368 . . . . 74.219999999999999 110.006 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.11 133.44 57.71 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.666 2.244 . . . . 74.140000000000001 112.03 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.9 135.7 57.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.999 -0.546 . . . . 34.340000000000003 110.763 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.02 -24.83 11.31 Favored Glycine 0 C--O 1.235 0.201 0 C-N-CA 121.315 -0.469 . . . . 60.32 112.171 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -91.27 154.67 19.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.839 -0.8 . . . . 74.510000000000005 108.839 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -110.02 125.97 53.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.919 0.39 . . . . 63.219999999999999 110.141 -177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.1 p -91.87 122.99 43.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.98 0.419 . . . . 60.219999999999999 110.68 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 19' ' ' VAL . 58.4 t -72.94 -41.05 60.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.261 0.553 . . . . 73.329999999999998 109.561 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.425 ' HE1' ' HB2' ' A' ' 47' ' ' ALA . 49.2 t-80 -160.96 141.89 11.57 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.492 -0.777 . . . . 73.349999999999994 109.24 175.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.08 -170.68 47.25 Favored Glycine 0 N--CA 1.452 -0.297 0 O-C-N 123.598 0.561 . . . . 61.030000000000001 112.617 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.17 140.31 21.38 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.063 0.545 . . . . 74.340000000000003 110.583 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.425 ' HB2' ' HE1' ' A' ' 44' ' ' HIS . . . -143.57 -178.32 5.83 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.429 0.529 . . . . 73.409999999999997 112.429 -170.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -91.66 179.72 5.57 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.324 -0.853 . . . . 61.520000000000003 112.213 -173.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.534 ' O ' ' HB3' ' A' ' 52' ' ' CYS . 4.4 tmt_? -60.93 -40.82 94.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.428 -0.805 . . . . 74.329999999999998 111.734 -177.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.65 -36.05 81.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.144 0.497 . . . . 72.030000000000001 109.729 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 17' ' ' PHE . . . -68.31 -30.71 69.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.576 -0.738 . . . . 52.32 110.532 175.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 53.9 t -59.43 -47.59 84.88 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.356 -0.609 . . . . 61.32 109.356 170.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.503 HD11 ' NH1' ' A' ' 49' ' ' ARG . 85.5 mt -57.88 -32.76 68.02 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.6 -0.727 . . . . 74.319999999999993 110.689 177.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.54 -53.53 22.44 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.341 -0.39 . . . . 73.120000000000005 110.728 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.81 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 40.4 t80 -64.59 -43.83 92.59 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.991 0.367 . . . . 71.239999999999995 111.991 -173.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 52' ' ' CYS . 12.4 tt -64.11 -39.83 86.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.121 0.486 . . . . 72.140000000000001 110.978 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -73.52 -35.31 65.56 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.078 -0.51 . . . . 72.010000000000005 110.537 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -65.24 -38.72 91.24 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.285 -0.635 . . . . 74.420000000000002 109.285 171.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 54.3 54.86 8.88 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.711 -1.131 . . . . 71.519999999999996 110.584 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.471 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 1.7 t90 -53.24 -45.45 98.34 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.477 -0.783 . . . . 74.230000000000004 110.584 -178.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 60' ' ' TRP . 10.4 Cg_exo -72.24 102.52 1.38 Allowed 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.665 1.577 . . . . 74.040000000000006 110.637 170.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 64' ' ' ARG . 32.2 t70 -57.67 -54.03 51.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 74.439999999999998 110.399 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.731 HG13 ' H ' ' A' ' 64' ' ' ARG . 25.6 pt 42.39 -72.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.91 1.284 . . . . 44.5 113.637 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.731 ' H ' HG13 ' A' ' 63' ' ' ILE . 31.8 ttm-85 -160.95 92.22 1.53 Allowed Pre-proline 0 C--O 1.238 0.48 0 N-CA-C 109.688 -0.486 . . . . 72.230000000000004 109.688 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.22 85.47 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.841 2.361 . . . . 62.119999999999997 111.671 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -77.85 -5.62 51.51 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.998 -0.546 . . . . 64.540000000000006 111.016 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.3 m 62.28 -75.77 0.03 OUTLIER 'General case' 0 C--O 1.234 0.248 0 O-C-N 123.622 0.576 . . . . 72.439999999999998 109.572 -171.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.81 110.47 3.82 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.694 -0.854 . . . . 74.140000000000001 108.694 171.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.2 mtt180 -62.0 -35.61 79.04 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.937 -0.574 . . . . 72.540000000000006 110.385 -175.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -126.89 160.76 30.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.211 -0.663 . . . . 72.120000000000005 109.211 171.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -114.71 55.06 0.76 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.124 0.488 . . . . 71.420000000000002 110.085 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.6 tp -138.72 -36.24 0.56 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.102 -0.499 . . . . 75.409999999999997 110.723 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.34 92.93 0.82 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.154 0.502 . . . . 32.420000000000002 111.287 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.7 p -77.43 96.89 4.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.804 -0.635 . . . . 74.239999999999995 110.225 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -153.87 -173.71 23.26 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.107 -0.568 . . . . 72.519999999999996 112.049 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -70.0 83.13 0.5 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.72 0.295 . . . . 73.200000000000003 110.598 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.57 -55.73 4.9 Favored Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.512 -0.635 . . . . 61.109999999999999 111.512 177.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 64.9 t80 72.69 -38.23 0.41 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.714 0.806 . . . . 73.439999999999998 112.369 176.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -71.88 80.66 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 122.057 0.932 . . . . 74.109999999999999 110.836 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.166 -1.379 . . . . 63.520000000000003 109.72 174.191 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 111.998 -0.441 . . . . 64.540000000000006 111.998 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.56 -164.89 0.22 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.915 2.41 . . . . 72.439999999999998 112.117 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.87 -51.78 4.62 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.927 -0.654 . . . . 52.530000000000001 111.701 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.4 m -65.28 103.25 0.76 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.807 -0.442 . . . . 64.439999999999998 109.807 175.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.511 ' SD ' ' N ' ' A' ' 71' ' ' LYS . 39.3 tpp -54.2 -64.84 0.7 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.179 -0.464 . . . . 72.430000000000007 111.438 -176.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.6 m -157.51 115.75 3.16 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.828 -0.624 . . . . 74.200000000000003 109.722 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.53 88.05 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.11 0.481 . . . . 65.329999999999998 110.35 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -105.06 114.96 63.11 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.961 -0.563 . . . . 64.430000000000007 110.604 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.5 77.26 0.99 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.208 1.938 . . . . 71.439999999999998 110.483 171.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.505 ' HA ' HD12 ' A' ' 63' ' ' ILE . 42.6 p90 -75.46 158.1 33.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.371 -0.831 . . . . 72.319999999999993 110.753 -176.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 62' ' ' ASP . 27.0 t0 -99.95 152.41 20.21 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.208 -0.664 . . . . 75.400000000000006 109.208 174.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -90.73 45.58 1.27 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.485 0.66 . . . . 73.540000000000006 109.694 -174.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -79.59 -74.81 0.28 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.664 0.987 . . . . 74.530000000000001 113.664 -167.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.402 HD22 ' N ' ' A' ' 14' ' ' ASN . 0.9 OUTLIER -68.8 -30.37 68.93 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.045 0.387 . . . . 73.329999999999998 112.045 -167.747 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.612 ' HA2' ' CZ ' ' A' ' 17' ' ' PHE . . . 88.59 37.07 7.63 Favored Glycine 0 C--O 1.22 -0.763 0 C-N-CA 120.739 -0.743 . . . . 55.210000000000001 112.283 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.629 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 11.2 m -73.87 49.67 0.33 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.003 0.43 . . . . 71.319999999999993 110.606 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.687 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 3.4 p90 -162.82 143.25 9.52 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.278 1.214 . . . . 74.209999999999994 114.278 -162.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -151.15 130.5 12.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.333 -1.729 . . . . 74.439999999999998 106.333 148.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.6 HG22 ' CE1' ' A' ' 55' ' ' TYR . 17.3 t -151.87 122.25 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 112.373 0.509 . . . . 65.329999999999998 112.373 -168.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 42' ' ' VAL . 54.5 tp -96.42 144.83 26.19 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.621 -0.718 . . . . 71.329999999999998 109.785 174.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.68 126.1 64.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.278 0.561 . . . . 73.439999999999998 110.008 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.406 ' ND2' ' HZ3' ' A' ' 40' ' ' TRP . 1.1 m-20 -77.47 144.77 37.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.439 -0.8 . . . . 74.140000000000001 109.633 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -58.4 -17.85 23.59 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.802 0.811 . . . . 71.409999999999997 109.683 172.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.56 0.96 9.06 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.76 -1.109 . . . . 73.319999999999993 111.04 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 72.69 14.36 5.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.411 0.684 . . . . 73.299999999999997 111.035 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -90.05 161.31 15.89 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.546 -0.909 . . . . 54.009999999999998 108.546 172.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -152.33 140.85 20.71 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.186 0.448 . . . . 74.109999999999999 111.253 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -168.22 -166.27 0.69 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.552 -0.536 . . . . 70.430000000000007 109.552 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.809 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.1 pt? -94.44 161.65 14.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.691 0.281 . . . . 62.520000000000003 110.461 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -138.25 147.3 55.19 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.43 -0.35 . . . . 73.310000000000002 110.65 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.15 116.9 4.72 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.488 2.125 . . . . 52.539999999999999 111.543 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.0 -21.29 64.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.279 -0.418 . . . . 64.129999999999995 111.655 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -81.43 -20.16 40.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.855 0.359 . . . . 72.430000000000007 110.524 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.97 150.62 23.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.367 -0.379 . . . . 42.140000000000001 110.439 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -95.37 111.64 23.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.659 -0.497 . . . . 74.129999999999995 109.659 177.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.482 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.1 p -81.49 120.4 78.0 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.361 -0.381 . . . . 74.219999999999999 110.936 -176.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 5.9 Cg_exo -75.57 173.1 15.07 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.401 2.734 . . . . 74.140000000000001 113.107 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.42 152.35 44.12 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.957 -0.565 . . . . 34.340000000000003 110.911 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.54 -28.55 11.85 Favored Glycine 0 C--N 1.329 0.186 0 N-CA-C 110.935 -0.866 . . . . 60.32 110.935 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.406 ' HZ3' ' ND2' ' A' ' 22' ' ' ASN . 11.7 m95 -105.09 98.67 8.35 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.075 -1.083 . . . . 74.510000000000005 108.075 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -99.59 126.34 45.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.855 0.36 . . . . 63.219999999999999 111.3 -172.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 8.5 p -82.94 119.76 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.117 -0.492 . . . . 60.219999999999999 109.907 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.2 p -86.08 -26.87 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.527 0.679 . . . . 73.329999999999998 110.059 -175.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -131.96 107.18 8.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.218 -0.901 . . . . 73.349999999999994 108.652 174.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.55 173.26 5.72 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.19 -0.914 . . . . 61.030000000000001 114.453 -169.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.92 137.27 58.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.772 -0.714 . . . . 74.340000000000003 110.061 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.85 -177.97 6.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.678 0.275 . . . . 73.409999999999997 111.138 -174.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 7.7 m-20 -58.08 160.45 4.88 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.685 -0.689 . . . . 61.520000000000003 112.178 -175.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.514 ' O ' ' SG ' ' A' ' 52' ' ' CYS . 6.6 ttm180 -53.87 -44.18 70.2 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.477 -0.783 . . . . 74.329999999999998 110.004 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.69 -33.79 74.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.099 0.476 . . . . 72.030000000000001 110.539 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 15' ' ' GLY . . . -66.52 -42.22 87.6 Favored 'General case' 0 C--O 1.251 1.158 0 CA-C-N 115.751 -0.659 . . . . 52.32 111.059 -178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 49' ' ' ARG . 30.0 p -73.54 -35.79 65.57 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.66 -1.154 . . . . 61.32 111.233 174.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 60.0 mt -65.12 -34.75 79.15 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.363 -0.381 . . . . 74.319999999999993 110.222 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 16' ' ' SER . 0.4 OUTLIER -77.19 -37.24 54.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.239 -0.437 . . . . 73.120000000000005 110.504 173.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.687 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 23.2 t80 -46.35 -45.24 17.53 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.324 0.49 . . . . 71.239999999999995 112.324 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 53' ' ' LEU . 11.5 tt -63.48 -39.35 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 120.491 -0.484 . . . . 72.140000000000001 111.326 -176.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -73.78 -43.21 59.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.625 0.25 . . . . 72.010000000000005 110.973 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 59' ' ' HIS . 69.5 mm-40 -77.7 -41.12 39.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 111.758 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 95.2 m-70 83.06 -11.27 0.96 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.428 1.091 . . . . 71.519999999999996 113.076 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.479 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 43.1 t-105 -175.45 -55.39 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.06 0.393 . . . . 74.230000000000004 112.06 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 60' ' ' TRP . 74.0 Cg_endo -74.08 179.67 5.53 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 122.206 1.937 . . . . 74.040000000000006 112.657 -174.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 11' ' ' ASP . 27.2 t70 -114.05 -46.61 3.0 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.942 -0.572 . . . . 74.439999999999998 110.988 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 10' ' ' PHE . 53.7 mt -61.09 114.59 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 109.44 -0.578 . . . . 44.5 109.44 177.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.433 ' H ' ' CD ' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -92.87 113.72 60.54 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.717 -0.674 . . . . 72.230000000000004 111.371 -166.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 63' ' ' ILE . 15.8 Cg_exo -68.83 -27.43 31.14 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.108 1.872 . . . . 62.119999999999997 109.254 166.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.8 tptp 60.1 14.38 4.42 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 114.554 -1.203 . . . . 64.540000000000006 111.261 175.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.8 p -149.89 162.98 39.26 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.253 -0.43 . . . . 72.439999999999998 110.193 -177.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.9 tp -67.31 93.44 0.32 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.367 -0.379 . . . . 74.140000000000001 111.619 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -95.49 104.36 16.26 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.486 -0.931 . . . . 72.540000000000006 108.486 170.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -114.97 145.08 42.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.1 0.476 . . . . 72.120000000000005 111.138 -175.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.605 ' HA ' ' HE3' ' A' ' 71' ' ' LYS . 1.5 tpmt? -118.47 9.41 12.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.227 -0.897 . . . . 71.420000000000002 109.174 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.564 ' HG ' HG23 ' A' ' 74' ' ' THR . 42.8 tp -134.95 75.53 1.58 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.492 -0.776 . . . . 75.409999999999997 109.916 -170.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.35 80.87 7.66 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.457 -0.792 . . . . 32.420000000000002 109.917 174.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.564 HG23 ' HG ' ' A' ' 72' ' ' LEU . 22.7 p -67.52 -31.0 70.81 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.044 -0.525 . . . . 74.239999999999995 111.133 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.25 -144.23 34.26 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.927 -0.579 . . . . 72.519999999999996 112.11 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 40.4 ttt85 -139.59 25.15 2.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.428 0.632 . . . . 73.200000000000003 110.001 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.76 63.19 1.28 Allowed Glycine 0 CA--C 1.516 0.134 0 CA-C-N 115.796 -0.638 . . . . 61.109999999999999 111.775 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -90.61 147.68 23.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.625 0.25 . . . . 73.439999999999998 110.799 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.82 -53.58 14.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.906 -0.588 . . . . 74.109999999999999 110.35 177.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 C--O 1.252 1.235 0 CA-C-O 118.259 -0.877 . . . . 63.520000000000003 108.838 -178.428 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.807 0 N-CA-C 111.719 -0.552 . . . . 64.540000000000006 111.719 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.03 132.3 6.2 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.496 2.131 . . . . 72.439999999999998 112.848 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.95 56.57 3.32 Favored Glycine 0 CA--C 1.511 -0.182 0 N-CA-C 110.144 -1.182 . . . . 52.530000000000001 110.144 171.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.2 p -80.78 117.79 21.75 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.717 0.636 . . . . 64.439999999999998 112.717 -169.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.2 ttm -81.88 -55.25 4.72 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.898 -1.149 . . . . 72.430000000000007 107.898 167.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 p -162.74 111.97 1.38 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.105 -1.407 . . . . 74.200000000000003 109.214 174.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.2 mt -80.85 -64.66 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.537 -0.301 . . . . 65.329999999999998 110.323 -176.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.48 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 3.6 t-20 179.27 -47.82 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 115.579 -0.737 . . . . 64.430000000000007 110.337 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 8' ' ' ASN . 96.0 Cg_endo -83.26 176.28 7.51 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.916 1.744 . . . . 71.439999999999998 111.41 172.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 68.17 91.23 0.09 Allowed 'General case' 0 C--O 1.24 0.561 0 O-C-N 123.58 0.55 . . . . 72.319999999999993 110.493 -177.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 174.41 161.66 0.19 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.859 -1.064 . . . . 75.400000000000006 109.497 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -170.19 148.32 3.3 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.195 -0.457 . . . . 73.540000000000006 110.41 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.91 -60.16 3.74 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.884 -0.598 . . . . 74.530000000000001 111.661 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -82.54 -21.74 35.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.371 0.605 . . . . 73.329999999999998 110.073 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.49 73.3 1.28 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.202 -1.159 . . . . 55.210000000000001 110.202 -173.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.562 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 58.0 m -58.15 105.86 0.32 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 122.267 1.032 . . . . 71.319999999999993 110.617 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.736 ' HA ' ' HB2' ' A' ' 55' ' ' TYR . 38.4 m-85 -166.8 100.94 0.56 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 112.902 -1.954 . . . . 74.209999999999994 107.93 -162.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.63 ' CE2' ' HB1' ' A' ' 51' ' ' ALA . 98.1 m-85 -151.83 130.54 12.35 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 121.843 2.11 . . . . 74.439999999999998 109.871 172.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -164.22 143.29 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.931 0 N-CA-C 112.559 0.577 . . . . 65.329999999999998 112.559 -174.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.8 tp -102.3 123.6 46.4 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.575 -0.898 . . . . 71.329999999999998 108.575 165.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.4 t -113.58 125.83 70.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 73.439999999999998 110.15 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 40' ' ' TRP . 3.8 m-20 -97.53 158.34 15.54 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.419 -0.355 . . . . 74.140000000000001 110.435 -178.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.25 -20.54 59.37 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.705 0.764 . . . . 71.409999999999997 109.816 173.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -76.49 9.56 2.63 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.8 -1.091 . . . . 73.319999999999993 111.143 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 67.86 15.37 9.58 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.304 0.642 . . . . 73.299999999999997 111.09 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.411 ' HB2' ' HB2' ' A' ' 22' ' ' ASN . 80.6 mm-40 -78.06 146.42 35.28 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.789 -0.819 . . . . 54.009999999999998 108.789 173.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -153.48 102.54 2.58 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 110.022 -0.362 . . . . 74.109999999999999 110.022 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.3 t -170.86 -170.1 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.823 -0.626 . . . . 70.430000000000007 110.096 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.452 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.4 mp -80.65 166.26 21.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.771 -0.65 . . . . 62.520000000000003 110.67 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.504 ' CZ3' ' HA ' ' A' ' 32' ' ' ALA . 17.3 p-90 -143.36 155.29 61.13 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.521 -0.309 . . . . 73.310000000000002 111.11 -175.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.6 95.72 0.41 Allowed 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.5 2.133 . . . . 52.539999999999999 111.585 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HA ' ' CZ3' ' A' ' 30' ' ' TRP . . . -67.42 -18.31 65.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.657 -0.701 . . . . 64.129999999999995 112.004 -175.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -81.58 -20.84 39.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 72.430000000000007 110.709 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.13 176.38 6.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 42.140000000000001 110.837 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.46 138.57 37.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.944 -0.571 . . . . 74.129999999999995 109.873 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.617 HG22 ' NE1' ' A' ' 40' ' ' TRP . 7.4 p -104.46 129.77 24.45 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 109.968 -0.382 . . . . 74.219999999999999 109.968 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.511 ' O ' ' NE1' ' A' ' 40' ' ' TRP . 77.7 Cg_endo -76.4 -169.43 0.7 Allowed 'Trans proline' 0 N--CA 1.481 0.778 0 C-N-CA 123.125 2.55 . . . . 74.140000000000001 114.299 -171.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.95 152.43 24.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.92 -0.582 . . . . 34.340000000000003 111.14 171.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.0 27.18 7.51 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.741 -0.743 . . . . 60.32 114.42 168.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.617 ' NE1' HG22 ' A' ' 36' ' ' VAL . 48.2 p-90 -130.36 174.63 9.67 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.337 0.589 . . . . 74.510000000000005 111.213 176.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -154.66 125.92 7.32 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.964 -1.124 . . . . 63.219999999999999 107.964 174.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.87 131.93 36.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.735 -0.469 . . . . 60.219999999999999 109.735 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.3 t -91.29 -23.99 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.655 0.74 . . . . 73.329999999999998 109.56 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.443 ' HB3' ' CD1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -171.06 131.24 0.79 Allowed 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.605 -1.18 . . . . 73.349999999999994 107.928 174.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 18' ' ' PHE . . . -73.41 139.91 27.44 Favored Glycine 0 C--N 1.338 0.642 0 O-C-N 124.333 1.021 . . . . 61.030000000000001 114.089 -167.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -25.89 124.63 0.06 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.015 1.326 . . . . 74.340000000000003 114.539 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.492 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . . . -131.65 -176.98 4.22 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.015 -0.993 . . . . 73.409999999999997 109.419 175.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -52.57 153.01 3.29 Favored 'General case' 0 C--O 1.249 1.054 0 CA-C-O 121.267 0.556 . . . . 61.520000000000003 110.98 176.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.45 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 14.0 ttp180 -54.26 -31.28 53.18 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 115.293 -0.867 . . . . 74.329999999999998 110.248 -176.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.89 -45.05 83.42 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.09 0.471 . . . . 72.030000000000001 111.012 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.63 ' HB1' ' CE2' ' A' ' 18' ' ' PHE . . . -63.21 -40.18 96.73 Favored 'General case' 0 C--O 1.274 2.359 0 CA-C-O 121.683 0.754 . . . . 52.32 111.483 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.595 ' O ' ' HB3' ' A' ' 55' ' ' TYR . 64.9 m -73.46 -37.99 65.61 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 113.57 -1.65 . . . . 61.32 112.309 175.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 49' ' ' ARG . 25.9 mt -70.11 -44.3 69.28 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.823 -0.436 . . . . 74.319999999999993 109.823 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 16' ' ' SER . 0.8 OUTLIER -68.72 -25.98 65.03 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 118.911 -0.566 . . . . 73.120000000000005 110.353 175.353 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.736 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -45.39 -61.5 1.65 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 118.141 -1.424 . . . . 71.239999999999995 111.352 162.584 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 tt -68.59 -35.76 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.754 0.311 . . . . 72.140000000000001 111.302 -176.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 54' ' ' GLU . 8.3 tp10 -62.53 -43.26 99.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.181 0.515 . . . . 72.010000000000005 110.244 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -66.97 -40.24 87.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.144 -0.935 . . . . 74.420000000000002 110.57 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.7 t60 70.86 11.18 7.1 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.621 -0.718 . . . . 71.519999999999996 111.2 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 16.8 m0 67.43 114.69 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.512 0 C-N-CA 123.249 0.62 . . . . 74.230000000000004 112.018 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.18 134.79 25.74 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.09 1.86 . . . . 74.040000000000006 109.997 167.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -71.8 16.09 0.13 Allowed 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.437 0.532 . . . . 74.439999999999998 112.437 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.537 HD13 ' HA ' ' A' ' 70' ' ' ASP . 40.6 mt -75.36 -89.91 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.368 -0.975 . . . . 44.5 108.368 170.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 63' ' ' ILE . 29.8 mmm180 -147.19 145.71 22.95 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 106.262 -1.755 . . . . 72.230000000000004 106.262 169.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.506 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 25.2 Cg_exo -64.42 70.22 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.761 2.308 . . . . 62.119999999999997 113.808 -175.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 56.8 tttp 169.38 116.63 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.962 0.905 . . . . 64.540000000000006 109.128 176.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.9 t -76.64 93.63 3.65 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.964 0.411 . . . . 72.439999999999998 110.644 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -154.66 16.03 0.44 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.775 -0.648 . . . . 74.140000000000001 109.325 176.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 17.6 ptp180 -173.51 167.82 4.57 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.748 -0.66 . . . . 72.540000000000006 109.612 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.537 ' HA ' HD13 ' A' ' 63' ' ' ILE . 4.2 p30 -122.31 -173.52 2.69 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.108 0.48 . . . . 72.120000000000005 112.204 -171.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HE3' HG12 ' A' ' 63' ' ' ILE . 29.7 mmtp -66.35 -28.43 68.65 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.558 -0.747 . . . . 71.420000000000002 112.286 -175.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 54.9 tp -84.28 -40.12 18.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.253 0.549 . . . . 75.409999999999997 109.588 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 69' ' ' ARG . . . -96.72 76.24 2.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.583 -0.735 . . . . 32.420000000000002 110.607 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.7 p -77.71 -55.41 5.37 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.788 -0.449 . . . . 74.239999999999995 109.788 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 48.67 63.67 3.67 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.416 -0.811 . . . . 72.519999999999996 113.256 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 84.7 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.196 0.522 . . . . 73.200000000000003 109.703 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.2 -151.96 22.09 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.667 -0.697 . . . . 61.109999999999999 111.387 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -138.87 143.73 38.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.102 0.477 . . . . 73.439999999999998 111.066 -177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -94.21 -28.78 15.45 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.361 -0.836 . . . . 74.109999999999999 109.223 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.226 0 CA-C-N 114.918 -1.037 . . . . 63.520000000000003 109.363 177.53 . . . . . . . . 1 1 . 1 stop_ save_